Relation Extraction Examples (3845)

check_circle_outline   F1 = 100.000
check_circle_outline   F1 >= 50.00
highlight_off   F1 < 50.00
  True Positive  
  False Positive  
  False Negative

Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIsotretinoin Entityteratogenicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNiacin Entitymaculopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAllopurinol Entityhypersensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTamoxifen Entityretinopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetronidazole Entityneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCyclophosphamide Entitypneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGold Entitynephropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOcular ethambutol toxicity Entityethambutol toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClozapine induced Entitypolyserositis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySulfadiazine Entitycrystalluria revisited.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityPulmonary gold toxicity Entitygold toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylaxis to Entitycalcitonin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDermatitis to Entitycaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Entitydapsone Entityhypersensitivity syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnisocoria from transdermal Entityscopolamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPriapism associated with Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylaxis to intrathecal Entitydiamorphine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDiclofenac - associated Entityhepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCarbamazepine - induced Entityhyperammonemia .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityImidazoline EntityImidazoline intoxication in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGold - induced Entitypneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCarbamazepine - induced Entitytics .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPriapism associated with Entityzuclopenthixol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDelayed hypersensitivity to Entityflurbiprofen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMorphea after Entitybromocriptine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmpicillin - associated Entityseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAtenolol - induced Entitypseudolymphoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLosartan - induced Entityangioedema .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDisulfiram - induced Entityhepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetoclopramide - induced Entityparkinsonism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPhenylpropanolamine - induced Entitypsychosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClofazimine induced Entitynail changes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCiprofloxacin - induced Entitypsychosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityJaundice induced by Entitystreptokinase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAgranulocytosis during Entityclozapine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHeparin - induced Entityhyperkalemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityStupor from Entitylamotrigine toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCimetidine - induced Entityfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVancomycin - induced Entityvasculitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGigantomastia induced by Entitybucillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIsoniazid - induced Entityanaphylaxis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVincristine induced Entitycranial polyneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBromocriptine - induced Entityschizophrenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatic reactions to Entitycyclofenil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityQuetiapine - induced Entitymyoclonus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEnalaprilat induced Entityacute parotitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTemsirolimus - induced Entityglomerulopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRhabdomyolysis following Entityclarithromycin monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTaxane - induced Entityglaucoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFurosemide - associated Entityfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThalidomide Entityneuropathy in childhood.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatitis following Entitycimetidine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLansoprazole - induced Entitythrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityColchicine - induced Entityrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityKeratitis in Entitymethamphetamine abusers.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLocalized purpura associated with Entitylamotrigine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCiprofloxacin - induced Entityhemorrhagic vasculitis .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityCodeine EntityCodeine intoxication in the neonate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRosaceiform eruption induced by Entityerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethyldopa - induced Entityliver injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcetazolamide - accelerated anticonvulsant Entityosteomalacia .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityCephalexin EntityCephalexin rash in infectious mononucleosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityScleritis complicating Entityzoledronic acid infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySeizures associated with Entityfluoxetine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary fibrosis associated with Entitynabumetone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetabolic acidosis induced by Entityacetazolamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Probable Entityenoxaparin - induced Entityhepatotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary toxicity associated with Entityerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFixed drug eruption to Entityrofecoxib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEnoxaparin - induced Entitygeneralized exanthem .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Biomicroscopy revealed Entityamiodarone Entitycorneal deposits .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAlbendazole - induced Entitypseudomembranous colitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCatatonia associated with Entitydisulfiram therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropylthiouracil - induced Entitycutaneous vasculitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNodular scleritis following Entityalendronate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute dystonia induced by Entitylamivudine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Occult Entityquinine - induced Entitythrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProtamine - induced Entityfatal anaphylaxis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityChlorpropamide - induced Entityhemolytic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityParaplegia following intrathecal Entitycytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySarcoma complicating therapy with Entitycyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityQuinine - induced Entityhearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGold - induced Entityaplastic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTardive dyskinesia induced by Entitysulpiride .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous Entitydiazepam exacerbated the Entityseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEzetimibe - induced Entityacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCefuroxime - induced Entityimmune hemolysis .
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect EntityLamotrigine toxicity secondary to Entitysertraline .
0.9992 Adverse-Effect EntityLamotrigine EntityLamotrigine toxicity secondary to sertraline.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAzathioprine can cause severe Entitymyelosuppression .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute leukaemia during Entitytamoxifen therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVortex keratopathy associated with Entityatovaquone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Paradoxical Entityseizures in Entityphenytoin toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatic damage after Entitydanazol treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInsulin - induced Entitycardiac failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNail staining from Entityhydroquinone cream.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDelusional parasitosis associated with Entityphenelzine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPiritrexim - induced Entitypulmonary toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropecia - associated Entitybilateral cataract .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTerlipressin - induced Entityventricular arrhythmia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAsterixis induced by Entitycarbamazepine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCardiorespiratory toxicity due to Entitymiconazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNabumetone - associated Entityinterstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHuman insulin - induced Entitylipoatrophy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySulfasalazine - induced Entitylupus erythematosus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLichenoid drug eruption to Entitysalsalate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Uncontrolled Entityheadache induced by Entityoxcarbazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous Entityazithromycin - induced Entityototoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFulminant hepatitis associated with Entitydisulfiram .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary toxicity secondary to Entityprocarbazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMesalamine - induced Entityhypersensitivity pneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPsychotic disorder associated with Entityisoniazid .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityMagnesium EntityMagnesium toxicosis in two horses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySeizures associated with Entityofloxacin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPemphigus foliaceus induced by Entityrifampicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylactic reaction to Entitybacitracin ointment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRifampicin - induced Entityrenal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intranasal Entitydesmopressin - induced Entityhyponatremia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityChloroquine - induced Entitybilateral ptosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDisopyramide - induced Entityheart block .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCarbamazepine - induced EntityDiabetes mellitus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEtoposide - related Entitymyocardial infarction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMyoclonic spasms following intrathecal Entitymorphine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate - induced Entityliver cirrhosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCefoxitin - associated Entityrenal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute psychosis associated with Entitylevetiracetam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetastatic osteomyelitis following EntityBCG vaccination.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAtrial fibrillation after Entityvardenafil therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVisual hallucinations associated with Entityzonisamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGliclazide - induced Entityacute hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRisperidone - induced Entitytardive dyskinesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAllergic contact dermatitis from Entity4 - chloro - 7 - nitrobenzofurazan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNitrendipine - induced Entitygingival hyperplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAdenosine - induced Entityventricular fibrillation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEdema associated with Entityibuprofen therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTegaserod - associated Entityischemic colitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProgressive hypokalemia developed during Entityphosphate treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProgressive pulmonary fibrosis complicating Entitycyclophosphamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCardiopulmonary arrest following intravenous Entityphenytoin loading.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityQuetiapine - induced Entityleucopenia and thrombocytopenia.
0.9999 Adverse-Effect EntityQuetiapine - induced leucopenia and Entitythrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entityparadoxical ocular effect of Entitybrimonidine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Entityvancomycin - induced Entityanaphylactic reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFulminant hepatic failure associated with Entitybicalutamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTuberculous uveitis after treatment with Entityetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCardiac arrest following use of Entitysumatriptan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early Entityritonavir - induced Entitymaculopapular eruption .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCarbamazepine - induced Entitysystemic lupus erythematosus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySalicylate - induced Entityhepatotoxicity is reviewed.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect An unusual case of EntityEcstasy EntityEcstasy poisoning .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOculomotor disturbances associated with Entity5 - fluorouracil chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Does Entityacyclovir Entityincrease serum lithium levels ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Exacerbation of Entityschizophrenia associated with Entityamantadine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Diagnosis : Entitypractolol induced Entitysclerosing peritonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityErythema multiforme bullosum due to Entityrifampicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Suspected Entityciprofloxacin - induced Entityinterstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Widespread Entitycutaneous vasculitis associated with Entitydiltiazem .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute interstitial nephritis due to Entitypantoprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAllergic contact angioedema to Entitybenzoyl peroxide .
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect EntityDapsone EntityDapsone syndrome in cutaneous lupus erythematosus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNonconvulsive status epilepticus due to Entityifosfamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPersisent ocular hypertension following intravitreal Entityranibizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTrichiasis associated with Entityprostaglandin analog use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPersistent light reactivity from systemic Entityquinine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterstitial granulomatous dermatitis associated with Entitydarifenacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIfosfamide - induced Entitynonconvulsive status epilepticus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNephrotic syndrome associated with Entitylithium therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Aminophylline Entityhypersensitivity apparently due to Entityethylenediamine .
0.9999 Adverse-Effect EntityAminophylline Entityhypersensitivity apparently due to ethylenediamine.
Adverse-Effect EntityAminophylline hypersensitivity apparently due to Entityethylenediamine .
Adverse-Effect EntityAminophylline EntityAminophylline hypersensitivity apparently due to ethylenediamine.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect The 3 - week Entitysulphasalazine Entitysulphasalazine syndrome strikes again.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDoxycycline - induced Entityphoto - onycholysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBleomycin Entitypneumonitis potentiated by oxygen administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute Entityvalproate ingestion induces Entitysymptomatic methemoglobinemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate induced Entitysprue - like syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPolymyositis after Entitypropylthiouracil treatment for hyperthyroidism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAtrial fibrillation following Entitymethylprednisolone pulse therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOesophageal ulceration due to Entityemepronium bromide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTroglitazone - induced Entityfulminant hepatic failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityToxic epidermal necrolysis associated with Entityinterleukin - 2 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCaptopril - associated " Entitypseudocholangitis '.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFulminant liver failure associated with Entityclarithromycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCefuroxime - induced Entityacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNail - changes induced by Entitypenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPsoriasis induced by Entityinterferon - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGentamicin - associated Entityacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRadiation recall pneumonitis induced by Entitygemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Can Entitymagnesium sulfate therapy impact Entitylactogenesis ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySalicylate Entityhepato toxicity in rheumatic fever.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPemphigus vulgaris precipitated by Entityglibenclamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFlurbiprofen - associated Entityacute tubulointerstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fluorouracil for Entityallergic reactions to Entitycapecitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Chronic Entityfentanyl application induces Entityadrenocortical insufficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Agranulocytosis and Entitygranulocytopenia associated with Entityquetiapine .
0.9999 Adverse-Effect EntityAgranulocytosis and granulocytopenia associated with Entityquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of Entitylithium Entitytremor with metoprolol.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBarbiturate - induced Entitysubmassive hepatic necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityUlcerating enteritis associated with Entityflucytosine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityExfoliative dermatitis secondary to Entitytobramycin sulfate .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Protease inhibitor - induced Entitycarbamazepine Entitycarbamazepine toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere hepatitis caused by Entitycyproterone acetate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGabapentin withdrawal presenting as Entitystatus epilepticus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySuxamethonium Entityapnoea terminated with commercial serumcholinesterase.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTransient hemiparesis caused by Entityphenytoin toxicity.
Score Relation Text (Head - Tail)
Adverse-Effect Systemic corticosteroids in the Entityphenytoin Entityphenytoin hypersensitivity syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeurotoxicity of intrathecal administration of Entityamphotericin B .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySustained monomorphic ventricular tachycardia after Entityadenosine infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere hepatocellular dysfunction following Entitycyproterone acetate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBleomycin induced Entityhyperpigmentation with yolk sac tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Atypical Entityneuroleptic malignant syndrome associated with Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFocal renal cortical necrosis associated with Entityzomepirac .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCapecitabine - induced Entityheadache responding to diltiazem.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute coronary syndrome induced by Entitycapecitabine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute Entityisoniazid Entityneurotoxicity in an urban hospital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInappropriate antidiuretic hormone following Entityadenine arabinoside administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Skin rash and Entitysplinter hemorrhages from Entityganciclovir .
0.9998 Adverse-Effect EntitySkin rash and splinter hemorrhages from Entityganciclovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPriapism as a complication of Entityheparin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThrombocytosis under Entityciprofloxacin and tazobactam / piperacillin.
0.9999 Adverse-Effect EntityThrombocytosis under ciprofloxacin and Entitytazobactam / piperacillin.
0.9999 Adverse-Effect EntityThrombocytosis under ciprofloxacin and tazobactam / Entitypiperacillin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNonoliguric acute renal failure after Entitycaptopril therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCaptopril - induced Entityacute reversible renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGastro - oesophageal reflux associated with Entitynifedipine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIsoniazid associated, painful, Entitybilateral gynaecomastia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPiloerection induced by replacing Entityfluvoxamine with milnacipran.
0.9999 Adverse-Effect EntityPiloerection induced by replacing fluvoxamine with Entitymilnacipran .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Allergic and Entityirritant contact dermatitis to Entitycalcipotriol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case studies in Entityheparin - induced Entitythrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitybleeding resolved on discontinuation of EntityAPV .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DIAGNOSIS : EntityInterferon alpha - 2b - induced Entitycardiomyopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case study : Entityadverse response to Entityclonidine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySyncope induced by Entitypropranolol in hypertrophic cardiomyopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prolonged Entitysevere cholestasis induced by Entityoxacillin derivatives.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLithium - induced EntityCreutzfeldt - Jakob syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEctropion secondary to bolus injection of Entity5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCarbamazepine - related Entityhyponatremia following cardiopulmonary bypass.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinical and morphological features of Entitygold Entityneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySporadic rippling muscle disease unmasked by Entitysimvastatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRefractory hypoglycemia from Entityciprofloxacin and glyburide interaction.
0.9999 Adverse-Effect EntityRefractory hypoglycemia from ciprofloxacin and Entityglyburide interaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients had Entityampicillin - associated Entityseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAngioimmunoblastic lymphadenopathy with dysproteinemia following Entitydoxycycline administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethadone - induced Entitymyoclonus in advanced cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityParadoxical cerebral cortical hyperexcitability following Entityflupirtine overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTorsade de pointes during loading with Entityamiodarone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Entityabdominal pain in low dosage Entityclofazimine .
1.0000 Adverse-Effect EntitySevere abdominal pain in low dosage Entityclofazimine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIschaemic colitis in a patient taking Entitymeloxicam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Probable Entitypropafenone - induced Entitytransient global amnesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute myocardial necrosis during administration of Entityamsacrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGeneralized argyria after habitual use of EntityAgNO3 .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityCorneal endothelial dysfunction associated with Entityamantadine toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible Entitynonthrombocytopenic palpable purpura associated with Entitymetoclopramide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Methylphenidate and Entitydextroamphetamine - induced Entityperipheral vasculopathy .
0.9998 Adverse-Effect EntityMethylphenidate and dextroamphetamine - induced Entityperipheral vasculopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPure red cell aplasia associated with Entityfenoprofen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCicatricial entropion associated with chronic Entitydipivefrin application.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLeflunomide - associated Entityinfections in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A possible case of Entitycarbamazepine induced Entitypancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Lichen planus and Entityacne provoked by Entitygold .
0.9999 Adverse-Effect EntityLichen planus and acne provoked by Entitygold .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCutaneous mycobacterial infection post intravesical EntityBCG installation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An Entityamiodarone Entityoptic neuropathy has been described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Regression of Entitythyrotoxic ophthalmopathy following Entitylithium withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute leukopenia associated with Entitysilver sulfadiazine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTrimethoprim - sulfamethoxazole - induced Entityaseptic meningitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unique Entitybehavioral change with Entitycinepazide in parkinsonism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIsoniazid induced Entitygynaecomastia : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapidly developing Entityhyperglycemia during treatment with Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The disease predisposes to severe Entityvincristine Entityneurotoxicity .
Adverse-Effect The disease predisposes to severe Entityvincristine Entityvincristine neurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intrahepatic cholestasis and Entitysicca complex after Entitythiabendazole .
0.9999 Adverse-Effect EntityIntrahepatic cholestasis and sicca complex after Entitythiabendazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNaproxen - associated Entitysudden sensorineural hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Neonatal Entitymydriasis : intravenous Entitylidocaine adverse reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLinear IgA bullous dermatosis occurring after Entitycarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBilateral anterior uveitis associated with Entityclomiphene citrate .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityEthambutol toxicity manifesting as Entityacute onset psychosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entitydrug interaction between Entityzafirlukast and theophylline.
0.9998 Adverse-Effect A Entitydrug interaction between zafirlukast and Entitytheophylline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRecurrent hyponatremia associated with Entitycitalopram and mirtazapine.
0.9999 Adverse-Effect EntityRecurrent hyponatremia associated with citalopram and Entitymirtazapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySeizures associated with Entityfluoxetine therapy are uncommon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySpontaneous splenic infarction associated with Entitysumatriptan use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNicotinic acid - induced Entityfulminant hepatic failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTriazolam - induced Entitynocturnal bingeing with amnesia.
1.0000 Adverse-Effect EntityTriazolam - induced nocturnal bingeing with Entityamnesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Asthma and Entityurticaria during Entitydisodium cromoglycate treatment.
0.9997 Adverse-Effect EntityAsthma and urticaria during Entitydisodium cromoglycate treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCerebral and ocular toxicity induced by Entitydesferrioxamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute drug induced Entityhepatitis due to Entityerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPanic anxiety after abrupt discontinuation of Entitymianserin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient on Entityouabain also developed Entitycardiomyopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySotalol - induced Entitybradycardia reversed by glucagon.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityPilocarpine EntityPilocarpine toxicity and the treatment of xerostomia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Probable early Entityacute hepatitis with parenteral Entityamiodarone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute respiratory distress syndrome after Entityrituximab infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBromide intoxication secondary to Entitypyridostigmine bromide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute generalized exanthematous pustulosis induced by Entitynimesulide .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect EntityPhenytoin EntityPhenytoin toxicity due to concomitant antituberculosis therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unusual Entitypigmentary changes associated with Entity5 - fluorouracil therapy.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityJuvenile absence epilepsy exacerbated by Entityvalproic acid .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterstitial pneumopathy and low - dosage Entityamiodarone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLevofloxacin - induced Entitydelirium with psychotic features .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMultifocal inflammatory leukoencephalopathy associated with Entitylevamisole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProthipendylhydrochloride - induced Entitypriapism : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPravastatin is associated with Entitymyotonia in animals.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHemodynamic collapse following Entitylabetalol administration in preeclampsia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Entityserotonin syndrome induced by Entitymirtazapine monotherapy.
1.0000 Adverse-Effect EntitySevere serotonin syndrome induced by Entitymirtazapine monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGemcitabine - induced Entityrectus abdominus radiation recall .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Entityhyponatremia caused by Entityvinblastine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Long lasting Entityrespiratory depression induced by Entitymorphine - 6 - glucuronide ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGlaucoma secondary to epithelial downgrowth and Entity5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Entityfever due to Entitydiltiazem .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitymania associated with Entityfluoxetine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityColchicine - induced Entitymyopathy in renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Entityhyperkalemia induced by Entityarginine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDepressive symptoms disappeared after Entityinterferon therapy was stopped.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEruptive epidermoid cysts resulting from treatment with Entityimiquimod .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDeepening of lid sulcus from topical Entitybimatoprost therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We diagnosed this case as Entitydanazol induced Entitythrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAliskiren - associated Entityacute renal failure with hyperkalemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCiprofloxacin - induced Entityrenal insufficiency in cystic fibrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fixed drug Entityeruption in hands caused by Entityomeprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReversible cardiomyopathy caused by administration of Entityinterferon alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAlprazolam - induced Entitymania : two clinical cases.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityFulminant hepatitis and lymphocyte sensitization due to Entitypropylthiouracil .
1.0000 Adverse-Effect Fulminant hepatitis and Entitylymphocyte sensitization due to Entitypropylthiouracil .
Score Relation Text (Head - Tail)
0.9989 Adverse-Effect EntityTheophylline intoxication following Entityviloxazine induced decrease in clearance.
0.9959 Adverse-Effect EntityTheophylline EntityTheophylline intoxication following viloxazine induced decrease in clearance.
Adverse-Effect Theophylline intoxication following Entityviloxazine induced Entitydecrease in clearance .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMycophenolate mofetil - induced Entityneutropenia in liver transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAllergic contact dermatitis to compound tincture of Entitybenzoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pulmonary infiltrates and Entityskin pigmentation associated with Entitysulfasalazine .
1.0000 Adverse-Effect EntityPulmonary infiltrates and skin pigmentation associated with Entitysulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySpindle coma in Entitybenzodiazepine toxicity : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTiclopidine - induced Entitymarrow aplasia treated with cyclosporine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPriapism associated with Entitytrazodone therapy : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect MR findings in Entitymethotrexate - induced EntityCNS abnormalities .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible findings of restricted diffusion in Entity5 - fluorouracil Entityneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : EntityBudesonide use can cause Entitycontact dermatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRestless legs syndrome due to Entityinterferon - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entitylethal complication of peripheral vein Entityvasopressin infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Allergic reaction to Entitygemfibrozil manifesting as Entityeosinophilic gastroenteritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProgressive interstitial lung disease from prolonged Entitymethotrexate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Angioedema and Entitymaculopapular eruptions associated with Entitycarbamazepine administration.
0.9999 Adverse-Effect EntityAngioedema and maculopapular eruptions associated with Entitycarbamazepine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal toxic epidermal necrolysis related to Entitylamotrigine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNitrofurantoin - induced Entityacute liver damage in pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCyclophosphamide can rarely cause Entityinterstitial pneumonitis and fibrosis.
1.0000 Adverse-Effect EntityCyclophosphamide can rarely cause interstitial pneumonitis and Entityfibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute bilateral phrenic neuropathy following treatment with Entityadalimumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmpicillin may aggravate clinical and experimental Entitymyasthenia gravis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityincreased libido disappeared after Entityfluvoxamine was discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmiodarone was discontinued, and Entitythyrotoxicosis gradually abated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVisceral herpesvirus infections in leukemic patients receiving Entitycytarabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBowel perforation associated with intraperitoneal Entitychromic phosphate instillation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCo - trimoxazole Entityred cell aplasia in leukaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recurrent hypotension immediately after Entityseizures in Entitynortriptyline overdose.
0.9999 Adverse-Effect EntityRecurrent hypotension immediately after seizures in Entitynortriptyline overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNephropathy caused by Entitymethicillin therapy for staphylococcal septicemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDapsone - induced Entityerythroderma with Beau's lines.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEsophageal spasm following Entitypropranolol overdose relieved by glucagon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetformin - associated Entitylactic acidosis precipitated by diarrhea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmoxapine - induced Entitycognitive impairment in two patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect First case of Entityivermectin - induced Entitysevere hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute sensorineural hearing loss following intravenous Entityketoralac administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLeishmania infantum leishmaniasis in Entitycorticosteroid - - treated patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethemoglobinemia : an occupational hazard of Entityphenylpropanolamine production.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPentazocine - induced Entityfibrous myopathy and localized neuropathy.
0.9997 Adverse-Effect EntityPentazocine - induced fibrous myopathy and localized Entityneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylactoid reaction to 50 % solution of Entitydextrose .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLeflunomide - associated Entityweight loss in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnterior ischemic optic neuropathy secondary to Entityinterferon alfa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPhenobarbital Entityhepatotoxicity in an 8 - month - old infant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude Entityperipheral neuropathy with Entity5 - FU is rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PET scintigraphy of Entityetoposide - induced Entitypulmonary toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He had Entitypriapism following the use of Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylaxis to Entitycisplatin following nine previous uncomplicated cycles.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : EntityHypersensitivity reactions to Entitycyclosporine are rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary oedema after Entityhexoprenaline administration in preterm labour.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After abstinence from Entityoolong tea his Entitydelirium resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityQuinine induced Entitycoagulopathy - - a near fatal experience.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitypulmonary toxicity is probably induced by Entitypiritrexim .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect MR findings in Entitymethotrexate - induced EntityCNS abnormalities .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOsteomyelitis occurring during Entityinfliximab treatment of severe psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was thus diagnosed as having EntityAZ EntityAZ intoxication .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal failure associated with the use of Entitydextran - 40 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAripiprazole - induced Entityhiccups : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRhabdomyolysis associated with the use of intravenous Entityvasopressin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Other Entityupper tract neoplasms after Entitycyclophosphamide are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBisphosphonate - related Entityosteonecrosis of the skull base .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute asthma associated with sustained - release Entityverapamil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityErosion of psoriatic plaques after chronic Entitymethotrexate administration.
Score Relation Text (Head - Tail)
Adverse-Effect We suspect that nefazodone Entityinhibits metabolism of tacrolimus Entitytacrolimus .
Adverse-Effect We suspect that Entitynefazodone Entityinhibits metabolism of tacrolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHyponatraemia developed after rechallenge with controlled release Entitycarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTriiodothyronine - induced Entitythyrotoxicosis in ophthalmic Graves disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInsulin - induced Entitylipoatrophy in type I diabetes.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOptic neuropathy in Entityethambutol - treated renal tuberculosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Localized dyskeratotic plaque with Entitymilia associated with Entitysorafenib .
0.9999 Adverse-Effect EntityLocalized dyskeratotic plaque with milia associated with Entitysorafenib .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityChoroidal hemorrhage associated with systemic Entitytissue plasminogen activator .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere acute encephalopathy following inadvertent intrathecal Entitydoxorubicin administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary lymphohistiocytic reactions temporally related to Entityetanercept therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of EntitySIADH induced by Entitymizoribin administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPhoto - onycholysis caused by Entityolanzapine and aripiprazole.
0.9999 Adverse-Effect EntityPhoto - onycholysis caused by olanzapine and Entityaripiprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A woman developed Entitydelusional parasitosis when taking Entityphenelzine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityEosinophilic cystitis after bladder instillation with Entitydimethyl sulfoxide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTransient asymptomatic bradycardia in patients on infusional Entity5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Easily reversible hypoxemia and Entityhypotension induced by Entitynimodipine .
0.9999 Adverse-Effect Easily reversible Entityhypoxemia and hypotension induced by Entitynimodipine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityGelofusine EntityGelofusine allergy - - the need for identification jewellery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDisseminated salmonellosis in a patient treated with Entitytemozolomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEpoprostenol may be associated rarely with severe Entityerythroderma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityChromosome abnormalities after Entitychlorambucil therapy of polycythaemia vera.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute acoustic nerve palsy associated with Entityvincristine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report of withdrawal Entitydyskinesia associated with Entityamoxapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInsulin - dependent diabetes mellitus associated with Entitydanazol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute dystonic reaction with low - dose Entitypimozide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFalling backward in two elderly patients taking Entitybupropion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible Entitysirolimus - associated Entitypneumonitis after heart transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRifampin - associated Entitythrombocytopenia secondary to poor compliance.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInappropriate antidiuretic hormone secretion after high dose Entityvinblastine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClozapine - induced Entityakathisia in children with schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entityfatal case of pancytopenia due to Entitylevomepromazine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Near fatal acute Entitycolchicine Entitycolchicine intoxication in a child.
0.9999 Adverse-Effect EntityNear fatal acute Entitycolchicine intoxication in a child.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAtenolol induced Entitymemory impairment : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After discontinuation of Entitydanazol the Entitydiabetes completely resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate Entitypneumonitis in nonsurgical treatment of ectopic pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTardive dyskinesia in 2 patients treated with Entityziprasidone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Encephalopathy and Entityseizures induced by intravesical Entityalum irrigations.
0.9999 Adverse-Effect EntityEncephalopathy and seizures induced by intravesical Entityalum irrigations.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Entitycranial dystonia following Entitytrihexyphenidyl withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFlaccid quadriparesis was noted after discontinuation of Entityvecuronium .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityTheophylline EntityTheophylline intoxication mimicking diabetic ketoacidosis in a child.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intraventricular Entitynafcillin - induced Entityseizures in a neonate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLinear immunoglobulin A bullous dermatosis induced by Entitygemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal failure associated with Entityacetazolamide therapy for glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGangrene of the fingertips after Entitybleomycin and methotrexate.
1.0000 Adverse-Effect EntityGangrene of the fingertips after bleomycin and Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFlucloxacillin - induced Entityaplastic anaemia and liver failure.
0.9999 Adverse-Effect EntityFlucloxacillin - induced aplastic anaemia and Entityliver failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The course of Entitydelirium due to Entitylithium intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere neurotoxicity with Entitymethyl G : CALGB experience.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Spontaneous Entitybacterial peritonitis induced by intraarterial Entityvasopressin therapy.
1.0000 Adverse-Effect EntitySpontaneous bacterial peritonitis induced by intraarterial Entityvasopressin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Their Entityparkinsonism improved on discontinuation of Entitymetoclopramide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLinezolid - induced Entitydyserythropoiesis : chloramphenicol toxicity revisited.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRifampin - induced Entityhypothyroidism without underlying thyroid disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere acidosis from Entityacetazolamide in a diabetic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute pancreatitis associated with Entitydanazol treatment for endometriosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySirolimus - associated Entityhepatotoxicity in the kidney graft recipient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Transient Entityphenytoin induced EntityIgA deficiency and permanent IgE increase.
0.9998 Adverse-Effect Transient Entityphenytoin induced IgA deficiency and permanent EntityIgE increase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMefloquine - associated Entityhypoglycaemia in a cachectic AIDS patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLansoprazole - associated Entitycollagenous colitis : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEnalapril - induced Entityanemia in two kidney transplant recipients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Transient leucopenia and Entitythrombocytopenia associated with Entitysodium nitroprusside infusion.
0.9990 Adverse-Effect Transient Entityleucopenia and thrombocytopenia associated with Entitysodium nitroprusside infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitycolchicine - induced Entityrhabdomyolysis is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A diagnosis of Entitytrastuzumab - induced Entitypneumonitis was made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAlprazolam withdrawal Entitydelirium unresponsive to diazepam : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAbnormal retinal function associated with Entityisotretinoin therapy for acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRupture of a cerebral aneurysm associated with Entitynifedipine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Phantom limb pain as a manifestation of Entitypaclitaxel Entityneurotoxicity .
1.0000 Adverse-Effect EntityPhantom limb pain as a manifestation of Entitypaclitaxel neurotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPapillary necrosis associated with the HIV protease inhibitor Entityindinavir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmpicillin - induced Entityinterstitial nephritis with generalised exfoliative dermatitis.
0.9999 Adverse-Effect EntityAmpicillin - induced interstitial nephritis with Entitygeneralised exfoliative dermatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Traumatic late flap dehiscence and EntityEnterobacter keratitis following EntityLASIK .
0.9999 Adverse-Effect EntityTraumatic late flap dehiscence and Enterobacter keratitis following EntityLASIK .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOfloxacin : a probable cause of Entitytoxic epidermal necrolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBisphosphonate induced Entityosteochemonecrosis of the jaw mimicking a tumour.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report illustrates the Entityneurotoxicity unique to EntityHDARAC .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three cases of Entitygold - related Entityneuropathy are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropranolol - induced Entityhypertension in treatment of cocaine intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySerotonin syndrome caused by interaction between Entitycitalopram and fentanyl.
1.0000 Adverse-Effect EntitySerotonin syndrome caused by interaction between citalopram and Entityfentanyl .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxicity after high - dose Entitymethylprednisolone for demyelinating disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAccelerated nodulosis during Entitymethotrexate therapy for juvenile rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThrombotic thrombocytopenic purpura during Entitypenicillamine therapy in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute respiratory depression as a complication of nebulised Entitymorphine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCeftriaxone - induced Entityfixed drug eruption : first report.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityComeoscleral perforation after pterygium excision and intraoperative Entitymitomycin C .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIfosfamide is a known nephrotoxic drug with demonstrated Entitytubulopathies .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxicity associated with Entity6 - thioguanine therapy for Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxicity of Entityhycanthone in patients with metastatic breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDisulfiram Entityencephalopathy as a cause of the catatonia syndrome.
0.9999 Adverse-Effect EntityDisulfiram encephalopathy as a cause of the Entitycatatonia syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySensorimotor polyneuropathy with Entity5 - aminosalicylic acid : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Delayed Entityneurotoxicity of intraventricular Entityinterleukin - 2 : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unusual Entityhypersensitivity to Entitywarfarin in a critically ill patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVasomotor reactions after Entitygold sodium thiomalate are well recognized.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intrahepatic cholestasis and Entitycutaneous bullae associated with Entityglibenclamide therapy.
0.9999 Adverse-Effect EntityIntrahepatic cholestasis and cutaneous bullae associated with Entityglibenclamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTrazodone - induced Entitytransient hypomanic symptoms and their management.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Some patients develop Entityhypersensitivity rash in response to EntityHCQ .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible recurrence of Entityamiodarone Entitypulmonary toxicity following corticosteroid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxicity related to Entityitraconazole : report of three cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySeptic knee arthritis after intra - articular Entityhyaluronate injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMultiple sclerosis - like disease secondary to Entityalpha interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The literature of Entityvincristine Entityoptic nerve toxicity is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An Entityintertrigo - like eruption from pegylated liposomal Entitydoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hypotension and Entitysinus arrest with Entitynifedipine in pulmonary hypertension.
0.9999 Adverse-Effect EntityHypotension and sinus arrest with Entitynifedipine in pulmonary hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Liver transplantation for Entityfulminant hepatitis related to Entitynevirapine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDiabetes Mellitus was observed in a patient given Entitycarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate - induced Entitypapular eruption following treatment of psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary hypertension during Entitylithium therapy : clinical case study.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClofazimine Entityenteropathy in a pediatric bone marrow transplant recipient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCardiac arrest associated with Entitysulprostone use during caesarean section.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropafenone - induced Entityataxia : report of three cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Disseminated muscular cysticercosis with Entitymyositis induced by Entitypraziquantel therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitymyoclonus induced by Entityquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatopathy subsided after the cessation of Entitycarbamazepine and lynestrenol.
1.0000 Adverse-Effect EntityHepatopathy subsided after the cessation of carbamazepine and Entitylynestrenol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Large dose of Entitymethylphenidate may cause Entitycataract and glaucoma.
1.0000 Adverse-Effect Large dose of Entitymethylphenidate may cause cataract and Entityglaucoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySyndrome of inappropriate antidiuretic hormone associated with Entityvinorelbine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute pancreatitis after long - term Entity5 - aminosalicylic acid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFoscarnet - induced Entitysevere hypomagnesemia and other electrolyte disorders.
0.9999 Adverse-Effect EntityFoscarnet - induced severe hypomagnesemia and other Entityelectrolyte disorders .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylactoid reaction to Entitymethylprednisolone pulsed therapy for multiple sclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Simvastatin - induced Entityrhabdomyolysis following Entitycyclosporine treatment for uveitis.
1.0000 Adverse-Effect EntitySimvastatin - induced Entityrhabdomyolysis following cyclosporine treatment for uveitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The spectrum of Entitynitrofurantoin Entitylung injury continues to widen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Paradoxical ventricular tachycardia and Entityfibrillation after intravenous Entitybretylium therapy.
0.9999 Adverse-Effect EntityParadoxical ventricular tachycardia and fibrillation after intravenous Entitybretylium therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient developed grade 3 Entitycapecitabine - induced Entityheadache .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEmbolia cutis medicamentosa following subcutaneous injection of Entityglatiramer acetate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These results indicate that Entitylithium may cause Entitybiochemical hyperparathyroidism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A new type of Entityminocycline - induced Entitycutaneous hyperpigmentation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReversible corneal keratinization following trabeculectomy and treatment with Entity5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute endophthalmitis following intravitreal Entitybevacizumab ( Avastin ) injection.
1.0000 Adverse-Effect EntityAcute endophthalmitis following intravitreal bevacizumab ( EntityAvastin ) injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCamptocormia , a new side effect of Entitysodium valproate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Histopathology of the thyroid in Entityamiodarone - induced Entityhypothyroidism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMultiple seizures after Entitybupropion overdose in a small child.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Successful challenge with Entityclozapine in a history of Entityeosinophilia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitypyridoxine - dependent Entityseizures is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySystemic lupus erythematosus during Entitypenicillamine therapy for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two Entityfatal cases of poisoning by Entityparacetamol are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNephrotic range pseudoproteinuria in a Entitytolmetin - treated patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCaptopril - related ( and - induced? ) Entityasthma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitynoncardiogenic pulmonary edema by Entityethanolamine oleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypercalcemia in an AIDS patient treated with Entitygrowth hormone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySystemic vasculitis complicating hairy cell leukaemia treatment with Entitycladribine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCephalosporins are most likely associated with EntityVitamin K deficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible cholestasis with Entitybile duct injury following Entityazathioprine therapy.
0.9999 Adverse-Effect Reversible Entitycholestasis with bile duct injury following Entityazathioprine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityUveitis associated with Entityrifabutin therapy : a clinical alert.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmiodarone - induced Entitythyrotoxicosis associated with thyrotropin receptor antibody.
0.9999 Adverse-Effect EntityAmiodarone - induced thyrotoxicosis associated with Entitythyrotropin receptor antibody .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Peripheral neuropathy and Entitycerebellar syndrome associated with Entityamiodarone therapy.
0.9999 Adverse-Effect EntityPeripheral neuropathy and cerebellar syndrome associated with Entityamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitypriapism associated with Entitytrazodone is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : EntityElectrolyte disorders associated with Entityfoscarnet are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMyocardial ischemia associated with high - dose Entitycarmustine infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethylphenidate - associated Entityenuresis in attention deficit hyperactivity disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Entityporphyria cutanea tarda after treatment with Entitycyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute reversible ataxo - myoclonic encephalopathy with Entityflecainide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus cabergoline may cause similar Entitypleuropulmonary abnormalities to Entitybromocriptine .
1.0000 Adverse-Effect Thus Entitycabergoline may cause similar Entitypleuropulmonary abnormalities to bromocriptine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHigh - grade atrioventricular block during Entitydipyridamole stress testing.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDisulfiram - like reactions with newer cephalosporins : Entitycefmenoxime .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest discontinuing Entitygemcitabine if Entityradiation recall is observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFluoxetine - induced Entityakathisia : clinical and theoretical implications.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityharlequin color change and association with Entityprostaglandin E1 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Management and successful desensitization in Entitymethotrexate - induced Entityanaphylaxis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Response of a Entitypromethazine - induced Entitycoma to flumazenil.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Multifocal electroretinographic abnormalities in Entityethambutol - induced Entityvisual loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute renal failure in a child associated with Entityacyclovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Withdrawal of EntityDepakote resulted in resolution of the Entityeffusion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDipyrone - induced Entitygranulocytopenia : a case for awareness.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second patient exhibited sudden EntityPLMS following Entityolanzapine injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFixed drug eruption of the scrotum due to Entitymethylphenidate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxic effects in a child receiving Entityvalproate and carnitine.
0.9999 Adverse-Effect EntityHepatotoxic effects in a child receiving valproate and Entitycarnitine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Isoniazid and Entityethambutol as a cause of Entityoptic neuropathy .
0.9999 Adverse-Effect EntityIsoniazid and ethambutol as a cause of Entityoptic neuropathy .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityAmphotericin B Entitynephrotoxicity in humans decreased by salt repletion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLevofloxacin induced Entitypolymorphic ventricular tachycardia with normal QT interval.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary edema as a delayed complication of Entityritodrine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityToxicity related to Entitychloroquine treatment of resistant vivax malaria.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityCarbamazepine toxicity induced by Entityclarithromycin coadministration in psychiatric patients.
0.9994 Adverse-Effect EntityCarbamazepine EntityCarbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Circulating anticoagulant in the Entityprocainamide - induced Entitylupus syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMyotonia associated with sarcoidosis : marked exacerbation with Entitypravastatin .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Gold Entitynephropathy due to Entityauranofin obscured by tolmetin pseudoproteinuria.
0.9998 Adverse-Effect EntityGold Entitynephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
0.9742 Adverse-Effect Gold Entitynephropathy due to auranofin obscured by Entitytolmetin pseudoproteinuria.
Adverse-Effect EntityGold nephropathy due to Entityauranofin obscured by tolmetin pseudoproteinuria.
Adverse-Effect Gold nephropathy due to auranofin obscured by Entitytolmetin Entitypseudoproteinuria .
Adverse-Effect EntityGold nephropathy due to auranofin obscured by Entitytolmetin pseudoproteinuria.
Adverse-Effect EntityGold EntityGold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDoxycycline - induced Entityhypoglycemia in a nondiabetic young man.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTetany in a child with AIDS receiving intravenous Entitytobramycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report : Entityacute renal failure after administering intravenous Entityimmunoglobulin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDyspnea possibly associated with controlled - release Entitymorphine sulfate tablets.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute kidney injury caused by Entityzonisamide - induced Entityhypersensitivity syndrome .
0.9999 Adverse-Effect EntityAcute kidney injury caused by Entityzonisamide - induced hypersensitivity syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The renal consequences of Entityindinavir - associated Entitynephrotoxicity are uncertain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Occurrence of EntityIDDM during Entityinterferon therapy for chronic viral hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A further case of Entityanaphylactoid reaction to Entitymethylprednisolone is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBull's - eye maculopathy associated with Entityquinacrine therapy for malaria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Can Entitypropofol precipitate Entitypancreatitis in patients with Cushing's syndrome?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClonidine - induced Entitybradycardia in patients with spinal cord injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLymphoma developing in a patient with rheumatoid arthritis taking Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmphotericin B overdose in pediatric patients with associated Entitycardiac arrest .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIsoniazid causing Entitybreast tissue enlargement has been very rarely reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityParadoxical pulmonary vasoconstriction induced by Entitynitroglycerin in idiopathic pulmonary hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, recurrent Entitystaphylococcus aureus sepsis developed during EntityCyA therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNoncardiogenic pulmonary edema during intrabiliary infusion of Entitymono - octanoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMoxalactam is more likely to be associated with Entityplatelet dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere Raynaud's phenomenon with Entityyohimbine therapy for erectile dysfunction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere systemic hypersensitivity reaction to Entityibuprofen occurring after prolonged therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fatal Entitygemcitabine - induced Entitypulmonary toxicity in metastatic gallbladder adenocarcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Massive plasmocytosis due to Entitymethimazole - induced Entitybone marrow toxicity .
0.9999 Adverse-Effect EntityMassive plasmocytosis due to Entitymethimazole - induced bone marrow toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ketanserin in the treatment of Entityprotamine - induced Entitypulmonary hypertension .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Bradycardia and Entitycongestive heart failure associated with ocular Entitytimolol maleate .
0.9996 Adverse-Effect EntityBradycardia and congestive heart failure associated with ocular Entitytimolol maleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityUlcerative proctitis in juvenile systemic lupus erythematosus after Entityibuprofen treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed Entitycholestatic hepatitis while being treated with Entitynitrofurantoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDorzolamide - induced Entitychoroidal detachment in a surgically untreated eye.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMitomycin C - related Entityhemolytic uremic syndrome in cancer patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible Entityserotonin syndrome associated with Entityclomipramine after withdrawal of clozapine.
0.9996 Adverse-Effect Possible Entityserotonin syndrome associated with clomipramine after withdrawal of Entityclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityrecall pneumonitis induced by Entitygemcitabine is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoglobinuria and Entityacute renal failure associated with intravenous Entityvasopressin infusion.
1.0000 Adverse-Effect EntityMyoglobinuria and acute renal failure associated with intravenous Entityvasopressin infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmphotericin B - induced Entityseizures in a patient with AIDS.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityallopurinol Entityhypersensitivity syndrome is a rare adverse drug reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : We report an unusual Entityparadoxical effect of Entitybrimonidine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most likely cause of such Entityhyponatremic episode is Entityvinblastine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCefoxitin therapy for Mycobacterium fortuitum bacteremia with associated Entitygranulomatous hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcceleration of ventricular response to atrial flutter after intravenous Entityadenosine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entityhypereosinophilia related to Entityzafirlukast therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal damage associated with long term use of Entitylithium carbonate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible Entityvalproic acid - induced Entitydementia : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere hypo - alpha - lipoproteinemia during treatment with Entityrosiglitazone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Excluding other causes, EntityPentasa - associated Entitypancytopenia was considered.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThrombo - embolic complication after Entitystreptokinase therapy of pulmonary emboli.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Entitypersistent late onset asthma following treatment with Entitycaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmphotericin B - induced Entitycutaneous leucocytoclastic vasculitis : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropranolol - related Entitybronchospasm in patients without history of asthma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTrimethoprim - sulfamethoxazole - induced Entityhepatotoxicity in a pediatric patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBronchiolitis obliterans organising pneumonia associated with the use of Entitynitrofurantoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCerebral edema associated with EntityGliadel wafers : two case studies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAgranulocytosis induced by Entityvancomycin in an ESRD patient on CAPD.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityZidovudine induced Entitypure red cell aplasia : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Various case reports concerning Entitydapsone - induced Entityagranulocytosis are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeurotoxicity of Entityvalacyclovir in peritoneal dialysis : a pharmacokinetic study.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recently, EntityCD20 - negative tumors have been described after EntityRituximab therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCutaneous ulceration : an unusual complication of intravenous Entitypentamidine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Aplastic anemia and Entityagranulocytosis in patients using Entitymethazolamide for glaucoma.
0.9999 Adverse-Effect EntityAplastic anemia and agranulocytosis in patients using Entitymethazolamide for glaucoma.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityLethargy in a newborn : Entitylithium toxicity or lab error?
Adverse-Effect Lethargy in a newborn : Entitylithium Entitylithium toxicity or lab error?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLevofloxacin - induced Entitytoxic epidermal necrolysis in an elderly patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMental nerve neuropathy as a result of Entityhepatitis B vaccination .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMuzolimine - induced Entitysevere neuromyeloencephalopathy : report of seven cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After Entity5 - ASA was discontinued, the Entitypolyneuropathy symptoms recovered gradually.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCimetidine is a rare cause of drug - induced Entityfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He was later skin tested to confirm Entityallergy to EntityMTX .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Secondary Entityacute myeloid leukemia after Entityetoposide therapy for haemophagocytic lymphohistiocytosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMinocycline as a cause of drug - induced Entityautoimmune hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMacular infarction after endophthalmitis treated with vitrectomy and intravitreal Entitygentamicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 57 - year - old man developed Entitymorphea while taking Entitybromocriptine .
Score Relation Text (Head - Tail)
Adverse-Effect EntityMethotrexate is an effective but Entitypotentially toxic treatment for psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIsonicotinic acid hydrazide induced Entityanagen effluvium and associated lichenoid eruption.
0.9994 Adverse-Effect EntityIsonicotinic acid hydrazide induced anagen effluvium and associated Entitylichenoid eruption .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLovastatin - induced Entityrhabdomyolysis possibly associated with clarithromycin and azithromycin.
1.0000 Adverse-Effect Lovastatin - induced Entityrhabdomyolysis possibly associated with Entityclarithromycin and azithromycin.
0.9992 Adverse-Effect Lovastatin - induced Entityrhabdomyolysis possibly associated with clarithromycin and Entityazithromycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of Entityacute hepatitis is best known for Entityketoconazole .
Adverse-Effect The occurrence of acute Entityhepatitis is best known for Entityketoconazole .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Our experience supports hemodialysis for ESRF patients with Entityatenolol Entityatenolol toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityStevens - Johnson syndrome caused by the antiretroviral drug Entitynevirapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDasatinib - induced Entitypleural effusions : a lymphatic network disorder?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Increasing the Entityolanzapine dosage severely aggravated the symptoms of EntityRLS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hemodialysis was also shown to reverse Entityifosfamide - related Entityneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeurologic toxicity associated with hepatic artery infusion HAI of EntityFUdR .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityPapilledema without peripheral neuropathy in a patient taking Entityperhexiline maleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sudden cardiac death due to Entityhypersensitivity myocarditis during Entityclozapine treatment.
0.9999 Adverse-Effect EntitySudden cardiac death due to hypersensitivity myocarditis during Entityclozapine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Marked Entityelevation of serum creatine kinase associated with Entityolanzapine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDoxorubicin Entitycardiotoxicity : possible role of digoxin in its prevention.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityParoxysmal supraventricular tachycardia during treatment with Entitycisplatin and etoposide combination.
0.9999 Adverse-Effect EntityParoxysmal supraventricular tachycardia during treatment with cisplatin and Entityetoposide combination.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal acute encephalomyelitis after a single dose of intrathecal Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Oxygen potentiation of Entitybleomycin - induced Entitypulmonary toxicity is discussed.
0.9978 Adverse-Effect EntityOxygen potentiation of bleomycin - induced Entitypulmonary toxicity is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAllergy to Entitycloxacillin with normal tolerance to amoxicillin and cefuroxime.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMagnesium tocolysis as the cause of Entityurinary calculus during pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHemorrhagic cystitis is a significant toxic effect of Entitycyclophosphamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypokalemia after normal doses of neubulized Entityalbuterol ( salbutamol ).
1.0000 Adverse-Effect EntityHypokalemia after normal doses of neubulized albuterol ( Entitysalbutamol ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityToxic hepatitis induced by Entitydisulfiram in a non - alcoholic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute renal failure during Entitylisinopril and losartan therapy for proteinuria.
0.9999 Adverse-Effect EntityAcute renal failure during lisinopril and Entitylosartan therapy for proteinuria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHair loss associated with Entityparoxetine treatment : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere diffuse interstitial pneumonitis induced by Entitycarmustine ( BCNU ).
0.9999 Adverse-Effect EntitySevere diffuse interstitial pneumonitis induced by carmustine ( EntityBCNU ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitycough continued for the duration of therapy with Entityquinapril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMulticentric hepatocellular carcinoma following Entityphosphate diethylstilbestrol therapy for prostatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCough induced by Entityquinapril with resolution after changing to fosinopril.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityLipoid pneumonia : a silent complication of Entitymineral oil aspiration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCorneal edema recurred when the administration of Entityamantadine was resumed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFluphenazine - induced Entityneuroleptic malignant syndrome in a schizophrenic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After stopping Entityindapamide , Entityglucose tolerance impairing may be reversed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTransient acute myopia resulting from Entityisotretinoin ( accutane ) therapy.
1.0000 Adverse-Effect EntityTransient acute myopia resulting from isotretinoin ( Entityaccutane ) therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCardiac decompensation following Entityverapamil therapy in infants with supraventricular tachycardia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients developed Entityproteinuria following Entitygold therapy for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nephrotic syndrome related to Entitysystemic lupus erythematosus after Entitygriseofulvin therapy.
0.9999 Adverse-Effect EntityNephrotic syndrome related to systemic lupus erythematosus after Entitygriseofulvin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Colitis as a manifestation of Entityinfliximab - associated Entitydisseminated cryptococcosis .
1.0000 Adverse-Effect EntityColitis as a manifestation of Entityinfliximab - associated disseminated cryptococcosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGabapentin - induced Entitymood changes with hypomanic features in adults.
0.9999 Adverse-Effect EntityGabapentin - induced mood changes with Entityhypomanic features in adults.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Discontinuation of the Entityitraconazole caused resolution of the Entitydrug eruption .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Tacrolimus ( EntityFK506 ) - induced Entitymutism after liver transplant.
0.9999 Adverse-Effect EntityTacrolimus ( FK506 ) - induced Entitymutism after liver transplant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCarbamazepine induced Entityright bundle branch block in a Greenlandic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Angioedema and Entitydysphagia caused by contact allergy to inhaled Entitybudesonide .
1.0000 Adverse-Effect EntityAngioedema and dysphagia caused by contact allergy to inhaled Entitybudesonide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Apparent Entitycyclophosphamide ( cytoxan ) Entityembryopathy : a distinct phenotype?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient had MRI T2 abnormalities compatible with Entitycyclosporin Entityneurotoxicity .
0.9997 Adverse-Effect One patient had EntityMRI T2 abnormalities compatible with Entitycyclosporin neurotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute renal failure in a patient receiving treatment with Entitysuramin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityCarboplatin hypersensitivity presenting as Entitycoronary vasospasm - a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere symptomatic hyponatremia during Entitysibutramine therapy : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPhenytoin toxicity : an easily missed cause of Entitycerebellar syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This pattern is suggestive of Entityrenal toxicity due to Entitytobramycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDelay of corneal wound healing in patients treated with Entitycolchicine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityWarfarin - associated Entitythoracic aortic dissection in an elderly woman.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypersensitivity to Entityzonisamide was confirmed by the skin patch test.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPseudoephedrine - induced Entityhemorrhage associated with a cerebral vascular malformation.
0.9997 Adverse-Effect EntityPseudoephedrine - induced hemorrhage associated with a Entitycerebral vascular malformation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of acute cardiomyopathy and Entitypericarditis associated with Entitymethylphenidate .
0.9999 Adverse-Effect A case of Entityacute cardiomyopathy and pericarditis associated with Entitymethylphenidate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySyncope in a 65 - year - old woman after Entitynitrate ingestion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DIAGNOSIS : EntitySustained ventricular tachycardia possibly owing to Entitythalidomide treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute lung injury associated with Entity5 - fluorouracil and oxaliplatinum combined chemotherapy.
0.9999 Adverse-Effect EntityAcute lung injury associated with 5 - fluorouracil and Entityoxaliplatinum combined chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCardiac toxicity related to EntityBCNU has not been described well.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCiprofloxacin - induced Entityhemorrhagic vasculitis is a rare side effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An immediate Entityhemolytic reaction induced by repeated administration of Entityoxaliplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcyclovir Entityneurotoxicity : clinical experience and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute syphilitic posterior placoid chorioretinitis following intravitreal Entitytriamcinolone acetonide injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRisperidone - induced Entityobsessive - compulsive symptoms in two children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFibrosis of corpus cavernosum after intracavernous injection of Entityphentolamine / papaverine.
1.0000 Adverse-Effect EntityFibrosis of corpus cavernosum after intracavernous injection of phentolamine / Entitypapaverine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This Entityeruption appears to be a distinct cutaneous toxicity of EntityPLD .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityErosion of psoriatic plaques : an early sign of Entitymethotrexate toxicity.
Adverse-Effect Erosion of psoriatic plaques : an early sign of Entitymethotrexate Entitymethotrexate toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After nine previous uncomplicated cycles she developed severe Entityanaphylaxis to Entitycisplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityColchicine - induced Entitymyopathy in a teenager with familial Mediterranean fever.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIbopamine - induced reversible Entityleukopenia during treatment for congestive heart failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We also describe a case of Entitytimolol - induced Entityocular pemphigoid .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute aluminum toxicity after continuous intravesical Entityalum irrigation for hemorrhagic cystitis.
Adverse-Effect Acute Entityaluminum toxicity after continuous intravesical Entityalum irrigation for hemorrhagic cystitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only a few reports of overt Entityjaundice are associated with Entitystreptokinase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sensory neuropathy revealing Entitynecrotizing vasculitis during Entityinfliximab therapy for rheumatoid arthritis.
0.9999 Adverse-Effect EntitySensory neuropathy revealing necrotizing vasculitis during Entityinfliximab therapy for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityElectrical proarrhythmia with Entityprocainamide : a new ICD - drug interaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLivedo reticularis associated with Entityinterferon alpha therapy in two melanoma patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association of Entityphenothiazine overdose and Entityrespiratory distress syndrome merits consideration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethemoglobinemia associated with dermal application of Entitybenzocaine cream in a cat.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When the Entitytrazodone was reduced, the Entityinvoluntary movements promptly ceased.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnastrozole - associated Entitysclerosing glomerulonephritis in a patient with breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTransfusion haemosiderosis inspite of regular use of Entitydesferrioxamine : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This concerns 2 male patients who experienced Entityincontinence while taking Entityvenlafaxine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient had Entitysevere temporary weakness after an Entityampicillin sodium challenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityArterial hypertension associated with topical ocular use of Entityphenylephrine in dogs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTigecycline - induced Entityacute pancreatitis : case report and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAntineutrophil cytoplasmic antibody - positive crescentic glomerulonephritis associated with Entitypropylthiouracil therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Chronic Entityhydroxychloroquine use associated with EntityQT prolongation and refractory ventricular arrhythmia.
1.0000 Adverse-Effect Chronic Entityhydroxychloroquine use associated with QT prolongation and Entityrefractory ventricular arrhythmia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a rare case of Entitypleuropericarditis due to Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Inadvertent and accidental Entityepinephrine overdose might result in potentially Entitylethal complications .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReversible heart failure in a patient receiving Entityetanercept for ankylosing spondylitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityExtensive forearm deep venous thrombosis following a severe Entityinfliximab infusion reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Entitytuberculous uveitis due to Entityetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five months after initiating Entitymirtazapine therapy, she developed Entitysymptomatic hyponatremia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : A case of Entitycarbamazepine - induced Entityhyperammonemia is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pneumonitis with pleural and pericardial effusion and Entityneuropathy during Entityamiodarone therapy.
0.9999 Adverse-Effect EntityPneumonitis with pleural and pericardial effusion and neuropathy during Entityamiodarone therapy.
0.9999 Adverse-Effect Pneumonitis with Entitypleural and pericardial effusion and neuropathy during Entityamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal hepatitis after long - term pulse Entityitraconazole treatment for onychomycosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a rare case of EntityARDS associated with Entitylithium intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypersensitivity reactions due to Entitychloramphenicol are rarely reported in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIschaemia following selfadministered intra - arterial injection of Entitymethylphenidate and diamorphine.
1.0000 Adverse-Effect EntityIschaemia following selfadministered intra - arterial injection of methylphenidate and Entitydiamorphine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unaccountable severe Entityhypercalcemia in a patient treated for hypoparathyroidism with Entitydihydrotachysterol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAllopurinol - associated Entityhand and foot deformities in chronic tophaceous gout.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of EntityRitalin - associated Entitycataract and glaucoma.
1.0000 Adverse-Effect We report a case of EntityRitalin - associated cataract and Entityglaucoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nephrogenic diabetes insipidus and Entityrenal tubular acidosis secondary to Entityfoscarnet therapy.
0.9999 Adverse-Effect EntityNephrogenic diabetes insipidus and renal tubular acidosis secondary to Entityfoscarnet therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a case of EntityTEN after administration of Entityciprofloxacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : EntityAnaphylactoid reactions have been described previously with Entitycisplatin administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCentral nervous system toxicity associated with Entitymeperidine use in hepatic disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Entityagranulocytosis during treatment with Entityinfliximab in enteropathic spondyloarthropathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One other patient on Entitydigoxin stopped taking it and developed Entitycardiomyopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAdrenaline Entitydacryolith : detection by ultrasound examination of the nasolacrimal duct.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGabapentin toxicity in Entityrenal failure : the importance of dose adjustment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe steroid - induced Entityglaucoma following intravitreal injection of Entitytriamcinolone acetonide .
1.0000 Adverse-Effect Severe Entitysteroid - induced Entityglaucoma following intravitreal injection of triamcinolone acetonide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A short review on Entityimatinib - related Entityhepatotoxicity is also presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInteraction between Entitytacrolimus and nefazodone in a stable renal transplant recipient.
1.0000 Adverse-Effect EntityInteraction between tacrolimus and Entitynefazodone in a stable renal transplant recipient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere apnea in an infant exposed to Entitylamotrigine in breast milk.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHalothane Entityhepatitis and prompt resolution with methionine therapy : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The elicitation of a Entitymovement disorder by Entitytrazodone : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPrimary central nervous system lymphoma in a patient treated with Entitynatalizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of Entityamiodarone - induced Entitytorsades de pointe .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prominent Entitypositive U waves appearing with high - dose intravenous Entityphenylephrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCentral nervous system manifestations of an Entityibuprofen overdose reversed by naloxone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of EntityPeyronie's disease during long - term Entitycolchicine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcne provoked by Entitygold seems not to have been described elsewhere.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Entitysulfadiazine Entityhypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sustained - release Entityprocainamide - induced Entityreversible granulocytopenia after myocardial infarction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Carbamyl phosphate synthetase - 1 deficiency discovered after Entityvalproic acid - induced Entitycoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatobiliary disorders associated with orally administered Entityterbinafine have rarely been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Diffusion - weighted MRI correlates of subacute Entitymethotrexate - related Entityneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityWithdrawal emergent syndrome in an infant associated with maternal Entityhaloperidol therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient suffered a Entitylife - threatening anaphylactoid reaction to Entityamifostine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three senile patients developed Entityfatal acute encephalopathy while receiving Entitycalcium hopantenate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatocellular damage following therapeutic intravenous Entityiron sucrose infusion in a child.
Score Relation Text (Head - Tail)
0.9991 Adverse-Effect This paper reports a case of Entityfatal perhexiline maleate liver injury Entityperhexiline maleate liver injury.
0.9991 Adverse-Effect This paper reports a case of Entityfatal perhexiline maleate liver injury Entitymaleate liver injury.
0.9981 Adverse-Effect This paper reports a case of fatal Entityperhexiline maleate Entityperhexiline maleate liver injury .
0.9980 Adverse-Effect This paper reports a case of fatal Entityperhexiline maleate liver injury Entitymaleate liver injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Proton MRS examination demonstrated a persistent Entitylactate elevation during Entitymetronidazole treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A typical case of Entitydextran - 40 associated Entityacute renal failure is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMycobacterium marinum infection complicating Crohn's disease, treated with Entityinfliximab .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSION : EntityAcetic acid is corrosive and may cause Entityvagina bleeding .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who became Entityhypothyroid while taking Entityferrous sulfate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCaptopril - induced Entitylichen planus pemphigoides with pemphigus - like features.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThrombocytosis associated with Entityenoxaparin : A very rare cause in newborns.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypersensitivity reaction following Entitychloramphenicol administration in a patient with typhoid fever.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylactic reaction to Entityrecombinant insulin - like growth factor - I .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two reports of Entityspindle coma are noted with alcohol and Entityimipramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This therapy was also complicated by EntityWarfarin - induced Entityskin necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetipranolol associated Entitygranulomatous anterior uveitis : not so uncommon as thought.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Choanal atresia and athelia : Entitymethimazole Entityteratogenicity or a new syndrome?
1.0000 Adverse-Effect Choanal atresia and Entityathelia : Entitymethimazole teratogenicity or a new syndrome?
0.9996 Adverse-Effect EntityChoanal atresia and athelia : Entitymethimazole teratogenicity or a new syndrome?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Erythropoietin is beneficial in Entitymitomycin - induced Entityhemolytic - uremic syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report four cases of Entitysevere corneal ulceration in Entitymethamphetamine abusers.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPneumocystis carinii pneumonia as a complication of Entitymethotrexate treatment of asthma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClofazimine Entityenteropathy caused by crystal deposition can be life - threatening.
0.9994 Adverse-Effect EntityClofazimine enteropathy caused by crystal deposition can be Entitylife - threatening .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterference with the cortisol axis by the microtubule antagonist, EntityCPH82 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDisulfiram - induced Entityfulminant hepatic failure in an active duty soldier.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - dose Entityphosphate treatment leads to Entityhypokalemia in hypophosphatemic osteomalacia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible mechanisms for Entitydamage to the urothelium by Entityketamine are suggested.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxicity induced by Entitycyproterone acetate : a report of three cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Caution with use of cimetidine in Entitytolazoline induced Entityupper gastrointestinal bleeding .
0.9998 Adverse-Effect Caution with use of Entitycimetidine in tolazoline induced Entityupper gastrointestinal bleeding .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypersensitivity pneumonitis - like syndrome associated with the use of Entitylenalidomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The medical examiner's report indicated Entitydeath caused by Entityfluoxetine toxicity.
0.9999 Adverse-Effect The medical examiner's report indicated death caused by Entityfluoxetine Entityfluoxetine toxicity .
Score Relation Text (Head - Tail)
Adverse-Effect In all the patients, Entitypellagra symptoms appeared during Entityisoniazid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We hypothesize that Entitycapecitabine - induced Entityheadache is vascular in nature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDesipramine - associated EntitySIADH in an elderly woman : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMitomycin - C induced Entityhemolytic uremic syndrome : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEsophageal candidiasis following Entityomeprazole therapy : a report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The syndrome of irreversible Entitylithium - effectuated Entityneurotoxicity ( SILENT ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thrombotic microangiopathy with Entityrenal failure in two patients undergoing Entitygemcitabine chemotherapy.
0.9999 Adverse-Effect EntityThrombotic microangiopathy with renal failure in two patients undergoing Entitygemcitabine chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe heparin associated Entitythrombocytopenia is a rare complication of Entityheparin therapy.
1.0000 Adverse-Effect Severe Entityheparin associated Entitythrombocytopenia is a rare complication of heparin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMammary gigantism is a rare complication of EntityD - penicillamine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Zolpidem tissue concentrations in a multiple drug related Entitydeath involving EntityAmbien .
Adverse-Effect EntityZolpidem tissue concentrations in a multiple drug related Entitydeath involving Ambien.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patient 1 presented Entitybilateral ballism 1 week after intravenous Entityheroin injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It occasionally accompanies the Entityheparin - associated Entitythrombocytopenia and thrombosis syndrome.
0.9999 Adverse-Effect It occasionally accompanies the Entityheparin - associated thrombocytopenia and Entitythrombosis syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Selective estrogen receptor modulator Entityraloxifene - associated Entityaggravation of nonalcoholic steatohepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHemolytic uremic syndrome following the infusion of Entityoxaliplatin : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dose - dependent Entityolanzapine - associated Entityleukopenia : three case reports.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPellagra encephalopathy among tuberculous patients : its relation to Entityisoniazid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of EntityIHA associated with Entitycefuroxime administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The HIV protease inhibitor Entityindinavir may cause Entitynephrolithiasis and interstitial nephritis.
0.9999 Adverse-Effect The HIV protease inhibitor Entityindinavir may cause nephrolithiasis and Entityinterstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware that Entityindinavir Entitynephrolithiasis may cause papillary necrosis.
0.9998 Adverse-Effect Physicians should be aware that Entityindinavir nephrolithiasis may cause Entitypapillary necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTenofovir - associated Entitynephrotoxicity in two HIV - infected adolescent males.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityCarbamazepine toxicity following EntityOxybutynin and Dantrolene administration : a case report.
0.9997 Adverse-Effect EntityCarbamazepine EntityCarbamazepine toxicity following Oxybutynin and Dantrolene administration : a case report.
0.9972 Adverse-Effect EntityCarbamazepine toxicity following Oxybutynin and EntityDantrolene administration : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When Entityco - trimoxazole was stopped the Entityred cell aplasia resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGemcitabine - induced Entitypericardial effusion and tamponade after unblocked cardiac irradiation.
0.9999 Adverse-Effect EntityGemcitabine - induced pericardial effusion and Entitytamponade after unblocked cardiac irradiation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCytarabine - induced Entitycerebellar syndrome : case report and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGemcitabine - related Entityradiation recall preferentially involves internal tissue and organs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Can roxithromycin and Entitybetamethasone induce Entityacute pancreatitis ? A case report.
0.9999 Adverse-Effect Can Entityroxithromycin and betamethasone induce Entityacute pancreatitis ? A case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient who developed Entityacute pancreatitis during Entityamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of Entitybilateral ptosis induced by Entitychloroquine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySorafenib induced Entitytumor lysis syndrome in an advanced hepatocellular carcinoma patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityToxic optic neuropathy associated with Entityethambutol : implications for current therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityLeukaemoid monocytosis in M4 AML following chemotherapy and EntityG - CSF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Heparin - dependent antibodies and thrombosis without Entityheparin - induced Entitythrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, an association of EntityRitalin with Entityglaucoma has been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNonconvulsive status epilepticus : the role of Entitymorphine and its antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with Entitysevere cholestatic jaundice induced by Entitycaptopril is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterstitial pneumonitis associated with Entitysirolimus : a dilemma for lung transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Complete remission of the Entitynephrosis occurred after discontinuation of Entityhydroxychloroquine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGold Entitynephropathy : tissue analysis by X - ray fluorescent spectroscopy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The role of EntityAdriamycin in the production of Entitycardiotoxicity is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHyponatremia in patients treated with Entitylorcainide , a new antiarrhythmic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySpontaneous hemothorax following anticoagulation with low - molecular - weight Entityheparin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitypsychotic behavior resolved completely soon after the discontinuation of Entitylevetiracetam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRetinoic acid may increase the risk of Entitybone marrow transplant nephropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The relationship between Entityinfliximab treatment and Entitylymphoma in Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, Entityamantadine was permanently discontinued and the Entitycornea cleared again.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first reported case of Entityhepatolithiasis during Entityoctreotide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The literature search revealed 22 cases of Entityhypersensitivity reaction to Entitycyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Seizure with Entityhyponatremia in a child prescribed Entitydesmopressin for nocturnal enuresis.
1.0000 Adverse-Effect EntitySeizure with hyponatremia in a child prescribed Entitydesmopressin for nocturnal enuresis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rebound Entityhyperglycemia following overdosing of Entityinsulin in cats with diabetes mellitus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVocal cord paralysis as a consequence of peritonsillar infiltration with Entitybupivacaine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGemcitabine - related Entityradiation recall in a patient with pancreatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropylthiouracil - induced Entitysensorineural hearing loss associated with antineutrophil cytoplasmic antibodies.
0.9999 Adverse-Effect EntityPropylthiouracil - induced sensorineural hearing loss associated with Entityantineutrophil cytoplasmic antibodies .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxicity associated with use of EntityD - penicillamine in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMesalamine may cause Entityhypersensitivity pneumonitis in patients with Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, Entitycyclosporine dependency is associated with the risk of Entitynephrotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCapecitabine - induced Entitymultifocal leukoencephalopathy : a report of five cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the third child, the Entitytics ceased after EntityCBZ discontinuation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Can Entityketamine prescribed for pain cause Entitydamage to the urinary tract ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been only two reports of Entitycimetidine - induced Entityhepatitis .
Score Relation Text (Head - Tail)
Adverse-Effect Lower extremity Entityarterial insufficiency after long - term Entitymethysergide maleate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityElevated serum triglycerides with Entityclozapine resolved with risperidone in four patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityUlcer became worse after Entitytobramycin and gentamycin treatment for 2 days.
1.0000 Adverse-Effect EntityUlcer became worse after tobramycin and Entitygentamycin treatment for 2 days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In some cases this seems to happen because Entityspironolactone causes Entitydiarrhoea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Secondary hyperparathyroidism in certain patients with Entitylithium Entitynephrotoxicity is also possible.
0.9999 Adverse-Effect EntitySecondary hyperparathyroidism in certain patients with Entitylithium nephrotoxicity is also possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been several reported cases of Entityomeprazole - induced EntityAIN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Stroke - like syndrome after Entitygold sodium thiomalate induced Entityvasomotor reaction .
0.9999 Adverse-Effect EntityStroke - like syndrome after Entitygold sodium thiomalate induced vasomotor reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTorsade de pointes represents a potential complication of chronic Entityamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intraventricular Entityvancomycin - induced Entitycerebrospinal fluid eosinophilia : report of two patients.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect The Entityampicillin Entityampicillin rash occurring in cases of infectious mononucleosis is well documented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an unusual pattern of Entitysupravenous hyperpigmentation occurring after EntityCHOP chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHydroxyurea - induced Entityacute interstitial pneumonitis in a patient with essential thrombocythemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGraft versus host - like illness in a child with Entityphenobarbital hypersensitivity.
1.0000 Adverse-Effect Graft versus host - like illness in a child with Entityphenobarbital Entityhypersensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Neutropenia and Entityagranulocytosis are risks known to occur with Entityphenothiazines and clozapine.
1.0000 Adverse-Effect Neutropenia and Entityagranulocytosis are risks known to occur with phenothiazines and Entityclozapine .
0.9999 Adverse-Effect EntityNeutropenia and agranulocytosis are risks known to occur with Entityphenothiazines and clozapine.
0.9998 Adverse-Effect EntityNeutropenia and agranulocytosis are risks known to occur with phenothiazines and Entityclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMilk - alkali syndrome induced by Entity1, 25 ( OH ) 2D in a patient with hypoparathyroidism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPregabalin - induced Entitycortical negative myoclonus in a patient with neuropathic pain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Arthritis and Entitybursitis in multiple sclerosis patients treated with Entityinterferon - beta .
0.9997 Adverse-Effect EntityArthritis and bursitis in multiple sclerosis patients treated with Entityinterferon - beta .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 53 - year - old man developed EntityNMS without rigidity while taking Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Accordingly, Entitycamptocormia is a dose - dependent side effect of Entityvalproate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient who experienced EntityLABD shortly after starting Entitycarbamazepine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTiclopidine - induced Entityaplastic anemia ( TIAA ) is considered very uncommon.
1.0000 Adverse-Effect EntityTiclopidine - induced aplastic anemia ( EntityTIAA ) is considered very uncommon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDystonia associated with Entitycarbamazepine administration : experience in brain - damaged children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient who developed Entityacute rhabdomyolysis after taking Entitycerivastatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient with systemic lupus erythematosus developed Entityerythema multiforme after taking Entitygriseofulvin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Listeria brain abscess, Pneumocystis pneumonia and EntityKaposi's sarcoma after Entitytemozolomide .
0.9999 Adverse-Effect Listeria brain abscess, EntityPneumocystis pneumonia and Kaposi's sarcoma after Entitytemozolomide .
0.9999 Adverse-Effect EntityListeria brain abscess , Pneumocystis pneumonia and Kaposi's sarcoma after Entitytemozolomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In these patients, long - acting Entityoctreotide may trigger Entityserious hypoglycemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAlbuterol - induced Entityhypokalemia and its potential cardiac toxicity are discussed briefly.
0.9997 Adverse-Effect EntityAlbuterol - induced hypokalemia and its potential Entitycardiac toxicity are discussed briefly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityInfectious endophthalmitis is a potential complication of intravitreal Entitybevacizumab injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHeat stroke in schizophrenia during Entityclozapine treatment : rapid recognition and management.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCutaneous reactions to Entitypropylthiouracil and methimazole occur in 3 % - 5 % of adults.
0.9999 Adverse-Effect EntityCutaneous reactions to propylthiouracil and Entitymethimazole occur in 3 % - 5 % of adults.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a probable case of Entityinfliximab - induced Entitymembranous nephropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTemozolomide - induced Entitydesquamative skin rash in a patient with metastatic melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This represents the first report of Entitynonconvulsive status epilepticus induced by Entityifosfamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entitysotalol - induced Entitybradycardia reversed by glucagon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEye movement disorders in bone marrow transplant patients on Entitycyclosporin and ganciclovir.
0.9999 Adverse-Effect EntityEye movement disorders in bone marrow transplant patients on cyclosporin and Entityganciclovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityphotosensitivity is still present 3 years after the withdrawal of Entityquinine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical picture was identical to that of chloroquine and Entityhydroxychloroquine Entitymaculopathy .
0.9993 Adverse-Effect The clinical picture was identical to that of Entitychloroquine and hydroxychloroquine Entitymaculopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Entityinterstitial lung disease associated with Entitytrastuzumab : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Combining Entitymethylephedrine and Chinese herbal drugs might carry a risk of Entitystroke .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the potentially Entitylethal side effects of Entitydapsone .
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect The use of pamidronate for hypercalcemia secondary to acute Entityvitamin D Entityvitamin D intoxication .
0.9998 Adverse-Effect The use of Entitypamidronate for Entityhypercalcemia secondary to acute vitamin D intoxication.
0.9966 Adverse-Effect The use of pamidronate for Entityhypercalcemia secondary to acute Entityvitamin D intoxication.
0.9677 Adverse-Effect The use of Entitypamidronate for hypercalcemia secondary to acute Entityvitamin D intoxication .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both patients suddenly became Entityhypotensive after injection of Entitychymopapain into a disk.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : A case of probable Entityenoxaparin - induced Entityhepatotoxicity is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLithium - associated Entitytransient thyrotoxicosis in 4 Chinese women with autoimmune thyroiditis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The literature search found 12 cases of Entityradiation recall caused by Entitygemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients on long - term Entitylithium therapy developed the Entitynephrotic syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFulminant hepatic failure is a rare complication of Entitydisulfiram treatment for alcoholism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Incidence of Entityseizures in pediatric cancer patients treated with Entityimipenem / cilastatin.
1.0000 Adverse-Effect Incidence of Entityseizures in pediatric cancer patients treated with imipenem / Entitycilastatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIncomplete posterior hyaloid detachment after intravitreal Entitypegaptanib injection in diabetic macular edema.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere corneal toxicity after topical Entityfluoroquinolone therapy : report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTardive oculogyric crisis during treatment with Entityclozapine : report of three cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous Entityvalproate associated with significant Entityhypotension in the treatment of status epilepticus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnterior spinal artery syndrome - - a complication of cervical intrathecal Entityphenol injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPericardial hemorrhage due to Entityacetylsalicylic acid in a patient with essential thrombocythemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He developed a late Entitysecondary infection in some sites treated with Entityimiquimod .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report a case of Entitynodular scleritis following Entityalendronate sodium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityToxic hepatitis due to combination therapy with Entitymethotrexate and etretinate in psoriasis.
0.9999 Adverse-Effect EntityToxic hepatitis due to combination therapy with methotrexate and Entityetretinate in psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySuccinylcholine - induced Entityhyperkalemia in a patient with mucositis secondary to chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNonsustained polymorphous ventricular tachycardia during Entityamiodarone therapy for atrial fibrillation complicating cardiomyopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityAmphotericin B overdose can be Entityfatal in children and infants.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityStupor and fast activity on electroencephalography in a child treated with Entityvalproate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeurological side effects in two patients receiving Entitygold injections for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIncreased libido in a woman treated with Entityfluvoxamine : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Marked Entitysinus tachycardia resulting from the synergistic effects of marijuana and Entitynortriptyline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityexophthalmos improved dramatically within 72 hours of the withdrawal of Entitylithium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hyperglycemia and Entitydiabetic coma : possible relationship to diuretic - Entitypropranolol therapy.
1.0000 Adverse-Effect EntityHyperglycemia and diabetic coma : possible relationship to diuretic - Entitypropranolol therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDisseminated cellulitic cryptococcosis in the setting of Entityprednisone monotherapy for pemphigus vulgaris.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of prolonged Entityterbinafine - induced Entitycholestatic liver disease .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, 1 eye had Entityvitreous hemorrhage after repeated injections of EntitytPA .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityStuttering priapism complicating Entitywarfarin therapy in a patient with protein C deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Delayed Entitybowel injury is an infrequently observed complication of Entitychromic phosphate administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMalignant mixed mullerian tumor of the uterus in a patient taking Entityraloxifene .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Entity5 - Fluorouracil Entitycardiotoxicity complicating treatment of stage IIB cervical cancer - - case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware that EntityPLP can occur after initiation of Entitypaclitaxel .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGynaecomastia is a rarely reported adverse drug reaction due to Entityisoniazid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Autopsy findings were consistent with bleomycin and Entityoxygen - induced Entitypulmonary damage .
0.9999 Adverse-Effect Autopsy findings were consistent with Entitybleomycin and oxygen - induced Entitypulmonary damage .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPolymyoclonus seizure resulting from accidental injection of Entitytranexamic acid in spinal anesthesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pediatric Entityheparin - induced Entitythrombocytopenia : management with Danaparoid ( orgaran ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitysustained hypotension after administration of parenteral Entityverapamil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical course suggests that the Entityinterstitial pneumonitis was induced by Entityhydroxyurea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect 5 - fluorouracil ( Entity5 - FU ) - associated Entityperipheral neuropathy is an uncommon event.
0.9999 Adverse-Effect Entity5 - fluorouracil ( 5 - FU ) - associated Entityperipheral neuropathy is an uncommon event.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Abdominal wall ulceration and Entitymucinosis secondary to Entityrecombinant human interferon - beta - 1b .
0.9992 Adverse-Effect EntityAbdominal wall ulceration and mucinosis secondary to Entityrecombinant human interferon - beta - 1b .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityToxic epidermal necrolysis after the use of high - dose Entitycytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySymptomatic hypoglycemia secondary to a Entityglipizide - trimethoprim / sulfamethoxazole drug interaction.
0.9998 Adverse-Effect EntitySymptomatic hypoglycemia secondary to a glipizide - Entitytrimethoprim / sulfamethoxazole drug interaction.
0.9998 Adverse-Effect EntitySymptomatic hypoglycemia secondary to a glipizide - trimethoprim / Entitysulfamethoxazole drug interaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAngio - oedema as an unusual tolerable side effect of Entityvoriconazole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Entityacute hyponatraemia induced by low dose Entitycyclophosphamide and indomethacin.
0.9999 Adverse-Effect Life - threatening Entityacute hyponatraemia induced by low dose cyclophosphamide and Entityindomethacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report five additional cases of Entitycapecitabine - induced Entitymultifocal leukoencephalopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityChlormadinone acetate Entitywithdrawal syndrome under combined androgen blockade for advanced prostate cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary fibrosis subsequent to high doses of EntityCCNU for chronic myeloid leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three distinct types of Entityminocycline - induced Entitycutaneous pigmentation have been described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDocetaxel - induced EntityMeibomian duct inflammation and blockage leading to chalazion formation.
0.9999 Adverse-Effect EntityDocetaxel - induced Meibomian duct inflammation and blockage leading to Entitychalazion formation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmikacin - induced Entitytype 5 Bartter - like syndrome with severe hypocalcemia.
0.9999 Adverse-Effect EntityAmikacin - induced type 5 Bartter - like syndrome with Entitysevere hypocalcemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal outcome of intravesical Entityformalin instillation, with changes mimicking renal tuberculosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The use of Entityrituximab has been uncommonly associated with Entitydelayed pulmonary toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeuroleptic malignant syndrome in an adolescent receiving Entityolanzapine - lithium combination therapy.
0.9999 Adverse-Effect EntityNeuroleptic malignant syndrome in an adolescent receiving olanzapine - Entitylithium combination therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Therapy with Entityindapamide may induce Entitydiabetes in essential hypertension patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAdriamycin - induced Entitycardiomyopathy aggravated by cis - platinum nephrotoxicity requiring dialysis.
Adverse-Effect Adriamycin - induced cardiomyopathy aggravated by Entitycis - platinum Entitynephrotoxicity requiring dialysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReversible MR imaging and MR spectroscopy abnormalities in association with Entitymetronidazole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityCefazolin was a probable cause of this patient's Entityleukopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Evaluation revealed Entityelevated serum LTG levels EntityLTG levels and no other etiology for encephalopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three diabetic cases of Entityacute dizziness due to initial administration of Entityvoglibose .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hemodialysis should be performed for rapid reversal of Entitymannitol - induced EntityARF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 54 - year - old man, treated with Entityamiodarone , developed Entitythyrotoxicosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityMetoclopramide may cause reversible Entitynonthrombocytopenic vascular - type palpable purpura .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect EntityFatal pulmonary fibrosis following 1, 3 - bis ( 2 - chloroethyl ) - 1 - nitrosourea ( EntityBCNU ) therapy.
Adverse-Effect EntityFatal pulmonary fibrosis following Entity1, 3 - bis ( 2 - chloroethyl ) - 1 - nitrosourea ( BCNU ) therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report presents a potential case of Entityrisperidone - induced Entitytardive dyskinesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entityangioedema associated with Entitylosartan administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed Entityoptic neuropathy while being treated with Entityisoniazid and ethambutol.
1.0000 Adverse-Effect A patient developed Entityoptic neuropathy while being treated with isoniazid and Entityethambutol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPeripheral nervous system disturbances caused by Entitycytosine arabinoside have rarely been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases demonstrate that EntityCBZ can induce simple Entitymotor tics in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : EntityAnterior ischemic optic neuropathy may complicate treatment with Entityinterferon alfa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOptic neuropathy associated with Entitypenicillamine therapy in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDiffuse alveolar hemorrhage after Entityleflunomide therapy in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first reported case of suspected EntityDIAN due to Entitycefuroxime .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityGeneralized lichen nitidus with involvement of the palms following Entityinterferon alpha treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHigh - grade endometrial stromal sarcoma after Entitytamoxifen therapy for breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Correction of serum electrolyte imbalance prevents Entitycardiac arrhythmia during Entityamphotericin B administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOphthalmologic and neurologic findings in two children exposed to Entityvigabatrin in utero.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The exact mechanism of EntityIVIG - associated Entityacute renal failure remains unclear.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Due to the severity of the Entityrash , Entitytemozolomide was permanently discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible interaction between lopinavir / ritonavir and Entityvalproic Acid exacerbates Entitybipolar disorder .
0.9999 Adverse-Effect Possible interaction between Entitylopinavir / ritonavir and valproic Acid exacerbates Entitybipolar disorder .
0.9999 Adverse-Effect Possible interaction between lopinavir / Entityritonavir and valproic Acid exacerbates Entitybipolar disorder .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Retinal dysfunction and Entityanterior segment deposits in a patient treated with Entityrifabutin .
1.0000 Adverse-Effect EntityRetinal dysfunction and anterior segment deposits in a patient treated with Entityrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of EntityEGE manifested as an allergy to Entitygemfibrozil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myasthenic patients receiving Entityampicillin should be closely monitored for possible Entityacute exacerbations .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHyperpigmentation during Entityinterferon - alpha therapy for chronic hepatitis C virus infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Primary cutaneous coccidioidomycosis and subsequent Entitydrug eruption to Entityitraconazole in a dog.
0.9999 Adverse-Effect EntityPrimary cutaneous coccidioidomycosis and subsequent drug eruption to Entityitraconazole in a dog.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOtotoxicity as a result of Entitycis - platinum administration is well documented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of pediatric Entitybupropion ingestion resulting in Entitymultiple seizures .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityNephrotic syndrome in a multiple sclerosis patient treated with Entityinterferon beta 1a .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmifostine - induced Entityfever : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal intravascular autoimmune hemolytic anemia after Entityfludarabine treatment for chronic lymphocytic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of patients who developed Entityleukopenia during Entityolanzapine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He became Entityhyperkalemic on rechallenge with Entitytimolol and normokalemic following its withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySerious adverse events experienced by patients with chronic heart failure taking Entityspironolactone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAminoglutethimide was discontinued until completion of radiotherapy, and the Entityrash resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLeflunomide - induced Entitytoxic epidermal necrolysis in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Abnormalities of the pupil and visual - evoked potential in Entityquinine Entityamblyopia .
0.9999 Adverse-Effect EntityAbnormalities of the pupil and visual - evoked potential in Entityquinine amblyopia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute myocardial ischemia following accidental intravenous administration of Entityepinephrine in high concentration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepato - biliary abnormalities secondary to Entityceftriaxone use : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetabolic acidosis induced by Entitycetrimide - chlorhexidine solution in hydatid cyst surgery.
0.9997 Adverse-Effect EntityMetabolic acidosis induced by cetrimide - Entitychlorhexidine solution in hydatid cyst surgery.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityBone formation induced in an infant by systemic Entityprostaglandin - E2 administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInfliximab - induced Entitylupus in Crohn's disease : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProtamine allergy as a complication of Entityinsulin hypersensitivity : A case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Additionally, Entitydanazol produces Entityhepatocellular damage in approximately 10 % of women.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThymic enlargement in a patient with juvenile idiopathic arthritis during Entityetanercept therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEsophageal candidiasis was diagnosed at endoscopy in two patients receiving Entityomeprazole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Symptoms and Entityendoscopic lesions quickly regressed within 1 week of Entitymeloxicam withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 61 year - old male patient developed Entitygynecomastia after starting Entitytheophylline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Papilloedema and Entityhepatic dysfunction apparently induced by Entityperhexiline maleate ( Pexid ).
0.9997 Adverse-Effect EntityPapilloedema and hepatic dysfunction apparently induced by Entityperhexiline maleate ( Pexid ).
0.9997 Adverse-Effect Papilloedema and Entityhepatic dysfunction apparently induced by perhexiline maleate ( EntityPexid ).
0.9995 Adverse-Effect EntityPapilloedema and hepatic dysfunction apparently induced by perhexiline maleate ( EntityPexid ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Managing Entitycardiovascular collapse in severe Entityflecainide overdose without recourse to extracorporeal therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These Entitynail changes gradually disappeared when the dose of Entityclofazimine was reduced.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with Entitytacrolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Severe and Entitysustained ocular hypertension may occur after intravitreal Entityranibizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOxcarbazepine - induced Drug Reaction with Eosinophilia and Systemic Symptoms ( EntityDRESS ).
1.0000 Adverse-Effect EntityOxcarbazepine - induced EntityDrug Reaction with Eosinophilia and Systemic Symptoms ( DRESS ).
Adverse-Effect EntityOxcarbazepine - induced EntityDrug Reaction with Eosinophilia and Systemic Symptoms ( DRESS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySerotonin syndrome induced by transitioning from Entityphenelzine to venlafaxine : four patient reports.
1.0000 Adverse-Effect EntitySerotonin syndrome induced by transitioning from phenelzine to Entityvenlafaxine : four patient reports.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRadiation recall related to Entitygemcitabine has been reported in lung and breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHeparin - induced Entitythrombocytopenia is a rare and serious complication of anticoagulation therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed papilloedema and Entityhepatic dysfunction while being treated with Entityperhexiline maleate .
0.9997 Adverse-Effect A patient developed Entitypapilloedema and hepatic dysfunction while being treated with Entityperhexiline maleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRestless legs syndrome may thus be an adverse effect of EntityIFN alpha treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The responsibility of EntityCCNU in the pathogenesis of Entitypulmonary fibrosis seems very likely.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Indolent Entityaspergillus arthritis complicating Entityfludarabine - based non - myeloablative stem cell transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report suggests that Entitybleomycin Entitylung toxicity may be reversible if treated aggressively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three days after intravitreal injection of Entitybevacizumab , Entityacute ocular ischemic syndrome occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report two cases of Entityacute endophthalmitis following intravitreal Entitybevacizumab injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityAmphotericin B seems to be the probable cause of the Entityseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute myocardial infarction due to Entitycoronary spasm associated with EntityL - thyroxine therapy.
0.9983 Adverse-Effect EntityAcute myocardial infarction due to coronary spasm associated with EntityL - thyroxine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxicity of Entityparacetamol enhanced by ingestion of alcohol : report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early Entityoveranticoagulation with Entityacenocoumarol due to a genetic polymorphism of cytochrome P450 CYP2C9.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute pancreatitis is a known, although rare, complication of Entitymesalamine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : The occurrence of Entitypriapism in our patient was related to Entityzuclopenthixol .
Score Relation Text (Head - Tail)
0.9986 Adverse-Effect Neurointensive care management of Entityraised intracranial pressure caused by severe Entityvalproic acid intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitynormotensive scleroderma renal crisis after high - dose Entitymethylprednisolone treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRhabdomyolysis has been recognized as a complication of tocolytic therapy with Entityritodrine hydrochloride .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIbuprofen - induced Entitymeningitis : detection of intrathecal IgG synthesis and immune complexes.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Transtentorial herniation caused by an Entityintracranial mass lesion following high - dose Entitymethotrexate .
0.9999 Adverse-Effect EntityTranstentorial herniation caused by an intracranial mass lesion following high - dose Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeuroleptic malignant syndrome due to Entityrisperidone treatment in a child with Joubert syndrome.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntitySkin necrosis after extravasation of low - dose Entityvasopressin administered for septic shock.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Histological examination of the Entitydacryolith suggested its derivation from breakdown products of Entityadrenaline .
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect Itraconazole - related increased Entityvincristine Entityneurotoxicity : case report and review of literature.
0.9821 Adverse-Effect EntityItraconazole - related increased vincristine Entityneurotoxicity : case report and review of literature.
Adverse-Effect EntityItraconazole - related increased Entityvincristine neurotoxicity : case report and review of literature.
Adverse-Effect Itraconazole - related increased Entityvincristine Entityvincristine neurotoxicity : case report and review of literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPara - aminosalicylic acid - induced Entityhypoglycaemia in a patient with diabetic nephropathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prolonged severe Entity5 - fluorouracil - associated Entityneurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : reports on Entitydelated cutaneous reactions to Entitycaptopril have been seldom reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe leukopenia associated with Entitymild hepatotoxicity in an HIV carrier treated with Entitynevirapine .
0.9999 Adverse-Effect EntitySevere leukopenia associated with mild hepatotoxicity in an HIV carrier treated with Entitynevirapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse reaction in a patient with Entityaspirin - induced Entityasthma treated with zafirlukast.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal complication of intravesical Entityformalin during control of intractable hemorrhage from radiation cystitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCerebral infarcts in a pediatric patient secondary to Entityphenylpropanolamine , a recalled medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 45 - year - old woman with thyrotoxicosis developed Entityagranulocytosis after treatment with Entitypropylthiouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal interstitial lung disease after Entityerlotinib administration in a patient with radiation fibrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute renal failure following intravenous Entityimmunoglobulin therapy in a HIV - infected patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Restless legs syndrome and Entityperiodic limb movements during sleep probably associated with Entityolanzapine .
1.0000 Adverse-Effect EntityRestless legs syndrome and periodic limb movements during sleep probably associated with Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPancytopenia associated with Entity5 - aminosalicylic acid use in a patient with Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report the first case of Entitybucillamine - induced Entitygiant mammary hyperplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute myeloid leukemia evolving from essential thrombocythemia in two patients treated with Entityhydroxyurea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There is no consensus on the treatment of Entityticlopidine - induced Entitymarrow aplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRisperidone - induced Entitypsychosis and depression in a child with a mitochondrial disorder.
0.9999 Adverse-Effect EntityRisperidone - induced psychosis and Entitydepression in a child with a mitochondrial disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityStevens - Johnson syndrome in a boy with nephrotic syndrome during Entityprednisolone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcyclovir - induced Entityneurotoxicity : concentration - side effect relationship in acyclovir overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : EntityAlendronate led to Entitynodular scleritis and rechallenge caused recurrence of scleritis.
0.9999 Adverse-Effect CONCLUSION : EntityAlendronate led to nodular scleritis and rechallenge caused recurrence of Entityscleritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDeposits of plasma proteins in the skin during treatment with Entitycarbamazepine and diphenylhydantoin.
1.0000 Adverse-Effect EntityDeposits of plasma proteins in the skin during treatment with carbamazepine and Entitydiphenylhydantoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityL - asparaginase - provoked Entityseizures as singular expression of central nervous toxicity.
0.9984 Adverse-Effect EntityL - asparaginase - provoked seizures as singular expression of Entitycentral nervous toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Provocation of Entitynon - convulsive status epilepticus by Entitytiagabine in three adolescent patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nineteen cases of Entityallergic contact dermatitis to compound tincture of Entitybenzoin are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case extends the spectrum of Entityfludarabine Entitypulmonary toxicity to include pulmonary nodules.
0.9998 Adverse-Effect This case extends the spectrum of Entityfludarabine pulmonary toxicity to include Entitypulmonary nodules .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityoculogyric crisis induced by Entitymetoclopramide is described in this paper.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClostridium difficile toxin - induced colitis after use of Entityclindamycin phosphate vaginal cream.
1.0000 Adverse-Effect Clostridium difficile toxin - induced Entitycolitis after use of Entityclindamycin phosphate vaginal cream.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARIES : Two patients who received Entityifosfamide - containing chemotherapy developed EntityNCSE .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of the Entitycatatonia syndrome associated with Entitydisulfiram therapy.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect EntityProlonged prostate - specific antigen response in Entityflutamide withdrawal syndrome despite disease progression.
Adverse-Effect Prolonged prostate - specific antigen response in Entityflutamide Entityflutamide withdrawal syndrome despite disease progression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnticonvulsant hypersensitivity syndrome associated with EntityBellamine S , a therapy for menopausal symptoms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two weeks following rechallenge with Entityalendronate sodium resulted in recurrence of his Entityscleritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient developed Entitylarge intramural esophageal hematoma as a complication of Entityheparin therapy.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The patient was diagnosed with Entitycarbamazepine toxicity related to the introduction of Entityritonavir .
0.9997 Adverse-Effect The patient was diagnosed with Entitycarbamazepine Entitycarbamazepine toxicity related to the introduction of ritonavir.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityL - asparaginase - induced Entitysevere necrotizing pancreatitis successfully treated with percutaneous drainage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of a Entitysustained monomorphic ventricular tachycardia following Entityadenosine infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTremor : a newly described adverse event with long - term Entityitraconazole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 2 patients who developed Entitypolyarteritis nodosa following Entityvaccination against hepatitis B .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients receiving Entitygold salt treatment for rheumatoid arthritis developed severe Entityaplastic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHemorrhage from a falx meningioma after internal use of low - dose Entityaspirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTemozolomide was restarted 2 months later ; the patient again developed a Entityfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal injury due to Entityanastrozole has not been published in the English literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mechanism of Entitytopiramate - induced Entityacute - onset myopia and angle closure glaucoma.
0.9999 Adverse-Effect Mechanism of Entitytopiramate - induced acute - onset myopia and Entityangle closure glaucoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There is a putative role of Entityliothyronine administration in precipitating or activating Entityhyperthyroidism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was treated with Entityacyclovir and subsequently developed EntityVZV antigen - positive zoster .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClostridium difficile colitis associated with Entitycisplatin - based chemotherapy in ovarian cancer patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Polysomnographic and pharmacokinetic findings in Entitylevodopa - induced augmentation of Entityrestless legs syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPemphigus foliaceus was seen in a patient with pulmonary tuberculosis during Entityrifampicin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Intrathecal Entitybaclofen can Entityimpair sexual function and ejaculation in some patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute Entityrenal failure should be recognized as a potential complication of Entitysuramin treatment.
Score Relation Text (Head - Tail)
Adverse-Effect Lower extremity Entityarterial thrombosis following sonographically guided Entitythrombin injection of a femoral pseudoaneurysm.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEEG abnormalities were observed in two of the nine children during Entitychlorambucil therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySchneiderian first - rank symptoms associated with Entityfluvoxamine treatment : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Progression of chronic myeloid leukemia to Entityblast crisis during treatment with Entityimatinib mesylate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylaxis from Entityisoniazid is a possible side effect to this commonly prescribed antibiotic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Differential diagnoses included ocular rosacea with cicatrizing conjunctivitis and Entity5 - FU - induced Entityectropion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitybaclofen Entitywithdrawal syndrome resulting from oral baclofen underdosing.
0.9999 Adverse-Effect We report a case of baclofen Entitywithdrawal syndrome resulting from oral Entitybaclofen underdosing.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with Entitycyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A MEDLINE search identified all the reported cases of Entityhypersensitivity reactions to Entitycyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mechanism of EntityRTA induced by EntityFK506 has not yet been clearly elucidated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethysergide - induced Entityretroperitoneal fibrosis : successful outcome and two new laboratory features.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two renal transplant patients developed Entityanemia during treatment of hypertension with Entityenalapril medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, the Entityeosinophilia myalgia syndrome can be associated with parenteral Entitytryptophan administration.
Score Relation Text (Head - Tail)
Adverse-Effect When measured, the Entityserum lithium level had increased 4 - fold during Entityacyclovir therapy.
Adverse-Effect When measured, the Entityserum lithium level had increased Entitylithium level had increased 4 - fold during acyclovir therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitypapillary necrosis in a patient treated with Entityindinavir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFluoxetine - related Entitydeath in a child with cytochrome P - 450 2D6 genetic deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVisual loss after a single small dose of Entityvincristine has never been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLaryngeal dyspnea in relation to an interaction between Entityacenocoumarol and topical econazole lotion.
0.9999 Adverse-Effect EntityLaryngeal dyspnea in relation to an interaction between acenocoumarol and topical Entityeconazole lotion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report that acute Entitylamotrigine poisoning may result in severe Entityencephalopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Extensive Entitysquamous metaplasia was found in endometrial glands following Entityprogestin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect They continued to rise for five more days before Entitysalicylate Entityhepatotoxicity was suspected.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a patient with Entityifosfamide - induced Entitynonconvulsive status epilepticus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After four months, while receiving EntityRH , he developed painful Entitybilateral gynaecomastia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five cases of Entityclindamycin - associated Entitypseudomembranous colitis in leukaemic patients are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTrimethoprim - sulfamethoxazole - induced Entityhypersensitivity syndrome associated with reactivation of human herpesvirus - 6.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, several case reports have suggested that Entityclozapine could also cause EntityTD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAtrial fibrillation occurring in a patient taking Entityetanercept plus methotrexate for rheumatoid arthritis.
0.9999 Adverse-Effect EntityAtrial fibrillation occurring in a patient taking etanercept plus Entitymethotrexate for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : All cases developed Entitycorneal endothelial deposits after previous use of Entityrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of EntityRTA secondary to EntityFK506 administration in liver transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An adverse reaction to EntityIFN was strongly suspected as the cause of EntityCHF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both PAN and Entitymethotrexate have been independently demonstrated to cause Entitysensorineural hearing loss .
0.9999 Adverse-Effect Both EntityPAN and methotrexate have been independently demonstrated to cause Entitysensorineural hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityAnastrozole may be the causative factor in patients with Entitysclerosing glomerulonephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThrombotic thrombocytopenic purpura induced by Entitytrimethoprim - sulfamethoxazole in a Jehovah's Witness.
0.9996 Adverse-Effect EntityThrombotic thrombocytopenic purpura induced by trimethoprim - Entitysulfamethoxazole in a Jehovah's Witness.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySubacute cholestatic hepatitis likely related to the use of Entitysenna for chronic constipation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute myocardial infarction during high - dose Entitymethylprednisolone therapy for Graves'ophthalmopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only 3 cases of Entityimatinib - induced Entitytumor lysis syndrome have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCiprofloxacin - induced Entitytoxic epidermal necrolysis in a patient with systemic lupus erythematosus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report two cases of Entityfixed drug eruption induced by Entitymethylphenidate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Concomitant administration of lithium with Entityolanzapine may place patients at risk for EntityNMS .
0.9999 Adverse-Effect Concomitant administration of Entitylithium with olanzapine may place patients at risk for EntityNMS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : Three patients with apparent Entityitraconazole - induced Entityliver injury were studied.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinical profile of Entityoxcarbazepine - related Entityangioneurotic edema : case report and review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our series of 3 patients supports a causal connection between Entitybleomycin and Entityscleroderma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is concluded that EntitySIADH is an important side effect of Entitylorcainide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment - related Entitymyelodysplastic syndrome after Entitytemozolomide for recurrent high - grade glioma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySustained hypothyroidism induced by Entityrecombinant alpha interferon in patients with chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLeukopenia due to parvovirus B19 in a Crohn's disease patient using Entityazathioprine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Bleomycin and Entitycyclophosphamide toxicity simulating Entitymetastatic nodules to the lungs in childhood cancer.
0.9998 Adverse-Effect EntityBleomycin and cyclophosphamide toxicity simulating Entitymetastatic nodules to the lungs in childhood cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVerapamil in effort - induced Entityangina pectoris in patients with normal coronary arteries.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of EntityUFT - induced Entityscleroderma - like reaction .
Adverse-Effect This is the first report of EntityUFT EntityUFT - induced scleroderma - like reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySelf - limited edema is a well - recognized complication of Entityinsulin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCeliac disease onset after Entitypegylated interferon and ribavirin treatment of chronic hepatitis C.
0.9999 Adverse-Effect EntityCeliac disease onset after pegylated interferon and Entityribavirin treatment of chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySexual dysfunction associated with intrathecal Entitybaclofen use : a report of two cases.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityScleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on Entityinterferon beta - 1a .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cases of EntityCBZ - induced EntitySLE reported in the literature were reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of Entitycarbimazole - induced Entityagranulocytosis and sepsis with granulocyte colony stimulating factor.
1.0000 Adverse-Effect Treatment of Entitycarbimazole - induced agranulocytosis and Entitysepsis with granulocyte colony stimulating factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early peritoneal dialysis has not previously been reported for Entitylisinopril induced Entitymultiorgan failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCyclosporine - induced Entitypain syndrome in a child undergoing hematopoietic stem cell transplant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBaclofen withdrawal : a cause of prolonged Entityfever in the intensive care unit.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGeneralised cutaneous rash associated with Entityganciclovir therapy has rarely been reported in literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityValproate Entityembryopathy in three sets of siblings : further proof of hereditary susceptibility.
Adverse-Effect EntityValproate EntityValproate embryopathy in three sets of siblings : further proof of hereditary susceptibility.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Granulocytopenia and Entityagranulocytosis are considered among the most dangerous adverse effects of Entityclozapine .
1.0000 Adverse-Effect EntityGranulocytopenia and agranulocytosis are considered among the most dangerous adverse effects of Entityclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The observations suggest that testicular swelling and Entitypain are side effects of Entitydesipramine .
1.0000 Adverse-Effect The observations suggest that Entitytesticular swelling and pain are side effects of Entitydesipramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeurologic degeneration associated with Entitynitrous oxide anesthesia in patients with vitamin B12 deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of a Entitydisulfiram - like reaction with Entitycefmenoxime .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : We report two cases of Entitypseudoporphyria caused by Entitynaproxen and oxaprozin.
1.0000 Adverse-Effect METHODS : We report two cases of Entitypseudoporphyria caused by naproxen and Entityoxaprozin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitycontact dermatitis due to Entitysodium bisulfite in an ophthalmic solution.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report 2 cases of Entityrenal damage associated with Entitylithium carbonate treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cutaneous rashes and Entityeruptions can be caused by many medications, including Entitycarbamazepine .
1.0000 Adverse-Effect EntityCutaneous rashes and eruptions can be caused by many medications, including Entitycarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute generalized exanthematous pustulosis induced by Entitysalazosulfapyridine in a patient with ulcerative colitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible linkage of Entityamprenavir with Entityintracranial bleeding in an HIV - infected hemophiliac.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTamoxifen is suggested to be Entitycarcinogenic both through direct genotoxic and epigenetic mechanisms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clearance rates of cerivastatin metabolites in a patient with Entitycerivastatin - induced Entityrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of Entitysirolimus - associated Entitypneumonitis have been reported after cardiac transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Seizures and Entitytransient blindness following intravenous pulse Entitymethylprednisolone in children with primary glomerulonephritis.
1.0000 Adverse-Effect EntitySeizures and transient blindness following intravenous pulse Entitymethylprednisolone in children with primary glomerulonephritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that MB is an effective treatment for Entityifosfamide - induced Entityencephalopathy .
Adverse-Effect We conclude that MB is an effective treatment for Entityifosfamide Entityifosfamide - induced encephalopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible Entityheart failure exacerbation associated with Entityrosiglitazone : case report and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute interstitial pneumonia induced by EntityONO - 1078 ( pranlukast ), a leukotriene receptor antagonist.
0.9999 Adverse-Effect EntityAcute interstitial pneumonia induced by ONO - 1078 ( Entitypranlukast ), a leukotriene receptor antagonist.
Adverse-Effect Acute Entityinterstitial pneumonia induced by EntityONO - 1078 ( pranlukast ), a leukotriene receptor antagonist.
Adverse-Effect Acute Entityinterstitial pneumonia induced by ONO - 1078 ( Entitypranlukast ), a leukotriene receptor antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 48 - year - old woman who was treated for thyrotoxicosis with Entitymethimazole developed Entityagranulocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapid resolution of topiramate - induced Entityangle - closure glaucoma with Entitymethylprednisolone and mannitol.
1.0000 Adverse-Effect Rapid resolution of Entitytopiramate - induced Entityangle - closure glaucoma with methylprednisolone and mannitol.
0.9998 Adverse-Effect Rapid resolution of topiramate - induced Entityangle - closure glaucoma with methylprednisolone and Entitymannitol .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityRetinopathy in hepatitis C patients due to combination therapy with Entitypegylated interferon and ribavirin.
0.9998 Adverse-Effect EntityRetinopathy in hepatitis C patients due to combination therapy with pegylated interferon and Entityribavirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, EntityEO - induced Entitynoncardiogenic pulmonary edema has not been reported in human.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is reported of a child with Entityfatal pulmonary fibrosis following EntityBCNU therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal interstitial pneumonitis following high - dose intermittent Entitychlorambucil therapy for chronic lymphocyte leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylactic reaction to oral Entityprednisone : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The following is a report of 2 cases of Entityrifampicin - induced Entityrenal insufficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - dose Entitymethotrexate - associated Entityacute renal failure may be an avoidable complication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityFixed drug rash induced by Entitymethylphenidate is a possible but rare phenomenon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here, we report a case of Entityangio - oedema associated with EntityVRC therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate - induced Entityhepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityScleroderma in association with the use of Entitybleomycin : a report of 3 cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Voriconazole ( EntityVRC ) has not previously been reported to cause Entityangio - oedema .
0.9999 Adverse-Effect EntityVoriconazole ( VRC ) has not previously been reported to cause Entityangio - oedema .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five days after the fourth dose of Entityvincristine , she presented with Entitybilateral ptosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, repeated intracameral EntitytPA injections may cause unwanted complications such as Entityvitreous hemorrhage .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Oral Entity25 - hydroxyvitain D3 in treatment of osteomalacia associated with Entityileal resection and cholestyramine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySideroblastic anemia due to Entitylinezolid in a patient with a left ventricular assist device.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIdiosyncratic pulmonary reactions to Entitynitrofurantoin are not unusual, often presenting as eosinophilic pneumonia.
1.0000 Adverse-Effect Idiosyncratic pulmonary reactions to Entitynitrofurantoin are not unusual, often presenting as Entityeosinophilic pneumonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatotoxicity resolved once Entityerlotinib was discontinued and serum transaminases returned to baseline normal values.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with acute changes suggesting Entityacute hepatitis after parenteral Entityamiodarone administration is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCardiomyopathy after widely separated courses of Entityadriamycin exacerbated by actinomycin - D and mithramycin.
0.9984 Adverse-Effect EntityCardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin - D and Entitymithramycin .
0.9980 Adverse-Effect EntityCardiomyopathy after widely separated courses of adriamycin exacerbated by Entityactinomycin - D and mithramycin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because Entitynephrotic syndrome may be induced by EntityIFN therapy, the IFN was stopped.
0.9963 Adverse-Effect Because Entitynephrotic syndrome may be induced by IFN therapy, the EntityIFN was stopped.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDecreased plasma cortisol level during Entityalprazolam treatment of panic disorder : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Neurological improvement and rehabilitation potential following Entitytoxic myelopathy due to intrathecal injection of Entitydoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPersistent hypoglycemia in a patient with diabetes taking Entityetanercept for the treatment of psoriasis.
Score Relation Text (Head - Tail)
0.6311 Adverse-Effect An unusual cause of Entityburn injury : unsupervised use of drugs that contain Entitypsoralens .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous Entityhaloperidol is generally well tolerated, but Entitymultiform ventricular tachycardia has been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When EntityDSCG was withdrawn, Entityurticaria vanished and the child remained symptom - free.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGrowth and adrenal suppression in asthmatic children treated with high - dose Entityfluticasone propionate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of EntityCrohn's disease in a patient with multiple sclerosis treated with Entitycopaxone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A young woman developed Entitygalactorrhea during treatment with a new Entitydibenzoxazepine antidepressant, amoxapine.
0.9999 Adverse-Effect A young woman developed Entitygalactorrhea during treatment with a new dibenzoxazepine antidepressant, Entityamoxapine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Central pontine myelinolysis manifested by Entitytemporary blindness : a possible complication of Entitylithium toxicity.
Adverse-Effect EntityCentral pontine myelinolysis manifested by temporary blindness : a possible complication of Entitylithium toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Skin manifestations of a case of Entityphenylbutazone - induced Entityserum sickness - like reactions .
0.9999 Adverse-Effect EntitySkin manifestations of a case of Entityphenylbutazone - induced serum sickness - like reactions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCardiac arrest after Entityesmolol administration : a review of acute beta - blocker toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitynephrotic syndrome developed in a patient receiving therapy with Entitygold for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVitiligo associated with Entityalpha - interferon in a patient with chronic active hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAll - trans retinoic acid - induced Entityfocal myositis , synovitis, and mononeuritis.
0.9995 Adverse-Effect EntityAll - trans retinoic acid - induced focal myositis, Entitysynovitis , and mononeuritis.
0.9993 Adverse-Effect EntityAll - trans retinoic acid - induced focal myositis, synovitis, and Entitymononeuritis .
Score Relation Text (Head - Tail)
Adverse-Effect Subcutaneous EntityIL - 2 is safe and well tolerated, with a Entitymortality rate < 3 %.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of EntityIDDM which occurred during Entityinterferon therapy for chronic hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere autoimmune hemolytic anemia following Entityrituximab therapy in a patient with a lymphoproliferative disorder.
Adverse-Effect Severe Entityautoimmune hemolytic anemia following Entityrituximab therapy in a patient with a lymphoproliferative disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CCBs should be considered in the treatment of 5 - FU or Entitycapecitabine - induced Entityheadaches .
0.9999 Adverse-Effect CCBs should be considered in the treatment of Entity5 - FU or capecitabine - induced Entityheadaches .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She developed a Entitysevere urticarial rash 3 weeks following initiation of therapy with EntityEnoxaparin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three months after starting Entitycitalopram , she experienced episodes of Entitychest tightness and dizziness.
1.0000 Adverse-Effect Three months after starting Entitycitalopram , she experienced episodes of chest tightness and Entitydizziness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterstitial pneumonia probably associated with Entitysorafenib treatment : An alert of an adverse event.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Detection of activated eosinophils in nasal polyps of an Entityaspirin - induced Entityasthma patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityToxic epidermal necrolysis resulted after 19 days of treatment with Entity5 - fluorocytosine and amphotericin B.
0.9998 Adverse-Effect EntityToxic epidermal necrolysis resulted after 19 days of treatment with 5 - fluorocytosine and Entityamphotericin B .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitysevere aplastic anemia secondary to treatment with Entitylenalidomide for multiple myeloma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatic angiosarcoma occurring after Entitycyclophosphamide therapy : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of Entitysevere hepatotoxicity related to Entitybenzarone , a benzofuran derivative.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two infants developed Entityhyperkalemia shortly after cessation of prolonged EntityACTH therapy for infantile spasms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, acute cardiomyopathy and Entitypericarditis secondary to Entitymethylphenidate use has been rarely reported.
0.9999 Adverse-Effect However, Entityacute cardiomyopathy and pericarditis secondary to Entitymethylphenidate use has been rarely reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We now present four cases of EntityRSDS in kidney transplant recipients treated with Entitytacrolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This sulfonamide like nephropathy should be differentiated from Entityacetazolamide - related Entitycalcium phosphate nephrolithiasis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAlveolar - interstitial pneumopathy after Entitygold - salts compounds administration, requiring mechanical ventilation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The epivodes of EntityNMS occured under treatment with Entityclozapine , risperidone, and amisulpride.
1.0000 Adverse-Effect The epivodes of EntityNMS occured under treatment with clozapine, Entityrisperidone , and amisulpride.
1.0000 Adverse-Effect The epivodes of EntityNMS occured under treatment with clozapine, risperidone, and Entityamisulpride .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cardiac hypersensitivity and Entitymyopericarditis have been reported during long - term treatment with Entitymesalazine .
0.9999 Adverse-Effect EntityCardiac hypersensitivity and myopericarditis have been reported during long - term treatment with Entitymesalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterstitial fibrosis of the lung is a potential complication of Entitymethotrexate therapy for psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The events of Entitynon - convulsive status epilepticus subsided following reduction in Entitytiagabine dosages.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : This case illustrates a potential link between Entitydermatologic and ocular 5 - FU toxicities Entity5 - FU toxicities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVisual hallucinations after intravitreal injection of Entitybevacizumab in vascular age - related macular degeneration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Symptoms and pathologic changes of Entitycolitis are associated with exposure to Entityrofecoxib .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityReye - like syndrome following treatment with the pantothenic acid antagonist, Entitycalcium hopantenate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Presented is a case of Entityacute renal failure induced by Entityacetazolamide therapy for glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Such anagen effluvium with Entitylichenoid eruption following EntityINH therapy has not been observed previously.
0.9999 Adverse-Effect Such Entityanagen effluvium with lichenoid eruption following EntityINH therapy has not been observed previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mean time from starting EntityMMF to the development of Entityneutropenia was 4 months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPsoriasis - like skin reaction in a patient with rheumatoid arthritis after Entitysulphasalazine therapy.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Severe rhabdomyolysis following massive ingestion of Entityoolong tea : Entitycaffeine intoxication with coexisting hyponatremia.
0.9990 Adverse-Effect Severe rhabdomyolysis following massive ingestion of oolong tea : Entitycaffeine Entitycaffeine intoxication with coexisting hyponatremia.
1.0000 Adverse-Effect EntitySevere rhabdomyolysis following massive ingestion of Entityoolong tea : caffeine intoxication with coexisting hyponatremia.
0.9991 Adverse-Effect EntitySevere rhabdomyolysis following massive ingestion of oolong tea : Entitycaffeine intoxication with coexisting hyponatremia.
Adverse-Effect Severe Entityrhabdomyolysis following massive ingestion of Entityoolong tea : caffeine intoxication with coexisting hyponatremia.
Adverse-Effect Severe Entityrhabdomyolysis following massive ingestion of oolong tea : Entitycaffeine intoxication with coexisting hyponatremia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIbuprofen overdose is usually characterized by EntityGI upset , dizziness, and mild sedation.
1.0000 Adverse-Effect EntityIbuprofen overdose is usually characterized by GI upset, Entitydizziness , and mild sedation.
0.9999 Adverse-Effect EntityIbuprofen overdose is usually characterized by GI upset, dizziness, and Entitymild sedation .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Administration of cisplatin in three patients with Entitycarboplatin Entityhypersensitivity : is skin testing useful?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere hepatotoxicity related to Entitybenzarone : a report of three cases with two fatalities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of reversible Entitynonthrombocytopenic palpable purpura associated with Entitymetoclopramide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityActinomycin D associated Entityhepatic veno - occlusive disease - - a report of 2 cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed typical EntityECM after subcutaneous selfinjection of Entityglatiramer acetate for multiple sclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients are described who developed testicular swelling and Entitypain during treatment with Entitydesipramine .
1.0000 Adverse-Effect Two patients are described who developed Entitytesticular swelling and pain during treatment with Entitydesipramine .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Putaminal infarct in Entitymethanol Entitymethanol intoxication : case report and role of brain imaging studies.
0.9966 Adverse-Effect EntityPutaminal infarct in Entitymethanol intoxication : case report and role of brain imaging studies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityWorsening of neurologic syndrome in patients with Wilson's disease with initial Entitypenicillamine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first histologically confirmed case of EntityNASH that was aggravated by Entityraloxifene .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This was accepted as evidence for Entitypropranolol being the cause of this Entityconduction disorder .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPeripheral nerve dysfunction is a potentially serious complication of high - dose Entitycytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTorsade de pointes associated with Entitymoxifloxacin : a rare but potentially fatal adverse event.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHyperammonemia secondary to Entityvalproic acid as a cause of lethargy in a postictal patient.
0.9997 Adverse-Effect Hyperammonemia secondary to Entityvalproic acid as a cause of Entitylethargy in a postictal patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A small number of Entityoxaliplatin - related Entityhemolytic and / or thrombocytopenic reactions have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinical signs of Entityhypermagnesemia are an uncommon complication following oral administration of Entitymagnesium sulfate .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect EntityAcute hemorrhagic gastritis associated with Entityacetazolamide intoxication in a patient with chronic renal failure.
Adverse-Effect Acute hemorrhagic gastritis associated with Entityacetazolamide Entityacetazolamide intoxication in a patient with chronic renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMyasthenia gravis during low - dose EntityIFN - alpha therapy for chronic hepatitis C.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect His fever resolved, but he developed symptoms consistent with those of Entitychloroquine Entitychloroquine toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLupus - like syndrome caused by Entity5 - aminosalicylic acid in patients with inflammatory bowel disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intensive high - flux hemodiafiltration is often used in the management of Entityvancomycin Entityvancomycin toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She developed Entityneurotoxicity with an adjustment dosage of Entityvalacyclovir for a cutaneous zoster infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThalidomide was withdrawn from world markets in 1961 following recognition of its Entityteratogenic effects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Itch and Entityskin rash from chocolate during Entityfluoxetine and sertraline treatment : case report.
1.0000 Adverse-Effect EntityItch and skin rash from chocolate during Entityfluoxetine and sertraline treatment : case report.
0.9999 Adverse-Effect EntityItch and skin rash from chocolate during fluoxetine and Entitysertraline treatment : case report.
0.9998 Adverse-Effect Itch and Entityskin rash from chocolate during fluoxetine and Entitysertraline treatment : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of Entitythrombocytopenia associated with the administration of Entitylansoprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Special care should be taken when Entitypulmonary symptoms appear in association with Entityticlopidine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is well - recognized that Entityflucloxacillin may occasionally result in Entityfatal hepatic injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is the first case of Entityciprofloxacin - induced EntityVBDS successfully treated with tacrolimus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We attribute the clinical and radiographic findings to Entitycytotoxic edema secondary to intrathecal Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBenzocaine - induced Entitymethemoglobinemia has been reported in man, dogs, and cats.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySquamous - cell carcinoma arising in a basal - cell epithelioma treated with Entity5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRisperidone withdrawal - related Entityrespiratory dyskinesia : a case diagnosed by spirography and fibroscopy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Induction of Entityrapid mood cycling during EntityL - dopa treatment in a bipolar patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug induced Entitypolymyositis secondary to Entityleuprolide acetate ( Lupron ) therapy for prostate carcinoma.
0.9999 Adverse-Effect Drug induced Entitypolymyositis secondary to leuprolide acetate ( EntityLupron ) therapy for prostate carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylaxis to intravenous Entitycyclosporine and tolerance to oral cyclosporine : case report and review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute renal failure in a patient treated by continuous Entitypovidone - iodine mediastinal irrigation.
0.9999 Adverse-Effect EntityAcute renal failure in a patient treated by continuous povidone - Entityiodine mediastinal irrigation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the first case of Entitydisseminated salmonellosis in a patient treated with Entitytemozolomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect New onset of EntityCrohn's disease during treatment of active ankylosing spondylitis with Entityetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Topical Entitybrimonidine may be associated with Entitycentral nervous system depression in infants.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPseudomembranous colitis readily occurs in at least certain population groups receiving Entitytrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect EntityPseudomembranous colitis readily occurs in at least certain population groups receiving trimethoprim - Entitysulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe that the Entityacute renal failure in our patient was associated with Entityanastrozole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoclonus was induced and enhanced by EntityL - dopa , developing into Entitygeneralized seizures .
1.0000 Adverse-Effect EntityMyoclonus was induced and enhanced by EntityL - dopa , developing into generalized seizures.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Intravenous administration of levodopa ameliorated a refractory Entityakathisia case induced by Entityinterferon - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCutaneous seeding after ultrasound - guided percutaneous Entityethanol injection for treatment of hepatocellular carcinoma.
Adverse-Effect EntityCutaneous seeding after ultrasound - guided percutaneous Entityethanol injection for treatment of hepatocellular carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient presented with Entitydilated cardiomyopathy after many years of overusing an Entityadrenaline inhaler.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Are nasal decongestants safer than rhinitis? A case of Entityoxymetazoline - induced Entitysyncope .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sixteen of 33 patients developed significant hyponatremia and Entityhypoosmolality during oral treatment with Entitylorcainide .
1.0000 Adverse-Effect Sixteen of 33 patients developed significant Entityhyponatremia and hypoosmolality during oral treatment with Entitylorcainide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Serious Entityphenytoin Entityhypersensitivity reactions may appear as dermatologic, lymphoid, or hepatic syndromes.
0.9999 Adverse-Effect Serious Entityphenytoin hypersensitivity reactions may appear as Entitydermatologic, lymphoid, or hepatic syndromes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGemcitabine should be added to the list of drugs known to cause Entityradiation recall .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Symptomatic hypocalcaemia and Entityrenal impairment associated with Entitybisphosphonate treatment in patients with multiple myeloma.
0.9999 Adverse-Effect EntitySymptomatic hypocalcaemia and renal impairment associated with Entitybisphosphonate treatment in patients with multiple myeloma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one case, Entitydisulfiram was the only potential Entityteratogen exposed to the fetus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Conventional and diffusion - weighted MRI findings of Entitymethotrexate related Entitysub - acute neurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHOD : We describe three case - reports concerning Entityhaematological adverse effects of Entityquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Oral intake and Entityacarbose were withheld and the Entityileus spontaneously resolved after 2 days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityKaposi's sarcoma in a patient treated with Entityimatinib mesylate for chronic myeloid leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Entity2 - CdA induces Entitylymphocytopenia , which may explain the improvement in this patient's psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Entitytics in a thirteen - year - old male following Entityatomoxetine use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGynecomastia in epileptics treated with Entityphenobarbital , phenytoin and fluoresone : two case reports.
1.0000 Adverse-Effect EntityGynecomastia in epileptics treated with phenobarbital, Entityphenytoin and fluoresone : two case reports.
1.0000 Adverse-Effect EntityGynecomastia in epileptics treated with phenobarbital, phenytoin and Entityfluoresone : two case reports.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The two middle aged women presented with Entityrespiratory symptoms after prolonged treatment with Entitynitrofurantoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Visual system side effects caused by Entityparasympathetic dysfunction after Entitybotulinum toxin type B injections.
0.9988 Adverse-Effect EntityVisual system side effects caused by parasympathetic dysfunction after Entitybotulinum toxin type B injections.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeutropenic colitis during standard dose combination chemotherapy with Entitynedaplatin and irinotecan for testicular cancer.
1.0000 Adverse-Effect EntityNeutropenic colitis during standard dose combination chemotherapy with nedaplatin and Entityirinotecan for testicular cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pharmacokinetic determinants of Entity6 - mercaptopurine Entitymyelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This supports the well - reported potential of Entitybleomycin to trigger Entityacral vascular toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We discuss a variety of bronchopulmonary complications of EntityIBD and their association with Entitysulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate - induced Entitypapular eruption following treatment of psoriasis has not been previously reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute erythroid leukemia after Entitycyclophosphamide therapy for multiple myeloma : report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityibuprofen - induced Entitymeningitis in an otherwise healthy individual.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityFatal digoxin poisoning Entitydigoxin poisoning : an unsuccessful resuscitation with use of digoxin - immune Fab.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : EntityHeadaches have been reported as a potential side effect of Entitycapecitabine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTransient cardiac arrhythmias related to Entitylopinavir / ritonavir in two patients with HIV infection.
0.9999 Adverse-Effect EntityTransient cardiac arrhythmias related to lopinavir / Entityritonavir in two patients with HIV infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityChlorambucil - induced Entitychromosome damage to human lymphocytes is dose - dependent and cumulative.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A complex pattern of melanonychia and Entityonycholysis after treatment with Entitypemetrexed for lung cancer.
1.0000 Adverse-Effect A complex pattern of Entitymelanonychia and onycholysis after treatment with Entitypemetrexed for lung cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNiflumic acid - induced Entityskeletal fluorosis : iatrogenic disease or therapeutic perspective for osteoporosis?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Bone marrow aplasia and Entitysevere skin rash after a single low dose of Entitymethotrexate .
0.9999 Adverse-Effect EntityBone marrow aplasia and severe skin rash after a single low dose of Entitymethotrexate .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityDelayed pseudocyst of the pancreas can be a complication of intramuscular EntityL - asparaginase .
Score Relation Text (Head - Tail)
Adverse-Effect EntityDrug rash with eosinophilia and systemic symptoms after Entitychlorambucil treatment in chronic lymphocytic leukaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was initially treated with hydration and Entityfurosemide but developed Entitycongestive heart failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There are now reports of Entityliver failure following treatment of childhood cancers with EntityAMD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Calcification and Entityossification of the spinal arachnoid after intrathecal administration of EntityDepo - Medrol .
0.9998 Adverse-Effect EntityCalcification and ossification of the spinal arachnoid after intrathecal administration of EntityDepo - Medrol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association of central diabetes insipidus ( EntityCDI ) with Entitylithium use is rare.
0.9999 Adverse-Effect The association of Entitycentral diabetes insipidus ( CDI ) with Entitylithium use is rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProcainamide - induced Entityincessant supraventricular tachycardia in the Wolff - Parkinson - White syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityUpper tract urothelial malignancy after Entitycyclophosphamide therapy : a case report and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitysevere visual loss following a single dose of Entityvincristine is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Graves'hyperthyroidism following Entitytransient thyrotoxicosis during Entityinterferon therapy for chronic hepatitis type C.
0.9999 Adverse-Effect EntityGraves'hyperthyroidism following transient thyrotoxicosis during Entityinterferon therapy for chronic hepatitis type C.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After 5 weeks of therapy, she stopped taking Entitypantoprazole due to Entitygeneral malaise .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute severe intoxication with Entitycarbamazepine is associated with Entityseizures , coma and respiratory depression.
1.0000 Adverse-Effect Acute severe intoxication with Entitycarbamazepine is associated with seizures, coma and Entityrespiratory depression .
0.9999 Adverse-Effect Acute severe intoxication with Entitycarbamazepine is associated with seizures, Entitycoma and respiratory depression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a probable case of Entitytransient global amnesia caused by Entitypropafenone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This clinical course suggests that the Entitysensorimotor polyneuropathy may have been caused by Entity5 - ASA .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Vanishing bile duct and EntityStevens - Johnson syndrome associated with Entityciprofloxacin treated with tacrolimus.
0.9999 Adverse-Effect EntityVanishing bile duct and Stevens - Johnson syndrome associated with Entityciprofloxacin treated with tacrolimus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityParadoxical precipitation of tonic seizures by Entitylorazepam in a child with atypical absence seizures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCaptopril - induced Entitypulmonary infiltrates with eosinophilia in an infant with congenital heart disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reduction of Entitymethylprednisolone dosage rather than insulin therapy resulted in better control of Entityglycemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of chronic use of EntityHCQ associated with Entitytorsade de pointes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatolithiasis ( intrahepatic stone ) during Entityoctreotide therapy for acromegaly : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityglaucoma induced by Entitydoxetaxel therapy for metastatic breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLithium therapy was discontinued because of poor compliance to the medication and intolerable Entitypolyuria .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Horner's syndrome and Entitydemyelinating peripheral neuropathy caused by high - dose Entitycytosine arabinoside .
0.9997 Adverse-Effect EntityHorner's syndrome and demyelinating peripheral neuropathy caused by high - dose Entitycytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLeiomyosarcoma in urinary bladder after Entitycyclophosphamide therapy for retinoblastoma and review of bladder sarcomas.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors caution that treatment with Entityalprazolam may be complicated by the induction of Entitymania .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect To treat hepatitis B, Entityinterferon alpha was administered until the proximal Entitymuscle weakness developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAggressive endometrial carcinoma in a breast cancer patient treated with Entitytamoxifen with normal transvaginal ultrasonography.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two children with rheumatic fever developed Entityanicteric hepatitis while on high - dose Entityaspirin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMyoclonus associated with continuous Entitydobutamine infusion in a patient with end - stage renal disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Induction of Entitysystemic lupus erythematosus by Entityinterferon - gamma in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the case of Entityacute hepatitis induced by Entitygliclazide , a second generation sulfonylurea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcyclovir produces Entityneurologic symptoms that resemble extension of viral infection into the central nervous system.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the occurrence of Entityanaphylactoid reactions to intraperitoneal Entitycisplatin in 3 patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of polymyositis with Entitydilated cardiomyopathy associated with Entityinterferon alpha treatment for hepatitis B.
0.9996 Adverse-Effect A case of Entitypolymyositis with dilated cardiomyopathy associated with Entityinterferon alpha treatment for hepatitis B.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Focal glomerulonephritis and Entityinterstitial nephritis in Entitymethicillin - treated, heroin - related infective endocarditis.
0.9999 Adverse-Effect EntityFocal glomerulonephritis and interstitial nephritis in Entitymethicillin - treated, heroin - related infective endocarditis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two women who developed EntityHUS after EntityMMC therapy and presented massive pulmonary bleeding.
0.9999 Adverse-Effect We describe two women who developed HUS after EntityMMC therapy and presented Entitymassive pulmonary bleeding .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Basilar invagination and Entitymid - line skeletal abnormalities due to in utero exposure to Entityphenytoin .
1.0000 Adverse-Effect EntityBasilar invagination and mid - line skeletal abnormalities due to in utero exposure to Entityphenytoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : There is very little published information regarding Entityofloxacin - induced Entitytoxic epidermal necrolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While undergoing treatment with Entityalbendazole , he developed Entityworsening diarrhea with abdominal pain and fever.
1.0000 Adverse-Effect While undergoing treatment with Entityalbendazole , he developed worsening diarrhea with Entityabdominal pain and fever.
0.9999 Adverse-Effect While undergoing treatment with Entityalbendazole , he developed worsening diarrhea with abdominal pain and Entityfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of Entitypulmonary hypertension in an adult patient during Entitylithium therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCystoid macular edema in a low - risk patient after switching from Entitylatanoprost to bimatoprost.
0.9999 Adverse-Effect EntityCystoid macular edema in a low - risk patient after switching from latanoprost to Entitybimatoprost .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient's Entityarthritis flared after the second infusion of Entityinfliximab , which was discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, parenteral Entityamiodarone was implicated as the cause of Entityacute hepatitis in this patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The other patient developed Entitytransient intraoperative hypertension immediately after inadvertent submucosal injection of concentrated Entityepinephrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySustained ventricular tachycardia in a Entitythalidomide - treated patient with primary plasma - cell leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVogt - Koyanagi - Harada disease occurring during Entityinterferon alpha therapy for chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following discontinuation of Entityclozapine , she was rechallenged and again was observed to have Entityseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Discontinuation of simvastatin and Entitycyclosporine resulted in resolution of Entityrhabdomyolysis and normalization of renal function.
1.0000 Adverse-Effect Discontinuation of Entitysimvastatin and cyclosporine resulted in resolution of Entityrhabdomyolysis and normalization of renal function.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClozapine is speculated to cause Entityrhabdomyolysis in patients with defective calcium - activated K + channels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRecurrent palmar - plantar erythrodysaesthesia following high - dose Entitycytarabine treatment for acute lymphoblastic leukemia.
Adverse-Effect Recurrent Entitypalmar - plantar erythrodysaesthesia following high - dose Entitycytarabine treatment for acute lymphoblastic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal tubular acidosis secondary to EntityFK506 in living donor liver transplantation : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year - old man with rheumatoid arthritis developed Entitylichen planus during treatment with Entitygold .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present an AIDS patient with severe and prolonged Entitylactic acidosis on Entitystavudine and lamivudine.
0.9999 Adverse-Effect We present an AIDS patient with severe and prolonged Entitylactic acidosis on stavudine and Entitylamivudine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDiphenylhydantoin apparently adversely affected both the clinical and biochemical parameters of the Entityacute intermittent porphyria .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients who were receiving EntityTolazoline by infusion developed Entityduodenal ulceration and subsequent intestinal perforation.
0.9999 Adverse-Effect Two patients who were receiving EntityTolazoline by infusion developed duodenal ulceration and subsequent Entityintestinal perforation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here, we report a case of EntityRFP - induced Entityhypothyroidism without underlying thyroid disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGeneralized maculopapular and papular purpuric eruptions are perhaps the most common Entitythionamide - induced reactions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case illustrates the potential Entitydecoupling of PSA response from disease status in Entityflutamide withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIntracranial haemorrhage from a meningioma in a patient receiving Entityaspirin prophylaxis : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is likely that EntityRA contributed to the Entitydeterioration in renal function in these patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 21 - year - old female patient with Entitydapsone Entityhypersensitivity syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNitrofurantoin - induced Entitylung disease : two cases demonstrating resolution of apparently irreversible CT abnormalities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere hemolytic uremic syndrome in an advanced ovarian cancer patient treated with Entitycarboplatin and gemcitabine.
1.0000 Adverse-Effect EntitySevere hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and Entitygemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Polyarthritis, hepatitis and Entityanti - native DNA antibodies after treatment with Entityethambutol and rifampicin.
1.0000 Adverse-Effect Polyarthritis, Entityhepatitis and anti - native DNA antibodies after treatment with Entityethambutol and rifampicin.
1.0000 Adverse-Effect EntityPolyarthritis , hepatitis and anti - native DNA antibodies after treatment with Entityethambutol and rifampicin.
0.9999 Adverse-Effect Polyarthritis, Entityhepatitis and anti - native DNA antibodies after treatment with ethambutol and Entityrifampicin .
0.9999 Adverse-Effect Polyarthritis, hepatitis and Entityanti - native DNA antibodies after treatment with ethambutol and Entityrifampicin .
0.9999 Adverse-Effect EntityPolyarthritis , hepatitis and anti - native DNA antibodies after treatment with ethambutol and Entityrifampicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There was a clear relationship between restarting the EntityAccutane and recurrence of the Entitytransient myopia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first Entitygranulomatous reaction described after Entitycalcium hydroxylapatite injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myelodysplasia terminating in Entityacute myeloid leukemia in a hairy cell leukemia patient treated with Entity2 - deoxycoformycin .
0.9999 Adverse-Effect EntityMyelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with Entity2 - deoxycoformycin .
Score Relation Text (Head - Tail)
Adverse-Effect EntityProconvulsive tendency of imipenem / Entitycilastatin is one of its well - known side effects.
Adverse-Effect EntityProconvulsive tendency of Entityimipenem / cilastatin is one of its well - known side effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thoracoscopic biopsy to confirm metastasis revealed instead Entityfibrotic lesions apparently attributable to Entitybleomycin or cyclophosphamide.
1.0000 Adverse-Effect Thoracoscopic biopsy to confirm metastasis revealed instead Entityfibrotic lesions apparently attributable to bleomycin or Entitycyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFlecainide - associated Entitypneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome.
0.9998 Adverse-Effect EntityFlecainide - associated pneumonitis with Entityacute respiratory failure in a patient with the LEOPARD syndrome.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of Entitycontact dermatitis due to Entitysodium bisulfite in Tathion eye drops.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient : a complication of Entitycyclophosphamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityEpsilon - aminocaproic acid and Entityrenal complications : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The use of Entitybeclomethasone diproprionate inhaler complicated by the development of an Entityeosinophilic pneumonia reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDe novo absence status of late onset following withdrawal of Entitylorazepam : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two elderly women suffered an Entityacute deterioration of renal function after treatment with Entitycefoxitin sodium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case study : a modified topical treatment regimen for sodium Entitywarfarin - induced Entitynecrotizing fasciitis .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityThyroid dysfunction has been reported in patients with malignant disease treated with Entityrecombinant alpha interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : EntityAccutane a Entityteratogenic prescription drug licensed to treat severe, recalcitrant nodular acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The use of Entitycyclosporin has been associated with the development of Entitycholelithiasis in transplant recipients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : These cases suggest that Entitymoxifloxacin may interfere with the healing of Entitycorneal ulcers .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The literature on Entitythiabendazole - induced Entitycholestasis and its association with sicca complex is reviewed.
0.9999 Adverse-Effect The literature on Entitythiabendazole - induced cholestasis and its association with Entitysicca complex is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients with vitamin B12 deficiency are exceedingly sensitive to Entityneurologic deterioration following Entitynitrous oxide anesthesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should include Entityphenolphthalein in their list of possible causes of drug - induced EntityTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityStatin - associated Entitymyasthenia gravis : report of 4 cases and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fever, pulmonary infiltrates, and Entitypleural effusion following Entityacyclovir therapy for herpes zoster ophthalmicus.
0.9999 Adverse-Effect EntityFever , pulmonary infiltrates, and pleural effusion following Entityacyclovir therapy for herpes zoster ophthalmicus.
0.9999 Adverse-Effect Fever, Entitypulmonary infiltrates , and pleural effusion following Entityacyclovir therapy for herpes zoster ophthalmicus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, other factors or drugs ( e. g. Entitycresol ) are thought to induce EntityMH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two cases of Entityneutropenia following Entitycaptopril use in cardiac patients with trisomy 21.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Entityalterations in heart rate after the use of Entityadenosine in atrial flutter.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityliver damage following treatment with EntityDanazol for fibrocystic breast disease is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Alopecia, nausea, and Entityvomiting were attributed to the Entitycyclophosphamide component of the therapy.
1.0000 Adverse-Effect Alopecia, Entitynausea , and vomiting were attributed to the Entitycyclophosphamide component of the therapy.
1.0000 Adverse-Effect EntityAlopecia , nausea, and vomiting were attributed to the Entitycyclophosphamide component of the therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one case, the readministration of Entityriluzole was followed by the relapse of Entityhepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySubfulminant hepatitis B after Entityinfliximab in Crohn's disease : need for HBV - screening?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySystemic capillary leak syndrome after Entitygranulocyte colony - stimulating factor ( G - CSF ).
0.9992 Adverse-Effect EntitySystemic capillary leak syndrome after granulocyte colony - stimulating factor ( EntityG - CSF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Markedly Entityincreased pigmementation of skin immediately overlying veins used for multiple Entity5 - fluorouracil infusions was noted.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere hyperkalemia as a complication of Entitytimolol , a topically applied beta - adrenergic antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the second report of Entitylactic acidosis in a patient on Entitystavudine and lamivudine.
1.0000 Adverse-Effect This is the second report of Entitylactic acidosis in a patient on stavudine and Entitylamivudine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Entityeosinophilia is a non - dose - dependent side effect of Entityclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A review of the literature showed no previous description of this pattern in Entitybenzodiazepine Entitycoma .
0.9993 Adverse-Effect A review of the literature showed no previous description of this pattern in Entitybenzodiazepine Entitybenzodiazepine coma .
0.9159 Adverse-Effect A review of the literature showed no previous description of this pattern in Entitybenzodiazepine coma Entitycoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of intrathecal Entitymethotrexate Entityneurotoxicity manifesting as left arm weakness and aphasia.
0.9998 Adverse-Effect We report a case of intrathecal Entitymethotrexate neurotoxicity manifesting as left arm weakness and Entityaphasia .
0.9997 Adverse-Effect We report a case of intrathecal Entitymethotrexate neurotoxicity manifesting as Entityleft arm weakness and aphasia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prior neurologic illness and the syndrome of irreversible Entitylithium - effectuated Entityneurotoxicity ( SILENT ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Herein we report four patients who underwent liver transplantation and developed Entityneutropenia while receiving EntityMMF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Multiple myeloma complicated by Entitycongestive heart failure following first administration of Entityrecombinant alpha - interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, Entitytacrolimus - induced EntityHUS is a rare cause of ARF in nephrotic syndrome.
0.9999 Adverse-Effect Thus, Entitytacrolimus - induced HUS is a rare cause of EntityARF in nephrotic syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect According to the Naranjo probability scale, the Entitypapular eruption was probably caused by Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCerebral demyelinating disease developed in a patient during adjuvant therapy with Entitylevamisole for malignant melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, re - initiation of Entitysunitinib treatment was followed by Entitybilateral breast enlargement again.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients developed Entitydiabetic coma when taking a combination of a Entitythiazide diuretic and propranolol.
1.0000 Adverse-Effect Two patients developed Entitydiabetic coma when taking a combination of a thiazide diuretic and Entitypropranolol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Surprisingly, we found that three patients appeared to develop Entitytardive OGC while taking Entityclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect So far, few cases of Entitypulmonary side effects caused by Entityticlopidine have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The present findings suggest that Entityfluvoxamine can cause Entityincreased libido in some patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal hypophosphatemia in this patient was caused by the erroneous intake of 1 g Entitydoxycycline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal pulmonary fibrosis induced by Entitypaclitaxel : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAdrenal suppression in a fetus due to administration of Entitymethylprednisolone has hitherto been rarely published.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cis - retinoic acid ( EntityRA ) may further increase the risk of developing EntityBMTN .
0.9999 Adverse-Effect EntityCis - retinoic acid ( RA ) may further increase the risk of developing EntityBMTN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 3 cases of Entitydiphenhydramine - induced Entitycardiac toxicity that were responsive to bicarbonate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropoxyphene - induced Entitywide QRS complex dysrhythmia responsive to sodium bicarbonate - - a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPleuropulmonary fibrosis after long - term treatment with the dopamine agonist Entitypergolide for Parkinson Disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute onset of Entitynephrotic syndrome during Entityinterferon - alpha retreatment for chronic active hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySweet's syndrome associated with Entitysargramostim ( granulocyte - macrophage colony stimulating factor ) treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Entitydoxycycline - induced Entityhypoglycemia in a young nondiabetic man.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Under the suspicion of Entityamiodarone - induced Entityacute pancreatitis , amiodarone was substituted by propafenone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A diagnosis of Entityinfliximab - induced Entitylupus was made and the drug treatment was withdrawn.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Aggressive management of Entitydoxorubicin - induced Entitycardiomyopathy associated with'low'doses of doxorubicin.
0.9945 Adverse-Effect Aggressive management of doxorubicin - induced Entitycardiomyopathy associated with'low'doses of Entitydoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypertension develops in most patients after transplantation when immunosuppression is based on Entitycyclosporine and prednisone.
1.0000 Adverse-Effect EntityHypertension develops in most patients after transplantation when immunosuppression is based on cyclosporine and Entityprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, each infant demonstrated Entityhemodynamic decompensation shortly after Entityverapamil administration and required cardiopulmonary resuscitation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityaseptic pleuropericarditis in a patient with chronic plaque psoriasis under Entitymethotrexate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a Entitybullous lichenoid eruption due to the intake of Entitycaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therapy with EntityIFN - beta has rarely been associated with the development of Entityautoimmune disorders .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The side effects of EntityMMF , such as Entitybone marrow toxicity , have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypoglycemia induced by long - acting Entitysomatostatin analogues in a patient with nonfunctional neuroendocrine tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : Symptomatic Entityvisual field constriction thought to be associated with Entityvigabatrin has been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An 11 - day - old infant became lethargic and Entityapneic after a single drop of Entitybrimonidine .
1.0000 Adverse-Effect An 11 - day - old infant became Entitylethargic and apneic after a single drop of Entitybrimonidine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ballistic movements due to Entityischemic infarcts after intravenous Entityheroin overdose : report of two cases.
0.9999 Adverse-Effect EntityBallistic movements due to ischemic infarcts after intravenous Entityheroin overdose : report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although myelosuppression is mild, immunosuppression and Entitysuperinfection are potential hazards of treatment with EntityDCF .
0.9999 Adverse-Effect Although myelosuppression is mild, Entityimmunosuppression and superinfection are potential hazards of treatment with EntityDCF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this recurrence of Entityamiodarone Entitypulmonary toxicity has not been reported previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : EntitySquamous metaplasia in these cases appears to be a consequence of Entityprogestin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient in whom Entitynoncardiogenic pulmonary edema developed during intrabiliary infusion of Entitymonooctanoin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Occurrence of withdrawal Entitydyskinesia indicates that the neuroleptic effects of Entityamoxapine may be clinically significant.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityPulmonary fibrosis is a severe complication associated with Entitybis - chloronitrosourea ( BCNU ) therapy.
0.9997 Adverse-Effect EntityPulmonary fibrosis is a severe complication associated with bis - chloronitrosourea ( EntityBCNU ) therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be aware of the possibility that Entityvinorelbine may cause EntitySIADH and possibly hypokalemia.
1.0000 Adverse-Effect Clinicians should be aware of the possibility that Entityvinorelbine may cause SIADH and possibly Entityhypokalemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early recognition of Entityrenal toxicity of high - dose Entitymethotrexate therapy : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReactivation of cytomegalovirus probably followed the treatment of Wegener's granulomatosis with corticosteroids and Entityazathioprine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInfections are a major adverse effect during the treatment with Entityanti - TNF - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entity15 - kg weight gain developed in a patient during the third week of Entityibuprofen therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nephrogenic diabetes insipidus ( EntityNDI ) is a well - documented complication of Entitylithium use.
1.0000 Adverse-Effect EntityNephrogenic diabetes insipidus ( NDI ) is a well - documented complication of Entitylithium use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Introduction of Entityetanercept was also clinically effective but followed by development of Entitysevere heart failure .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Nineteen cases of unusual enhanced Entityvincristine Entityneurotoxicity related to itraconazole have been reported in children.
0.9999 Adverse-Effect Nineteen cases of unusual enhanced vincristine Entityneurotoxicity related to Entityitraconazole have been reported in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropranolol : an unrecognized cause of Entitycentral nervous system dysfunction in patients undergoing cardiopulmonary bypass.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere acidosis in patients taking Entitymetformin - - rapid reversal and survival despite high APACHE score.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a child with fatal Entityvalproate - related Entityhepatotoxic effects despite this supplementation.
Adverse-Effect We report on a child with Entityfatal Entityvalproate - related hepatotoxic effects despite this supplementation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypogammaglobulinemia associated with Entitygold therapy : evidence for a partial maturation blockade of B cells.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Erythromycin is a macrolide antibiotic that may increase the risk of Entitylovastatin - induced Entityrhabdomyolysis .
0.9997 Adverse-Effect EntityErythromycin is a macrolide antibiotic that may increase the risk of lovastatin - induced Entityrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mechanism of Entityanaphylactoid reaction to Entityzomepirac in this case, therefore, remains unclear.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, the occurrence and management of Entityakathisia induced by Entityfluvoxamine have not been described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Upon discontinuation of EntityMTX , her Entityascites resolved, and her arthritis became more active.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary fibrosis is a complication of Entitypaclitaxel therapy that may occur despite treatments with corticosteroids.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Onset of male Entitygynaecomastia in a patient treated with Entitysunitinib for metastatic renal cell carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethemoglobinemia after axillary block with Entitybupivacaine and additional injection of lidocaine in the operative field.
0.9999 Adverse-Effect EntityMethemoglobinemia after axillary block with bupivacaine and additional injection of Entitylidocaine in the operative field.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute dystonia with Entitythalamic and brainstem lesions after initial Entitypenicillamine treatment in Wilson's disease.
0.9999 Adverse-Effect EntityAcute dystonia with thalamic and brainstem lesions after initial Entitypenicillamine treatment in Wilson's disease.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In two patients Entityclozapine was reinstated after risperidone was discontinued ; Entityserum triglyceride levels increased .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNifedipine may induce, or aggravate, pre - existing, Entitygastro - oesophageal reflux .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A major limitation in the use of Entityamphotericin B is its potential to cause Entitynephrotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After receiving 3 doses of ifosfamide / Entitymesna , she was found to be Entityunresponsive .
1.0000 Adverse-Effect After receiving 3 doses of Entityifosfamide / mesna, she was found to be Entityunresponsive .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRhabdomyolysis caused by tocolysis with oral Entityritodrine hydrochloride in a pregnant patient with myotonic dystrophy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of EntitySIADH associated with Entitydesipramine treatment in an elderly depressed woman is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We assume that EntityrIFN - gamma induced the de novo development of EntitySLE in our patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypernatraemia induced by Entitysodium polystyrene sulphonate ( Kayexalate ) in two extremely low birth weight newborns.
0.9997 Adverse-Effect EntityHypernatraemia induced by sodium polystyrene sulphonate ( EntityKayexalate ) in two extremely low birth weight newborns.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRifampicin - induced Entityadrenal insufficiency in the acquired immunodeficiency syndrome : difficulties in diagnosis and treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRituximab - CHOP induced Entityinterstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early - onset Entityacute transverse myelitis following Entityhepatitis B vaccination and respiratory infection : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is presented which illustrates a probably Entityfatal interaction between Entityminoxidil and a coagulation disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed transient, Entityacute myopia while on Entityisotretinoin ( Accutane ) therapy for acne.
0.9999 Adverse-Effect A patient developed transient, Entityacute myopia while on isotretinoin ( EntityAccutane ) therapy for acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient that received Entitymethadone for cancer - associated pain developed Entitymyoclonus as a side effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recovery of the Entitytubular dysfunction took 15 days following cessation of the offending drug, EntityAmikacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal toxicities have been reported in less than one percent of the patients receiving Entityciprofloxacin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoglobinuria and Entityacute renal failure were observed in two patients with Entityvasopressin - treated gastrointestinal hemorrhage.
0.9999 Adverse-Effect EntityMyoglobinuria and acute renal failure were observed in two patients with Entityvasopressin - treated gastrointestinal hemorrhage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityValproic acid induced Entitycoma is presented in an adult patient without a history of metabolic disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two patients with Entityinfectious mononucleosis - like syndrome induced by Entitysalazosulfapyridine ( SASP ).
0.9999 Adverse-Effect We report two patients with Entityinfectious mononucleosis - like syndrome induced by salazosulfapyridine ( EntitySASP ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect over the past 3 years there have been several reports of Entityuveitis associated with Entityrifabutin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPosterior leukoencephalopathy following Entitycisplatin , bleomycin and vinblastine therapy for germ cell tumor of the ovary.
0.9999 Adverse-Effect EntityPosterior leukoencephalopathy following cisplatin, Entitybleomycin and vinblastine therapy for germ cell tumor of the ovary.
0.9998 Adverse-Effect EntityPosterior leukoencephalopathy following cisplatin, bleomycin and Entityvinblastine therapy for germ cell tumor of the ovary.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityColonic mucosal necrosis following administration of Entitycalcium polystryrene sulfonate ( Kalimate ) in a uremic patient.
0.9999 Adverse-Effect EntityColonic mucosal necrosis following administration of calcium polystryrene sulfonate ( EntityKalimate ) in a uremic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients are described in whom subtle Entitycognitive impairments are associated with therapeutic doses of Entityamoxapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, Entitytardive seizures in our cases are thought to be related to Entitypiperacillin and cefotiam.
0.9999 Adverse-Effect Thus, Entitytardive seizures in our cases are thought to be related to piperacillin and Entitycefotiam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySecondary leukemia in a child with neuroblastoma while on oral Entityetoposide : what is the cause?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The incidence of Entityangioedema secondary to Entitylosartan , an angiotensin II receptor antagonist, is unknown.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case report of a patient with probable cisplatin and Entitybleomycin - induced EntityTMA is presented.
0.9998 Adverse-Effect A case report of a patient with probable Entitycisplatin and bleomycin - induced EntityTMA is presented.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntitySkin necrosis secondary to Entitylow - molecular weight heparin in a patient with antiphospholipid antibody syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These case reports provide evidence that Entity5 - aminosalicylic acid may induce Entityacute pancreatitis after long term treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The fifth patient exhibited paraesthesia and Entityagitation caused by Entityolanzapine that was misdiagnosed as psychotic agitation.
0.9999 Adverse-Effect The fifth patient exhibited Entityparaesthesia and agitation caused by Entityolanzapine that was misdiagnosed as psychotic agitation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere respiratory syncytial virus pulmonary infection in a patient treated with Entityfludarabine for chronic lymphocytic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a case of cardiovascular and Entityneurological depression induced by Entityoxymetalzoline in a toddler.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dihydropyrimidine dehydrogenase deficiency : a pharmacogenetic defect causing Entitysevere adverse reactions to Entity5 - fluorouracil - based chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThrombotic stroke associated with the use of Entityporcine factor VIII in a patient with acquired haemophilia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe four patients who had Entityseizures while receiving Entityofloxacin ; no other causes were evident.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two adults who received gabapentin ( EntityGBP ) and subsequently developed Entitybehavioural side effects .
0.9999 Adverse-Effect We report two adults who received Entitygabapentin ( GBP ) and subsequently developed Entitybehavioural side effects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When tuberculosis patients on Entityisoniazid eat certain varieties of fish they may develop a Entityhistamine reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityexfoliative dermatitis clearly linked to intravenous and intraperitoneal administration of Entitytobramycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Within 24 hours of fluid restriction and cessation of Entitydesmopressin , her symptoms and Entityhyponatremia resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hepatitis with bridging fibrosis and Entityreversible hepatic insufficiency in a woman with rheumatoid arthritis taking Entitymethotrexate .
1.0000 Adverse-Effect EntityHepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking Entitymethotrexate .
1.0000 Adverse-Effect Hepatitis with Entitybridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 64 - year - old man with schizophrenia developed Entitymyoclonic jerks when given higher doses of Entityquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute renal failure is a rare complication following the administration of intravenous Entityimmunoglobulin ( IVIG ).
1.0000 Adverse-Effect Acute Entityrenal failure is a rare complication following the administration of intravenous Entityimmunoglobulin ( IVIG ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is concluded that simultaneous administration of ciprofloxacin and tazobactam / Entitypiperacillin may cause marked Entitythrombocytosis .
0.9999 Adverse-Effect It is concluded that simultaneous administration of ciprofloxacin and Entitytazobactam / piperacillin may cause marked Entitythrombocytosis .
0.9999 Adverse-Effect It is concluded that simultaneous administration of Entityciprofloxacin and tazobactam / piperacillin may cause marked Entitythrombocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The present report describes the first case of Entityacute pancreatitis associated with Entitydanazol treatment of endometriosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Emergence of EntityPhiladelphia positive chronic myeloid leukaemia during treatment with Entityhydroxyurea for Philadelphia negative essential thrombocythaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient experienced muscle twitches, tremulousness, and Entityanxiety on day 17 of Entityfoscarnet therapy.
1.0000 Adverse-Effect The patient experienced muscle twitches, Entitytremulousness , and anxiety on day 17 of Entityfoscarnet therapy.
0.9999 Adverse-Effect The patient experienced Entitymuscle twitches , tremulousness, and anxiety on day 17 of Entityfoscarnet therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityScrotal ulceration induced by Entityall - trans retinoic acid in a patient with acute promyelocytic leukemia.
Adverse-Effect EntityScrotal ulceration induced by all - trans Entityretinoic acid in a patient with acute promyelocytic leukemia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Acute Entityesmolol Entityesmolol toxicity may be self - limiting because of its extremely short half - life.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a surprising case of a woman schizophrenic patient treated with Entityclozapine suffering from EntityEPS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first description, to our knowledge, of Entityductopenia apparently caused by Entityclindamycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this case is the first published report of Entitylevofloxacin - induced EntityTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCutaneous sarcoidosis during Entityinterferon alfa and ribavirin treatment of hepatitis C virus infection : two cases.
0.9997 Adverse-Effect EntityCutaneous sarcoidosis during interferon alfa and Entityribavirin treatment of hepatitis C virus infection : two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLichen planus induced by Entityhepatitis B vaccination : a new case and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityContact dermatitis due to Entitybudesonide : report of five cases and review of the Japanese literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Potential mechanisms involved in the occurrence of Entityischemic colitis in patients receiving Entitytegaserod are also discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In four patients, Entityspasm occurred spontaneous and in one patient after 0. 05 mg of Entityergonovine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There is a dose - effect relationship between Entitydoxorubicin and the incidence of Entitysymptomatic cardiac failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A rechallenge, performed in both patients, confirmed the diagnosis of Entitymesalamine - induced Entitypancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The findings in these two patients suggest that Entitycolchicine may Entitydelay corneal wound healing .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 69 - year - old man developed Entitypure red cell aplasia after taking Entityfenoprofen for ten months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect New onset of CD may be considered as an Entityimmune - mediated injury induced by Entityetanercept .
0.9999 Adverse-Effect New onset of EntityCD may be considered as an immune - mediated injury induced by Entityetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients with no history of asthma or allergy developed Entitybronchospasm while taking Entitypropranolol for hypertension.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect OBJECTIVE : To report a case of EntityCarbamazepine toxicity following the administration of EntityOxybutynin and Dantrolene.
0.9995 Adverse-Effect OBJECTIVE : To report a case of EntityCarbamazepine EntityCarbamazepine toxicity following the administration of Oxybutynin and Dantrolene.
0.9984 Adverse-Effect OBJECTIVE : To report a case of EntityCarbamazepine toxicity following the administration of Oxybutynin and EntityDantrolene .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The delayed Entityencephalopathy developed 9 and 22 months respectively after the first dose of intrathecal Entitymethotrexate .
Score Relation Text (Head - Tail)
0.9977 Adverse-Effect Hepatotoxicity associated with choline magnesium trisalicylate : case report and review of Entitysalicylate - induced Entityhepatotoxicity .
Adverse-Effect EntityHepatotoxicity associated with Entitycholine magnesium trisalicylate : case report and review of salicylate - induced hepatotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySulfasalazine has been associated with Entitybronchopulmonary complications of inflammatory bowel disease ( IBD ) in adults.
1.0000 Adverse-Effect EntitySulfasalazine has been associated with bronchopulmonary complications of inflammatory bowel disease ( EntityIBD ) in adults.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityZoledronic acid - induced Entitysevere hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInfliximab therapy may cause a Entitylupus - like syndrome that is reversible upon discontinuing this agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : This case shows that switching to Entityzidovudine potentially can lead to a Entityhyperlactatemia relapse .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 15 - year follow - up of Entityphenytoin - induced Entityunilateral gingival hyperplasia : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This finding suggests that Entityfluvoxamine can precipitate EntitySchneiderian first - rank symptoms in some susceptible patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The hearing impairment and Entitytinnitus were gradually reduced after EntityPTU withdrawal and corticosteroid and azathioprine treatment.
0.9989 Adverse-Effect The Entityhearing impairment and tinnitus were gradually reduced after EntityPTU withdrawal and corticosteroid and azathioprine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The changes were progressive regardless of discontinuation of Entitycyclophosphamide and led to Entitysevere restrictive ventilatory defect .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere hyperkalemia occurred in a patient with radiation pneumonitis and glaucoma shortly after beginning Entityprednisone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGlomerulonephritis in Entityprocainamide induced lupus erythematosus : report of a case and review of the literature.
1.0000 Adverse-Effect Glomerulonephritis in Entityprocainamide induced Entitylupus erythematosus : report of a case and review of the literature.
Score Relation Text (Head - Tail)
0.9983 Adverse-Effect Atrial fibrillation was induced by diltiazem in two patients and Entityverapamil induced Entitysyncope in one patient.
0.9932 Adverse-Effect EntityAtrial fibrillation was induced by Entitydiltiazem in two patients and verapamil induced syncope in one patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To present a single case of Entityzuclopenthixol - induced Entitypriapism and a literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityallopurinol Entityhypersensitivity , possibly the first in a black African, is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prolonged used of Entityhydroxyurea in patients with ET may lead to therapy - associated Entityacute leukemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySulfasalazine - induced Entityhypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein - Barr virus.
1.0000 Adverse-Effect EntitySulfasalazine - induced hypersensitivity syndrome and Entityhemophagocytic syndrome associated with reactivation of Epstein - Barr virus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one child, a second course of Entitycarbamazepine resulted in a return of the Entitydystonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Two patients with ocular inflammation of unknown origin developed Entitysevere chorioretinitis after EntityIVTA injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Flumazenil reversal of Entitybenzodiazepine - induced Entitysedation for a patient with severe pre - ECT anxiety.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These multiple overlapping factors probably lead to Entityrhabdomyolysis in a minority of patients receiving Entityvasopressin infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Six patients with rheumatoid arthritis developed a syndrome resembling Entitylupus erythematosus while being treated with Entitypenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute neutrophilic dermatosis induced by Entityall - trans - retinoic acid treatment for acute promyelocytic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A second episode of Entityjaundice followed the intravaginal administration of a mixture of Entityfurazolidone and nifuroxime.
1.0000 Adverse-Effect A second episode of Entityjaundice followed the intravaginal administration of a mixture of furazolidone and Entitynifuroxime .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, the Entitytachycardia persisted and was repeatedly spontaneously reinitiated for prolonged periods after Entityprocainamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Within 6 months of Entitypranlukast withdrawal, Entityanemia resolved and urinary sediment and renal function normalized.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Successful treatment of hyperthyroidism with amiodarone in a patient with Entitypropylthiouracil - induced Entityacute hepatic failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An objective causality assessment suggests that the EntityJHR in our patient was probably related to Entitypenicillin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute pancreatitis in a child with idiopathic ulcerative colitis on long - term Entity5 - aminosalicylic acid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Systemic disease, most commonly renal dysfunction, preceded all 30 reported cases of Entityacyclovir Entityneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of Entitypolymorphic ventricular tachycardia induced by the administration of Entityverapamil against paroxysmal supraventricular tachycardia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first case of Entityhydroxyurea - induced Entityacute interstitial pneumonitis reported in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitysub - conjunctival haematoma in a patient receiving Entitywarfarin can pose a significant management challenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGemcitabine therapy has been associated with Entityradiation recall reactions when used in the treatment of carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySkin necrosis is a rare complication of subcutaneous Entityheparin therapy that usually occurs at injection sites.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It may cause a severe adverse drug reaction with multiorgan involvement known as Entitydapsone Entityhypersensitivity syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReversible sclerotic changes of lumbar spine and femur due to long - term oral Entityisotretinoin therapy.
Adverse-Effect Reversible Entitysclerotic changes of lumbar spine and femur due to long - term oral Entityisotretinoin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We explored Entityophthalmic and neurologic findings in two children who have been exposed prenatally to EntityVGB .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possible role of Entityinterferon beta in the pathogenesis of Entitysarcoidosis in this patient is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed transient Entitypanhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with Entityprednisolone and cyclophosphamide.
0.9999 Adverse-Effect We observed transient Entitypanhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with prednisolone and Entitycyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMassive prolapse of the urethral mucosa following periurethral injection of Entitycalcium hydroxylapatite for stress urinary incontinence.
1.0000 Adverse-Effect Massive prolapse of the Entityurethral mucosa following periurethral injection of Entitycalcium hydroxylapatite for stress urinary incontinence.
Adverse-Effect Massive Entityprolapse of the urethral mucosa following periurethral injection of Entitycalcium hydroxylapatite for stress urinary incontinence.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the second report of acute lung injury and Entitydiffuse alveolar damage caused by Entitymefloquine .
0.9999 Adverse-Effect This is the second report of Entityacute lung injury and diffuse alveolar damage caused by Entitymefloquine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySudden death in an infant from methemoglobinemia after administration of " Entitysweet spirits of nitre ".
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with rheumatoid arthritis developed an Entityacute intrahepatic cholestasis after 100 mg of Entitysodium aurothiomalate .
Adverse-Effect A patient with rheumatoid arthritis developed an acute Entityintrahepatic cholestasis after 100 mg of Entitysodium aurothiomalate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute myopathy with selective Entitydegeneration of myosin filaments following status asthmaticus treated with Entitymethylprednisolone and vecuronium.
1.0000 Adverse-Effect Acute myopathy with selective Entitydegeneration of myosin filaments following status asthmaticus treated with methylprednisolone and Entityvecuronium .
0.9999 Adverse-Effect EntityAcute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with Entitymethylprednisolone and vecuronium.
0.9998 Adverse-Effect EntityAcute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and Entityvecuronium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We discuss the association between Entitycarbamazepine and Entityhyponatremia and the causes of hyponatremia after cardiopulmonary bypass.
0.9998 Adverse-Effect We discuss the association between Entitycarbamazepine and hyponatremia and the causes of Entityhyponatremia after cardiopulmonary bypass.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitybarbiturate - induced Entitysubmassive hepatic necrosis is presented and the literature is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entityreversible toxic liver damage was observed in a non - alcoholic woman treated with Entitydisulfiram .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHaemolytic - uraemic syndrome complicating long - term Entitymitomycin C and 5 - fluorouracil therapy for gastric carcinoma.
0.9999 Adverse-Effect EntityHaemolytic - uraemic syndrome complicating long - term mitomycin C and Entity5 - fluorouracil therapy for gastric carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityZidovudine use in pregnancy : a report on 104 cases and the occurrence of Entitybirth defects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCoagulopathy associated with the use of Entitycephalosporin or moxalactam antibiotics in acute and chronic renal failure.
1.0000 Adverse-Effect EntityCoagulopathy associated with the use of cephalosporin or Entitymoxalactam antibiotics in acute and chronic renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pulmonary hemorrhage as a clinical manifestation of Entityhemolytic - uremic syndrome associated with Entitymitomycin C therapy.
0.9989 Adverse-Effect EntityPulmonary hemorrhage as a clinical manifestation of hemolytic - uremic syndrome associated with Entitymitomycin C therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySyringotropic hypersensitivity reaction associated with Entityinfliximab and leflunomide combination therapy in a child with psoriatic arthritis.
0.9999 Adverse-Effect EntitySyringotropic hypersensitivity reaction associated with infliximab and Entityleflunomide combination therapy in a child with psoriatic arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of a Entitycatatonic syndrome occurring in a patient receiving Entitydisulfiram treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DLST is a good diagnostic tool for EntityAZA Entityallergy , especially for severe drug allergy cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitytimolol - associated Entityheart failure in a 73 - year old white man is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a renal transplant recipient maintained on cyclosporine and Entityprednisone developing EntityNocardia Asteroides brain abscess .
0.9999 Adverse-Effect We describe a renal transplant recipient maintained on Entitycyclosporine and prednisone developing EntityNocardia Asteroides brain abscess .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Visceral leishmaniasis and Entitymacrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with Entityadalimumab .
1.0000 Adverse-Effect EntityVisceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with Entityadalimumab .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Cholesterol crystal embolization - associated Entityrenal failure after therapy with recombinant Entitytissue - type plasminogen activator .
0.9969 Adverse-Effect EntityCholesterol crystal embolization - associated renal failure after therapy with recombinant Entitytissue - type plasminogen activator .
1.0000 Adverse-Effect Cholesterol crystal embolization - associated Entityrenal failure after therapy with Entityrecombinant tissue - type plasminogen activator .
0.9992 Adverse-Effect EntityCholesterol crystal embolization - associated renal failure after therapy with Entityrecombinant tissue - type plasminogen activator .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHeparin - induced Entitythrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement.
0.9998 Adverse-Effect EntityHeparin - induced thrombocytopenia complicated with Entitymassive thrombosis of the inferior vena cava after filter placement.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cholelithiasis and Entitythrombosis of the central retinal vein in a renal transplant recipient treated with Entitycyclosporin .
1.0000 Adverse-Effect EntityCholelithiasis and thrombosis of the central retinal vein in a renal transplant recipient treated with Entitycyclosporin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Young children undergoing Entitycisplatin chemotherapy are known to be at risk for Entityprogressive sensorineural hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prolongation of the QT interval and Entityventricular tachyarrhymias have been described in patients on Entityamiodarone therapy.
0.9999 Adverse-Effect EntityProlongation of the QT interval and ventricular tachyarrhymias have been described in patients on Entityamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDiarrhea - associated over - anticoagulation in a patient taking Entitywarfarin : therapeutic role of cholestyramine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient whose case is reviewed had Entitymigraine headaches and received Entitymethysergide maleate for 13 years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityAcute severe hepatitis though rare is occasionally observed with EGFR inhibitors Entitygefitinib or erlotinib.
1.0000 Adverse-Effect CONCLUSIONS : EntityAcute severe hepatitis though rare is occasionally observed with EGFR inhibitors gefitinib or Entityerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hypoxia is a predisposing factor for Entitypremature ductal closure and often occurs after maternal Entityindomethacin therapy.
1.0000 Adverse-Effect EntityHypoxia is a predisposing factor for premature ductal closure and often occurs after maternal Entityindomethacin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients should be informed about the risk of Entityosteonecrosis when taking Entitydexamethasone as an antiemetic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapid onset of Entityquetiapine - induced Entitydiabetic ketoacidosis in an elderly patient : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the other hand, Entityaspirin may have promoted the Entityenlargement of spontaneous hemorrhage from meningioma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal failure after high - dose Entitymethotrexate in a child homozygous for MTHFR C677 T polymorphism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal interstitial pneumonitis associated with Entitydocetaxel administration in a patient with hormone - refractory prostate cancer.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In vitro Entityinhibition of hematopoiesis in a patient with systemic sclerosis treated with EntityD - penicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe adenovirus pneumonia ( EntityAVP ) following Entityinfliximab infusion for the treatment of Crohn's disease.
1.0000 Adverse-Effect EntitySevere adenovirus pneumonia ( AVP ) following Entityinfliximab infusion for the treatment of Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCapecitabine was discontinued and the Entityallergic reactions resolved after the woman took diphenhydramine for 1 week.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a unique case of EntityGTBM in a patient with myeloma following treatment with EntityMelphalan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on our findings, it is thus concluded that Entitycisplatin may cause EntityC. difficile colitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of excessive Entityinsulin induced Entityhypoglycemia within 4 to 8 hours, followed by rebound hyperglycemia.
0.9996 Adverse-Effect Administration of excessive Entityinsulin induced hypoglycemia within 4 to 8 hours, followed by Entityrebound hyperglycemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityfluoxetine induced Entityseizures , in a person with Down syndrome, is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary edema occurred 24 hours after intravenous Entityritodrine therapy and 10 hours after subcutaneous terbutaline therapy.
0.9995 Adverse-Effect EntityPulmonary edema occurred 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous Entityterbutaline therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After treatment with a beta - sympathomimetic drug ( EntityPartusisten ) one fetus developed Entitysupraventricular tachycardia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityChlorambucil Entitycentral nervous toxicity : a significant side effect of chlorambucil therapy in childhood nephrotic syndrome.
1.0000 Adverse-Effect Chlorambucil Entitycentral nervous toxicity : a significant side effect of Entitychlorambucil therapy in childhood nephrotic syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitypulmonary toxicity of Entitygold salts is an uncommon cause of life - threatening respiratory failure.
0.9999 Adverse-Effect The pulmonary toxicity of Entitygold salts is an uncommon cause of life - threatening Entityrespiratory failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Antacid and Entitysucralfate - induced Entityhypophosphatemic osteomalacia : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following are two clinical case reports demonstrating profound Entitycerebral edema associated with implantation of EntityGliadel wafers.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere visual loss after a single dose of Entityvincristine in a patient with spinal cord astrocytoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus any case of Entitysevere neutropenia occurring in a patient receiving Entityolanzapine is alarming to clinicians.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The 9 other reported cases of EntityD - penicillamine induced Entityrapidly progressive glomerulonephritis have been reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPigmentary disorders are recognized adverse effects of the semi - synthetic tetracycline derivative antibiotic, Entityminocycline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHerpes simplex esophagitis in a renal transplant patient treated with Entitycyclosporine A : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with idiopathic RLS who developed Entityaugmentation after 8 months of Entitylevodopa treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with osteomyelitis who developed Entityreversible cholestatic jaundice during treatment with Entityoxacillin derivatives are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only one report links Entityphenylpropanolamine consumption to an Entityintracerebral hemorrhage in a patient with an AVM.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOlanzapine - induced Entityhyperglycaemic coma and neuroleptic malignant syndrome : case report and review of literature.
0.9999 Adverse-Effect EntityOlanzapine - induced hyperglycaemic coma and Entityneuroleptic malignant syndrome : case report and review of literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In all cases, Entityseizures were controlled by withdrawal of Entityphenytoin and reduction of drug levels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A young patient experienced marked Entitysinus tachycardia while smoking marijuana and receiving therapeutic doses of Entitynortriptyline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A severe form of Entityexophthalmos resulting from Entitylithium therapy has not been described in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Bulbar and Entitypseudobulbar palsy complicating therapy with high - dose Entitycytosine arabinoside in children with leukemia.
0.9998 Adverse-Effect EntityBulbar and pseudobulbar palsy complicating therapy with high - dose Entitycytosine arabinoside in children with leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cause of his bleeding was a Entitysevere thrombocytopoaenia , induced by chronic ingestion of Entityquinine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityL - asparaginase - induced Entityposterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Adverse-Effect EntityL - asparaginase - induced Entityposterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nevertheless, the Entitycoagulopathy seemed to be most closely associated with the administration of the Entitycephalosporin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Favorable outcome of de novo Entityhepatitis B infection after liver transplantation with Entitylamivudine and adefovir therapy.
1.0000 Adverse-Effect Favorable outcome of de novo Entityhepatitis B infection after liver transplantation with lamivudine and Entityadefovir therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThrombocytosis induced by Entityenoxaparin has been reported as a rare adverse effect of this medication in adults.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of Entitynon - convulsive status epilepticus provoked by Entitytiagabine in adolescent patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityL - asparaginase - induced Entitypancreatitis has been reported during or closely following administration of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The majority of Entityradiation recall reactions attributed to Entitygemcitabine are reported to affect internal tissue or organs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMinimal change disease in a patient receiving EntityIFN - alpha therapy for chronic hepatitis C virus infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClozapine - induced Entityeosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In association with this tocolysis, Entityurinary calculus of Entitymagnesium ammonium phosphate occurred at 34 weeks gestation.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Cessation of EntityD - Pen and the start of corticosteroid therapy were followed by recovery from Entitybicytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a 37 - year - old female who complained of moderate Entityhair loss during Entityparoxetine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These novel findings may offer specific therapeutic targets in the treatment of EntityBCNU - associated Entitypulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An insulin - dependent diabetic patient with nephropathy developed Entitysevere acidosis after treatment with Entityacetazolamide for glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Interstitial lung disease ( EntityILD ) related to therapy with the drug Entitygefitinib has been well reported.
1.0000 Adverse-Effect EntityInterstitial lung disease ( ILD ) related to therapy with the drug Entitygefitinib has been well reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : This study confirmed that in most patients EntityMTX - induced Entityliver cirrhosis is not aggressive.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since Entitytamoxifen therapy can induce Entityendometrial disorders , surveillance schemes of women taking tamoxifen have been recommended.
1.0000 Adverse-Effect Since tamoxifen therapy can induce Entityendometrial disorders , surveillance schemes of women taking Entitytamoxifen have been recommended.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous cytarabine and Entitymethotrexate appear to act synergistically to enhance the potential for Entitycentral nervous system toxicity .
0.9999 Adverse-Effect Intravenous Entitycytarabine and methotrexate appear to act synergistically to enhance the potential for Entitycentral nervous system toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The fundus picture shown in these cases may be typical of EntityASPPC after EntityIVTA injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityLTG overdose may result in a severe but reversible Entityencephalopathy , a previously undescribed phenomenon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Several such EntityHBV reactivations were reported after combined Entityrituximab and multiagent chemotherapy for B - cell lymphomas.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute renal insufficiency is known to occur in patients who are taking Entityciprofloxacin , particularly the elderly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Soon after its introduction in 1952, Entitychlorpromazine was noted to induce Entitysymptoms resembling Parkinson's disease .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A young woman with epilepsy had Entitytonic - clonic seizures during antineoplastic therapy with Entityadriamycin and cisplatin.
1.0000 Adverse-Effect A young woman with epilepsy had Entitytonic - clonic seizures during antineoplastic therapy with adriamycin and Entitycisplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe six patients who developed Entitytardive dyskinesia after treatment with Entitysulpiride for depression or gastrointestinal symptoms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two heroin addicts, aged 34 and 19 years, developed Entityballistic movements after intravenous Entityheroin overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGeneralised pustular psoriasis induced by Entitycyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityClozapine - induced Entitytardive dyskinesia in schizophrenic patients taking clozapine as a first - line antipsychotic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Interstitial pneumonitis and Entityalveolar hemorrhage complicating use of Entityrituximab : case report and review of the literature.
1.0000 Adverse-Effect EntityInterstitial pneumonitis and alveolar hemorrhage complicating use of Entityrituximab : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Use of the Naranjo probability scale determined the association between Entitycephalosporin use and Entityleukopenia to be probable.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityAmantadine can cause Entityreversible corneal edema but can irreversibly reduce the density of endothelial cells.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted Entityamiodarone - induced Entitythyroiditis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An asymptomatic HIV - infected woman experienced right - sided Entityrenal colicky pain during treatment with Entityindinavir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The temporal relationship suggests that the Entityspinal cord infarction may be related to the use of Entityzolmitriptan .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect To date, there have been few reports of Entityvisual disturbances associated with EntityBTX - B use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two cases of Entityacute pancreatitis that occurred after long term Entitymesalamine therapy for ulcerative colitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite administration of phenytoin and lorazepam, the Entityseizures persisted and occurred only during Entityamphotercin B administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In both patients the Entityrippling phenomena worsened with Entitypyridostigmine treatment but markedly improved after immunosuppression with azathioprine.
0.9999 Adverse-Effect In both patients the Entityrippling phenomena worsened with pyridostigmine treatment but markedly improved after immunosuppression with Entityazathioprine .
Score Relation Text (Head - Tail)
Adverse-Effect Acute Entityhyperphosphatemia caused by Entitysodium phosphate enema in a patient with liver dysfunction and chronic renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A new case of EntityCreutzfeldt - Jakob disease associated with Entityhuman growth hormone therapy in New Zealand.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Naranjo probability scale suggests a highly probable relationship between EntityAIN and Entitypantoprazole therapy in this patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Inadvertent subsequent rechallenge with Entityceliprolol led to recurrence of the Entitypneumonitis , 10 weeks after drug readministration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of acute kidney injury due to Entityzonisamide - induced EntityDRESS / DIHS.
1.0000 Adverse-Effect This is the first report of Entityacute kidney injury due to Entityzonisamide - induced DRESS / DIHS.
0.9999 Adverse-Effect This is the first report of acute kidney injury due to Entityzonisamide - induced DRESS / EntityDIHS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life - threatening Entityvincristine Entityneurotoxicity .
Adverse-Effect Early recognition of hereditary motor and sensory neuropathy type 1 can avoid Entitylife - threatening vincristine neurotoxicity Entityvincristine neurotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is tempting to speculate that Entityinterferon alpha may be involved in the pathogenesis of Entitylichen nitidus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These data indicated that Entityinfliximab possibly triggered Entityproduction of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis.
1.0000 Adverse-Effect These data indicated that Entityinfliximab possibly triggered production of granulocyte and neutrophil autoantibodies with resultant Entityautoimmune agranulocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be aware of Entityfasting hypoglycemia as an unusual but potentially serious complication of Entitydisopyramide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIFNalpha - induced recurrence of EntityGraves'disease ten years after thyroidectomy in chronic viral hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following 7 days of Entitytigecycline she developed Entitysevere abdominal pain and elevated pancreatic enzymes suggesting acute pancreatitis.
0.9999 Adverse-Effect Following 7 days of Entitytigecycline she developed severe abdominal pain and Entityelevated pancreatic enzymes suggesting acute pancreatitis.
0.9999 Adverse-Effect Following 7 days of Entitytigecycline she developed severe abdominal pain and elevated pancreatic enzymes suggesting Entityacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since its FDA approval in 2002, there are no known citations of Entityezetimibe - induced Entitypancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of life - threatening Entityhyponatremia associated with Entitysibutramine use in an obese woman.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 14 - year - old girl with newly diagnosed SLE developed a Entitypruritic bullous eruption while on Entityprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : EntityTamoxifen may cause Entitymalignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of Entitypyridoxine to an infant after a long period of convulsions was followed by Entityacute hypotonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case report of fatal Entitydapsone - induced Entityagranulocytosis in an Indian mid - borderline leprosy patient.
Score Relation Text (Head - Tail)
0.9910 Adverse-Effect Warfarin - induced skin necrosis and Entityheparin - induced Entitythrombocytopenia following mitral valve replacement for marantic endocarditis.
0.9653 Adverse-Effect EntityWarfarin - induced Entityskin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for marantic endocarditis.
0.9996 Adverse-Effect Warfarin - induced skin necrosis and heparin - induced Entitythrombocytopenia following Entitymitral valve replacement for marantic endocarditis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be vigilant when monitoring for Entitycardiotoxicity in patients receiving Entitypentamidine throughout the duration of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a depressive patient who developed mild parkinsonian signs and Entitycamptocormia after the introduction of Entityolanzapine .
0.9999 Adverse-Effect We present a depressive patient who developed Entitymild parkinsonian signs and camptocormia after the introduction of Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite the underlying hepatitis C, this case represents Entityrenal abnormalities consistent with EntityIFNalpha therapy for CML.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The ocular motor disturbances are probably an expression of regional Entity5 - FU Entityneurotoxicity primarily affecting the brain stem.
1.0000 Adverse-Effect The Entityocular motor disturbances are probably an expression of regional Entity5 - FU neurotoxicity primarily affecting the brain stem.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : EntityQuetiapine was associated with Entityleucopenia in two patients and clinically apparent agranulocytosis in one patient.
0.9996 Adverse-Effect RESULTS : EntityQuetiapine was associated with leucopenia in two patients and clinically apparent Entityagranulocytosis in one patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a 61 - year - old man receiving chronic low - dosage Entityamiodarone an Entityinterstitial pneumopathy was observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCerebrovascular complications of EntityL - asparaginase therapy in children with leukemia : aphasia and other neuropsychological deficits.
1.0000 Adverse-Effect Cerebrovascular complications of EntityL - asparaginase therapy in children with leukemia : Entityaphasia and other neuropsychological deficits.
0.9993 Adverse-Effect Cerebrovascular complications of EntityL - asparaginase therapy in children with leukemia : aphasia and other Entityneuropsychological deficits .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitymetoclopramide - induced Entityoculogyric crisis in a 16 - year - old girl with cystic fibrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of severe aplastic anemia ( EntityAA ) that was probably induced by Entitylenalidomide .
1.0000 Adverse-Effect We describe a case of Entitysevere aplastic anemia ( AA ) that was probably induced by Entitylenalidomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report : Entitydapsone Entityhypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Experience with five patients in whom Entityimpaired renal function developed early during Entityamphotericin B therapy is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : We report a patient who had an Entityanaphylactic reaction during the intravenous infusion of Entitycyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : There may be an association between Entityraloxifene and the development of Entitymalignant mixed mesodermal tumor .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : To describe the occurrence of Entityocular hypertension in four patients following injection of Entityranibizumab intravitreally.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVancomycin is the most frequently implicated drug, but other agents have been reported to cause EntityLABD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two of our patients developed EntityTD after 23 months and 34 months of Entityziprasidone monotherapy, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While both amiodarone and Entitydigoxin can cause permanent Entityvisual changes , the ocular effects are often reversible.
0.9999 Adverse-Effect While both amiodarone and Entitydigoxin can cause permanent visual changes, the Entityocular effects are often reversible.
0.9998 Adverse-Effect While both Entityamiodarone and digoxin can cause permanent visual changes, the Entityocular effects are often reversible.
0.9998 Adverse-Effect While both Entityamiodarone and digoxin can cause permanent Entityvisual changes , the ocular effects are often reversible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entityfatal massive pulmonary embolus developed in a patient treated with Entitystreptokinase for acute deep vein thrombosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect L - Carnitine supplementation has been recommended to prevent the Entityfatal hepatotoxic effects associated with Entityvalproic acid .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Biopsy - proven Entityacute interstitial nephritis associated with the tyrosine kinase inhibitor Entitysunitinib : a class effect?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four patients receiving high - dose Entitytamoxifen for greater than 1 year have demonstrated similar Entityretinal changes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After five and six weeks of continuous oral administration of Entitymethylprednisolone , the boys developed Entitysteroid diabetes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Multiple complications of Entitypropylthiouracil treatment : Entitygranulocytopenia , eosinophilia, skin reaction and hepatitis with lymphocyte sensitization.
1.0000 Adverse-Effect Multiple complications of Entitypropylthiouracil treatment : granulocytopenia, eosinophilia, skin reaction and Entityhepatitis with lymphocyte sensitization.
0.9999 Adverse-Effect Multiple complications of Entitypropylthiouracil treatment : granulocytopenia, Entityeosinophilia , skin reaction and hepatitis with lymphocyte sensitization.
0.9999 Adverse-Effect Multiple complications of Entitypropylthiouracil treatment : granulocytopenia, eosinophilia, skin reaction and hepatitis with Entitylymphocyte sensitization .
0.9999 Adverse-Effect Multiple complications of Entitypropylthiouracil treatment : granulocytopenia, eosinophilia, Entityskin reaction and hepatitis with lymphocyte sensitization.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoclonus and Entityseizures in a patient with parkinsonism : induction by Entitylevodopa and its confirmation on SEPs.
0.9999 Adverse-Effect EntityMyoclonus and seizures in a patient with parkinsonism : induction by Entitylevodopa and its confirmation on SEPs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient of organic bipolar affective disorder who developed Entityhiccups with the atypical antipsychotic Entityaripiprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on the history and clinical features, a diagnosis of Entityinsulin - induced Entitylipohypertrophy was made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a neonate with a seizure disorder who acutely developed Entitypupillary mydriasis secondary to Entitylidocaine overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There are, however, case studies describing patients experiencing recurrences of Entitytics following treatment with Entityatomoxetine .
Score Relation Text (Head - Tail)
0.9976 Adverse-Effect We report the use of pamidronate for acute, severe hypercalcemia secondary to iatrogenic Entityvitamin D Entityvitamin D poisoning .
0.9744 Adverse-Effect We report the use of pamidronate for acute, Entitysevere hypercalcemia secondary to iatrogenic Entityvitamin D poisoning.
0.9994 Adverse-Effect We report the use of Entitypamidronate for acute, Entitysevere hypercalcemia secondary to iatrogenic vitamin D poisoning.
0.6577 Adverse-Effect We report the use of Entitypamidronate for acute, severe hypercalcemia secondary to iatrogenic Entityvitamin D poisoning .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entityphoto - onycholysis in a patient treated with Entitydoxycycline for acne vulgaris.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We herein report this rare case of acute onset of Entitynephrotic syndrome during Entityinterferon - alpha retreatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of severe EntityAIHA in CLL patients treated with Entityfludarabine has been reported by several authors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the first case of a patient with Entitypriapism after oral intake of the phenothiazine Entityprothipendylhydrochloride .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of Entityamodiaquine and artesunate.
1.0000 Adverse-Effect EntityAcute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and Entityartesunate .
Adverse-Effect Acute Entityasymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of Entityamodiaquine and artesunate.
Adverse-Effect Acute Entityasymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and Entityartesunate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case highlights the possible development of Entityacute coronary syndrome as a side effect of EntityCapecitabine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAvascular necrosis of the femoral head in patients with prostate cancer treated with Entitycyproterone acetate and radiotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTorsemide appears to also be a part of a long list of agents that can cause Entitypancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute renal failure most likely was secondary to the nephrotoxic effect of Entitycaptopril on chronically hypoperfused kidneys.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was given Entitymethimazole instead of propylthiouracil but, 10 weeks later, Entityagranulocytosis again occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The present case is the first report of Entityhypercalcemia induced by Entityvitamin D3 ointment and thiazide simultaneously.
0.9998 Adverse-Effect The present case is the first report of Entityhypercalcemia induced by vitamin D3 ointment and Entitythiazide simultaneously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Entityclozapine - induced Entityseizures in a patient with treatment - resistant schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPleuropulmonary changes during treatment of Parkinson's disease with a long - acting ergot derivative, Entitycabergoline .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect However, because Entitydiphenhydramine also exhibits type IA sodium channel blockade, Entitycardiac toxicity is also possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While 40 mg / day of Entityprednisolone improved hepatic dysfunction dramatically, her Entitydiabetic milieu deteriorated seriously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of Entityhypothyroidism in patients with chronic hepatitis C treated with Entityrecombinant alpha interferon are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report EntityAZA - induced Entitydrug eruption that developed in two cases of systemic scleroderma with polymyositis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The condition should be suspected in patients who develop unexplained abdominal pain or Entitycollapse following Entityvasopressin treatment.
1.0000 Adverse-Effect The condition should be suspected in patients who develop unexplained Entityabdominal pain or collapse following Entityvasopressin treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversal of Entitygold - induced Entityneutropenia with granulocyte colony - stimulating factor ( G - CSF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPsychosis in a 12 - year - old HIV - positive girl with an increased serum concentration of Entityefavirenz .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 35 - year - old man with seropositive rheumatoid arthritis developed selective EntityIgA deficiency during treatment with Entityfenclofenac .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of recurrent Entitytorsades de pointes following treatment with pentavalent antimonial drugs and Entityamiodarone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect SUBSEQUENT COURSE : The Entitynephrosis resolved almost completely once the Entityinterferon was stopped and after immunosuppressive treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAsthenozoospermia : possible association with long - term exposure to an anti - epileptic drug of Entitycarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : We studied a case of Entityvortex keratopathy that was associated with the use of Entityatovaquone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report 2 cases of nonconvulsive status epilepticus ( EntityNCSE ) following infusion of Entityifosfamide .
1.0000 Adverse-Effect OBJECTIVE : To report 2 cases of Entitynonconvulsive status epilepticus ( NCSE ) following infusion of Entityifosfamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cause is presumed to be secondary to hypercoagulability due to Entityasparaginase - induced Entityantithrombin III deficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe the development of Entityvalproate - related Entityreproductive endocrine disorders in women with epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians treating patients with Entitymethotrexate for juvenile rheumatoid arthritis must be aware of this Entityextraarticular side effect .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Slow acetylator genotypes as a possible risk factor for Entityinfectious mononucleosis - like syndrome induced by Entitysalazosulfapyridine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case, to our knowledge, of Entityrituximab - related Entityautoimmune hemolytic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A depressed woman with no history of bipolar illness developed a Entitymanic episode during treatment with Entityfluoxetine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect With Entityitraconazole , Entityhepatotoxic reactions have only very rarely been reported, and histologic data are lacking.
1.0000 Adverse-Effect With Entityitraconazole , Entityhepatotoxic reactions have only very rarely been reported, and histologic data are lacking.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The other woman had rheumatoid arthritis and developed Entityacute tubular necrosis after treatment with Entitygentamicin and cefoxitin.
0.9999 Adverse-Effect The other woman had rheumatoid arthritis and developed Entityacute tubular necrosis after treatment with gentamicin and Entitycefoxitin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of possible Entityfoscarnet - induced Entitysevere hypomagnesemia and other electrolyte disorders.
1.0000 Adverse-Effect OBJECTIVE : To report a case of possible Entityfoscarnet - induced severe hypomagnesemia and other Entityelectrolyte disorders .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSION : EntityLipoid pneumonia as a result of Entitymineral oil aspiration still occurs in the pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySecretory endometrial adenocarcinoma in a patient on Entitytamoxifen for breast cancer : a report of a case.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : Five cases of Entitycontact dermatitis due to Entitybudesonide , a nonhalogenated steroid, are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 children with cerebral palsy who suffered significant Entitymorbidity immediately after treatment with Entityhyperbaric oxygen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cyclosporine is a potent inhibitor of simvastatin metabolism, and may therefore facilitate Entitysimvastatin - induced Entityrhabdomyolysis .
0.9990 Adverse-Effect EntityCyclosporine is a potent inhibitor of simvastatin metabolism, and may therefore facilitate simvastatin - induced Entityrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, no prior cases of Entitypenicillamine - induced EntityTTP in RA have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two patients with acne vulgaris with a fourth type of Entityminocycline - induced Entitycutaneous pigmentation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTumor lysis syndrome after transcatheter arterial infusion of Entitycisplatin and embolization therapy for liver metastases of melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere cardiomyopathy following treatment with the tumour necrosis factor - alpha inhibitor Entityadalimumab for Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Detection of antineutrophil cytoplasmic antibody in a patient with EntityL - tryptophan induced Entityeosinophilia - myalgia syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with seropositive rheumatoid arthritis developed Entityascites while taking weekly doses of Entitymethotrexate ( MTX ).
1.0000 Adverse-Effect A patient with seropositive rheumatoid arthritis developed Entityascites while taking weekly doses of methotrexate ( EntityMTX ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 3 elderly patients with moderate to severe Entityataxia that occurred while they were taking Entitypropafenone .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityAluminum intoxication, along with other factors, was considered to be the cause of EntityTC development.
0.9998 Adverse-Effect EntityAluminum EntityAluminum intoxication , along with other factors, was considered to be the cause of TC development.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTransient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with Entitylithium use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProlongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with Entityhalofantrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first histopathologically documented case of Entityoral mucosa pigmentation after OLP treatment with topical Entitytacrolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After cessation of Entityamantadine , the Entityedema resolved, and the endothelial cell densities were < or = 600 / mm.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A possible mechanism for Entityfocal neurological deficit in brain - damaged patients on Entityphenytoin therapy is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute generalized exanthematous pustulosis caused by Entitymorphine , confirmed by positive patch test and lymphocyte transformation test.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a patient developing Entityfulminant liver failure while being treated with Entityclarithromycin for pneumonia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient suffered Entitycoronary artery vasospasm , attributed to the use of topical 1 : 1000 Entityepinephrine during surgery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcetazolamide may have accelerated the development of Entityosteomalacia by several mechanisms, including increased renal calcium excretion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The incidence of 5 - fluorouracil ( Entity5 - FU ) - related Entitycardiotoxicity seems to be dosage and schedule dependent.
0.9998 Adverse-Effect The incidence of Entity5 - fluorouracil ( 5 - FU ) - related Entitycardiotoxicity seems to be dosage and schedule dependent.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A case of Entityacute respiratory failure due to diaphragmatic weakness following Entityadalimumab therapy for psoriasis is described.
1.0000 Adverse-Effect A case of acute respiratory failure due to Entitydiaphragmatic weakness following Entityadalimumab therapy for psoriasis is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIndinavir - associated Entitynephrolithiasis and chronic interstitial nephritis were the only possible causes identified in this patient.
0.9995 Adverse-Effect EntityIndinavir - associated nephrolithiasis and chronic Entityinterstitial nephritis were the only possible causes identified in this patient.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Diagnosis of Entityhypothyroidism during treatment can be difficult because of the common side effects of Entityalpha interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entitycutaneous and hematologic toxicity in a patient treated with EntityIL - 2 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Improved awareness of and further investigation into the Entityneurotoxic effects of Entityofloxacin may enhance its safe use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Several possible explanations of the mechanism of Entityrenal failure associated with the use of Entitydextran - 40 are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We postulate that the bolus of Entitysulprostone resulted in possible Entitycoronary spasm that resulted in cardiac arrest.
0.9999 Adverse-Effect We postulate that the bolus of Entitysulprostone resulted in possible coronary spasm that resulted in Entitycardiac arrest .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Neurophysiological mechanisms which aid in elucidating the role of Entitydisulfiram in the etiology of Entitycatatonia are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There is documentation of Entityocular toxicity with Entityethambutol when administered at dosages generally pronounced as being safe.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hydrocortisone may decrease the incidence of mortality associated with Entitycardiac arrhythmias in children receiving Entityamphotericin B overdoses.
0.9995 Adverse-Effect Hydrocortisone may decrease the incidence of Entitymortality associated with cardiac arrhythmias in children receiving Entityamphotericin B overdoses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There are no previous reports in the literature about the emergence of EntityCML during treatment with Entityhydroxyurea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An infertile patient with amenorrhea - galactorrhea syndrome Entitylost vision during a pregnancy occurring after EntityBromocryptine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Herein, we present a patient with severe and prolonged Entityhypoglycemia after long - acting Entityoctreotide treatment.
Adverse-Effect Herein, we present a patient with severe and Entityprolonged hypoglycemia after long - acting Entityoctreotide treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Entitypneumonitis following local administration of Entitymethotrexate for nonsurgical termination of an ectopic pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProgressive hypoxemia mandated endotracheal intubation 1 week after Entityrituximab administration and led to death 4 weeks after admission.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityHUS has been reported after several anticancer chemotherapies and most often after Entitymitomycin C - based chemotherapy regimens.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Evidence of neurological improvement and rehabilitation potential after Entitysevere myelopathy due to intrathecal injection of Entitydoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hyperkalaemia with Entityrenal tubular dysfunction by Entitysulfamethoxazole - trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.
0.9992 Adverse-Effect EntityHyperkalaemia with renal tubular dysfunction by Entitysulfamethoxazole - trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : EntityAtovaquone should be added to the list of agents causing Entityvortex keratopathy involving the corneal epithelium.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPosterior reversible encephalopathy syndrome associated with Entitymethotrexate neurotoxicity : conventional magnetic resonance and diffusion - weighted imaging findings.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 23 - year - old woman with systemic lupus erythematosus had a Entitysevere hypersensitivity reaction to the drug Entityibuprofen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of EntityGraves'hyperthyroidism induced by long - term Entityinterferon ( IFN ) therapy.
0.9999 Adverse-Effect We report a case of EntityGraves'hyperthyroidism induced by long - term interferon ( EntityIFN ) therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Entityulcerative proctitis after Entityibuprofen treatment in a girl with juvenile systemic lupus erythematosus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases indicate that Entitysulpiride can cause Entitytardive dyskinesia and that this drug should be administered with caution.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPremature closure of the ductus arteriosus : variable response among monozygotic twins after in utero exposure to Entityindomethacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When Entityvague symptoms develop during Entitydesmopressin therapy, hyponatremia must be considered as part of the differential diagnosis.
1.0000 Adverse-Effect When vague symptoms develop during Entitydesmopressin therapy, Entityhyponatremia must be considered as part of the differential diagnosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 78 - year - old man with a transvenous cardioverter defibrillator system developed frequent Entityshocks during oral Entityprocainamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Transient left homonymous hemianopsia and Entityencephalopathy following treatment of testicular carcinoma with Entitycisplatinum , vinblastine, and bleomycin.
1.0000 Adverse-Effect EntityTransient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with Entitycisplatinum , vinblastine, and bleomycin.
0.9999 Adverse-Effect Transient left homonymous hemianopsia and Entityencephalopathy following treatment of testicular carcinoma with cisplatinum, Entityvinblastine , and bleomycin.
0.9999 Adverse-Effect Transient left homonymous hemianopsia and Entityencephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and Entitybleomycin .
0.9999 Adverse-Effect EntityTransient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, Entityvinblastine , and bleomycin.
0.9999 Adverse-Effect EntityTransient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and Entitybleomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPirmenol hydrochloride - induced EntityQT prolongation and T wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation.
0.9992 Adverse-Effect EntityPirmenol hydrochloride - induced QT prolongation and EntityT wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reported are three children who developed Entityprogressive paraparesis after intrathecal Entitymethotrexate administration followed by complete or partial recovery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dexamethasone treatment of Entityamiodarone - induced Entitythyrotoxicosis ( AIT ) with or without persistent administration of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Gallstones and Entitybile sludge are common side effects of Entityoctreotide therapy but rarely become symptomatic or require treatment.
1.0000 Adverse-Effect EntityGallstones and bile sludge are common side effects of Entityoctreotide therapy but rarely become symptomatic or require treatment.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityIsoniazid inhibits the conversion of tryptophan to niacin and may induce Entitypellagra , particularly in poorly nourished patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : A review of the cases of EntitySS with implication of Entitymirtazapine as the cause was performed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both 6 - MP and EntityAZA are widely used and are known to cause Entityhepatotoxicity in a proportion of patients.
0.9999 Adverse-Effect Both Entity6 - MP and AZA are widely used and are known to cause Entityhepatotoxicity in a proportion of patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of radiotherapy - enhanced Entityaminoglutethimide Entityskin toxicity in a patient with metastatic breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is increasingly recognized that dose adjustment of oral Entityvalacyclovir in renal failure is necessary to avoid Entityneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Long - term follow - up after Entityneoplastic seeding complicating percutaneous Entityethanol injection for treatment of hepatocellular carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of lamotrigine, especially in combination with Entityvalproic acid , may lead to the development of EntityTEN .
0.9999 Adverse-Effect Administration of Entitylamotrigine , especially in combination with valproic acid, may lead to the development of EntityTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe that this is the first report of Entitysecretory carcinoma of the endometrium associated with Entitytamoxifen use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, four cases of Entityinterstitial pneumonitis associated with Entityfludarabine have been reported in medical literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of widespread Entitycutaneous vasculitis are described in association with Entitydiltiazem , a recently introduced calcium antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first reported case of Entitybromide intoxication due to Entitypyridostigmine bromide administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVerapamil is widely used for the termination of paroxysmal supraventricular tachycardia ( PSVT ) with little Entityproarrhythmic effect .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, the amount of Entityprednisone required to maintain normotension resulted in EntityCushingoid features and has been discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a case of Entitypseudoephedrine - induced Entityintracerebral hemorrhage in a patient with an underlying vascular malformation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNitrofurantoin - induced Entitypulmonary toxicity during pregnancy : a report of a case and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Knowledge regarding potential adverse effects of EntityCAP is paramount and dose modification is indicated with development of Entityneurotoxicity .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A 75 - year - old man developed Entitybilateral lower leg edema 6 months after switching from troglitazone to Entitypioglitazone .
1.0000 Adverse-Effect A 75 - year - old man developed Entitybilateral lower leg edema 6 months after switching from Entitytroglitazone to pioglitazone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with an allergy to a macrolide antibiotic was given Entitytacrolimus and developed a Entitysudden cutaneous reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, there are few reports in the literature of Entityampicillin as a cause of Entityacute interstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pulmonary eosinophilia or granulomas, classically seen in previously reported cases of Entitymethotrexate Entitypneumonitis , were not observed.
1.0000 Adverse-Effect Pulmonary eosinophilia or Entitygranulomas , classically seen in previously reported cases of Entitymethotrexate pneumonitis, were not observed.
0.9998 Adverse-Effect EntityPulmonary eosinophilia or granulomas, classically seen in previously reported cases of Entitymethotrexate pneumonitis, were not observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute myelogenous leukemia in patients receiving Entitychlorambucil as long - term adjuvant chemotherapy for stage II breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHepatoxicity is a rare complication of EntitySRL therapy and may be connected with some diagnostic and / or therapeutic problems.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Replacing Entityvalproate with lamotrigine resulted in a Entitydecrease in serum testosterone concentrations in all 3 women.
Adverse-Effect RESULTS : Replacing Entityvalproate with lamotrigine resulted in a decrease in Entityserum testosterone concentrations in all 3 women.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Tacrolimus ( EntityFK506 ), an immunosuppressant, has been associated with Entitymutism in adults after liver transplant.
1.0000 Adverse-Effect EntityTacrolimus ( FK506 ), an immunosuppressant, has been associated with Entitymutism in adults after liver transplant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both the longitudinal melanonychia and the Entitymultiple skin cancers first appeared after approximately 6 months of Entityhydroxyurea treatment.
1.0000 Adverse-Effect Both the Entitylongitudinal melanonychia and the multiple skin cancers first appeared after approximately 6 months of Entityhydroxyurea treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The NZ Pharmacovigilance Centre has received 7 additional reports of Entitysevere infections in patients with RA taking Entityleflunomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityINH , which is a leading cause of Entitydrug eruptions in the above group of drugs was withdrawn.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two cases of cerebrospinal fluid eosinophilia ( EntityCSFE ) secondary to the intraventricular administration of Entityvancomycin .
1.0000 Adverse-Effect We report two cases of Entitycerebrospinal fluid eosinophilia ( CSFE ) secondary to the intraventricular administration of Entityvancomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : The Naranjo probability scale indicated a probable relationship between Entitysertraline treatment and the onset of Entityrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : We have introduced a case of Entityanaphylaxis by Entitycalcitonin that suggest an IgE mediated hypersensitivity reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect No explanation for this delay was found, other than the possibility that Entitymagnesium sulfate treatment Entityimpeded lactogenesis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we report Entityramipril - induced Entitycutaneous vasculitis in a patient who required steroid therapy to control it.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHydroxyurea associated with concomitant occurrence of Entitydiffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
1.0000 Adverse-Effect EntityHydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and Entitymultiple squamous cell carcinomas in an elderly subject.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case suggests the importance of careful observation for Entityextramedullary relapse in patients who are treated with EntityATRA .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect With the increasing use of EntityCyclosporine A in transplant patients, the incidence of Entityherpes esophagitis may increase.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIsotretinoin , a drug used for the treatment of acne, has been shown to have Entityteratogenic effects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityazathioprine dose was low ( 1 mg / kg ) and Entitypancytopenia occurred after 56 days therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 3 patients with Entitysevere hepatocellular damage due to EntityCPA therapy, 2 with fatal fulminant hepatitis.
0.9994 Adverse-Effect We report 3 patients with severe hepatocellular damage due to EntityCPA therapy, 2 with Entityfatal fulminant hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case study describes an atypical case of refractory, Entitysodium warfarin - induced Entitynecrotizing fasciitis and myonecrosis.
0.9995 Adverse-Effect This case study describes an atypical case of refractory, Entitysodium warfarin - induced necrotizing fasciitis and Entitymyonecrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 77 - year - old man developed Entityankle, hand, and facial swelling 2 weeks after starting Entityrosiglitazone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It has been reported that Entityfluoroquinolone antimicrobials prolong the corrected QT interval but rarely cause Entitytorsade de pointes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Beneficial effect of low - dose mianserin on Entityfluvoxamine - induced Entityakathisia in an obsessive - compulsive patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLinezolid - associated Entityacute interstitial nephritis and drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome.
0.9999 Adverse-Effect EntityLinezolid - associated acute interstitial nephritis and Entitydrug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome.
0.9999 Adverse-Effect EntityLinezolid - associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms ( EntityDRESS ) syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Immunosuppression elicited by the extensive administration of Entityprednisolone was suspected for the initiation of the generalized Entitymite infestation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : EntityAphthous stomatitis , a common mucocutaneous disorder, is a well accepted complication of Entitysirolimus therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report two cases of acute dystonic reactions ( EntityADRs ) as a side effect of Entitylamivudine .
1.0000 Adverse-Effect The authors report two cases of Entityacute dystonic reactions ( ADRs ) as a side effect of Entitylamivudine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 52 - year - old woman developed symmetric sensorimotor polyneuropathy and Entitycerebellar syndrome after 24 months of Entityamiodarone treatment.
0.9999 Adverse-Effect A 52 - year - old woman developed Entitysymmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of Entityamiodarone treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is hoped that this case report creates awareness that Entityofloxacin - induced Entitytoxic epidermal necrolysis is possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A second possibility is an interaction between clarithromycin and Entityisradipine , potentially Entityincreasing the hepatic toxicity of isradipine.
0.9999 Adverse-Effect A second possibility is an interaction between clarithromycin and isradipine, potentially Entityincreasing the hepatic toxicity of Entityisradipine .
0.9994 Adverse-Effect A second possibility is an interaction between Entityclarithromycin and isradipine, potentially Entityincreasing the hepatic toxicity of isradipine.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect These cases highlight the occurrence of Entitylivedo reticularis as an uncommon side - effect of Entityinterferon alpha treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Significant Entityweight loss is a potential adverse event in patients with rheumatoid arthritis treated with Entityleflunomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityacne fulminans occurring during treatment with Entity13 - cis - retinoic acid for cystic acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fever and Entitymaculopapular rashes appeared at 10 days after Entityphenytoin initiation, and then the drug was discontinued.
0.9999 Adverse-Effect EntityFever and maculopapular rashes appeared at 10 days after Entityphenytoin initiation, and then the drug was discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case and other published evidence should alert physicians to the possibility of fatal Entityerlotinib - induced EntityILD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityototoxicity of Entityquinine can accurately be studied with ultrahigh frequency audiometry ( up to 20 kHz ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One case of Entitypriapism occurred during Entityheparin therapy for a previous surgical operation to the knee is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This prompted us to suspect that EntityddI might be responsible for Entityfulminant hepatitis in all three AIDS patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDrug eruption caused by Entityazathioprine : value of using the drug - induced lymphocytes stimulation test for diagnosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reye syndrome ( EntityRS ) is believed to occur infrequently among children receiving long - term Entityaspirin therapy.
1.0000 Adverse-Effect EntityReye syndrome ( RS ) is believed to occur infrequently among children receiving long - term Entityaspirin therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A retrospective study was conducted of 40 Entityloperamide Entityloperamide poisoning cases recorded at the Centre National d'Informations Toxicologiques Veterinaires.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of a bipolar patient who developed thyrotoxicosis with Entitysevere exophthalmos while on Entitylithium therapy is described.
0.9999 Adverse-Effect The case of a bipolar patient who developed Entitythyrotoxicosis with severe exophthalmos while on Entitylithium therapy is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reports of Entitycolonic perforation as a result of the administration of Entitycalcium polystyrene sulfonate and sorbitol are rare.
0.9998 Adverse-Effect Reports of Entitycolonic perforation as a result of the administration of calcium polystyrene sulfonate and Entitysorbitol are rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : EntityOvarian cancer arising from an endometriotic cyst in a postmenopausal woman under Entitytamoxifen therapy is rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of steroid and decreasing the dose of EntityPTU produced a good clinical response and the EntityANCA disappeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prior reports have emphasized the Entitytubular and interstitial lesions associated with intermittent or discontinuous Entityrifampin therapy for tuberculosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a Entityscleroderma - like reaction induced by long - term administration of EntityUFT .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityFludarabine induced Entitylung toxicity must be considered in all patients who develop unexplained lung disease while receiving fludarabine.
Adverse-Effect Fludarabine induced lung toxicity must be considered in all patients who develop unexplained Entitylung disease while receiving Entityfludarabine .
Adverse-Effect EntityFludarabine induced lung toxicity must be considered in all patients who develop unexplained Entitylung disease while receiving fludarabine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Phenylpropanolamine ( EntityPPA ) recently has been publicly implicated as a cause of Entitystroke and other neurologic events.
1.0000 Adverse-Effect Phenylpropanolamine ( EntityPPA ) recently has been publicly implicated as a cause of stroke and other Entityneurologic events .
1.0000 Adverse-Effect EntityPhenylpropanolamine ( PPA ) recently has been publicly implicated as a cause of Entitystroke and other neurologic events.
1.0000 Adverse-Effect EntityPhenylpropanolamine ( PPA ) recently has been publicly implicated as a cause of stroke and other Entityneurologic events .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first case, to our knowledge, of onset of prolonged Entityinfliximab - induced Entitylupus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRitonavir should be added to the list of drugs that can induce Entityadverse cutaneous reactions in HIV patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - dose Entitymethylprednisolone in a pregnant woman with Crohn's disease and Entityadrenal suppression in her newborn.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 55 - year - old woman developed symptoms suggestive of Entityhepatitis 12 weeks after first receiving Entitymethyldopa for hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Successful recovery from Entityinterstitial pneumonitis , induced by Entitybicalutamide and leuprorelin acetate given as treatment for prostate cancer.
0.9996 Adverse-Effect Successful recovery from Entityinterstitial pneumonitis , induced by bicalutamide and Entityleuprorelin acetate given as treatment for prostate cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After the patient discontinued Entityrifampicin , the Entityskin lesions cleared completely within 5 weeks without any systemic medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMannitol - induced EntityARF responds promptly to hemodialysis with rapid resolution of anuria and recovery of renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a patient with severe renovascular hypertension, Entitynonoliguric acute renal failure developed after she received Entitycaptopril treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entitycutaneous leucocytoclastic vasculitis in which Entityamphotericin B might presumably be the aetiological factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of an adverse effect of Entityfetal renal circulation by maternal ingestion of Entitynimesulide .
Adverse-Effect This is the first report of an Entityadverse effect of fetal renal circulation by maternal ingestion of Entitynimesulide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient who developed Entityhypersensitivity pneumonitis during treatment with the beta - blocker, Entityceliprolol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He developed recurrent skin rash, fever, hypereosinophilia, and Entityacute renal failure after rechallenge with Entitychlorambucil .
1.0000 Adverse-Effect He developed recurrent skin rash, fever, Entityhypereosinophilia , and acute renal failure after rechallenge with Entitychlorambucil .
1.0000 Adverse-Effect He developed recurrent skin rash, Entityfever , hypereosinophilia, and acute renal failure after rechallenge with Entitychlorambucil .
0.9999 Adverse-Effect He developed recurrent Entityskin rash , fever, hypereosinophilia, and acute renal failure after rechallenge with Entitychlorambucil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a male patient with advanced AIDS who developed Entityhypercalcemia 2 weeks after institution of EntityrhGH therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A rare case of advanced ovarian carcinoma who developed Entitydifficulty walking 25 days after treatment with weekly Entitypaclitaxel .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two cases that developed acute myeloid leukaemia ( EntityAML ) during Entitytamoxifen therapy for breast cancer.
1.0000 Adverse-Effect We report two cases that developed Entityacute myeloid leukaemia ( AML ) during Entitytamoxifen therapy for breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of Entitysevere hypocalcaemia associated with i. v. Entitybisphosphonate treatment in patients with multiple myeloma.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The authors report two cases of Entitydelayed elimination of Entitymethotrexate in patients receiving ciprofloxacin, with severe toxicity.
0.9943 Adverse-Effect The authors report two cases of Entitydelayed elimination of methotrexate in patients receiving Entityciprofloxacin , with severe toxicity.
0.9983 Adverse-Effect The authors report two cases of delayed elimination of methotrexate in patients receiving Entityciprofloxacin , with Entitysevere toxicity .
0.9534 Adverse-Effect The authors report two cases of delayed elimination of Entitymethotrexate in patients receiving ciprofloxacin, with Entitysevere toxicity .
Adverse-Effect The authors report two cases of delayed elimination of methotrexate in patients receiving Entityciprofloxacin , with severe Entitytoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of Entityamantadine was associated with Entitypsychotic decompensations in two schizophrenic patients being maintained on concomitant neuroleptic medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients are described who developed Entitysensory neuropathy after the ingestion of 30. 6 and 114 g Entitymetronidazole respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal ventricular fibrillation after treatment with Entitydigoxin in a 27 - year - old man with mitral leaflet prolapse syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of interstitial pulmonary disease that occurred together with Entitylymphocytic colitis during treatment with Entityticlopidine .
0.9999 Adverse-Effect We report a case of Entityinterstitial pulmonary disease that occurred together with lymphocytic colitis during treatment with Entityticlopidine .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect These Entityskin lesions may be induced or worsened during antiviral therapy with Entityinterferon - alpha ( IFN ).
0.9996 Adverse-Effect These Entityskin lesions may be induced or worsened during antiviral therapy with interferon - alpha ( EntityIFN ).
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect After treatment with Entitycimetidine , there was a rapid deterioration with Entitydecreased oxygen saturation and arterial PO2 values.
1.0000 Adverse-Effect After treatment with Entitycimetidine , there was a rapid Entitydeterioration with decreased oxygen saturation and arterial PO2 values.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFlecainide overdose can rapidly result in profound Entitycardiovascular collapse , and is associated with a relatively high mortality.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The three reported cases demonstrate that Entitytroglitazone is an idiosyncratic hepatotoxin that can lead to Entityirreversible liver injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : The aim of this paper is to describe a case of Entityincreased libido during Entityfluvoxamine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The development of erythroid leukemia plus Entitycarcinoma in these two men suggests mutagenic change secondary to Entitycyclophosphamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute renal failure with Entitysevere tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with Entityenalapril .
1.0000 Adverse-Effect EntityAcute renal failure with severe tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with Entityenalapril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : To our knowledge this is the first reported case of Entitytuberculous uveitis following treatment with Entityetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityL - asparaginase - induced Entitypancreatitis is an uncommon but potential lethal complication of the treatment of leukemia.
0.9970 Adverse-Effect EntityL - asparaginase - induced pancreatitis is an uncommon but potential Entitylethal complication of the treatment of leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cases of two asthmatic patients who became Entityhypokalemic after inhalation of normal doses of Entityalbuterol are presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect How low can you go? Use of very low dosage of Entitygold in patients with Entitymucocutaneous reactions .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRhabdomyolysis associated with Entityclozapine treatment in a patient with decreased calcium - dependent potassium permeability of cell membranes.
Score Relation Text (Head - Tail)
0.9938 Adverse-Effect EntityPosterior reversible encephalopathy syndrome ( PRES ) induced by Entitycyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Adverse-Effect Posterior reversible encephalopathy syndrome ( EntityPRES ) induced by Entitycyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Adverse-Effect EntityPosterior reversible encephalopathy syndrome ( EntityPRES ) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association of Entityvenlafaxine treatment with Entityischaemic events could be explained by its unique pharmacological and haemodynamic properties.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of a Entitydiffuse papular eruption following treatment of psoriasis with Entitymethotrexate injections.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Attenuation of Entityasparaginase - induced Entityhyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Posthypoglycemic hyperglycemia ( Entityrebound hyperglycemia ) after overdosing of Entityinsulin was diagnosed in 6 cats with diabetes mellitus.
0.9999 Adverse-Effect EntityPosthypoglycemic hyperglycemia ( rebound hyperglycemia ) after overdosing of Entityinsulin was diagnosed in 6 cats with diabetes mellitus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityclozapine - induced Entitytonic - clonic seizures managed with valproate : implications for clinical care.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of Entityneuroleptic malignant syndrome due to Entityrisperidone in a child with Joubert syndrome.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect It has been suggested that EntityPPE caused by Entitycytarabine does not recur with subsequent cytarabine re - challenge.
0.9602 Adverse-Effect It has been suggested that EntityPPE caused by cytarabine does not recur with subsequent Entitycytarabine re - challenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of Entityamiodarone - induced Entitythyrotoxicosis ( AIT ) with thionamide, lithium or radioactive iodine is ineffective.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 68 - year - old female patient with advanced ovarian carcinoma Entitycollapsed whilst receiving a Entitycarboplatin and cyclophosphamide infusion.
1.0000 Adverse-Effect A 68 - year - old female patient with advanced ovarian carcinoma Entitycollapsed whilst receiving a carboplatin and Entitycyclophosphamide infusion.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityImidazoline EntityImidazoline intoxication due to overdose or accidental ingestion but also after normal therapeutic usage is frequent in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of EntityBMTN in two children treated with EntityRA in our unit is unlikely to be coincidental.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Multiple pulmonary nodules : an unusual presentation of Entityfludarabine Entitypulmonary toxicity : case report and review of literature.
0.9997 Adverse-Effect EntityMultiple pulmonary nodules : an unusual presentation of Entityfludarabine pulmonary toxicity : case report and review of literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityExtrapyramidal symptoms are well - documented complications of therapy with Entityhaloperidol , even when small doses are used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report : Entitylife - threatening hypoglycaemia associated with Entitysulfadoxine - pyrimethamine , a commonly used antimalarial drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBenzocaine , an ester - type local anesthetic, was believed responsible for apparent Entitymethemoglobinemia in a cat.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of EntityNEH masquerading as cutaneous vasculitis in a woman receiving Entitycyclophosphamide for lupus nephritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two cases of tenofovir ( EntityTDF ) - associated Entitynephrotoxicity in perinatally HIV - infected adolescents.
0.9997 Adverse-Effect We report two cases of Entitytenofovir ( TDF ) - associated Entitynephrotoxicity in perinatally HIV - infected adolescents.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate may rarely provoke Entityserositis , even with low doses and after just a few weeks of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, Entityethambutol rarely causes Entityvisual loss during the early period or when given at lower doses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCushing's syndrome persisted more than 6 months while EntityTCA concentrations remained detectable for at least 80 days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with bipolar affective disorder and a history of bronchospastic phenomena experienced Entitytremor during Entitylithium carbonate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Both patients experienced a previously unreported side effect - - Entityfalling backward - - associated with Entitybupropion use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVision declined after treatment with Entitymethylprednisolone , after which fundus examination became consistent with progressive outer retinal necrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with chronic myelomonocytic leukemia developed drug - induced Entitypulmonary toxicity after using low dose oral Entityetoposide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the possible association between the use of Entityalteplase and the development of Entitysubfascial hemorrhage .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient, while on intravenous Entityritodrine therapy for preterm labor, experienced an episode of Entityacute chest pain .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and Entitydermatitis : a severe adverse reaction to Entityminocycline .
1.0000 Adverse-Effect Fever, lymphadenopathy, eosinophilia, lymphocytosis, Entityhepatitis , and dermatitis : a severe adverse reaction to Entityminocycline .
1.0000 Adverse-Effect Fever, lymphadenopathy, eosinophilia, Entitylymphocytosis , hepatitis, and dermatitis : a severe adverse reaction to Entityminocycline .
0.9999 Adverse-Effect Fever, lymphadenopathy, Entityeosinophilia , lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to Entityminocycline .
0.9999 Adverse-Effect EntityFever , lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to Entityminocycline .
0.9999 Adverse-Effect Fever, Entitylymphadenopathy , eosinophilia, lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to Entityminocycline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of EntityErythema Multiforme Bullosum in patient of lepromatous leprosy with pulmonary tuberculosis due to EntityRifampicin is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityColchicine - induced Entitymyopathy should be excluded in patients with FMF who present with generalized muscle weakness.
0.9941 Adverse-Effect CONCLUSIONS : EntityColchicine - induced myopathy should be excluded in patients with FMF who present with Entitygeneralized muscle weakness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because of a Entityhypersensitivity reaction , initial therapy with Entitypenicillin G and gentamicin was stopped and substituted with cefazolin.
0.9998 Adverse-Effect Because of a Entityhypersensitivity reaction , initial therapy with penicillin G and Entitygentamicin was stopped and substituted with cefazolin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of Entityneuroleptic malignant syndrome that occurred in a patient on Entityamitriptyline and lithium carbonate.
0.9996 Adverse-Effect The authors describe a case of Entityneuroleptic malignant syndrome that occurred in a patient on amitriptyline and Entitylithium carbonate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Typically, drug - induced Entityneutropenia occurs in a patient receiving a semisynthetic Entitypenicillin for two weeks or more.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethimazole - induced Entityaplastic anemia in third exposure : successful treatment with recombinant human granulocyte colony - stimulating factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The newborn manifested a four day course of Entitylethargy with unexplained high Entitylithium levels in the adult toxic range.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We experienced 2 cases of Entitymequitazine - induced Entityphotosensitivity reaction in patients who took mequitazine for their dermatologic problems.
1.0000 Adverse-Effect We experienced 2 cases of mequitazine - induced Entityphotosensitivity reaction in patients who took Entitymequitazine for their dermatologic problems.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Fixed drug Entityeruption is associated with many drugs but this is the first such report with Entityomeprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFSGS induced by EntityAdriamycin ( Pharmacia & Upjohn, Columbus, OH ) has been observed experimentally in rats.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPulmonary leukostasis secondary to Entityall - trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An objective causality assessment by use of the Naranjo probability scale revealed that EntityNCSE due to Entityifosfamide was probable.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with acute esophageal variceal bleeding developed Entityfatal rhabdomyolysis during treatment with a continuous intravenous infusion of Entityvasopressin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Electrocardiographic findings and laboratory data indicated a diagnosis of Entityacute myocardial infarction due to the EntityL - thyroxine therapy.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Establishment of diuresis with fluids and IV administration of calcium may provide successful treatment of Entitymagnesium Entitymagnesium toxicosis in horses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who presented with Entitybloody diarrhoea after 15 mg Entitymeloxicam daily for 10 days for osteoarthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four cases of Entityoesophageal damage associated with ingestion of the urinary anti - spasmodic agent Entityemepronium bromide are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityheatstroke is reported in a 32 - year - old man diagnosed with schizophrenia and on Entityclozapine monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Due to discomfort, diplopia and lagophthalmos, the Entityhaematoma necessitated suspension of Entitywarfarin therapy and a surgical evacuation.
0.9999 Adverse-Effect Due to discomfort, diplopia and Entitylagophthalmos , the haematoma necessitated suspension of Entitywarfarin therapy and a surgical evacuation.
0.9999 Adverse-Effect Due to discomfort, Entitydiplopia and lagophthalmos, the haematoma necessitated suspension of Entitywarfarin therapy and a surgical evacuation.
0.9999 Adverse-Effect Due to Entitydiscomfort , diplopia and lagophthalmos, the haematoma necessitated suspension of Entitywarfarin therapy and a surgical evacuation.
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect Atypical ventricular tachycardia ( Entitytorsade de pointes ) induced by Entityamiodarone : arrhythmia previously induced by quinidine and disopyramide.
0.9972 Adverse-Effect Atypical ventricular tachycardia ( torsade de pointes ) induced by amiodarone : Entityarrhythmia previously induced by Entityquinidine and disopyramide.
0.9657 Adverse-Effect EntityAtypical ventricular tachycardia ( torsade de pointes ) induced by Entityamiodarone : arrhythmia previously induced by quinidine and disopyramide.
0.7344 Adverse-Effect Atypical ventricular tachycardia ( torsade de pointes ) induced by amiodarone : Entityarrhythmia previously induced by quinidine and Entitydisopyramide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of Entitysertraline - induced Entityrhabdomyolysis in an elderly patient with dementia and comorbidities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing Entitytryptophan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of a patient in a Entitypromethazine - induced Entitycoma responding to treatment with flumazenil.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityMineral oil , a hydrocarbon, may not elicit a normal protective cough reflex and may Entityimpair mucociliary transport .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 3 children with epilepsy who developed Entityfacial motor tics after initiation of EntityCBZ for complex partial seizures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 43 - year - old white man developed a shallow Entityerosion of a psoriatic plaque after chronic administration of Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One case of Entitytacrolimus - induced Entityhepatic VOD developing after lung transplantation ( LT ) has been recently reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While the mechanism of Entitydextran - associated Entityrenal failure remains unsolved, plasma exchange seems to be effective therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoclonus and Entityseizures disappeared after discontinuation of EntityL - dopa and the introduction of valproate sodium ( VPA ).
0.9999 Adverse-Effect EntityMyoclonus and seizures disappeared after discontinuation of EntityL - dopa and the introduction of valproate sodium ( VPA ).
0.9999 Adverse-Effect Myoclonus and Entityseizures disappeared after discontinuation of L - dopa and the introduction of Entityvalproate sodium ( VPA ).
0.9999 Adverse-Effect Myoclonus and Entityseizures disappeared after discontinuation of L - dopa and the introduction of valproate sodium ( EntityVPA ).
0.9995 Adverse-Effect EntityMyoclonus and seizures disappeared after discontinuation of L - dopa and the introduction of valproate sodium ( EntityVPA ).
0.9995 Adverse-Effect EntityMyoclonus and seizures disappeared after discontinuation of L - dopa and the introduction of Entityvalproate sodium ( VPA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE DESCRIPTION : A 59 - year - old man with known neurocysticercosis developed a Entitylarge cerebral infarction during Entitypraziquantel therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Atypical endometriosis may act as a precancerous lesion in the process of Entitytamoxifen - induced Entitymalignant transformation of endometriosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mechanisms and triggering factors of Entityhypoglycaemia induced by Entitymefloquine and some other anti - malarial quinine analogues are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect a 67 - year - old man with bipolar disorder developed a EntityCreutzfeldt - Jakob like syndrome during Entitylithium carbonate treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTiagabine overdose causes an unusual array of Entityneurological symptoms , many similar to reported adverse effects during therapeutic use.
Adverse-Effect EntityTiagabine overdose causes an Entityunusual array of neurological symptoms , many similar to reported adverse effects during therapeutic use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Increased lash length, thickness, and Entitypigmentation are well - documented side effects of Entityprostaglandin analog glaucoma drops.
1.0000 Adverse-Effect EntityIncreased lash length , thickness, and pigmentation are well - documented side effects of Entityprostaglandin analog glaucoma drops.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have reported six cases of Entitymetoclopramide - induced Entityparkinsonism seen in consultation over a two - year period.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHOD : We describe two patients who presented with Entitydiabetic ketoacidosis after treatment with Entityquetiapine and risperidone, respectively.
1.0000 Adverse-Effect METHOD : We describe two patients who presented with Entitydiabetic ketoacidosis after treatment with quetiapine and Entityrisperidone , respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two cases of PSVT that changed to Entitynon - sustained polymorphic ventricular tachycardia after administration of Entityverapamil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Gastric tumor, endometrial carcinoma and Entitycervical adenocarcinoma in situ were detected after treatment with Entitytamoxifen for breast cancer.
1.0000 Adverse-Effect EntityGastric tumor , endometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with Entitytamoxifen for breast cancer.
1.0000 Adverse-Effect Gastric tumor, Entityendometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with Entitytamoxifen for breast cancer.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Intravenous sodium bicarbonate appears to be indicated prophylactically in combating the associated Entitymetabolic acidosis due to absorbed Entityformic acid .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a detailed case of Entityfulminant hepatitis induced by Entitynevirapine ( Viramune ) and treated by liver transplantation.
0.9999 Adverse-Effect We describe a detailed case of Entityfulminant hepatitis induced by nevirapine ( EntityViramune ) and treated by liver transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterferon - alpha - induced Entityhyperthyroidism : a three - stage evolution from silent thyroiditis towards Graves'disease.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A diagnosis of masked Entitytheophylline Entitytheophylline poisoning should be considered in similar situations involving a rapid decrease of insulin requirements.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, our report is one of the first on shock and Entityangio - oedema from Entityirbesartan .
0.9999 Adverse-Effect To our knowledge, our report is one of the first on Entityshock and angio - oedema from Entityirbesartan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of Balint syndrome with irreversible Entityposterior leukoencephalopathy on MRI following intrathecal Entitymethotrexate and cytarabine.
1.0000 Adverse-Effect The authors report a case of EntityBalint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal Entitymethotrexate and cytarabine.
0.9999 Adverse-Effect The authors report a case of Balint syndrome with irreversible Entityposterior leukoencephalopathy on MRI following intrathecal methotrexate and Entitycytarabine .
0.9999 Adverse-Effect The authors report a case of EntityBalint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal methotrexate and Entitycytarabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Aseptic meningitis, hemolytic anemia, hepatitis, and Entityorthostatic hypotension in a patient treated with Entitytrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Aseptic meningitis, hemolytic anemia, hepatitis, and Entityorthostatic hypotension in a patient treated with trimethoprim - Entitysulfamethoxazole .
0.9999 Adverse-Effect Aseptic meningitis, hemolytic anemia, Entityhepatitis , and orthostatic hypotension in a patient treated with Entitytrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Aseptic meningitis, Entityhemolytic anemia , hepatitis, and orthostatic hypotension in a patient treated with Entitytrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect EntityAseptic meningitis , hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with Entitytrimethoprim - sulfamethoxazole.
0.9998 Adverse-Effect Aseptic meningitis, hemolytic anemia, Entityhepatitis , and orthostatic hypotension in a patient treated with trimethoprim - Entitysulfamethoxazole .
0.9998 Adverse-Effect Aseptic meningitis, Entityhemolytic anemia , hepatitis, and orthostatic hypotension in a patient treated with trimethoprim - Entitysulfamethoxazole .
0.9998 Adverse-Effect EntityAseptic meningitis , hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim - Entitysulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed Entitypancreatitis caused by Entitymeglumine antimoniate .
0.9995 Adverse-Effect Successful treatment of visceral leishmaniasis with allopurinol plus Entityketoconazole in an infant who developed Entitypancreatitis caused by meglumine antimoniate.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSIONS : The administration of Entityprostaglandin E1 to neonates can cause Entitygastric - outlet obstruction due to antral hyperplasia.
0.9991 Adverse-Effect CONCLUSIONS : The administration of Entityprostaglandin E1 to neonates can cause gastric - outlet obstruction due to Entityantral hyperplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Entityrhabdomyolysis related to the administration of Entityclarithromycin without concurrent use of other medications.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 cases of EntitySJS related to Entitynevirapine use and review the literature on this newly recognized association.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Used injudiciously, Entitynaloxone can lead to Entitywithdrawal syndrome , return of severe pain, and other adverse effects.
0.9999 Adverse-Effect Used injudiciously, Entitynaloxone can lead to withdrawal syndrome, return of Entitysevere pain , and other adverse effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case concerns the Entitysudden death of a 29 - year - old male during Entityclozapine therapy started 2 weeks before.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prior neurologic illness or CNS insult of any kind is known to increase the vulnerability to Entityneurotoxicity of Entitylithium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The objective of this report is to describe a case of fixed drug Entityeruption that occurred during Entityomeprazole treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIatrogenic Cushing syndrome after epidural Entitytriamcinolone injections in an HIV type 1 - infected patient receiving therapy with ritonavir - lopinavir.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical symptoms of Entitygastric mucosa foveolar hyperplasia due to long - term EntityPGE1 therapy simulate hypertrophic pyloric stenosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Occasionally, despite good therapeutic response, Entityclozapine must be stopped due to dangerous side effects such as Entityagranulocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Findings on discontinuation and rechallenge supported the assumption that the Entityhair loss was a side effect of the Entityparoxetine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPsoriasis triggered by toll - like receptor 7 agonist Entityimiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIatrogenic hypercalcemia due to Entityvitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
0.9996 Adverse-Effect EntityIatrogenic hypercalcemia due to vitamin D3 ointment ( Entity1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
0.9994 Adverse-Effect EntityIatrogenic hypercalcemia due to vitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with Entitythiazide diuretics in a case of psoriasis.
Adverse-Effect Iatrogenic Entityhypercalcemia due to vitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with Entitythiazide diuretics in a case of psoriasis.
Adverse-Effect Iatrogenic Entityhypercalcemia due to vitamin D3 ointment ( Entity1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
Adverse-Effect Iatrogenic Entityhypercalcemia due to Entityvitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with ulcerative colitis developed skin pigmentation and Entitydiffuse pulmonary shadowing without respiratory symptomatology, while taking Entitysulfasalazine .
0.9999 Adverse-Effect A patient with ulcerative colitis developed Entityskin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology, while taking Entitysulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, EntityCIPS was considered to be probably associated with Entitycyclosporine according to the Naranjo probability scale.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This treatment has the potential to cause severe vision loss as a result of intractable Entitycorticosteroid - induced Entityglaucoma .
0.9999 Adverse-Effect This treatment has the potential to cause Entitysevere vision loss as a result of intractable Entitycorticosteroid - induced glaucoma.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect EntityLithium neurotoxicity should be considered in EntityCreutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
1.0000 Adverse-Effect EntityLithium Entityneurotoxicity should be considered in Creutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
Adverse-Effect EntityLithium EntityLithium neurotoxicity should be considered in Creutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitypenile fibrosis after intracavernous self - injection of a combination of Entityphentolamine and papaverine.
1.0000 Adverse-Effect We report a case of Entitypenile fibrosis after intracavernous self - injection of a combination of phentolamine and Entitypapaverine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of a 54 - year - old Turkish woman who presented with Entityceftriaxone - induced EntityFDE .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report such a series of patients who had Entitytransient asymptomatic bradycardia after being treated with continuous infusion Entity5 - FU .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Relief by naloxone of Entitymorphine - induced Entityspasm of the sphincter of Oddi in a post - cholecystectomy patient.
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect The present report suggests that clarithromycin coadministration induces increased plasma carbamazepine concentrations, which may result in Entitycarbamazepine Entitycarbamazepine toxicity .
0.9985 Adverse-Effect The present report suggests that clarithromycin coadministration induces increased plasma Entitycarbamazepine concentrations, which may result in Entitycarbamazepine toxicity .
0.9926 Adverse-Effect The present report suggests that Entityclarithromycin coadministration induces increased plasma carbamazepine concentrations, which may result in Entitycarbamazepine toxicity .
Adverse-Effect The present report suggests that clarithromycin coadministration induces Entityincreased plasma carbamazepine Entitycarbamazepine concentrations, which may result in carbamazepine toxicity.
Adverse-Effect The present report suggests that Entityclarithromycin coadministration induces Entityincreased plasma carbamazepine concentrations, which may result in carbamazepine toxicity.
Adverse-Effect The present report suggests that clarithromycin coadministration induces Entityincreased plasma carbamazepine concentrations, which may result in Entitycarbamazepine toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityphenobarbital Entityexacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy.
0.9999 Adverse-Effect A case of Entityphenobarbital Entityphenobarbital exacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intracranial hemorrhage and Entityfocal seizures secondary to use of EntityL - asparaginase during induction therapy of acute lymphocytic leukemia.
0.9997 Adverse-Effect EntityIntracranial hemorrhage and focal seizures secondary to use of EntityL - asparaginase during induction therapy of acute lymphocytic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of prolonged Entitysuxamethonium Entityapnoea successfully terminated by the infusion of a commercial preparation of serumcholinesterase is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After the Entitychlorambucil was discontinued, the wbc count began to slowly rise and the patient developed clinical EntityAML .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 patients with prior amputation who experienced phantom limb pain ( EntityPLP ) after receiving Entitypaclitaxel therapy.
1.0000 Adverse-Effect We describe 2 patients with prior amputation who experienced Entityphantom limb pain ( PLP ) after receiving Entitypaclitaxel therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Localized panniculitis and subsequent Entitylipoatrophy with subcutaneous Entityglatiramer acetate ( Copaxone ) injection for the treatment of multiple sclerosis.
0.9999 Adverse-Effect Localized panniculitis and subsequent Entitylipoatrophy with subcutaneous glatiramer acetate ( EntityCopaxone ) injection for the treatment of multiple sclerosis.
0.9997 Adverse-Effect EntityLocalized panniculitis and subsequent lipoatrophy with subcutaneous Entityglatiramer acetate ( Copaxone ) injection for the treatment of multiple sclerosis.
0.9992 Adverse-Effect EntityLocalized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate ( EntityCopaxone ) injection for the treatment of multiple sclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The aim of our paper was to describe Entityhepatotoxicity of Entitysirolimus ( SRL ) in a kidney graft recipient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of drug - induced Entitypemphigus caused by an angiotensin - converting enzyme inhibitor, Entitycaptopril .
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect OBJECTIVE : To report Entityteicoplanin - related Entityneutropenia that developed after an episode of neutropenia induced by vancomycin therapy.
0.9988 Adverse-Effect OBJECTIVE : To report teicoplanin - related neutropenia that developed after an episode of Entityneutropenia induced by Entityvancomycin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with HLH developed Entityetoposide - related Entitysecondary acute myeloid leukemia ( sAML ) following therapy for HLH.
0.9999 Adverse-Effect Two patients with HLH developed Entityetoposide - related secondary acute myeloid leukemia ( EntitysAML ) following therapy for HLH.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first patient is undergoing hemodialysis and, though responding to Entitysunitinib , is having significant Entityfatigue and hypertension.
1.0000 Adverse-Effect The first patient is undergoing hemodialysis and, though responding to Entitysunitinib , is having significant fatigue and Entityhypertension .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This communication describes a patient who developed EntitySchneiderian first - rank symptoms in the course of treatment with Entityfluvoxamine .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Initiation of Entityposaconazole led to clinical improvement until the patient's demise from bacteremic vancomycin - resistant Entityenterococcal peritonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRed blood cell anemia in a patient with pemphigus vulgaris induced by the use of Entitymycophenolate mofetil and prednisone.
0.9998 Adverse-Effect EntityRed blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and Entityprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After 3 - to 13 - month period of therapy without Entityindapamide , glucose levels of all patients decreased and Entitydiabetes disappeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entitysevere apnea in an infant exposed to Entitylamotrigine through breast - feeding.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect According to the Naranjo adverse drug reaction probability scale, Entitytigecycline was the probable cause of her Entityacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The time course of events suggested that Entityamphotericin B was the cause of the Entityseizures in this AIDS patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case history and toxicological findings of an infant Entityfatality involving Entitypseudoephedrine , brompheniramine, and dextromethorphan are presented.
1.0000 Adverse-Effect The case history and toxicological findings of an infant Entityfatality involving pseudoephedrine, Entitybrompheniramine , and dextromethorphan are presented.
1.0000 Adverse-Effect The case history and toxicological findings of an infant Entityfatality involving pseudoephedrine, brompheniramine, and Entitydextromethorphan are presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This regimen could prove useful for other patients who develop Entityhypersensitivity reactions to Entitycarboplatin and allow therapy to continue.
1.0000 Adverse-Effect This regimen could prove useful for other patients who develop Entityhypersensitivity reactions to Entitycarboplatin and allow therapy to continue.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most common side effects associated with Entityamifostine are Entitynausea , vomiting, hypotension, hypocalcemia and allergic reactions.
1.0000 Adverse-Effect The most common side effects associated with Entityamifostine are nausea, Entityvomiting , hypotension, hypocalcemia and allergic reactions.
1.0000 Adverse-Effect The most common side effects associated with Entityamifostine are nausea, vomiting, Entityhypotension , hypocalcemia and allergic reactions.
0.9999 Adverse-Effect The most common side effects associated with Entityamifostine are nausea, vomiting, hypotension, Entityhypocalcemia and allergic reactions.
0.9999 Adverse-Effect The most common side effects associated with Entityamifostine are nausea, vomiting, hypotension, hypocalcemia and Entityallergic reactions .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 51 - year old physically fit woman experienced angio - oedema and Entityhypotensive shock after Entityirbesartan ingestion requiring noradrenaline infusion.
0.9997 Adverse-Effect A 51 - year old physically fit woman experienced Entityangio - oedema and hypotensive shock after Entityirbesartan ingestion requiring noradrenaline infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case supports the assessment that MH and diabetes are associated diseases and that Entitycresol could possibly trigger EntityMH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the third report of reversible Entityhepatic decompensation associated with prolonged EntityMTX therapy in patients with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient is described who developed a poorly differentiated Entitysarcoma after Entitycyclophosphamide was used to treat his rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both colchicine and Entitystatin therapy may be associated with Entitymyopathy , which usually occurs after several months of therapy.
1.0000 Adverse-Effect Both Entitycolchicine and statin therapy may be associated with Entitymyopathy , which usually occurs after several months of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two patients with anhedonic ejaculation ( Entityejaculation without orgasm ) associated with initiation of treatment with Entitydesipramine .
1.0000 Adverse-Effect We report two patients with Entityanhedonic ejaculation ( ejaculation without orgasm ) associated with initiation of treatment with Entitydesipramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Including our own patient, a total of 26 cases of Entitygemcitabine - associated EntityHUS were identified.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 5 - year - old girl showed recovery of Entityvincristine induced Entitycranial polyneuropathy with pyridoxine and pyridostigmine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was placed on adjuvant Adriamycin ( Entitydoxorubicin ) chemotherapy, but 6 months later Entitydied of Adriamycin toxicity.
0.9998 Adverse-Effect She was placed on adjuvant EntityAdriamycin ( doxorubicin ) chemotherapy, but 6 months later Entitydied of Adriamycin toxicity.
0.9993 Adverse-Effect She was placed on adjuvant Adriamycin ( doxorubicin ) chemotherapy, but 6 months later died of EntityAdriamycin EntityAdriamycin toxicity .
0.9989 Adverse-Effect She was placed on adjuvant Adriamycin ( Entitydoxorubicin ) chemotherapy, but 6 months later died of EntityAdriamycin toxicity .
0.9962 Adverse-Effect She was placed on adjuvant Adriamycin ( doxorubicin ) chemotherapy, but 6 months later Entitydied of EntityAdriamycin toxicity.
0.9942 Adverse-Effect She was placed on adjuvant EntityAdriamycin ( doxorubicin ) chemotherapy, but 6 months later died of EntityAdriamycin toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Quinine and its isomer Entityquinidine are well - known causes of Entityiatrogenic hypoglycaemia , due to excessive insulin secretion.
0.9997 Adverse-Effect EntityQuinine and its isomer quinidine are well - known causes of Entityiatrogenic hypoglycaemia , due to excessive insulin secretion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, he developed acute renal failure, hyperkalemia, and Entityhyperuricemia 30 d after receiving the Entitysorafenib treatment.
0.9999 Adverse-Effect However, he developed acute renal failure, Entityhyperkalemia , and hyperuricemia 30 d after receiving the Entitysorafenib treatment.
0.9999 Adverse-Effect However, he developed Entityacute renal failure , hyperkalemia, and hyperuricemia 30 d after receiving the Entitysorafenib treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : A woman receiving Entityenoxaparin every 12 hours developed signs and symptoms of Entityhepatotoxicity after the second dose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She had been on EntityCopaxone 20 mg / day treatment for 2 years when she first exhibited Entitygastrointestinal symptoms .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, dermatologists should be cautious about a Entityphotosensitivity reaction induced by Entitymequitazine or other phenothiazine - derivative drugs.
1.0000 Adverse-Effect However, dermatologists should be cautious about a Entityphotosensitivity reaction induced by Entitymequitazine or other phenothiazine - derivative drugs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To date, this is the first reported case of what appears to be isolated Entitythrombocytopenia associated with Entitylansoprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes the first case of Entityinsulin - induced Entitycardiac failure in a patient without underlying heart disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients receiving Entityneutral protamine Hagedorn ( NPH ) insulin are at increased risk for the development of Entityprotamine hypersensitivity .
1.0000 Adverse-Effect Patients receiving neutral Entityprotamine Hagedorn ( NPH ) insulin are at increased risk for the development of Entityprotamine hypersensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRadiation recall from Entitygemcitabine is rare, but can potentially arise in any site that has been previously irradiated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNeutropenia is an infrequent complication following administration of the angiotensin - converting enzyme ( ACE ) inhibitor, Entitycaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cholestatic liver disease with ductopenia ( Entityvanishing bile duct syndrome ) after administration of Entityclindamycin and trimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect EntityCholestatic liver disease with ductopenia ( vanishing bile duct syndrome ) after administration of Entityclindamycin and trimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Cholestatic liver disease with Entityductopenia ( vanishing bile duct syndrome ) after administration of Entityclindamycin and trimethoprim - sulfamethoxazole.
0.9998 Adverse-Effect Cholestatic liver disease with ductopenia ( Entityvanishing bile duct syndrome ) after administration of clindamycin and Entitytrimethoprim - sulfamethoxazole .
0.9992 Adverse-Effect EntityCholestatic liver disease with ductopenia ( vanishing bile duct syndrome ) after administration of clindamycin and Entitytrimethoprim - sulfamethoxazole .
0.9990 Adverse-Effect Cholestatic liver disease with Entityductopenia ( vanishing bile duct syndrome ) after administration of clindamycin and Entitytrimethoprim - sulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should keep in mind that taxanes such as Entitypaclitaxel have the potential to cause Entitypneumonitis and lung fibrosis.
0.9999 Adverse-Effect Physicians should keep in mind that taxanes such as Entitypaclitaxel have the potential to cause pneumonitis and Entitylung fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hypersensitivity to Entityaspirin can be manifested as acute asthma, Entityurticaria and / or angioedema, or a systemic anaphylactoid reaction.
0.9999 Adverse-Effect Hypersensitivity to Entityaspirin can be manifested as acute asthma, urticaria and / or Entityangioedema , or a systemic anaphylactoid reaction.
0.9999 Adverse-Effect Hypersensitivity to Entityaspirin can be manifested as acute asthma, urticaria and / or angioedema, or a Entitysystemic anaphylactoid reaction .
1.0000 Adverse-Effect Hypersensitivity to Entityaspirin can be manifested as Entityacute asthma , urticaria and / or angioedema, or a systemic anaphylactoid reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravitreal Entitytriamcinolone may have had an influence on the Entityexacerbation of retinochoroiditis in the posterior pole of the patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 30 - year - old pharmacist suffered from Entityacute allergic contact dermatitis due to Entity4 - chloro - 7 - nitrobenzofurazan ( NBD - Cl ).
0.9996 Adverse-Effect A 30 - year - old pharmacist suffered from Entityacute allergic contact dermatitis due to 4 - chloro - 7 - nitrobenzofurazan ( EntityNBD - Cl ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPneumonitis is emerging as one of the most unpredictable and potentially serious, adverse effects of treatment with EntityMTX .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The female patient received Entityclozapine in a daily dose of 400 mg, which induced Entityagranulocytosis after 2 months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She continued to receive regular Entityinsulin 4 times per day over the following 3 years with only occasional Entityhives .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPropoxyphene - induced Entitywide complex dysrhythmia responsive to sodium bicarbonate therapy has not been previously reported in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProgressive anemia following combination therapy with Entityinterferon - alpha and interleukin - 2 in a patient with metastatic renal cell carcinoma.
0.9991 Adverse-Effect EntityProgressive anemia following combination therapy with interferon - alpha and Entityinterleukin - 2 in a patient with metastatic renal cell carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVisual changes secondary to initiation of Entityamiodarone : a case report and review involving ocular management in cardiac polypharmacy.
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect Metabolic balance studies and rechallenge with Entityhydrochlorothiazide were undertaken to investigate the mechanism of the thiazide - induced Entityhyponatremia .
1.0000 Adverse-Effect Metabolic balance studies and rechallenge with hydrochlorothiazide were undertaken to investigate the mechanism of the Entitythiazide - induced Entityhyponatremia .
Score Relation Text (Head - Tail)
0.9962 Adverse-Effect Goiter and hypothyroidism during re - treatment with amiodarone in a patient who previously experienced Entityamiodarone - induced Entitythyrotoxicosis .
0.9934 Adverse-Effect Goiter and Entityhypothyroidism during re - treatment with Entityamiodarone in a patient who previously experienced amiodarone - induced thyrotoxicosis.
0.9165 Adverse-Effect EntityGoiter and hypothyroidism during re - treatment with Entityamiodarone in a patient who previously experienced amiodarone - induced thyrotoxicosis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Other thiazolidinediones currently in clinical trials may be able to provide the therapeutic benefits of Entitytroglitazone without significant Entityhepatotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our case is the second one in which Entityhemorrhage from a meningioma may have been induced by Entityaspirin prophylaxis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report one case of Entityincomplete posterior hyaloid detachment ( PHD ) following intravitreal Entitypegaptanib to treat DME.
1.0000 Adverse-Effect The authors report one case of incomplete posterior hyaloid detachment ( EntityPHD ) following intravitreal Entitypegaptanib to treat DME.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityL - DOPA - induced excessive Entitydaytime sleepiness in PD : a placebo - controlled case with MSLT assessment.
1.0000 Adverse-Effect EntityL - DOPA - induced Entityexcessive daytime sleepiness in PD : a placebo - controlled case with MSLT assessment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nine azotemic patients who developed a Entitycoagulopathy associated with the use of either Entitycephalosporin or moxalactam antibiotics are reported.
1.0000 Adverse-Effect Nine azotemic patients who developed a Entitycoagulopathy associated with the use of either cephalosporin or Entitymoxalactam antibiotics are reported.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Two patients treated with Entityalprazolam had histories suggestive of a bipolar disorder and developed lithium - responsive Entitymanic episodes .
1.0000 Adverse-Effect Two patients treated with alprazolam had histories suggestive of a bipolar disorder and developed Entitylithium - responsive Entitymanic episodes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with generalized MG was effectively managed with EntityMM but developed EntityCNS lymphoma after 3 years of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - dose intravenous Entitymannitol infusion in various clinical settings may result in Entityacute renal failure ( ARF ).
1.0000 Adverse-Effect High - dose intravenous Entitymannitol infusion in various clinical settings may result in acute renal failure ( EntityARF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This progressed to Entitytracheal compression with stridor after he had taken some Entityaspirin for relief of the neck pain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : There was a temporal relationship between the onset of Entitynonconvulsive status epilepticus and initiation of Entityifosfamide infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians should be aware that EntityCrohn's disease is a potential novel adverse drug effect of EntityCopaxone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 45 - year - old psoriasis patient who developed Entityeruptive mollusca contagiosa during an antipsoriatic treatment with Entityefalizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of EntitySweet's syndrome in association with Entitysargramostim treatment following chemotherapy for acute myelogenous leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityScleroderma - like reaction induced by Entityuracil - tegafur ( UFT ), a second - generation anticancer agent.
0.9997 Adverse-Effect EntityScleroderma - like reaction induced by uracil - tegafur ( EntityUFT ), a second - generation anticancer agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : We report a case of Entitycutaneous KS lesions in a patient affected by CML treated with Entityimatinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of a 53 - year - old man who developed Entityacute pneumonitis after Entitybleomycin and moderate oxygen administration is presented.
0.9997 Adverse-Effect A case of a 53 - year - old man who developed Entityacute pneumonitis after bleomycin and moderate Entityoxygen administration is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Caution is, therefore, needed to prevent undesired accumulation of EntityTCA that may lead to protracted EntityCushing's syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a postoperative patient with pre - existent myasthenia gravis, oral Entityverapamil caused a marked Entityexacerbation in myasthenic weakness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The concomitant use, however, of colchicine and Entitystatin has been associated with the rapid onset of Entitymuscle weakness .
0.9998 Adverse-Effect The concomitant use, however, of Entitycolchicine and statin has been associated with the rapid onset of Entitymuscle weakness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 64 - year - old man presented with Entityproteinuria during postoperative Entityinterferon ( IFN ) - beta therapy against malignant melanoma.
0.9999 Adverse-Effect A 64 - year - old man presented with Entityproteinuria during postoperative interferon ( EntityIFN ) - beta therapy against malignant melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recognition of a potential drug - induced EntityFanconi syndrome is important when managing pediatric oncology patients previously treated with Entityifosfamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We experienced a case of chronic renal failure in a patient suffering from acute hemorrhagic gastritis associated with EntityAZ EntityAZ intoxication .
0.9985 Adverse-Effect We experienced a case of chronic renal failure in a patient suffering from Entityacute hemorrhagic gastritis associated with EntityAZ intoxication.
0.9991 Adverse-Effect We experienced a case of chronic Entityrenal failure in a patient suffering from acute hemorrhagic gastritis associated with EntityAZ intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient's other comorbidities and medications have not been suggested as possible interactions with Entitysertraline that can cause Entityrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of the authors'knowledge, this is the first reported case of EntityPropecia - associated Entitycataract .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Our patient developed Crohn's disease while on EntityCopaxone treatment as a consequence of Entitylong - term immunosuppression .
Adverse-Effect RESULTS : Our patient developed EntityCrohn's disease while on EntityCopaxone treatment as a consequence of long - term immunosuppression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, we describe a fatal Entitygemcitabine - induced Entitypulmonary toxicity in a patient with gallbladder metastatic adenocarcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that Entitymeloxicam might have Entityintestinal toxic effects when taken in high doses, because of reduced COX - 2 selectivity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A chronic reaction associated with long - term treatment with Entitynitrofurantoin has also been reported and causes irreversible Entitypulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient developed Entitysevere hyponatremia with serum Na + of 108 mEq / L when Entityhydrochlorothiazide was given to control hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 43 - year - old man who developed signs and symptoms of Entitybilateral optic neuropathy during treatment with Entityethambutol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitynoncardiogenic pulmonary edema developed after therapeutic trial of EntityEO as sclerosing agent for esophageal varix.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : A patient with CHF and ESRD developed Entitymyoclonic muscle spasms after receiving Entitydobutamine by continuous i. v. infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of an 11 - year - old boy who experienced an Entityanaphylactic reaction after administration of Entitybacitracin ointment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These two cases highlight the importance of considering lopinavir / Entityritonavir induced Entityarrhythmias when dealing with HIV - positive individuals.
0.9999 Adverse-Effect These two cases highlight the importance of considering Entitylopinavir / ritonavir induced Entityarrhythmias when dealing with HIV - positive individuals.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the other hand, EntityMTX - induced Entitypneumonitis seems to be very rare in psoriatic arthritis ( PsA ).
Score Relation Text (Head - Tail)
0.9931 Adverse-Effect Patients treated with captopril who develop " atypical cholangitis " should be suspected of having Entitycaptopril - associated Entityliver damage .
0.9883 Adverse-Effect Patients treated with Entitycaptopril who develop " Entityatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.9736 Adverse-Effect Patients treated with Entitycaptopril who develop " Entityatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.9736 Adverse-Effect Patients treated with Entitycaptopril who develop " Entityatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.9735 Adverse-Effect Patients treated with Entitycaptopril who develop " Entityatypical cholangitis " should be suspected of having captopril - associated liver damage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He developed fever, nausea, diarrhea, and Entitymalaise and stopped taking on the third day after commencing EntityPentasa .
1.0000 Adverse-Effect He developed fever, nausea, Entitydiarrhea , and malaise and stopped taking on the third day after commencing EntityPentasa .
1.0000 Adverse-Effect He developed fever, Entitynausea , diarrhea, and malaise and stopped taking on the third day after commencing EntityPentasa .
1.0000 Adverse-Effect He developed Entityfever , nausea, diarrhea, and malaise and stopped taking on the third day after commencing EntityPentasa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors'results suggest that EntityL - dopa may cause Entitydaytime somnolence in some patients with Parkinson's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The aim of this study was to describe the occurrence of Entityacute coronary syndromes in 3 cases of Entityrituximab infusions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite a very low complication rate, several Entitysevere arterial thrombotic events have been reported following Entitythrombin injection of pseudoaneurysms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the first patient, two episodes of Entityventricular tachycardia requiring cardioversion occurred in close temporal sequence with administering Entitybretylium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of multiple episodes of Entityseizure activity in an AIDS patent following Entityamphotericin B infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A drug addict with staphylococcal endocarditis treated with Entitymethicillin , who developed Entitymassive proteinuria and acute nephritic syndrome is described.
1.0000 Adverse-Effect A drug addict with staphylococcal endocarditis treated with Entitymethicillin , who developed massive proteinuria and Entityacute nephritic syndrome is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Prolonged exposure to Entityitraconazole , administered either continuously or intermittently, may precipitate Entitysevere and irreversible hepatotoxic events .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient's defects may be due to Entitymethimazole Entityteratogenicity or could represent a previously undescribed syndrome affecting ectodermal structures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGestational diabetes was no less severe ( degree of hyperglycaemia, need for insulin therapy ) when associated with Entitynorethisterone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityUveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of Entityrifabutin , clarithromycin and ethambutol.
1.0000 Adverse-Effect EntityUveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of rifabutin, Entityclarithromycin and ethambutol.
1.0000 Adverse-Effect EntityUveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of rifabutin, clarithromycin and Entityethambutol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following several of these courses of therapy, Entityrespiratory distress occurred 9 to 12 days after the Entitychlorambucil was given.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three cases of Entityacute renal toxicity in patients receiving long - term therapy with Entitymitomycin C and 5 - fluorouracil are reported.
0.9999 Adverse-Effect Three cases of Entityacute renal toxicity in patients receiving long - term therapy with mitomycin C and Entity5 - fluorouracil are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRamipril - induced Entitycutaneous vasculitis is particularly rare and our case was atypical because the patient had tolerated lisinopril before.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a young adolescent with Entitybenign intracranial hypertension which we attribute to the use of Entityminocycline for acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An adolescent male developed acute pancreatitis and Entitypseudocyst of the pancreas 16 weeks after cessation of intramuscular EntityL - asparaginase .
0.9994 Adverse-Effect An adolescent male developed Entityacute pancreatitis and pseudocyst of the pancreas 16 weeks after cessation of intramuscular EntityL - asparaginase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four cases of Entityfat embolism are described in infants receiving prolonged intravenous infusion of fat ( EntityIntralipid 20 % ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect According to the Naranjo probability scale, the relationship of Entitygemcitabine treatment with Entitycutaneous eruption in our patient is possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A boy with chronic neutropenia and recurrent inflammatory skin lesions developed Entitymultiple erythematous nodules following administration of EntityG - CSF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite the known Entitypulmonary side effects of Entitynitrofurantoin , there is no report of this toxicity occurring in pregnant patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Evidence is shown in this report that Entityadenosine was associated with dangerous worsening of Entityarrhythmia in patients with atrial flutter.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A third patient experienced Entitydisabling neurotoxicity in the extremity of a prior ulnar nerve and tendon transposition after receiving Entitypaclitaxel .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of urinary incontinence ( EntityUI ) that occurred in a woman after administration of Entityvenlafaxine .
1.0000 Adverse-Effect The authors report a case of Entityurinary incontinence ( UI ) that occurred in a woman after administration of Entityvenlafaxine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four days after intravenous EntityZoledronic acid , the patient presented to emergency room with complaints of Entitycarpopedal spasm and bronchospasm.
0.9995 Adverse-Effect Four days after intravenous EntityZoledronic acid , the patient presented to emergency room with complaints of carpopedal spasm and Entitybronchospasm .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four patients who manifested symptoms of the antiepileptic drug ( AED ) Entityhypersensitivity syndrome during therapy with Entitycarbamazepine are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A review of the literature revealed two other cases of Entityhepatic angiosarcoma in patients after long - term Entitycyclophosphamide treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityneurotoxicity seen with EntityHDARAC is dose - related and has occurred in up to 60 percent of treated patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIntra - neural ceroid - like pigment following the treatment of lepromatous leprosy with Entityclofazimine ( B663 ; Lamprene ).
0.9999 Adverse-Effect EntityIntra - neural ceroid - like pigment following the treatment of lepromatous leprosy with clofazimine ( B663 ; EntityLamprene ).
0.9999 Adverse-Effect EntityIntra - neural ceroid - like pigment following the treatment of lepromatous leprosy with clofazimine ( EntityB663 ; Lamprene ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report on the histopathological findings of thyroid tissue from a patient with Entityamiodarone - induced Entityhypothyroidism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Herein, we describe 2 patients who developed unusual EntityCD8 + cutaneous lymphoproliferative disorders after treatment with Entityefalizumab and infliximab.
0.9999 Adverse-Effect Herein, we describe 2 patients who developed unusual EntityCD8 + cutaneous lymphoproliferative disorders after treatment with efalizumab and Entityinfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After excluding other causes of long QT syndrome, the EntityHCQ was suspected as the cause of her Entityventricular tachycardia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that neurosurgeons and neurologists should be aware of calcium antagonist - - related Entityileus in patients treated with Entitynimodipine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNMS is a drug - related response to various medications, such as EntityHaloperidol , which the patient was receiving.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The noted Entityincrease in the theophylline level after Entityzafirlukast administration is in contrast to the original reports by the manufacturer.
0.9998 Adverse-Effect The noted Entityincrease in the theophylline level Entitytheophylline level after zafirlukast administration is in contrast to the original reports by the manufacturer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case of Entityivermectin - induced Entitysevere liver disease published in the literature.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect EntityPalpable purpuric skin lesions on the anterior surface of both legs appeared on the 55th day of Entityamphotericin B treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three years later, treatment with Entityampicillin caused another episode of Entitycholestatic hepatitis with cholestasis and duct paucity on rebiopsy.
1.0000 Adverse-Effect Three years later, treatment with Entityampicillin caused another episode of cholestatic hepatitis with Entitycholestasis and duct paucity on rebiopsy.
0.9999 Adverse-Effect Three years later, treatment with Entityampicillin caused another episode of cholestatic hepatitis with cholestasis and Entityduct paucity on rebiopsy.
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect Teicoplanin - induced agranulocytosis that followed Entityvancomycin - induced Entityagranulocytosis suggests a possible cross - reactivity between the 2 drugs.
0.9897 Adverse-Effect EntityTeicoplanin - induced Entityagranulocytosis that followed vancomycin - induced agranulocytosis suggests a possible cross - reactivity between the 2 drugs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This unusual pattern of low - grade endometrial carcinoma adds to the spectrum of Entityuterine neoplasia associated with Entitytamoxifen therapy.
0.9999 Adverse-Effect This unusual pattern of Entitylow - grade endometrial carcinoma adds to the spectrum of uterine neoplasia associated with Entitytamoxifen therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a case report of subtle, mild Entityhypothermia in a 54 - year old female patient receiving Entityrisperidone for schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Infliximab and its serious adverse effects are discussed, and other cases of Entityosteomyelitis with Entityinfliximab use are also reviewed.
0.9943 Adverse-Effect EntityInfliximab and its serious adverse effects are discussed, and other cases of Entityosteomyelitis with infliximab use are also reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a unique autopsy case of Entityhepatocellular carcinoma closely related to Entitydiethylstilbestrol ( DES ) therapy for prostatic cancer.
0.9999 Adverse-Effect This is a unique autopsy case of Entityhepatocellular carcinoma closely related to diethylstilbestrol ( EntityDES ) therapy for prostatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVigabatrin - induced Entityvisual field defects are at present the most important safety issue in the use of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a child with metastatic osteosarcoma, who experienced an Entityanaphylactic / anaphylactoid reaction to Entitymethotrexate .
1.0000 Adverse-Effect We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic Entity/ anaphylactoid reaction to Entitymethotrexate .
1.0000 Adverse-Effect We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic / Entityanaphylactoid reaction to Entitymethotrexate .
Score Relation Text (Head - Tail)
0.9928 Adverse-Effect Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included Entitycisplatinum Entitynephrotoxicity and adriamycin cardiotoxicity.
0.9832 Adverse-Effect Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included Entitycisplatinum Entitycisplatinum nephrotoxicity and adriamycin cardiotoxicity.
Adverse-Effect Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included cisplatinum nephrotoxicity and Entityadriamycin Entitycardiotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RTA is one type of Entitynephrotoxicity induced by EntityFK506 , and it is reversible in mild cases when appropriately treated.
0.9999 Adverse-Effect EntityRTA is one type of nephrotoxicity induced by EntityFK506 , and it is reversible in mild cases when appropriately treated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three male patients aged 78 - 83 years are presented, in whom Entitysevere hepatotoxic reactions emerged after EntityCPA administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with Entityextrapyramidal side effects after the use of Entityfluphenazine decanoate were evaluated by means of IBZM - SPECT.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Muscle biopsy revealed variation in muscle fiber size and few vacuolated fibers which were features of Entitycolchicine - induced Entitymyopathy .
1.0000 Adverse-Effect Muscle biopsy revealed variation in muscle fiber size and few Entityvacuolated fibers which were features of Entitycolchicine - induced myopathy.
0.9998 Adverse-Effect Muscle biopsy revealed Entityvariation in muscle fiber size and few vacuolated fibers which were features of Entitycolchicine - induced myopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Allergic side effects of AZA are rare, and reported Entityallergic skin eruptions from EntityAZA are very limited in Japan.
0.9999 Adverse-Effect Allergic side effects of EntityAZA are rare, and reported Entityallergic skin eruptions from AZA are very limited in Japan.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse effects of Entityamiodarone including Entitypulmonary toxicity , hepatotoxicity, aggravation of arrhythmia, and thyroid diseases are well understood.
0.9999 Adverse-Effect Adverse effects of Entityamiodarone including pulmonary toxicity, hepatotoxicity, Entityaggravation of arrhythmia , and thyroid diseases are well understood.
0.9999 Adverse-Effect Adverse effects of Entityamiodarone including pulmonary toxicity, hepatotoxicity, aggravation of arrhythmia, and Entitythyroid diseases are well understood.
0.9998 Adverse-Effect Adverse effects of Entityamiodarone including pulmonary toxicity, Entityhepatotoxicity , aggravation of arrhythmia, and thyroid diseases are well understood.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient presented with fulminant microangiopathic hemolytic anemia and Entitythrombocytopenia within 48 hr of initiating therapy with Entitytrimethoprim - sulfamethoxazole.
1.0000 Adverse-Effect The patient presented with fulminant microangiopathic hemolytic anemia and Entitythrombocytopenia within 48 hr of initiating therapy with trimethoprim - Entitysulfamethoxazole .
0.9999 Adverse-Effect The patient presented with Entityfulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with Entitytrimethoprim - sulfamethoxazole.
0.9997 Adverse-Effect The patient presented with Entityfulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim - Entitysulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : For all patients with Entityvancomycin - induced Entityneutropenia , possible cross - reactivity of teicoplanin should be monitored.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Reinstitution of penicillamine treatment caused a recurrence thus proving a causal relationship between Entitypenicillamine and the described Entitynail - changes .
0.9937 Adverse-Effect Reinstitution of Entitypenicillamine treatment caused a recurrence thus proving a causal relationship between penicillamine and the described Entitynail - changes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To investigate the mechanisms involved in Entityhypersensitivity reactions to Entitycyclosporine and determine the feasibility of future cyclosporine use.
0.9990 Adverse-Effect OBJECTIVE : To investigate the mechanisms involved in Entityhypersensitivity reactions to cyclosporine and determine the feasibility of future Entitycyclosporine use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitytuberculosis in a patient on EntityEfalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
1.0000 Adverse-Effect A case of Entitytuberculosis in a patient on Efalizumab and EntityEtanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Entitynephrotic syndrome in a patient with acute myeloblastic leukemia after treatment with Entitymacrophage - colony - stimulating factor .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Typical symptoms of active EntityCD occurred 11, 12, and 26 months after start of Entityetanercept therapy, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The dermatology literature heretofore has not noted that Entityanemia is a side effect of patients taking EntityMMF to treat pemphigus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a girl with the Rett syndrome who had Entityacute encephalopathy probably induced by Entitycalcium hopantenate ( HOPA ).
0.9996 Adverse-Effect We report a girl with the Rett syndrome who had Entityacute encephalopathy probably induced by calcium hopantenate ( EntityHOPA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Increased awareness is needed on the possible occurrence of EntityLPD resembling gastric cancer in rheumatoid arthritis patients treated with EntityMTX .
1.0000 Adverse-Effect Increased awareness is needed on the possible occurrence of LPD resembling Entitygastric cancer in rheumatoid arthritis patients treated with EntityMTX .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityOptic neuropathy developed in a patient with rheumatoid arthritis who had been receiving EntityD - penicillamine for about 1 year.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Surgeons and physicians should therefore be aware of the potential for EntityRTA to occur with EntityFK506 after any organ transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 4 patients who developed symptoms of Entitymyasthenia gravis within 2 weeks of starting treatment with a Entitystatin drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was treated with EntityPancrease MT 16 , but had consistent Entityvomiting 1 to 2 hours after administration of enzymes.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a rare case of Entityritodrine - hydrochloride - induced Entityrhabdomyolysis in a pregnant patient with myotonic dystrophy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our literature review revealed an additional six cases of onset of Entityinflammatory arthritis in MS patients receiving EntityIFN - beta .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityImatinib mesylate - related Entityfatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect PURPOSE : To describe Entitybilateral optic neuritis that occurred as an adverse effect of recombinant and natural Entityinterferon alpha administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our findings reveal that even in patients without a history of seizures, Entitypregabalin can cause a Entitycortical negative myoclonus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Disseminated intravascular coagulation associated with acute hemoglobinemia or Entityhemoglobinuria following EntityRh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
0.9993 Adverse-Effect Disseminated intravascular coagulation associated with Entityacute hemoglobinemia or hemoglobinuria following EntityRh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
0.9993 Adverse-Effect EntityDisseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following EntityRh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pneumocystis pneumonia should be considered in asthmatic patients taking Entitymethotrexate who present with Entityfever , pulmonary infiltrates, and hypoxia.
1.0000 Adverse-Effect EntityPneumocystis pneumonia should be considered in asthmatic patients taking Entitymethotrexate who present with fever, pulmonary infiltrates, and hypoxia.
1.0000 Adverse-Effect Pneumocystis pneumonia should be considered in asthmatic patients taking Entitymethotrexate who present with fever, pulmonary infiltrates, and Entityhypoxia .
0.9999 Adverse-Effect Pneumocystis pneumonia should be considered in asthmatic patients taking Entitymethotrexate who present with fever, Entitypulmonary infiltrates , and hypoxia.
Score Relation Text (Head - Tail)
0.9950 Adverse-Effect EntityADH hypersecretion in relation to plasma osmolality was reversed by Entitymizoribin withdrawal, suggesting that bredinin might adversely induce SIADH.
0.9997 Adverse-Effect ADH hypersecretion in relation to Entityplasma osmolality was reversed by Entitymizoribin withdrawal, suggesting that bredinin might adversely induce SIADH.
0.8839 Adverse-Effect ADH hypersecretion in relation to plasma osmolality was reversed by Entitymizoribin withdrawal, suggesting that bredinin might adversely induce EntitySIADH .
Adverse-Effect ADH hypersecretion in relation to plasma osmolality was reversed by mizoribin withdrawal, suggesting that Entitybredinin might adversely induce EntitySIADH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The known side effects of Entitysibutramine , ie, Entityhypertension and tachycardia, depend on its adrenergic and serotoninergic effects.
0.9998 Adverse-Effect The known side effects of Entitysibutramine , ie, hypertension and Entitytachycardia , depend on its adrenergic and serotoninergic effects.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect During the anti - tuberculous therapy, Entityvisual loss can be related to Entityethambutol toxicity or the tuberculosis infection itself.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Late development of Entitydiabetes mellitus after Entityinterferon - alfa and ribavirin therapy for chronic hepatitis C : a case report.
0.9995 Adverse-Effect Late development of Entitydiabetes mellitus after interferon - alfa and Entityribavirin therapy for chronic hepatitis C : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : To describe clinical and pathologic findings in patients noted to develop Entitylower gastrointestinal symptoms when exposed to Entityrofecoxib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The probability of developing Entityacute leukemia in this study was not significantly correlated to the total cumulative dosage of EntityTreosulfan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Carboplatin Entityhypersensitivity induced by low - dose Entitypaclitaxel / carboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
1.0000 Adverse-Effect EntityCarboplatin Entityhypersensitivity induced by low - dose paclitaxel / carboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
0.9995 Adverse-Effect Carboplatin Entityhypersensitivity induced by low - dose paclitaxel / Entitycarboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Elderly patients for whom Entitynitrate has been prescribed should be warned of the occurrence of Entityhypotension , leading to unconsciousness.
0.9999 Adverse-Effect Elderly patients for whom Entitynitrate has been prescribed should be warned of the occurrence of hypotension, leading to Entityunconsciousness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityQuetiapine and Entityobsessive - compulsive symptoms ( OCS ) : case report and review of atypical antipsychotic - induced OCS.
0.9999 Adverse-Effect EntityQuetiapine and obsessive - compulsive symptoms ( EntityOCS ) : case report and review of atypical antipsychotic - induced OCS.
0.9958 Adverse-Effect EntityQuetiapine and obsessive - compulsive symptoms ( OCS ) : case report and review of atypical antipsychotic - induced EntityOCS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unintended exposure to Entityacyclovir early in pregnancy, which is not uncommon, may cause Entityexcessive maternal and physician anxiety .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After the second Entityinfliximab infusion, he was found to have a Entitysevere transient neutropenia ( 0. 5 x 10 ( 9 ) / L ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect INTERPRETATION : When high doses of Entityfluticasone propionate are used, Entitygrowth may be retarded and adrenal suppression may occur.
0.9996 Adverse-Effect INTERPRETATION : When high doses of Entityfluticasone propionate are used, growth may be retarded and Entityadrenal suppression may occur.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect OBJECTIVE : To report the first five cases of Entityamphotericin B overdose with secondary Entitycardiac complications in a pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because Entitypsoralens sensitize skin to ultraviolet A light, Entityphototoxic reactions are the most frequent adverse effect of this treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A unique case of a transient, nonpigmenting Entityfixed drug eruption caused by the radiopaque contrast medium Entityiothalamate is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityhalothane induced Entityhepatitis is reported in a middle aged woman who underwent gastric surgery for morbid obesity.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect With the first Entitycyclosporine dose, the patient complained of Entityleg pain that was most severe during the cyclosporine infusion.
0.9999 Adverse-Effect With the first cyclosporine dose, the patient complained of Entityleg pain that was most severe during the Entitycyclosporine infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityColonic necrosis is known as a rare complication following the administration of EntityKayexalate ( sodium polystryrene sulfonate ) in sorbitol.
0.9997 Adverse-Effect EntityColonic necrosis is known as a rare complication following the administration of Kayexalate ( Entitysodium polystryrene sulfonate ) in sorbitol.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is suggested therefore that Entitymethotrexate be added to the list of agents capable of inducing Entitydiffuse interstitial pulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The renal insufficiency of three patients and the timing of the Entityseizures implicate accumulation of Entityofloxacin as a contributing factor.
0.9994 Adverse-Effect The Entityrenal insufficiency of three patients and the timing of the seizures implicate accumulation of Entityofloxacin as a contributing factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although an association between exposure to Entitybleomycin and the development of Entityscleroderma has been suspected, few cases are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cause of death was determined to be Entityacute intoxication by Entityolanzapine , and the manner of death was accidental.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We recommended periodic examination of the serum proteins in patients receiving Entitydiphenylhydantoin in order to detect development of Entitymonoclonal gammopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute non - lymphocytic leukemia in patients with ovarian carcinoma following long - term treatment with EntityTreosulfan ( = dihydroxybusulfan ).
1.0000 Adverse-Effect EntityAcute non - lymphocytic leukemia in patients with ovarian carcinoma following long - term treatment with Treosulfan ( = Entitydihydroxybusulfan ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In our patient, EntityDIAN possibly was related to Entitycefuroxime , but the patient did not experience associated allergic symptoms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASES : Two postmenopausal women treated with Entitytamoxifen and progestational agents for breast carcinoma developed Entityuterine enlargement and intermittent spotting.
1.0000 Adverse-Effect CASES : Two postmenopausal women treated with Entitytamoxifen and progestational agents for breast carcinoma developed uterine enlargement and Entityintermittent spotting .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect As far as we know, this is the first case report of acute hemorrhagic gastritis associated with EntityAZ EntityAZ intoxication .
0.9995 Adverse-Effect As far as we know, this is the first case report of Entityacute hemorrhagic gastritis associated with EntityAZ intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRitonavir acted as a CYP3A4 inhibitor, Entitydiminishing carbamazepine metabolism and provoking an increase in serum levels and clinical toxicity.
1.0000 Adverse-Effect EntityRitonavir acted as a CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an Entityincrease in serum levels and clinical toxicity.
0.9999 Adverse-Effect EntityRitonavir acted as a CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an increase in serum levels and Entityclinical toxicity .
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Diagnosis of Entitysclerosing glomerulonephritis occurred in this patient during Entityanastrozole use, suggesting a newly defined side effect of anastrozole.
0.9647 Adverse-Effect Diagnosis of Entitysclerosing glomerulonephritis occurred in this patient during anastrozole use, suggesting a newly defined side effect of Entityanastrozole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient who developed Entityspontaneous splenic infarction after the use of Entitysumatriptan for the treatment of migraine headache.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A potential role for renal and hepatic impairment in the observed protracted course of Entityamiodarone - induced Entitythyrotoxicosis is suggested.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of marked Entityelevation of serum creatine kinase ( CK ) associated with Entityolanzapine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 21 - year - old patient developed Entityrhabdomyolysis during his nineteenth week of treatment with Entityclozapine for drug - resistant schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of acute renal failure with Entityhyperkalemia associated with the recently marketed direct renin inhibitor Entityaliskiren .
0.9999 Adverse-Effect We report the first case of Entityacute renal failure with hyperkalemia associated with the recently marketed direct renin inhibitor Entityaliskiren .
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect A case is reported of Entitytheophylline Entitytheophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of viloxazine.
0.9616 Adverse-Effect A case is reported of Entitytheophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of Entityviloxazine .
0.4835 Adverse-Effect A case is reported of Entitytheophylline intoxication due to a dramatic decrease in Entitytheophylline clearance following concomitant administration of viloxazine.
Adverse-Effect A case is reported of theophylline intoxication due to a dramatic Entitydecrease in theophylline clearance following concomitant administration of Entityviloxazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Postoperative Entityhypocalcemic tetany caused by Entityfleet phospho - soda preparation in a patient taking alendronate sodium : report of a case.
0.9988 Adverse-Effect Postoperative Entityhypocalcemic tetany caused by fleet phospho - soda preparation in a patient taking Entityalendronate sodium : report of a case.
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect The patient expired after seven cycles of treatment had been completed because of Entitypulmonary fibrosis and the drug toxicity of Entitybleomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, we confirm that desensitization may be a safe procedure in patients with cancer who experience Entitymethotrexate - induced Entityanaphylaxis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 10 - year - old girl with Lennox - Gastaut syndrome who received intravenous Entitylorazepam for atypical absence status Entityseizures is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The induction of Entityhypoglycaemia with EntityPAS in this patient suggests a potential role for PAS in the treatment of diabetes mellitus.
0.9885 Adverse-Effect The induction of Entityhypoglycaemia with PAS in this patient suggests a potential role for EntityPAS in the treatment of diabetes mellitus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In two patients, Entityapomorphine remained effective in the morning, but increased the intensity of the Entitydyskinesias in the afternoon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The visual loss in this patient seems to result from Entityphenol Entityneurotoxicity rather than mechanical compression of the intraorbital optic nerve.
0.9999 Adverse-Effect The Entityvisual loss in this patient seems to result from Entityphenol neurotoxicity rather than mechanical compression of the intraorbital optic nerve.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we describe another case of EntityVOD occurring after LT, but in which the causative role was played by Entityazathioprine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the safe use of fluorouracil in a patient with breast cancer who had Entityallergic reactions to Entitycapecitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : The patient required insulin desensitization for severe urticaria, angioedema, and occasional Entitywheezing resulting from her Entityinsulin dose.
1.0000 Adverse-Effect METHODS : The patient required Entityinsulin desensitization for Entitysevere urticaria , angioedema, and occasional wheezing resulting from her insulin dose.
0.9999 Adverse-Effect METHODS : The patient required Entityinsulin desensitization for severe urticaria, Entityangioedema , and occasional wheezing resulting from her insulin dose.
0.9999 Adverse-Effect METHODS : The patient required Entityinsulin desensitization for severe urticaria, angioedema, and occasional Entitywheezing resulting from her insulin dose.
0.9999 Adverse-Effect METHODS : The patient required insulin desensitization for severe urticaria, Entityangioedema , and occasional wheezing resulting from her Entityinsulin dose.
0.9999 Adverse-Effect METHODS : The patient required insulin desensitization for Entitysevere urticaria , angioedema, and occasional wheezing resulting from her Entityinsulin dose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Arrhythmias and Entitycardiac arrest have been reported during Entityamphotericin B administration but no effective technique has been described to prevent them.
0.9998 Adverse-Effect EntityArrhythmias and cardiac arrest have been reported during Entityamphotericin B administration but no effective technique has been described to prevent them.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the first case of de novo Entityasthma following treatment with the angiotensin converting enzyme ( ACE ) inhibitor Entitycaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two new cases of Entitysarcoidosis in two patients with hepatitis C virus infection treated with Entityinterferon alfa and ribavirin.
0.9999 Adverse-Effect We report two new cases of Entitysarcoidosis in two patients with hepatitis C virus infection treated with interferon alfa and Entityribavirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Methotrexate ( EntityMTX ) may induce Entityliver damage , which in some psoriatics will lead to fibrosis or cirrhosis.
0.9999 Adverse-Effect BACKGROUND : EntityMethotrexate ( MTX ) may induce Entityliver damage , which in some psoriatics will lead to fibrosis or cirrhosis.
0.9999 Adverse-Effect BACKGROUND : Methotrexate ( EntityMTX ) may induce liver damage, which in some psoriatics will lead to Entityfibrosis or cirrhosis.
0.9999 Adverse-Effect BACKGROUND : Methotrexate ( EntityMTX ) may induce liver damage, which in some psoriatics will lead to fibrosis or Entitycirrhosis .
0.9998 Adverse-Effect BACKGROUND : EntityMethotrexate ( MTX ) may induce liver damage, which in some psoriatics will lead to fibrosis or Entitycirrhosis .
0.9997 Adverse-Effect BACKGROUND : EntityMethotrexate ( MTX ) may induce liver damage, which in some psoriatics will lead to Entityfibrosis or cirrhosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Inhaled Entitytobramycin solution - associated Entityrecurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis : a case report.
0.9999 Adverse-Effect Inhaled Entitytobramycin solution - associated recurrent eosinophilia and Entitysevere persistent bronchospasm in a patient with cystic fibrosis : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Within 3 weeks of beginning continuous daily isoniazid and Entityrifampin therapy for pulmonary tuberculosis, a patient developed Entityacute renal failure .
0.9999 Adverse-Effect Within 3 weeks of beginning continuous daily Entityisoniazid and rifampin therapy for pulmonary tuberculosis, a patient developed Entityacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patient B developed Entityperioral and upper extremity paresthesias during the fourth cycle of EntityCAP alone ( 2500 mg / m2 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Moreover, these findings suggest that the incidence of EntityBOOP following Entityrituximab therapy may be higher than has been previously appreciated.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This compound, used by adults in the child's home, had caused accidental Entitytheophylline Entitytheophylline poisoning , mimicking diabetic ketoacidosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Up to four percent of patients treated with Entityimatinib may develop Entityhepatotoxicity , which usually resolves with discontinuation of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityL - Thyroxine - induced Entityleukopenia in a patient with Hashimoto's disease : involvement of suppressor - cytotoxic T cells.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate - induced Entityleukoencephalopathy is treatable with high - dose folinic acid : a case report and analysis of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityhyperpigmentation due to Entitybleomycin treatment in a patient with acquired immune deficiency syndrome ( AIDS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Entityfluoxetine - induced Entityheadache occurred in one patient, the other five reported no side effects at the doses used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRifampin can be associated with severe adverse effects such as Entityhepatitis , acute renal failure, hemolytic anemia, and thrombocytopenia.
1.0000 Adverse-Effect EntityRifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, Entityhemolytic anemia , and thrombocytopenia.
1.0000 Adverse-Effect EntityRifampin can be associated with severe adverse effects such as hepatitis, Entityacute renal failure , hemolytic anemia, and thrombocytopenia.
1.0000 Adverse-Effect EntityRifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, hemolytic anemia, and Entitythrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To date, eight cases of TEN and one of EntitySJS related to Entitylamotrigine administration have been reported in the literature.
1.0000 Adverse-Effect To date, eight cases of EntityTEN and one of SJS related to Entitylamotrigine administration have been reported in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : Patients with Entity5 - FU - induced Entityectropion experience tender, red, scaled lids, making contact lens wear difficult.
0.9999 Adverse-Effect DISCUSSION : Patients with Entity5 - FU - induced ectropion experience Entitytender, red, scaled lids , making contact lens wear difficult.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the case of a 5 - year - old girl who developed Entitybilateral vocal cord paralysis following preoperative peritonsillar Entitybupivacaine infiltration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It remains to be seen whether the Entityhepatotoxicity associated with Entitytroglitazone is a drug - class effect or specific to troglitazone.
0.9966 Adverse-Effect It remains to be seen whether the Entityhepatotoxicity associated with troglitazone is a drug - class effect or specific to Entitytroglitazone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere hepatotoxicity from Entityphenobarbital occurred in an infant boy who had a complicated illness with chronic bilateral subdural hematomas and sepsis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of our knowledge, this is the first case of Entitylithium - associated EntityCDI and NDI presenting concurrently.
1.0000 Adverse-Effect To the best of our knowledge, this is the first case of Entitylithium - associated CDI and EntityNDI presenting concurrently.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the finding of Entitysquamous metaplasia within endometrial glands occurring as a result of Entityprogestin therapy of hyperplasia.
Adverse-Effect OBJECTIVE : To report the finding of Entitysquamous metaplasia within endometrial glands occurring as a result of Entityprogestin therapy of hyperplasia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was concluded that potassium loss occurred by a non - renal ( intestinal ) route in Entityphosphate - induced Entityhypokalemia .
0.9999 Adverse-Effect It was concluded that Entitypotassium loss occurred by a non - renal ( intestinal ) route in Entityphosphate - induced hypokalemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Significant ocular complications such as an Entityirreversible decrease of visual acuity may develop in patients treated with Entitypegylated interferon .
0.9996 Adverse-Effect CONCLUSION : Significant Entityocular complications such as an irreversible decrease of visual acuity may develop in patients treated with Entitypegylated interferon .
1.0000 Adverse-Effect CONCLUSION : Significant ocular complications such as an irreversible Entitydecrease of visual acuity may develop in patients treated with Entitypegylated interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CD4 T - lymphocyte depletion, myelosuppression, and subsequent Entitysevere infections are the major side effects of Entityfludarabine phosphate therapy.
0.9998 Adverse-Effect EntityCD4 T - lymphocyte depletion , myelosuppression, and subsequent severe infections are the major side effects of Entityfludarabine phosphate therapy.
0.9996 Adverse-Effect CD4 T - lymphocyte depletion, Entitymyelosuppression , and subsequent severe infections are the major side effects of Entityfludarabine phosphate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : Repeated blood samples were drawn in a patient with severe Entityacyclovir overdose who developed Entitycoma and nonoliguric renal failure.
1.0000 Adverse-Effect METHODS : Repeated blood samples were drawn in a patient with severe Entityacyclovir overdose who developed coma and Entitynonoliguric renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : This is, to our knowledge, the first report of Entitysevere myelopathy following accidental intrathecal administration of Entitydoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a man, treated with Entitymesalazine for Crohn's disease who developed drug - induced Entitypericarditis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors presented a case of Entitypulmonary hypertension during Entitylithium therapy, while she has been on lithium for 6 years.
0.9992 Adverse-Effect The authors presented a case of Entitypulmonary hypertension during lithium therapy, while she has been on Entitylithium for 6 years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following the institution of intravenous therapy with Entityacyclovir , the patient developed Entityfever , hemoptysis, and a pleural friction rub.
1.0000 Adverse-Effect Following the institution of intravenous therapy with Entityacyclovir , the patient developed fever, Entityhemoptysis , and a pleural friction rub.
0.9999 Adverse-Effect Following the institution of intravenous therapy with Entityacyclovir , the patient developed fever, hemoptysis, and a Entitypleural friction rub .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 3 cases of children with acute lymphoblastic leukemia who developed seizures and Entityaltered sensorium after EntityL - asparaginase therapy.
0.9997 Adverse-Effect We report 3 cases of children with acute lymphoblastic leukemia who developed Entityseizures and altered sensorium after EntityL - asparaginase therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : There are only a few confirmed cases of Entitygemcitabine - associated EntityHUS despite the widespread use of the drug.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of Entityacute generalized exanthematous pustulosis ( AGEP ) induced by Entitysalazosulfapyridine in a patient with ulcerative colitis.
1.0000 Adverse-Effect We report a case of acute generalized exanthematous pustulosis ( EntityAGEP ) induced by Entitysalazosulfapyridine in a patient with ulcerative colitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We presented a patient with status asthmaticus treated with a combination of theophylline and Entityprednisone who developed a Entityperforated gastric ulcer .
1.0000 Adverse-Effect We presented a patient with status asthmaticus treated with a combination of Entitytheophylline and prednisone who developed a Entityperforated gastric ulcer .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient described feeling cold with worsening headache and Entitychills approximately one hour after infusion of the first dose of Entitypenicillin .
1.0000 Adverse-Effect The patient described feeling cold with Entityworsening headache and chills approximately one hour after infusion of the first dose of Entitypenicillin .
0.9999 Adverse-Effect The patient described Entityfeeling cold with worsening headache and chills approximately one hour after infusion of the first dose of Entitypenicillin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The capacity of Entityzuclopenthixol to induce Entitypriapism is thought to be due to its antagonist activity on alpha - adrenergic receptors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After discontinuing Entitycaptopril and starting systemic steroids, her symptomatology rapidly improved, and her Entityeosinophilia and radiographic abnormalities both resolved.
0.9999 Adverse-Effect After discontinuing Entitycaptopril and starting systemic steroids, her symptomatology rapidly improved, and her eosinophilia and Entityradiographic abnormalities both resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 13 year - old male who developed life - threatening Entityanaphylaxis early in the course of EntityIncrelex therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report patients who presented to the oculoplastics department for repair of Entitycicatrical entropion after topical use of Entitydipivefrin .
Score Relation Text (Head - Tail)
Adverse-Effect CONCLUSION : Long - term treatment with Entityrifabutin may have a reversible and previously undescribed Entityside - effect on retinal function .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : EntityClozapine causes few Entityextrapyramidal symptoms and is recommended as a treatment drug for severe tardive dyskinesia ( TD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 27 - year - old Indian woman who developed maculopapular rash and Entityangioedema secondary to Entitycarbamazepine administration.
1.0000 Adverse-Effect We report the case of a 27 - year - old Indian woman who developed Entitymaculopapular rash and angioedema secondary to Entitycarbamazepine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The present study describes a patient who had Entityunusual weight fluctuation under corticosteroid and psychotropic treatment such as Entitymianserin and aripiprazole.
1.0000 Adverse-Effect The present study describes a patient who had Entityunusual weight fluctuation under corticosteroid and psychotropic treatment such as mianserin and Entityaripiprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient who developed Entityheparin associated Entitythrombocytopenia during continuous arteriovenous haemofiltration and discuss its implications and alternative anticoagulant treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of an adult who developed both hepatic dysfunction and an Entityimpaired macrophage migration after exposure to Entitycimetidine is discussed.
1.0000 Adverse-Effect The case of an adult who developed both Entityhepatic dysfunction and an impaired macrophage migration after exposure to Entitycimetidine is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityIbuprofen rarely causes lower Entitygastrointestinal adverse reactions but has been implicated in systemic and local side effects in patients with lupus.
1.0000 Adverse-Effect EntityIbuprofen rarely causes Entitylower gastrointestinal adverse reactions but has been implicated in systemic and local side effects in patients with lupus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Presently, treatment of acute Entityibuprofen Entityibuprofen intoxication with complications requires supportive therapy until the symptoms resolve over 24 to 48 hours.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The international literature regarding Entityopportunistic infections after immunosuppressive therapy with Entityalemtuzumab with particular attention on fungal infections has also been reviewed.
1.0000 Adverse-Effect The international literature regarding opportunistic infections after immunosuppressive therapy with Entityalemtuzumab with particular attention on Entityfungal infections has also been reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of Entitycolchicine resulted in resolution of clinical and biochemical features of Entityrhabdomylysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 15 - year - old female patient diagnosed with Entityacute lymphoblastic leukemia presenting with status epilepticus after receiving intrathecal Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mechanism by which Entitysunitinib induces Entitygynaecomastia is thought to be associated with an unknown direct action on breast hormonal receptors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the following case report, a patient developed acute interstitial nephritis with renal failure and Entityexfoliative dermatitis following Entityampicillin therapy.
0.9999 Adverse-Effect In the following case report, a patient developed acute interstitial nephritis with Entityrenal failure and exfoliative dermatitis following Entityampicillin therapy.
0.9999 Adverse-Effect In the following case report, a patient developed Entityacute interstitial nephritis with renal failure and exfoliative dermatitis following Entityampicillin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two dark - skinned patients who developed Entityhyperpigmented skin and tongue lesions during combination therapy with EntityIFN and ribavirin.
1.0000 Adverse-Effect We describe two dark - skinned patients who developed hyperpigmented skin and Entitytongue lesions during combination therapy with EntityIFN and ribavirin.
0.9999 Adverse-Effect We describe two dark - skinned patients who developed Entityhyperpigmented skin and tongue lesions during combination therapy with IFN and Entityribavirin .
0.9999 Adverse-Effect We describe two dark - skinned patients who developed hyperpigmented skin and Entitytongue lesions during combination therapy with IFN and Entityribavirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entitycolchicine - induced Entitymyopathy in a teenager with familial Mediterranean fever ( FMF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitybasilar invagination which is thought to have arisen from the patient's intrauterine exposure to Entityphenytoin is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterferon - alpha - induced Entityfocal segmental glomerulosclerosis in chronic myelogenous leukemia : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe Entityrupture of a cerebral arterial aneurysm in a 32 year old hypertensive woman following the introduction of Entitynifedipine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Presentation of three palliative care patients who were given Entityketamine as an analgesic and subsequently developed significant and debilitating Entityurological symptoms .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with the Wolff - Parkinson - White syndrome presented with Entityincessant orthodromic atrioventricular tachycardia following initiation of Entityprocainamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of linear immunoglobulin ( Ig ) A bullous dermatosis ( EntityLABD ) induced by Entitygemcitabine .
0.9999 Adverse-Effect OBJECTIVE : To report a case of Entitylinear immunoglobulin ( Ig ) A bullous dermatosis ( LABD ) induced by Entitygemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Naranjo probability scale indicated a probable relationship between Entityapnea and exposure to Entitylamotrigine through breast - feeding in this infant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In patients with Entitymethotrexate - induced Entityanaphylaxis , discontinuation of treatment may increase the risk of death due to cancer progression.
0.9993 Adverse-Effect In patients with Entitymethotrexate - induced anaphylaxis, discontinuation of treatment may increase the risk of Entitydeath due to cancer progression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the fifth day of tocolysis with magnesium sulfate, nifedipine, terbutaline and Entitybetamethasone , Entityedema developed in both labia.
0.9999 Adverse-Effect On the fifth day of tocolysis with magnesium sulfate, nifedipine, Entityterbutaline and betamethasone, Entityedema developed in both labia.
0.9999 Adverse-Effect On the fifth day of tocolysis with magnesium sulfate, Entitynifedipine , terbutaline and betamethasone, Entityedema developed in both labia.
0.9998 Adverse-Effect On the fifth day of tocolysis with Entitymagnesium sulfate , nifedipine, terbutaline and betamethasone, Entityedema developed in both labia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityseizure associated with EntityL - asparaginase therapy but no evidence of hemorrhagic or thrombotic cerebrovascular events.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 28 year old white schizophrenic male has been under Entityrisperidone monotherapy for about one year when he developed Entitydyskinetic movements .
Score Relation Text (Head - Tail)
Adverse-Effect The second patient, who developed cholestasis after receiving Entitytrimethoprim - sulfamethoxazole , had marked Entityduct paucity in the liver biopsy.
Adverse-Effect The second patient, who developed Entitycholestasis after receiving Entitytrimethoprim - sulfamethoxazole , had marked duct paucity in the liver biopsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTiclopidine - induced Entityaplastic anemia : two new case reports, review, and meta - analysis of 55 additional cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFulminant hepatic failure developed in a 24 - year - old black woman who had been treated with Entitypropylthiouracil and propranolol for hyperthyroidism.
0.9999 Adverse-Effect EntityFulminant hepatic failure developed in a 24 - year - old black woman who had been treated with propylthiouracil and Entitypropranolol for hyperthyroidism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Children receiving Entityzonisamide should be monitored for Entityoligohidrosis and the development of neurological symptoms associated with an elevation of body temperature.
0.9999 Adverse-Effect Children receiving Entityzonisamide should be monitored for oligohidrosis and the development of Entityneurological symptoms associated with an elevation of body temperature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 72 - year - old woman with a history of thyrotoxicosis presented with sore throat and Entityfever two weeks after starting Entitycarbimazole .
1.0000 Adverse-Effect A 72 - year - old woman with a history of thyrotoxicosis presented with Entitysore throat and fever two weeks after starting Entitycarbimazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Soon after introduction of Entityinsulin therapy, she developed Entitysevere anasarca , including marked peripheral oedema, ascites and pleural effusion.
1.0000 Adverse-Effect Soon after introduction of Entityinsulin therapy, she developed severe anasarca, including marked Entityperipheral oedema , ascites and pleural effusion.
0.9999 Adverse-Effect Soon after introduction of Entityinsulin therapy, she developed severe anasarca, including marked peripheral oedema, Entityascites and pleural effusion.
0.9999 Adverse-Effect Soon after introduction of Entityinsulin therapy, she developed severe anasarca, including marked peripheral oedema, ascites and Entitypleural effusion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNiacin causes a Entityreversible toxic cystoid maculopathy that occurs in approximately 0. 67 % of patients taking high doses of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After the addition of Entitycitalopram , a Entitydesmethylclomipramine plasma level increase and an 8 - hydroacy - desmethylclomipramine plasma level decrease were observed.
0.9998 Adverse-Effect After the addition of Entitycitalopram , a desmethylclomipramine plasma level increase and an Entity8 - hydroacy - desmethylclomipramine plasma level decrease were observed.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect An 8 - year - old child with familial Mediterranean fever exhibited signs of Entitycolchicine Entitycolchicine intoxication while receiving prophylactic doses of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients treated with 5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of Entity5 - FU Entityneurotoxicity .
1.0000 Adverse-Effect Two patients treated with 5 - fluorouracil ( Entity5 - FU ) for disseminated adenocarcinoma of the colon developed Entitycerebellar dysfunction typical of 5 - FU neurotoxicity.
0.9999 Adverse-Effect Two patients treated with Entity5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed Entitycerebellar dysfunction typical of 5 - FU neurotoxicity.
0.9993 Adverse-Effect Two patients treated with 5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed Entitycerebellar dysfunction typical of Entity5 - FU neurotoxicity.
0.9990 Adverse-Effect Two patients treated with Entity5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5 - FU Entityneurotoxicity .
0.9989 Adverse-Effect Two patients treated with 5 - fluorouracil ( Entity5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5 - FU Entityneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the first documented case of Entityazathioprine - induced severe Entitymyelosuppression due to thiopurine methyltransferase deficiency in autoimmune liver disease.
1.0000 Adverse-Effect We describe the first documented case of Entityazathioprine - induced Entitysevere myelosuppression due to thiopurine methyltransferase deficiency in autoimmune liver disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We recommend that clinicians monitor patients for signs and symptoms of pancreatitis, including Entityabdominal pain , during treatment with Entitytigecycline .
1.0000 Adverse-Effect We recommend that clinicians monitor patients for signs and symptoms of Entitypancreatitis , including abdominal pain, during treatment with Entitytigecycline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBortezomib - induced Entityparalytic ileus is a potential gastrointestinal side effect of this first - in - class anticancer proteasome inhibitor.
0.9998 Adverse-Effect EntityBortezomib - induced paralytic ileus is a potential Entitygastrointestinal side effect of this first - in - class anticancer proteasome inhibitor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The male patient was treated with 225 - mg / day Entityclozapine and the time to the diagnosis of Entityagranulocytosis was 6 weeks.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect BACKGROUND : How to best treat psychotic patients who have had past Entityclozapine - induced agranulocytosis or Entitygranulocytopenia remains a problem.
1.0000 Adverse-Effect BACKGROUND : How to best treat psychotic patients who have had past Entityclozapine - induced Entityagranulocytosis or granulocytopenia remains a problem.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have cared for three children in whom four episodes of dystonia proceeding to Entityopisthotonus occurred in association with Entitycarbamazepine use.
0.9999 Adverse-Effect We have cared for three children in whom four episodes of Entitydystonia proceeding to opisthotonus occurred in association with Entitycarbamazepine use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ten hours after the second Entitymethotrexate injection, the patient experienced a Entitydiffuse pruritic papular eruption located mainly on the limbs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with Entityalemtuzumab : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The pathogenesis of Entitymethotrexate - induced Entitypapular eruption in collagen vascular diseases may suggest cutaneous small - vessel vasculitis.
0.9947 Adverse-Effect CONCLUSIONS : The pathogenesis of Entitymethotrexate - induced papular eruption in collagen vascular diseases may suggest Entitycutaneous small - vessel vasculitis .
Score Relation Text (Head - Tail)
Adverse-Effect The patient developed Entityoccipital infarcts and was found to have extremely elevated levels of EntityPPA in his blood and dialysis fluid.
Adverse-Effect The patient developed occipital infarcts and was found to have Entityextremely elevated levels of PPA EntityPPA in his blood and dialysis fluid.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of childhood - onset schizophrenia associated with Entityclozapine - induced Entityakathisia responsive to beta - blocker treatment are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPolymyositis is a rare complication of Entityinterferon alpha treatment as a result of immune - modulating role of the drug itself.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the next day, after a total dose of only 600 mg of Entitydanazol , Entitygingival bleeding and purpura occurred.
1.0000 Adverse-Effect On the next day, after a total dose of only 600 mg of Entitydanazol , gingival bleeding and Entitypurpura occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two patients with Entityaspergillus arthritis of the knee joint following Entityfludarabine - based non - myeloablative stem cell transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Concurrent acute megaloblastic anaemia and Entitypneumonitis : a severe side - effect of low - dose Entitymethotrexate therapy during rheumatoid arthritis.
0.9999 Adverse-Effect Concurrent Entityacute megaloblastic anaemia and pneumonitis : a severe side - effect of low - dose Entitymethotrexate therapy during rheumatoid arthritis.
Adverse-Effect EntityConcurrent acute megaloblastic anaemia and pneumonitis : a severe side - effect of low - dose Entitymethotrexate therapy during rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present findings from three patients who experienced a Entitypsoriasiform eruption apparently due to the antiepileptic agents Entitysodium valproate and carbamazepine.
0.9999 Adverse-Effect We present findings from three patients who experienced a Entitypsoriasiform eruption apparently due to the antiepileptic agents sodium valproate and Entitycarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of a 21 - year - old woman who had developed mild Entityhepatotoxicity while receiving Entitycholine magnesium trisalicylate therapy is described.
1.0000 Adverse-Effect A case of a 21 - year - old woman who had developed Entitymild hepatotoxicity while receiving Entitycholine magnesium trisalicylate therapy is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : EntityTopiramate - induced Entityangle - closure glaucoma ( TiACG ) is believed to be related to its sulfonamide moiety.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : We report this case of the concomitant appearance of multiple skin cancers and Entitynail changes associated with Entityhydroxyurea use.
0.9999 Adverse-Effect CONCLUSIONS : We report this case of the concomitant appearance of Entitymultiple skin cancers and nail changes associated with Entityhydroxyurea use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report on two patients with Entitycorneal ulcers refractory to conventional treatment while the patients were undergoing oral Entitycolchicine therapy.
1.0000 Adverse-Effect The authors report on two patients with Entitycorneal ulcers refractory to conventional treatment while the patients were undergoing oral Entitycolchicine therapy.
1.0000 Adverse-Effect The authors report on two patients with Entitycorneal ulcers refractory to conventional treatment while the patients were undergoing oral Entitycolchicine therapy.
1.0000 Adverse-Effect The authors report on two patients with Entitycorneal ulcers refractory to conventional treatment while the patients were undergoing oral Entitycolchicine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entityfatal hyperkalemia owing to Entitysuccinylcholine administration in a patient with mucositis secondary to chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 52 - year - old Black woman on Entityphenytoin therapy for post - traumatic epilepsy developed Entitytransient hemiparesis contralateral to the injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The pharmacology and toxicology of Entitychloral hydrate are discussed with particular reference to the Entitycardiac arrhythmias that are seen with overdosage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case of Entitygriseofulvin - exacerbated Entitylupus in which nephrotic syndrome has been observed.
0.9999 Adverse-Effect To our knowledge, this is the first case of Entitygriseofulvin - exacerbated lupus in which Entitynephrotic syndrome has been observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report in detail an unusual adverse reaction to Entityinfliximab therapy, a drug - induced Entitylupus - like clinical syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When the disease recurred conventional Entityamphotericin B was used again, but had to be stopped because of Entitysevere side effects .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of acute Entityhyperphosphatemia secondary to rectal administration of Entitysodium phosphate and sodium biphosphate ( Fleet enema ).
0.9988 Adverse-Effect We report a case of acute Entityhyperphosphatemia secondary to rectal administration of sodium phosphate and Entitysodium biphosphate ( Fleet enema ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A case of Entityphenytoin - induced Entityhepatitis with mononucleosis is reported, and syndromes associated with phenytoin hypersensitivity reactions are discussed.
0.9097 Adverse-Effect A case of Entityphenytoin - induced hepatitis with Entitymononucleosis is reported, and syndromes associated with phenytoin hypersensitivity reactions are discussed.
0.9871 Adverse-Effect A case of phenytoin - induced hepatitis with mononucleosis is reported, and syndromes associated with Entityphenytoin Entityphenytoin hypersensitivity reactions are discussed.
Adverse-Effect A case of phenytoin - induced hepatitis with mononucleosis is reported, and syndromes associated with Entityphenytoin Entityhypersensitivity reactions are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityClarithromycin may be a cause of Entityfulminant liver failure either alone or by inhibiting the metabolism of other drugs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who developed EntityNEH on three separate occasions provoked by two different chemotherapeutic agents - - Entitycytarabine and mitoxantrone.
1.0000 Adverse-Effect We describe a patient who developed EntityNEH on three separate occasions provoked by two different chemotherapeutic agents - - cytarabine and Entitymitoxantrone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : A delayed Entitystroke - like leukoencephalopathy has been observed in patients receiving Entitymethotrexate ( MTX ) for childhood leukemia.
0.9999 Adverse-Effect OBJECTIVES : A delayed Entitystroke - like leukoencephalopathy has been observed in patients receiving methotrexate ( EntityMTX ) for childhood leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityacute subdural haematoma originating spontaneously from an angiomatous meningioma in a patient receiving prophylactic Entityaspirin therapy is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 41 yr old leprosy patient treated for 10 yrs with Entityclofazimine who underwent laparotomy for severe Entityabdominal pain .
1.0000 Adverse-Effect We describe a 41 yr old leprosy patient treated for 10 yrs with Entityclofazimine who underwent Entitylaparotomy for severe abdominal pain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBrugada type electrocardiographic changes induced by concomitant use of Entitylithium and propafenone in patient with Wolff - Parkinson - White syndrome.
1.0000 Adverse-Effect EntityBrugada type electrocardiographic changes induced by concomitant use of lithium and Entitypropafenone in patient with Wolff - Parkinson - White syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We evaluated a patient who developed a Entitypsychotic disorder after 4 months of Entityisoniazid prophylaxis for a positive tuberculosis tine test.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, these cases are the first published reports of Entitylovastatin - induced Entityrhabdomyolysis associated with azithromycin and clarithromycin.
1.0000 Adverse-Effect To our knowledge, these cases are the first published reports of lovastatin - induced Entityrhabdomyolysis associated with Entityazithromycin and clarithromycin.
0.9998 Adverse-Effect To our knowledge, these cases are the first published reports of lovastatin - induced Entityrhabdomyolysis associated with azithromycin and Entityclarithromycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 60 year - old woman with chronic renal failure developed Entityacute proximal muscle weakness after receiving a regular dosage of Entitycolchicine .
Adverse-Effect A 60 year - old woman with chronic renal failure developed acute Entityproximal muscle weakness after receiving a regular dosage of Entitycolchicine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a fatal case of Entitytoxic epidermal necrolysis in a man who was treated with oral Entityofloxacin for epididymitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with Entityvincristine sulfate , prednisone, and asparaginase.
0.9998 Adverse-Effect EntityDural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, Entityprednisone , and asparaginase.
0.9997 Adverse-Effect EntityDural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, prednisone, and Entityasparaginase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the first case ( to our knowledge ) of a potentially serious Entitydrug - drug interaction between Entityzafirlukast and theophylline.
1.0000 Adverse-Effect We present the first case ( to our knowledge ) of a potentially serious Entitydrug - drug interaction between zafirlukast and Entitytheophylline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityfetal valproate syndrome Entityvalproate syndrome ( FVS ) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay.
1.0000 Adverse-Effect The fetal Entityvalproate syndrome ( EntityFVS ) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay.
0.9999 Adverse-Effect The fetal Entityvalproate syndrome ( FVS ) is characterized by Entitydistinctive facial appearance , major and minor malformations, and developmental delay.
0.9999 Adverse-Effect The fetal Entityvalproate syndrome ( FVS ) is characterized by distinctive facial appearance, Entitymajor and minor malformations , and developmental delay.
0.9999 Adverse-Effect The fetal Entityvalproate syndrome ( FVS ) is characterized by distinctive facial appearance, major and minor malformations, and Entitydevelopmental delay .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This patient rapidly progressed from mild neurotoxicity to Entityfatal encephalopathy after one dose of intrathecal Entitymethotrexate during his third cycle of chemotherapy.
0.9999 Adverse-Effect This patient rapidly progressed from Entitymild neurotoxicity to fatal encephalopathy after one dose of intrathecal Entitymethotrexate during his third cycle of chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She died within six weeks of developing congestive heart failure coupled with liver failure due to Entityhaemosiderosis despite regular use of Entitydesferrioxamine .
0.9999 Adverse-Effect She died within six weeks of developing Entitycongestive heart failure coupled with liver failure due to haemosiderosis despite regular use of Entitydesferrioxamine .
0.9999 Adverse-Effect She died within six weeks of developing congestive heart failure coupled with Entityliver failure due to haemosiderosis despite regular use of Entitydesferrioxamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A second patient with a similar glucose tolerance test result showed Entitypostprandial hyperglycemia when treated similarly with Entitybetamethasone valerate cream 0. 1 %.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the clinical and liver biopsy morphologic features for 4 patients with Entityminocycline - induced Entityautoimmune hepatitis ( group 1 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Without other causes for the hyponatremia, she was diagnosed with the Entitysyndrome of inappropriate antidiuretic hormone , presumably caused by Entitydesmopressin .
0.9999 Adverse-Effect Without other causes for the Entityhyponatremia , she was diagnosed with the syndrome of inappropriate antidiuretic hormone, presumably caused by Entitydesmopressin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In contrast to chronic or subacute thyroiditis, EntityGraves'disease rarely complicates EntityIFN - alpha therapy for chronic viral C hepatitis.
0.9999 Adverse-Effect In contrast to chronic or Entitysubacute thyroiditis , Graves'disease rarely complicates EntityIFN - alpha therapy for chronic viral C hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a female acromegalic patient in whom multiple Entityhepatic adenomas appeared soon after Entitydanazol treatment for uterine fibromatosis.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect CONCLUSIONS : We have seen an increased incidence of acute EntityINH Entityneurotoxicity because of the resurgence of TB in New York City.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityParalytic ileus in patients undergoing Entitybortezomib treatment has been reported, although a definite attribution to bortezomib administration has not been established.
0.9743 Adverse-Effect EntityParalytic ileus in patients undergoing bortezomib treatment has been reported, although a definite attribution to Entitybortezomib administration has not been established.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect STUDY DESIGN : Case report of a 31 - year - old woman who presented with Entitytoxic myelopathy due to intrathecal administration of Entitydoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityColchicine - induced Entityrhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTelescoped digits of the hands and feet developed in a 69 - year - old male with severe chronic tophaceous gout during Entityallopurinol treatment.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Although other nitrites induce Entitymethemoglobinemia , exposure to Entitymethyl nitrite during phenylpropanolamine production appears to be a new cause of occupational methemoglobinemia.
0.9994 Adverse-Effect Although other nitrites induce methemoglobinemia, exposure to Entitymethyl nitrite during phenylpropanolamine production appears to be a new cause of occupational Entitymethemoglobinemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect FINDINGS : Six children with growth retardation noted after treatment with high - dose Entityfluticasone propionate were found to have Entityadrenal suppression .
0.9999 Adverse-Effect FINDINGS : Six children with Entitygrowth retardation noted after treatment with high - dose Entityfluticasone propionate were found to have adrenal suppression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, the possible in vivo effects of insulin on adipocytes were clearly observed in this case of Entityinsulin - induced Entitylipohypertrophy .
0.9947 Adverse-Effect Thus, the possible in vivo effects of Entityinsulin on adipocytes were clearly observed in this case of insulin - induced Entitylipohypertrophy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNaproxen is a commonly used nonsteroidal anti - inflammatory drug ( NSAID ) whose side effects include Entitytinnitus and transient hearing loss.
1.0000 Adverse-Effect EntityNaproxen is a commonly used nonsteroidal anti - inflammatory drug ( NSAID ) whose side effects include tinnitus and Entitytransient hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We reviewed the records of 3 patients with lymphoproliferative disorders who experienced Entityacute coronary syndromes associated with their initial infusion of Entityrituximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient, a 28 - year - old man suffering from panic disorder, developed several Entityfirst - rank symptoms during Entityfluvoxamine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although this EntityG - CSF - driven Entityleucocytosis was alarming it did not appear to have adversely affected the patient's prognosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We also describe a new, noninvasive method to assess Entitymagnesium - induced Entityneuromuscular block when curariform muscle relaxant was given simultaneously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute non - lymphocytic leukemia occurred in eight women following long - term treatment with EntityTreosulfan ( = dihydroxybusulfan ) for ovarian carcinoma.
1.0000 Adverse-Effect EntityAcute non - lymphocytic leukemia occurred in eight women following long - term treatment with Treosulfan ( = Entitydihydroxybusulfan ) for ovarian carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We concluded that the colonic ulcer and the Entitysigmoidovesical fistula had been caused by the administration of Entitycalcium polystyrene sulfonate and sorbitol.
0.9998 Adverse-Effect We concluded that the colonic ulcer and the Entitysigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and Entitysorbitol .
0.9995 Adverse-Effect We concluded that the Entitycolonic ulcer and the sigmoidovesical fistula had been caused by the administration of Entitycalcium polystyrene sulfonate and sorbitol.
0.9993 Adverse-Effect We concluded that the Entitycolonic ulcer and the sigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and Entitysorbitol .
Score Relation Text (Head - Tail)
Adverse-Effect This case suggests that Entityacyclovir when given intravenously in doses of 10 mg / kg may result in Entityincreased serum lithium concentrations.
Adverse-Effect This case suggests that acyclovir when given intravenously in doses of 10 mg / kg may result in Entityincreased serum lithium Entitylithium concentrations.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute delirium resulting from Entitylevofloxacin therapy is an exceedingly rare complication that has been thought to occur more commonly in elderly patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sixteen hours after the first administration of IFN, EntityIFN was suspended by the symptoms of Entitycongestive heart failure ( CHF ).
0.9998 Adverse-Effect Sixteen hours after the first administration of IFN, EntityIFN was suspended by the symptoms of congestive heart failure ( EntityCHF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of a 4 - year - old girl with Entityvalproate - induced Entitystupor and electroencephalographic pattern of increased fast activity is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of biopsy proven Entitymyositis whose symptoms began within 10 days of receiving Entityleuprolide acetate therapy for prostate cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOsteonecrosis is a serious side effect of antiemetic treatment with Entitydexamethasone and this serious complication should be incorporated in the current guidelines.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report : lack of control of diabetes and Entityweight gain in a patient on initiation and rechallenge of therapy with Entityolanzapine .
1.0000 Adverse-Effect Case report : lack of control of Entitydiabetes and weight gain in a patient on initiation and rechallenge of therapy with Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She developed a generalized rash and itching, sore throat, and Entitydizziness approximately 4 hours after the first dose of Entitycapecitabine .
1.0000 Adverse-Effect She developed a generalized rash and itching, Entitysore throat , and dizziness approximately 4 hours after the first dose of Entitycapecitabine .
1.0000 Adverse-Effect She developed a Entitygeneralized rash and itching, sore throat, and dizziness approximately 4 hours after the first dose of Entitycapecitabine .
1.0000 Adverse-Effect She developed a generalized rash and Entityitching , sore throat, and dizziness approximately 4 hours after the first dose of Entitycapecitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We described the occurrence of EntityL - dopa - induced Entitymyoclonus and seizures in a case of parkinsonism with its SEPs findings.
0.9998 Adverse-Effect We described the occurrence of EntityL - dopa - induced myoclonus and Entityseizures in a case of parkinsonism with its SEPs findings.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed Entityrestless legs symptoms paralleling the course of Entityinterferon - alpha ( IFN alpha ) therapy for chronic hepatitis C.
0.9997 Adverse-Effect A patient developed Entityrestless legs symptoms paralleling the course of interferon - alpha ( EntityIFN alpha ) therapy for chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the other patient, a 78 - year - old woman, EntityNeisseria mucosa knee arthritis occurred after a single Entitysodium hyaluronate injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prominent eye movements during NREM sleep and EntityREM sleep behavior disorder associated with Entityfluoxetine treatment of depression and obsessive - compulsive disorder.
1.0000 Adverse-Effect EntityProminent eye movements during NREM sleep and REM sleep behavior disorder associated with Entityfluoxetine treatment of depression and obsessive - compulsive disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In patients with chronic heart failure, Entityspironolactone added to conventional treatment may lead to serious and, occasionally, Entityfatal hyperkalaemia .
Adverse-Effect In patients with chronic heart failure, Entityspironolactone added to conventional treatment may lead to Entityserious and, occasionally, fatal hyperkalaemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityvitiligo that occurred during the second month of Entityinterferon alpha 2a therapy for chronic active hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Second, we report a case of Entityneutropenia , which proved to be fatal in a schizophrenia patient receiving Entityolanzapine and thiazide.
0.9999 Adverse-Effect Second, we report a case of Entityneutropenia , which proved to be fatal in a schizophrenia patient receiving olanzapine and Entitythiazide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The results of the ultrasound examination combined with clinical anamnesis allowed diagnosis of Entitygastric mucosa foveolar hyperplasia due to prolonged EntityPGE1 therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The potential role of Entitypropranolol in inducing Entitycentral nervous system disturbances is emphasized, and the literature on the subject is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, we concluded that this patient's Entitypulmonary disease was caused by Entitycalcium stearate , an additive for an antihistaminic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DATA SYNTHESIS : A 49 - year - old man developed symptoms of Entitysevere psychosis concomitant with Entityciprofloxacin ( 250 mg bid ) treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a patient with human immunodeficiency virus infection under treatment with Entityfoscarnet for CMV retinitis who complained of Entitythirst and polyuria.
1.0000 Adverse-Effect We present a patient with human immunodeficiency virus infection under treatment with Entityfoscarnet for CMV retinitis who complained of thirst and Entitypolyuria .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a fatal case of Entityacute interstitial pneumonitis in a patient treated with Entitycarmustine ( BCNU ) for a brain tumor.
1.0000 Adverse-Effect We report a fatal case of Entityacute interstitial pneumonitis in a patient treated with carmustine ( EntityBCNU ) for a brain tumor.
0.9999 Adverse-Effect We report a Entityfatal case of acute interstitial pneumonitis in a patient treated with Entitycarmustine ( BCNU ) for a brain tumor.
0.9997 Adverse-Effect We report a Entityfatal case of acute interstitial pneumonitis in a patient treated with carmustine ( EntityBCNU ) for a brain tumor.
Adverse-Effect We report a Entityfatal case of acute interstitial pneumonitis in a patient treated with carmustine ( EntityBCNU ) for a brain tumor.
Adverse-Effect We report a Entityfatal case of acute interstitial pneumonitis in a patient treated with Entitycarmustine ( BCNU ) for a brain tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 10 - year - old white girl with bilateral optic glioma developed a Entityhypersensitivity reaction to Entitycarboplatin after nine courses.
1.0000 Adverse-Effect CASE SUMMARY : A 10 - year - old white girl with bilateral optic glioma developed a Entityhypersensitivity reaction to Entitycarboplatin after nine courses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a young healthy woman who presented an early Entityoveranticoagulation when receiving Entityacenocoumarol for a first thromboembolic episode.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Beginning ductopenia was present in two, suggesting that Entityitraconazole might be responsible for the occurrence of prolonged drug - induced Entitycholangiopathy .
1.0000 Adverse-Effect Beginning Entityductopenia was present in two, suggesting that Entityitraconazole might be responsible for the occurrence of prolonged drug - induced cholangiopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early - onset Entitypentamidine - associated Entitysecond - degree heart block and sinus bradycardia : case report and review of the literature.
1.0000 Adverse-Effect Early - onset Entitypentamidine - associated second - degree heart block and Entitysinus bradycardia : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : We believe this to be the first reported case of EntityrhGH - induced Entityhypercalcemia in an HIV - infected patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We reported a case of Entitydisulfiram - induced Entityhepatitis with unique clinical features and compared our case with others in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of severe Entityhypotension associated with intravenous Entityvalproate used to treat status epilepticus in an 11 - year - old girl.
1.0000 Adverse-Effect We report a case of Entitysevere hypotension associated with intravenous Entityvalproate used to treat status epilepticus in an 11 - year - old girl.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect AIM : To report three cases of extensive Entityskin necrosis in cirrhotic patients treated with the vasoconstrictor agent Entityterlipressin ( Glypressin ).
0.9999 Adverse-Effect AIM : To report three cases of extensive Entityskin necrosis in cirrhotic patients treated with the vasoconstrictor agent terlipressin ( EntityGlypressin ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of neuromuscular blockade and the resulting Entitypotentiation of muscle relaxants during Entitymagnesium sulfate ( MgSO4 ) administration is well known.
0.9999 Adverse-Effect The occurrence of neuromuscular blockade and the resulting Entitypotentiation of muscle relaxants during magnesium sulfate ( EntityMgSO4 ) administration is well known.
0.9997 Adverse-Effect The occurrence of Entityneuromuscular blockade and the resulting potentiation of muscle relaxants during Entitymagnesium sulfate ( MgSO4 ) administration is well known.
0.9994 Adverse-Effect The occurrence of Entityneuromuscular blockade and the resulting potentiation of muscle relaxants during magnesium sulfate ( EntityMgSO4 ) administration is well known.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thirty patients with Entityhepatic reactions to Entitycyclofenil , a non - steroidal drug with a stimulating effect on ovulation, are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect His symptoms of brain stem compression were alleviated and the role of Entityphenytoin in the production of his Entitycraniocervical abnormality is discussed.
0.9999 Adverse-Effect His symptoms of Entitybrain stem compression were alleviated and the role of Entityphenytoin in the production of his craniocervical abnormality is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second had acute cystitis and was treated by sulphonamide and the third developed Entitymyopia coincident with Entitymetronidazole treatment for trichomonas vaginalis.
0.9999 Adverse-Effect The second had acute cystitis and was treated by Entitysulphonamide and the third developed Entitymyopia coincident with metronidazole treatment for trichomonas vaginalis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The renal biopsy showed Entityfocal segmental glomerulosclerosis , which has only been previously reported in two cases of CML treated with EntityIFNalpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most commonly recognized toxic effect of Entityethambutol is Entityoptic neuropathy , which generally is considered uncommon and reversible in medical literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on the clinical status of the patient, it was suspected that several conditions contributed to the Entityabnormal hypersensitivity to Entitywarfarin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is presented in which a 68 - year - old man became Entitydelirious after being withdrawn from a low dosage of Entityalprazolam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, Entityadenosine shortens the antegrade refractoriness of accessory atrioventricular connections and may cause Entityacceleration of the ventricular rate during atrial fibrillation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nonspecific but Entitysignificant abnormalities have been described in the infants of women treated with Entitydisulfiram in the first trimester of their pregnancies.
1.0000 Adverse-Effect Nonspecific but significant Entityabnormalities have been described in the infants of women treated with Entitydisulfiram in the first trimester of their pregnancies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityToxicity , pharmacokinetics, and in vitro hemodialysis clearance of Entityifosfamide and metabolites in an anephric pediatric patient with Wilms'tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case resembles two previously reported cases of Entityoptic neuropathy which occurred in patients with Wilson's disease who were receiving Entitypenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the present paper, we discuss the first Japanese vivax malaria patient whose EntityQT interval was prolonged after treatment with Entityhalofantrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Anaphylactoid shock, disseminated intravascular coagulation, and Entityanuric renal failure requiring dialysis occurred in a patient receiving Entityzomepirac sodium for toothache.
0.9998 Adverse-Effect EntityAnaphylactoid shock , disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving Entityzomepirac sodium for toothache.
0.9996 Adverse-Effect Anaphylactoid shock, Entitydisseminated intravascular coagulation , and anuric renal failure requiring dialysis occurred in a patient receiving Entityzomepirac sodium for toothache.
Adverse-Effect EntityAnaphylactoid shock , disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving Entityzomepirac sodium for toothache.
Adverse-Effect Anaphylactoid shock, Entitydisseminated intravascular coagulation , and anuric renal failure requiring dialysis occurred in a patient receiving Entityzomepirac sodium for toothache.
Adverse-Effect Anaphylactoid shock, disseminated intravascular coagulation, and Entityanuric renal failure requiring dialysis occurred in a patient receiving Entityzomepirac sodium for toothache.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - resolution computed tomography scan findings were consistent with ILD, which was sufficient to diagnose as Entityerlotinib - induced EntityILD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She had been taking Entitynabumetone for 6 months, but had discontinued the agent 2 weeks before admission due to progressive Entityedema .
Score Relation Text (Head - Tail)
Adverse-Effect The reversal of heparin by Entityprotamine may cause Entitysevere hemodynamic deterioration , characterized by systemic hypotension, pulmonary hypertension, and bronchoconstriction.
Adverse-Effect The reversal of heparin by Entityprotamine may cause severe hemodynamic deterioration, characterized by systemic hypotension, pulmonary hypertension, and Entitybronchoconstriction .
Adverse-Effect The reversal of heparin by Entityprotamine may cause severe hemodynamic deterioration, characterized by systemic hypotension, Entitypulmonary hypertension , and bronchoconstriction.
Adverse-Effect The reversal of heparin by Entityprotamine may cause severe hemodynamic deterioration, characterized by Entitysystemic hypotension , pulmonary hypertension, and bronchoconstriction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report a case of angiographically documented Entitycystoid macula edema occurring after switching a pseudophakic patient from Entitylatanoprost to bimatoprost.
0.9999 Adverse-Effect PURPOSE : To report a case of angiographically documented Entitycystoid macula edema occurring after switching a pseudophakic patient from latanoprost to Entitybimatoprost .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitynodules regressed after withdrawal of Entitymethotrexate therapy in one patient and were arrested with the addition of hydroxychloroquine in the other.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians should be aware of the possible association of Entitythrombocytopenia with Entitylansoprazole and discontinue the drug if thrombocytopenia becomes apparent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, these cases represent the first reports of EntityTDF - associated Entityirreversible renal failure and rickets in pediatric patients.
0.9999 Adverse-Effect To our knowledge, these cases represent the first reports of EntityTDF - associated irreversible renal failure and Entityrickets in pediatric patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCyclosporin side effects included Entityhirsutism , hypertension, increased blood levels of urea and creatinine, and abnormalities in liver function tests.
1.0000 Adverse-Effect EntityCyclosporin side effects included hirsutism, Entityhypertension , increased blood levels of urea and creatinine, and abnormalities in liver function tests.
0.9999 Adverse-Effect EntityCyclosporin side effects included hirsutism, hypertension, increased blood levels of urea and creatinine, and Entityabnormalities in liver function tests .
0.9999 Adverse-Effect EntityCyclosporin side effects included hirsutism, hypertension, Entityincreased blood levels of urea and creatinine , and abnormalities in liver function tests.
0.9999 Adverse-Effect EntityCyclosporin side effects included hirsutism, hypertension, Entityincreased blood levels of urea and creatinine, and abnormalities in liver function tests.
0.9999 Adverse-Effect EntityCyclosporin side effects included hirsutism, hypertension, Entityincreased blood levels of urea and creatinine, and abnormalities in liver function tests.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Atrioventricular block complicating Entityamiodarone - induced Entityhypothyroidism in a patient with pre - excitation and rate - dependent bilateral bundle branch block.
1.0000 Adverse-Effect EntityAtrioventricular block complicating Entityamiodarone - induced hypothyroidism in a patient with pre - excitation and rate - dependent bilateral bundle branch block.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Behavioral side effects associated with Entityclonazepam may include Entityagitation , aggression, hyperactivity, irritability, property destruction, and temper tantrums.
1.0000 Adverse-Effect Behavioral side effects associated with Entityclonazepam may include agitation, Entityaggression , hyperactivity, irritability, property destruction, and temper tantrums.
1.0000 Adverse-Effect Behavioral side effects associated with Entityclonazepam may include agitation, aggression, Entityhyperactivity , irritability, property destruction, and temper tantrums.
1.0000 Adverse-Effect Behavioral side effects associated with Entityclonazepam may include agitation, aggression, hyperactivity, Entityirritability , property destruction, and temper tantrums.
0.9999 Adverse-Effect Behavioral side effects associated with Entityclonazepam may include agitation, aggression, hyperactivity, irritability, property destruction, and Entitytemper tantrums .
0.9999 Adverse-Effect Behavioral side effects associated with Entityclonazepam may include agitation, aggression, hyperactivity, irritability, Entityproperty destruction , and temper tantrums.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To determine the frequency of Entityweight loss in patients treated with Entityleflunomide for rheumatoid arthritis at an arthritis referral center.
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect A well - recognized complication of Entityethambutol use is Entityoptic neuropathy , but the potential ocular toxicity of isoniazid is often overlooked.
0.9899 Adverse-Effect A well - recognized complication of ethambutol use is optic neuropathy, but the potential Entityocular toxicity of Entityisoniazid is often overlooked.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The increasing prevalence of Type 2 diabetes and its treatment with Entitymetformin might result in more cases of Entitylactic acidosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of APL in pregnancy is controversial as the use of EntityATRA has been questioned due to the Entityteratogenic effect of retinoids.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : One case of recurrent primary peritoneal carcinoma previously treated with a Entitycarboplatin - based regimen, developed a Entityplatinum hypersensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Controversy concerning the nephrotoxicity of lithium is discussed, and recommendations for the evaluation of Entityrenal failure during Entitylithium therapy are provided.
0.9997 Adverse-Effect Controversy concerning the Entitynephrotoxicity of Entitylithium is discussed, and recommendations for the evaluation of renal failure during lithium therapy are provided.
0.6897 Adverse-Effect Controversy concerning the nephrotoxicity of Entitylithium is discussed, and recommendations for the evaluation of Entityrenal failure during lithium therapy are provided.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To describe Entitybilateral corneal endothelial dysfunction in a patient with Parkinson disease who was treated with long - term Entityamantadine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate - induced Entitypneumonitis in patients with rheumatoid arthritis and psoriatic arthritis : report of five cases and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Type I second - degree AV block ( Mobitz type I, EntityWenckebach AV block ) during Entityritodrine therapy for preterm labor.
1.0000 Adverse-Effect Type I second - degree AV block ( EntityMobitz type I , Wenckebach AV block ) during Entityritodrine therapy for preterm labor.
0.9999 Adverse-Effect EntityType I second - degree AV block ( Mobitz type I, Wenckebach AV block ) during Entityritodrine therapy for preterm labor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the case of a 58 - year - old woman who ingested more than 35 g of Entitycaffeine in a Entitysuicide attempt .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInsulin - dependent diabetes mellitus developed in a young woman 8 weeks after the initiation of Entitydanazol for treatment of pelvic endometriosis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A patient with coccidioidal meningitis was treated with intrathecally administered Entityamphotericin B , and an Entityacute toxic delirium with EEG abnormalities developed.
0.9992 Adverse-Effect A patient with coccidioidal meningitis was treated with intrathecally administered Entityamphotericin B , and an acute toxic delirium with EntityEEG abnormalities developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 46 - yr - old woman with ovarian carcinoma who developed Entityporphyria cutanea tarda while undergoing treatment with Entitycisplatin and cyclophosphamide.
1.0000 Adverse-Effect We report a 46 - yr - old woman with ovarian carcinoma who developed Entityporphyria cutanea tarda while undergoing treatment with cisplatin and Entitycyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on these findings, the patient was diagnosed with Entitydiabetes insipidus secondary to Entitylithium therapy and was treated successfully with amiloride.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, the patient's clinical course and workup strongly support a diagnosis of Entitylenalidomide - induced Entityhypersensitivity pneumonitis - like syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe EntityC. difficile colitis occurred in 2 patients ( 6. 1 % ) after receiving Entitycisplatin - based combination chemotherapy for ovarian malignancies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the potential for developing a Entitygemcitabine - induced Entityradiation recall reaction resulting in hemodynamically significant pericardial effusion.
0.9998 Adverse-Effect Physicians should be aware of the potential for developing a Entitygemcitabine - induced radiation recall reaction resulting in hemodynamically significant Entitypericardial effusion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A cause - effect relationship to capecitabine was suggested due to resolution of Entityheadache with Entitycapecitabine withdrawal and reappearance with capecitabine rechallenge.
0.9998 Adverse-Effect A cause - effect relationship to Entitycapecitabine was suggested due to resolution of Entityheadache with capecitabine withdrawal and reappearance with capecitabine rechallenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report highlights a case of drug - induced Entitydysphagia in a patient receiving Entityhaloperidol for obsessive nocturnal thoughts and auditory disturbances.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Does the use of Entityinsulin in a patient with liver dysfunction increase water retention in the body, i. e. cause insulin Entityoedema ?
0.9950 Adverse-Effect Does the use of Entityinsulin in a patient with liver dysfunction increase water retention in the body, i. e. cause Entityinsulin oedema ?
0.5166 Adverse-Effect Does the use of insulin in a patient with liver dysfunction increase water retention in the body, i. e. cause Entityinsulin oedema Entityoedema ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article describes the case of a 25 - year - old man found Entitydead at home who had been prescribed Entityolanzapine for schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is very likely that the Entitydexamethasone used in the antiemetic drug regimen contributed to the development of Entityosteonecrosis in these patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAngioedema , a rare side effect of Entitycarbamazepine , involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and / or bradykinins.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Like other atypical neuroleptics Entityolanzapine is considered to show a reduced prevalence of Entityextrapyramidal side effects when compared to classical neuroleptic drugs.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The favourable outcome in these two patients contrasts with the Entityfatal outcome of the two other reported cases of Entitynitrofurantoin induced BOOP.
1.0000 Adverse-Effect The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of Entitynitrofurantoin induced EntityBOOP .
Adverse-Effect The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of Entitynitrofurantoin Entitynitrofurantoin induced BOOP .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A clinical diagnosis of Entityfixed drug eruption owing to use of the PDE5 inhibitor Entitytadalafil ( Cialis ) was made.
1.0000 Adverse-Effect RESULTS : A clinical diagnosis of Entityfixed drug eruption owing to use of the PDE5 inhibitor tadalafil ( EntityCialis ) was made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Protease inhibitors ( ritonavir and Entitysaquinavir ) were added to the treatment and the patient developed Entityprogressive ataxia related to carbamazepine toxicity.
0.9999 Adverse-Effect Protease inhibitors ( Entityritonavir and saquinavir ) were added to the treatment and the patient developed Entityprogressive ataxia related to carbamazepine toxicity.
0.9999 Adverse-Effect Protease inhibitors ( ritonavir and saquinavir ) were added to the treatment and the patient developed progressive ataxia related to Entitycarbamazepine Entitycarbamazepine toxicity .
0.9987 Adverse-Effect Protease inhibitors ( ritonavir and Entitysaquinavir ) were added to the treatment and the patient developed progressive ataxia related to Entitycarbamazepine toxicity .
0.9984 Adverse-Effect Protease inhibitors ( ritonavir and saquinavir ) were added to the treatment and the patient developed Entityprogressive ataxia related to Entitycarbamazepine toxicity.
0.9965 Adverse-Effect Protease inhibitors ( Entityritonavir and saquinavir ) were added to the treatment and the patient developed progressive ataxia related to Entitycarbamazepine toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 56 - year - old male parkinsonian patient developed a unique Entitybehavioral change following the oral administration of Entitycinepazide , a cerebral vasodilator.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOvarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under Entitytamoxifen therapy for breast cancer : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first case of EntityTMP - SMX - induced Entityhypersensitivity syndrome associated with the reactivation of a latent viral infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of 48 - year - old woman with seizure disorder on divalproex sodium ( EntityDepakote ) who presented with Entitydyspnea .
0.9999 Adverse-Effect We report a case of 48 - year - old woman with seizure disorder on Entitydivalproex sodium ( Depakote ) who presented with Entitydyspnea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Skin rash began after 2 weeks of treatment, and signs of Entityhepatocellular failure developed 3 weeks after Entityphenobarbital had been started.
0.9995 Adverse-Effect EntitySkin rash began after 2 weeks of treatment, and signs of hepatocellular failure developed 3 weeks after Entityphenobarbital had been started.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect OBJECTIVE : To report a case of Entitysevere chloroquine toxicity Entitychloroquine toxicity in the presence of high - grade chloroquine - resistant Plasmodium vivax.
0.9993 Adverse-Effect OBJECTIVE : To report a case of severe Entitychloroquine Entitychloroquine toxicity in the presence of high - grade chloroquine - resistant Plasmodium vivax.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Ethambutol, and to a lesser extent Entityisoniazid , are both implicated in the Entitydevelopment of visually related side effects .
1.0000 Adverse-Effect RESULTS : EntityEthambutol , and to a lesser extent isoniazid, are both implicated in the Entitydevelopment of visually related side effects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our objective is to present a retrospective analysis of the DWI findings in four patients who suffered Entitysubacute neurotoxicity after intrathecal EntityMTX .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rituximab - based therapy for Entitygemcitabine - induced Entityhemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient receiving chronic Entitylithium therapy who presented with a transient EntityCDI occurring in the setting of underlying chronic NDI.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Syndrome of inappropriate secretion of ADH ( EntitySIADH ) following Entitycisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
0.9998 Adverse-Effect EntitySyndrome of inappropriate secretion of ADH ( SIADH ) following Entitycisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this paper, we report a patient with primary anti - phospholipid syndrome treated by Entitycorticosteroid , who developed Entitydisseminated nocardiosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A wide variety of Entityadverse central nervous system effects have been reported in association with Entitypropafenone ; dizziness is the most common.
1.0000 Adverse-Effect A wide variety of adverse central nervous system effects have been reported in association with Entitypropafenone ; Entitydizziness is the most common.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pulmonary hemorrhage is an uncommon feature in the HUS, and seems to appear especially in the EntityHUS associated with EntityMMC therapy.
0.9999 Adverse-Effect Pulmonary hemorrhage is an uncommon feature in the EntityHUS , and seems to appear especially in the HUS associated with EntityMMC therapy.
0.9999 Adverse-Effect EntityPulmonary hemorrhage is an uncommon feature in the HUS, and seems to appear especially in the HUS associated with EntityMMC therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Center for Disease Control has received numerous reports of an Entityeosinophilia - myalgia syndrome related to products containing EntityL - tryptophan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityfatal pulmonary toxicity in a patient with advanced non - small cell lung cancer who received Entityerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 76 - year - old man who developed an Entityacute blistering eruption following high - dose Entitypenicillin treatment for pneumococcal septicaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The spectrum of Entityrenal lesions occurring during antituberculous therapy, particularly in association with Entityrifampin , may be wider than previously suspected.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Complications associated with Entityprimary and secondary perforation of the bladder following immediate instillations of Entityepirubicin after transurethral resection of superficial urothelial tumours.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Entity2 - Chloro - deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to Entitynon - Hodgkin's lymphoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 42 year old man, treated for testicular carcinoma with combination chemotherapy that included Entitybleomycin , developed life threatening Entityinterstitial pneumonitis .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Severe histological Entityosteomalacia developed in a woman with Crohn's disease 2 years after ileal resection and the start of Entitycholestyramine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Entityherpes esophagitis in a renal transplant patient treated with EntityCyclosporine A while on chronic steroid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is reported of a 40 year old woman treated with intraventricular EntityIL - 2 for leptomeningeal disease who developed progressive Entitycognitive dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the essential cause of EntityPV is unclear, its onset has occasionally been associated with drug therapy, in particular Entitypenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case history of a 15 - year - old boy who developed incapacitating Entitytardive dyskinesia that resolved during treatment with Entitydeanol is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases suggest the possibility that, in some patients, leukopenia or Entityagranulocytosis during Entityolanzapine treatment might be dose - related.
0.9999 Adverse-Effect These cases suggest the possibility that, in some patients, Entityleukopenia or agranulocytosis during Entityolanzapine treatment might be dose - related.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterferon - induced Entitypsychosis as a " psychiatric contraindication " to hepatitis C treatment : a review and case - based discussion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The use of fluorouracil treatment with careful monitoring can be considered in a patient with mild Entityallergic reactions to Entitycapecitabine .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect In patients with a known access to INH, Entityseizures should be considered to be caused by EntityINH toxicity unless proved otherwise.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During the first treatment, dysarthria and Entityataxia were seen after completion of the patient's eighth and final dose of EntityHDARAC .
1.0000 Adverse-Effect During the first treatment, Entitydysarthria and ataxia were seen after completion of the patient's eighth and final dose of EntityHDARAC .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe onset of syndrome of inappropriate antidiuretic hormone ( EntitySIADH ) associated with Entityvinorelbine therapy for advanced breast cancer.
1.0000 Adverse-Effect OBJECTIVE : To describe onset of Entitysyndrome of inappropriate antidiuretic hormone ( SIADH ) associated with Entityvinorelbine therapy for advanced breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about Entitytigecycline - induced Entityacute pancreatitis have recently been raised.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only one case of Entitysevere symptomatic hepatitis occurring after pulse therapy with Entityitraconazole for onychomycosis and requiring transplantation has been reported previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of rapidly occurring Entityhyperglycemia that occurred in a geriatric patient 3 days after treatment with Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While on a maximal dose of Entityphenylephrine she developed prominent Entitypositive U waves , which disappeared with the cessation of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is suggested that the fatal stroke may have resulted from Entityarterial spasm caused by Entityergotamine overdosage and possibly complicated by thrombosis.
0.9999 Adverse-Effect It is suggested that the Entityfatal stroke may have resulted from arterial spasm caused by Entityergotamine overdosage and possibly complicated by thrombosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Electro - oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with Entityvigabatrin - attributed Entityvisual field constriction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recombinant VIIa concentrate in the management of bleeding following Entityprothrombin complex concentrate - related Entitymyocardial infarction in patients with haemophilia and inhibitors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityfatal fulminant hepatitis caused by the use of Entitydisulfiram in a man with previously normal hepatocellular function.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 73 - year - old woman who developed serious systemic vasculitis with associated Entitythrombocytopenia in the course of treatment with Entitycladribine .
0.9997 Adverse-Effect We describe a 73 - year - old woman who developed serious Entitysystemic vasculitis with associated thrombocytopenia in the course of treatment with Entitycladribine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A combination of behavioural and cognitive adverse effects is illustrated in this case report of a recurrent Entitytriazolam - induced Entityeating disorder .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Extra caution should be taken in using Entityoctreotide or its long - acting analog in patients otherwise predisposed to Entityintrahepatic bile stasis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 3 cases of HIV - 1 infected patients who experienced symptomatic Entityangiolipomas shortly after starting antiretroviral therapy including the protease inhibitor Entityindinavir .
1.0000 Adverse-Effect We report 3 cases of HIV - 1 infected patients who experienced Entitysymptomatic angiolipomas shortly after starting antiretroviral therapy including the protease inhibitor Entityindinavir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case Entitysenna was likely the cause of a Entitysubacute cholestatic hepatitis exemplifying again the potential role of herbal related liver injury.
0.9998 Adverse-Effect In this case Entitysenna was likely the cause of a subacute cholestatic hepatitis exemplifying again the potential role of herbal related Entityliver injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Chronic myelogenous leukemia ( CML ), hepatitis C, and interferon alpha ( EntityIFNalpha ) have all been associated with Entityrenal dysfunction .
0.9998 Adverse-Effect Chronic myelogenous leukemia ( CML ), hepatitis C, and Entityinterferon alpha ( IFNalpha ) have all been associated with Entityrenal dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors conclude that among patients taking high doses of oral Entityniacin only those who experience Entityvisual symptoms need to be ophthalmologically evaluated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 37 - year - old woman with relapsing invasive vertebral aspergillosis received intravenous EntityVRC and developed Entityangio - oedema 10 days after starting therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case demonstrates the association of selective EntityIgA deficiency with remission in rheumatoid arthritis induced by Entityfenclofenac as well as aurothiomalate and sulphasalazine.
0.9997 Adverse-Effect This case demonstrates the association of selective EntityIgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as aurothiomalate and Entitysulphasalazine .
0.9997 Adverse-Effect This case demonstrates the association of selective EntityIgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as Entityaurothiomalate and sulphasalazine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A 55 - year - old woman became Entitystuporous after overdose with Entitylamotrigine ( LTG ) and valproic acid ( VPA ) tablets.
1.0000 Adverse-Effect METHODS : A 55 - year - old woman became Entitystuporous after overdose with lamotrigine ( EntityLTG ) and valproic acid ( VPA ) tablets.
1.0000 Adverse-Effect METHODS : A 55 - year - old woman became Entitystuporous after overdose with lamotrigine ( LTG ) and valproic acid ( EntityVPA ) tablets.
0.9999 Adverse-Effect METHODS : A 55 - year - old woman became Entitystuporous after overdose with lamotrigine ( LTG ) and Entityvalproic acid ( VPA ) tablets.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She received an accidental 450 - mg bolus injection of Entitymorphine intrathecally and developed Entityhypertension , status epilepticus, intracerebral hemorrhage, and respiratory failure.
1.0000 Adverse-Effect She received an accidental 450 - mg bolus injection of Entitymorphine intrathecally and developed hypertension, status epilepticus, Entityintracerebral hemorrhage , and respiratory failure.
1.0000 Adverse-Effect She received an accidental 450 - mg bolus injection of Entitymorphine intrathecally and developed hypertension, status epilepticus, intracerebral hemorrhage, and Entityrespiratory failure .
0.9999 Adverse-Effect She received an accidental 450 - mg bolus injection of Entitymorphine intrathecally and developed hypertension, Entitystatus epilepticus , intracerebral hemorrhage, and respiratory failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 49 - year - old man with Crohn's disease treated with prednisone and mesalamine ( Entity5 - ASA ) developed Entityworsening respiratory distress and fever.
1.0000 Adverse-Effect A 49 - year - old man with Crohn's disease treated with prednisone and Entitymesalamine ( 5 - ASA ) developed Entityworsening respiratory distress and fever.
1.0000 Adverse-Effect A 49 - year - old man with Crohn's disease treated with Entityprednisone and mesalamine ( 5 - ASA ) developed Entityworsening respiratory distress and fever.
0.9999 Adverse-Effect A 49 - year - old man with Crohn's disease treated with prednisone and Entitymesalamine ( 5 - ASA ) developed worsening respiratory distress and Entityfever .
0.9999 Adverse-Effect A 49 - year - old man with Crohn's disease treated with Entityprednisone and mesalamine ( 5 - ASA ) developed worsening respiratory distress and Entityfever .
0.9999 Adverse-Effect A 49 - year - old man with Crohn's disease treated with prednisone and mesalamine ( Entity5 - ASA ) developed worsening respiratory distress and Entityfever .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Massive pulmonary embolism due to late - onset Entityheparin - induced Entitythrombocytopenia following coronary artery bypass graft surgery : successful treatment with lepirudin.
0.9994 Adverse-Effect EntityMassive pulmonary embolism due to late - onset Entityheparin - induced thrombocytopenia following coronary artery bypass graft surgery : successful treatment with lepirudin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethemoglobinemia is another common finding among patients receiving Entitydapsone therapy, but rarely does it result in prominent symptoms other than transient pallor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians using this " new " drug must be aware of the potential danger of Entitysulfonamide - induced Entityinjury to the urinary tract .
Score Relation Text (Head - Tail)
0.9885 Adverse-Effect Since the Entitybronchospasm was relieved with discontinuation of Entitypropranolol and supportive bronchodilator therapy, the bronchospasm was believed to be caused by propranolol.
0.9694 Adverse-Effect Since the bronchospasm was relieved with discontinuation of propranolol and supportive bronchodilator therapy, the Entitybronchospasm was believed to be caused by Entitypropranolol .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Destructive Entitythyrotoxicosis appeared 4 - 6 months after starting EntityIFN - alpha , followed by Graves'hyperthyroidism within 8 to 11 months.
0.9985 Adverse-Effect Destructive thyrotoxicosis appeared 4 - 6 months after starting EntityIFN - alpha , followed by EntityGraves'hyperthyroidism within 8 to 11 months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sagittal sinus thrombosis associated with Entitytransient free protein S deficiency after EntityL - asparaginase treatment : case report and review of the literature.
0.9993 Adverse-Effect EntitySagittal sinus thrombosis associated with transient free protein S deficiency after EntityL - asparaginase treatment : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityReversible leukopenia was documented in an 81 - year - old woman treated with adjunctive Entityibopamine 100 mg t. i. d. for chronic congestive heart failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possibility of severe rhabdomyolysis should be considered in a patient with Entitywater intoxication due to massive ingestion of Entitycaffeine - containing beverages.
0.9999 Adverse-Effect The possibility of severe Entityrhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of Entitycaffeine - containing beverages.
0.9999 Adverse-Effect The possibility of Entitysevere rhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of Entitycaffeine - containing beverages.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second patient developed both autoimmune thyroid disease and a Entityrefractory pre - patellar bursitis after 50 months of EntityIFN - beta therapy.
0.9996 Adverse-Effect The second patient developed both Entityautoimmune thyroid disease and a refractory pre - patellar bursitis after 50 months of EntityIFN - beta therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with Entitypulmonary toxicity characterized by cough, dyspnea and diffuse pulmonary infiltrates.
0.9998 Adverse-Effect EntityAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by Entitycough , dyspnea and diffuse pulmonary infiltrates.
0.9998 Adverse-Effect EntityAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, Entitydyspnea and diffuse pulmonary infiltrates.
0.9997 Adverse-Effect EntityAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, dyspnea and Entitydiffuse pulmonary infiltrates .
Score Relation Text (Head - Tail)
0.9918 Adverse-Effect The biochemistry of paracetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the Entityhepatotoxic effects of Entityparacetamol is remarked upon.
0.9896 Adverse-Effect The biochemistry of Entityparacetamol Entityhepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of paracetamol is remarked upon.
0.9701 Adverse-Effect The biochemistry of Entityparacetamol Entityparacetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of paracetamol is remarked upon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the development of Entitysquamous - cell carcinoma within a basal - cell epithelioma that was treated with intralesional injections of Entity5 - FU .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient presented with a Entitypainful , oedematous, cyanosed hand having injected a solution of Entitydiamorphine and methylphenidate into his radial artery.
0.9999 Adverse-Effect A patient presented with a Entitypainful , oedematous, cyanosed hand having injected a solution of diamorphine and Entitymethylphenidate into his radial artery.
Adverse-Effect A patient presented with a Entitypainful, oedematous, cyanosed hand having injected a solution of Entitydiamorphine and methylphenidate into his radial artery.
Adverse-Effect A patient presented with a Entitypainful, oedematous, cyanosed hand having injected a solution of diamorphine and Entitymethylphenidate into his radial artery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on three patients who developed Entityacute liver damage during therapy with Entityitraconazole , and in whom liver biopsy specimens were obtained.
Adverse-Effect We report on three patients who developed acute Entityliver damage during therapy with Entityitraconazole , and in whom liver biopsy specimens were obtained.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thiopurine methyltransferase deficiency occurs at a frequency of one in 300 and is associated with profound Entitymyelosuppression after a short course of Entityazathioprine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect AIM : To report a patient with diabetic rubeosis who suffered from acute retinal ischemic change and Entitystroke after intravitreal injection of Entitybevacizumab .
1.0000 Adverse-Effect AIM : To report a patient with diabetic rubeosis who suffered from Entityacute retinal ischemic change and stroke after intravitreal injection of Entitybevacizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a case report of possible association of Entitymethylphenidate and Entityenuresis in an 11 - year - old boy with attention deficit hyperactivity disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Methylene blue in the treatment and prevention of Entityifosfamide - induced Entityencephalopathy : report of 12 cases and a review of the literature.
Adverse-Effect Methylene blue in the treatment and prevention of Entityifosfamide Entityifosfamide - induced encephalopathy : report of 12 cases and a review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNCSE , an epileptic disorder in which typical convulsive activity is absent, has previously been reported in only 4 patients receiving Entityifosfamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first case of EntityHBV reactivation occurring during the year following Entityrituximab monotherapy in the absence of any other immunosuppressive factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Entitysubcutaneous metastasis along the needle track after percutaneous Entityethanol injection ( PEI ) for treatment of hepatocellular carcinoma.
1.0000 Adverse-Effect We describe a case of Entitysubcutaneous metastasis along the needle track after percutaneous Entityethanol injection ( PEI ) for treatment of hepatocellular carcinoma.
0.9999 Adverse-Effect We describe a case of Entitysubcutaneous metastasis along the needle track after percutaneous ethanol injection ( EntityPEI ) for treatment of hepatocellular carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes an unexpected drug - induced Entityhepatitis in a previously healthy young woman exposed to 2 doses of Entityamodiaquine and artesunate.
1.0000 Adverse-Effect This report describes an unexpected drug - induced Entityhepatitis in a previously healthy young woman exposed to 2 doses of amodiaquine and Entityartesunate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTumor - volume increase at beginning of primary treatment with topical Entityinterferon alpha 2 - beta in a case of conjunctiva - cornea intraepithelial neoplasia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This entity is probably related to a combination of high doses of corticosteroids, Entityvecuronium administration and metabolic abnormalities associated with Entityrespiratory failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who, after receiving his first dose of Entitypregabalin to relieve neuropathic pain, presented with a Entitynegative myoclonus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who had a Entitysystemic allergic contact dermatitis to Entity8 - MOP develop during her second course of PUVA treatment for psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In two of these cases Entityakathisia resolved after withdrawal of Entityolanzapine and substitution by a classical or an atypical neuroleptic agent, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the Entitymovement disorder could not with certainty be attributed to Entitytrazodone alone, the drug at least acted as an eliciting agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : EntityCentral nervous system ( CNS ) toxicity has been described with Entityifosfamide , with most cases reported in the pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Albeit rare among Western patients, such Entitylithium - associated Entitythyroid dysfunctions appeared to be more likely to occur in Hong Kong Chinese.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFever caused by the use of Entityfurosemide was proved ; the fever resolved after discontinuation of this medication and recurred after its reintroduction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 10 - year - old boy with ulcerative colitis who developed Entityacute pancreatitis while on long - term treatment with Entity5 - aminosalicylic acid .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This case represents the third example of Entityerythroid aplasia associated with an anti - inflammatory agent and the first instance due to Entityfenoprofen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After approximately two weeks of Entitysertraline treatment he noted an Entityintense itching sensation in his scalp after eating a piece of chocolate cake.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEosinophilia has been encountered from 0. 2 to 61. 7 % in Entityclozapine - treated patients, mostly with a transient course and spontaneous remission.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute intravascular hemolysis developed when a diabetic patient, previously treated with Entityglyburide , was started on another oral sulfonylurea drug, chlorpropamide.
0.9998 Adverse-Effect EntityAcute intravascular hemolysis developed when a diabetic patient, previously treated with glyburide, was started on another oral sulfonylurea drug, Entitychlorpropamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, clinical recognition of Entitysleep disordered breathing should be taken into account when rheumatoid arthritis patients are to be treated with Entityinfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with disseminated herpes zoster developed a syndrome of inappropriate antidiuretic hormone and profound Entityhyponatremia secondary to the administration of Entityadenine arabinoside .
0.9995 Adverse-Effect A patient with disseminated herpes zoster developed a Entitysyndrome of inappropriate antidiuretic hormone and profound hyponatremia secondary to the administration of Entityadenine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We report a case of Entityacute severe hepatitis resulting from Entityerlotinib monotherapy in a patient with locally advanced pancreatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Described here are 2 patients who developed Entitythrombotic microangiopathy of the kidneys after receiving high cumulative doses of the new anticancer drug Entitygemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Entitychlorambucil - induced EntityDRESS syndrome in a 70 - year - old man recently diagnosed with chronic lymphocytic leukaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, we describe a patient receiving Entitylenalidomide in whom Entitydyspnea , fever, hypoxia, and diffuse pulmonary infiltrates developed.
1.0000 Adverse-Effect In this report, we describe a patient receiving Entitylenalidomide in whom dyspnea, fever, Entityhypoxia , and diffuse pulmonary infiltrates developed.
1.0000 Adverse-Effect In this report, we describe a patient receiving Entitylenalidomide in whom dyspnea, Entityfever , hypoxia, and diffuse pulmonary infiltrates developed.
0.9999 Adverse-Effect In this report, we describe a patient receiving Entitylenalidomide in whom dyspnea, fever, hypoxia, and Entitydiffuse pulmonary infiltrates developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on the Naranjo probability scale, Entityserotonin syndrome was a probable adverse reaction associated with co - administration of Entitycitalopram and fentanyl.
1.0000 Adverse-Effect Based on the Naranjo probability scale, Entityserotonin syndrome was a probable adverse reaction associated with co - administration of citalopram and Entityfentanyl .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHOD : The authors followed a patient with chronic HCV who received interferon and Entityribavirin and who developed Entityhallucinations ultimately requiring psychiatric hospitalization.
1.0000 Adverse-Effect METHOD : The authors followed a patient with chronic HCV who received Entityinterferon and ribavirin and who developed Entityhallucinations ultimately requiring psychiatric hospitalization.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 2 : A 43 - year - old male alcoholic remained completely abstinent with Entitycyanamide treatment for 5 years and complained of Entitygeneral fatigue .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A healthy, 30 - year - old man, exposed to Entitysulindac on two separate occasions, had an incapacitating Entityisolated idential sensory neuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect According to the Naranjo et al. adverse - reaction probability scale, Entityenoxaparin was the probable cause of Entityhepatotoxicity in this patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians treating elderly patients with Entityolanzapine should be aware of the potential for rapidly developing Entityhyperglycemia and monitor such patients accordingly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with extranodal non - Hodgkin lymphoma who developed Entitysystemic candidiasis after treatment with a Entitycyclophosphamide - based chemotherapy regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mitomycin C ( EntityMMC ) is an alkylating agent that has been recently associated with the Entityhemolytic - uremic syndrome ( HUS ).
0.9999 Adverse-Effect Mitomycin C ( EntityMMC ) is an alkylating agent that has been recently associated with the hemolytic - uremic syndrome ( EntityHUS ).
0.9998 Adverse-Effect EntityMitomycin C ( MMC ) is an alkylating agent that has been recently associated with the Entityhemolytic - uremic syndrome ( HUS ).
0.9997 Adverse-Effect EntityMitomycin C ( MMC ) is an alkylating agent that has been recently associated with the hemolytic - uremic syndrome ( EntityHUS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : EntityOlanzapine , like other atypical antipsychotic drugs, may cause Entitymuscle injury with concomitant elevations of serum CK of muscle origin.
Adverse-Effect DISCUSSION : EntityOlanzapine , like other atypical antipsychotic drugs, may cause Entitymuscle injury with concomitant elevations of serum CK of muscle origin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : Two children with attention deficit disorder treated with Entitymethylphenidate as a simple drug developed Entityfixed drug eruption of the scrotum .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Jet - injection devices might constitute a helpful method to treat those patients affected by severe Entityhuman insulin - induced Entitylipoatrophy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAkathisia is a relatively rare side effect with the newer atypical antipsychotic agents, particularly Entityclozapine , and is easily misdiagnosed in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS / RESULTS : This paper presents a new case of Entityrifabutin Entityuveitis and a review of the various published reports to date.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Effect of beta - blockade on symptomatic Entitydexamethasone - induced Entityhypertrophic obstructive cardiomyopathy in premature infants : three case reports and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : To describe the presentation and treatment of acute isoniazid ( EntityINH ) Entityneurotoxicity appearing at an inner - city municipal hospital.
0.9996 Adverse-Effect OBJECTIVES : To describe the presentation and treatment of acute Entityisoniazid ( INH ) Entityneurotoxicity appearing at an inner - city municipal hospital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An 11 - year - old boy developed a Entitysevere enteropathy 2 years after initiation of Entityclofazimine treatment for graft - versus - host disease.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Because the Entitycerebellar toxicity may be worsened by continuation of therapy after initial onset of symptoms, prompt termination of EntityHDARAC is recommended.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case of spontaneous remission of EntityMTX - associated Entitygastric LPD after discontinuation of MTX therapy.
0.9999 Adverse-Effect To our knowledge, this is the first case of spontaneous remission of MTX - associated Entitygastric LPD after discontinuation of EntityMTX therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Under certain circumstances topical Entitybrimonidine can cause Entityparadoxical raised IOP necessitating vigilance in follow - up of patients on topical brimonidine.
1.0000 Adverse-Effect CONCLUSION : Under certain circumstances topical Entitybrimonidine can cause Entityparadoxical raised IOP necessitating vigilance in follow - up of patients on topical brimonidine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitypropranolol overdose complicated by Entityesophageal spasm preventing extrication of an orogastric lavage tube and relieved by intravenous glucagon is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the first case of ovarian endometrioid carcinoma and Entityendometriosis in a postmenopausal patient who was treated with Entitytamoxifen for breast cancer.
0.9999 Adverse-Effect We present the first case of Entityovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with Entitytamoxifen for breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be cognizant of this possibility and consider a diagnosis of HDAs in patients with ongoing Entitythrombosis who are receiving Entityheparin therapy.
1.0000 Adverse-Effect Clinicians should be cognizant of this possibility and consider a diagnosis of EntityHDAs in patients with ongoing thrombosis who are receiving Entityheparin therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Second cancers including various types of Entityhematological malignancy have been reported in patients with hairy cell leukemia treated with chemotherapy or Entityinterferon alfa .
0.9999 Adverse-Effect EntitySecond cancers including various types of hematological malignancy have been reported in patients with hairy cell leukemia treated with chemotherapy or Entityinterferon alfa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityabnormal rhythm disappeared with the withdrawal of Entitypropranolol and when the drug was restarted a 2 / 1 S - A block was seen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In both cases, high fever, skin rash, liver dysfunction and Entityatypical lymphocytosis developed 3 weeks after initiating treatment with EntitySASP .
1.0000 Adverse-Effect In both cases, Entityhigh fever , skin rash, liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with EntitySASP .
0.9999 Adverse-Effect In both cases, high fever, skin rash, Entityliver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with EntitySASP .
0.9999 Adverse-Effect In both cases, high fever, Entityskin rash , liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with EntitySASP .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the specifics of 12 cases of Entitysevere hypertension after the intraoperative use of topical Entityphenylephrine , submucosal epinephrine, or both.
1.0000 Adverse-Effect We report the specifics of 12 cases of Entitysevere hypertension after the intraoperative use of topical phenylephrine, submucosal Entityepinephrine , or both.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Three patients who developed symptoms of inflammatory bowel disease ( EntityIBD ) during Entityrofecoxib exposure are described along with pathology findings.
1.0000 Adverse-Effect RESULTS : Three patients who developed symptoms of Entityinflammatory bowel disease ( IBD ) during Entityrofecoxib exposure are described along with pathology findings.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of secondary Entityglaucoma caused by epithelial downgrowth in which filtration surgery was performed with adjunctive use of subconjunctival Entity5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an allogeneic bone marrow transplant recipient who developed EntityCMV infection refractory to sequential therapy with Entityganciclovir , foscarnet, and cidofovir.
1.0000 Adverse-Effect We report an allogeneic bone marrow transplant recipient who developed EntityCMV infection refractory to sequential therapy with ganciclovir, Entityfoscarnet , and cidofovir.
1.0000 Adverse-Effect We report an allogeneic bone marrow transplant recipient who developed EntityCMV infection refractory to sequential therapy with ganciclovir, foscarnet, and Entitycidofovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPtosis occurring 24 h after Entitychloroquine therapy, with full recovery 48 h after cessation of chloroquine, has not been described previously.
0.9997 Adverse-Effect EntityPtosis occurring 24 h after chloroquine therapy, with full recovery 48 h after cessation of Entitychloroquine , has not been described previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dyspnea, hypoxemia, and Entitypleuritic chest pain occurred within 24 hours of Entityrituximab administration, and there was no other apparent explanation.
1.0000 Adverse-Effect Dyspnea, Entityhypoxemia , and pleuritic chest pain occurred within 24 hours of Entityrituximab administration, and there was no other apparent explanation.
1.0000 Adverse-Effect EntityDyspnea , hypoxemia, and pleuritic chest pain occurred within 24 hours of Entityrituximab administration, and there was no other apparent explanation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Emphasis is given to the differentiation of Entitydiphenylhydantoin induced Entitygingival hyperplasia from the angiomatous enlargement of the gingiva before any treatment is planned.
Score Relation Text (Head - Tail)
0.9992 Adverse-Effect Most cases of Entitypancreatitis associated with EntityL - asparaginase toxicity are self - limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.
0.9938 Adverse-Effect Most cases of pancreatitis associated with EntityL - asparaginase EntityL - asparaginase toxicity are self - limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of significant over - anticoagulation temporally associated with a bout of protracted Entitydiarrhea in a patient on Entitywarfarin therapy.
0.9998 Adverse-Effect We present a case of significant Entityover - anticoagulation temporally associated with a bout of protracted diarrhea in a patient on Entitywarfarin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Regardless of a negative history of asthma, therefore, life - threatening Entitybronchospasm must be considered a possible complication of Entitypropranolol therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After three weeks of Entitycarbamazepine therapy, the patient arrived at the emergency department ( ED ) with Entitysevere agitation and aggressive behavior.
1.0000 Adverse-Effect After three weeks of Entitycarbamazepine therapy, the patient arrived at the emergency department ( ED ) with severe agitation and Entityaggressive behavior .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of Entityintoxication of a 41 - year - old female patient suffering from major depression with Entitymirtazapine complicated by severe hypothermia.
0.9912 Adverse-Effect We report the case of intoxication of a 41 - year - old female patient suffering from major depression with Entitymirtazapine complicated by Entitysevere hypothermia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 57 - year - old woman developed Entitypulmonary sarcoidosis during therapy with Entityinterferon beta for advanced renal cell carcinoma metastatic to mediastinal lymph nodes.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In addition to the recognized arrhythmic complications, the authors emphasize myocardial necrosis as a possible further manifestation of Entityamsacrine - related Entitycardiotoxicity .
0.9989 Adverse-Effect In addition to the recognized arrhythmic complications, the authors emphasize Entitymyocardial necrosis as a possible further manifestation of Entityamsacrine - related cardiotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article presents a case of an Entityatypical localized cutaneous eruption with an unusual course and protracted resolution time associated with Entitysorafenib therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Infant twins sustained Entitysevere circumoral and pharyngeal burns from a concentrated solution of Entitybenzalkonium ( Zephiran ) chloride prescribed for treatment of candidiasis.
0.9999 Adverse-Effect Infant twins sustained Entitysevere circumoral and pharyngeal burns from a concentrated solution of benzalkonium ( EntityZephiran ) chloride prescribed for treatment of candidiasis.
Adverse-Effect Infant twins sustained severe Entitycircumoral and pharyngeal burns from a concentrated solution of Entitybenzalkonium ( Zephiran ) chloride prescribed for treatment of candidiasis.
Adverse-Effect Infant twins sustained severe Entitycircumoral and pharyngeal burns from a concentrated solution of benzalkonium ( EntityZephiran ) chloride prescribed for treatment of candidiasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEpstein - Barr virus - associated lymphoproliferative disorder in a patient with rheumatoid arthritis on Entitymethotrexate and rofecoxib : idiosyncratic reaction or pharmacogenetics?
0.9999 Adverse-Effect EntityEpstein - Barr virus - associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and Entityrofecoxib : idiosyncratic reaction or pharmacogenetics?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityNorethisterone in these 69 pregnancies accounted for 33. 3 % ( 5 of 15 ) cases of Entityclitoral hypertrophy diagnosed in 100, 756 consecutive births.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityocular toxicity of EntityDCF , previously described as conjunctivitis, appears to be a keratitis of moderate severity which requires further study.
0.9997 Adverse-Effect The ocular toxicity of EntityDCF , previously described as Entityconjunctivitis , appears to be a keratitis of moderate severity which requires further study.
0.9994 Adverse-Effect The ocular toxicity of EntityDCF , previously described as conjunctivitis, appears to be a Entitykeratitis of moderate severity which requires further study.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a rare case of recurrent ( stuttering ) Entitypriapism in a patient with protein C deficiency while maintained on EntityWarfarin therapy.
1.0000 Adverse-Effect We report a rare case of recurrent ( Entitystuttering ) priapism in a patient with protein C deficiency while maintained on EntityWarfarin therapy.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect We report a case of severe Entityrespiratory failure due to Entitygold salt toxicity in a patient suffering from rheumatoid arthritis requiring mechanical ventilation.
0.9998 Adverse-Effect We report a case of Entitysevere respiratory failure due to Entitygold salt toxicity in a patient suffering from rheumatoid arthritis requiring mechanical ventilation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He was diagnosed with possible Entityserotonin syndrome ; his symptoms resolved after Entityclomipramine was stopped but before clozapine was restarted eight days later.
0.9994 Adverse-Effect He was diagnosed with possible Entityserotonin syndrome ; his symptoms resolved after clomipramine was stopped but before Entityclozapine was restarted eight days later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since amiodarone was first marketed in 1992 in Japan, the incidence of Entityamiodarone - induced Entitythyrotoxicosis ( AIT ) has been increasing.
0.9984 Adverse-Effect Since amiodarone was first marketed in 1992 in Japan, the incidence of Entityamiodarone - induced thyrotoxicosis ( EntityAIT ) has been increasing.
0.9920 Adverse-Effect Since Entityamiodarone was first marketed in 1992 in Japan, the incidence of amiodarone - induced Entitythyrotoxicosis ( AIT ) has been increasing.
0.9871 Adverse-Effect Since Entityamiodarone was first marketed in 1992 in Japan, the incidence of amiodarone - induced thyrotoxicosis ( EntityAIT ) has been increasing.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient suffering from a rare enzyme deficiency developed a Entitymalignant neuroleptic syndrome after having been treated with one single dose of Entityhaloperidol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One of the subjects who was using extemporaneous topical Entityminoxidil had Entityhypertension and arteriosclerotic disease and the other died of a myocardial infarction.
0.9999 Adverse-Effect One of the subjects who was using extemporaneous topical Entityminoxidil had hypertension and Entityarteriosclerotic disease and the other died of a myocardial infarction.
0.9997 Adverse-Effect One of the subjects who was using extemporaneous topical Entityminoxidil had hypertension and arteriosclerotic disease and the other died of a Entitymyocardial infarction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAutoimmune thyroid disease is a common side - effect of Entityinterferon - alpha ( IFN - alpha ) treatment of viral hepatitis C.
0.9996 Adverse-Effect EntityAutoimmune thyroid disease is a common side - effect of interferon - alpha ( EntityIFN - alpha ) treatment of viral hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A noninvasive method in the differential diagnosis of vecuronium - induced and Entitymagnesium - induced Entityprotracted neuromuscular block in a severely preeclamptic patient.
0.9993 Adverse-Effect A noninvasive method in the differential diagnosis of Entityvecuronium - induced and magnesium - induced Entityprotracted neuromuscular block in a severely preeclamptic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient received only the ophthalmic Entitysulfonamide , and it was used for one day, but he developed EntityStevens - Johnson syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This review presents the first case series of DIC associated with acute hemoglobinemia or Entityhemoglobinuria following Entityanti - D IGIV administration for ITP.
0.9997 Adverse-Effect This review presents the first case series of EntityDIC associated with acute hemoglobinemia or hemoglobinuria following Entityanti - D IGIV administration for ITP.
0.9991 Adverse-Effect This review presents the first case series of DIC associated with Entityacute hemoglobinemia or hemoglobinuria following Entityanti - D IGIV administration for ITP.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Patient A reported right leg weakness ( Entityfoot drop ) during week 4 of EntityCAP - XRT ( 1600 mg / m2 ).
0.9998 Adverse-Effect Patient A reported Entityright leg weakness ( foot drop ) during week 4 of EntityCAP - XRT ( 1600 mg / m2 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two case reports of Entitybilateral granulomatous anterior uveitis are described in patients with open angle glaucoma treated with Entitymetripranolol 0. 6 % eye drops.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 58 - year - old white woman developed Entityfulminant liver failure while being treated with the macrolide antibiotic Entityclarithromycin for pneumonia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethamphetamine ' s extensive physiologic effects, inconsistent street purity, and multiple routes of administration offer many possibilities for Entityinjury to the cornea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect TREATMENT / OUTCOME : Standard anti - tuberculosis therapy was administered but was complicated by interaction with Entitycyclosporine and drug - induced Entitycholestasis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that objective evaluation of retinal function with electrophysiological methods should be performed in patients with Entityvisual disturbance during treatment with Entityrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After reviewing the literature we suggest the EntityCPM was a complication of Entitylithium toxicity which affected the lateral geniculate nucleus which produced blindness.
0.9998 Adverse-Effect After reviewing the literature we suggest the CPM was a complication of Entitylithium toxicity which affected the lateral geniculate nucleus which produced Entityblindness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The pathophysiological mechanisms remain unknown, although the drug could act through massive cytokines liberation after Entitydestruction of CD20 positive cells by Entityrituximab .
0.9999 Adverse-Effect The pathophysiological mechanisms remain unknown, although the drug could act through Entitymassive cytokines liberation after destruction of CD20 positive cells by Entityrituximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a patient with Entityciprofloxacin - induced EntitySJS and acute onset of VBDS, and reviewed the related literature.
0.9997 Adverse-Effect We report a case of a patient with Entityciprofloxacin - induced SJS and acute onset of EntityVBDS , and reviewed the related literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : EntityZidovudine is well a known cause of Entityanaemia and thus should be used with caution in the initiation of antiretroviral therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMotor fluctuations appear after 2 - 3 years of Entitylevodopa treatment, and affect at least 50 % of patients after five years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second patient experienced Entitymild nitritoid symptoms following several EntityGSTM injections prior experiencing a cerebrovascular accident within several hours of her next injection.
1.0000 Adverse-Effect The second patient experienced mild nitritoid symptoms following several EntityGSTM injections prior experiencing a Entitycerebrovascular accident within several hours of her next injection.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We describe a case of Entityfibrosing alveolitis , diagnosed by lung biopsy, in a patient receiving Entityamiodarone which responded to corticosteroid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One type of SMON is associated with Entityacrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of Entityclioquinol .
1.0000 Adverse-Effect One type of EntitySMON is associated with acrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of Entityclioquinol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intrahepatic cholestasis and Entitycutaneous bullae associated with Entityglibenclamide therapy are described in a 61 - year - old diabetic patient who presented wit hypoglycaemic coma.
0.9999 Adverse-Effect EntityIntrahepatic cholestasis and cutaneous bullae associated with Entityglibenclamide therapy are described in a 61 - year - old diabetic patient who presented wit hypoglycaemic coma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entitysevere unilateral posterior scleritis associated with Entityzoledronic acid administration that was recognized and treated in a timely manner.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both had impaired lung function and Entityabnormal computed tomographic scans , and their condition improved when Entitynitrofurantoin was withdrawn and corticosteroid treatment commenced.
1.0000 Adverse-Effect Both had Entityimpaired lung function and abnormal computed tomographic scans, and their condition improved when Entitynitrofurantoin was withdrawn and corticosteroid treatment commenced.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first biopsy confirmed occurrence of Entityacute interstitial nephritis in a patient receiving treatment with EntitySunitinib for metastatic renal cell cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMeperidine - associated Entitycentral nervous system ( CNS ) excitatory toxicities are believed to be caused by accumulation of the active metabolite normeperidine.
0.9965 Adverse-Effect EntityMeperidine - associated central nervous system ( CNS ) excitatory toxicities are believed to be caused by Entityaccumulation of the active metabolite normeperidine .
0.9983 Adverse-Effect EntityMeperidine - associated central nervous system ( CNS ) excitatory toxicities are believed to be caused by Entityaccumulation of the active metabolite normeperidine.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect EntityAmiodarone is well recognized as an anti - arrhythmic drug containing a high dose of iodine with considerable potential to cause Entitythyroid dysfunction .
1.0000 Adverse-Effect Amiodarone is well recognized as an anti - arrhythmic drug containing a high dose of Entityiodine with considerable potential to cause Entitythyroid dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case report of the Entityhypersensitivity syndrome occurring in a patient being treated with Entitydapsone for a brown recluse spider bite is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians who use sulfasalazine to treat patients with inflammatory bowel disease should be aware of the signs of Entitysulfasalazine - induced Entitylupus syndrome .
0.9954 Adverse-Effect Physicians who use Entitysulfasalazine to treat patients with inflammatory bowel disease should be aware of the signs of sulfasalazine - induced Entitylupus syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this article, we describe a Japanese patient with Entitysevere interstitial pneumonia probably caused by Entitysorafenib treatment for metastatic renal cell carcinoma.
1.0000 Adverse-Effect In this article, we describe a Japanese patient with severe Entityinterstitial pneumonia probably caused by Entitysorafenib treatment for metastatic renal cell carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recognizing early signs of HMSN, such as areflexia and pes cavus deformity, can prevent Entitysevere neurotoxicity of polychemotherapy by avoiding Entityvincristine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was diagnosed with Epstein - Barr virus - associated polymorphic lymphoproliferative disorder ( LPD ) due to Entityimmunodeficiency caused by EntityMTX administration.
0.9971 Adverse-Effect She was diagnosed with Epstein - Barr virus - associated polymorphic lymphoproliferative disorder ( EntityLPD ) due to immunodeficiency caused by EntityMTX administration.
0.9949 Adverse-Effect She was diagnosed with EntityEpstein - Barr virus - associated polymorphic lymphoproliferative disorder ( LPD ) due to immunodeficiency caused by EntityMTX administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present three cases from the Provincial Toxicology Center of British Columbia, Canada in which Entitysuicidal overdose deaths were associated with Entityquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Entitytaxol has shown significant activity in advanced ovarian cancer, Entityperipheral neuropathy is likely to become the major dose - limiting toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was concluded that ANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with EntityPTU appeared to induce EntityANCA .
0.9997 Adverse-Effect It was concluded that EntityANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with EntityPTU appeared to induce ANCA.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect We recommend the cautious use of Entityketorolac in patients with underlying illnesses where NSAID - induced Entityototoxicity could result in adverse otologic consequences.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAnaphylaxis to Entitycisplatin is an infrequent life - threatening complication which may occur even in patients who have received prior treatment with cisplatin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of significant Entityelevation of serum transaminases in a patient treated with Entity6 - TG for a flare of Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Similar to previous findings of drug - induced vortex keratopathy, Entityatovaquone Entityvortex keratopathy is presumably caused by its lipophilic properties.
0.9973 Adverse-Effect RESULTS : Similar to previous findings of drug - induced Entityvortex keratopathy , Entityatovaquone vortex keratopathy is presumably caused by its lipophilic properties.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Although a definite association has not been proven, clinicians should be aware of the possibility of Entityagranulocytosis while using Entityquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 54 - year - old man developed EntityTEN 4 weeks after beginning Entitylamotrigine for complex partial seizures related to a glioblastoma multiforme brain tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have safely used recombinant factor VIIa to treat bleeding in the immediate and long - term period following EntityPCC - related EntityMI .
0.9977 Adverse-Effect We have safely used Entityrecombinant factor VIIa to treat bleeding in the immediate and long - term period following PCC - related EntityMI .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with inoperable pancreatic cancer who developed gastrointestinal bleeding secondary to Entityradiation - recall related to Entitygemcitabine and review literature.
0.9999 Adverse-Effect We report a patient with inoperable pancreatic cancer who developed Entitygastrointestinal bleeding secondary to radiation - recall related to Entitygemcitabine and review literature.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect METHODS : EntityGrowth retardation was observed in six severely asthmatic children after introduction of high - dose Entityfluticasone propionate treatment ( dry powder ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 40 - year - old woman who developed fulminant hepatic failure and Entityaplastic anaemia following a course of oral Entityflucloxacillin .
1.0000 Adverse-Effect We report the case of a 40 - year - old woman who developed Entityfulminant hepatic failure and aplastic anaemia following a course of oral Entityflucloxacillin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The hospital course of the acute renal failure is presented with a review of the literature on cases of Entityacute renal failure after EntityIVIG .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Use of the Naranjo probability scale indicated a highly probable relationship between the observed Entitycardiac toxicity and Entityamphotericin B deoxycholate therapy in this patient.
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect We describe 2 patients with cutaneous lupus erythematosus who developed severe Entitydapsone Entitydapsone reaction after low dose therapy, with a fatal outcome in one.
0.9977 Adverse-Effect We describe 2 patients with cutaneous lupus erythematosus who developed severe Entitydapsone reaction after low dose therapy, with a Entityfatal outcome in one.
0.9994 Adverse-Effect We describe 2 patients with cutaneous lupus erythematosus who developed severe Entitydapsone reaction after low dose therapy, with a Entityfatal outcome in one.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Because of its structural similarity to the other vinca alkaloids, Entityvinorelbine is believed to be responsible for EntitySIADH in our patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityInterferon - based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including Entityneuropsychiatric symptoms .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySevere osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of Entityphenytoin , phenobarbital, and acetazolamide.
1.0000 Adverse-Effect EntitySevere osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of phenytoin, Entityphenobarbital , and acetazolamide.
1.0000 Adverse-Effect EntitySevere osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of phenytoin, phenobarbital, and Entityacetazolamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute myeloid leukemia and Entitylung cancer occurring in a chronic lymphocytic leukemia patient treated with Entityfludarabine and autologous peripheral blood stem - cell transplantation.
1.0000 Adverse-Effect EntityAcute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with Entityfludarabine and autologous peripheral blood stem - cell transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Entityadalimumab who developed Entityfever , pancytopenia, splenomegaly, and extreme hyperferritinemia.
1.0000 Adverse-Effect OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Entityadalimumab who developed fever, Entitypancytopenia , splenomegaly, and extreme hyperferritinemia.
1.0000 Adverse-Effect OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Entityadalimumab who developed fever, pancytopenia, Entitysplenomegaly , and extreme hyperferritinemia.
0.9999 Adverse-Effect OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Entityadalimumab who developed fever, pancytopenia, splenomegaly, and Entityextreme hyperferritinemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The hyperpigmentation was diffuse scattered, flagellate like and linear streaking which was thought to be mainly related to the Entityskin toxicity of Entitybleomycin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect OBJECTIVE : This case report outlines a significant type of morbidity due to continued use of Entitygabapentin during an episode of Entityacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The findings were judged to be consistent with Entitysoft - tissue injury associated with intravenous administration of Entityphenytoin , also termed purple glove syndrome.
0.9999 Adverse-Effect The findings were judged to be consistent with soft - tissue injury associated with intravenous administration of Entityphenytoin , also termed Entitypurple glove syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Several case reports of Entityaplastic anemia with use of Entityacetazolamide , and two cases with use of methazolamide, have appeared in the literature.
0.9995 Adverse-Effect Several case reports of Entityaplastic anemia with use of acetazolamide, and two cases with use of Entitymethazolamide , have appeared in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 2 - year - old mentally retarded boy with frontal lobe epilepsy presented with an episode that resembled Entityheat stroke during the administration of Entityzonisamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFracture of the femoral neck occurred in one patient during EntityPSL therapy, although the relationship between the fracture and PSL therapy was uncertain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite a postulated dopaminergic mechanism, there seems to have been only one previous report of Entityamantadine ' s Entityprecipitating psychosis in a schizophrenic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 78 - year - old man who had Entityacute unilateral total visual loss after retrogasserian Entityphenol injection for the treatment of trigeminal neuralgia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition to its known effect on gallbladder stasis, Entityoctreotide Entityalters bile acid composition and may thus hasten intrahepatic sludge and stone formation.
1.0000 Adverse-Effect In addition to its known effect on Entitygallbladder stasis , Entityoctreotide alters bile acid composition and may thus hasten intrahepatic sludge and stone formation.
0.9999 Adverse-Effect In addition to its known effect on gallbladder stasis, Entityoctreotide alters bile acid composition and may thus Entityhasten intrahepatic sludge and stone formation.
0.9996 Adverse-Effect In addition to its known effect on gallbladder stasis, Entityoctreotide alters bile acid composition and may thus hasten intrahepatic sludge and Entitystone formation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case reported in the English literature of a Entitygeneralized exanthem due to subcutaneous injection of Entityenoxaparin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In keeping with findings in the literature, the Entityaortic wall in this case was damaged by secondary changes following irradiation and EntityBleomycin treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient with Entityincreased cerebral cortical excitability following intoxication with Entityflupirtine , a centrally acting analgesic and antispastic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 10 - year - old asthmatic boy began to suffer from urticarial rash and Entitymoderately severe bronchospasm after 8 weeks'treatment with Entitydisodium cromoglycate .
0.9998 Adverse-Effect A 10 - year - old asthmatic boy began to suffer from Entityurticarial rash and moderately severe bronchospasm after 8 weeks'treatment with Entitydisodium cromoglycate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of long lasting Entityrespiratory depression after intravenous administration of Entitymorphine to a 7 year old girl with haemolytic uraemic syndrome.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We believe that these skin eruptions belong to a spectrum of Entityneutrophilic dermatoses that can be induced or aggravated by EntityG - CSF therapy.
0.9990 Adverse-Effect We believe that these Entityskin eruptions belong to a spectrum of neutrophilic dermatoses that can be induced or aggravated by EntityG - CSF therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the clinical course of 2 patients with Crohn's disease ( CD ) in whom Entitylymphoma was diagnosed after treatment with Entityinfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ovarian endometrioid carcinoma and Entityendometriosis developing in a postmenopausal breast cancer patient during Entitytamoxifen therapy : a case report and review of the literature.
0.9999 Adverse-Effect EntityOvarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during Entitytamoxifen therapy : a case report and review of the literature.
Score Relation Text (Head - Tail)
0.9938 Adverse-Effect We report here two cases of Entitydyserythropoietic anaemia associated with long - term Entitylinezolid use that share striking similarities to chloramphenicol - associated myelotoxicity.
0.9922 Adverse-Effect We report here two cases of dyserythropoietic anaemia associated with long - term linezolid use that share striking similarities to Entitychloramphenicol - associated Entitymyelotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect With the negative viral serologies, the clinical picture was most consistent with an infectious Entitymononucleosis - like syndrome produced by the Entityminocycline ingestion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association between Entityheparin and Entitypriapism is often recognized ; abnormal platelet aggregation could play a role in the pathogenesis of this side effect.
0.9999 Adverse-Effect The association between Entityheparin and priapism is often recognized ; Entityabnormal platelet aggregation could play a role in the pathogenesis of this side effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a premenopausal woman who, while having Entitytamoxifen due to a diagnosis of in situ ductal carcinoma, developed Entityendometriosis requiring surgery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case describes Entityfulminant hepatic failure in a patient taking Entitydisulfiram with no previous liver disease and report of being compliant with alcohol abstinence.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ophthalmologists should be aware of the Entityocular side effects of EntityIFN therapy and carefully monitor patients for the possible occurrence of hypoalbuminemia and thrombocytopenia.
1.0000 Adverse-Effect Ophthalmologists should be aware of the ocular side effects of EntityIFN therapy and carefully monitor patients for the possible occurrence of Entityhypoalbuminemia and thrombocytopenia.
0.9997 Adverse-Effect Ophthalmologists should be aware of the ocular side effects of EntityIFN therapy and carefully monitor patients for the possible occurrence of hypoalbuminemia and Entitythrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe Entitypericardial hemorrhage , which is related to the use of low - dose Entityacetylsalicylic acid in a patient with essential thrombocythemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of a 29 - year - old man suffering from falciparum malaria disease who got a Entityreversible hearing loss from Entityquinine therapy is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Entityinterstitial hypoxaemiant pneumonitis probably related to Entityflecainide in a patient with the LEOPARD syndrome, a rare congenital disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, the syndrome of fever, pulmonary infiltrates, and Entitypleural effusion following use of Entityacyclovir has not been previously reported.
1.0000 Adverse-Effect To our knowledge, the syndrome of Entityfever , pulmonary infiltrates, and pleural effusion following use of Entityacyclovir has not been previously reported.
1.0000 Adverse-Effect To our knowledge, the syndrome of fever, Entitypulmonary infiltrates , and pleural effusion following use of Entityacyclovir has not been previously reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two patients who developed intense Entitylivedo reticularis clearly related to the administration of Entityinterferon alpha 2b as an adjuvant therapy for melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This profile should trigger a " red flag " as to the possibility of Entityphenobarbital Entitybehavioral side effects or exacerbation of preexisting maladaptive behaviors.
0.9998 Adverse-Effect This profile should trigger a " red flag " as to the possibility of Entityphenobarbital behavioral side effects or Entityexacerbation of preexisting maladaptive behaviors .
0.9999 Adverse-Effect This profile should trigger a " red flag " as to the possibility of Entityphenobarbital Entityphenobarbital behavioral side effects or exacerbation of preexisting maladaptive behaviors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 70 - year - old man was admitted to our hospital because of Entitydyspnea after taking an antihistaminic agent ( Entityhomochlorcyclizine hydrochloride ) for itching.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Marked QT prolongation and torsades de pointes secondary to Entityacute ischemia in an elderly man taking Entitydofetilide for atrial fibrillation : a cautionary tale.
1.0000 Adverse-Effect Marked QT prolongation and Entitytorsades de pointes secondary to acute ischemia in an elderly man taking Entitydofetilide for atrial fibrillation : a cautionary tale.
0.9999 Adverse-Effect EntityMarked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking Entitydofetilide for atrial fibrillation : a cautionary tale.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is described of Entitysevere splenic hemorrhage and rupture which developed 3 h after completion of EntitytPA infusion for suspected acute myocardial infarction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors present a case report of a granulomatous reaction leading to Entityurethral prolapse , 3 months after the transurethral injection of Entitycalcium hydroxylapatite .
0.9998 Adverse-Effect The authors present a case report of a Entitygranulomatous reaction leading to urethral prolapse, 3 months after the transurethral injection of Entitycalcium hydroxylapatite .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After only the third dose of Entitypentamidine , it was noted that the patient's Entityheart rate had decreased to 48 beats / minute.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, prolongation of 5 - FU half - life and an Entityincrease in INR have been reported with the concurrent use of Entity5 - FU and warfarin.
1.0000 Adverse-Effect However, prolongation of 5 - FU half - life and an Entityincrease in INR have been reported with the concurrent use of 5 - FU and Entitywarfarin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association with prolonged unopposed estrogen - like stimulation with Entitytamoxifen as a possible factor in the development of Entityovarian endometrioid carcinoma is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a patient with asymptomatic bronchial asthma and hypertension who developed an Entityacute asthma attack after receiving sustained - release Entityverapamil .
1.0000 Adverse-Effect OBJECTIVE : To describe a patient with asymptomatic bronchial asthma and hypertension who developed an Entityacute asthma attack after receiving sustained - release Entityverapamil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 53 - year - old - man who developed rippling muscle disease ( EntityRMD ) 2 months after starting Entitysimvastatin therapy for hypercholesterolemia.
1.0000 Adverse-Effect We report a 53 - year - old - man who developed Entityrippling muscle disease ( RMD ) 2 months after starting Entitysimvastatin therapy for hypercholesterolemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report describes a 38 - year - old male in whom EntitySIADH was strongly suspected secondary to EntityTegretol therapy to control a seizure disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : The aim of this study was to report on the possible development of Entitycorneal endothelial deposits resulting from the use of Entityrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : In an institutional practice setting, two women, aged 25 and 45, developed Entityacute myopia after starting Entitytopiramate for epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our case points to the need for increased awareness by the general pediatricians of the Entitypotential hazards of Entitymineral oil use for chronic constipation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although lung specimens were lacking from these three patients, it is suggested that the Entitypulmonary toxicity of EntityCCNU may be dose - related.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBaclofen Entitywithdrawal syndrome resulting from underdosing of oral baclofen should be considered as a potential source of prolonged fever in the intensive care unit.
1.0000 Adverse-Effect Baclofen Entitywithdrawal syndrome resulting from underdosing of oral Entitybaclofen should be considered as a potential source of prolonged fever in the intensive care unit.
0.9999 Adverse-Effect Baclofen withdrawal syndrome resulting from underdosing of oral Entitybaclofen should be considered as a potential source of prolonged Entityfever in the intensive care unit.
0.9990 Adverse-Effect EntityBaclofen withdrawal syndrome resulting from underdosing of oral baclofen should be considered as a potential source of prolonged Entityfever in the intensive care unit.
Score Relation Text (Head - Tail)
0.9758 Adverse-Effect PURPOSE : We evaluated the in vitro hemodialysis ratio and subsequent Entitytoxicity and pharmacokinetics of Entityifosfamide in an anephric patient with Wilms'tumor.
Adverse-Effect PURPOSE : We evaluated the in vitro hemodialysis ratio and subsequent Entitytoxicity and pharmacokinetics of Entityifosfamide in an anephric patient with Wilms'tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Five of 70 patients who had begun Entityleflunomide therapy had significant Entityweight loss that could not be linked to other identifiable etiologies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Eleven days after initiation of therapy with Entityamiodarone , the patient experienced Entitysyncope and was noted to have recurrent episodes of polymorphous ventricular tachycardia.
0.9998 Adverse-Effect Eleven days after initiation of therapy with Entityamiodarone , the patient experienced syncope and was noted to have recurrent episodes of Entitypolymorphous ventricular tachycardia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe loss of vision after removal of Entitycataract caused by intravitreal Entitytriamcinolone in combination with photodynamic therapy for exudative age - related macular degeneration.
1.0000 Adverse-Effect EntitySevere loss of vision after removal of cataract caused by intravitreal Entitytriamcinolone in combination with photodynamic therapy for exudative age - related macular degeneration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : The risk / benefit ratio of Entitywarfarin therapy changes in the over 75s, when Entityhaemorrhagic side - effects become more common.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case report of a patient who developed a Entityprolonged QT while being treated with oral Entitymethadone for a chronic pain syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : EntityMethotrexate - induced Entitypapular eruption is rarely reported shortly after beginning methotrexate therapy in patients with acute exacerbation of collagen vascular diseases.
0.9990 Adverse-Effect DISCUSSION : Methotrexate - induced Entitypapular eruption is rarely reported shortly after beginning Entitymethotrexate therapy in patients with acute exacerbation of collagen vascular diseases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Both cases presented here describe Entitycorneal ulcers that persisted and showed signs of worsening during weeks of frequent topical dosing with Entitymoxifloxacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entityhemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with Entityoxaliplatin , 5 - fluorouracil and leucovorin.
1.0000 Adverse-Effect We present a case of Entityhemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, Entity5 - fluorouracil and leucovorin.
1.0000 Adverse-Effect We present a case of Entityhemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, 5 - fluorouracil and Entityleucovorin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors think that although Entitylamivudine is widely used and well tolerated, it can cause EntityADRs , which are reversible after drug withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of a patient with infectious mononucleosis treated with Entitycephalexin who later showed a Entityrash is presented and the previous literature is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Twenty - four hours after the administration of Entitygemcitabine , a Entitysymmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 4 patients, 2 on methylphenidate and 2 on Entitydextroamphetamine who presented with Entityacral cyanosis , livedo reticularis, or Raynaud phenomenon.
0.9999 Adverse-Effect We report 4 patients, 2 on methylphenidate and 2 on Entitydextroamphetamine who presented with acral cyanosis, livedo reticularis, or EntityRaynaud phenomenon .
0.9999 Adverse-Effect We report 4 patients, 2 on methylphenidate and 2 on Entitydextroamphetamine who presented with acral cyanosis, Entitylivedo reticularis , or Raynaud phenomenon.
0.9998 Adverse-Effect We report 4 patients, 2 on Entitymethylphenidate and 2 on dextroamphetamine who presented with Entityacral cyanosis , livedo reticularis, or Raynaud phenomenon.
0.9998 Adverse-Effect We report 4 patients, 2 on Entitymethylphenidate and 2 on dextroamphetamine who presented with acral cyanosis, livedo reticularis, or EntityRaynaud phenomenon .
0.9997 Adverse-Effect We report 4 patients, 2 on Entitymethylphenidate and 2 on dextroamphetamine who presented with acral cyanosis, Entitylivedo reticularis , or Raynaud phenomenon.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect From these data, acute generalized dystonia with Entitybrainstem and thalamic lesions may occur in WD patients after an initial Entityd - penicillamine therapy.
0.9995 Adverse-Effect From these data, Entityacute generalized dystonia with brainstem and thalamic lesions may occur in WD patients after an initial Entityd - penicillamine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case report of a patient with typhoid fever who experienced a Entityhypersensitivity reaction subsequent to the infusion of Entitychloramphenicol sodium succinate .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A patient who had been treated with large doses of Entitythyroid hormone for several years developed features of secondary Entityhypothyroidism after thyroid hormone withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySeizures occurred in two patients with probable Alzheimer's disease who were receiving long - term treatment with Entitymetrifonate , an irreversible acetylcholinesterase inhibitor.
Score Relation Text (Head - Tail)
Adverse-Effect RESULTS : A previously healthy 42 - year - old woman presented with Entityacute - onset delirium with psychotic features as a consequence of Entitylevofloxacin therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The Entityexacerbation of psoriasis was accompanied by a massive induction of lesional type I interferon activity, detected by MxA expression after Entityimiquimod therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although adverse effects are usually mild, the author reports here a case of leucocytopenia and Entitythrombocytopenia with Entityquetiapine treatment that required its discontinuation.
0.9999 Adverse-Effect Although adverse effects are usually mild, the author reports here a case of Entityleucocytopenia and thrombocytopenia with Entityquetiapine treatment that required its discontinuation.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect EntityMethanol toxicity can cause Entitysevere central nervous system insult in which a characteristic pattern of bilateral putaminal injury is noted on brain imaging studies.
0.9992 Adverse-Effect EntityMethanol toxicity can cause severe central nervous system insult in which a characteristic pattern of Entitybilateral putaminal injury is noted on brain imaging studies.
Adverse-Effect EntityMethanol EntityMethanol toxicity can cause severe central nervous system insult in which a characteristic pattern of bilateral putaminal injury is noted on brain imaging studies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a 14 - year - old boy with severe haemophilia A who developed a Entityportal vein thrombosis during continuous infusion of EntityF VIII .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The 3 cases presented here illustrate the development of Entityreproductive endocrine disorders after the initiation of Entityvalproate therapy in women with epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitysevere AVP three weeks following the administration of Entityinfliximab for the treatment of Crohn's disease ( CD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : During and after EntityIFN therapy, OCT is a useful examination technique for revealing Entitymacular edema in patients who have decreased vision.
0.9998 Adverse-Effect CONCLUSION : During and after EntityIFN therapy, OCT is a useful examination technique for revealing macular edema in patients who have Entitydecreased vision .
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect The increasing prevalence of methamphetamine abuse and the severity of the associated ulcers should alert ophthalmologists to the problem of Entitymethamphetamine - related Entitykeratitis .
0.9978 Adverse-Effect The increasing prevalence of Entitymethamphetamine abuse and the severity of the associated Entityulcers should alert ophthalmologists to the problem of methamphetamine - related keratitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with Parkinson's disease, initially treated with bromocriptine and subsequently with Entitycabergoline , developed progressive Entitypleuropulmonary abnormalities during the latter therapy.
0.9998 Adverse-Effect A patient with Parkinson's disease, initially treated with Entitybromocriptine and subsequently with cabergoline, developed progressive Entitypleuropulmonary abnormalities during the latter therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is believed that this is the first reported case of reversible Entityazathioprine - induced Entitycholestasis associated with histological evidence of bile duct injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The pathogenic mechanisms involved in the development of Entityadriamycin Entitycardiomyopathy are reviewed, and the possible synergistic effect of other antitumor antibiotics is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One should therefore be aware of possible Entityextrapyramidal side effects with Entityolanzapine that are reduced compared to classical neuroleptic drugs but not completely eliminated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Entitysarcoidosis during Entityinterferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
0.9999 Adverse-Effect Development of Entitysarcoidosis during interferon alpha 2b and Entityribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
1.0000 Adverse-Effect Development of Entitysarcoidosis during Entityinterferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Exacerbation of Entityanthracycline - induced Entityearly chronic cardiomyopathy with ATRA : role of B - type natriuretic peptide as an indicator of cardiac dysfunction.
0.9863 Adverse-Effect Exacerbation of Entityanthracycline - induced early chronic cardiomyopathy with ATRA : role of B - type natriuretic peptide as an indicator of Entitycardiac dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A male and a female patient with spasticity treated with intrathecal Entitybaclofen were recognized to have Entitysexual dysfunction side effects from treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The diagnosis of Entityhypothermia was delayed until it was apparent for several days but resolved with the discontinuation of Entityrisperidone and continuation of clozapine.
0.9999 Adverse-Effect The diagnosis of Entityhypothermia was delayed until it was apparent for several days but resolved with the discontinuation of risperidone and continuation of Entityclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Other potential causes of Entityrenal failure were not present in our patient and his renal function gradually recovered with the cessation of Entitysuramin treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this paper we report a case of Entitynimodipine overdosage resulting in Entityprolonged hypotension and hypoxemia, which was successfully treated with calcium gluconate.
0.9999 Adverse-Effect In this paper we report a case of Entitynimodipine overdosage resulting in prolonged hypotension and Entityhypoxemia , which was successfully treated with calcium gluconate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first case concerns a 70 - year - old man who developed severe Entityaplastic anemia 7 weeks after treatment with 500 mg of Entityticlopidine daily.
1.0000 Adverse-Effect The first case concerns a 70 - year - old man who developed Entitysevere aplastic anemia 7 weeks after treatment with 500 mg of Entityticlopidine daily.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, an immunological mechanism might be involved in the mechanism of Entitypirmenol - induced EntityQT prolongation and T wave inversion on the electrocardiogram.
0.9999 Adverse-Effect Thus, an immunological mechanism might be involved in the mechanism of Entitypirmenol - induced QT prolongation and EntityT wave inversion on the electrocardiogram.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : EntityColchicine , the most important drug in treatment of FMF, can cause Entitymyopathy in patients with impaired renal and hepatic function.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After other potential causes of liver toxicity were excluded, EntityTMP - SMX was determined to be the cause of his Entityacute liver toxicity .
0.9996 Adverse-Effect After other potential causes of Entityliver toxicity were excluded, EntityTMP - SMX was determined to be the cause of his acute liver toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The autopsy findings and a detailed medical history supported the conclusion that Entityclozapine - induced Entityhypersensitivity myocarditis was the most likely cause of death.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and Entityinterferon - alpha can induce a condition resembling EntityRPLS .
0.9999 Adverse-Effect Moreover, treatment with immunosuppressive drugs such as cyclosporine, Entitycisplatin , tacrolimus, and interferon - alpha can induce a condition resembling EntityRPLS .
0.9998 Adverse-Effect Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, Entitytacrolimus , and interferon - alpha can induce a condition resembling EntityRPLS .
0.9998 Adverse-Effect Moreover, treatment with immunosuppressive drugs such as Entitycyclosporine , cisplatin, tacrolimus, and interferon - alpha can induce a condition resembling EntityRPLS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have recently encountered a patient with acquired haemophilia who developed a Entitythrombotic left middle cerebral artery distribution stroke while being treated with EntitypFVIII .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect We believe this is the first report of myocardial infarction due to Entitycoronary spasm , demonstrated by angiography associated with EntityL - thyroxine therapy.
0.9982 Adverse-Effect We believe this is the first report of Entitymyocardial infarction due to coronary spasm, demonstrated by angiography associated with EntityL - thyroxine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the case of an adult Crohn's disease patient with a parvovirus B19 infection and Entityleukopenia during long - term EntityAZA therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityThalidomide Entityneuropathy is often associated with proximal weakness and may progress even after discontinuation of treatment, in the phenomenon of'coasting '.
0.9997 Adverse-Effect EntityThalidomide neuropathy is often associated with Entityproximal weakness and may progress even after discontinuation of treatment, in the phenomenon of'coasting '.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The possibility of Entityphenytoin Entityhypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.9997 Adverse-Effect The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving Entityphenytoin have unusual symptoms, particularly Entityfever , rash, and lymphadenopathy.
0.9997 Adverse-Effect The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving Entityphenytoin have unusual symptoms, particularly fever, Entityrash , and lymphadenopathy.
0.9996 Adverse-Effect The possibility of phenytoin Entityhypersensitivity reactions should be considered when patients receiving Entityphenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.9990 Adverse-Effect The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving Entityphenytoin have unusual symptoms, particularly fever, rash, and Entitylymphadenopathy .
0.9973 Adverse-Effect The possibility of Entityphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, Entityrash , and lymphadenopathy.
0.9960 Adverse-Effect The possibility of Entityphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly Entityfever , rash, and lymphadenopathy.
0.9947 Adverse-Effect The possibility of Entityphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and Entitylymphadenopathy .
0.9994 Adverse-Effect The possibility of Entityphenytoin Entityphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.9962 Adverse-Effect The possibility of Entityphenytoin hypersensitivity reactions should be considered when patients receiving Entityphenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was administered Entitymetoclopramide because of nausea and, within 2 hours, developed Entityagitation , dysarthria, diaphoresis, and a movement disorder.
1.0000 Adverse-Effect She was administered Entitymetoclopramide because of nausea and, within 2 hours, developed agitation, Entitydysarthria , diaphoresis, and a movement disorder.
1.0000 Adverse-Effect She was administered Entitymetoclopramide because of nausea and, within 2 hours, developed agitation, dysarthria, Entitydiaphoresis , and a movement disorder.
0.9999 Adverse-Effect She was administered Entitymetoclopramide because of nausea and, within 2 hours, developed agitation, dysarthria, diaphoresis, and a Entitymovement disorder .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four Chinese female patients who suffered from manic - depressive disorder and underlying autoimmune thyroiditis developed transient episodes of Entitythyrotoxicosis during maintenance Entitylithium therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient described in this paper was a 78 - year - old diabetic man who developed Entityoral lesions of PV following institution of Entityglibenclamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report on the possible development of Entityserotonin syndrome in a patient receiving Entityclomipramine after clozapine was withdrawn from the treatment regimen.
0.9996 Adverse-Effect OBJECTIVE : To report on the possible development of Entityserotonin syndrome in a patient receiving clomipramine after Entityclozapine was withdrawn from the treatment regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two patients with rheumatoid factor - positive, polyarticular - onset juvenile rheumatoid arthritis in whom Entityaccelerated nodulosis developed during Entitymethotrexate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of an Entityextensive skin rash following a single dose of EntityMTX may be an early warning sign for life - threatening bone marrow aplasia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, follow - up revealed that Entitygestational diabetes when associated with Entitynorethisterone had a lesser risk of emerging diabetes mellitus and impaired glucose tolerance.
1.0000 Adverse-Effect However, follow - up revealed that gestational diabetes when associated with Entitynorethisterone had a lesser risk of emerging Entitydiabetes mellitus and impaired glucose tolerance.
1.0000 Adverse-Effect However, follow - up revealed that gestational diabetes when associated with Entitynorethisterone had a lesser risk of emerging diabetes mellitus and Entityimpaired glucose tolerance .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect After administration of Oxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of EntityCarbamazepine EntityCarbamazepine intoxication .
0.9967 Adverse-Effect After administration of Oxybutynin concomitantly with an increase in the dose of EntityDantrolene , she presented the clinical symptoms and laboratory finding of EntityCarbamazepine intoxication .
0.9928 Adverse-Effect After administration of EntityOxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of EntityCarbamazepine intoxication .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of Entitycodeine Entitycodeine intoxication in the neonate, in which the drug was prescribed for cough control during an emergency department visit.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 5 cases of Entityacute reversible renal failure coinciding with the onset of treatment with Entitycaptopril in patients with severe drug - resistant hypertension.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We present a Entityfatal case of subacute Entitymethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9999 Adverse-Effect We present a fatal case of subacute Entitymethanol toxicity with associated Entitydiffuse brain involvement , including bilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9997 Adverse-Effect We present a fatal case of subacute Entitymethanol toxicity with associated diffuse brain involvement, including Entitybilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9997 Adverse-Effect We present a fatal case of subacute Entitymethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with Entityventricular compression .
0.9995 Adverse-Effect We present a fatal case of subacute Entitymethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and Entitycerebral edema with ventricular compression.
Adverse-Effect We present a fatal case of subacute Entitymethanol Entitymethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Abrupt, accidental withdrawal of Entitytrihexyphenidyl triggered severe exacerbation of the Entitycranial dystonia associated with inspiratory stridor and acute respiratory difficulties, prompting emergency admission.
1.0000 Adverse-Effect Abrupt, accidental withdrawal of Entitytrihexyphenidyl triggered severe exacerbation of the cranial dystonia associated with Entityinspiratory stridor and acute respiratory difficulties, prompting emergency admission.
0.9999 Adverse-Effect Abrupt, accidental withdrawal of Entitytrihexyphenidyl triggered severe exacerbation of the cranial dystonia associated with inspiratory stridor and Entityacute respiratory difficulties , prompting emergency admission.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Such a case induced by Entityhypothyroidism complicating long - term therapy with Entityamiodarone in a 45 year old woman with pre - excitation is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After having received Entitygemcitabine on day 1 of the second course, the patient developed Entitydry cough , subfebrile temperatures and dyspnea within 48 h.
1.0000 Adverse-Effect After having received Entitygemcitabine on day 1 of the second course, the patient developed dry cough, Entitysubfebrile temperatures and dyspnea within 48 h.
1.0000 Adverse-Effect After having received Entitygemcitabine on day 1 of the second course, the patient developed dry cough, subfebrile temperatures and Entitydyspnea within 48 h.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, headache, and Entityseizure after receiving Entitycyclosporine .
1.0000 Adverse-Effect We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, Entityheadache , and seizure after receiving Entitycyclosporine .
1.0000 Adverse-Effect We report a case of a young woman with SLE and thrombocytopenia, who developed Entitysevere perspiration , headache, and seizure after receiving Entitycyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The more common grade 3 or 4 adverse effects of Entitysunitinib include Entityhypertension , fatigue, hand - foot syndrome, elevated lipase and lymphopenia.
1.0000 Adverse-Effect The more common grade 3 or 4 adverse effects of Entitysunitinib include hypertension, Entityfatigue , hand - foot syndrome, elevated lipase and lymphopenia.
1.0000 Adverse-Effect The more common grade 3 or 4 adverse effects of Entitysunitinib include hypertension, fatigue, hand - foot syndrome, elevated lipase and Entitylymphopenia .
0.9999 Adverse-Effect The more common grade 3 or 4 adverse effects of Entitysunitinib include hypertension, fatigue, Entityhand - foot syndrome , elevated lipase and lymphopenia.
0.9999 Adverse-Effect The more common grade 3 or 4 adverse effects of Entitysunitinib include hypertension, fatigue, hand - foot syndrome, Entityelevated lipase and lymphopenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four patients in whom Entitypulmonary oedema developed during tocolysis with Entityhexoprenaline are described and the aetiological factors and pathogenesis of this potentially lethal complication discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of a diabetic patient taking glyburide who was prescribed Entityciprofloxacin and developed Entityprolonged hypoglycemia , which persisted for over 24 hours.
0.9995 Adverse-Effect We present a case of a diabetic patient taking Entityglyburide who was prescribed ciprofloxacin and developed Entityprolonged hypoglycemia , which persisted for over 24 hours.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityZiprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing Entityextrapyramidal symptoms , including tardive dyskinesia ( TD ).
1.0000 Adverse-Effect EntityZiprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including tardive dyskinesia ( EntityTD ).
1.0000 Adverse-Effect EntityZiprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including Entitytardive dyskinesia ( TD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Entityhepatitis in an acromegalic patient during combined treatment with Entitypegvisomant and octreotide long - acting repeatable attributed to the use of pegvisomant.
0.9998 Adverse-Effect Drug - induced Entityhepatitis in an acromegalic patient during combined treatment with pegvisomant and Entityoctreotide long - acting repeatable attributed to the use of pegvisomant.
0.9997 Adverse-Effect Drug - induced Entityhepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long - acting repeatable attributed to the use of Entitypegvisomant .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect MATERIALS AND METHODS : We present two cases of significant morbidity related to Entityprimary and secondary perforation of the bladder following two instillations of Entityepirubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our patient developed both nephrogenic diabetes insipidus and Entityrenal tubular acidosis with a temporal pattern that demonstrated a link between Entityfoscarnet therapy and these abnormalities.
0.9999 Adverse-Effect Our patient developed both Entitynephrogenic diabetes insipidus and renal tubular acidosis with a temporal pattern that demonstrated a link between Entityfoscarnet therapy and these abnormalities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been numerous case reports of Entityhyperglycemia with Entityolanzapine in the literature, but none reported hyperglycemia within days of initiation of the medication.
0.9970 Adverse-Effect There have been numerous case reports of hyperglycemia with Entityolanzapine in the literature, but none reported Entityhyperglycemia within days of initiation of the medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, drug - induced Entityfever has not been reported with the use of Entitydiltiazem hydrochloride , a commonly prescribed calcium channel blocker.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect We present the case of a postictal patient with lethargy, Entityhyperammonemia , otherwise normal liver function tests, and a therapeutic Entityvalproic acid level.
0.9995 Adverse-Effect We present the case of a postictal patient with Entitylethargy , hyperammonemia, otherwise normal liver function tests, and a therapeutic Entityvalproic acid level.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In two patients with mycosis fungoides, a Entitysquamous cell carcinoma developed during therapy with Entitypsoralens plus long - wave ultraviolet radiation ( PUVA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySunburn may sometimes be a major injury in Entitypsoralen users because high doses or inappropriate use of the drug may render the skin extremely sensitive.
1.0000 Adverse-Effect Sunburn may sometimes be a major injury in Entitypsoralen users because high doses or inappropriate use of the drug may render the Entityskin extremely sensitive .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A 35 - year - old nephrotic man developed Entityacute renal failure with serum creatinine to 1543 micromol / l after a month of therapy with Entityenalapril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 33 - year - old man with a history of recreational Entitybenztropine abuse presented to the emergency department with Entityconfusion , abdominal pain, and distention.
1.0000 Adverse-Effect A 33 - year - old man with a history of recreational Entitybenztropine abuse presented to the emergency department with confusion, Entityabdominal pain , and distention.
1.0000 Adverse-Effect A 33 - year - old man with a history of recreational Entitybenztropine abuse presented to the emergency department with confusion, abdominal pain, and Entitydistention .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a fatal case of toxic epidermal necrolysis ( EntityTEN ) resulting from a high dose of Entitycytosine arabinoside ( ARA - C ).
0.9998 Adverse-Effect We report a fatal case of toxic epidermal necrolysis ( EntityTEN ) resulting from a high dose of cytosine arabinoside ( EntityARA - C ).
0.9997 Adverse-Effect We report a fatal case of Entitytoxic epidermal necrolysis ( TEN ) resulting from a high dose of Entitycytosine arabinoside ( ARA - C ).
0.9987 Adverse-Effect We report a fatal case of Entitytoxic epidermal necrolysis ( TEN ) resulting from a high dose of cytosine arabinoside ( EntityARA - C ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a third case of a 6 - week - old infant with Escherichia coli sepsis who received Entityampicillin and other antibiotics and subsequently developed EntityTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year old patient is reported who developed an Entityischaemic cerebrovascular accident 22 hours after successful thrombolysis with Entitystreptokinase for life - threatening pulmonary emboli.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It should be recognized that Entityibuprofen may be associated with Entitysalt and water retention in the same fashion as previously described with phenylbutazone and indomethacin.
1.0000 Adverse-Effect It should be recognized that ibuprofen may be associated with Entitysalt and water retention in the same fashion as previously described with Entityphenylbutazone and indomethacin.
0.9998 Adverse-Effect It should be recognized that ibuprofen may be associated with Entitysalt and water retention in the same fashion as previously described with phenylbutazone and Entityindomethacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, we describe the first reported case of isolated paresthesia and Entityperipheral neuropathy , without systemic involvement, secondary to Entitysulindac administration.
0.9999 Adverse-Effect To our knowledge, we describe the first reported case of Entityisolated paresthesia and peripheral neuropathy, without systemic involvement, secondary to Entitysulindac administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetoclopramide - induced Entityparkinsonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : EntityPhenolphthalein is the active ingredient in several over - the - counter laxative preparations and has only rarely been reported to cause EntityTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Charcoal haemoperfusion and cysteamine therapy led to the rapid removal of the Entityparacetamol from the body and consequently prevented the development of Entitysevere hepatic necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on three patients with acute schizophrenia, who developed Entitysevere akathisia during treatment with Entityolanzapine ( 20 - 25 mg / d ).
1.0000 Adverse-Effect We report on three patients with acute schizophrenia, who developed severe Entityakathisia during treatment with Entityolanzapine ( 20 - 25 mg / d ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMultiple syncopal episodes started to occur during Entitythalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of sustained ventricular tachycardia.
0.9996 Adverse-Effect Multiple syncopal episodes started to occur during Entitythalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of Entitysustained ventricular tachycardia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He had an immediate Entityhypersensitivity reaction during the initiation of the EntityMTX infusion with diffuse urticaria, facial swelling, cough, and chest tightness.
1.0000 Adverse-Effect He had an immediate hypersensitivity reaction during the initiation of the EntityMTX infusion with Entitydiffuse urticaria , facial swelling, cough, and chest tightness.
0.9999 Adverse-Effect He had an immediate hypersensitivity reaction during the initiation of the EntityMTX infusion with diffuse urticaria, facial swelling, Entitycough , and chest tightness.
0.9999 Adverse-Effect He had an immediate hypersensitivity reaction during the initiation of the EntityMTX infusion with diffuse urticaria, Entityfacial swelling , cough, and chest tightness.
0.9996 Adverse-Effect He had an immediate hypersensitivity reaction during the initiation of the EntityMTX infusion with diffuse urticaria, facial swelling, cough, and Entitychest tightness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report presents a case of Entitycolon perforation which occurred 4 months after treatment with intraperitoneal Entitychromic phosphate for stage IB ovarian papillary serous cystadenocarcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that Entityitraconazole should be added to the list of drugs that may be responsible for a drug - induced Entityvanishing bile duct syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect AIM : Report of a case of a woman patient who developed Entityceliac disease after Entitypegylated interferon alpha - 2a and ribavirin use for chronic hepatitis C.
0.9999 Adverse-Effect AIM : Report of a case of a woman patient who developed Entityceliac disease after pegylated interferon alpha - 2a and Entityribavirin use for chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings suggest that Entitybicytopenia in this patient was caused by EntityD - Pen and may be due to different sensitivities in the hematopoietic lineage.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We describe a case of needle - track Entitycutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous Entityethanol injection ( PEI ).
1.0000 Adverse-Effect We describe a case of needle - track Entitycutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous Entityethanol injection ( PEI ).
0.9999 Adverse-Effect We describe a case of needle - track Entitycutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous ethanol injection ( EntityPEI ).
0.9983 Adverse-Effect We describe a case of needle - track Entitycutaneous seeding of hepatocellular carcinoma ( EntityHCC ) after sonographically guided percutaneous ethanol injection ( PEI ).
0.6993 Adverse-Effect We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( EntityHCC ) after sonographically guided percutaneous Entityethanol injection ( PEI ).
0.5987 Adverse-Effect We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( EntityHCC ) after sonographically guided percutaneous Entityethanol injection ( PEI ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article reports the occurrence of Entityrifampin - associated Entitythrombocytopenia in an indigent patient after a four - month lapse in therapy for pulmonary tuberculosis.
Score Relation Text (Head - Tail)
Adverse-Effect Recent studies have shown that under experimental conditions Entityferrous sulfate may Entityreduce the gastrointestinal absorption of orally administered levothyroxine sodium in patients with primary hypothyroidism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We postulate that cyclosporin, possibly together with Entityganciclovir , can produce Entitytransient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.
0.9999 Adverse-Effect We postulate that Entitycyclosporin , possibly together with ganciclovir, can produce Entitytransient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.
0.9999 Adverse-Effect We postulate that cyclosporin, possibly together with Entityganciclovir , can produce transient brain stem or neuromuscular dysfunction with Entityeye movement abnormality in occasional patients.
0.9997 Adverse-Effect We postulate that Entitycyclosporin , possibly together with ganciclovir, can produce transient brain stem or neuromuscular dysfunction with Entityeye movement abnormality in occasional patients.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We believe that this is the first description of Entityacute hepatitis caused by an idiosyncratic adverse reaction to Entitygliclazide or to one of its metabolites.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second is a 29 - year - old man with CD in whom Entitynodular sclerosing Hodgkin's lymphoma was diagnosed 3 weeks after infusion with Entityinfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five personal observations of an Entityacute amnestic episode in younger individuals after intake of Entityclioquinol are described together with three observations from the medical literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, Entityinterferon alpha induced Entitypolymyositis and cardiomyopathy is diagnosed in a 33 - yr - old male patient with history of chronic hepatitis B.
0.9994 Adverse-Effect In this case, Entityinterferon alpha induced polymyositis and Entitycardiomyopathy is diagnosed in a 33 - yr - old male patient with history of chronic hepatitis B.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 3 : A 29 - year - old female alcoholic complained of general fatigue and a slight Entityfever after 1. 5 years of abstinence with Entitycyanamide treatment.
0.9999 Adverse-Effect Case 3 : A 29 - year - old female alcoholic complained of Entitygeneral fatigue and a slight fever after 1. 5 years of abstinence with Entitycyanamide treatment.
Adverse-Effect Case 3 : A 29 - year - old female alcoholic complained of general Entityfatigue and a slight fever after 1. 5 years of abstinence with Entitycyanamide treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A twelve year - old - girl with idiopathic partial epilepsy with secondary generalization, developed Entityacute psychosis 10 days after the administration of Entitylevetiracetam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition to disease refractoriness, rare instances of disease progression from chronic phase to Entityblast crisis during Entityimatinib therapy have recently been anecdotally reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors suggest that in patients with Entitycorneal ulcers refractory to conventional treatment who are receiving Entitycolchicine , cessation of colchicine therapy should be considered.
0.9994 Adverse-Effect The authors suggest that in patients with Entitycorneal ulcers refractory to conventional treatment who are receiving colchicine, cessation of Entitycolchicine therapy should be considered.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of Entitycefazolin - induced Entityleukopenia in a critically ill patient who developed this adverse reaction upon rechallenge with cefoxitin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of infection with EntityMycobacterium abscessus in a 67 - year - old woman receiving Entityinfliximab as a component of her therapy for RA.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This case study is the second report of Entitylocalized purpura after prolonged Entitylamotrigine treatment suggesting this may be an atypical lamotrigine - induced drug reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After identification of the index patient, additional inquiry revealed that the patient's mother was hospitalized previously for overwhelming Entitysepsis associated with Entitymetamizole use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although a few case reports link Entitymetronidazole with the development of Entitypseudomembranous colitis , albendazole has not been associated with the development of this condition.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Three cases of Entitypseudocyst of the pancreas in two women and one man have previously been reported with the use of intravenous EntityL - asparaginase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityoligohidrosis caused by Entityzonisamide was reversible in that the patient regained the ability to sweat within 2 weeks of the cessation of drug administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Massive EntityCBZ OD may produce a Entityreversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and cranial nerve areflexia.
0.9999 Adverse-Effect Massive EntityCBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a Entityprofound burst - suppression EEG pattern , and cranial nerve areflexia.
0.9998 Adverse-Effect Massive EntityCBZ OD may produce a reversible encephalopathy that includes Entitycortical hyperexcitability , a profound burst - suppression EEG pattern, and cranial nerve areflexia.
0.9998 Adverse-Effect Massive EntityCBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and Entitycranial nerve areflexia .
0.9996 Adverse-Effect Massive EntityCBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and cranial Entitynerve areflexia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProgressive interstitial fibrosis with roentgenographic honeycombing developed in the case of a psoriatic patient who had been on a regimen of Entitymethotrexate for 18 years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 4 : A 61 - year - old male alcoholic who remained completely abstinent while taking Entitycyanamide for 3 years showed slight Entityelevation of serum transaminases .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A retrospective review of TTP patients with Entityquinine - associated Entitythrombotic microangiopathy ( TMA ) for whom ADAMTS13 was measured before plasma exchange was performed.
0.9991 Adverse-Effect A retrospective review of TTP patients with Entityquinine - associated thrombotic microangiopathy ( EntityTMA ) for whom ADAMTS13 was measured before plasma exchange was performed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe children and adolescents with chronic hematologic and oncologic diseases who exhibited drug - seeking behavior or Entityanticholinergic symptoms with the use of Entitydiphenhydramine .
1.0000 Adverse-Effect We describe children and adolescents with chronic hematologic and oncologic diseases who exhibited Entitydrug - seeking behavior or anticholinergic symptoms with the use of Entitydiphenhydramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients are reported without a history of angina pectoris who had clinical and electrocardiographic evidence of Entitymyocardial ischemia during and immediately after EntityBCNU infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect No cases of renal acidosis, and only one case of Entitynephrogenic diabetes insipidus , has been previously reported as a complication of Entityfoscarnet treatment.
0.9999 Adverse-Effect No cases of Entityrenal acidosis , and only one case of nephrogenic diabetes insipidus, has been previously reported as a complication of Entityfoscarnet treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians have been aware of lithium toxicity for many years and traditionally have administered thiazide diuretics for Entitylithium - induced Entitypolyuria and nephrogenic diabetes insipidus.
0.9989 Adverse-Effect Clinicians have been aware of lithium toxicity for many years and traditionally have administered thiazide diuretics for Entitylithium - induced polyuria and Entitynephrogenic diabetes insipidus .
0.9490 Adverse-Effect Clinicians have been aware of Entitylithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced Entitypolyuria and nephrogenic diabetes insipidus.
0.9259 Adverse-Effect Clinicians have been aware of Entitylithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced polyuria and Entitynephrogenic diabetes insipidus .
0.9978 Adverse-Effect Clinicians have been aware of lithium toxicity for many years and traditionally have administered Entitythiazide diuretics for lithium - induced Entitypolyuria and nephrogenic diabetes insipidus.
0.9909 Adverse-Effect Clinicians have been aware of lithium toxicity for many years and traditionally have administered Entitythiazide diuretics for lithium - induced polyuria and Entitynephrogenic diabetes insipidus .
Adverse-Effect Clinicians have been aware of Entitylithium Entitylithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced polyuria and nephrogenic diabetes insipidus.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Thrombotic thrombocytopenic purpura ( EntityTTP ) developed in a patient with seropositive rheumatoid arthritis ( RA ) after 2 1 / 2 months of treatment with Entitypenicillamine .
0.9999 Adverse-Effect EntityThrombotic thrombocytopenic purpura ( TTP ) developed in a patient with seropositive rheumatoid arthritis ( RA ) after 2 1 / 2 months of treatment with Entitypenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These evolutional changes in both proteinuria and glomerular histology suggest a close linkage between the EntityM - CSF treatment and Entitymacrophage - related glomerular injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A previous review described data on 15 patients who experienced acute hemoglobinemia or Entityhemoglobinuria following Entityanti - D IGIV administration for ITP or secondary thrombocytopenia.
0.9992 Adverse-Effect A previous review described data on 15 patients who experienced Entityacute hemoglobinemia or hemoglobinuria following Entityanti - D IGIV administration for ITP or secondary thrombocytopenia.
1.0000 Adverse-Effect A previous review described data on 15 patients who experienced acute hemoglobinemia or Entityhemoglobinuria following Entityanti - D IGIV administration for ITP or secondary thrombocytopenia.
0.9992 Adverse-Effect A previous review described data on 15 patients who experienced Entityacute hemoglobinemia or hemoglobinuria following Entityanti - D IGIV administration for ITP or secondary thrombocytopenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is an image and brief case report of a 13 - year - old boy who presented with Entitysevere rash and systemic symptoms after starting Entityoxcarbazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of Entityoral - facial dyskinesia that occurred after discontinuation of Entityamoxapine , and antidepressant which may also have neuroleptic effects.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After Entitygastric - outlet obstruction was recognized in several infants who received Entityprostaglandin E1 , we studied the association between the drug and this complication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGynecomastia developed in two epileptic patients some months after the addition of oral Entityfluoresone 750 mg daily to the phenobarbital and phenytoin already being administered.
0.9999 Adverse-Effect EntityGynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the Entityphenobarbital and phenytoin already being administered.
0.9999 Adverse-Effect EntityGynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and Entityphenytoin already being administered.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case admitted with a first - detected, Entitysymptomatic paroxysmal atrial fibrillation in a healthy patient after self - medication with Entityvardenafil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : We present a case of a patient with CML who developed EntityKS 12 months after starting treatment with Entityimatinib 400 mg / d.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The probable Entityproarrhythmic action of Entityamiodarone , although rare, is reviewed along with a discussion of the novel use of intravenous magnesium sulfate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of EntityIFN beta induced Entityhepatitis in MS and discuss the pathology findings and possible mechanisms of drug - induced liver injury.
0.9964 Adverse-Effect We report three cases of EntityIFN beta induced hepatitis in MS and discuss the pathology findings and possible mechanisms of drug - induced Entityliver injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that low - dose EntityHU therapy in patients with thalassemia intermedia may Entityincrease total Hb levels sufficiently to eliminate the need for transfusions.
1.0000 Adverse-Effect We conclude that low - dose EntityHU therapy in patients with thalassemia intermedia may Entityincrease total Hb levels sufficiently to eliminate the need for transfusions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report describes the development of asymptomatic visual field defects ( EntityVFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive Entitytiagabine treatment.
0.9999 Adverse-Effect This case report describes the development of asymptomatic Entityvisual field defects ( VFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive Entitytiagabine treatment.
1.0000 Adverse-Effect This case report describes the development of Entityasymptomatic visual field defects ( VFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive Entitytiagabine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAmiodarone was the third drug to induce EntityAVT in this patient ; she received 200 mg / day six days per week for six months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three days after receiving intravitreal injection of Entitybevacizumab ( 1. 25 mg in 0. 1 ml ), he developed Entityacute vision loss and change of consciousness.
1.0000 Adverse-Effect Three days after receiving intravitreal injection of Entitybevacizumab ( 1. 25 mg in 0. 1 ml ), he developed acute vision loss and Entitychange of consciousness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two of these patients, who also received the anti - emetic Entityprochlorperazine , Entitylost consciousness for 48 - 72 h and then fully recovered.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSIONS : This is the second case report that describes Entitygemcitabine - induced Entityradiation recall in rectus abdominus muscles after gemcitabine - based radiation therapy.
0.9557 Adverse-Effect CONCLUSIONS : This is the second case report that describes gemcitabine - induced Entityradiation recall in rectus abdominus muscles after Entitygemcitabine - based radiation therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The 5 patients had severe renovascular disease which might thus represent a significant risk factor in the development of Entitycaptopril - induced Entityacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Entityvasculitis has been reported in the course of hairy cell leukaemia, it has only rarely been reported as the consequence of Entitycladribine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of ELP in children is generally supportive, with the symptoms and Entityroentgenographic abnormalities resolving within months after stopping the use of Entitymineral oil .
0.9998 Adverse-Effect Treatment of EntityELP in children is generally supportive, with the symptoms and roentgenographic abnormalities resolving within months after stopping the use of Entitymineral oil .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This case illustrates that the Entityhemophagocytic syndrome associated with reactivation of EBV can occur as part of drug hypersensitivity reactions in RA patients taking Entitysulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient was an 80 - year - old woman who was admitted for EntityStaphylococcus aureus knee arthritis after several intraarticular injections of Entitysodium hyaluronate and corticosteroids.
1.0000 Adverse-Effect One patient was an 80 - year - old woman who was admitted for EntityStaphylococcus aureus knee arthritis after several intraarticular injections of sodium hyaluronate and Entitycorticosteroids .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The incidence of oral - Entityverapamil - induced Entityhypotension in the presence of concomitant beta - adrenergic blockade by the oral route is quite rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Painful Entityneutrophilic skin lesions were observed in two children receiving Entitygranulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
0.9994 Adverse-Effect Painful Entityneutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( EntityG - CSF ) for treatment of idiopathic neutropenia.
1.0000 Adverse-Effect EntityPainful neutrophilic skin lesions were observed in two children receiving Entitygranulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
0.9998 Adverse-Effect EntityPainful neutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( EntityG - CSF ) for treatment of idiopathic neutropenia.
Adverse-Effect EntityPainful neutrophilic skin lesions were observed in two children receiving Entitygranulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
Adverse-Effect EntityPainful neutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( EntityG - CSF ) for treatment of idiopathic neutropenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case had radiation fibrosis, so we suggest that radiation fibrosis may be another contributor of the occurrence of EntityILD in patients taking Entityerlotinib .
0.9998 Adverse-Effect This case had radiation fibrosis, so we suggest that Entityradiation fibrosis may be another contributor of the occurrence of ILD in patients taking Entityerlotinib .
0.9989 Adverse-Effect This case had Entityradiation fibrosis , so we suggest that radiation fibrosis may be another contributor of the occurrence of ILD in patients taking Entityerlotinib .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and cardiac failure due to chronic Entitycibenzoline Entitycibenzoline intoxication .
0.9998 Adverse-Effect We cared for a patient with progressive renal impairment who presented with Entityblurred vision , QRS broadening and cardiac failure due to chronic Entitycibenzoline intoxication.
0.9997 Adverse-Effect We cared for a patient with progressive renal impairment who presented with blurred vision, EntityQRS broadening and cardiac failure due to chronic Entitycibenzoline intoxication.
0.9993 Adverse-Effect We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and Entitycardiac failure due to chronic Entitycibenzoline intoxication.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Seizures and Entityextrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with Entityinterferon beta - 1a and clomipramine.
0.9998 Adverse-Effect Seizures and Entityextrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta - 1a and Entityclomipramine .
0.9997 Adverse-Effect EntitySeizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with Entityinterferon beta - 1a and clomipramine.
0.9996 Adverse-Effect EntitySeizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta - 1a and Entityclomipramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : EntityColchicine has a known adverse effect on Entitywound healing through its inhibitory effect on tubulin - dependent cell functions and through collagenase activation.
Adverse-Effect BACKGROUND : EntityColchicine has a known Entityadverse effect on wound healing through its inhibitory effect on tubulin - dependent cell functions and through collagenase activation.
Adverse-Effect BACKGROUND : EntityColchicine has a known adverse effect on wound healing through its inhibitory effect on tubulin - dependent cell functions and through Entitycollagenase activation .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Thrombolytic therapy with tissue plasminogen activator ( EntitytPA ) for acute myocardial infarction may result in major bleeding complications such as Entitygastrointestinal or intracranial bleeding .
0.9998 Adverse-Effect Thrombolytic therapy with Entitytissue plasminogen activator ( tPA ) for acute myocardial infarction may result in major bleeding complications such as Entitygastrointestinal or intracranial bleeding .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the development of Entitycutaneous scleroderma in 3 patients coincident with the use of Entitybleomycin in low cumulative doses of less than 100 U.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Entitypsychosis resulted from the administration of Entityquinacrine hydrochloride at a dosage of 100 mg twice daily for the treatment of discoid lupus.
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect The interval between initiating treatment with Entityinterferon alfa and onset of Entityanterior ischemic optic neuropathy was similar to that of interferon - associated vascular retinopathy.
0.9952 Adverse-Effect The interval between initiating treatment with interferon alfa and onset of anterior ischemic optic neuropathy was similar to that of Entityinterferon - associated Entityvascular retinopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of AILD in an 80 - year - old male who presented with a generalized pruritic maculopapular eruption and Entityfever following Entitydoxycycline administration.
1.0000 Adverse-Effect We report a case of EntityAILD in an 80 - year - old male who presented with a generalized pruritic maculopapular eruption and fever following Entitydoxycycline administration.
1.0000 Adverse-Effect We report a case of AILD in an 80 - year - old male who presented with a Entitygeneralized pruritic maculopapular eruption and fever following Entitydoxycycline administration.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Post marketing studies of Interferon - beta ( EntityIFN beta ) therapy in multiple sclerosis ( MS ) have demonstrated surprisingly high rates of Entityhepatotoxicity .
0.9993 Adverse-Effect Post marketing studies of EntityInterferon - beta ( IFN beta ) therapy in multiple sclerosis ( MS ) have demonstrated surprisingly high rates of Entityhepatotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypersensitivity to Entitycarboplatin has been reported in up to 44 % of patients receiving this antineoplastic agent, usually occurring after several courses of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During her third cycle, she again received Entitycisplatin Entity100 mg / m2 over 30 minutes and developed palmar pruritus, urticaria, and edema.
0.9999 Adverse-Effect During her third cycle, she again received Entitycisplatin 100 mg / m2 over 30 minutes and developed Entitypalmar pruritus , urticaria, and edema.
0.9999 Adverse-Effect During her third cycle, she again received Entitycisplatin 100 mg / m2 over 30 minutes and developed palmar pruritus, Entityurticaria , and edema.
0.9999 Adverse-Effect During her third cycle, she again received Entitycisplatin 100 mg / m2 over 30 minutes and developed palmar pruritus, urticaria, and Entityedema .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a further case of Entitymethimazole - associated Entityliver damage and present a brief review of eleven previous cases found in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of fulminant Entityneuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six - hourly intravenous Entitymetoclopramide .
1.0000 Adverse-Effect We report a case of Entityfulminant neuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six - hourly intravenous Entitymetoclopramide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We describe 3 AS patients treated with Entityetanercept for active AS who developed new onset of EntityCD while AS related symptoms responded well to etanercept.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After a two - month interruption of interferon administration, natural Entityinterferon alpha was given but followed by another episode of the same Entityneurological manifestations .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with androgen - independent prostate cancer in whom EntityPSA continued to decrease for a period of 15 months after Entityflutamide withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect 46 - year - old woman developed painful ulcers over her lower abdomen in the form of Entityreticulate erythema after injecting Entityinterferon beta - 1b subcutaneously for multiple sclerosis.
0.9997 Adverse-Effect 46 - year - old woman developed Entitypainful ulcers over her lower abdomen in the form of reticulate erythema after injecting Entityinterferon beta - 1b subcutaneously for multiple sclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of EntitySJS in a 14 - year - old male with nephrotic syndrome, who was treated with oral Entityprednisolone for 6 weeks.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Data have been published regarding the possibility that Entitytamoxifen may be responsible for the subsequent development of Entitycarcinoma of the corpus uteri in these patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 56 - year - old Caucasian man who received concomitant chemotherapy and radiation for head and neck cancer developed Entityfever concurrent with the administration of Entityamifostine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCalcipotriol ( Daivonex R ; Leo Pharmaceuticals, Zurich, Switzerland ) may cause Entityirritation of the skin , whereas allergic reactions are less common.
1.0000 Adverse-Effect EntityCalcipotriol ( Daivonex R ; Leo Pharmaceuticals, Zurich, Switzerland ) may cause irritation of the skin, whereas Entityallergic reactions are less common.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSION : Patients with Entityinsulin allergy may not have complete resolution of their symptoms after standard desensitization, particularly those patients with concomitant Entityprotamine allergy .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect OBJECTIVE : To report a case of Entitytoxin - positive Clostridium difficile - induced colitis ( CDIC ) after use of Entityclindamycin phosphate vaginal cream.
1.0000 Adverse-Effect OBJECTIVE : To report a case of toxin - positive Clostridium difficile - induced colitis ( EntityCDIC ) after use of Entityclindamycin phosphate vaginal cream.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Pathogenesis of methotrexate - induced papular eruption in psoriasis may involve immune mechanisms other than those of Entitymethotrexate - induced Entitycutaneous vasculitis in collagen vascular disease.
0.9996 Adverse-Effect Pathogenesis of Entitymethotrexate - induced Entitypapular eruption in psoriasis may involve immune mechanisms other than those of methotrexate - induced cutaneous vasculitis in collagen vascular disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two of the five patients who worsened motorically also developed Entityencephalopathy during Entityrisperidone treatment ; the encephalopathy resolved when the patients were switched to clozapine treatment.
0.9998 Adverse-Effect Two of the five patients who Entityworsened motorically also developed encephalopathy during Entityrisperidone treatment ; the encephalopathy resolved when the patients were switched to clozapine treatment.
0.9999 Adverse-Effect Two of the five patients who worsened motorically also developed encephalopathy during risperidone treatment ; the Entityencephalopathy resolved when the patients were switched to Entityclozapine treatment.
0.9890 Adverse-Effect Two of the five patients who worsened motorically also developed encephalopathy during Entityrisperidone treatment ; the Entityencephalopathy resolved when the patients were switched to clozapine treatment.
0.9818 Adverse-Effect Two of the five patients who Entityworsened motorically also developed encephalopathy during risperidone treatment ; the encephalopathy resolved when the patients were switched to Entityclozapine treatment.
0.9608 Adverse-Effect Two of the five patients who worsened motorically also developed Entityencephalopathy during risperidone treatment ; the encephalopathy resolved when the patients were switched to Entityclozapine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAcute ocular ischemic change may be associated with intravitreal injection of Entitybevacizumab in patients with vascular compromised diabetic retinopathy and / or underlying stenosis of the carotid artery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was receiving phenytoin sodium 300 mg / day ; Entitycarbamazepine 200 mg four times daily had been discontinued four days before admission because of Entityleukopenia .
0.9992 Adverse-Effect She was receiving Entityphenytoin sodium 300 mg / day ; carbamazepine 200 mg four times daily had been discontinued four days before admission because of Entityleukopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect His Entityimpaired memory was found to be due to the Entityatenolol he was on and he made a complete recovery on withdrawing the beta - blocker.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe two cases of Entityrhabdomyolysis in patients taking Entitylovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and azithromycin.
0.9999 Adverse-Effect OBJECTIVE : To describe two cases of Entityrhabdomyolysis in patients taking lovastatin that were precipitated by the use of the newer macrolide antibiotics Entityclarithromycin and azithromycin.
0.9998 Adverse-Effect OBJECTIVE : To describe two cases of Entityrhabdomyolysis in patients taking lovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and Entityazithromycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This experience supports the hypothesis that heparin can be readministered early to patients with Entityheparin - associated Entitythrombocytopenia and thrombosis, provided antiplatelet therapy is given.
0.9994 Adverse-Effect This experience supports the hypothesis that heparin can be readministered early to patients with Entityheparin - associated thrombocytopenia and Entitythrombosis , provided antiplatelet therapy is given.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The frequency and relationship of Entitygranulocytopenia caused by sustained - release Entityprocainamide in patients with tachyarrhythmias are briefly discussed, and prior reported cases are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first report of significant Entityhypotension associated with intravenous Entityvalproate in the treatment of status epilepticus in the pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with rheumatoid arthritis treated with Entitygold salts, who developed Entitybilateral interstitial pulmonary abnormalities and showed a dramatic response on corticosteroid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, discontinuing Entitypiroxicam , a nonsteroidal anti - inflammatory drug, and starting a palliative treatment plan helped resolve a patient's Entityulcers .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed Entityventricular fibrillation in 2 patients who presented to the emergency department with pre - excited atrial fibrillation and were given 12 mg of Entityadenosine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect On the 3rd day, an inferior vena cava ( IVC ) filter was placed with a Entityheparin flush, after which massive EntityIVC thrombosis developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An 8 - year - old girl, who had been vaccinated with EntityBCG without subsequent regional reactions, developed Entityosteomyelitis in the left calcaneus 7 months later.
1.0000 Adverse-Effect An 8 - year - old girl, who had been vaccinated with EntityBCG without subsequent regional reactions, developed Entityosteomyelitis in the left calcaneus 7 months later.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In a female with acute lymphoblastic leukemia, inadvertent Entitydoxorubicin administration intrathecally caused severe, life - threatening, Entityacute encephalopathy with high - pressure hydrocephalus.
0.9999 Adverse-Effect In a female with acute lymphoblastic leukemia, inadvertent Entitydoxorubicin administration intrathecally caused severe, life - threatening, acute encephalopathy with Entityhigh - pressure hydrocephalus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In conclusion, this case strongly suggests that Entitygliclazide can induce Entityacute icteric liver necro - inflammation which may be misdiagnosed clinically as acute viral hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of reversible DKA and new - onset EntityDM that developed in a demented patient who was treated with Entityquetiapine for 14 days.
1.0000 Adverse-Effect We report a case of reversible EntityDKA and new - onset DM that developed in a demented patient who was treated with Entityquetiapine for 14 days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mean time between initiation of Entitygemcitabine therapy and onset of EntityHUS was 7. 4 + / - 3. 5 months, or 21. 9 + / - 10. 9 doses of gemcitabine.
1.0000 Adverse-Effect Mean time between initiation of gemcitabine therapy and onset of EntityHUS was 7. 4 + / - 3. 5 months, or 21. 9 + / - 10. 9 doses of Entitygemcitabine .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Sodium phenylbutyrate was added to treatment with EntityHU in two patients, but failed to produce an increase in total Hb despite Entityincreasing Hb F levels.
0.9994 Adverse-Effect EntitySodium phenylbutyrate was added to treatment with HU in two patients, but failed to produce an increase in total Hb despite Entityincreasing Hb F levels.
1.0000 Adverse-Effect Sodium phenylbutyrate was added to treatment with EntityHU in two patients, but failed to produce an Entityincrease in total Hb despite increasing Hb F levels.
0.9998 Adverse-Effect EntitySodium phenylbutyrate was added to treatment with HU in two patients, but failed to produce an Entityincrease in total Hb despite increasing Hb F levels.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect INTERVENTIONS AND RESULTS : EntityCardiac complications were observed in five pediatric patients who received between 4. 6 and 40. 8 mg / kg / d of Entityamphotericin B .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the case of a nonatopic 17 - year - old girl with bronchial asthma and aspirin intolerance who developed a dramatic Entityanaphylactic reaction to oral Entityprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There remains a paucity of information pertaining to alternative anticoagulation strategies for use during cardiopulmonary bypass concomitant with Entityheparin - induced Entitythrombocytopenia , especially in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal failure is a rare complication associated with the use of Entityrifampicin for the treatment of tuberculosis, usually occurring well into the course of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Of the four patients who responded to EntityHU with an Entityincrease in total Hb , all reported symptomatic improvement and three have not required further transfusions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although moderate myelosuppression is not uncommonly seen in patients treated with Entitylenalidomide , Entityaplastic anemia has not previously been reported to be associated with this agent.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The disease - modifying drugs he was taking, cyclosporin and Entitymethotrexate , were stopped, and the Entitylymphoma resolved spontaneously without the use of chemotherapy.
0.9999 Adverse-Effect The disease - modifying drugs he was taking, Entitycyclosporin and methotrexate, were stopped, and the Entitylymphoma resolved spontaneously without the use of chemotherapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The results clearly demonstrate that EntityCPH82 was associated with suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical Entityhypercortisolism .
Adverse-Effect The results clearly demonstrate that EntityCPH82 was associated with Entitysuppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, peripheral neuropathy and Entitybone marrow depression led to Entitylinezolid withdrawal in seven patients, and neuropathy may not be fully reversible in all patients.
0.9999 Adverse-Effect However, Entityperipheral neuropathy and bone marrow depression led to Entitylinezolid withdrawal in seven patients, and neuropathy may not be fully reversible in all patients.
0.9999 Adverse-Effect However, peripheral neuropathy and bone marrow depression led to Entitylinezolid withdrawal in seven patients, and Entityneuropathy may not be fully reversible in all patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDocetaxel induced EntityMeibomian duct inflammation and blockage is the likely cause of this presentation in a patient with no history of eyelid masses in the past.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entitystroke after EntityPPA ingestion that occurred 4 months after the recall in an 8 - year - old boy on chronic peritoneal dialysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of combined lithium and Entityhaloperidol toxicity characterized by Entityhyperpyrexia , severe rigidity, mutism, and development of irreversible tardive dyskinesia.
0.9999 Adverse-Effect The authors describe a case of combined lithium and Entityhaloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of Entityirreversible tardive dyskinesia .
0.9999 Adverse-Effect The authors describe a case of combined lithium and Entityhaloperidol toxicity characterized by hyperpyrexia, severe rigidity, Entitymutism , and development of irreversible tardive dyskinesia.
0.9998 Adverse-Effect The authors describe a case of combined lithium and Entityhaloperidol toxicity characterized by hyperpyrexia, Entitysevere rigidity , mutism, and development of irreversible tardive dyskinesia.
0.9998 Adverse-Effect The authors describe a case of combined Entitylithium and haloperidol toxicity characterized by Entityhyperpyrexia , severe rigidity, mutism, and development of irreversible tardive dyskinesia.
0.9997 Adverse-Effect The authors describe a case of combined Entitylithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of Entityirreversible tardive dyskinesia .
0.9996 Adverse-Effect The authors describe a case of combined Entitylithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, Entitymutism , and development of irreversible tardive dyskinesia.
0.9993 Adverse-Effect The authors describe a case of combined Entitylithium and haloperidol toxicity characterized by hyperpyrexia, Entitysevere rigidity , mutism, and development of irreversible tardive dyskinesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a child with yolk sac tumor who developed Entitylocalized pigmentation after the first course of chemotherapy regimen that included Entitycisplatin , etoposide and bleomycin.
1.0000 Adverse-Effect We report a child with yolk sac tumor who developed Entitylocalized pigmentation after the first course of chemotherapy regimen that included cisplatin, Entityetoposide and bleomycin.
1.0000 Adverse-Effect We report a child with yolk sac tumor who developed Entitylocalized pigmentation after the first course of chemotherapy regimen that included cisplatin, etoposide and Entitybleomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The site of thrombosis and the chronological relationship with the IIR implicates a Entityhypersensitivity to Entityinfliximab in the causation of the venous thrombosis in this case.
0.9998 Adverse-Effect The site of thrombosis and the chronological relationship with the EntityIIR implicates a hypersensitivity to Entityinfliximab in the causation of the venous thrombosis in this case.
0.9997 Adverse-Effect The site of thrombosis and the chronological relationship with the IIR implicates a hypersensitivity to Entityinfliximab in the causation of the Entityvenous thrombosis in this case.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The authors describe three families in whom the occurrence of EntityFVS in all the siblings strongly suggests hereditary susceptibility to Entityvalproic acid - induced adverse outcome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 60 - year - old woman who developed erythema and Entityerosions in the axilla and groin while on EntityPLD for breast cancer.
1.0000 Adverse-Effect We report the case of a 60 - year - old woman who developed Entityerythema and erosions in the axilla and groin while on EntityPLD for breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 73 - year - old woman presented with fever and Entitycough 2 weeks after completing the third cycle of Entityfludarabine for chronic lymphocytic leukemia ( CLL ).
1.0000 Adverse-Effect A 73 - year - old woman presented with Entityfever and cough 2 weeks after completing the third cycle of Entityfludarabine for chronic lymphocytic leukemia ( CLL ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed 3 diabetic patients with intolerable dizziness followed by nausea and Entityvomiting immediately after an initial administration of the alpha - glucosidase inhibitor, Entityvoglibose .
1.0000 Adverse-Effect We observed 3 diabetic patients with intolerable dizziness followed by Entitynausea and vomiting immediately after an initial administration of the alpha - glucosidase inhibitor, Entityvoglibose .
1.0000 Adverse-Effect We observed 3 diabetic patients with Entityintolerable dizziness followed by nausea and vomiting immediately after an initial administration of the alpha - glucosidase inhibitor, Entityvoglibose .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite minimal short - term side effects and apparent efficacy, chronic treatment of MG with EntityMM may be associated with increased risk of Entitylymphoproliferative disorders .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 62 - year - old Indian with diabetic nephropathy controlled with Entitymetformin , developed Entitymiliary tuberculosis for which he was treated with rifampicin, isoniazid and ethambutol.
1.0000 Adverse-Effect A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed Entitymiliary tuberculosis for which he was treated with Entityrifampicin , isoniazid and ethambutol.
0.9999 Adverse-Effect A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed Entitymiliary tuberculosis for which he was treated with rifampicin, Entityisoniazid and ethambutol.
0.9999 Adverse-Effect A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed Entitymiliary tuberculosis for which he was treated with rifampicin, isoniazid and Entityethambutol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entityethylenediamine - induced Entitydelayed hypersensitivity reaction in a 46 - year - old woman who received parenteral aminophylline for an acute asthma exacerbation.
1.0000 Adverse-Effect We present a case of ethylenediamine - induced Entitydelayed hypersensitivity reaction in a 46 - year - old woman who received parenteral Entityaminophylline for an acute asthma exacerbation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A mentally retarded 23 - year - old woman with myoclonic astatic epilepsy developed an abnormal posture of extreme forward flexion, called Entitycamptocormia , during Entityvalproate monotherapy.
0.9999 Adverse-Effect A mentally retarded 23 - year - old woman with myoclonic astatic epilepsy developed an Entityabnormal posture of extreme forward flexion , called camptocormia, during Entityvalproate monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of our knowledge, Entitycorneoscleral melting in the first postoperative week after a single intraoperative application of Entitymitomycin C has not been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To describe spectral - domain optical coherence tomography ( SD - OCT ) and adaptive optics ( AO ) imaging in Entityhydroxychloroquine Entityretinal toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient who received Entityclindamycin had liver biopsy findings of Entitymarked cholestasis , portal inflammation, bile duct injury and bile duct paucity ( ductopenia ).
0.9999 Adverse-Effect One patient who received Entityclindamycin had liver biopsy findings of marked cholestasis, portal inflammation, bile duct injury and bile duct paucity ( Entityductopenia ).
0.9999 Adverse-Effect One patient who received Entityclindamycin had liver biopsy findings of marked cholestasis, portal inflammation, Entitybile duct injury and bile duct paucity ( ductopenia ).
0.9999 Adverse-Effect One patient who received Entityclindamycin had liver biopsy findings of marked cholestasis, Entityportal inflammation , bile duct injury and bile duct paucity ( ductopenia ).
0.9999 Adverse-Effect One patient who received Entityclindamycin had liver biopsy findings of marked cholestasis, portal inflammation, bile duct injury and Entitybile duct paucity ( ductopenia ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case in which Entitydipyridamole induced Entityhigh - grade atrioventricular ( AV ) block that responded promptly to intravenous aminophylline but not to atropine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of acute generalized exanthematous pustulosis ( EntityAGEP ) in a 50 - year - old woman that was attributed to the ingestion of Entitynimesulide .
1.0000 Adverse-Effect We report a case of Entityacute generalized exanthematous pustulosis ( AGEP ) in a 50 - year - old woman that was attributed to the ingestion of Entitynimesulide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A girl with cystic fibrosis and cyclic neutropenia developed an Entityerythematous papular eruption without fever or neutrophilia 7 months after commencing therapy with EntityG - CSF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Entityanaphylactoid reaction to Entityamifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis : a case report with literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of our knowledge only two previous cases of EntityAML have been linked to treatment of HCL with purine analogs, both with Entity2 - chlorodeoxyadenosine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possible effects of tamoxifen upon the uterus are discussed in this article, in view of reports of Entitytamoxifen associated with Entityendometrial carcinoma and endometriosis.
0.9992 Adverse-Effect The possible effects of tamoxifen upon the uterus are discussed in this article, in view of reports of Entitytamoxifen associated with endometrial carcinoma and Entityendometriosis .
0.9938 Adverse-Effect The possible effects of Entitytamoxifen upon the uterus are discussed in this article, in view of reports of tamoxifen associated with Entityendometrial carcinoma and endometriosis.
0.9914 Adverse-Effect The possible effects of Entitytamoxifen upon the uterus are discussed in this article, in view of reports of tamoxifen associated with endometrial carcinoma and Entityendometriosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is suggested that the patient had Entitysulfasalazine - induced Entitylupus , which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms.
0.9999 Adverse-Effect It is suggested that the patient had Entitysulfasalazine - induced lupus, which manifested with Entityserositis and pulmonary parenchymal involvement in the absence of joint symptoms.
0.9999 Adverse-Effect It is suggested that the patient had Entitysulfasalazine - induced lupus, which manifested with serositis and Entitypulmonary parenchymal involvement in the absence of joint symptoms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of a patient who received Entityalteplase for acute myocardial infarction and developed spontaneous Entitysubfascial hematoma without any evidence of direct trauma.
1.0000 Adverse-Effect The authors report a case of a patient who received Entityalteplase for acute myocardial infarction and developed Entityspontaneous subfascial hematoma without any evidence of direct trauma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report five cases of restless legs syndrome ( RLS ) and periodic limb movements during sleep ( EntityPLMS ) that were probably associated with Entityolanzapine .
1.0000 Adverse-Effect We report five cases of Entityrestless legs syndrome ( RLS ) and periodic limb movements during sleep ( PLMS ) that were probably associated with Entityolanzapine .
1.0000 Adverse-Effect We report five cases of restless legs syndrome ( RLS ) and Entityperiodic limb movements during sleep ( PLMS ) that were probably associated with Entityolanzapine .
1.0000 Adverse-Effect We report five cases of restless legs syndrome ( EntityRLS ) and periodic limb movements during sleep ( PLMS ) that were probably associated with Entityolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The successful development and implementation of this protocol will have impact on patients who have Entityanaphylactic reactions to EntityMTX but require this medication for specific diseases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapid identification of Entityspeech loss linked to EntityFK506 may be important because reduction or cessation of the drug may be associated with reverse of speech loss.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOcular hypertension occurred 1 month after the second Entityranibizumab injection in patients 1 and 3, and 1 month after the first ranibizumab in patient 2.
0.9919 Adverse-Effect EntityOcular hypertension occurred 1 month after the second ranibizumab injection in patients 1 and 3, and 1 month after the first Entityranibizumab in patient 2.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBSERVATIONS : We observed Entityaggravation and spreading of a psoriatic plaque when treated topically with the toll - like receptor ( TLR ) 7 agonist Entityimiquimod .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 59 - year - old woman with myasthenia gravis who received a large dose of Entitypyridostigmine bromide developed Entitypostoperative psychosis and was diagnosed as having bromide intoxication.
0.9980 Adverse-Effect A 59 - year - old woman with myasthenia gravis who received a large dose of Entitypyridostigmine bromide developed postoperative psychosis and was diagnosed as having Entitybromide intoxication .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : EntityHydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long - term treatment is associated with Entitymucocutaneous adverse events and nail hyperpigmentation.
0.9999 Adverse-Effect BACKGROUND : EntityHydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long - term treatment is associated with mucocutaneous adverse events and Entitynail hyperpigmentation .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Due to the increasing use of EntityTMP - SMX in children, clinicians should be aware of this potentially life - threatening, Entityimmunemediated hypersensitivity reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitygeneralized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing Entitybromocil , diuron and aminotriazole.
0.9998 Adverse-Effect We report a case of Entitygeneralized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing bromocil, diuron and Entityaminotriazole .
0.9998 Adverse-Effect We report a case of Entitygeneralized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing bromocil, Entitydiuron and aminotriazole.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings suggest that the Entitycorneal and retinal changes are the result of a toxic effect of Entitytamoxifen when used in the doses and duration described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a premature infant who developed Entityseizures associated with intraventricular administration of Entitynafcillin and discuss the need for electroencephalographic monitoring of patients receiving intraventricular antibiotics.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the successful treatment of Entityheparin - induced Entitythrombocytopenia and subsequent hemorrhagic complications postoperatively in a 2 - year - old child with Danaparoid ( orgaran ).
0.9999 Adverse-Effect We report the successful treatment of Entityheparin - induced thrombocytopenia and subsequent Entityhemorrhagic complications postoperatively in a 2 - year - old child with Danaparoid ( orgaran ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This patient, who had a history of osteoarthritis, had severe Entityhepatitis 5 weeks after being started on Entitydiclofenac for increasing pain in the joints.
1.0000 Adverse-Effect This patient, who had a history of osteoarthritis, had Entitysevere hepatitis 5 weeks after being started on Entitydiclofenac for increasing pain in the joints.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Entityleflunomide consist of Entitydiarrhea , nausea, liver enzyme elevation, hypertension, alopecia, and allergic skin reactions.
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Entityleflunomide consist of diarrhea, nausea, liver enzyme elevation, hypertension, Entityalopecia , and allergic skin reactions.
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Entityleflunomide consist of diarrhea, Entitynausea , liver enzyme elevation, hypertension, alopecia, and allergic skin reactions.
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Entityleflunomide consist of diarrhea, nausea, liver enzyme elevation, Entityhypertension , alopecia, and allergic skin reactions.
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Entityleflunomide consist of diarrhea, nausea, liver enzyme elevation, hypertension, alopecia, and Entityallergic skin reactions .
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Entityleflunomide consist of diarrhea, nausea, Entityliver enzyme elevation , hypertension, alopecia, and allergic skin reactions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case supports the view that in Entitygold - induced Entitypneumonitis a prolonged treatment with corticosteroids may be necessary, as lung function continued to improve.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A patient who developed dramatic, permanent Entityvision loss after a 9 - month course of treatment with Entityethambutol and isoniazid for pulmonary tuberculosis is presented.
1.0000 Adverse-Effect METHODS : A patient who developed dramatic, permanent Entityvision loss after a 9 - month course of treatment with ethambutol and Entityisoniazid for pulmonary tuberculosis is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of symptoms that could be ascribed to an Entityacute coronary syndrome should always be taken seriously during the first Entityrituximab infusion and investigated aggressively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been many reports of probable Entitylithium - induced Entityorganic brain syndromes occurring when serum lithium levels are within or close to the therapeutic range.
0.9991 Adverse-Effect There have been many reports of probable lithium - induced Entityorganic brain syndromes occurring when serum Entitylithium levels are within or close to the therapeutic range.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case demonstrates that Entityhypersensitivity reaction to Entitypranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.
0.9999 Adverse-Effect The case demonstrates that hypersensitivity reaction to Entitypranlukast and resultant EntityATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.
0.9980 Adverse-Effect The case demonstrates that hypersensitivity reaction to pranlukast and resultant EntityATIN is possible, and that periodic urine testing in patients receiving Entitypranlukast should be considered.
0.9825 Adverse-Effect The case demonstrates that Entityhypersensitivity reaction to pranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving Entitypranlukast should be considered.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After 1 week of Entitynefazodone therapy the patient experienced Entityheadache , confusion, and " gray areas " in her vision, without abnormal ophthalmologic findings.
1.0000 Adverse-Effect After 1 week of Entitynefazodone therapy the patient experienced headache, Entityconfusion , and " gray areas " in her vision, without abnormal ophthalmologic findings.
0.9999 Adverse-Effect After 1 week of Entitynefazodone therapy the patient experienced headache, confusion, and " Entitygray areas " in her vision, without abnormal ophthalmologic findings.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The diagnosis was supported by the temporal course of Entityrenal deterioration during exposure to Entitycefuroxime and improvement on its discontinuation ; the pattern repeated with rechallenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although interferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of Entitysarcoidosis associated with Entityinterferon alpha therapy have been reported.
0.9507 Adverse-Effect Although Entityinterferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of Entitysarcoidosis associated with interferon alpha therapy have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Anti - tuberculous drugs had been stopped on the 2nd day of therapy due to development of Entityoptic neuritis secondary to Entityethambutol administration at another hospital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is presented of a patient who experienced Entitybenzodiazepine withdrawal symptoms on discontinuation of Entitynefazodone , an antidepressant that inhibits the cytochrome P450 3A4 isoenzyme.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We reported 3 patients who developed acute generalized dystonia and Entityakinetic rigid syndrome following an initial therapy with Entityd - penicillamine 125 - 500 mg daily.
0.9996 Adverse-Effect We reported 3 patients who developed Entityacute generalized dystonia and akinetic rigid syndrome following an initial therapy with Entityd - penicillamine 125 - 500 mg daily.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case presentation is of a patient who had the clinical appearance of epiglottitis, but actually had an Entityoro - pharyngeal dystonic reaction to Entityprochlorperazine .
1.0000 Adverse-Effect This case presentation is of a patient who had the clinical appearance of Entityepiglottitis , but actually had an oro - pharyngeal dystonic reaction to Entityprochlorperazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therapy with EntityIFN - alpha may be associated with a number of Entityneuropsychiatric symptoms , such as Parkinsonism, akathisia, seizure, and depressive disorders.
0.9997 Adverse-Effect Therapy with EntityIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as EntityParkinsonism , akathisia, seizure, and depressive disorders.
0.9997 Adverse-Effect Therapy with EntityIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and Entitydepressive disorders .
0.9997 Adverse-Effect Therapy with EntityIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, Entityakathisia , seizure, and depressive disorders.
0.9997 Adverse-Effect Therapy with EntityIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, Entityseizure , and depressive disorders.
Score Relation Text (Head - Tail)
0.9982 Adverse-Effect CONCLUSIONS : Low dosages of Entityquinacrine used for malaria prophylaxis can be associated with a delayed, Entitysevere maculopathy indistinguishable from chloroquine maculopathy in certain patients.
0.9964 Adverse-Effect CONCLUSIONS : Low dosages of Entityquinacrine used for malaria prophylaxis can be associated with a delayed, severe Entitymaculopathy indistinguishable from chloroquine maculopathy in certain patients.
Adverse-Effect CONCLUSIONS : Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, severe maculopathy indistinguishable from Entitychloroquine Entitymaculopathy in certain patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, a recent post - marketing survey in Japan revealed that Entityinterstitial pneumonia occurred in 4 among approximately 2 000 Japanese patients treated with Entitysorafenib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients received respectively 190 mg, 175 mg, and 196 mg of Entitymethotrexate and developed Entitybilateral pulmonary infiltrates without evidence of peripheral blood eosinophilia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An infant who developed Entitypancreatitis during Entitymeglumine antimoniate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and ketoconazole is reported.
0.9998 Adverse-Effect An infant who developed Entitypancreatitis during meglumine antimoniate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and Entityketoconazole is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe Entityhydroxychloroquine Entityretinopathy with 19 years follow - up.
1.0000 Adverse-Effect Normalization of generalized retinal function and Entityprogression of maculopathy after cessation of therapy in a case of severe Entityhydroxychloroquine retinopathy with 19 years follow - up.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, as illustrated by these and other cases reported to date, the onset of Entitytroglitazone - induced Entityliver injury is insidious and temporally variable.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 55 - year - old woman presented an episode of acute urticaria and Entitylabial angioedema 60 minutes after ingesting 500 mg of Entitycloxacillin for a skin abscess.
0.9999 Adverse-Effect A 55 - year - old woman presented an episode of Entityacute urticaria and labial angioedema 60 minutes after ingesting 500 mg of Entitycloxacillin for a skin abscess.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These features have not previously been reported as side effects of glibenclamide therapy, but Entityintrahepatic cholestasis may occur with Entitychlorpropamide , a similar sulphonylurea agent.
0.9997 Adverse-Effect These features have not previously been reported as side effects of Entityglibenclamide therapy, but Entityintrahepatic cholestasis may occur with chlorpropamide, a similar sulphonylurea agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The relation between tacrolimus treatment and staining was suggested by the appearance of Entitypigmentation during topical Entitytacrolimus treatment and its clinical disappearance when treatment was stopped.
0.9994 Adverse-Effect The relation between Entitytacrolimus treatment and staining was suggested by the appearance of Entitypigmentation during topical tacrolimus treatment and its clinical disappearance when treatment was stopped.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityhypercalcemia responded to discontinuation of EntityrhGH and a single dose of intravenous pamidronate disodium and has not recurred in 8 months of follow - up.
0.9998 Adverse-Effect The Entityhypercalcemia responded to discontinuation of rhGH and a single dose of intravenous Entitypamidronate disodium and has not recurred in 8 months of follow - up.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We document the abrupt development of an extensive Entitychoroidal detachment after initiation of Entitydorzolamide therapy in a surgically untreated eye with primary open - angle glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with the antiphospholipid syndrome who had Entityskin necrosis develop from Entitylow - molecular weight heparin therapy at sites distant from injection sites.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Since this amount of FAB was insufficient to bind all DGTX present in the serum, Entitycardiac DGTX toxicity EntityDGTX toxicity ( total AV - block ) persisted.
0.9990 Adverse-Effect Since this amount of FAB was insufficient to bind all DGTX present in the serum, cardiac EntityDGTX toxicity ( Entitytotal AV - block ) persisted.
0.9990 Adverse-Effect Since this amount of FAB was insufficient to bind Entityall DGTX present in the serum, Entitycardiac DGTX toxicity ( total AV - block ) persisted.
0.9983 Adverse-Effect Since this amount of FAB was insufficient to bind Entityall DGTX present in the serum, cardiac DGTX toxicity ( Entitytotal AV - block ) persisted.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We report four patients, three of whom first developed Entitypsoriasis and one who had an aggravation of the condition during treatment with Entityinterferon - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three months following splenectomy, Entitymultiple abscesses occurred in the muscles of both thighs while the patient was receiving the third course of the EntityCHOP regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possible development of a drug - induced vasculitis or Entitylupus - like syndrome should be added to the list of rare toxic effects of Entityvancomycin .
0.9999 Adverse-Effect The possible development of a drug - induced Entityvasculitis or lupus - like syndrome should be added to the list of rare toxic effects of Entityvancomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : In these 3 cases, the unique positive ocular finding was Entitycorneal endothelial deposits , which may be related to the use of Entityrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics Entityactinomycin - D ( NSC - 3053 ) and mithramycin ( NSC - 24559 ).
0.9999 Adverse-Effect EntityExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( NSC - 3053 ) and Entitymithramycin ( NSC - 24559 ).
0.9999 Adverse-Effect EntityExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( EntityNSC - 3053 ) and mithramycin ( NSC - 24559 ).
0.9999 Adverse-Effect EntityExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( NSC - 3053 ) and mithramycin ( EntityNSC - 24559 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A female patient with HER2 positive, metastatic breast cancer presented with pulmonary infiltrates, and a Entityplural effusion dyspnoea after several months of Entitytrastuzumab treatment.
0.9999 Adverse-Effect A female patient with HER2 positive, metastatic breast cancer presented with Entitypulmonary infiltrates , and a plural effusion dyspnoea after several months of Entitytrastuzumab treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMorphine , an opium alkaloid, frequently causes side effects such as Entityhyperhidrosis and facial flushing, but serious cutaneous adverse drug reactions are seldom observed.
0.9999 Adverse-Effect EntityMorphine , an opium alkaloid, frequently causes side effects such as hyperhidrosis and Entityfacial flushing , but serious cutaneous adverse drug reactions are seldom observed.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect CONCLUSIONS : EntitySpontaneous hemothorax is a rare phenomenon in conjunction with EntityLMWH but should be considered in cases of acute respiratory distress following commencement of LMWH.
0.9999 Adverse-Effect CONCLUSIONS : Spontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of Entityacute respiratory distress following commencement of EntityLMWH .
0.9985 Adverse-Effect CONCLUSIONS : Spontaneous hemothorax is a rare phenomenon in conjunction with EntityLMWH but should be considered in cases of Entityacute respiratory distress following commencement of LMWH.
0.9964 Adverse-Effect CONCLUSIONS : EntitySpontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of acute respiratory distress following commencement of EntityLMWH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient suffering from Entityheparin - associated Entitythrombocytopenia ( HAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard heparin is described.
1.0000 Adverse-Effect A patient suffering from heparin - associated thrombocytopenia ( HAT ), recurrent arteriothromboses, and Entityacute renal failure after treatment with standard Entityheparin is described.
0.9999 Adverse-Effect A patient suffering from heparin - associated thrombocytopenia ( HAT ), Entityrecurrent arteriothromboses , and acute renal failure after treatment with standard Entityheparin is described.
0.9999 Adverse-Effect A patient suffering from Entityheparin - associated thrombocytopenia ( HAT ), Entityrecurrent arteriothromboses , and acute renal failure after treatment with standard heparin is described.
0.9999 Adverse-Effect A patient suffering from Entityheparin - associated thrombocytopenia ( EntityHAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard heparin is described.
0.9999 Adverse-Effect A patient suffering from heparin - associated thrombocytopenia ( EntityHAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard Entityheparin is described.
0.9999 Adverse-Effect A patient suffering from Entityheparin - associated thrombocytopenia ( HAT ), recurrent arteriothromboses, and Entityacute renal failure after treatment with standard heparin is described.
0.9998 Adverse-Effect A patient suffering from heparin - associated Entitythrombocytopenia ( HAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard Entityheparin is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect AIMS : To present a case of Entitypiloerection after replacing Entityfluvoxamine maleate with milnacipran hydrochloride, and to analyse this effect based on receptor occupancy theory.
0.9998 Adverse-Effect AIMS : To present a case of Entitypiloerection after replacing fluvoxamine maleate with Entitymilnacipran hydrochloride , and to analyse this effect based on receptor occupancy theory.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect PURPOSE : To determine the cause of Entityspontaneous choroidal hemorrhage in a 67 - year - old man after a myocardial infarction and administration of Entitytissue plasminogen activator .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one instance a systemic hypoglycemic reaction resulting in head trauma and Entityconfusion ended in an emegency hospital admission following the substitution of Entityacetohexamide for acetazolamide.
0.9999 Adverse-Effect In one instance a Entitysystemic hypoglycemic reaction resulting in head trauma and confusion ended in an emegency hospital admission following the substitution of Entityacetohexamide for acetazolamide.
0.9999 Adverse-Effect In one instance a systemic hypoglycemic reaction resulting in Entityhead trauma and confusion ended in an emegency hospital admission following the substitution of Entityacetohexamide for acetazolamide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityItraconazole - induced Entityliver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia.
0.9999 Adverse-Effect CONCLUSIONS : EntityItraconazole - induced liver injury presents with a Entitycholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia.
0.9999 Adverse-Effect CONCLUSIONS : EntityItraconazole - induced liver injury presents with a cholestatic pattern of injury with Entitydamage to the interlobular bile ducts , possibly leading to ductopenia.
0.9999 Adverse-Effect CONCLUSIONS : EntityItraconazole - induced liver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to Entityductopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report four cases of encephalopathy coincident with elevated aluminum levels as well as one patient who developed Entityseizures while receiving continuous bladder irrigations with Entityalum .
0.9990 Adverse-Effect We report four cases of Entityencephalopathy coincident with elevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with Entityalum .
0.9990 Adverse-Effect We report four cases of encephalopathy coincident with Entityelevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with Entityalum .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and Entitythiazide , respectively, resulting in Entityhypercalciuria and hypercalcemia.
0.9999 Adverse-Effect We experienced a male patient with psoriasis and hypertension whose conditions were treated with Entitytacalcitol ointment and thiazide, respectively, resulting in Entityhypercalciuria and hypercalcemia.
0.9998 Adverse-Effect We experienced a male patient with psoriasis and hypertension whose conditions were treated with Entitytacalcitol ointment and thiazide, respectively, resulting in hypercalciuria and Entityhypercalcemia .
0.9992 Adverse-Effect We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and Entitythiazide , respectively, resulting in hypercalciuria and Entityhypercalcemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While for ribavirin antidepressant effects are not known, we suppose that antidepressants may prevent Entitychanges in serotonergic or noradrenergic neurotransmission caused by EntityIFN - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect As Entitylinezolid has been shown to have Entityhematologic side effects , blood count monitoring is recommended in patients receiving this drug for long - term therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with extrinsic asthma and coexistent insulin - dependent diabetes mellitus sustained an Entityanaphylactoid reaction after the intravenous administration of 50 % solution of Entitydextrose .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient is described who developed a rapid onset of Entitypulmonary fibrosis following treatment with a new non - steroidal anti - inflammatory drug, Entitynabumetone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although its side effects are few, Entitytamoxifen increases the incidence of Entityproliferative lesions of the endometrium , which theoretically should be preventable with progestational agents.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In four patients, thrombosis occurred 2 - 45 days after severe hepatic veno - occlusive disease ( EntityHVOD ) secondary to intensive chemotherapy containing Entitybusulfan .
1.0000 Adverse-Effect In four patients, Entitythrombosis occurred 2 - 45 days after severe hepatic veno - occlusive disease ( HVOD ) secondary to intensive chemotherapy containing Entitybusulfan .
1.0000 Adverse-Effect In four patients, thrombosis occurred 2 - 45 days after severe Entityhepatic veno - occlusive disease ( HVOD ) secondary to intensive chemotherapy containing Entitybusulfan .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect CONCLUSIONS : Although Entitybudesonide may be beneficial because of its anti - inflammatory effects, clinicians should be alert to its potential for causing Entitycontact dermatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was found to have Entityno motile sperm with a normal sperm count, while taking a dose of 400 mg / day of Entitycarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing Entitybusulfan and to be associated with HVOD.
0.9999 Adverse-Effect PVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing Entitybusulfan and to be associated with EntityHVOD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The development of cutaneous ecchymosis associated with a Entitysudden fall in hemoglobin after the administration of Entityalteplase should strongly suggest the possibility of diffuse subfascial hematoma.
0.9998 Adverse-Effect The development of Entitycutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of Entityalteplase should strongly suggest the possibility of diffuse subfascial hematoma.
0.9998 Adverse-Effect The development of cutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of Entityalteplase should strongly suggest the possibility of Entitydiffuse subfascial hematoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A 52 - year - old woman with Parkinson disease who had taken Entityamantadine for 6 years had Entitybilateral corneal edema for 2 months at baseline.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A few recent individual case reports have suggested that a Entitymyasthenic syndrome may be associated with Entitystatin treatment, but this association is not well described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityamiodarone - induced Entitythyrotoxicosis of protracted duration, unresponsive to conventional thionamide therapy, with therapy limited by severe adverse drug reactions.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We hypothesize that decreased renal elimination of EntityMTX induced by the COX - 2 inhibitor resulted in enhanced Entityhematopoietic toxicity and immunosuppression causing the EBV - associated lymphoproliferative disease.
0.9992 Adverse-Effect We hypothesize that decreased renal elimination of EntityMTX induced by the COX - 2 inhibitor resulted in enhanced hematopoietic toxicity and Entityimmunosuppression causing the EBV - associated lymphoproliferative disease.
0.9992 Adverse-Effect We hypothesize that decreased renal elimination of EntityMTX induced by the COX - 2 inhibitor resulted in enhanced hematopoietic toxicity and immunosuppression causing the EntityEBV - associated lymphoproliferative disease .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMTX - induced Entityhepatic injury and liver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.
0.9999 Adverse-Effect EntityMTX - induced hepatic injury and Entityliver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We herein described an additional patient with BCR - ABL ( ela2 ) positive acute lymphoblastic leukemia who developed Entitytumor lysis syndrome after 10 - day treatment with Entityimatinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article presents a patient with hypoparathyroidism who was treated with calcium carbonate and Entitycalcitriol resulting in two admissions to the hospital for Entitymilk - alkali syndrome .
0.9997 Adverse-Effect This article presents a patient with hypoparathyroidism who was treated with Entitycalcium carbonate and calcitriol resulting in two admissions to the hospital for Entitymilk - alkali syndrome .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Management of hypophosphatemia induced by high - flux hemodiafiltration for the treatment of Entityvancomycin Entityvancomycin toxicity : intravenous phosphorus therapy versus use of a phosphorus - enriched dialysate.
0.9989 Adverse-Effect Management of Entityhypophosphatemia induced by high - flux hemodiafiltration for the treatment of Entityvancomycin toxicity : intravenous phosphorus therapy versus use of a phosphorus - enriched dialysate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although this combination agent has been associated with a hypersensitivity syndrome involving cutaneous skin eruptions, pediatric cases of EntityTMP - SMX - induced Entityhepatotoxicity are rare.
0.9674 Adverse-Effect Although this combination agent has been associated with a hypersensitivity syndrome involving Entitycutaneous skin eruptions , pediatric cases of EntityTMP - SMX - induced hepatotoxicity are rare.
0.9475 Adverse-Effect Although this combination agent has been associated with a Entityhypersensitivity syndrome involving cutaneous skin eruptions, pediatric cases of EntityTMP - SMX - induced hepatotoxicity are rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The addition of intrathecal Entitymethotrexate to treatment protocols has increased survival rates in children with acute lymphoblastic leukemia but is also associated with varying degrees of Entityneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A teenage girl with crescentic glomerulonephritis had Entityantineutrophil cytoplasmic antibody ( ANCA ) detected after she had received Entitypropylthiouracil ( PTU ) for hyperthyroidism without cutaneous vasculitis.
1.0000 Adverse-Effect A teenage girl with crescentic glomerulonephritis had Entityantineutrophil cytoplasmic antibody ( ANCA ) detected after she had received propylthiouracil ( EntityPTU ) for hyperthyroidism without cutaneous vasculitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for Entityintracranial bleeding while receiving Entityaspirin and clopidogrel.
1.0000 Adverse-Effect A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for Entityintracranial bleeding while receiving aspirin and Entityclopidogrel .
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect OBJECTIVE : To study therapy with indapamide impairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of Entitydiabetes induced by Entityindapamide .
0.6736 Adverse-Effect OBJECTIVE : To study therapy with Entityindapamide impairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of Entitydiabetes induced by indapamide.
0.9466 Adverse-Effect OBJECTIVE : To study therapy with indapamide impairing Entitycarbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of Entitydiabetes induced by indapamide.
Adverse-Effect OBJECTIVE : To study therapy with Entityindapamide Entityimpairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of diabetes induced by indapamide.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Coadministration of antidepressant agents such as nefazodone, or any other drug that inhibits the CYP3A4 isoenzyme subfamily, should be anticipated to Entityinterfere with tacrolimus metabolism Entitytacrolimus metabolism.
0.9984 Adverse-Effect Coadministration of antidepressant agents such as Entitynefazodone , or any other drug that inhibits the CYP3A4 isoenzyme subfamily, should be anticipated to Entityinterfere with tacrolimus metabolism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Reproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and Entityhyperandrogenism seem to be common among women treated with Entitysodium valproate for epilepsy.
0.9998 Adverse-Effect BACKGROUND : Reproductive endocrine disorders characterized by Entitymenstrual disorders , polycystic ovaries, and hyperandrogenism seem to be common among women treated with Entitysodium valproate for epilepsy.
0.9998 Adverse-Effect BACKGROUND : Reproductive endocrine disorders characterized by menstrual disorders, Entitypolycystic ovaries , and hyperandrogenism seem to be common among women treated with Entitysodium valproate for epilepsy.
0.9998 Adverse-Effect BACKGROUND : EntityReproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and hyperandrogenism seem to be common among women treated with Entitysodium valproate for epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 52 - year - old, white female developed low - grade fever, cough, and Entitydyspnea after 8 weeks treatment with Entitysodium aurothiomalate for rheumatoid arthritis.
0.9998 Adverse-Effect A 52 - year - old, white female developed low - grade fever, Entitycough , and dyspnea after 8 weeks treatment with Entitysodium aurothiomalate for rheumatoid arthritis.
0.9998 Adverse-Effect A 52 - year - old, white female developed Entitylow - grade fever , cough, and dyspnea after 8 weeks treatment with Entitysodium aurothiomalate for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a 60 - year - old woman affected by squamous lung carcinoma, who developed Entityparoxysmal supraventricular tachycardia during Entitycisplatin and etoposide combination chemotherapy.
0.9999 Adverse-Effect We report a case of a 60 - year - old woman affected by squamous lung carcinoma, who developed Entityparoxysmal supraventricular tachycardia during cisplatin and Entityetoposide combination chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient experienced hallucinations, agitation, vomiting, tachycardia and Entityseizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Entitybupropion .
1.0000 Adverse-Effect The patient experienced hallucinations, agitation, vomiting, Entitytachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Entitybupropion .
1.0000 Adverse-Effect The patient experienced Entityhallucinations , agitation, vomiting, tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Entitybupropion .
1.0000 Adverse-Effect The patient experienced hallucinations, agitation, Entityvomiting , tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Entitybupropion .
1.0000 Adverse-Effect The patient experienced hallucinations, Entityagitation , vomiting, tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Entitybupropion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe Entityvalproate - induced Entityhyperammonemia and mental status changes in an 88 - year - old man, the first known reported case in an elderly patient.
0.9998 Adverse-Effect The authors describe Entityvalproate - induced hyperammonemia and Entitymental status changes in an 88 - year - old man, the first known reported case in an elderly patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : No published clinical studies in patients receiving Entityclindamycin vaginal cream for bacterial vaginosis have documented C. difficile toxin in stool samples of patients with Entitydiarrhea .
1.0000 Adverse-Effect DISCUSSION : No published clinical studies in patients receiving Entityclindamycin vaginal cream for bacterial vaginosis have documented EntityC. difficile toxin in stool samples of patients with diarrhea.
Adverse-Effect DISCUSSION : No published clinical studies in patients receiving Entityclindamycin vaginal cream for bacterial vaginosis have documented EntityC. difficile toxin in stool samples of patients with diarrhea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When Entitythrombosis develops during Entityheparin treatment, it is important to suspect HITTs and to assay for the associated antibodies, regardless of the actual platelet count.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with Wegener's granulomatosis rapidly developed a Entitycircumferential subglottic stenosis while on a Entitycyclophosphamide regimen that had caused resolution of systemic symptoms and pulmonary infiltrates.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In each of the three reported patients, alteration of eyelid appearance with Entitydeepening of the lid sulcus was evident as the result of topical Entitybimatoprost therapy.
1.0000 Adverse-Effect In each of the three reported patients, Entityalteration of eyelid appearance with deepening of the lid sulcus was evident as the result of topical Entitybimatoprost therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To evaluate the efficacy of the administration of insulin by a jet - injector device in stopping and reversing severe Entityhuman insulin - induced Entitylipoatrophy .
0.9979 Adverse-Effect OBJECTIVE : To evaluate the efficacy of the administration of Entityinsulin by a jet - injector device in stopping and reversing severe human insulin - induced Entitylipoatrophy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors intend to carry out a case - control study on patients treated with Entitytamoxifen for breast carcinoma to reveal the possible presence of Entityendometrial carcinoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, clinicians should pay close attention to possible onset of EntityRD in patients with multiple risk factors for TD, even when EntitySDA therapy is used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Children with acute lymphoblastic leukemia ( ALL ), treated with EntityL - asparaginase are at risk for Entitycerebral thrombosis or hemorrhage because of coagulation protein deficiencies.
0.9998 Adverse-Effect Children with acute lymphoblastic leukemia ( ALL ), treated with EntityL - asparaginase are at risk for cerebral thrombosis or Entityhemorrhage because of coagulation protein deficiencies.
0.9994 Adverse-Effect Children with acute lymphoblastic leukemia ( ALL ), treated with EntityL - asparaginase are at risk for cerebral thrombosis or hemorrhage because of Entitycoagulation protein deficiencies .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient with chronic lymphocytic leukemia ( CLL ) who developed fatal intravascular autoimmune hemolytic anemia ( EntityAIHA ) after Entityfludarabine treatment.
1.0000 Adverse-Effect We report the case of a patient with chronic lymphocytic leukemia ( CLL ) who developed Entityfatal intravascular autoimmune hemolytic anemia ( AIHA ) after Entityfludarabine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two ELBW infants affected by hyperkalaemia, treated with EntityKayexalate , who developed serious Entityhypernatraemia , that has never been reported before in preterm infants.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : To the best of our knowledge, this is the first time Entitycolchicine Entitycolchicine intoxication in this age group has been described in the English literature.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Initial treatment with Entityheparin was substituted with thrombolysis, which resulted in clinical improvement and dissolution of right heart thrombus but was followed by Entityfatal intracerebral haemorrhage .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nine Entitydelirious patients suffering from Entitylithium intoxication were examined with the Mini - Mental State Exam ( MMS ) to describe the clinical course of the disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recently, some studies have also reported association between patients with juvenile rheumatoid arthritis ( JRA ) treated with Methotrexate ( EntityMTX ) and Entitymalignant lymphoma developing.
0.9999 Adverse-Effect Recently, some studies have also reported association between patients with juvenile rheumatoid arthritis ( JRA ) treated with EntityMethotrexate ( MTX ) and Entitymalignant lymphoma developing.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect EntityRifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced Entityhypothyroidism , all associated with Hashimoto's thyroiditis.
0.9996 Adverse-Effect Rifampin ( EntityRFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced Entityhypothyroidism , all associated with Hashimoto's thyroiditis.
0.9995 Adverse-Effect EntityRifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced hypothyroidism, all associated with EntityHashimoto's thyroiditis .
0.9994 Adverse-Effect Rifampin ( EntityRFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced hypothyroidism, all associated with EntityHashimoto's thyroiditis .
1.0000 Adverse-Effect Rifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of EntityRFP - induced Entityhypothyroidism , all associated with Hashimoto's thyroiditis.
0.9993 Adverse-Effect Rifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of EntityRFP - induced hypothyroidism, all associated with EntityHashimoto's thyroiditis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the late development of Entityimmune - mediated diabetes mellitus after completion of Entityalfa - interferon therapy for hepatitis C in an Asian patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a woman with chronic schizophrenia who experienced delirium, grand mal seizure, and Entityphotosensitivity after the addition of Entitypropranolol to her neuroleptic regimen.
1.0000 Adverse-Effect The authors describe a woman with chronic schizophrenia who experienced Entitydelirium , grand mal seizure, and photosensitivity after the addition of Entitypropranolol to her neuroleptic regimen.
0.9999 Adverse-Effect The authors describe a woman with chronic schizophrenia who experienced delirium, Entitygrand mal seizure , and photosensitivity after the addition of Entitypropranolol to her neuroleptic regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Seven patients with hematologic malignancies who were treated with Entitymiconazole for either suspected or proven fungal infections developed eight episodes of major adverse Entitycardiorespiratory and anaphylactic reactions .
1.0000 Adverse-Effect Seven patients with hematologic malignancies who were treated with Entitymiconazole for either suspected or proven fungal infections developed eight episodes of major Entityadverse cardiorespiratory and anaphylactic reactions .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect k bipolar manic - depressive patient, developed while on Entitylithium prophylaxis, Entityakathisia at therapeutic serum lithium levels and subsequently bucco - linguo - masticatory dyskinesia.
0.9985 Adverse-Effect k bipolar manic - depressive patient, developed while on Entitylithium prophylaxis, akathisia at therapeutic serum lithium levels and subsequently Entitybucco - linguo - masticatory dyskinesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hydroxyurea ( HU ) and Entitysodium phenylbutyrate ( SPB ) have been shown to Entityincrease fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
0.9999 Adverse-Effect EntityHydroxyurea ( HU ) and sodium phenylbutyrate ( SPB ) have been shown to Entityincrease fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
0.9999 Adverse-Effect Hydroxyurea ( EntityHU ) and sodium phenylbutyrate ( SPB ) have been shown to Entityincrease fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second was an 82 - year - old man receiving Entityticlopidine for 2 years when, during a febrile episode, he was found Entityneutropenic with marrow aplasia.
0.9999 Adverse-Effect The second was an 82 - year - old man receiving Entityticlopidine for 2 years when, during a febrile episode, he was found neutropenic with Entitymarrow aplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 73 - year - old woman with non - Hodgkin's lymphoma had two episodes of severe, bilateral, Entitysensori - neural hearing loss after Entityvincristine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal radiation myelopathy after high - dose Entitybusulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma : a review of the literature and implications for practice.
1.0000 Adverse-Effect EntityFatal radiation myelopathy after high - dose busulfan and Entitymelphalan chemotherapy and radiotherapy for Ewing's sarcoma : a review of the literature and implications for practice.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 57 - year - old man developed chronic, Entitywatery diarrhea four weeks after Helicobacter pylori eradication therapy including Entitylansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease.
0.9997 Adverse-Effect A 57 - year - old man developed chronic, Entitywatery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by Entitylansoprazole monotherapy for gastroesophageal reflux disease.
Adverse-Effect A 57 - year - old man developed Entitychronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including Entitylansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease.
Adverse-Effect A 57 - year - old man developed Entitychronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by Entitylansoprazole monotherapy for gastroesophageal reflux disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : EntityCyanamide , an aversive agent widely used in Japan, is known to induce various degrees of Entityhepatic lesion with ground - glass inclusion bodies .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : To assess the nature, incidence, and risk factors of Entityretinopathy associated with Entitypegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.
0.9997 Adverse-Effect BACKGROUND : To assess the nature, incidence, and risk factors of Entityretinopathy associated with pegylated interferon and Entityribavirin combination therapy in chronic hepatitis C patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases were chosen for study because they were all Entitydeaths as a result of suicidal ingestion of drugs in which Entityquetiapine was considered a significant factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Exposure of the fetus to Entityindomethacin by administration of the drug to the mother may cause many side effects, including Entitypremature closure of the ductus arteriosus .
1.0000 Adverse-Effect EntityExposure of the fetus to Entityindomethacin by administration of the drug to the mother may cause many side effects, including premature closure of the ductus arteriosus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This increase when clozapine was switched to risperidone and vice versa is consistent with our previous report of Entityelevated serum triglyceride levels in Entityclozapine - treated patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitytoxic hepatitis caused by combination therapy with Entitymethotrexate and etretinate in the treatment of severe psoriasis is presented in a 47 - year - old woman.
1.0000 Adverse-Effect A case of Entitytoxic hepatitis caused by combination therapy with methotrexate and Entityetretinate in the treatment of severe psoriasis is presented in a 47 - year - old woman.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Entityrespiratory failure occurring in a woman at 16 weeks'gestation who was being treated with Entitynitrofurantoin for a urinary tract infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTiclopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with Entitysevere bone marrow suppression , typically aplastic anemia.
1.0000 Adverse-Effect EntityTiclopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with severe bone marrow suppression, typically Entityaplastic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pellagra should be suspected whenever tuberculous patients under treatment with Entityisoniazid develop Entitymental, neurological or gastrointestinal symptoms , even in the absence of typical pellagra dermatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment with Entityinfliximab is known to produce an Entityincrease of autoantibodies ( antinuclear antibodies, anti - double - stranded DNA ), but not clinical disease.
1.0000 Adverse-Effect Treatment with Entityinfliximab is known to produce an increase of autoantibodies ( Entityantinuclear antibodies , anti - double - stranded DNA ), but not clinical disease.
1.0000 Adverse-Effect Treatment with Entityinfliximab is known to produce an increase of autoantibodies ( antinuclear antibodies, Entityanti - double - stranded DNA ), but not clinical disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 21 - year - old man with Tourette's syndrome, pedophilia, Asperger's syndrome, and multiple sclerosis experienced Entityseizures after receiving therapy with Entityinterferon beta - 1a .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of a 58 - year - old female patient with Graves'disease who developed EntityAA in the third exposure to Entitymethimazole ( MMI ).
1.0000 Adverse-Effect We present a case of a 58 - year - old female patient with Graves'disease who developed EntityAA in the third exposure to methimazole ( EntityMMI ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityHypersensitivity to Entitycarboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute changes on ECG whilst receiving carboplatin therapy.
0.9997 Adverse-Effect Hypersensitivity to Entitycarboplatin is a rare but real complication of therapy and should be considered in patients presenting with Entityhyperacute changes on ECG whilst receiving carboplatin therapy.
1.0000 Adverse-Effect Hypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with Entityhyperacute changes on ECG whilst receiving Entitycarboplatin therapy.
0.9999 Adverse-Effect Hypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute Entitychanges on ECG whilst receiving Entitycarboplatin therapy.
0.9987 Adverse-Effect Hypersensitivity to Entitycarboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute Entitychanges on ECG whilst receiving carboplatin therapy.
0.9577 Adverse-Effect EntityHypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute changes on ECG whilst receiving Entitycarboplatin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityARA - C is frequently associated with Entitydermatologic toxicity , but this is only the second case of toxic epidermal necrolysis described in connection with this drug.
0.9985 Adverse-Effect EntityARA - C is frequently associated with dermatologic toxicity, but this is only the second case of Entitytoxic epidermal necrolysis described in connection with this drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After 5 days of treatment with EntityIL - 2 , the patient developed a Entityhemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 pancytopenia.
0.9997 Adverse-Effect After 5 days of treatment with EntityIL - 2 , the patient developed a hemorrhagic lesion that progressed to Entitytoxic epidermal necrolysis , as well as grade 4 pancytopenia.
0.9995 Adverse-Effect After 5 days of treatment with EntityIL - 2 , the patient developed a hemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 Entitypancytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect IV Entitypropranolol was used as the initial treatment for his hyperadrenergic state, resulting in a Entitydecrease in heart rate but a paroxsymal increase in blood pressure.
1.0000 Adverse-Effect IV Entitypropranolol was used as the initial treatment for his hyperadrenergic state, resulting in a decrease in heart rate but a Entityparoxsymal increase in blood pressure .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The currently available clinical and neuropharmacologic data suggest that Entitycarbamazepine may be an antagonist of dopamine and that this property is responsible for the production of Entitydystonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect All developed Entitymucocutaneous side effects within 20 weeks of beginning i m Entitygold therapy, at a time when RA had improved markedly compared to pretreatment status.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present three patients with paradoxical Entityseizures ; their serum Entityphenytoin levels were 43. 5 mcg / mL, 46. 5 mcg / mL and 38. 3 mcg / mL.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of Entityclofazimine , showed Entitydiscoloration of nail plate , subungual hyperkeratosis and onycholysis.
1.0000 Adverse-Effect Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of Entityclofazimine , showed discoloration of nail plate, Entitysubungual hyperkeratosis and onycholysis.
0.9999 Adverse-Effect Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of Entityclofazimine , showed discoloration of nail plate, subungual hyperkeratosis and Entityonycholysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Patients receiving intravitreal injections of Entitybevacizumab should be evaluated for potential systemic risk factors such as Entitycarotid insufficiency , coagulopathy and poorly controlled diabetes mellitus.
1.0000 Adverse-Effect CONCLUSIONS : Patients receiving intravitreal injections of Entitybevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency, Entitycoagulopathy and poorly controlled diabetes mellitus.
1.0000 Adverse-Effect CONCLUSIONS : Patients receiving intravitreal injections of Entitybevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency, coagulopathy and Entitypoorly controlled diabetes mellitus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 53 - year - old man developed Entitylower leg edema 4 weeks after Entityrosiglitazone was increased from 4 mg once / day to 4 mg twice / day.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 68 - year - old woman developed a dry, Entityirritating cough within one month of starting Entityquinapril therapy for the treatment of essential hypertension.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Three patients who had experienced neuroleptic - induced akathisia in the past reported that the symptoms of Entityfluoxetine - induced Entityakathisia were identical, although somewhat milder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Shortly after chemotherapy and an injection of Entitypegfilgrastim , the patient developed poorly defined, Entityrapidly progressive erythema , edema, and pain in his right forearm.
1.0000 Adverse-Effect Shortly after chemotherapy and an injection of Entitypegfilgrastim , the patient developed poorly defined, rapidly progressive erythema, edema, and Entitypain in his right forearm .
1.0000 Adverse-Effect Shortly after chemotherapy and an injection of Entitypegfilgrastim , the patient developed poorly defined, rapidly progressive erythema, Entityedema , and pain in his right forearm.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The results suggest that olanzapine may be useful in treating patients with Entityclozapine - induced Entitygranulocytopenia without the risk of recurrence of hematologic side effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : EntityGemcitabine - induced Entityrecall pneumonitis is a rarely reported phenomenon and should be taken into account even after extended time interval to the previous radiotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one patient, treatment with EntityDCA was associated with a Entitydecrease in blood lactate levels from 11. 2 mM before treatment to 0. 8 mM 16 h later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMitomycin - C is used widely in the treatment of malignancies and is associated with serious dose related adverse effects including the occurrence of Entityhemolytic uremic syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPancreatitis has been noted to be a complication in 2 - 16 % of patients undergoing treatment with EntityL - asparaginase for a variety of pediatric neoplasms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : EntityBrimonidine was observed to cause EntityIOP elevation , confirmed on rechallenge, scoring 8 ( strong probability ) on an adverse drug reaction probability score.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of EntityPRES in a patient with collapsing focal glomeruloesclerosis ( collapsing FGS ) with complete recovery after withdrawal of Entitycyclosporine ( CSA ).
1.0000 Adverse-Effect We describe a case of EntityPRES in a patient with collapsing focal glomeruloesclerosis ( collapsing FGS ) with complete recovery after withdrawal of cyclosporine ( EntityCSA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three of 50 patients treated with Entityisotretinoin ( 1 mg / kg / day ) for cystic acne complained of Entitypoor night vision and / or excessive glare sensitivity.
1.0000 Adverse-Effect Three of 50 patients treated with Entityisotretinoin ( 1 mg / kg / day ) for cystic acne complained of poor night vision and / or Entityexcessive glare sensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : A six - year - old boy with transfusion - dependent beta - thalassaemia developed a Entityunilateral hearing loss shortly after commencing Entitydesferrioxamine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE : A Entitymalignant mixed mesodermal tumor was diagnosed in a 64 - year - old woman with a bicornuate uterus while she was taking Entityraloxifene for osteoporosis prevention.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two cases that illustrate the use of Entitylithium in the treatment of veterans with PTSD who complained of serious problems with Entityirritability or angry outbursts.
0.9999 Adverse-Effect We describe two cases that illustrate the use of Entitylithium in the treatment of veterans with PTSD who complained of serious problems with irritability or Entityangry outbursts .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityDiazepam use by pregnant women can be associated with a later presentation of Entitywithdrawal symptoms in the neonate than that induced by the use of other drugs.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect She had just finished a 3 - week course of intravenous Entitytobramycin for bronchiectasis and had an elevated serum tobramycin trough level 1 week before the onset of Entitytetany .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Although adverse reactions to protamine are reported infrequently and are usually mild, we recently observed the first fatal case of Entitytype I anaphylaxis resulting from Entityprotamine .
0.9982 Adverse-Effect Although adverse reactions to Entityprotamine are reported infrequently and are usually mild, we recently observed the first Entityfatal case of type I anaphylaxis resulting from protamine.
0.9951 Adverse-Effect Although adverse reactions to Entityprotamine are reported infrequently and are usually mild, we recently observed the first fatal case of Entitytype I anaphylaxis resulting from protamine.
0.9924 Adverse-Effect Although adverse reactions to protamine are reported infrequently and are usually mild, we recently observed the first Entityfatal case of type I anaphylaxis resulting from Entityprotamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The treatment for acidosis and hyperkalaemia should be started as soon as EntityRTA is diagnosed, and the dosage of EntityFK506 should also be reduced if possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityLithium is known to cause Entityacute renal failure and tubulo - interstitial disease, but the recently described association with proteinuria or nephrotic syndrome is little recognized.
0.9999 Adverse-Effect EntityLithium is known to cause acute renal failure and Entitytubulo - interstitial disease , but the recently described association with proteinuria or nephrotic syndrome is little recognized.
0.9999 Adverse-Effect EntityLithium is known to cause acute renal failure and tubulo - interstitial disease, but the recently described association with proteinuria or Entitynephrotic syndrome is little recognized.
0.9999 Adverse-Effect EntityLithium is known to cause acute renal failure and tubulo - interstitial disease, but the recently described association with Entityproteinuria or nephrotic syndrome is little recognized.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Awareness of this route of intoxication might be important in patients in whom neurologic or Entitypsychiatric symptoms develop while large amounts of Entitylidocaine cream are being used.
1.0000 Adverse-Effect Awareness of this route of intoxication might be important in patients in whom Entityneurologic or psychiatric symptoms develop while large amounts of Entitylidocaine cream are being used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 4 - year - old girl who presented with acute bilateral blindness, a focal seizure and Entityhypertension 10 days after commencing Entityoxybutynin to treat enuresis.
1.0000 Adverse-Effect We report a 4 - year - old girl who presented with Entityacute bilateral blindness , a focal seizure and hypertension 10 days after commencing Entityoxybutynin to treat enuresis.
0.9999 Adverse-Effect We report a 4 - year - old girl who presented with acute bilateral blindness, a Entityfocal seizure and hypertension 10 days after commencing Entityoxybutynin to treat enuresis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The purpose of this study was to examine the incidence and cause of EntityClostridium difficile colitis occurring after Entitycisplatin - based combination chemotherapy in ovarian cancer patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAgranulocytosis is a rare adverse effect associated with prolonged Entityvancomycin therapy, and is potentially serious, especially in end stage renal disease ( ESRD ) patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two days after administration of EntityKalimate enema, he had Entityprofuse hematochezia , and a sigmoidoscopy showed diffuse colonic mucosal necrosis in the rectum and sigmoid colon.
0.9997 Adverse-Effect Two days after administration of EntityKalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed Entitydiffuse colonic mucosal necrosis in the rectum and sigmoid colon.
Adverse-Effect Two days after administration of EntityKalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed diffuse Entitycolonic mucosal necrosis in the rectum and sigmoid colon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A 34 - year - old man acquired visual field defects and Entitysevere vision loss in both eyes after intravitreal injection of Entitytriamcinolone for diabetic macular edema.
1.0000 Adverse-Effect RESULTS : A 34 - year - old man acquired Entityvisual field defects and severe vision loss in both eyes after intravitreal injection of Entitytriamcinolone for diabetic macular edema.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A case is presented of a 45 - year - old woman on prolonged Entitygemcitabine treatment for ovarian cancer who developed EntityHUS and recovered after drug discontinuation.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect The failure of therapy with disopyramide and mexiletine to reproduce this observation suggests either a previously unreported Entityelectrophysiologic effect of, or idiosyncratic response to, Entityprocainamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In 2 of the 3 cases the patients were also taking Entitylithium carbonate and beta - blockers, both of which could have contributed to the Entityincontinence .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases are reported of patients who developed a Entityhematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with Entityetoglucid , doxorubicin, and mitomycin C.
0.9999 Adverse-Effect Two cases are reported of patients who developed a Entityhematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, Entitydoxorubicin , and mitomycin C.
0.9998 Adverse-Effect Two cases are reported of patients who developed a Entityhematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and Entitymitomycin C .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although differential diagnostic alternatives can be considered in all described cases it is very likely that Entityvincristine does cause Entitysevere visual loss in a small number of patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of neuroleptic malignant syndrome ( EntityNMS ) associated with Entityfluphenazine in a schizophrenic patient and review the literature related to this condition.
0.9999 Adverse-Effect OBJECTIVE : To report a case of Entityneuroleptic malignant syndrome ( NMS ) associated with Entityfluphenazine in a schizophrenic patient and review the literature related to this condition.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This latest ( third ) report suggests that the safety profile should be reexamined and at least raises the question of potential Entityrenal toxicity of Entityinterferons in MS.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After a second dose of Entitymetoclopramide , these symptoms recurred and were associated with Entityconfusion , agitation, fever, diaphoresis, tachypnea, tachycardia, and hypertension.
1.0000 Adverse-Effect After a second dose of Entitymetoclopramide , these symptoms recurred and were associated with confusion, Entityagitation , fever, diaphoresis, tachypnea, tachycardia, and hypertension.
1.0000 Adverse-Effect After a second dose of Entitymetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, Entitydiaphoresis , tachypnea, tachycardia, and hypertension.
1.0000 Adverse-Effect After a second dose of Entitymetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, Entitytachypnea , tachycardia, and hypertension.
1.0000 Adverse-Effect After a second dose of Entitymetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, tachypnea, Entitytachycardia , and hypertension.
1.0000 Adverse-Effect After a second dose of Entitymetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, tachypnea, tachycardia, and Entityhypertension .
1.0000 Adverse-Effect After a second dose of Entitymetoclopramide , these symptoms recurred and were associated with confusion, agitation, Entityfever , diaphoresis, tachypnea, tachycardia, and hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sulindac ( EntityClinoril ), a nonsteroidal anti - inflammatory agent, has few reported Entityneurologic toxic effects , all of which have been associated with systemic disease.
0.9999 Adverse-Effect EntitySulindac ( Clinoril ), a nonsteroidal anti - inflammatory agent, has few reported Entityneurologic toxic effects , all of which have been associated with systemic disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 59 - year - old patient with chronic myeloid leukemia, who developed Entitysevere interstitial lung fibrosis after short term and sequential treatment with Entitymelphalan and busulfan.
1.0000 Adverse-Effect We report a 59 - year - old patient with chronic myeloid leukemia, who developed Entitysevere interstitial lung fibrosis after short term and sequential treatment with melphalan and Entitybusulfan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An association of granulocytopenia, eosinophilia, skin reaction and Entityhepatitis during Entitypropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
1.0000 Adverse-Effect An association of granulocytopenia, eosinophilia, skin reaction and Entityhepatitis during propylthiouracil ( EntityPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9999 Adverse-Effect An association of granulocytopenia, Entityeosinophilia , skin reaction and hepatitis during Entitypropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9999 Adverse-Effect An association of Entitygranulocytopenia , eosinophilia, skin reaction and hepatitis during Entitypropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9999 Adverse-Effect An association of granulocytopenia, eosinophilia, Entityskin reaction and hepatitis during Entitypropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9998 Adverse-Effect An association of granulocytopenia, Entityeosinophilia , skin reaction and hepatitis during propylthiouracil ( EntityPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9998 Adverse-Effect An association of Entitygranulocytopenia , eosinophilia, skin reaction and hepatitis during propylthiouracil ( EntityPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9997 Adverse-Effect An association of granulocytopenia, eosinophilia, Entityskin reaction and hepatitis during propylthiouracil ( EntityPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report five cases of Entitytremor related to Entityitraconazole therapy, which occurred within 1 - 12 months of initiating treatment and resolved gradually following itraconazole withdrawal.
0.9966 Adverse-Effect The authors report five cases of Entitytremor related to itraconazole therapy, which occurred within 1 - 12 months of initiating treatment and resolved gradually following Entityitraconazole withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, unlike those previously reported, Entityhyponatremia recurred 5 months after switching from Entitycitalopram to mirtazapine, which is believed to be a safe antidepressant.
1.0000 Adverse-Effect In this case, unlike those previously reported, Entityhyponatremia recurred 5 months after switching from citalopram to Entitymirtazapine , which is believed to be a safe antidepressant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityTorsades de Pointes induced by a combination of Entitygarenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide - 4 - influencing drugs during hypokalemia due to licorice.
1.0000 Adverse-Effect EntityTorsades de Pointes induced by a combination of garenoxacin and Entitydisopyramide and other cytochrome P450, family 3, subfamily A polypeptide - 4 - influencing drugs during hypokalemia due to licorice.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When the data of the 57 patients are evaluated, a reversible direct Entitycytotoxic effect of Entityticlopidine on the pluripotent / bipotent hematopoietic progenitor stem cell is proposed.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and Entitycirrhosis related to Entitybenzarone .
0.9977 Adverse-Effect Our cases constitute the most severe cases of Entitybenzarone Entityhepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and cirrhosis related to benzarone.
Adverse-Effect Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far, and comprise the first cases of Entity( sub ) fulminant hepatitis and cirrhosis related to Entitybenzarone .
Adverse-Effect Our cases constitute the most severe cases of Entitybenzarone hepatotoxicity reported so far, and comprise the first cases of Entity( sub ) fulminant hepatitis and cirrhosis related to benzarone.
Adverse-Effect Our cases constitute the most severe cases of Entitybenzarone hepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and Entitycirrhosis related to benzarone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 2 demonstrated after 40 months on Entitychlorambucil the presence of a Entitybalanced translocation , t ( 1 ; 5 ) ( p36 ; q31 ) in 90 % of the cells.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityFDE from Entitycephalosporins has been rarely reported, and to the best of our knowledge there is no published report of ceftriaxone - induced FDE in the literature.
Adverse-Effect FDE from cephalosporins has been rarely reported, and to the best of our knowledge there is no published report of Entityceftriaxone - induced EntityFDE in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We report the case of a 58 year old patient who, after 2 days of treatment with roxithromycin and Entitybetamethasone , manifested Entityacute pancreatitis .
0.9999 Adverse-Effect CASE REPORT : We report the case of a 58 year old patient who, after 2 days of treatment with Entityroxithromycin and betamethasone, manifested Entityacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient had a lower average heart rate and two patients had Entitylower average mean blood pressure values during Entitypropranolol treatment, none of which was clinically significant.
0.9999 Adverse-Effect One patient had a Entitylower average heart rate and two patients had lower average mean blood pressure values during Entitypropranolol treatment, none of which was clinically significant.
1.0000 Adverse-Effect One patient had a lower average heart rate and two patients had Entitylower average mean blood pressure values during Entitypropranolol treatment, none of which was clinically significant.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect These cases and a review of the literature suggested that Entityhepatotoxicity , though rare, should be added to the list of adverse reactions to EntityD - penicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient with multiple myeloma who developed Entityacute life - threatening water intoxication following treatment with oral Entityindomethacin and low dose intravenous cyclophosphamide.
1.0000 Adverse-Effect We report the case of a patient with multiple myeloma who developed acute life - threatening Entitywater intoxication following treatment with oral Entityindomethacin and low dose intravenous cyclophosphamide.
0.9999 Adverse-Effect We report the case of a patient with multiple myeloma who developed Entityacute life - threatening water intoxication following treatment with oral indomethacin and low dose intravenous Entitycyclophosphamide .
0.9998 Adverse-Effect We report the case of a patient with multiple myeloma who developed acute life - threatening Entitywater intoxication following treatment with oral indomethacin and low dose intravenous Entitycyclophosphamide .
Adverse-Effect We report the case of a patient with multiple myeloma who developed acute Entitylife - threatening water intoxication following treatment with oral Entityindomethacin and low dose intravenous cyclophosphamide.
Adverse-Effect We report the case of a patient with multiple myeloma who developed acute Entitylife - threatening water intoxication following treatment with oral indomethacin and low dose intravenous Entitycyclophosphamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report the occurrence of renal failure due to Entitycholesterol crystal embolization following thrombolytic therapy with intravenous Entityrecombinant tissue - type plasminogen activator ( t - PA ).
0.9996 Adverse-Effect We report the occurrence of renal failure due to Entitycholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( Entityt - PA ).
0.9996 Adverse-Effect We report the occurrence of Entityrenal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous Entityrecombinant tissue - type plasminogen activator ( t - PA ).
0.9994 Adverse-Effect We report the occurrence of Entityrenal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( Entityt - PA ).
0.9997 Adverse-Effect We report the occurrence of renal failure due to Entitycholesterol crystal embolization following thrombolytic therapy with intravenous recombinant Entitytissue - type plasminogen activator ( t - PA ).
0.9993 Adverse-Effect We report the occurrence of Entityrenal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant Entitytissue - type plasminogen activator ( t - PA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : The occurrence of Entitymyoclonus associated with continuous i. v. infusion of Entitydobutamine in a patient with end - stage renal disease ( ESRD ) is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect I saw two patients with kala - azar resistant to sodium stibogluconate who developed Entitycardiac arrest after Entityamphotericin infusion ( in spite of tolerating a test dose ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, in order to avoid Entityneuropathic side effects , patients under Entitythalidomide therapy should be monitored every 6 months with nerve conduction studies while taking the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitytoxicity and plasma concentrations of Entityifosfamide , chloroacetaldehyde, and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
0.9998 Adverse-Effect The Entitytoxicity and plasma concentrations of ifosfamide, chloroacetaldehyde, and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of Entityifosfamide .
0.9998 Adverse-Effect The Entitytoxicity and plasma concentrations of ifosfamide, Entitychloroacetaldehyde , and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
0.9998 Adverse-Effect The Entitytoxicity and plasma concentrations of ifosfamide, chloroacetaldehyde, and Entity4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A brief review of reported cases of Entitychloramphenicol Entityhypersensitivity in the English - language literature, as well as possible alternative explanations in this case, are provided.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In this paper, we report a case of 3 years - old boy who developed Entityacute onset tetraparesia following a viral respiratory infecction and Entityhepatitis B vaccination .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who developed EntityHUS after treatment with Entitymitomycin C ( total dose 144 mg / m2 ) due to a carcinoma of the ascending colon.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect However, as the use of Entityhepatitis B vaccination is growing, adverse side effects, including Entitymental nerve neuropathy , should be observed with an increased frequency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a relatively healthy, 9 - year - old boy who developed a CA - MRSA skin and Entitysoft tissue infection and was treated with EntityTMP - SMX .
0.9993 Adverse-Effect We describe a relatively healthy, 9 - year - old boy who developed a EntityCA - MRSA skin and soft tissue infection and was treated with EntityTMP - SMX .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mild immunosuppression that occurs with Entitymethotrexate therapy probably places patients with rheumatoid arthritis at added risk of developing Entitylymphoproliferative diseases , but coincidence can not be excluded.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect These are the first reported patients to show mfERG abnormalities that correspond to Entitybitemporal visual field defects and add to the growing evidence that Entityethambutol damages the retina.
0.9998 Adverse-Effect These are the first reported patients to show EntitymfERG abnormalities that correspond to bitemporal visual field defects and add to the growing evidence that Entityethambutol damages the retina.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMusculoskeletal complaints were the presenting symptoms in four of 44 children ( 9 % ) treated for relapsed Wilms'tumors with Entityifosfamide , a derivative of cyclophosphamide.
0.9997 Adverse-Effect EntityMusculoskeletal complaints were the presenting symptoms in four of 44 children ( 9 % ) treated for relapsed Wilms'tumors with ifosfamide, a derivative of Entitycyclophosphamide .
Score Relation Text (Head - Tail)
0.9991 Adverse-Effect This case suggests that EntityBH - AC , a derivative of cytosine arabinoside ( 1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible Entityencephalopathy syndrome .
1.0000 Adverse-Effect This case suggests that BH - AC, a derivative of cytosine arabinoside ( Entity1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible Entityencephalopathy syndrome .
0.9996 Adverse-Effect This case suggests that BH - AC, a derivative of Entitycytosine arabinoside ( 1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible Entityencephalopathy syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the data indicate an immune - complex cause for Entitygold - salt Entitynephropathy , the incident antigen ( or antigens ) and mechanism of action remain unidentified.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 40 - year - old man with a long standing history of rheumatoid arthritis was treated with EntityMTX over a 6 month period and developed an Entityoverwhelming hepatic necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a 64 - year - old man with secondary Entityadrenocortical insufficiency who has been on a chronic transdermal Entityfentanyl treatment because of sciatic pain syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We now report the first known cancer patient who developed Entitylife - threatening complications after treatment with topical Entity5 - FU and was shown subsequently to have profound DPD deficiency.
0.9999 Adverse-Effect We now report the first known cancer patient who developed life - threatening complications after treatment with topical Entity5 - FU and was shown subsequently to have profound EntityDPD deficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 62 - year - old Caucasian man with atrial fibrillation who was taking Entitywarfarin reported an episode of Entityhematochezia ; his international normalized ratio ( INR ) was 1. 74.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 9 - year - old boy developed Entityacute renal failure following intravenous Entityacyclovir ( 30 mg / kg per day ) administered for 6 days to treat herpetic encephalitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with acute leukemia who developed Horner's syndrome and a severe demyelinating peripheral neuropathy leading to Entitydeath after receiving high - dose Entitycytosine arabinoside .
0.9998 Adverse-Effect We describe a patient with acute leukemia who developed Horner's syndrome and a Entitysevere demyelinating peripheral neuropathy leading to death after receiving high - dose Entitycytosine arabinoside .
0.9997 Adverse-Effect We describe a patient with acute leukemia who developed EntityHorner's syndrome and a severe demyelinating peripheral neuropathy leading to death after receiving high - dose Entitycytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a 23 - year - old man who developed a Entityvancomycin - induced Entityanaphylactic reaction in the treatment of methicillin - resistant Staphylococcus aureus infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed 2 cases of Entityhepatotoxicity after a high - dose Entitymethylprednisolone treatment of a demyelinating disease and evaluated the potential relationship in the light of available evidence.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMasculinization of a female fetus occurred in 5 of 39 ( 12. 8 % ) exposed to Entitynorethisterone ; all were cases of clitoral hypertrophy not requiring surgical treatment.
0.9999 Adverse-Effect Masculinization of a female fetus occurred in 5 of 39 ( 12. 8 % ) exposed to Entitynorethisterone ; all were cases of Entityclitoral hypertrophy not requiring surgical treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Observations in our patient suggest that the Entityleukoencephalopathy that developed in previously reported patients who received Entity5 - fluorouracil and levamisole may have been caused at least partly by levamisole.
0.9996 Adverse-Effect Observations in our patient suggest that the Entityleukoencephalopathy that developed in previously reported patients who received 5 - fluorouracil and Entitylevamisole may have been caused at least partly by levamisole.
0.9992 Adverse-Effect Observations in our patient suggest that the Entityleukoencephalopathy that developed in previously reported patients who received 5 - fluorouracil and levamisole may have been caused at least partly by Entitylevamisole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : In some abstainers who take Entitycyanamide for several years, thin Entityseptum - like liver fibrosis progresses along with the emergence of ground - glass hepatocytes.
0.9999 Adverse-Effect CONCLUSION : In some abstainers who take Entitycyanamide for several years, thin septum - like liver fibrosis progresses along with the emergence of Entityground - glass hepatocytes .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityArgatroban is hepatically cleared and may be the preferred direct thrombin inhibitor in the presence of significant renal impairment, but conversely has prolonged effects in Entityhepatic failure .
0.9999 Adverse-Effect EntityArgatroban is hepatically cleared and may be the preferred direct thrombin inhibitor in the presence of significant Entityrenal impairment , but conversely has prolonged effects in hepatic failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In patients with cirrhosis, the metabolism of Entitymeperidine is decreased, leading to Entityaccumulation of the parent drug and possible CNS depressive effects similar to hepatic encephalopathy.
0.9997 Adverse-Effect In patients with cirrhosis, the metabolism of Entitymeperidine is decreased, leading to accumulation of the parent drug and possible EntityCNS depressive effects similar to hepatic encephalopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityhepatolithiasis ( intrahepatic stone ) complicated by gram - negative sepsis in a 37 year old male with acromegaly being treated with Entityoctreotide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entityrash seen in this patient, who was treated with Entitycephalexin , may be similar to the rash seen with ampicillin treatment of patients with infectious mononucleosis.
0.9789 Adverse-Effect The rash seen in this patient, who was treated with Entitycephalexin , may be similar to the Entityrash seen with ampicillin treatment of patients with infectious mononucleosis.
Adverse-Effect The rash seen in this patient, who was treated with cephalexin, may be similar to the Entityrash seen with Entityampicillin treatment of patients with infectious mononucleosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on three observations of parkinsonian patients with Entitylevo - dopa - induced Entitydiphasic dyskinesias , who received subcutaneous apomorphine to reduce the duration of abnormal movements.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two cases of Entitysulfadiazine - induced Entitycrystalluria and renal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.
1.0000 Adverse-Effect We describe two cases of Entitysulfadiazine - induced crystalluria and Entityrenal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and Entitycalcitriol are Entitysecondary hyperparathyroidism and vitamin D intoxication, potassium loss also should be kept in mind.
0.9998 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and Entitycalcitriol are secondary hyperparathyroidism and vitamin D intoxication, Entitypotassium loss also should be kept in mind.
0.9996 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and Entitycalcitriol are secondary hyperparathyroidism and Entityvitamin D intoxication , potassium loss also should be kept in mind.
0.9994 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with Entityphosphate and calcitriol are secondary hyperparathyroidism and vitamin D intoxication, Entitypotassium loss also should be kept in mind.
0.9993 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with Entityphosphate and calcitriol are Entitysecondary hyperparathyroidism and vitamin D intoxication, potassium loss also should be kept in mind.
0.9979 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with Entityphosphate and calcitriol are secondary hyperparathyroidism and Entityvitamin D intoxication , potassium loss also should be kept in mind.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After 39 hours on Entityargatroban , the infusion was stopped when minor Entitybleeding was observed with a concurrent activated partial thromboplastin time ( aPTT ) of 100 seconds.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report rules out other causes of Entitytoxic epidermal necrolysis and implicates Entityofloxacin in what appears to be an atypical presentation of drug - induced toxic epidermal necrolysis.
0.9998 Adverse-Effect This report rules out other causes of toxic epidermal necrolysis and implicates Entityofloxacin in what appears to be an atypical presentation of drug - induced Entitytoxic epidermal necrolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntitySensorineural hearing loss due to Entityquinine therapy for malaria has frequently been mentioned in the literature but has not been a subject of research during the last decades.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 31 - year - old female developed multiple episodes of Entitygrand mal seizures after combination chemotherapy with Entitycisplatin , vinblastine and bleomycin for germ cell ovarian cancer stage Ic.
1.0000 Adverse-Effect A 31 - year - old female developed multiple episodes of Entitygrand mal seizures after combination chemotherapy with cisplatin, Entityvinblastine and bleomycin for germ cell ovarian cancer stage Ic.
1.0000 Adverse-Effect A 31 - year - old female developed multiple episodes of Entitygrand mal seizures after combination chemotherapy with cisplatin, vinblastine and Entitybleomycin for germ cell ovarian cancer stage Ic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 12 year old patient with atrial flutter is presented, in whom intravenous Entityadenosine was followed by Entityacceleration of the heart rate to a potentially dangerous arrhythmia.
0.9999 Adverse-Effect A 12 year old patient with atrial flutter is presented, in whom intravenous Entityadenosine was followed by acceleration of the heart rate to a potentially dangerous Entityarrhythmia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case in which Entityhemorrhage occurred in an asymptomatic falx meningioma known beforehand, after the internal use of low - dose Entityaspirin for 16 months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityhypoglycaemia after Entitymefloquine therapy ( 1, 500 mg over two days ) for severe gastrointestinal cryptosporidiasis in a cachectic AIDS patient with protracted diarrhoea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of paradoxical, intravenous Entityvalproic acid - induced Entityseizure exacerbation in a child with juvenile absence epilepsy, documented by video - electroencephalography.
0.9966 Adverse-Effect This report describes a case of Entityparadoxical , intravenous valproic acid - induced Entityseizure exacerbation in a child with juvenile absence epilepsy, documented by video - electroencephalography.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect That review suggested that patients receiving Entityanti - D IGIV be monitored for those and other potential complications of Entityhemoglobinemia , particularly disseminated intravascular coagulation ( DIC ).
0.9998 Adverse-Effect That review suggested that patients receiving Entityanti - D IGIV be monitored for those and other potential complications of hemoglobinemia, particularly disseminated intravascular coagulation ( EntityDIC ).
0.9995 Adverse-Effect That review suggested that patients receiving Entityanti - D IGIV be monitored for those and other potential complications of hemoglobinemia, particularly Entitydisseminated intravascular coagulation ( DIC ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mequitazine seemed to play a part similar to chlorpromazine, and absence of Entitymequitazine - induced Entityphotosensitivity may be due to a relatively low dosage of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors suggest that Entityrisperidone may Entityincrease affect in patients with schizophrenia and that some patients, especially those with anxiety, may have difficulty managing the increase.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The risk of new - onset Entitydiabetic ketoacidosis in patients with diabetic risk factors who are taking Entityperospirone hydrochloride or other atypical antipsychotics should be kept in mind.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Among the many presentations of Entityifosfamide Entityneurotoxicity , clinicians should consider NCSE as a possible explanation for changes in consciousness in a patient receiving this agent.
0.9831 Adverse-Effect CONCLUSIONS : Among the many presentations of Entityifosfamide neurotoxicity, clinicians should consider EntityNCSE as a possible explanation for changes in consciousness in a patient receiving this agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH - receptor autoantibodies, and then the occurrence of EntityGraves'hyperthyroidism during EntityIFN therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A transient tonic pupillary response, denervation supersensitivity, and Entityabnormal visual - evoked potentials in Entityquinine toxicity, to our knowledge, have not been previously reported.
0.9998 Adverse-Effect A Entitytransient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials in Entityquinine toxicity, to our knowledge, have not been previously reported.
0.9998 Adverse-Effect A transient tonic pupillary response, Entitydenervation supersensitivity , and abnormal visual - evoked potentials in Entityquinine toxicity, to our knowledge, have not been previously reported.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect An encephalopathy and Entitycardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced renal failure while receiving an intravesical Entityaluminum infusion for hemorrhagic cystitis.
0.9998 Adverse-Effect An Entityencephalopathy and cardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced renal failure while receiving an intravesical Entityaluminum infusion for hemorrhagic cystitis.
1.0000 Adverse-Effect An encephalopathy and cardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced Entityrenal failure while receiving an intravesical Entityaluminum infusion for hemorrhagic cystitis.
Score Relation Text (Head - Tail)
0.9991 Adverse-Effect Pancreatitis is a very rare adverse effect associated with the use of amiodarone, and only four cases of Entityamiodarone - induced Entitypancreatitis have been reported in literature.
0.9967 Adverse-Effect EntityPancreatitis is a very rare adverse effect associated with the use of Entityamiodarone , and only four cases of amiodarone - induced pancreatitis have been reported in literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONTEXT : Previous investigators have reported Entitydiscrepancies between hematologic, marrow morphologic, and cytogenetic responses to Entityimatinib mesylate among patients with chronic myeloid leukemia ( CML ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The administration of Entitytissue plasminogen activator was responsible for the large extent of Entityhemorrhage and should be considered in the differential diagnosis of hemorrhagic choroidal detachment.
0.9993 Adverse-Effect CONCLUSION : The administration of Entitytissue plasminogen activator was responsible for the large extent of hemorrhage and should be considered in the differential diagnosis of Entityhemorrhagic choroidal detachment .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To describe Entitytransient structured visual hallucinations in a patient with vascular age - related macular degeneration ( AMD ), following an intravitreal EntityAvastin - injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAtaxia caused by Entitypropafenone has been reported to the pharmaceutical companies and drug monitoring agencies, but has not been well described or emphasized in the medical literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with Entityolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, Entityleukocytosis , and increased serum transaminase and creatine kinase levels while receiving treatment with Entityolanzapine and lithium.
0.9999 Adverse-Effect A 16 - year - old boy developed Entityfever , generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with Entityolanzapine and lithium.
0.9999 Adverse-Effect A 16 - year - old boy developed fever, Entitygeneralized rigidity , leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with Entityolanzapine and lithium.
0.9999 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Entitylithium .
0.9998 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, Entityleukocytosis , and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Entitylithium .
0.9998 Adverse-Effect A 16 - year - old boy developed Entityfever , generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Entitylithium .
0.9998 Adverse-Effect A 16 - year - old boy developed fever, Entitygeneralized rigidity , leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Entitylithium .
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with Entityolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with Entityolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with Entityolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with Entityolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Entitylithium .
0.9999 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Entitylithium .
0.9999 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Entitylithium .
0.9998 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Entityincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Entitylithium .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We suggest adding this side effect to the list of untoward effects of lidocaine and to the differential diagnosis of fixed Entitydilated pupils in neonates treated with Entitylidocaine .
0.9993 Adverse-Effect We suggest adding this side effect to the list of untoward effects of Entitylidocaine and to the differential diagnosis of fixed Entitydilated pupils in neonates treated with lidocaine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that Entitymyocardial infarction may develop in patients treated with high - dose Entityglucocorticoids for Graves'ophthalmopathy, and increased blood pressure may herald this complication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After intravitreal injection of Entitytriamcinolone acetonide , Entitycataract may rapidly develop in eyes that have been intensively treated, topically and systemically, by corticosteroids for several years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The current study investigated the visual fields and visual electrophysiology of eight patients with known Entityvigabatrin - attributed Entityvisual field loss , three of whom were reported previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityQuinapril is an angiotensin - converting enzyme inhibitor ( ACE - inhibitor ) and overdose can lead to Entityprolonged hypotension and, less frequently, transient renal impairment.
1.0000 Adverse-Effect EntityQuinapril is an angiotensin - converting enzyme inhibitor ( ACE - inhibitor ) and overdose can lead to prolonged hypotension and, less frequently, Entitytransient renal impairment .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 60 - year - old woman with diabetes mellitus ( type 2 ) developed an Entityacute icteric hepatitis - like illness 6 weeks after the initiation of Entitygliclazide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - yr - old male patient with essential thrombocythaemia ( ET ) developed chronic myeloid leukaemia ( EntityCML ) after continuous uneventful treatment with Entityhydroxyurea for 18 yr.
1.0000 Adverse-Effect A 58 - yr - old male patient with essential thrombocythaemia ( ET ) developed Entitychronic myeloid leukaemia ( CML ) after continuous uneventful treatment with Entityhydroxyurea for 18 yr.
Score Relation Text (Head - Tail)
Adverse-Effect The purpose of this report is to document a new case of in utero EntityCP exposure with Entitymultiple congenital anomalies and to establish an apparent CP embryopathy phenotype.
Adverse-Effect The purpose of this report is to document a new case of in utero CP exposure with multiple congenital anomalies and to establish an apparent EntityCP Entityembryopathy phenotype.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entitycalcineurin - induced Entitypain syndrome ( CIPS ) in a child undergoing his second hematopoietic stem cell transplant ( HSCT ).
0.9999 Adverse-Effect OBJECTIVE : To report a case of Entitycalcineurin - induced pain syndrome ( EntityCIPS ) in a child undergoing his second hematopoietic stem cell transplant ( HSCT ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, skin eruptions, leukocytopenia, and Entitythrombocytopenia , 3 weeks after treatment with Entitysulfasalazine .
1.0000 Adverse-Effect A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, skin eruptions, Entityleukocytopenia , and thrombocytopenia, 3 weeks after treatment with Entitysulfasalazine .
1.0000 Adverse-Effect A 58 - year - old woman with rheumatoid arthritis ( RA ) developed Entityfever , skin eruptions, leukocytopenia, and thrombocytopenia, 3 weeks after treatment with Entitysulfasalazine .
0.9999 Adverse-Effect A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, Entityskin eruptions , leukocytopenia, and thrombocytopenia, 3 weeks after treatment with Entitysulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In deciding if tamoxifen therapy is warranted, all potentially life - threatening adverse events associated with Entitytamoxifen should be considered, including Entityendometrial adenocarcinoma or uterine sarcoma.
0.9995 Adverse-Effect In deciding if Entitytamoxifen therapy is warranted, all potentially life - threatening adverse events associated with tamoxifen should be considered, including Entityendometrial adenocarcinoma or uterine sarcoma.
0.9995 Adverse-Effect In deciding if tamoxifen therapy is warranted, all potentially life - threatening adverse events associated with Entitytamoxifen should be considered, including endometrial adenocarcinoma or Entityuterine sarcoma .
0.9986 Adverse-Effect In deciding if Entitytamoxifen therapy is warranted, all potentially life - threatening adverse events associated with tamoxifen should be considered, including endometrial adenocarcinoma or Entityuterine sarcoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although various manifestations of Entitypentamidine - induced Entitycardiotoxicity have been reported, to our knowledge, second - degree heart block associated with this agent has not been described.
0.9973 Adverse-Effect Although various manifestations of Entitypentamidine - induced cardiotoxicity have been reported, to our knowledge, Entitysecond - degree heart block associated with this agent has not been described.
Score Relation Text (Head - Tail)
Adverse-Effect We report the syndrome of inappropriate Entityantidiuresis as a much earlier side - effect of Entitycarbamazepine administration in a 29 - year Nigerian female patient with generalized tonic - elonic seizures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Amphotericin B ( EntityAmB ) is effective, but its use is limited by toxicity : Entityrenal impairment , anaemia, fever, malaise, and hypokalaemia are common.
1.0000 Adverse-Effect Amphotericin B ( EntityAmB ) is effective, but its use is limited by toxicity : renal impairment, Entityanaemia , fever, malaise, and hypokalaemia are common.
1.0000 Adverse-Effect Amphotericin B ( EntityAmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, Entitymalaise , and hypokalaemia are common.
0.9999 Adverse-Effect Amphotericin B ( EntityAmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, malaise, and Entityhypokalaemia are common.
0.9999 Adverse-Effect Amphotericin B ( EntityAmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, Entityfever , malaise, and hypokalaemia are common.
0.9998 Adverse-Effect EntityAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, Entityanaemia , fever, malaise, and hypokalaemia are common.
0.9998 Adverse-Effect EntityAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : Entityrenal impairment , anaemia, fever, malaise, and hypokalaemia are common.
0.9998 Adverse-Effect EntityAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, Entitymalaise , and hypokalaemia are common.
0.9998 Adverse-Effect EntityAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, malaise, and Entityhypokalaemia are common.
0.9997 Adverse-Effect EntityAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, Entityfever , malaise, and hypokalaemia are common.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This case suggests that sarcoidosis and Entitypravastatin , two entities not frequently associated with myotonia, may interact in a synergistic manner to produce severe clinical Entitymyotonia in humans.
0.9999 Adverse-Effect This case suggests that sarcoidosis and Entitypravastatin , two entities not frequently associated with Entitymyotonia , may interact in a synergistic manner to produce severe clinical myotonia in humans.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We present two cases of Entityanaphylaxis under anaesthesia where return of spontaneous circulation was refractory to epinephrine, but occurred following the administration of the alpha - agonist Entitymetaraminol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the cases of two female patients diagnosed with relapsing - remitting multiple sclerosis ( RRMS ) who developed Entityinflammatory musculoskeletal manifestations , following EntityIFN - beta therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBSERVATIONS : A 48 - year - old woman presented with Entitydisfiguring facial edema 10 weeks after she began antiviral therapy with Entitypeginterferon alfa - 2a and ribavirin for chronic hepatitis C infection.
0.9999 Adverse-Effect OBSERVATIONS : A 48 - year - old woman presented with Entitydisfiguring facial edema 10 weeks after she began antiviral therapy with peginterferon alfa - 2a and Entityribavirin for chronic hepatitis C infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityAkathisia appeared to be a common side effect of Entityfluoxetine and generally responded well to treatment with the beta - adrenergic antagonist propranolol, dose reduction, or both.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 45 - year - old Chinese man with CML and chronic hepatitis B virus infection, on Entityimatinib treatment, presenting with Entityherpetic rash and acute liver failure.
1.0000 Adverse-Effect We report a 45 - year - old Chinese man with CML and chronic hepatitis B virus infection, on Entityimatinib treatment, presenting with herpetic rash and Entityacute liver failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal agranulocytosis in an Indian male receiving 100 mg of Entitydapsone daily, hospitalized for mid - borderline leprosy in type I reaction with triple nerve paralysis is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe that mucositis was a contributing factor to this case of Entityfatal hyperkalemia after administration of Entitysuccinylcholine , with a mechanism similar to that reported with thermal injury.
0.9998 Adverse-Effect We believe that Entitymucositis was a contributing factor to this case of fatal hyperkalemia after administration of Entitysuccinylcholine , with a mechanism similar to that reported with thermal injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In eight patients, a mean Entitydecrease in serum Na + of 8. 25 + / - 3. 2 mEq / L was observed after a single 200 mg intravenous dose of Entitylorcainide .
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect Since early symptoms of the toxic effects of Entitytheophylline can mimic Entitypeptic ulcer disease , cimetidine might be prescribed for the gastrointestinal symptoms with subsequent worsening of theophylline poisoning.
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect Clinicians should be aware of the signs and symptoms of Entityneurotoxicity during treatment, as well as predisposing factors that put patients receiving Entitymethotrexate at risk for neurotoxic effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case describes a 52 - year - old white woman who developed a Entityspontaneous nasal septal perforation after given the antiangiogenic drug, Entitybevacizumab , for metastatic ovarian cancer treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of a Entityfluoxetine - related Entitydeath in a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCutaneous necrosis as a result of Entityinterferon alfa is an infrequent complication with unknown pathogenesis, in which a cutaneous local immune - mediated inflammatory process might be involved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been more than 20 observations of the appearance or aggravation of this Entitygranulomatosis with Entityinterferon alfa and more recently with the combination of interferon alfa plus ribavirin.
0.9997 Adverse-Effect There have been more than 20 observations of the appearance or aggravation of this Entitygranulomatosis with interferon alfa and more recently with the combination of interferon alfa plus Entityribavirin .
0.9995 Adverse-Effect There have been more than 20 observations of the appearance or aggravation of this Entitygranulomatosis with interferon alfa and more recently with the combination of Entityinterferon alfa plus ribavirin.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We describe a patient with Wilson's disease who presented with neurologic disease, was treated with EntityD - penicillamine , and suffered sudden Entityneurologic deterioration coincident with therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to hypoxia and thus was more susceptible to Entityductal closure in response to Entityindomethacin exposure.
0.9999 Adverse-Effect This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to Entityhypoxia and thus was more susceptible to ductal closure in response to Entityindomethacin exposure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This Entityeruption emerged after 1 month of therapy with Entitysalsalate , persisted for as long as salsalate was administered, and cleared within 3 weeks of discontinuing the medication.
0.9995 Adverse-Effect This Entityeruption emerged after 1 month of therapy with salsalate, persisted for as long as Entitysalsalate was administered, and cleared within 3 weeks of discontinuing the medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitycough following the administration of Entityquinapril , with complete resolution after changing to the alternative ACE inhibitor fosinopril in a patient with essential hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recent reports have shown that Decadron ( dexamethasone ; Merck Sharp & Dohme, West Point, Pa ) has a significant antiemetic effect on Entitycisplatin - induced Entityvomiting .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and Entitysevere hypersensitivity reactions to Entitycarboplatin .
0.9996 Adverse-Effect Prick tests and intradermal tests with a series of dilutions of carboplatin and Entitycisplatin were performed on three patients who had exhibited medium and Entitysevere hypersensitivity reactions to carboplatin.
0.9978 Adverse-Effect Prick tests and intradermal tests with a series of dilutions of Entitycarboplatin and cisplatin were performed on three patients who had exhibited medium and Entitysevere hypersensitivity reactions to carboplatin.
Adverse-Effect Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and Entitysevere hypersensitivity reactions to Entitycarboplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe that this represents an unusual case of moderate - dose EntityMTX - induced Entityneurotoxicity in a patient with gastric cancer, which has not previously been reported.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and vincristine and Entityactinomycin D in case 2, were given before the Entityhepatotoxicity developed.
0.9994 Adverse-Effect The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and Entityvincristine and actinomycin D in case 2, were given before the Entityhepatotoxicity developed.
0.9990 Adverse-Effect The chemotherapeutics, including Entityvincristine , actinomycin D, and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the Entityhepatotoxicity developed.
0.9990 Adverse-Effect The chemotherapeutics, including vincristine, actinomycin D, and Entityepirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the Entityhepatotoxicity developed.
0.9984 Adverse-Effect The chemotherapeutics, including vincristine, Entityactinomycin D , and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the Entityhepatotoxicity developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient with renal artery stenosis who had only 1 kidney and in whom acute renal impairment developed with Entitytransient anuria after the administration of Entitycaptopril .
0.9999 Adverse-Effect We report on a patient with renal artery stenosis who had only 1 kidney and in whom Entityacute renal impairment developed with transient anuria after the administration of Entitycaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sweet's syndrome is an Entityacute febrile neutrophilic dermatosis that is a known complication of the administration of Entityfilgrastim , a drug that causes increased neutrophil proliferation and differentiation.
1.0000 Adverse-Effect EntitySweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of Entityfilgrastim , a drug that causes increased neutrophil proliferation and differentiation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMetformin - associated Entitylactic acidosis ( MALA ) is a serious metabolic complication that occurs because of metformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9966 Adverse-Effect Metformin - associated Entitylactic acidosis ( MALA ) is a serious metabolic complication that occurs because of Entitymetformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9989 Adverse-Effect Metformin - associated lactic acidosis ( EntityMALA ) is a serious metabolic complication that occurs because of Entitymetformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9987 Adverse-Effect EntityMetformin - associated lactic acidosis ( EntityMALA ) is a serious metabolic complication that occurs because of metformin accumulation in patients who become dehydrated or developed acute renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, a new episode of Entityneutropenia , with a WBC count of 2. 8 x 10 ( 3 ) / mm3 and ANC of 0. 448 x 10 ( 3 ) / mm3, occurred 11 days after Entityteicoplanin initiation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitysevere anemia , which responded well to steroid therapy, in a patient receiving EntityIL - 2 plus IFN - alpha for metastatic renal cell carcinoma.
0.9998 Adverse-Effect We report a case of Entitysevere anemia , which responded well to steroid therapy, in a patient receiving IL - 2 plus EntityIFN - alpha for metastatic renal cell carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After extensive neurological'work up ', we realized that the Entityanisocoria was related to the transdermal Entityscopolamine patch that we had prescribed for weaning off the opioid.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient in whom the anti - depressant trazodone hydrochloride ( EntityMolipaxin , Roussel ), a serotonin antagonist, provoked Entitygeneralized pustular psoriasis ( GPP ).
0.9999 Adverse-Effect We report a patient in whom the anti - depressant trazodone hydrochloride ( EntityMolipaxin , Roussel ), a serotonin antagonist, provoked generalized pustular psoriasis ( EntityGPP ).
0.9998 Adverse-Effect We report a patient in whom the anti - depressant Entitytrazodone hydrochloride ( Molipaxin, Roussel ), a serotonin antagonist, provoked Entitygeneralized pustular psoriasis ( GPP ).
0.9995 Adverse-Effect We report a patient in whom the anti - depressant Entitytrazodone hydrochloride ( Molipaxin, Roussel ), a serotonin antagonist, provoked generalized pustular psoriasis ( EntityGPP ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, there is a report on Entityprolonged ECT seizure related to Entityciprofloxacin , which has an epileptogenic property with a similar action to beta - lactam antibiotics.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here, we present a case of Entitysirolimus - associated Entityinterstitial pneumonitis in a cardiac transplant recipient that resolved completely with withdrawal of the drug and treatment with corticosteroids.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In rare cases mitomycin C ( EntityMMC ) may induce cancer - associated Entityhemolytic uremic syndrome , which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9998 Adverse-Effect In rare cases mitomycin C ( EntityMMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by Entityhemolytic anemia , thrombocytopenia and progressive renal failure.
0.9997 Adverse-Effect In rare cases Entitymitomycin C ( MMC ) may induce cancer - associated Entityhemolytic uremic syndrome , which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9997 Adverse-Effect In rare cases mitomycin C ( EntityMMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, Entitythrombocytopenia and progressive renal failure.
0.9995 Adverse-Effect In rare cases Entitymitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by Entityhemolytic anemia , thrombocytopenia and progressive renal failure.
0.9995 Adverse-Effect In rare cases mitomycin C ( EntityMMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and Entityprogressive renal failure .
0.9993 Adverse-Effect In rare cases Entitymitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, Entitythrombocytopenia and progressive renal failure.
0.9988 Adverse-Effect In rare cases Entitymitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and Entityprogressive renal failure .
0.9995 Adverse-Effect In rare cases mitomycin C ( MMC ) may induce Entitycancer - associated Entityhemolytic uremic syndrome , which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9895 Adverse-Effect In rare cases mitomycin C ( EntityMMC ) may induce Entitycancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9796 Adverse-Effect In rare cases mitomycin C ( MMC ) may induce Entitycancer - associated hemolytic uremic syndrome, which is characterized by Entityhemolytic anemia , thrombocytopenia and progressive renal failure.
0.9714 Adverse-Effect In rare cases mitomycin C ( MMC ) may induce Entitycancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, Entitythrombocytopenia and progressive renal failure.
0.9475 Adverse-Effect In rare cases mitomycin C ( MMC ) may induce Entitycancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and Entityprogressive renal failure .
0.5681 Adverse-Effect In rare cases Entitymitomycin C ( MMC ) may induce Entitycancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityBisphosphonate - related Entityosteonecrosis of the jaw ( BRONJ ) is reported in up to 18. 6 % of patients treated with intravenous bisphosphonates and can result in significant morbidity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Hypersensitivity reaction should be considered in patients who develop recurrent eosinophilia and Entitydeterioration of pulmonary function following the use of Entitytobramycin by inhalation or by intravenous administration.
1.0000 Adverse-Effect CONCLUSION : Hypersensitivity reaction should be considered in patients who develop Entityrecurrent eosinophilia and deterioration of pulmonary function following the use of Entitytobramycin by inhalation or by intravenous administration.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Finally, Entityreserpine Entityreserpine toxicity , in particular central nervous system ( CNS ) disturbances, was reported more frequently in patients also receiving barbiturates, suggesting additive CNS effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : At our institution, no children appeared with acute EntityINH Entityneurotoxicity in the period 1985 through 1990, whereas seven patients were treated from 1991 through 1993.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An 83 - year - old man receiving glipizide 10 mg bid developed Entitysymptomatic hypoglycemia within three days of adding Entitytrimethoprim / sulfamethoxazole ( TMP / SMX ) to his regimen.
1.0000 Adverse-Effect An 83 - year - old man receiving Entityglipizide 10 mg bid developed Entitysymptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( TMP / SMX ) to his regimen.
0.9999 Adverse-Effect An 83 - year - old man receiving glipizide 10 mg bid developed Entitysymptomatic hypoglycemia within three days of adding trimethoprim / Entitysulfamethoxazole ( TMP / SMX ) to his regimen.
0.9999 Adverse-Effect An 83 - year - old man receiving glipizide 10 mg bid developed Entitysymptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( EntityTMP / SMX ) to his regimen.
0.9999 Adverse-Effect An 83 - year - old man receiving glipizide 10 mg bid developed Entitysymptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( TMP / EntitySMX ) to his regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors present a case of Entityt - AML that developed in a child with metastatic neuroblastoma 18 months after he received oral Entityetoposide , given for palliation purpose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the case of a 50 - year - old woman with advanced non - small cell lung cancer who developed Entitystatus epilepticus shortly after receiving Entitycisplatin and gemcitabine chemotherapy.
0.9999 Adverse-Effect We describe the case of a 50 - year - old woman with advanced non - small cell lung cancer who developed Entitystatus epilepticus shortly after receiving cisplatin and Entitygemcitabine chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a rare case of Entitycolonic mucosal necrosis following EntityKalimate ( calcium polystryrene sulfonate ), an analogue of Kayexalate without sorbitol in a 34 - yr - old man.
0.9992 Adverse-Effect We report a rare case of Entitycolonic mucosal necrosis following Kalimate ( Entitycalcium polystryrene sulfonate ), an analogue of Kayexalate without sorbitol in a 34 - yr - old man.
0.9985 Adverse-Effect We report a rare case of Entitycolonic mucosal necrosis following Kalimate ( calcium polystryrene sulfonate ), an analogue of EntityKayexalate without sorbitol in a 34 - yr - old man.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most likely cause of Entityliver failure in this patient was, therefore, Entityclarithromycin , which undergoes hepatic metabolism and has been reported to cause fulminant hepatic failure.
0.9999 Adverse-Effect The most likely cause of liver failure in this patient was, therefore, Entityclarithromycin , which undergoes hepatic metabolism and has been reported to cause Entityfulminant hepatic failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The development of an IgG lambda - type monoclonal gammopathy and subsequent Entitymultiple myeloma in an epilepsy patient on Entitydiphenylhydantoin ( DILANTIN ) therapy for 20 years is reported.
1.0000 Adverse-Effect The development of an EntityIgG lambda - type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on Entitydiphenylhydantoin ( DILANTIN ) therapy for 20 years is reported.
1.0000 Adverse-Effect The development of an IgG lambda - type monoclonal gammopathy and subsequent Entitymultiple myeloma in an epilepsy patient on diphenylhydantoin ( EntityDILANTIN ) therapy for 20 years is reported.
0.9999 Adverse-Effect The development of an EntityIgG lambda - type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on diphenylhydantoin ( EntityDILANTIN ) therapy for 20 years is reported.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In all three cases, autopsy revealed gross and microscopic features indistinguishable from those seen in the Hamman - Rich syndrome, and Entitymethotrexate Entityhepatotoxicity was present in one.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 44 - year - old woman with t - MDS ( Entityrefractory anemia with excess blasts ) following treatment of recurrent anaplastic astrocytoma with Entitytemozolomide ( TMZ ).
1.0000 Adverse-Effect We report a 44 - year - old woman with t - MDS ( Entityrefractory anemia with excess blasts ) following treatment of recurrent anaplastic astrocytoma with temozolomide ( EntityTMZ ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report a case of severe Entitycorticosteroid - induced Entityglaucoma after intravitreal injection of triamcinolone acetate in a 34 - year - old man without a history of glaucoma.
0.9997 Adverse-Effect PURPOSE : To report a case of severe corticosteroid - induced Entityglaucoma after intravitreal injection of Entitytriamcinolone acetate in a 34 - year - old man without a history of glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present two children with acute lymphocytic leukemia who developed Entityleukoencephalopathy following administration of a combination of intravenous Entityara = C and methotrexate during the consolidation phase of chemotherapy.
0.9999 Adverse-Effect We present two children with acute lymphocytic leukemia who developed Entityleukoencephalopathy following administration of a combination of intravenous ara = C and Entitymethotrexate during the consolidation phase of chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the second day of hospitalization, it was noted that the patient's dyspnea and Entitysinus bradycardia could be related to a recent increase in his Entitytimolol dosage.
0.9999 Adverse-Effect On the second day of hospitalization, it was noted that the patient's Entitydyspnea and sinus bradycardia could be related to a recent increase in his Entitytimolol dosage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be aware that an erythematous and Entityexfoliative rash may be induced by Entitytemozolomide , and be familiar with the pharmacologic and supportive measures necessary for its treatment.
0.9998 Adverse-Effect Clinicians should be aware that an Entityerythematous and exfoliative rash may be induced by Entitytemozolomide , and be familiar with the pharmacologic and supportive measures necessary for its treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the potential for the development of EntityRS among children who are receiving long - term Entityaspirin therapy for the treatment of systemic inflammatory illnesses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A review of the literature found 11 children and 2 adults in whom intranasal Entitydesmopressin was associated with Entityhyponatremia , all of whom experienced seizures or altered mental status.
0.9999 Adverse-Effect A review of the literature found 11 children and 2 adults in whom intranasal Entitydesmopressin was associated with hyponatremia, all of whom experienced Entityseizures or altered mental status.
0.9999 Adverse-Effect A review of the literature found 11 children and 2 adults in whom intranasal Entitydesmopressin was associated with hyponatremia, all of whom experienced seizures or Entityaltered mental status .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of severe Entityskin necrosis resulting from peripheral intravenous administration of low - dose Entityvasopressin in a patient with catecholamine - resistant septic shock.
1.0000 Adverse-Effect OBJECTIVE : To describe a case of Entitysevere skin necrosis resulting from peripheral intravenous administration of low - dose Entityvasopressin in a patient with catecholamine - resistant septic shock.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians who manage cachectic patients, particularly those with protracted diarrhoea and / or receiving anti - malarial drugs including Entitymefloquine , should be aware of the risk of Entitysevere hypoglycaemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 25 - year - old postpartum white woman developed multiple watery stools and Entityabdominal cramping on day 6 of therapy with Entityclindamycin vaginal cream for bacterial vaginosis.
1.0000 Adverse-Effect CASE SUMMARY : A 25 - year - old postpartum white woman developed Entitymultiple watery stools and abdominal cramping on day 6 of therapy with Entityclindamycin vaginal cream for bacterial vaginosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians should be aware of this adverse reaction when facing similar complex Entityneurologic symptoms in patients who are receiving the antibiotic treatment described here, especially Entityvancomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a Entitypulmonary adverse reaction , a feature never previously associated with Entityoxaliplatinum and 5 - fluorouracil regimens.
0.9999 Adverse-Effect It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a Entitypulmonary adverse reaction , a feature never previously associated with oxaliplatinum and Entity5 - fluorouracil regimens.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect For patients who suffer from osteogenic sarcoma and have Entityanaphylactic reactions to EntityMTX , this desensitization protocol will allow these patients to continue with needed therapeutic or palliative chemotherapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Here we present the case of a Entitygeneralized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with Entityinterferon alpha and ribavirin.
0.9999 Adverse-Effect Here we present the case of a Entitygeneralized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with interferon alpha and Entityribavirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect First, a review of the literature produced 41 anecdotic cases of neutropenia or Entityagranulocytosis during treatment with Entityolanzapine ( Zyprexa ) reported in a total of 24 publications.
1.0000 Adverse-Effect First, a review of the literature produced 41 anecdotic cases of neutropenia or Entityagranulocytosis during treatment with olanzapine ( EntityZyprexa ) reported in a total of 24 publications.
0.9999 Adverse-Effect First, a review of the literature produced 41 anecdotic cases of Entityneutropenia or agranulocytosis during treatment with Entityolanzapine ( Zyprexa ) reported in a total of 24 publications.
0.9998 Adverse-Effect First, a review of the literature produced 41 anecdotic cases of Entityneutropenia or agranulocytosis during treatment with olanzapine ( EntityZyprexa ) reported in a total of 24 publications.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCisplatin - induced Entitysyndrome of inappropriate antidiuretic hormone ( SIADH ) in a patient with neuroendocrine tumor of the cervix : a case report and review of the literature.
0.9999 Adverse-Effect EntityCisplatin - induced syndrome of inappropriate antidiuretic hormone ( EntitySIADH ) in a patient with neuroendocrine tumor of the cervix : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 21 - year - old woman suffering from bipolar affective disorder developed systemic lupus erythematosus ( EntitySLE ) with characteristic laboratory findings, 18 months after starting Entitycarbamazepine maintenance treatment.
1.0000 Adverse-Effect A 21 - year - old woman suffering from bipolar affective disorder developed Entitysystemic lupus erythematosus ( SLE ) with characteristic laboratory findings, 18 months after starting Entitycarbamazepine maintenance treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : To our knowledge, this is the first case report illustrating Entityneuralgic amyotrophy triggered by exposure to the antibiotics Entityvancomycin , tobramycin, and piperacillin / tazobactam.
1.0000 Adverse-Effect DISCUSSION : To our knowledge, this is the first case report illustrating Entityneuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, Entitytobramycin , and piperacillin / tazobactam.
1.0000 Adverse-Effect DISCUSSION : To our knowledge, this is the first case report illustrating Entityneuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, tobramycin, and piperacillin / Entitytazobactam .
0.9999 Adverse-Effect DISCUSSION : To our knowledge, this is the first case report illustrating Entityneuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, tobramycin, and Entitypiperacillin / tazobactam.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We hereby report a case of radiation recall dermatitis and Entitymyositis occurring on Entitygemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.
0.9999 Adverse-Effect CASE REPORT : We hereby report a case of Entityradiation recall dermatitis and myositis occurring on Entitygemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Caution in longterm usage and early recognition of Entitypentazocine Entitypentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized neuropathy.
0.9986 Adverse-Effect Caution in longterm usage and early recognition of Entitypentazocine toxicity as a Entityneuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized neuropathy.
0.9964 Adverse-Effect Caution in longterm usage and early recognition of Entitypentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced Entityfibrous myopathy and localized neuropathy.
0.9960 Adverse-Effect Caution in longterm usage and early recognition of Entitypentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized Entityneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 40 - year - old man with advanced HIV infection and Mycobacterium avium complex infection experienced Entityrapid cognitive decline after commencement of Entityethambutol , and symptoms fully resolved with cessation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He was started on Entitydigoxin , 0. 25 mg daily, because of echocardiographically demonstrated Entityleft ventricular dilatation and functional impairment ; he died of ventricular fibrillation 15 days later.
0.9999 Adverse-Effect He was started on Entitydigoxin , 0. 25 mg daily, because of echocardiographically demonstrated left ventricular dilatation and functional impairment ; he died of Entityventricular fibrillation 15 days later.
0.9998 Adverse-Effect He was started on Entitydigoxin , 0. 25 mg daily, because of echocardiographically demonstrated left ventricular dilatation and Entityfunctional impairment ; he died of ventricular fibrillation 15 days later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of EntityMMC - related Entityhemolytic uremic syndrome , and discuss the etiologic parameters, clinical aspects, prognosis and treatment modalities of this severe syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An obese patient, not diabetic, treated with Entitymetformin for some weeks, was referred to us with Entitysevere inferior digestive hemorrhage , diagnosed with Meckel's diverticulum.
0.9999 Adverse-Effect An obese patient, not diabetic, treated with Entitymetformin for some weeks, was referred to us with severe inferior digestive hemorrhage, diagnosed with EntityMeckel's diverticulum .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 61 - year - old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia developed Entitygeneralized erythema with high fever 3 weeks after taking Entitysulfamethoxazole / trimethoprim.
0.9999 Adverse-Effect A 61 - year - old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia developed Entitygeneralized erythema with high fever 3 weeks after taking sulfamethoxazole / Entitytrimethoprim .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient had recurrence of urticaria and Entityangioedema a year and a half later, at which point the EntityNPH was stopped and she was desensitized to regular insulin.
0.9999 Adverse-Effect The patient had recurrence of urticaria and Entityangioedema a year and a half later, at which point the NPH was stopped and she was desensitized to regular Entityinsulin .
0.9998 Adverse-Effect The patient had recurrence of Entityurticaria and angioedema a year and a half later, at which point the EntityNPH was stopped and she was desensitized to regular insulin.
0.9998 Adverse-Effect The patient had recurrence of Entityurticaria and angioedema a year and a half later, at which point the NPH was stopped and she was desensitized to regular Entityinsulin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was positive for antibody against complexes of heparin and platelet factor 4, and was diagnosed as Entityheparin - induced Entitythrombocytopenia with thrombosis syndrome ( HITTS ).
0.9997 Adverse-Effect The patient was positive for antibody against complexes of heparin and platelet factor 4, and was diagnosed as Entityheparin - induced thrombocytopenia with Entitythrombosis syndrome ( HITTS ).
0.9987 Adverse-Effect The patient was positive for antibody against complexes of Entityheparin and platelet factor 4, and was diagnosed as heparin - induced Entitythrombocytopenia with thrombosis syndrome ( HITTS ).
0.9979 Adverse-Effect The patient was positive for antibody against complexes of Entityheparin and platelet factor 4, and was diagnosed as heparin - induced thrombocytopenia with Entitythrombosis syndrome ( HITTS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 73 year - old patient with Wolff - Parkinson - White syndrome and paroxysmic supraventricular tachycardia developed an Entityacute reversible encephalopathy within 15 days of initiation of Entityflecainide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of our knowledge, this is the first reported patient with Entitycaptopril - induced Entitypemphigus in whom no new lesions developed after subsequent treatment with enalapril.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Entitypraziquantel administration may have been effective in killing the parasite in both patients, we are concerned about the production of marked Entityinflammation as a result of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the occurrence of Entityanterior ischemic optic neuropathy as a complication of treatment with Entityinterferon alfa and to consider the possible underlying mechanisms for this association.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The authors describe a patient with hemiparesis who developed the syndrome of irreversible Entitylithium - effectuated Entityneurotoxicity ( SILENT ) while being treated with lithium for a manic episode.
0.9917 Adverse-Effect The authors describe a patient with hemiparesis who developed the syndrome of irreversible lithium - effectuated Entityneurotoxicity ( SILENT ) while being treated with Entitylithium for a manic episode.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of unintentional overdose of oral Entitypilocarpine tablets that resulted in Entitybradycardia , mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome.
1.0000 Adverse-Effect We report a case of unintentional overdose of oral Entitypilocarpine tablets that resulted in bradycardia, Entitymild hypotension , and muscarinic symptoms in a patient with Sjogren's syndrome.
1.0000 Adverse-Effect We report a case of unintentional overdose of oral Entitypilocarpine tablets that resulted in bradycardia, mild hypotension, and Entitymuscarinic symptoms in a patient with Sjogren's syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGold - salt therapy may result in Entitydamage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an autoimmune membranous nephropathy.
0.9978 Adverse-Effect EntityGold - salt therapy may result in damage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an Entityautoimmune membranous nephropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the present paper, we describe two patients with active UC who developed a Entitysevere systemic CMV infection during a treatment with an oral microemulsion form of Entitycyclosporine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect When the acute manic state is characterized by marked psychotic symptoms and intense anxiety, it may be associated with increased vulnerability to the development of severe Entitylithium Entityneurotoxicity .
0.9989 Adverse-Effect When the acute manic state is characterized by marked Entitypsychotic symptoms and intense anxiety, it may be associated with increased vulnerability to the development of severe Entitylithium neurotoxicity.
0.9987 Adverse-Effect When the acute manic state is characterized by marked psychotic symptoms and Entityintense anxiety , it may be associated with increased vulnerability to the development of severe Entitylithium neurotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient with an embryonal teratocarcinoma of the testicle who had the syndrome of Entityinappropriate secretion of antidiuretic hormone after receiving a high dose of Entityvinblastine .
1.0000 Adverse-Effect We report on a patient with an embryonal teratocarcinoma of the testicle who had the Entitysyndrome of inappropriate secretion of antidiuretic hormone after receiving a high dose of Entityvinblastine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although a lot of Entityamiodarone - induced Entitytorsades de pointe have been published, a review of all these cases and the underlying risk - factors has never been made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Type II Entityheparin - induced Entitythrombocytopenia ( HIT ) is an immunological disorder characterized by antibodies to heparin - platelet factor 4 complexes and a high risk of thrombotic complications.
0.9991 Adverse-Effect Type II Entityheparin - induced thrombocytopenia ( EntityHIT ) is an immunological disorder characterized by antibodies to heparin - platelet factor 4 complexes and a high risk of thrombotic complications.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Immobilization, while Paget's bone disease was present, and perhaps enhanced activation of Entitydihydrotachysterol by rifampicin, could have led to Entityincreased calcium - release into the circulation.
1.0000 Adverse-Effect Immobilization, while Paget's bone disease was present, and perhaps enhanced activation of dihydrotachysterol by Entityrifampicin , could have led to Entityincreased calcium - release into the circulation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although useful in the management of chronic alcoholism, Entitydisulfiram is being increasingly associated with a wide spectrum of side effects and untoward medical sequelae, which now include Entitycatatonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was enrolled in a weight - loss clinic, and his diabetes medications were adjusted. Subsequently, Entityolanzapine was discontinued because of Entityweight gain and uncontrolled diabetes.
1.0000 Adverse-Effect The patient was enrolled in a weight - loss clinic, and his diabetes medications were adjusted. Subsequently, Entityolanzapine was discontinued because of weight gain and Entityuncontrolled diabetes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect I report a 35 - year - old woman with occult coronary artery disease who experienced Entitycardiac arrest within minutes after receiving a first - time dose of subcutaneous Entitysumatriptan for migraine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite a hematologic response in all 3 patients, none of them achieved cytogenetic remission, and all progressed to Entityblast crisis at 7 to 10 months of Entityimatinib therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because Entitysumatriptan can cause Entitycoronary artery vasospasm , patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of sumatriptan.
0.9968 Adverse-Effect Because sumatriptan can cause Entitycoronary artery vasospasm , patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of Entitysumatriptan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated transient ischemic attacks followed by a Entityseizure during consolidation treatment with EntityL - asparaginase .
0.9995 Adverse-Effect We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated Entitytransient ischemic attacks followed by a seizure during consolidation treatment with EntityL - asparaginase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityProliferation of abnormal bone marrow histiocytes , an undesired effect of Entitygranulocyte macrophage - colony - stimulating factor therapy in a patient with Hurler's syndrome undergoing bone marrow transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The diagnosis was based on the rapid onset of Entityrenal failure , presence of eosinophilia, skin rash, and characteristic renal biopsy finding, following the administration of Entityampicillin .
1.0000 Adverse-Effect The diagnosis was based on the rapid onset of renal failure, presence of eosinophilia, Entityskin rash , and characteristic renal biopsy finding, following the administration of Entityampicillin .
1.0000 Adverse-Effect The diagnosis was based on the rapid onset of renal failure, presence of Entityeosinophilia , skin rash, and characteristic renal biopsy finding, following the administration of Entityampicillin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Monitoring of liver function tests should be mandatory in patients receiving high doses of Entitycyproterone acetate ; the drug should be withdrawn immediately if Entityabnormal liver function tests are found.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first patient developed a Entitymonoarthritis 2 weeks after initiation of EntityIFN - beta , which persisted during the 14 months of therapy and resolved with discontinuation of the medication.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityNaproxen , the most common offender, has been associated with a dimorphic clinical pattern : a PCT - like presentation and one simulating Entityerythropoietic protoporphyria in the pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Parenteral pyridoxine, the specific antidote for EntityINH - induced Entityrefractory seizures , should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.
0.9997 Adverse-Effect Parenteral Entitypyridoxine , the specific antidote for INH - induced Entityrefractory seizures , should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Alternating sinus rhythm and Entityintermittent sinoatrial ( S - A ) block was observed in a 57 - year - old woman, under treatment for angina with 80 mg Entitypropranolol daily.
1.0000 Adverse-Effect EntityAlternating sinus rhythm and intermittent sinoatrial ( S - A ) block was observed in a 57 - year - old woman, under treatment for angina with 80 mg Entitypropranolol daily.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the development of Entityischemic colitis in a woman who was treated with Entitytegaserod and review the relationship among ischemic colitis, tegaserod use, and irritable bowel syndrome.
1.0000 Adverse-Effect We describe the development of ischemic colitis in a woman who was treated with Entitytegaserod and review the relationship among Entityischemic colitis , tegaserod use, and irritable bowel syndrome.
0.9999 Adverse-Effect We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis, Entitytegaserod use, and Entityirritable bowel syndrome .
0.9992 Adverse-Effect We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among Entityischemic colitis , Entitytegaserod use, and irritable bowel syndrome.
0.9991 Adverse-Effect We describe the development of Entityischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis, Entitytegaserod use, and irritable bowel syndrome.
0.9987 Adverse-Effect We describe the development of ischemic colitis in a woman who was treated with Entitytegaserod and review the relationship among ischemic colitis, tegaserod use, and Entityirritable bowel syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 7 - year - old girl developed diabetes mellitus and Entityexocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with Entityazathioprine and / or prednisone for idiopathic auto - immune haemolytic anaemia.
1.0000 Adverse-Effect A 7 - year - old girl developed Entitydiabetes mellitus and exocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with Entityazathioprine and / or prednisone for idiopathic auto - immune haemolytic anaemia.
1.0000 Adverse-Effect A 7 - year - old girl developed diabetes mellitus and Entityexocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with azathioprine and / or Entityprednisone for idiopathic auto - immune haemolytic anaemia.
0.9999 Adverse-Effect A 7 - year - old girl developed Entitydiabetes mellitus and exocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with azathioprine and / or Entityprednisone for idiopathic auto - immune haemolytic anaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Flare of Kaposi's sarcoma ( EntityKS ) is well described in immunosuppressed patients treated with corticosteroids and Entityrituximab , but has not yet been reported during treatment with imatinib.
1.0000 Adverse-Effect Flare of EntityKaposi's sarcoma ( KS ) is well described in immunosuppressed patients treated with corticosteroids and Entityrituximab , but has not yet been reported during treatment with imatinib.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect The uncomplicated long - term use of adequately - dosed EntityAZA and stable non - toxic metabolite levels could not acknowledge TPMT deficiency as a primary cause of the Entityleukopenia .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Theoretical basal ganglia toxicologic mechanisms of Entitymethanol Entitymethanol poisoning are reviewed, and the role of brain imaging studies will regard to diagnosis, prognosis and impact on management is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of biopsy - proven Entityacute tubulointerstitial nephritis associated with a second course of Entityflurbiprofen , a nonsteroidal anti - inflammatory drug of the propionic acid class.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Entitysyringotropic hypersensitivity reaction after 9 months of therapy with Entityinfliximab and leflunomide is described.
1.0000 Adverse-Effect A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Entitysyringotropic hypersensitivity reaction after 9 months of therapy with infliximab and Entityleflunomide is described.
1.0000 Adverse-Effect A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Entitysyringotropic hypersensitivity reaction after 9 months of therapy with Entityinfliximab and leflunomide is described.
0.9999 Adverse-Effect A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Entitysyringotropic hypersensitivity reaction after 9 months of therapy with infliximab and Entityleflunomide is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dipyrone, also known as Entitymetamizole , is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with Entityagranulocytosis .
0.9999 Adverse-Effect EntityDipyrone , also known as metamizole, is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with Entityagranulocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is, to the best of our knowledge, the first report of a case in which Entityagranulocytosis followed treatment with both Entitypropylthiouracil and methimazole in the same patient.
1.0000 Adverse-Effect This is, to the best of our knowledge, the first report of a case in which Entityagranulocytosis followed treatment with both propylthiouracil and Entitymethimazole in the same patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although they had only a few nodules at diagnosis, the Entitynodules increased in number and size 3 to 4 months after the start of Entitymethotrexate therapy in both patients.
0.9997 Adverse-Effect Although they had only a few Entitynodules at diagnosis, the nodules increased in number and size 3 to 4 months after the start of Entitymethotrexate therapy in both patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE : We present an 11 - year old male with Budd - Chiari syndrome who experienced profound Entityworsening of chronic aphthous ulcers after immunosuppressive therapy was changed from Entitytacrolimus to sirolimus.
1.0000 Adverse-Effect CASE : We present an 11 - year old male with Budd - Chiari syndrome who experienced profound Entityworsening of chronic aphthous ulcers after immunosuppressive therapy was changed from tacrolimus to Entitysirolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Though hypotension, dry mouth, and constipation are well - documented possible adverse effects, the possibility of Entityclonidine - induced Entitybradycardia is less well recognized and is rare.
0.9998 Adverse-Effect Though hypotension, dry mouth, and Entityconstipation are well - documented possible adverse effects, the possibility of Entityclonidine - induced bradycardia is less well recognized and is rare.
0.9992 Adverse-Effect Though Entityhypotension , dry mouth, and constipation are well - documented possible adverse effects, the possibility of Entityclonidine - induced bradycardia is less well recognized and is rare.
0.9992 Adverse-Effect Though hypotension, Entitydry mouth , and constipation are well - documented possible adverse effects, the possibility of Entityclonidine - induced bradycardia is less well recognized and is rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASES : " A " was an 8 - year - old boy with attention deficit and chronic tic disorder who developed Entityobsessive - compulsive symptoms within 2 weeks of starting Entityrisperidone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 71 - year male with castration - resistant metastatic prostate cancer who was treated with weekly Entitydocetaxel for 12 weeks and developed significant Entityeye irritation and dryness during treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : All doctors need to be aware of the need to review the indications for Entitygabapentin use during periods of acute illness, especially with regard to Entityrenal impairment .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the presented case Entityfluvoxamine - induced Entityakathisia in an OCD patient was partially resistant to the anticholinergic agent biperiden, and was successfully treated with the 5 - HT2A / 5 - HT2C antagonist mianserin.
Score Relation Text (Head - Tail)
0.9975 Adverse-Effect The wide use of phenytoin during the recent tuberculosis epidemic makes it imperative to suspect this drug interaction in patients exhibiting clinical features that might be related to Entityphenytoin Entityphenytoin toxicity .
0.9891 Adverse-Effect The wide use of Entityphenytoin during the recent tuberculosis epidemic makes it imperative to suspect this drug interaction in patients exhibiting clinical features that might be related to Entityphenytoin toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Review of the literature relating to Entitymethicillin - induced Entitynephropathy suggests a hypersensitivity origin for this disorder, but immunologic and ultrastructural investigation to date has failed to elucidate pathogenesis.
0.9794 Adverse-Effect Review of the literature relating to Entitymethicillin - induced nephropathy suggests a Entityhypersensitivity origin for this disorder, but immunologic and ultrastructural investigation to date has failed to elucidate pathogenesis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We hypothesize that Entitycaffeine Entitycaffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
0.9992 Adverse-Effect We hypothesize that Entitycaffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe Entityrhabdomyolysis .
0.9991 Adverse-Effect We hypothesize that Entitycaffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the Entitycoexisting hyponatremia , to result in unusually severe rhabdomyolysis.
0.9990 Adverse-Effect We hypothesize that Entitycaffeine toxicity injured the muscle cells, which were fragile due to the Entitypotassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
Adverse-Effect We hypothesize that Entitycaffeine toxicity Entityinjured the muscle cells , which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In conclusion, EntityRSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug ( EntityCyA or tacrolimus ), even under monotherapy or with a low steroid dose.
1.0000 Adverse-Effect In conclusion, EntityRSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug ( CyA or Entitytacrolimus ), even under monotherapy or with a low steroid dose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityinterstitial pneumonitis induced by Entitybicalutamide and / or leuprorelin acetate given as therapy for prostate cancer, in which the pneumonitis was successfully managed by steroid treatment.
0.9993 Adverse-Effect We report a case of Entityinterstitial pneumonitis induced by bicalutamide and / or Entityleuprorelin acetate given as therapy for prostate cancer, in which the pneumonitis was successfully managed by steroid treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with postoperative hypophosphatemia and Entityhypocalcemic tetany after bowel preparation with EntityFleet Phospho - Soda .
1.0000 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( EntityFosamax ) and presented with postoperative Entityhypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9999 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( EntityFosamax ) and presented with postoperative hypophosphatemia and Entityhypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9999 Adverse-Effect This case report describes a patient who was previously prescribed Entityalendronate ( Fosamax ) and presented with postoperative Entityhypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9998 Adverse-Effect This case report describes a patient who was previously prescribed Entityalendronate ( Fosamax ) and presented with postoperative hypophosphatemia and Entityhypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9995 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with postoperative Entityhypophosphatemia and hypocalcemic tetany after bowel preparation with EntityFleet Phospho - Soda .
1.0000 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( EntityFosamax ) and presented with Entitypostoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9999 Adverse-Effect This case report describes a patient who was previously prescribed Entityalendronate ( Fosamax ) and presented with Entitypostoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9997 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with Entitypostoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with EntityFleet Phospho - Soda .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients from endemic areas referred to transplant centers may be at high risk for Entitydisseminated histoplasmosis when treated with long - term Entityprednisone for graft - versus - host disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The third patient had been suffering from serious Entityakathisia while on Entityrisperidone , and was cured after switching to olanzapine, but thereafter the patient suffered from RLS at nighttime.
1.0000 Adverse-Effect The third patient had been suffering from serious akathisia while on risperidone, and was cured after switching to Entityolanzapine , but thereafter the patient suffered from EntityRLS at nighttime.
0.9999 Adverse-Effect The third patient had been suffering from serious akathisia while on Entityrisperidone , and was cured after switching to olanzapine, but thereafter the patient suffered from EntityRLS at nighttime.
0.9995 Adverse-Effect The third patient had been suffering from serious Entityakathisia while on risperidone, and was cured after switching to Entityolanzapine , but thereafter the patient suffered from RLS at nighttime.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : We recently experienced a case of fatal Entityerlotinib - induced EntityILD , diagnosed based on clinical and radiologic findings, which occurred in a patient with radiation fibrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the second case, five cardiac arrests due to ventricular tachycardia and Entityfibrillation occurred during several hours after beginning a trial of Entitybretylium maintenance therapy for complex ventricular ectopy.
0.9999 Adverse-Effect In the second case, five cardiac arrests due to Entityventricular tachycardia and fibrillation occurred during several hours after beginning a trial of Entitybretylium maintenance therapy for complex ventricular ectopy.
0.9999 Adverse-Effect In the second case, five Entitycardiac arrests due to ventricular tachycardia and fibrillation occurred during several hours after beginning a trial of Entitybretylium maintenance therapy for complex ventricular ectopy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, hypotension, and Entitytachycardia soon after administration of EntityCBDCA .
1.0000 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, Entityhypotension , and tachycardia soon after administration of EntityCBDCA .
1.0000 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed Entityeruptions , hypotension, and tachycardia soon after administration of EntityCBDCA .
0.9999 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including Entitycardiac arrest and apnea, and another four patients developed eruptions, hypotension, and tachycardia soon after administration of EntityCBDCA .
0.9999 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and Entityapnea , and another four patients developed eruptions, hypotension, and tachycardia soon after administration of EntityCBDCA .
0.9999 Adverse-Effect However, one patient exhibited Entitysevere hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, hypotension, and tachycardia soon after administration of EntityCBDCA .
Score Relation Text (Head - Tail)
0.9883 Adverse-Effect A patient with chronic myeloid leukaemia treated with Entitybusulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and Entityjaundice .
0.9865 Adverse-Effect A patient with chronic myeloid leukaemia treated with Entitybusulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with ascites, Entityoesophageal varices and jaundice.
0.9864 Adverse-Effect A patient with chronic myeloid leukaemia treated with Entitybusulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with Entityascites , oesophageal varices and jaundice.
0.9737 Adverse-Effect A patient with chronic myeloid leukaemia treated with Entitybusulphan for 4 - 5 years, developed signs of busulphan toxicity and Entityportal hypertension with ascites, oesophageal varices and jaundice.
0.9988 Adverse-Effect A patient with chronic myeloid leukaemia treated with Entitybusulphan for 4 - 5 years, developed signs of Entitybusulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.
0.9874 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Entitybusulphan Entitybusulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.
0.8683 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Entitybusulphan toxicity and portal hypertension with Entityascites , oesophageal varices and jaundice.
0.8632 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Entitybusulphan toxicity and portal hypertension with ascites, Entityoesophageal varices and jaundice.
0.8610 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Entitybusulphan toxicity and portal hypertension with ascites, oesophageal varices and Entityjaundice .
0.7955 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Entitybusulphan toxicity and Entityportal hypertension with ascites, oesophageal varices and jaundice.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 65 - year - old woman, in the intensive care unit because of septic shock and acute renal failure, had a Entitysmall - bowel obstruction due to EntityAmphojel concretions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case report that demonstrates the occurrence of Entityfever with low - dose Entityamifostine therapy without the manifestation of accompanying rash or hypotension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 17 - year - old boy with acute lymphoblastic leukemia developed Entityacute renal failure within 48 h of an intravenous high - dose Entitymethotrexate ( 5 g / m2 ) infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 17 - year - old male who developed chest pain, elevated cardiac biomarkers, and Entityacute left ventricular dysfunction following a single dose of Entitymethylphenidate .
1.0000 Adverse-Effect We report the case of a 17 - year - old male who developed chest pain, Entityelevated cardiac biomarkers , and acute left ventricular dysfunction following a single dose of Entitymethylphenidate .
0.9999 Adverse-Effect We report the case of a 17 - year - old male who developed Entitychest pain , elevated cardiac biomarkers, and acute left ventricular dysfunction following a single dose of Entitymethylphenidate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entityfatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with Entitylevomepromazine , diazepam and lithium carbonate.
0.9998 Adverse-Effect A Entityfatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with levomepromazine, Entitydiazepam and lithium carbonate.
0.9995 Adverse-Effect A Entityfatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with levomepromazine, diazepam and Entitylithium carbonate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Entitytardive dyskinesia is a known adverse reaction of sustained treatment with traditional neuroleptic agents, it was only rarely reported in association with Entitysulpiride , a selective D2 - receptor antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year - old woman developed Entityunilateral acute angle - closure glaucoma four days after the application of a patch of transdermal Entityscopolamine delivery system ( TRANSDERM - V ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect At the end of his fifth cycle of Entitysunitinib therapy, the patient complained of the Entitydevelopment of abnormally large mammary glands associated with pain and peri - areolar erythema.
1.0000 Adverse-Effect At the end of his fifth cycle of Entitysunitinib therapy, the patient complained of the development of abnormally large mammary glands associated with Entitypain and peri - areolar erythema.
0.9999 Adverse-Effect At the end of his fifth cycle of Entitysunitinib therapy, the patient complained of the development of abnormally large mammary glands associated with pain and Entityperi - areolar erythema .
1.0000 Adverse-Effect At the end of his fifth cycle of Entitysunitinib therapy, the patient complained of the development of Entityabnormally large mammary glands associated with pain and peri - areolar erythema.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSIONS : This observation of " on - off " risperidone treatment suggests that Entityrisperidone may have worsened both Entitypsychiatric and physical manifestations of the mitochondrial disorder in this adolescent.
0.9993 Adverse-Effect CONCLUSIONS : This observation of " on - off " Entityrisperidone treatment suggests that risperidone may have worsened both Entitypsychiatric and physical manifestations of the mitochondrial disorder in this adolescent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 50 - year - old woman with a history of migraine without aura, predominantly occurring around her menstrual periods, developed a Entityspinal cord lesion following the use of Entityzolmitriptan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Healthcare professionals should be aware of the possible development of Entityserotonin syndrome as a complication of initiation of Entityfentanyl and other phenylpiperidine opioids in patients treated with SSRIs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of acute compromise of renal function associated with Entityhypotension in a 7 - year - old boy treated with the ACE inhibitor Entitylisinopril and the ARB losartan.
1.0000 Adverse-Effect This report describes a case of acute compromise of renal function associated with Entityhypotension in a 7 - year - old boy treated with the ACE inhibitor lisinopril and the ARB Entitylosartan .
0.9998 Adverse-Effect This report describes a case of Entityacute compromise of renal function associated with hypotension in a 7 - year - old boy treated with the ACE inhibitor Entitylisinopril and the ARB losartan.
0.9994 Adverse-Effect This report describes a case of Entityacute compromise of renal function associated with hypotension in a 7 - year - old boy treated with the ACE inhibitor lisinopril and the ARB Entitylosartan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first patient developed mild nitritoid symptoms and pain in a band - like distribution, corresponding to EntityT10 - T12 dermatomes , shortly after Entitygold sodium thiomalate ( GSTM ) injection.
0.9998 Adverse-Effect The first patient developed mild nitritoid symptoms and pain in a band - like distribution, corresponding to EntityT10 - T12 dermatomes , shortly after gold sodium thiomalate ( EntityGSTM ) injection.
0.9998 Adverse-Effect The first patient developed mild nitritoid symptoms and Entitypain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after Entitygold sodium thiomalate ( GSTM ) injection.
0.9997 Adverse-Effect The first patient developed Entitymild nitritoid symptoms and pain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after Entitygold sodium thiomalate ( GSTM ) injection.
0.9993 Adverse-Effect The first patient developed mild nitritoid symptoms and Entitypain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after gold sodium thiomalate ( EntityGSTM ) injection.
0.9993 Adverse-Effect The first patient developed Entitymild nitritoid symptoms and pain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after gold sodium thiomalate ( EntityGSTM ) injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of an 11 - month - old female infant with a Entitydepressed level of consciousness after ingestion of Entityibuprofen whose mental status markedly improved with administration of naloxone.
Score Relation Text (Head - Tail)
0.9969 Adverse-Effect Acute EntityINH Entityneurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute INH neurotoxicity was made.
0.9950 Adverse-Effect Acute INH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute EntityINH Entityneurotoxicity was made.
0.9828 Adverse-Effect Acute INH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute EntityINH EntityINH neurotoxicity was made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year - old man with advanced renal cell carcinoma developed grade 3 Entityproteinuria ( 8. 5 g / 24 h ) without microscopic hematuria or renal insufficiency five days after Entitytemsirolimus infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients treated for chronic myeloid leukemia with high doses of EntityCCNU ( 1100 mg / m2 and 1240 mg / m2, respectively ) developed a Entityfatal pulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the cases of two patients who developed Entityacute hepatitis after taking Entityriluzole at the recommended dose ( 100 mg daily ) for 7 and 4 weeks, respectively.
Adverse-Effect We report the cases of two patients who developed acute Entityhepatitis after taking Entityriluzole at the recommended dose ( 100 mg daily ) for 7 and 4 weeks, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, orthostatic hypotension, and Entityaseptic meningitis simultaneously after using Entitytrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, orthostatic hypotension, and Entityaseptic meningitis simultaneously after using trimethoprim - Entitysulfamethoxazole .
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, Entityorthostatic hypotension , and aseptic meningitis simultaneously after using Entitytrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed Entityhemolytic anemia , hepatitis, orthostatic hypotension, and aseptic meningitis simultaneously after using Entitytrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, Entityhepatitis , orthostatic hypotension, and aseptic meningitis simultaneously after using Entitytrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed Entityhemolytic anemia , hepatitis, orthostatic hypotension, and aseptic meningitis simultaneously after using trimethoprim - Entitysulfamethoxazole .
0.9998 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, Entityorthostatic hypotension , and aseptic meningitis simultaneously after using trimethoprim - Entitysulfamethoxazole .
0.9998 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, Entityhepatitis , orthostatic hypotension, and aseptic meningitis simultaneously after using trimethoprim - Entitysulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHashimoto's disease during Entityinterferon - alpha therapy in a patient with pre - treatment negative anti - thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It should be emphasized that the recurrence of Entitynephrotic syndrome was observed after the following chemotherapy, including EntityM - CSF , whereas the bone marrow still remained completely remitted.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ceftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of Entityceftriaxone with Entityelevated hepato - biliary enzymes and transient biliary stasis.
0.9991 Adverse-Effect Ceftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of Entityceftriaxone with elevated hepato - biliary enzymes and Entitytransient biliary stasis .
0.9969 Adverse-Effect EntityCeftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of ceftriaxone with Entityelevated hepato - biliary enzymes and transient biliary stasis.
0.9953 Adverse-Effect EntityCeftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of ceftriaxone with elevated hepato - biliary enzymes and Entitytransient biliary stasis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a women in whom a Entitymalignant mixed mesodermal tumor was diagnosed while she was taking Entityraloxifene , which is also a selective estrogen receptor modulator.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The risk of drug - induced Entityrhabdomyolysis due to the potential interaction between Entitylovastatin and azithromycin or clarithromycin should be considered before the concomitant use of these agents.
0.9999 Adverse-Effect CONCLUSIONS : The risk of drug - induced Entityrhabdomyolysis due to the potential interaction between lovastatin and Entityazithromycin or clarithromycin should be considered before the concomitant use of these agents.
0.9999 Adverse-Effect CONCLUSIONS : The risk of drug - induced Entityrhabdomyolysis due to the potential interaction between lovastatin and azithromycin or Entityclarithromycin should be considered before the concomitant use of these agents.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four days after the initial injection of 3. 6 mg of Entitygoserelin acetate , Entitysevere dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a flare - up.
0.9994 Adverse-Effect Four days after the initial injection of 3. 6 mg of Entitygoserelin acetate , severe dyspnea developed due to Entityworsening pleuritis carcinomatosa , which was considered as a flare - up.
0.9991 Adverse-Effect Four days after the initial injection of 3. 6 mg of Entitygoserelin acetate , severe dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a Entityflare - up .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 43 - year - old woman with multiple sclerosis ( MS ) had Entitynephrotic syndrome 21 months after starting treatment with Entityinterferon ( IFN ) - beta - 1b ( subcutaneous administration ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Interferon ( EntityIFN ) - associated Entityretinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9998 Adverse-Effect BACKGROUND : Interferon ( EntityIFN ) - associated retinopathy is typically characterized by Entityretinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9998 Adverse-Effect BACKGROUND : Interferon ( EntityIFN ) - associated retinopathy is typically characterized by retinal hemorrhages and Entitycotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9997 Adverse-Effect BACKGROUND : EntityInterferon ( IFN ) - associated Entityretinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9992 Adverse-Effect BACKGROUND : EntityInterferon ( IFN ) - associated retinopathy is typically characterized by Entityretinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9992 Adverse-Effect BACKGROUND : EntityInterferon ( IFN ) - associated retinopathy is typically characterized by retinal hemorrhages and Entitycotton wool spots at the posterior fundus, but visual function is usually maintained.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four months after receiving an orthotopic liver transplant, a 51 - year - old man was admitted for progressive liver failure and Entitysevere hepatocellular necrosis thought to be due to Entitytacrolimus .
0.9999 Adverse-Effect Four months after receiving an orthotopic liver transplant, a 51 - year - old man was admitted for Entityprogressive liver failure and severe hepatocellular necrosis thought to be due to Entitytacrolimus .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We present a case of a 20 - year - old woman who ingested 900 mg of Entityglyburide causing refractory Entityhypoglycemia resistant to treatment with intravenous dextrose, glucagon, and diazoxide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 25 - year - old man with a history of mid - borderline ( BB ) Hansen's disease developing a Entityreversal reaction after starting Entitydapsone and rifampin therapy is presented.
1.0000 Adverse-Effect A 25 - year - old man with a history of mid - borderline ( BB ) Hansen's disease developing a Entityreversal reaction after starting dapsone and Entityrifampin therapy is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One of these was Entityclofazimine , an aniline aposafranine derivative known to produce a Entityceroid - like pigment in the tissues of patients treated with this drug or lepromatous leprosy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was restarted 6 weeks later, and 10 weeks after that, the patient presented with Entityfulminant hepatic failure , which resolved rapidly after cessation of Entitynicotinic acid therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of an infant with complex congenital heart disease who was placed on Entitycaptopril for afterload reduction following cardiac surgery and subsequently developed Entitypulmonary infiltrates with eosinophilia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic Entitymineral oil ingestion presenting as asymptomatic Entityexogenous lipoid pneumonia ( ELP ).
0.9999 Adverse-Effect We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic Entitymineral oil ingestion presenting as asymptomatic exogenous lipoid pneumonia ( EntityELP ).
1.0000 Adverse-Effect We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic Entitymineral oil ingestion presenting as Entityasymptomatic exogenous lipoid pneumonia ( ELP ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed Entityanticonvulsant hypersensitivity syndrome while taking EntityBellamine S ( belladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
0.9999 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed Entityanticonvulsant hypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; ergotamine ; Entityphenobarbital ) for hot flashes.
0.9999 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed Entityanticonvulsant hypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; Entityergotamine ; phenobarbital ) for hot flashes.
0.9999 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed Entityanticonvulsant hypersensitivity syndrome while taking Bellamine S ( Entitybelladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
1.0000 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Entityhypersensitivity syndrome while taking EntityBellamine S ( belladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
0.9998 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Entityhypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; ergotamine ; Entityphenobarbital ) for hot flashes.
0.9998 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Entityhypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; Entityergotamine ; phenobarbital ) for hot flashes.
0.9998 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Entityhypersensitivity syndrome while taking Bellamine S ( Entitybelladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect EntityPortal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of EntityF VIII after intramural jejunal bleeding - - successful thrombolysis under heparin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Oncologists supervising future clinical trials for lung cancer should be alert to the fact that Entitysorafenib can potentially induce serious Entityinterstitial lung disease , although this might depend on racial differences.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Escape atrial complexes, which occurred following junctional premature complexes, failed to initiate tachycardia in the control state but Entitytachycardia was always reinitiated by an identical escape sequence after Entityprocainamide .
0.9921 Adverse-Effect Escape atrial complexes, which occurred following junctional premature complexes, failed to initiate Entitytachycardia in the control state but tachycardia was always reinitiated by an identical escape sequence after Entityprocainamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for Entityerlotinib Entitypulmonary toxicity .
0.9997 Adverse-Effect Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known Entitypulmonary fibrosis may be at particular risk for Entityerlotinib pulmonary toxicity.
0.9958 Adverse-Effect Similar to reports in patients receiving Entitygefitinib , those with pathologic findings of UIP on resected lung specimens or known Entitypulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity.
0.9744 Adverse-Effect Similar to reports in patients receiving Entitygefitinib , those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib Entitypulmonary toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who experienced chronic nausea and an episode of Entityconfusion while treated with a small, stable dose of oral Entitymorphine in the setting of mild renal insufficiency.
1.0000 Adverse-Effect We describe a patient who experienced Entitychronic nausea and an episode of confusion while treated with a small, stable dose of oral Entitymorphine in the setting of mild renal insufficiency.
1.0000 Adverse-Effect We describe a patient who experienced chronic Entitynausea and an episode of confusion while treated with a small, stable dose of oral Entitymorphine in the setting of mild renal insufficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 22 - year - old drug - abuser injected Entityflunitrazepam tablets dissolved in tap water into her left femoral artery and presented with clinical signs of Entityacute ischaemia of the left leg .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report four cases of hemodynamically significant Entitypericardial effusion in patients with refractory lymphoma who were receiving Entitygemcitabine , all of whom had a history of mediastinal radiation without subcarinal blocking.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHyperammonemia has been described as a complication of Entityvalproic acid therapy but may often be overlooked as a cause of lethargy in the postictal patient who presents to the emergency department.
0.9996 Adverse-Effect Hyperammonemia has been described as a complication of Entityvalproic acid therapy but may often be overlooked as a cause of Entitylethargy in the postictal patient who presents to the emergency department.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 66 - year - old mand suffering from severe coronary heart disease took Entitydigoxin with suicidal intent an was treated for the ensuing Entitycomplete atrioventricular block with digoxin - specific antibody fragments.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We described a very atypical case of a high stage, high grade Entityendometrial cancer associated with Entitytamoxifen in a 64 - year - old woman with a past history of breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of an acute flare of Entityeosinophilic cystitis in a 51 - year - old woman after bladder instillation with Entitydimethyl sulfoxide ( DMSO ) for presumed interstitial cystitis.
0.9999 Adverse-Effect We report the first case of an acute flare of Entityeosinophilic cystitis in a 51 - year - old woman after bladder instillation with dimethyl sulfoxide ( EntityDMSO ) for presumed interstitial cystitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that vincristine and Entityactinomycin D were the cause of this rare from of Entityhepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.
0.9998 Adverse-Effect We conclude that Entityvincristine and actinomycin D were the cause of this rare from of Entityhepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityTransient anuria following administration of angiotensin I - converting enzyme inhibitor ( EntitySQ 14225 ) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Flutamide withdrawal syndrome is characterized by a Entitydecrease in prostate - specific antigen ( PSA ) after Entityflutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
0.9995 Adverse-Effect EntityFlutamide withdrawal syndrome is characterized by a Entitydecrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
1.0000 Adverse-Effect EntityFlutamide Entitywithdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
0.9999 Adverse-Effect Flutamide Entitywithdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after Entityflutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
Adverse-Effect EntityFlutamide withdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after Entityflutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
Adverse-Effect EntityFlutamide EntityFlutamide withdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect All patients had taken Entityphenytoin for variable time periods ( range 16 - 80 days ; mean : 40 ) and were on the medication when the Entityskin lesions first appeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On day 7 of Entitylinezolid treatment, the patient developed Entitysevere pruritus , macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
1.0000 Adverse-Effect On day 7 of Entitylinezolid treatment, the patient developed severe pruritus, Entitymacular rash , facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
1.0000 Adverse-Effect On day 7 of Entitylinezolid treatment, the patient developed severe pruritus, macular rash, Entityfacial edema , eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
1.0000 Adverse-Effect On day 7 of Entitylinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, Entitymarked increase in serum creatinine level , and mild hepatitis.
1.0000 Adverse-Effect On day 7 of Entitylinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, Entityeosinophilia , marked increase in serum creatinine level, and mild hepatitis.
0.9999 Adverse-Effect On day 7 of Entitylinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and Entitymild hepatitis .
0.9999 Adverse-Effect On day 7 of Entitylinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked Entityincrease in serum creatinine level , and mild hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityGemcitabine is a known risk factor for Entityhemolytic uremic syndrome ( HUS ), which can often have a rapidly fatal clinical course despite intervention with steroids, plasmapheresis and hemodialysis.
1.0000 Adverse-Effect EntityGemcitabine is a known risk factor for hemolytic uremic syndrome ( EntityHUS ), which can often have a rapidly fatal clinical course despite intervention with steroids, plasmapheresis and hemodialysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE : We report a case of a woman with severe Entityhuman insulin - induced Entitylipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of IDDM.
0.9999 Adverse-Effect CASE : We report a case of a woman with severe human insulin - induced Entitylipoatrophy who has been treated exclusively with Entityrecombinant DNA human insulin since the onset of IDDM.
0.9999 Adverse-Effect CASE : We report a case of a woman with severe human insulin - induced lipoatrophy who has been treated exclusively with Entityrecombinant DNA human insulin since the onset of EntityIDDM .
0.9971 Adverse-Effect CASE : We report a case of a woman with severe Entityhuman insulin - induced lipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of EntityIDDM .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Entitypolymorphic ventricular tachycardia with normal QT interval associated with the oral use of Entitylevofloxacin in the absence of other etiologies known to cause these arrhythmias.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, it was suspected that a combination of cigarette smoking, pulmonary fibrosis, and low - dose Entitymethotrexate therapy might have promoted the development of Entitylung cancer .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on our experience and on previously published data, serum ammonia levels appear to be indicated in all ED patients on Entityvalproic acid therapy who present with Entityaltered mental status .
Score Relation Text (Head - Tail)
0.9992 Adverse-Effect CONCLUSIONS : Optic neuritis in combination with other Entityneurological signs , simulating multiple sclerosis, should be included in the list of adverse effects of recombinant and natural Entityinterferon alpha administration.
0.9988 Adverse-Effect CONCLUSIONS : EntityOptic neuritis in combination with other neurological signs, simulating multiple sclerosis, should be included in the list of adverse effects of recombinant and natural Entityinterferon alpha administration.
0.9996 Adverse-Effect CONCLUSIONS : Optic neuritis in combination with other neurological signs, simulating Entitymultiple sclerosis , should be included in the list of adverse effects of recombinant and natural Entityinterferon alpha administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low - dose Entitymethotrexate : an Entityacute megaloblastic anaemia and a pneumonitis.
0.9999 Adverse-Effect In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low - dose Entitymethotrexate : an acute megaloblastic anaemia and a Entitypneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, synovitis, and Entitypossible vasculitis , after receiving Entityall - trans retinoic acid therapy.
0.9998 Adverse-Effect Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, Entitysynovitis , and possible vasculitis, after receiving Entityall - trans retinoic acid therapy.
0.9996 Adverse-Effect Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed Entityacute focal myositis , synovitis, and possible vasculitis, after receiving Entityall - trans retinoic acid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We report a case of Entityintracerebral hemorrhage occurring in a middle - aged man who suffered from chronic sinusitis and had been ingesting Entitypseudoephedrine daily for one year.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, an immediate Entityerythematous macule was observed on the photopatch test site of Entitymequitazine directly after UV exposure which was similar to the immediate erythema noted in chlorpromazine photoallergy.
0.9962 Adverse-Effect In addition, an immediate erythematous macule was observed on the photopatch test site of Entitymequitazine directly after UV exposure which was similar to the immediate Entityerythema noted in chlorpromazine photoallergy.
Adverse-Effect In addition, an immediate erythematous macule was observed on the photopatch test site of Entitymequitazine directly after UV exposure which was similar to the Entityimmediate erythema noted in chlorpromazine photoallergy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present here a female patient who developed Entityacute bilateral parotitis within minutes of i. v. Entityenalaprilat injection and recovered within 24 hours of stopping the drug and with symptomatic treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed fatal cerebral edema and Entitybrainstem herniation after she received a single dose of intravenous Entitymethotrexate .
1.0000 Adverse-Effect A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed Entityfatal cerebral edema and brainstem herniation after she received a single dose of intravenous Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 20 - year - old female with polyarteritis nodosa ( PAN ) who developed Entitybilateral sensorineural hearing loss 25 minutes after receiving 30 mg of intravenous Entityketoralac .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of hypothyroidism with Entityincreased serum thyroid - stimulating hormone ( TSH ) concentrations after switching from 1 Entitylevothyroxine product to another.
1.0000 Adverse-Effect CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of hypothyroidism with increased serum thyroid - stimulating hormone ( EntityTSH ) concentrations after switching from 1 Entitylevothyroxine product to another.
1.0000 Adverse-Effect CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of Entityhypothyroidism with increased serum thyroid - stimulating hormone ( TSH ) concentrations after switching from 1 Entitylevothyroxine product to another.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A search of the United States Food and Drug Administration's Adverse Event Reporting System identified nine cases of Entityoxcarbazepine - associated Entityangioedema in pediatric patients aged 16 years and younger.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This fourth type of cutaneous Entityminocycline Entityhyperpigmentation may be a variant of Type I, but based on clinical, pathological and microanalytical differences, appears to be a new entity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report presents a case of Entityacute lung injury developing within hours after administration of Entitymefloquine for a low - level Plasmodium falciparum malaria, which was persistent despite halofantrine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An evaluation of ovarian structure and function should be considered in women of reproductive age being treated with Entityvalproate for epilepsy, especially if they develop Entitymenstrual cycle disturbances during treatment.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We speculate that platelet activation induced by EntitypFVIII may have contributed to Entitythrombosis and suggest that pFVIII be used with caution in elderly patients with pre - existing cardiovascular risk factors.
0.9999 Adverse-Effect We speculate that Entityplatelet activation induced by EntitypFVIII may have contributed to thrombosis and suggest that pFVIII be used with caution in elderly patients with pre - existing cardiovascular risk factors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We strongly suspect that this Entitylethal anuria was mainly due to Entityifosfamide , occurring in a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.
0.9995 Adverse-Effect We strongly suspect that this Entitylethal anuria was mainly due to ifosfamide, occurring in a patient having received previous Entitycisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A study following large patient groups on theophylline and a combination of Entitytheophylline and steroids might clarify the risk of Entityulcer formation in patients being treated with these medications for asthma.
1.0000 Adverse-Effect A study following large patient groups on Entitytheophylline and a combination of theophylline and steroids might clarify the risk of Entityulcer formation in patients being treated with these medications for asthma.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSION : The chronic use of EntityHCQ for rheumatic diseases, or as an anti - malarial drug, should be balanced against the risk of developing potentially lethal Entitycardiac arrhythmias .
1.0000 Adverse-Effect CONCLUSION : The chronic use of EntityHCQ for rheumatic diseases, or as an anti - malarial drug, should be balanced against the risk of developing potentially Entitylethal cardiac arrhythmias .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When the patient was treated again with Entityfludarabine nine months later, the EntityDAT became positive with anti - IgG and anti - C3d antiglobulins after the second course of treatment.
Adverse-Effect When the patient was treated again with Entityfludarabine nine months later, the EntityDAT became positive with anti - IgG and anti - C3d antiglobulins after the second course of treatment.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CASE SUMMARIES : While conducting a protocol evaluating the efficacy of intraperitoneal Entitycisplatin and hyperthermia in the treatment of recurrent ovarian cancer, 3 patients were noted to exhibit Entityanaphylactoid reactions .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset .
0.9999 Adverse-Effect EntityRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant human Entityinterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Entityhuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect EntityRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect EntityRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect EntityRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant human Entityinterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset .
0.9999 Adverse-Effect Recombinant human Entityinterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant human Entityinterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Entityhuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset .
0.9999 Adverse-Effect Recombinant human Entityinterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Entityhuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Entityhuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Entityhuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Entityexacerbate psoriasis or trigger off its onset.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The value of multihormonal therapy in breast carcinoma is not established, and the addition of progestogens to Entitytamoxifen may not reduce of developing Entityendometrial lesions , including carcinoma.
0.9999 Adverse-Effect CONCLUSIONS : The value of multihormonal therapy in breast carcinoma is not established, and the addition of progestogens to Entitytamoxifen may not reduce of developing endometrial lesions, including Entitycarcinoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : This case describes the clinically significant Entityincrease of INR in an elderly patient after adding a chemotherapy regimen of Entitylevamisole and 5 - FU to a previous regimen of warfarin alone.
1.0000 Adverse-Effect CONCLUSIONS : This case describes the clinically significant Entityincrease of INR in an elderly patient after adding a chemotherapy regimen of levamisole and Entity5 - FU to a previous regimen of warfarin alone.
0.9999 Adverse-Effect CONCLUSIONS : This case describes the clinically significant Entityincrease of INR in an elderly patient after adding a chemotherapy regimen of levamisole and 5 - FU to a previous regimen of Entitywarfarin alone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, a 31 - year - old man with obsessive - compulsive disorder developed EntityRBD soon after starting Entityfluoxetine therapy, which persisted at PSG study 19 months after fluoxetine discontinuation.
0.9997 Adverse-Effect In addition, a 31 - year - old man with obsessive - compulsive disorder developed EntityRBD soon after starting fluoxetine therapy, which persisted at PSG study 19 months after Entityfluoxetine discontinuation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing Entityheparin - induced Entitythrombocytopenia ( HIT ) postoperatively.
0.9991 Adverse-Effect Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing Entityheparin - induced thrombocytopenia ( EntityHIT ) postoperatively.
0.9907 Adverse-Effect Most cardiac surgical patients have had previous exposure to Entityheparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin - induced Entitythrombocytopenia ( HIT ) postoperatively.
0.9860 Adverse-Effect Most cardiac surgical patients have had previous exposure to Entityheparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin - induced thrombocytopenia ( EntityHIT ) postoperatively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, given the clinically significant result to the interaction between tolazoline and cimetidine we report, the use of cimetidine in Entitytolazoline induced Entityupper gastrointestinal hemorrhage should deserve more attention.
0.9971 Adverse-Effect However, given the clinically significant result to the interaction between tolazoline and cimetidine we report, the use of Entitycimetidine in tolazoline induced Entityupper gastrointestinal hemorrhage should deserve more attention.
0.9963 Adverse-Effect However, given the clinically significant result to the interaction between tolazoline and Entitycimetidine we report, the use of cimetidine in tolazoline induced Entityupper gastrointestinal hemorrhage should deserve more attention.
0.9957 Adverse-Effect However, given the clinically significant result to the interaction between Entitytolazoline and cimetidine we report, the use of cimetidine in tolazoline induced Entityupper gastrointestinal hemorrhage should deserve more attention.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case report, we present clinical and laboratory findings of a case with chronic hepatitis B that developed Entityacute dystonia soon after the first dose of Entitypegylated interferon alpha .
0.9999 Adverse-Effect In this case report, we present clinical and laboratory findings of a case with chronic Entityhepatitis B that developed Entityacute dystonia soon after the first dose of pegylated interferon alpha.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The induced hyperglycaemia could not be controlled sufficiently, despite a high dose of Entityinsulin ( > 110 units / day ), suggesting the existence of Entityinsulin insensitivity and hyperinsulinaemia.
0.9997 Adverse-Effect The induced hyperglycaemia could not be controlled sufficiently, despite a high dose of Entityinsulin ( > 110 units / day ), suggesting the existence of insulin insensitivity and Entityhyperinsulinaemia .
1.0000 Adverse-Effect The induced Entityhyperglycaemia could not be controlled sufficiently, despite a high dose of Entityinsulin ( > 110 units / day ), suggesting the existence of insulin insensitivity and hyperinsulinaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Continuous EEG monitoring is helpful in managing Entityseizures that occur as a complication of EntityCBZ OD, after the course of recovery or worsening, and in providing assistance with prognosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed complete heart block ( EntityCHB ) following administration of Entitydisopyramide phosphate ( Norpace ).
0.9999 Adverse-Effect A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed complete heart block ( EntityCHB ) following administration of disopyramide phosphate ( EntityNorpace ).
0.9999 Adverse-Effect A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed Entitycomplete heart block ( CHB ) following administration of Entitydisopyramide phosphate ( Norpace ).
0.9997 Adverse-Effect A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed Entitycomplete heart block ( CHB ) following administration of disopyramide phosphate ( EntityNorpace ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Use of the Naranjo adverse drug reaction probability scale indicated a probable relationship ( score of 5 ) between the patient's development of Entityhepatotoxicity and the EntityTMP - SMX therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 40 - year - old man with relapsing - remitting multiple sclerosis ( MS ) developed primary central nervous system lymphoma ( EntityPCNSL ) after having received 21 doses of Entitynatalizumab monotherapy.
1.0000 Adverse-Effect A 40 - year - old man with relapsing - remitting multiple sclerosis ( MS ) developed Entityprimary central nervous system lymphoma ( PCNSL ) after having received 21 doses of Entitynatalizumab monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityWarfarin - associated Entitybleeding generally is considered deleterious ; however, in our patient it unmasked an early stage of colon cancer and thus may have saved the patient's life.
0.9995 Adverse-Effect EntityWarfarin - associated bleeding generally is considered Entitydeleterious ; however, in our patient it unmasked an early stage of colon cancer and thus may have saved the patient's life.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, disopyramide, and Entityquinidine , administered alone separately, induced Entityatypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9999 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, Entitydisopyramide , and quinidine, administered alone separately, induced Entityatypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9999 Adverse-Effect A 44 - year - old woman is described in whom Entityamiodarone , disopyramide, and quinidine, administered alone separately, induced Entityatypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9999 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, disopyramide, and Entityquinidine , administered alone separately, induced atypical ventricular tachycardia ( AVT, Entitytorsade de pointes ).
0.9997 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, disopyramide, and Entityquinidine , administered alone separately, induced atypical ventricular tachycardia ( EntityAVT , torsade de pointes ).
0.9997 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, Entitydisopyramide , and quinidine, administered alone separately, induced atypical ventricular tachycardia ( AVT, Entitytorsade de pointes ).
0.9997 Adverse-Effect A 44 - year - old woman is described in whom Entityamiodarone , disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia ( AVT, Entitytorsade de pointes ).
0.9993 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, Entitydisopyramide , and quinidine, administered alone separately, induced atypical ventricular tachycardia ( EntityAVT , torsade de pointes ).
0.9993 Adverse-Effect A 44 - year - old woman is described in whom Entityamiodarone , disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia ( EntityAVT , torsade de pointes ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report four cases of Entitysensorimotor axonal neuropathy in children aged 10 - 15 years, treated with Entitythalidomide for myxopapillary ependymoma, Crohn's disease and recurrent giant aphthous ulceration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entityserotonin syndrome associated with interaction between Entityfentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.
0.9998 Adverse-Effect OBJECTIVE : To report a case of Entityserotonin syndrome associated with interaction between fentanyl and Entitycitalopram , as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.
0.9993 Adverse-Effect OBJECTIVE : To report a case of Entityserotonin syndrome associated with interaction between fentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of Entityfentanyl .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We review the literature on previously reported cases of Entitycutaneous necrosis after injection of standard Entityinterferon alfa or pegylated interferon alfa - 2b and discuss the different pathophysiologic mechanisms that might be involved.
0.9997 Adverse-Effect We review the literature on previously reported cases of Entitycutaneous necrosis after injection of standard interferon alfa or Entitypegylated interferon alfa - 2b and discuss the different pathophysiologic mechanisms that might be involved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a pediatric patient with leukemia and a severe, EntityL - asparaginase - induced Entitynecrotizing pancreatitis , treated successfully with percutaneous drainage used to flush the infected necrotic parts.
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Entitylithium Entitylithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.9991 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a Entityneuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily Entitythioridazine .
0.9952 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Entitylithium toxicity that occurs in combination with phenothiazines, primarily Entitythioridazine .
0.9940 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a Entityneuroleptic malignant extrapyramidal syndrome and a Entitylithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.9997 Adverse-Effect The authors postulate that two types of combined Entitylithium - neuroleptic toxicity occur : a Entityneuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.9991 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a Entityneuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with Entityphenothiazines , primarily thioridazine.
0.9984 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Entitylithium toxicity that occurs in combination with Entityphenothiazines , primarily thioridazine.
0.9882 Adverse-Effect The authors postulate that two types of combined Entitylithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Entitylithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possibility can be raised that EntityM - CSF accelerated the underlying Entityrenal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of nephrotic syndrome.
0.9989 Adverse-Effect The possibility can be raised that EntityM - CSF accelerated the underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of Entitynephrotic syndrome .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report here on a heretofore undescribed Entityrespiratory syncytial virus ( RSV ) infection in a patient with a long - standing history of refractory CLL that was treated with Entityfludarabine phosphate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of hyponatremia associated with a Entitygrand mal seizure in a 28 month - old child after intra - nasal Entitydesmopressin administration for high fluid intake with nocturnal enuresis.
1.0000 Adverse-Effect We report a case of Entityhyponatremia associated with a grand mal seizure in a 28 month - old child after intra - nasal Entitydesmopressin administration for high fluid intake with nocturnal enuresis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an additional case of Entityisotretinoin Entityteratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.
0.9999 Adverse-Effect We report an additional case of Entityisotretinoin teratogenicity in which the patient had Entityagenesis of the cerebellar vermis , multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.
0.9999 Adverse-Effect We report an additional case of Entityisotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and Entityabnormalities of the corticospinal tracts .
0.9998 Adverse-Effect We report an additional case of Entityisotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, Entitymultiple leptomeningeal neuroglial heterotopias , hydrocephalus, and abnormalities of the corticospinal tracts.
0.9998 Adverse-Effect We report an additional case of Entityisotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, Entityhydrocephalus , and abnormalities of the corticospinal tracts.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, continued low - dose EntityMTX led, in spite of normal liver tests, 8 years after the last biopsy to Entityliver failure and death in 1 of our patients.
0.9999 Adverse-Effect However, continued low - dose EntityMTX led, in spite of normal liver tests, 8 years after the last biopsy to liver failure and Entitydeath in 1 of our patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 56 - year - old woman with scleroderma developed rapidly progressive glomerulonephritis with epithelial crescents associated with Entityhemoptysis after 27 months of EntityD - penicillamine therapy and a cumulative dose of 1, 200 g.
0.9996 Adverse-Effect A 56 - year - old woman with scleroderma developed rapidly progressive glomerulonephritis with Entityepithelial crescents associated with hemoptysis after 27 months of EntityD - penicillamine therapy and a cumulative dose of 1, 200 g.
0.9995 Adverse-Effect A 56 - year - old woman with scleroderma developed Entityrapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis after 27 months of EntityD - penicillamine therapy and a cumulative dose of 1, 200 g.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a phase II study of Entityhycanthone in patients with breast cancer we have recently observed Entitysevere hepatotoxicity , even at lower doses, which resulted in two drug - related deaths.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The development of systemic lupus erythematosus ( EntitySLE ) after 38 months of therapy with Entityrecombinant human interferon gamma ( rIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9998 Adverse-Effect The development of systemic lupus erythematosus ( EntitySLE ) after 38 months of therapy with recombinant human interferon gamma ( EntityrIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9997 Adverse-Effect The development of Entitysystemic lupus erythematosus ( SLE ) after 38 months of therapy with Entityrecombinant human interferon gamma ( rIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9985 Adverse-Effect The development of Entitysystemic lupus erythematosus ( SLE ) after 38 months of therapy with recombinant human interferon gamma ( EntityrIFN - gamma ) was observed in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 2 cases of maculopapular eruption and Entityfever in patients infected with human immunodeficiency virus ( HIV ) on the 2nd day of first administration of Entityritonavir , a protease inhibitor.
1.0000 Adverse-Effect We report 2 cases of Entitymaculopapular eruption and fever in patients infected with human immunodeficiency virus ( HIV ) on the 2nd day of first administration of Entityritonavir , a protease inhibitor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of severe thrombocytopenia, and confirmed the etiology of Entityquinine - induced Entitythrombocytopenia .
0.9762 Adverse-Effect Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of severe Entitythrombocytopenia , and confirmed the etiology of Entityquinine - induced thrombocytopenia.
0.9844 Adverse-Effect Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of Entitysevere thrombocytopenia , and confirmed the etiology of Entityquinine - induced thrombocytopenia.
Adverse-Effect Even after a strict warning, he took another Entityquinine tablet that evening, which triggered his fifth episode of severe Entitythrombocytopenia , and confirmed the etiology of quinine - induced thrombocytopenia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Six patients developed Entityperipheral neuropathy and five patients bone marrow depression, blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of Entitylinezolid .
0.9999 Adverse-Effect Six patients developed peripheral neuropathy and five patients Entitybone marrow depression , blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of Entitylinezolid .
Score Relation Text (Head - Tail)
0.9962 Adverse-Effect Herein is reported an unusual case of coexistent warfarin - induced skin necrosis and Entityheparin - induced Entitythrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.
0.9957 Adverse-Effect Herein is reported an unusual case of coexistent Entitywarfarin - induced Entityskin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis ( EntityASPPC ) that developed after intravitreal Entitytriamcinolone acetonide ( IVTA ) injection.
0.9999 Adverse-Effect BACKGROUND : We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis ( EntityASPPC ) that developed after intravitreal triamcinolone acetonide ( EntityIVTA ) injection.
0.9999 Adverse-Effect BACKGROUND : We describe the ophthalmic features and clinical course of two cases of Entityacute syphilitic posterior placoid chorioretinitis ( ASPPC ) that developed after intravitreal Entitytriamcinolone acetonide ( IVTA ) injection.
0.9996 Adverse-Effect BACKGROUND : We describe the ophthalmic features and clinical course of two cases of Entityacute syphilitic posterior placoid chorioretinitis ( ASPPC ) that developed after intravitreal triamcinolone acetonide ( EntityIVTA ) injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of intraoperative Entitygelatine - induced Entityanaphylaxis whose diagnosis was delayed as the use of gelatine during surgical procedures was omitted for two times in patient's medical records.
0.9999 Adverse-Effect We describe a case of intraoperative gelatine - induced Entityanaphylaxis whose diagnosis was delayed as the use of Entitygelatine during surgical procedures was omitted for two times in patient's medical records.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here, we describe a case of EntityVogt - Koyanagi - Harada disease occurring 4 months after the start of Entityinterferon alpha treatment, probably induced by the immunomodulatory effects of interferon.
0.9960 Adverse-Effect Here, we describe a case of EntityVogt - Koyanagi - Harada disease occurring 4 months after the start of interferon alpha treatment, probably induced by the immunomodulatory effects of Entityinterferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityPheripheral edema was observed in five female patients after taking proton pump inhibitors Entityomeprazole , lansoprazole, or pantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
0.9999 Adverse-Effect EntityPheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, Entitylansoprazole , or pantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
0.9999 Adverse-Effect EntityPheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, lansoprazole, or Entitypantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We describe two patients in whom painful erosions of their psoriasis developed as the presenting sign of Entitymethotrexate Entitymethotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
0.9995 Adverse-Effect We describe two patients in whom Entitypainful erosions of their psoriasis developed as the presenting sign of Entitymethotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
0.9991 Adverse-Effect We describe two patients in whom painful Entityerosions of their psoriasis developed as the presenting sign of Entitymethotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We recommend that a TMA in association with quinine be consistently referred to as Entityquinine - associated Entitythrombotic microangiopathy ( quinine - TMA ) to better distinguish this entity from idiopathic TTP.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 77 - year - old woman with no history of epilepsy presented a probable Entitynonconvulsive status epilepticus while receiving continuous intravenous Entitymorphine for back pain relating to vertebral metastasis of a malignant lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of the syndrome of inappropriate antidiuretic hormone ( EntitySIADH ) secondary to Entitycisplatin therapy in a patient with advanced - stage large cell neuroendocrine carcinoma of the cervix.
0.9999 Adverse-Effect We present a case of the Entitysyndrome of inappropriate antidiuretic hormone ( SIADH ) secondary to Entitycisplatin therapy in a patient with advanced - stage large cell neuroendocrine carcinoma of the cervix.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prenatal cytomegalovirus ( CMV ) infection associated with severe Entitybrain damage was detected in an infant whose mother had been treated with Entityprednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
1.0000 Adverse-Effect Prenatal cytomegalovirus ( CMV ) infection associated with severe Entitybrain damage was detected in an infant whose mother had been treated with prednisolone and Entityazathioprine for systemic lupus erythematosus ( SLE ).
1.0000 Adverse-Effect EntityPrenatal cytomegalovirus ( CMV ) infection associated with severe brain damage was detected in an infant whose mother had been treated with Entityprednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
0.9999 Adverse-Effect EntityPrenatal cytomegalovirus ( CMV ) infection associated with severe brain damage was detected in an infant whose mother had been treated with prednisolone and Entityazathioprine for systemic lupus erythematosus ( SLE ).
1.0000 Adverse-Effect Prenatal cytomegalovirus ( CMV ) infection associated with Entitysevere brain damage was detected in an infant whose mother had been treated with Entityprednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
1.0000 Adverse-Effect Prenatal cytomegalovirus ( CMV ) infection associated with Entitysevere brain damage was detected in an infant whose mother had been treated with prednisolone and Entityazathioprine for systemic lupus erythematosus ( SLE ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant Entitymethemoglobinemia after an axillary block with Entitybupivacaine and additional injection of lidocaine in the operative field.
0.9999 Adverse-Effect We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant Entitymethemoglobinemia after an axillary block with bupivacaine and additional injection of Entitylidocaine in the operative field.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Review of this and previously reported cases indicates the need for early diagnosis of Entityamiodarone Entitypneumonitis , immediate withdrawal of amiodarone, and prompt but continued steroid therapy to ensure full recovery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two years later, 24 hours following an increase in the dose of Entitydisopyramide from 300 to 600 mg / day, EntityAVT with syncope occurred ; isoproterenol abolished the arrhythmia instantly.
0.9999 Adverse-Effect Two years later, 24 hours following an increase in the dose of Entitydisopyramide from 300 to 600 mg / day, AVT with Entitysyncope occurred ; isoproterenol abolished the arrhythmia instantly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 74 - year - old patient with idiopathic Parkinson's disease was evaluated for Entityunintended sleep episodes that occurred after long - term treatment with 400 mg / day of EntityL - dopa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prior to surgery, Entitylevodopa induced Entitydyskinesia had improved ( < or = 50 % ) under treatment with amantadine ( 400 mg / day, po ) in all three patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient with acromegaly who developed severe drug - induced Entityhepatitis during combined treatment with the long - acting somatostatin - analog Entityoctreotide and the GH receptor antagonist pegvisomant.
0.9999 Adverse-Effect We report on a patient with acromegaly who developed severe drug - induced Entityhepatitis during combined treatment with the long - acting somatostatin - analog octreotide and the GH receptor antagonist Entitypegvisomant .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : EntityTopiramate may be associated with Entityciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and angle - closure glaucoma.
1.0000 Adverse-Effect CONCLUSIONS : EntityTopiramate may be associated with ciliochoroidal effusion with forward Entitydisplacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and angle - closure glaucoma.
0.9999 Adverse-Effect CONCLUSIONS : EntityTopiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and Entityangle - closure glaucoma .
0.9999 Adverse-Effect CONCLUSIONS : EntityTopiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in Entityacute myopia and angle - closure glaucoma.
0.9999 Adverse-Effect CONCLUSIONS : EntityTopiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and Entityanterior chamber shallowing , resulting in acute myopia and angle - closure glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of high - grade endometrial stromal sarcoma, confined into an Entityintrauterine polypoid growth , in a woman with a history of breast cancer who was treated with adjuvant Entitytamoxifen .
1.0000 Adverse-Effect A case of Entityhigh - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth, in a woman with a history of breast cancer who was treated with adjuvant Entitytamoxifen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because of serious side effects of an increase in the QT interval causing Entitytorsades de pointes , Entitydofetilide must be initiated with close monitoring of the QT interval in an inpatient setting.
0.9999 Adverse-Effect Because of serious side effects of an Entityincrease in the QT interval causing torsades de pointes, Entitydofetilide must be initiated with close monitoring of the QT interval in an inpatient setting.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The typical Entityfluoxetine - induced symptoms of Entityrestlessness , constant pacing, purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9999 Adverse-Effect The typical Entityfluoxetine - induced symptoms of restlessness, constant pacing, Entitypurposeless movements of the feet and legs , and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9999 Adverse-Effect The typical Entityfluoxetine - induced symptoms of restlessness, Entityconstant pacing , purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9997 Adverse-Effect The typical Entityfluoxetine - induced symptoms of restlessness, constant pacing, purposeless movements of the feet and legs, and Entitymarked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.8799 Adverse-Effect The typical Entityfluoxetine - induced symptoms of restlessness, constant pacing, purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced Entityakathisia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entityphenolphthalein - induced Entitytoxic epidermal necrolysis ( TEN ) in a patient maintained on several other medications more commonly known to be associated with TEN.
1.0000 Adverse-Effect OBJECTIVE : To report a case of Entityphenolphthalein - induced toxic epidermal necrolysis ( EntityTEN ) in a patient maintained on several other medications more commonly known to be associated with TEN.
0.9998 Adverse-Effect OBJECTIVE : To report a case of Entityphenolphthalein - induced toxic epidermal necrolysis ( TEN ) in a patient maintained on several other medications more commonly known to be associated with EntityTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After Entityinfliximab treatment, additional sleep studies revealed an Entityincrease in the number of apneic events and SaO2 dips suggesting that TNFalpha plays an important role in the pathophysiology of sleep apnea.
0.9999 Adverse-Effect After Entityinfliximab treatment, additional sleep studies revealed an increase in the number of apneic events and EntitySaO2 dips suggesting that TNFalpha plays an important role in the pathophysiology of sleep apnea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : We report a patient who developed neutropenia on Entityclozapine , but behind the cell count decrease showed to be a Entitydiurnal variation of the white blood cells ( WBC ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect An infant girl with choanal atresia, Entityathelia , minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with Entitymethimazole and propranolol.
0.9999 Adverse-Effect An infant girl with Entitychoanal atresia , athelia, minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with Entitymethimazole and propranolol.
0.9998 Adverse-Effect An infant girl with choanal atresia, Entityathelia , minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and Entitypropranolol .
0.9997 Adverse-Effect An infant girl with Entitychoanal atresia , athelia, minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and Entitypropranolol .
Adverse-Effect An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate Entitymental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with Entitymethimazole and propranolol.
Adverse-Effect An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate Entitymental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and Entitypropranolol .
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Acute Entitynitrite Entitynitrite toxicity results from industrial exposure, accidental ingestion ( e. g., abuse of organic nitrites as an aphrodisiac, especially in the male homosexual population ), and suicidal ingestion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe rash, including the Stevens - Johnson syndrome ( EntitySJS ), is the major toxicity of Entitynevirapine and is described in the package labeling with a prominent, boxed warning.
0.9999 Adverse-Effect EntitySevere rash , including the Stevens - Johnson syndrome ( SJS ), is the major toxicity of Entitynevirapine and is described in the package labeling with a prominent, boxed warning.
0.9999 Adverse-Effect Severe rash, including the EntityStevens - Johnson syndrome ( SJS ), is the major toxicity of Entitynevirapine and is described in the package labeling with a prominent, boxed warning.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of sulphasalazine ( EntitySASP ) therapy developed a severe and lasting Entitypsoriasis - like skin reaction .
0.9999 Adverse-Effect Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of Entitysulphasalazine ( SASP ) therapy developed a severe and lasting Entitypsoriasis - like skin reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is reported in which severe hypocalcemia, with a low plasma parathyroid hormone ( EntityPTH ) concentration, resulted from the therapeutic use of Entitymagnesium sulfate for toxemia of pregnancy.
0.9999 Adverse-Effect A case is reported in which severe hypocalcemia, with a Entitylow plasma parathyroid hormone ( PTH ) concentration, resulted from the therapeutic use of Entitymagnesium sulfate for toxemia of pregnancy.
0.9998 Adverse-Effect A case is reported in which Entitysevere hypocalcemia , with a low plasma parathyroid hormone ( PTH ) concentration, resulted from the therapeutic use of Entitymagnesium sulfate for toxemia of pregnancy.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The electrocardiogram ( ECG ), which was read as normal prior to ritodrine infusion, demonstrated a Entitytype I second - degree AV block which disappeared upon discontinuation of Entityritodrine therapy.
0.9997 Adverse-Effect The electrocardiogram ( ECG ), which was read as normal prior to Entityritodrine infusion, demonstrated a Entitytype I second - degree AV block which disappeared upon discontinuation of ritodrine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is reported of an elderly woman who developed Entityfebrile agranulocytosis several weeks after commencing Entityticlopidine but who had a favorable outcome after cessation of that drug and treatment with filgastrim.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect METHODS : Two patients with exudative age - related macular degeneration were treated sequentially with an intravitreal injection of Entitybevacizumab and developed signs of severe but Entitypainless infectious endophthalmitis 2 days later.
1.0000 Adverse-Effect METHODS : Two patients with exudative age - related Entitymacular degeneration were treated sequentially with an intravitreal injection of Entitybevacizumab and developed signs of severe but painless infectious endophthalmitis 2 days later.
Adverse-Effect METHODS : Two patients with exudative Entityage - related macular degeneration were treated sequentially with an intravitreal injection of Entitybevacizumab and developed signs of severe but painless infectious endophthalmitis 2 days later.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect 3. Thus, the Entitydecreased plasma cortisol level during Entityalprazolam treatment of panic disorder was suggested to be caused not by symptom alleviation due to alprazolam but by alprazolam administration itself.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the Entityt - AML developed following oral Entityetoposide therapy, the child had previously received high - dose, multiagent chemotherapy, and rearrangement of the MLL gene was not demonstrated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 66 - year - old Japanese woman with severe scleroderma developed anemia and Entitythrombocytopenia due to EntityD - penicillamine ( D - Pen ) treatment, although the leukopenia was not markedly severe.
0.9996 Adverse-Effect A 66 - year - old Japanese woman with severe scleroderma developed Entityanemia and thrombocytopenia due to EntityD - penicillamine ( D - Pen ) treatment, although the leukopenia was not markedly severe.
0.9994 Adverse-Effect A 66 - year - old Japanese woman with severe scleroderma developed anemia and Entitythrombocytopenia due to D - penicillamine ( EntityD - Pen ) treatment, although the leukopenia was not markedly severe.
0.9988 Adverse-Effect A 66 - year - old Japanese woman with severe scleroderma developed Entityanemia and thrombocytopenia due to D - penicillamine ( EntityD - Pen ) treatment, although the leukopenia was not markedly severe.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While Entitydoxorubicin was administered, the patient presented Entitythoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.
0.9999 Adverse-Effect While Entitydoxorubicin was administered, the patient presented thoracic pain and Entitybreathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 67 - year - old patient, with primary polymyositis and without previous evidence of liver disease, developed clinical and biochemical features of Entitysevere cholestasis 3 months after initiation of Entityazathioprine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a life threatening side effect of acute Entityepoprostenol infusion ( Entitypulmonary edema ) in a patient with pulmonary hypertension associated with limited scleroderma and discuss its management and potential etiology.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / Entityinfarction shortly after Entitycis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.9998 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / Entityinfarction shortly after cis - diamine - dichloroplatinum II ( Entitycisplatin ) - based chemotherapy.
0.9997 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed Entityacute coronary ischemia / infarction shortly after Entitycis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.9990 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed Entityacute coronary ischemia / infarction shortly after cis - diamine - dichloroplatinum II ( Entitycisplatin ) - based chemotherapy.
1.0000 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / Entityinfarction shortly after Entitycis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.9997 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed Entityacute coronary ischemia / infarction shortly after Entitycis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In three of these patients the infection was clinically unsuspected ; in the fourth, Entitycutaneous herpes zoster developed after administration of 300 mg of Entitycytarabine daily for the preceding five days.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect INTRODUCTION - The aim of this case report is to present a 15 - year follow - up of a patient with phenytoin ( EntityPHT ) intoxication with Entityunilateral gingival hyperplasia ( GH ).
0.9993 Adverse-Effect INTRODUCTION - The aim of this case report is to present a 15 - year follow - up of a patient with Entityphenytoin ( PHT ) intoxication with Entityunilateral gingival hyperplasia ( GH ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Though physicians treating large populations of patients with HIV are well aware of this complication, only one other report of Entitynevirapine - associated EntitySJS has been documented in the dermatology literature.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityGrade 3 hepatotoxicity ( AST and ALT > 5 to 20 upper limit normal ) or higher has been observed in as many as 1. 4 % of MS patients on EntityIFN beta .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : To describe the clinicopathologic features of 3 patients with CML who rapidly progressed from chronic phase to Entityblast crisis while taking Entityimatinib and to perform a review of the literature.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The purpose of this review is to increase awareness among physicians and other health care professionals that EntityDIC may be a rare but potentially severe complication of Entityanti - D IGIV treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our patient was a 72 - year - old man with advanced Parkinson's disease ( PD ) who received Entitylevodopa and anti - cholinergic drugs and whose head had become almost Entitycompletely bald .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : These results suggest that Entityclozapine may cause EntityTD ; however, the prevalence is low and the severity is relatively mild, with no or mild self - reported discomfort.
0.9999 Adverse-Effect CONCLUSIONS : These results suggest that Entityclozapine may cause TD ; however, the prevalence is low and the severity is relatively mild, with no or mild self - reported Entitydiscomfort .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The observation that Entityneurotoxicity developed with a delay of 24 to 48 hours after Entityacyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases.
0.9998 Adverse-Effect CONCLUSIONS : The observation that Entityneurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of Entityacyclovir levels reported in similar cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We highlight two instances of Entitysystemic allergic reaction , and discuss the potential side effects of local Entityaprotinin injections in the orthopaedic setting as well as the evidence base for its use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Diarrhoea, T - CD4 + lymphopenia and Entitybilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with Entityoxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
1.0000 Adverse-Effect EntityDiarrhoea , T - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with Entityoxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
0.9999 Adverse-Effect Diarrhoea, EntityT - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with Entityoxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
0.9999 Adverse-Effect Diarrhoea, T - CD4 + lymphopenia and Entitybilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and Entity5 - fluorouracil for unresectable rectum carcinoma.
0.9999 Adverse-Effect EntityDiarrhoea , T - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and Entity5 - fluorouracil for unresectable rectum carcinoma.
0.9998 Adverse-Effect Diarrhoea, EntityT - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and Entity5 - fluorouracil for unresectable rectum carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Several cases of Entitylithium - induced EntityCreutzfeldt - Jakob syndrome have been reported to date ; all of them were elderly patients and a half had " therapeutic " lithium serum levels.
0.9999 Adverse-Effect Several cases of lithium - induced EntityCreutzfeldt - Jakob syndrome have been reported to date ; all of them were elderly patients and a half had " therapeutic " Entitylithium serum levels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entityfulminant hepatic failure associated with Entitydidanosine and masquerading as a surgical abdomen and compare the clinical, biologic, histologic, and ultrastructural findings with reports described previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin who developed acute respiratory distress syndrome ( EntityARDS ) after a single infusion of Entityrituximab .
1.0000 Adverse-Effect We report the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin who developed Entityacute respiratory distress syndrome ( ARDS ) after a single infusion of Entityrituximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an unusual case of simultaneous transitional cell carcinoma of the renal pelvis and Entitydistal ureter without transitional cell carcinoma of the bladder occurring after chronic Entitycyclophosphamide therapy for nonHodgkin's lymphoma.
1.0000 Adverse-Effect We report an unusual case of simultaneous Entitytransitional cell carcinoma of the renal pelvis and distal ureter without transitional cell carcinoma of the bladder occurring after chronic Entitycyclophosphamide therapy for nonHodgkin's lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One week after the initial - dose of Entityadalimumab ( 160 mg ), which was initiated due to an acute exacerbation of Crohn's disease, the patient developed a Entityfulminant cardiomyopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because there were no other obvious causes of renal failure in either patient, we propose that Entityskeletal muscle ischemia developed during Entityvasopressin infusion, followed by release of myoglobin and renal damage.
0.9975 Adverse-Effect Because there were no other obvious causes of renal failure in either patient, we propose that skeletal muscle ischemia developed during Entityvasopressin infusion, followed by release of myoglobin and Entityrenal damage .
0.9995 Adverse-Effect Because there were no other obvious causes of Entityrenal failure in either patient, we propose that skeletal muscle ischemia developed during Entityvasopressin infusion, followed by release of myoglobin and renal damage.
0.9804 Adverse-Effect Because there were no other obvious causes of renal failure in either patient, we propose that Entityskeletal muscle ischemia developed during vasopressin infusion, followed by release of Entitymyoglobin and renal damage.
0.9510 Adverse-Effect Because there were no other obvious causes of Entityrenal failure in either patient, we propose that skeletal muscle ischemia developed during vasopressin infusion, followed by release of Entitymyoglobin and renal damage.
0.6259 Adverse-Effect Because there were no other obvious causes of renal failure in either patient, we propose that skeletal muscle ischemia developed during vasopressin infusion, followed by release of Entitymyoglobin and Entityrenal damage .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of Entityvalvular heart disease in a 48 - year - old woman receiving Entitybenfluorex ( 150 mg t. i. d. for 8 years ) and leading to surgical mitral valve replacement.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCD20 - negative T - cell - rich B - cell lymphoma as a progression of a nodular lymphocyte - predominant Hodgkin's lymphoma treated with Entityrituximab : a molecular analysis using laser capture microdissection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 65 - year - old man on Entitywarfarin therapy with a sudden spontaneous onset of Entitysub - conjunctival haematoma associated with bloody tears was assessed in the clinic following a referral from an optometrist.
0.9999 Adverse-Effect A 65 - year - old man on Entitywarfarin therapy with a sudden spontaneous onset of sub - conjunctival haematoma associated with Entitybloody tears was assessed in the clinic following a referral from an optometrist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the clinical response, as determined by Entityincreases in total Hb and decreased transfusion needs, in five patients with thalassemia intermedia treated with EntityHU alone or in combination with SPB.
0.9999 Adverse-Effect We describe the clinical response, as determined by Entityincreases in total Hb and decreased transfusion needs, in five patients with thalassemia intermedia treated with HU alone or in combination with EntitySPB .
1.0000 Adverse-Effect We describe the clinical response, as determined by increases in total Hb and Entitydecreased transfusion needs , in five patients with thalassemia intermedia treated with EntityHU alone or in combination with SPB.
0.9998 Adverse-Effect We describe the clinical response, as determined by increases in total Hb and Entitydecreased transfusion needs , in five patients with thalassemia intermedia treated with HU alone or in combination with EntitySPB .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 31 - year - old women with recurrent Hodgkin's lymphoma and unrecognized HMSN - 1 who developed Entitysevere motor neuropathy 3 weeks after the first cycle of treatment including 2 mg of Entityvincristine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This paper reports an autopsy case of a 78 - year - old male with Entitymultiple nodules in the liver developed after long - termed administration of Entityphosphate diethylstilbestrol ( PDES ) for prostatic cancer.
0.9999 Adverse-Effect This paper reports an autopsy case of a 78 - year - old male with Entitymultiple nodules in the liver developed after long - termed administration of phosphate diethylstilbestrol ( EntityPDES ) for prostatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true thymic hyperplasia ), mediastinal lymphadenopathy and Entitypleurisy associated with systemic symptoms under EntityEtanercept treatment.
0.9999 Adverse-Effect In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true thymic hyperplasia ), Entitymediastinal lymphadenopathy and pleurisy associated with systemic symptoms under EntityEtanercept treatment.
0.9999 Adverse-Effect In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true Entitythymic hyperplasia ), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under EntityEtanercept treatment.
0.9999 Adverse-Effect In this report we described a case of juvenile idiopathic arthritis patient who developed Entitythymic enlargement ( true thymic hyperplasia ), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under EntityEtanercept treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, the use of Entitylithium should be avoided with any patient who is purging, since it may exacerbate the Entityloss of intracellular potassium , thereby increasing the risk of cardiac toxicity.
0.9999 Adverse-Effect However, the use of Entitylithium should be avoided with any patient who is purging, since it may exacerbate the loss of intracellular potassium, thereby increasing the risk of Entitycardiac toxicity .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and Entitycitalopram , which caused propafenone adverse effects ( eg, Entitydizziness , falls ) and mimicked coronary artery disease.
0.9994 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between Entitypropafenone and citalopram, which caused propafenone adverse effects ( eg, Entitydizziness , falls ) and mimicked coronary artery disease.
0.9993 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and Entitycitalopram , which caused propafenone adverse effects ( eg, dizziness, Entityfalls ) and mimicked coronary artery disease.
0.9990 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between Entitypropafenone and citalopram, which caused propafenone adverse effects ( eg, dizziness, Entityfalls ) and mimicked coronary artery disease.
0.9989 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and Entitycitalopram , which caused propafenone adverse effects ( eg, dizziness, falls ) and mimicked Entitycoronary artery disease .
0.9984 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between Entitypropafenone and citalopram, which caused propafenone adverse effects ( eg, dizziness, falls ) and mimicked Entitycoronary artery disease .
0.9998 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Entitypropafenone adverse effects ( Entityeg , dizziness, falls ) and mimicked coronary artery disease.
0.9997 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and Entitycitalopram , which caused propafenone adverse effects ( Entityeg , dizziness, falls ) and mimicked coronary artery disease.
0.9996 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Entitypropafenone adverse effects ( eg, Entitydizziness , falls ) and mimicked coronary artery disease.
0.9995 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between Entitypropafenone and citalopram, which caused propafenone adverse effects ( Entityeg , dizziness, falls ) and mimicked coronary artery disease.
0.9993 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Entitypropafenone adverse effects ( eg, dizziness, Entityfalls ) and mimicked coronary artery disease.
0.9991 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Entitypropafenone adverse effects ( eg, dizziness, falls ) and mimicked Entitycoronary artery disease .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( LE ) cell preparation, and Entitydiffuse proliferative glomerulonephritis following 26 months of Entityprocainamide therapy.
1.0000 Adverse-Effect A 61 - year - old man developed Entityclinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Entityprocainamide therapy.
1.0000 Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, Entitypositive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Entityprocainamide therapy.
0.9999 Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with Entitypositive antinuclear antibody , positive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Entityprocainamide therapy.
0.9999 Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( EntityLE ) cell preparation , and diffuse proliferative glomerulonephritis following 26 months of Entityprocainamide therapy.
Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive Entitylupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Entityprocainamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of Entityflucytosine - associated Entityulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, ulceration, and marked separation of loops of bowel.
0.9999 Adverse-Effect This report describes a case of Entityflucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, Entityulceration , and marked separation of loops of bowel.
0.9999 Adverse-Effect This report describes a case of Entityflucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated Entitysevere luminal narrowing , ulceration, and marked separation of loops of bowel.
0.9998 Adverse-Effect This report describes a case of Entityflucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, ulceration, and Entitymarked separation of loops of bowel .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Entitypro - arrhythmic effects of Entityprocainamide may be explained on the basis of both its vagolytic action on the atrioventricular node as well as by prolongation of refractoriness in the accessory pathway.
0.9999 Adverse-Effect The pro - arrhythmic effects of Entityprocainamide may be explained on the basis of both its vagolytic action on the atrioventricular node as well as by Entityprolongation of refractoriness in the accessory pathway .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When Entitypilsicainide is prescribed in patients with coronary artery disease or renal dysfunction, close attention must be paid to avoid Entitylife - threatening arrhythmias due to high plasma concentrations of the drug.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Sodium valproate and Entitycarbamazepine , antiepileptic drugs that are associated with a relatively low rate of adverse cutaneous reactions, should be added to the growing list of drugs that produce Entitypsoriasiform eruptions .
0.9997 Adverse-Effect EntitySodium valproate and carbamazepine, antiepileptic drugs that are associated with a relatively low rate of adverse cutaneous reactions, should be added to the growing list of drugs that produce Entitypsoriasiform eruptions .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal pulmonary fibrosis associated with EntityBCNU : the relative role of platelet - derived growth factor - B, insulin - like growth factor I, transforming growth factor - beta1 and cyclooxygenase - 2.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the development of Entityscrotal ulcer in a patient with acute promyleocytic leukemia ( APL ) within 10 days of treatment with EntityATRA at a dose of 40 mg orally twice daily.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( EntitySIADH ) following systemic chemotherapy with Entitycisplatin ( CDDP ) and vindesine ( VDS ).
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( EntitySIADH ) following systemic chemotherapy with cisplatin ( EntityCDDP ) and vindesine ( VDS ).
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the Entitysyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with Entitycisplatin ( CDDP ) and vindesine ( VDS ).
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( EntitySIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and Entityvindesine ( VDS ).
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( EntitySIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and vindesine ( EntityVDS ).
0.9999 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the Entitysyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( EntityCDDP ) and vindesine ( VDS ).
0.9999 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the Entitysyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and Entityvindesine ( VDS ).
0.9999 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the Entitysyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and vindesine ( EntityVDS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 60 - year - old white man with chronic bronchitis was noted to develop acute respiratory failure and Entitymetabolic acidosis four days after being started on Entitymethazolamide ( Neptazane ) for an ophthalmologic problem.
1.0000 Adverse-Effect A 60 - year - old white man with chronic bronchitis was noted to develop acute respiratory failure and Entitymetabolic acidosis four days after being started on methazolamide ( EntityNeptazane ) for an ophthalmologic problem.
1.0000 Adverse-Effect A 60 - year - old white man with chronic bronchitis was noted to develop Entityacute respiratory failure and metabolic acidosis four days after being started on Entitymethazolamide ( Neptazane ) for an ophthalmologic problem.
0.9999 Adverse-Effect A 60 - year - old white man with chronic bronchitis was noted to develop Entityacute respiratory failure and metabolic acidosis four days after being started on methazolamide ( EntityNeptazane ) for an ophthalmologic problem.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A 76 - year - old woman with primary open - angle glaucoma and no history of ocular surgery developed a Entitychoroidal detachment 12 hours after initiation of therapy with Entitydorzolamide eye drops.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report describes an adolescent with Entitysevere lupus erythematosus who received Entitycyclophosphamide ( CY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
0.9999 Adverse-Effect This case report describes an adolescent with Entitysevere lupus erythematosus who received cyclophosphamide ( EntityCY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
1.0000 Adverse-Effect This case report describes an adolescent with severe Entitylupus erythematosus who received Entitycyclophosphamide ( CY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
0.9999 Adverse-Effect This case report describes an adolescent with severe Entitylupus erythematosus who received cyclophosphamide ( EntityCY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityARDS has been associated with the administration of other monoclonal antibodies, such as Entityinfliximab , gemtuzumab ozogamicin, and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
0.9999 Adverse-Effect EntityARDS has been associated with the administration of other monoclonal antibodies, such as infliximab, Entitygemtuzumab ozogamicin , and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
0.9999 Adverse-Effect EntityARDS has been associated with the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and EntityOKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Well - differentiated Entityendometrial adenocarcinoma of the secretory type ( FIGO Grade 1 ) with minimal myometrial invasion occurred in a postmenopausal patient on Entitytamoxifen therapy 5 years after mastectomy for breast carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitysevere acute hepatitis caused by Entitycyproterone acetate in a 71 year old man with prostatic carcinoma is reported with a review of the literature on hepatic reactions to this drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of an 11 - year - old female treated for mediastinal T - cell lymphoma who presented Entityrenal failure following the second cycle of high - dose Entitymethotrexate ( HDMTX ).
1.0000 Adverse-Effect We report the case of an 11 - year - old female treated for mediastinal T - cell lymphoma who presented Entityrenal failure following the second cycle of high - dose methotrexate ( EntityHDMTX ).
Score Relation Text (Head - Tail)
0.9986 Adverse-Effect Since Entityethambutol is actively excreted via the renal system, compromise of renal function such as due to renal tuberculosis may lead to serum concentration elevations of ethambutol sufficient to produce Entityoptic neuropathy .
0.9999 Adverse-Effect Since ethambutol is actively excreted via the renal system, compromise of renal function such as due to renal tuberculosis may lead to serum concentration elevations of Entityethambutol sufficient to produce Entityoptic neuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Autopsy evidence of Entityherpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of Entitycytarabine ( cytosine arabinoside ; Ara - C ) shortly before their death.
0.9999 Adverse-Effect Autopsy evidence of Entityherpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of cytarabine ( Entitycytosine arabinoside ; Ara - C ) shortly before their death.
0.9999 Adverse-Effect Autopsy evidence of Entityherpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of cytarabine ( cytosine arabinoside ; EntityAra - C ) shortly before their death.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three patients, all of whom had preexisting diabetic dyslipidemia, who showed a profound Entityreduction in plasma HDL cholesterol and apolipoprotein AI levels soon after the initiation of Entityrosiglitazone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report marked QT prolongation and torsades de pointes in a setting of flash pulmonary edema resulting from Entityacute myocardial ischemia in a patient who was being treated with Entitydofetilide for atrial fibrillation.
0.9999 Adverse-Effect We report marked QT prolongation and torsades de pointes in a setting of Entityflash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with Entitydofetilide for atrial fibrillation.
0.9999 Adverse-Effect We report marked QT prolongation and Entitytorsades de pointes in a setting of flash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with Entitydofetilide for atrial fibrillation.
0.9999 Adverse-Effect We report marked EntityQT prolongation and torsades de pointes in a setting of flash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with Entitydofetilide for atrial fibrillation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious Entityextrapyramidal reactions in patients receiving Entitysertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9999 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious Entityextrapyramidal reactions in patients receiving sertraline or Entityvenlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9998 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of Entityserotonin syndrome with serious extrapyramidal reactions in patients receiving Entitysertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9998 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious Entityextrapyramidal reactions in patients receiving sertraline or venlafaxine when Entitymetoclopramide is coadministered even in a single, conventional dose.
0.9995 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of Entityserotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or Entityvenlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9993 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of Entityserotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or venlafaxine when Entitymetoclopramide is coadministered even in a single, conventional dose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although both patients recovered from the colitis after the administration of vancomycin, the first case demonstrated a relapse of the Entitycolitis after receiving a subsequent course of the same chemotherapy with Entitycisplatin .
0.9993 Adverse-Effect Although both patients recovered from the colitis after the administration of Entityvancomycin , the first case demonstrated a relapse of the Entitycolitis after receiving a subsequent course of the same chemotherapy with cisplatin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three nephrotic patients who had reduced renal function and active renal disease with progressive deterioration of renal function prior to the use of MP developed Entitytransient renal failure following an EntityMP pulse therapy.
0.9999 Adverse-Effect Three nephrotic patients who had reduced renal function and active renal disease with progressive deterioration of renal function prior to the use of EntityMP developed Entitytransient renal failure following an MP pulse therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We discuss a patient who developed Entitysevere renal tubular dysfunction secondary to short - term therapy with EntityAmikacin , resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.
1.0000 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with EntityAmikacin , resulting in Entityrefractory hypokalemia , hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.
0.9999 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with EntityAmikacin , resulting in refractory hypokalemia, Entityhypocalcemia , hypomagnesemia, metabolic alkalosis, and polyuria.
0.9999 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with EntityAmikacin , resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and Entitypolyuria .
0.9999 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with EntityAmikacin , resulting in refractory hypokalemia, hypocalcemia, Entityhypomagnesemia , metabolic alkalosis, and polyuria.
0.9999 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with EntityAmikacin , resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, Entitymetabolic alkalosis , and polyuria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most serious dental side effect of Entitybisphosphonate treatment ( particularly when it is administered intravenously ) is, paradoxically, Entityosteonecrosis of the mandible or the maxilla represented by exposed nonhealing bone.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityThrombin is highly effective for stopping intractable arterial hemorrhage during stereotactic brain biopsy ; however, it is a vasospastic agent and may have been responsible for the Entitycerebral infarctions in one patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that Entitysarcoidosis may develop in chronic hepatitis C patients during Entityinterferon alpha and / or ribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow - ups.
0.9998 Adverse-Effect We suggest that Entitysarcoidosis may develop in chronic hepatitis C patients during interferon alpha and / or Entityribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow - ups.
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect We postulate that gastritis caused by dexamethasone, Entitymucositis caused by Entitydoxorubicin , and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.
0.9816 Adverse-Effect We postulate that Entitygastritis caused by Entitydexamethasone , mucositis caused by doxorubicin, and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present two cases of Entitynitrofurantoin - induced Entitypulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.
0.9998 Adverse-Effect We present two cases of Entitynitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated Entitydistortion of the lung parenchyma , thought to represent established fibrosis.
0.9998 Adverse-Effect We present two cases of Entitynitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a Entitywidespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.
0.9997 Adverse-Effect We present two cases of Entitynitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established Entityfibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of exacerbated Entitymania potentially related to an interaction between Entitylopinavir / ritonavir and valproic acid ( VPA ) and propose a mechanism of action for this interaction.
1.0000 Adverse-Effect OBJECTIVE : To describe a case of exacerbated Entitymania potentially related to an interaction between lopinavir / Entityritonavir and valproic acid ( VPA ) and propose a mechanism of action for this interaction.
1.0000 Adverse-Effect OBJECTIVE : To describe a case of exacerbated Entitymania potentially related to an interaction between lopinavir / ritonavir and valproic acid ( EntityVPA ) and propose a mechanism of action for this interaction.
0.9999 Adverse-Effect OBJECTIVE : To describe a case of exacerbated Entitymania potentially related to an interaction between lopinavir / ritonavir and Entityvalproic acid ( VPA ) and propose a mechanism of action for this interaction.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect EntityTranstubular potassium gradient ( TTKG ) also decreased and an inverse correlation was found between TTKG and doses of Entityphosphate ( r = - 0. 37 ; p < 0. 02 ; N = 38 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first known report of Entityquetiapine Entityexacerbating OCS in a 43 - year - old man with obsessive - compulsive disorder ( OCD ), trichotillomania, delusional disorder and bipolar II disorder is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A 79 - year - old woman being treated with Entityimiquimod 5 days per week for a nodular basal cell developed a Entityverrucous plaque over the treatment area after 7 weeks of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 57 - year - old female with cardiomyopathy and " sulfa " ( trimethoprim / sulfamethoxazole ) allergy documented as pancreatitis presented with symptoms consistent with Entitypancreatitis after use of Entityfurosemide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We thus concluded that an excessive dose of EntityAZ had probably Entitydestroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
0.9999 Adverse-Effect We thus concluded that an excessive dose of EntityAZ had probably destroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of Entityhemorrhagic gastritis .
0.9997 Adverse-Effect We thus concluded that an excessive dose of EntityAZ had probably destroyed the gastric mucosal barrier or Entitythrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
Adverse-Effect We thus concluded that an excessive dose of EntityAZ had probably destroyed the gastric mucosal barrier or Entitythrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this article, we present the case of a vitiligo patient who was admitted to our facility with an Entityintense burn after the topical use of Entity8 - methoxypsoralen solution as a suntanning agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 36 - year - old man being treated with cisplatinum, vinblastine, and Entitybleomycin for testicular carcinoma developed a dense Entityleft homonymous hemianopsia , encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9999 Adverse-Effect A 36 - year - old man being treated with cisplatinum, vinblastine, and Entitybleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, Entityencephalopathy , and a partial nondominant parietal lobe syndrome.
0.9999 Adverse-Effect A 36 - year - old man being treated with cisplatinum, vinblastine, and Entitybleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a Entitypartial nondominant parietal lobe syndrome .
0.9999 Adverse-Effect A 36 - year - old man being treated with cisplatinum, Entityvinblastine , and bleomycin for testicular carcinoma developed a dense Entityleft homonymous hemianopsia , encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9998 Adverse-Effect A 36 - year - old man being treated with Entitycisplatinum , vinblastine, and bleomycin for testicular carcinoma developed a dense Entityleft homonymous hemianopsia , encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9998 Adverse-Effect A 36 - year - old man being treated with cisplatinum, Entityvinblastine , and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, Entityencephalopathy , and a partial nondominant parietal lobe syndrome.
0.9997 Adverse-Effect A 36 - year - old man being treated with Entitycisplatinum , vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, Entityencephalopathy , and a partial nondominant parietal lobe syndrome.
0.9997 Adverse-Effect A 36 - year - old man being treated with cisplatinum, Entityvinblastine , and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a Entitypartial nondominant parietal lobe syndrome .
0.9996 Adverse-Effect A 36 - year - old man being treated with Entitycisplatinum , vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a Entitypartial nondominant parietal lobe syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARIES : In each case, the patients were treated over 5 years with Entitylovastatin and developed Entityrhabdomyolysis that coincided with the completion of a prescribed regimen of a newer macrolide antibiotic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Retinal abnormalities, including retinal hemorrhage and Entity" cotton - wool " spots , often occur within the first 8 weeks in the course of Entityinterferon therapy in patients with chronic hepatitis C.
0.9999 Adverse-Effect Retinal abnormalities, including Entityretinal hemorrhage and " cotton - wool " spots, often occur within the first 8 weeks in the course of Entityinterferon therapy in patients with chronic hepatitis C.
0.9999 Adverse-Effect EntityRetinal abnormalities , including retinal hemorrhage and " cotton - wool " spots, often occur within the first 8 weeks in the course of Entityinterferon therapy in patients with chronic hepatitis C.
1.0000 Adverse-Effect Retinal abnormalities, including retinal hemorrhage and " Entitycotton - wool " spots , often occur within the first 8 weeks in the course of Entityinterferon therapy in patients with chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To date, only three cases of Entityseizures associated with Entityamphotericin B have been reported in the literature, but healthcare providers should be aware of the potential for this rare adverse effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Zolpidem ( EntityAmbien ), a relatively new nonbenzodiazepine sedative - hypnotic, was involved in the Entitydeath of a 39 - year - old obese male who was being treated for depression and insomnia.
1.0000 Adverse-Effect EntityZolpidem ( Ambien ), a relatively new nonbenzodiazepine sedative - hypnotic, was involved in the Entitydeath of a 39 - year - old obese male who was being treated for depression and insomnia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 45 - year - old woman with steroid - dependent Crohn's colitis, successfully managed with maintenance infliximab infusions and Entitymethotrexate , developed a Entitylupus - like syndrome eight months after her initial infusion.
0.9996 Adverse-Effect A 45 - year - old woman with steroid - dependent Crohn's colitis, successfully managed with maintenance Entityinfliximab infusions and methotrexate, developed a Entitylupus - like syndrome eight months after her initial infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although there have been numerous reports of effusions, none have provided complete pleural fluid analysis ; therefore, we report 2 patients with Entitydasatinib - induced Entitypleural effusion with complete pleural fluid analysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 53 year old Greenlandic male was admitted twice over a period of 4 years with a new complete Entityright bundle branch block after ingestion of 10 g and 4 g of Entitycarbamazepine respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 65 - year - old female patient presented with jaundice followed 2 days later by severe dyspnea and Entitytachypnea which worsened when patient was lying flat, 1 week after the fourth dose of Entityadalimumab .
0.9999 Adverse-Effect A 65 - year - old female patient presented with Entityjaundice followed 2 days later by severe dyspnea and tachypnea which worsened when patient was lying flat, 1 week after the fourth dose of Entityadalimumab .
0.9999 Adverse-Effect A 65 - year - old female patient presented with jaundice followed 2 days later by Entitysevere dyspnea and tachypnea which worsened when patient was lying flat, 1 week after the fourth dose of Entityadalimumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE PRESENTATION : We report a patient with CF who developed recurrent eosinophilia and Entitysevere persistent bronchospasm following repeated administration of preservative - free Entitytobramycin by inhalation, beginning at 16 months of age.
1.0000 Adverse-Effect CASE PRESENTATION : We report a patient with CF who developed Entityrecurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative - free Entitytobramycin by inhalation, beginning at 16 months of age.
Score Relation Text (Head - Tail)
0.9989 Adverse-Effect Three patients with Entityniacin - induced Entityvisual symptoms had cystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.9901 Adverse-Effect Three patients with niacin - induced visual symptoms had cystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of Entityvisual symptoms upon discontinuation of Entityniacin .
0.9279 Adverse-Effect Three patients with Entityniacin - induced visual symptoms had Entitycystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.9295 Adverse-Effect Three patients with niacin - induced visual symptoms had Entitycystoid maculopathy without leakage on Entityfluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.6200 Adverse-Effect Three patients with niacin - induced Entityvisual symptoms had cystoid maculopathy without leakage on Entityfluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After an extensive review of the literature, we believe that this is the first communication of the successful use of amiodarone to control hyperthyroidism in a patient with EntityPTU - induced Entityfulminant hepatitis .
0.9065 Adverse-Effect After an extensive review of the literature, we believe that this is the first communication of the successful use of Entityamiodarone to control hyperthyroidism in a patient with PTU - induced Entityfulminant hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors present a case study of a mentally healthy man who repeatedly experienced short - lived, Entityobsessional - like suicidal ideas and images after ingestion of the anti - fungal drug Entityketoconazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 50 - year - old diabetic and hypertensive male patient is reported who had Entityticlopidine - induced Entitymarrow aplasia partially responsive to colony - stimulating factors and corticosteroids, but experienced complete recovery with cyclosporine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case report, we have described a patient with Crohn's disease who developed Entitysubfulminant hepatitis B after the fourth infusion of Entityinfliximab due to an unrecognized HBs - antigen carrier state.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although Entityretinoic acid is well tolerated by the majority of patients with this disease, a potentially Entityfatal complication of this kind of treatment has been reported : " the retinoic acid syndrome ".
0.9993 Adverse-Effect Although Entityretinoic acid is well tolerated by the majority of patients with this disease, a potentially fatal complication of this kind of treatment has been reported : " the Entityretinoic acid syndrome ".
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Preliminary results suggest that the higher concentrations of Entitydextrose induce Entityincreased histamine release from blood cells, and that this phenomenon is more marked in diabetic, and particularly diabetic - allergic, individuals.
Score Relation Text (Head - Tail)
0.9966 Adverse-Effect The literature is also reviewed for ARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of Entitymannitol Entitynephrotoxicity are discussed.
0.9954 Adverse-Effect The literature is also reviewed for EntityARF associated with Entitymannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of mannitol nephrotoxicity are discussed.
0.9860 Adverse-Effect The literature is also reviewed for ARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of Entitymannitol Entitymannitol nephrotoxicity are discussed.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with severe cerebral swelling and Entityraised intracranial pressure ( ICP ) after severe Entitysodium valproic acid ( VPA ) intoxication.
0.9994 Adverse-Effect INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with Entitysevere cerebral swelling and raised intracranial pressure ( ICP ) after severe Entitysodium valproic acid ( VPA ) intoxication.
0.9984 Adverse-Effect INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with severe cerebral swelling and Entityraised intracranial pressure ( ICP ) after severe sodium valproic acid ( EntityVPA ) intoxication.
0.9980 Adverse-Effect INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with Entitysevere cerebral swelling and raised intracranial pressure ( ICP ) after severe sodium valproic acid ( EntityVPA ) intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four years after the beginning of EntityIFN therapy, he acutely developed Entitymoderate hyperglycemia and severe ketonuria with positive islet cell antibody, and then 28 units / day of insulin injection was started.
0.9997 Adverse-Effect Four years after the beginning of EntityIFN therapy, he acutely developed moderate hyperglycemia and Entitysevere ketonuria with positive islet cell antibody, and then 28 units / day of insulin injection was started.
0.9998 Adverse-Effect Four years after the beginning of IFN therapy, he acutely developed moderate hyperglycemia and severe ketonuria with Entitypositive islet cell antibody , and then 28 units / day of Entityinsulin injection was started.
0.9997 Adverse-Effect Four years after the beginning of EntityIFN therapy, he acutely developed moderate hyperglycemia and severe ketonuria with Entitypositive islet cell antibody , and then 28 units / day of insulin injection was started.
0.9990 Adverse-Effect Four years after the beginning of IFN therapy, he acutely developed moderate hyperglycemia and Entitysevere ketonuria with positive islet cell antibody, and then 28 units / day of Entityinsulin injection was started.
0.9989 Adverse-Effect Four years after the beginning of IFN therapy, he acutely developed Entitymoderate hyperglycemia and severe ketonuria with positive islet cell antibody, and then 28 units / day of Entityinsulin injection was started.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityARDS is rarely associated with Entityrituximab infusion for lympho - proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops severe pulmonary symptoms soon after infusion.
0.9995 Adverse-Effect ARDS is rarely associated with rituximab infusion for lympho - proliferative disorders, but it should be considered by those administering Entityrituximab , especially when a patient develops Entitysevere pulmonary symptoms soon after infusion.
0.8815 Adverse-Effect EntityARDS is rarely associated with rituximab infusion for lympho - proliferative disorders, but it should be considered by those administering Entityrituximab , especially when a patient develops severe pulmonary symptoms soon after infusion.
0.7604 Adverse-Effect ARDS is rarely associated with Entityrituximab infusion for lympho - proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops Entitysevere pulmonary symptoms soon after infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, a large case - control study included three cases of either Stevens - Johnson syndrome or Entitytoxic epidermal necrolysis associated with Entityofloxacin use, but no details of the cases were given.
0.9999 Adverse-Effect However, a large case - control study included three cases of either EntityStevens - Johnson syndrome or toxic epidermal necrolysis associated with Entityofloxacin use, but no details of the cases were given.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The reported case represents an unusual association between medication with the proton pump inhibitor Entitylansoprazole and the development of Entitycollagenous colitis suggesting the importance of evaluation of drug use in patients with microscopic colitis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of Entitypulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of Entityetanercept therapy.
Adverse-Effect This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of Entitypulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of Entityetanercept therapy.
Score Relation Text (Head - Tail)
0.9951 Adverse-Effect The former patient had complained once that his Entityvisual acuity had decreased after the termination of EntityIFN therapy, and the latter patient complained twice during IFN therapy that his visual acuity had decreased.
0.9712 Adverse-Effect The former patient had complained once that his visual acuity had decreased after the termination of IFN therapy, and the latter patient complained twice during EntityIFN therapy that his Entityvisual acuity had decreased .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 39 - year - old white Jewish schizophrenic man treated with Entityolanzapine developed an Entityelevated serum CK concentration with a peak concentration of 4000 IU / L ( normal < 230 ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We are concerned that the Entitymacular lesion was a retinal toxic effect of Entitygentamicin because of the recent description of similar lesions occurring after the inadvertent intraocular injection of massive doses of this drug.
1.0000 Adverse-Effect We are concerned that the macular lesion was a Entityretinal toxic effect of Entitygentamicin because of the recent description of similar lesions occurring after the inadvertent intraocular injection of massive doses of this drug.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Seventy - four per cent of patients with epileptogenic disorders seen at the Emergency Unit at Groote Schuur Hospital were on Entityphenytoin and 11. 6 % of these had Entityblood levels in the toxic range .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Entitypoisoning with Entity3, 4 - methylenedioxymet - amphetamine Ecstasy that presented with all the features suggestive of a fatal outcome, including a creatinine phosphokinase level markedly higher than any previously reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Total blindness with a transient tonic pupillary response, denervation supersensitivity, and Entityabnormal visual - evoked potentials developed in a 54 - year - old man after the use of Entityquinine sulfate for leg cramps.
0.9997 Adverse-Effect Total blindness with a transient tonic pupillary response, Entitydenervation supersensitivity , and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Entityquinine sulfate for leg cramps.
0.9997 Adverse-Effect Total blindness with a Entitytransient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Entityquinine sulfate for leg cramps.
0.9994 Adverse-Effect EntityTotal blindness with a transient tonic pupillary response, denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Entityquinine sulfate for leg cramps.
Adverse-Effect EntityTotal blindness with a transient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Entityquinine sulfate for leg cramps.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient who developed polyserositis ( pericardial effusion, pleural effusion, and Entitypericarditis ) after being started on Entityclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9999 Adverse-Effect We report the case of a patient who developed polyserositis ( pericardial effusion, pleural effusion, and Entitypericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Entityclozapine .
0.9998 Adverse-Effect We report the case of a patient who developed Entitypolyserositis ( pericardial effusion, pleural effusion, and pericarditis ) after being started on Entityclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9998 Adverse-Effect We report the case of a patient who developed polyserositis ( pericardial effusion, Entitypleural effusion , and pericarditis ) after being started on Entityclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9998 Adverse-Effect We report the case of a patient who developed polyserositis ( Entitypericardial effusion , pleural effusion, and pericarditis ) after being started on Entityclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9995 Adverse-Effect We report the case of a patient who developed Entitypolyserositis ( pericardial effusion, pleural effusion, and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Entityclozapine .
0.9995 Adverse-Effect We report the case of a patient who developed polyserositis ( pericardial effusion, Entitypleural effusion , and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Entityclozapine .
0.9994 Adverse-Effect We report the case of a patient who developed polyserositis ( Entitypericardial effusion , pleural effusion, and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Entityclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article reports the case of an otherwise healthy patient who experienced permanent Entitysensorineural hearing loss after a brief course of Entitynaproxen and reviews the literature on NSAID - related permanent sensorineural hearing loss.
0.9962 Adverse-Effect This article reports the case of an otherwise healthy patient who experienced permanent sensorineural hearing loss after a brief course of Entitynaproxen and reviews the literature on NSAID - related permanent Entitysensorineural hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityHypo - oestrogenic and anabolic / androgenic side - effects of Entitydanazol are well known by the gynaecologist and some of them are present in > 50 % of patients being treated for endometriosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Entitysulfadiazine for reactivated chorioretinitis developed Entityfever , severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Entitysulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, Entityabdominal pain and transaminitis, persisting weeks after withholding medicines.
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Entitysulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, Entityswelling , abdominal pain and transaminitis, persisting weeks after withholding medicines.
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Entitysulfadiazine for reactivated chorioretinitis developed fever, Entitysevere cutaneous involvement , swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Entitysulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and Entitytransaminitis , persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Entitypyrimethamine and sulfadiazine for reactivated chorioretinitis developed Entityfever , severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Entitypyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, Entityabdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Entitypyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, Entityswelling , abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Entitypyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, Entitysevere cutaneous involvement , swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Entitypyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and Entitytransaminitis , persisting weeks after withholding medicines.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The case reported here is of a child given a large dose of intravenous Entityiron sucrose ( 16 mg / kg ) over 3 hours, who subsequently developed features of Entitysystemic iron toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first patient was a 61 - year - old man with a 30 - year history of fistulizing CD in whom EntityB - cell non - Hodgkin's lymphoma was diagnosed 9 months after treatment with Entityinfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of focal myocardial necrosis, presenting clinically as an Entityacute myocardial infarction during the administration of the antineoplastic drug, Entityamsacrine , in a patient without coronary artery disease.
1.0000 Adverse-Effect The authors report a case of Entityfocal myocardial necrosis , presenting clinically as an acute myocardial infarction during the administration of the antineoplastic drug, Entityamsacrine , in a patient without coronary artery disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : The authors described a case of Entityinterferon - induced Entitypsychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and Entitystatus epilepticus secondary to Entitygabapentin withdrawal.
0.9995 Adverse-Effect Although Entitygabapentin withdrawal has been previously reported and usually consists of Entityanxiety , diaphoresis, and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.9892 Adverse-Effect Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with Entitygeneralized seizures and status epilepticus secondary to Entitygabapentin withdrawal.
0.9793 Adverse-Effect Although Entitygabapentin withdrawal has been previously reported and usually consists of anxiety, Entitydiaphoresis , and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.9128 Adverse-Effect Although Entitygabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and Entitypalpitations , this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.5342 Adverse-Effect Although Entitygabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with Entitygeneralized seizures and status epilepticus secondary to gabapentin withdrawal.
Adverse-Effect Although Entitygabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and Entitystatus epilepticus secondary to gabapentin withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possibility of Entitydeep vein thrombosis caused by the compression of the veins by necrotic tumor should be considered in patients with abdominal or pelvic metastases of GIST, including patients treated with Entityimatinib .
1.0000 Adverse-Effect The possibility of deep vein thrombosis caused by the Entitycompression of the veins by necrotic tumor should be considered in patients with abdominal or pelvic metastases of GIST, including patients treated with Entityimatinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Though proteinuria and Entitynephrotic syndrome is a rare adverse effect of EntityIFN - beta - 1b therapy, physicians treating MS patients with this agent should pay careful attention to new clinical symptoms and laboratory findings.
0.9998 Adverse-Effect Though Entityproteinuria and nephrotic syndrome is a rare adverse effect of EntityIFN - beta - 1b therapy, physicians treating MS patients with this agent should pay careful attention to new clinical symptoms and laboratory findings.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Possible mechanisms by which Entityclonidine decreases spasticity are described, probable mechanisms of induced Entitybradycardia are reviewed, and specific treatment recommendations for the use of clonidine in spinal cord injured patients are presented.
0.9997 Adverse-Effect Possible mechanisms by which clonidine decreases spasticity are described, probable mechanisms of induced Entitybradycardia are reviewed, and specific treatment recommendations for the use of Entityclonidine in spinal cord injured patients are presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect None of them had a history of cardiac disease, and with the possible exception of one case of Entitycardiac arrest , where the patient received Entitydoxorubicin , no predisposing factors could be found.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Interestingly, the use of carboplatin ( CBDCA ) and VDS in the subsequent treatment course was well tolerated indicating that the EntitySIADH was most likely to have been induced by administration of EntityCDDP .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A woman 38 - year - old, suffering for about ten years from multiple sclerosis and treated with repeated therapy cycles of intrathecal EntityDepo - Medrol , developed a Entityspastic paraparesis at the lower limbs .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with acute myeloblastic leukemia ( AML ) who developed Entitynephrotic syndrome after receiving several courses of chemotherapy, including Entitymacrophage - colony - stimulating factor ( M - CSF ).
0.9999 Adverse-Effect We describe a patient with acute myeloblastic leukemia ( AML ) who developed Entitynephrotic syndrome after receiving several courses of chemotherapy, including macrophage - colony - stimulating factor ( EntityM - CSF ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Only after three subsequent episodes of severe, symptomatic Entitythrombocytopenia over the next four weeks did he say, upon repeat questioning, that he had continued to take Entityquinine for night leg cramps.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityCaptopril is an angiotensin - converting enzyme ( ACE ) inhibitor and their Entitycutaneous side - effects are documented, but little has been published concerning the usefulness of patch test when they occur.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Slow acetylators, who comprise roughly 50 % of the South African population, are likely to develop clinical and biochemical features of Entityphenytoin Entityphenytoin toxicity when this drug is given together with antituberculosis therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During intravenous treatment with Entityterlipressin for recurrent gastrointestinal ( GI ) bleeding, a 50 - year - old male with no history of heart disease developed a newly Entityprolonged QT interval and torsade de pointes.
1.0000 Adverse-Effect During intravenous treatment with Entityterlipressin for recurrent gastrointestinal ( GI ) bleeding, a 50 - year - old male with no history of heart disease developed a newly prolonged QT interval and Entitytorsade de pointes .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect OBJECTIVE : To describe what is believed, as of November 4, 2003, to be the first case published in the literature of Entityacute interstitial nephritis ( AIN ) due to Entitypantoprazole .
1.0000 Adverse-Effect OBJECTIVE : To describe what is believed, as of November 4, 2003, to be the first case published in the literature of acute interstitial nephritis ( EntityAIN ) due to Entitypantoprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 33 - year - old male presented with Entitybrown discolouration of the fingernails following the application of Entity4 % hydroquinone in sorbolene cream and 0. 1 % tretinoin cream to the face intermittently for 9 months.
0.9980 Adverse-Effect A 33 - year - old male presented with Entitybrown discolouration of the fingernails following the application of 4 % hydroquinone in sorbolene cream and Entity0. 1 % tretinoin cream to the face intermittently for 9 months.
Adverse-Effect A 33 - year - old male presented with Entitybrown discolouration of the fingernails following the application of 4 % hydroquinone in sorbolene cream and Entity0. 1 % tretinoin cream to the face intermittently for 9 months.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect CONCLUSION : This report describes a case of a probable interaction between topical econazole lotion 1 % and Entityacenocoumarol that resulted in overanticoagulation and a life - threatening Entitylaryngeal hematoma in this elderly patient.
0.9991 Adverse-Effect CONCLUSION : This report describes a case of a probable interaction between topical Entityeconazole lotion 1 % and acenocoumarol that resulted in overanticoagulation and a life - threatening Entitylaryngeal hematoma in this elderly patient.
1.0000 Adverse-Effect CONCLUSION : This report describes a case of a probable interaction between topical econazole lotion 1 % and Entityacenocoumarol that resulted in Entityoveranticoagulation and a life - threatening laryngeal hematoma in this elderly patient.
0.9995 Adverse-Effect CONCLUSION : This report describes a case of a probable interaction between topical Entityeconazole lotion 1 % and acenocoumarol that resulted in Entityoveranticoagulation and a life - threatening laryngeal hematoma in this elderly patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We report a patient who developed a EntityDAT - positive hemolytic episode after a red cell ( RBC ) transfusion was delivered during the infusion of her 17th cycle of Entityoxaliplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient with the acquired immunodeficiency syndrome treated with Entityrifampicin who had a'normal'screening test for adrenal insufficiency, yet had clinical evidence of Entityadrenal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityParaplegia following prophylactic intrathecal Entitycytosine arabinoside ( Ara - C ) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg / m2 / d for 5 consecutive days.
0.9999 Adverse-Effect EntityParaplegia following prophylactic intrathecal cytosine arabinoside ( EntityAra - C ) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg / m2 / d for 5 consecutive days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Infants are particularly susceptible to chronic Entitynitrate - induced Entitymethemoglobinemia because of their low stomach acid production, large numbers of nitrite - reducing bacteria, and the relatively easy oxidation of fetal hemoglobin.
0.7845 Adverse-Effect Infants are particularly susceptible to chronic nitrate - induced Entitymethemoglobinemia because of their low stomach acid production, large numbers of Entitynitrite - reducing bacteria, and the relatively easy oxidation of fetal hemoglobin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this study, we report on three individual patients who received BTX - B and who subsequently developed Entityparasympathetic dysfunction of the visual system after injections of EntityBTX - B at remote sites.
0.9999 Adverse-Effect In this study, we report on three individual patients who received EntityBTX - B and who subsequently developed Entityparasympathetic dysfunction of the visual system after injections of BTX - B at remote sites.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible Entityvalproic acid - induced Entitydementia was documented in a 21 - year - old man with epilepsy who had a 3 - year history of insidious progressive decline in global cognitive abilities documented by serial neuropsychological studies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient with subarachnoid haemorrhage who developed an acute life - threatening pseudo - obstruction of the colon, a variant of Entityadynamic ileus , while being treated with intravenous Entitynimodipine .
0.9999 Adverse-Effect We report on a patient with subarachnoid haemorrhage who developed an acute life - threatening Entitypseudo - obstruction of the colon , a variant of adynamic ileus, while being treated with intravenous Entitynimodipine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Although high - dose Entitymethotrexate has been shown to be useful in the treatment of primary osteogenic sarcoma, the tumoricidal effects of therapy appear to have caused a Entityfatal rise in intracranial pressure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five and one - half years after the diagnosis of myeloma, while in remission on Entitycyclophosphamide therapy, the patient experienced severe Entityabdominal right lower quadrant pain due to a large cecal lymphoma.
0.9998 Adverse-Effect Five and one - half years after the diagnosis of myeloma, while in remission on Entitycyclophosphamide therapy, the patient experienced severe abdominal right lower quadrant pain due to a large Entitycecal lymphoma .
1.0000 Adverse-Effect Five and one - half years after the diagnosis of myeloma, while in remission on Entitycyclophosphamide therapy, the patient experienced Entitysevere abdominal right lower quadrant pain due to a large cecal lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the exceptional development of AML and Entitylung cancer in a patient with previously diagnosed CLL in minimal residual disease status after Entityfludarabine treatment followed by autologous peripheral blood stem - cell transplantation.
1.0000 Adverse-Effect We describe the exceptional development of EntityAML and lung cancer in a patient with previously diagnosed CLL in minimal residual disease status after Entityfludarabine treatment followed by autologous peripheral blood stem - cell transplantation.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Three of these patients had Entityconvulsions attributed to Entityimipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9976 Adverse-Effect Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / Entitycilastatin administrations was followed by a Entityseizure attack.
0.9782 Adverse-Effect Three of these patients had Entityconvulsions attributed to imipenem / Entitycilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9579 Adverse-Effect Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of Entityimipenem / cilastatin administrations was followed by a Entityseizure attack.
0.5234 Adverse-Effect Three of these patients had convulsions attributed to imipenem / Entitycilastatin ; 3. 6 % of the patients had Entityseizure , or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9987 Adverse-Effect Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / Entitycilastatin administrations was followed by a Entityseizure attack .
0.9764 Adverse-Effect Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of Entityimipenem / cilastatin administrations was followed by a Entityseizure attack .
Adverse-Effect Three of these patients had convulsions attributed to Entityimipenem / cilastatin ; 3. 6 % of the patients had Entityseizure , or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since elevated cortisol levels in Cushing's disease poses a threat for pancreatitis, there is a possibility that patients with Cushing's disease might be more prone to Entityacute pancreatitis following Entitypropofol administration.
0.9966 Adverse-Effect Since elevated cortisol levels in Cushing's disease poses a threat for Entitypancreatitis , there is a possibility that patients with Cushing's disease might be more prone to acute pancreatitis following Entitypropofol administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitytorsade de pointes following a single oral dose of Entityamiodarone ( 1400 mg or 30 mg kg - 1 ) administered after short intravenous loading for prevention of paroxysmal atrial flutter.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Eighty - two patients with various malignancies who received imipenem / Entitycilastatin 143 times for Entityneutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.
1.0000 Adverse-Effect Eighty - two patients with various malignancies who received Entityimipenem / cilastatin 143 times for Entityneutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 36 - y - o patient with schizophrenia, who had consumed gradually increasing quantities of Entityoolong tea that eventually reached 15 L each day, became Entitydelirious and was admitted to a psychiatric hospital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, two cases of ET which evolved into EntityAL without prior exposure to radiation or alkylating agents, and which were treated with long - term Entityhydroxyurea therapy, are described.
1.0000 Adverse-Effect In this report, two cases of EntityET which evolved into AL without prior exposure to radiation or alkylating agents, and which were treated with long - term Entityhydroxyurea therapy, are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Animals treated with EntityHAL showed a highly significant 32 % - 46 Entity% loss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
1.0000 Adverse-Effect Animals treated with EntityHAL showed a highly significant 32 % - 46 % Entityloss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
Adverse-Effect Animals treated with EntityHAL showed a highly Entitysignificant 32 % - 46 % loss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient's clinical presentation, histologic features on liver biopsy and favorable course after stopping the drug suggest that Entitybarbiturates can be added to the list of agents which can cause Entitysubmassive hepatic necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pneumonitis, bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and Entitypositive autoantibodies developed in a 43 - year - old man, who was receiving long - term Entitysulfasalazine therapy for chronic ulcerative colitis.
1.0000 Adverse-Effect Pneumonitis, bilateral pleural effusions, echocardiographic evidence of Entitycardiac tamponade , and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term Entitysulfasalazine therapy for chronic ulcerative colitis.
1.0000 Adverse-Effect EntityPneumonitis , bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term Entitysulfasalazine therapy for chronic ulcerative colitis.
1.0000 Adverse-Effect Pneumonitis, Entitybilateral pleural effusions , echocardiographic evidence of cardiac tamponade, and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term Entitysulfasalazine therapy for chronic ulcerative colitis.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The present report illustrates a rare case of refractory Entityakathisia after Entityinterferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
0.9988 Adverse-Effect The present report illustrates a rare case of refractory akathisia after interferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the Entityneurotoxicity associated with Entityinterferon - alpha .
0.9999 Adverse-Effect The present report illustrates a rare case of Entityrefractory akathisia after Entityinterferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
0.6066 Adverse-Effect The present report illustrates a rare case of refractory akathisia after interferon - alpha treatment and also that Entitylevodopa treatment would be theoretically and practically useful in reducing the Entityneurotoxicity associated with interferon - alpha.
0.5589 Adverse-Effect The present report illustrates a rare case of Entityrefractory akathisia after interferon - alpha treatment and also that Entitylevodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the case of a young woman with Graves'disease in whom ototoxicity developed because of propylthiouracil ( EntityPTU ) - induced Entityantineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis .
1.0000 Adverse-Effect OBJECTIVE : To report the case of a young woman with Graves'disease in whom Entityototoxicity developed because of Entitypropylthiouracil ( PTU ) - induced antineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis.
0.9999 Adverse-Effect OBJECTIVE : To report the case of a young woman with Graves'disease in whom ototoxicity developed because of Entitypropylthiouracil ( PTU ) - induced Entityantineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis .
0.9990 Adverse-Effect OBJECTIVE : To report the case of a young woman with Graves'disease in whom Entityototoxicity developed because of propylthiouracil ( EntityPTU ) - induced antineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 20 - year - old woman originally from Cameroon who was infected by the L. loa parasite and developed Entitysevere hepatitis , identified 1 month after a single dose of Entityivermectin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapamycin / sirolimus ( SR ), trade named EntityRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Entitymyelosuppression , hypertension, hyperlipidemia, and infection.
1.0000 Adverse-Effect Rapamycin / sirolimus ( SR ), trade named EntityRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Entityhypertension , hyperlipidemia, and infection.
0.9999 Adverse-Effect Rapamycin / sirolimus ( SR ), trade named EntityRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Entityhyperlipidemia , and infection.
0.9999 Adverse-Effect EntityRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Entitymyelosuppression , hypertension, hyperlipidemia, and infection.
0.9999 Adverse-Effect EntityRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Entityhypertension , hyperlipidemia, and infection.
0.9999 Adverse-Effect Rapamycin / Entitysirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Entitymyelosuppression , hypertension, hyperlipidemia, and infection.
0.9999 Adverse-Effect EntityRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Entityhyperlipidemia , and infection.
0.9999 Adverse-Effect Rapamycin / sirolimus ( SR ), trade named EntityRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Entityinfection .
0.9999 Adverse-Effect Rapamycin / Entitysirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Entityhypertension , hyperlipidemia, and infection.
0.9999 Adverse-Effect Rapamycin / Entitysirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Entityhyperlipidemia , and infection.
0.9999 Adverse-Effect EntityRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Entityinfection .
0.9999 Adverse-Effect Rapamycin / Entitysirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Entityinfection .
Adverse-Effect Rapamycin / sirolimus ( EntitySR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Entityhyperlipidemia , and infection.
Adverse-Effect Rapamycin / sirolimus ( EntitySR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Entityhypertension , hyperlipidemia, and infection.
Adverse-Effect Rapamycin / sirolimus ( EntitySR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Entityinfection .
Adverse-Effect Rapamycin / sirolimus ( EntitySR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Entitymyelosuppression , hypertension, hyperlipidemia, and infection.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The main side - effects of EntityLp - TAE combined with HT were Entitylow - grade fever , localized pain, myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9997 Adverse-Effect The main side - effects of EntityLp - TAE combined with HT were low - grade fever, Entitylocalized pain , myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9993 Adverse-Effect The main side - effects of EntityLp - TAE combined with HT were low - grade fever, localized pain, Entitymyelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9989 Adverse-Effect The main side - effects of EntityLp - TAE combined with HT were low - grade fever, localized pain, myelo - suppression and Entityliver dysfunction , but these were transient and eventually disappeared.
1.0000 Adverse-Effect The main side - effects of Lp - TAE combined with EntityHT were Entitylow - grade fever , localized pain, myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9998 Adverse-Effect The main side - effects of Lp - TAE combined with EntityHT were low - grade fever, Entitylocalized pain , myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9994 Adverse-Effect The main side - effects of Lp - TAE combined with EntityHT were low - grade fever, localized pain, Entitymyelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9990 Adverse-Effect The main side - effects of Lp - TAE combined with EntityHT were low - grade fever, localized pain, myelo - suppression and Entityliver dysfunction , but these were transient and eventually disappeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hyperkalaemia with Entityrenal tubular dysfunction by oral therapy of Entitysulfamethoxazole - trimethoprim ( co - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9998 Adverse-Effect EntityHyperkalaemia with renal tubular dysfunction by oral therapy of Entitysulfamethoxazole - trimethoprim ( co - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9996 Adverse-Effect Hyperkalaemia with Entityrenal tubular dysfunction by oral therapy of sulfamethoxazole - trimethoprim ( Entityco - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9992 Adverse-Effect EntityHyperkalaemia with renal tubular dysfunction by oral therapy of sulfamethoxazole - trimethoprim ( Entityco - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
Score Relation Text (Head - Tail)
0.9634 Adverse-Effect A young diamond dealer developed visual impairment attributed to Entitybilateral posterior subcapsular cataracts following only four courses of intermittent EntityDecadron used as part of a five - drug antiemetic regimen for cisplatin - associated nausea.
0.7002 Adverse-Effect A young diamond dealer developed Entityvisual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent EntityDecadron used as part of a five - drug antiemetic regimen for cisplatin - associated nausea.
Adverse-Effect A young diamond dealer developed visual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five - drug antiemetic regimen for Entitycisplatin - associated Entitynausea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 22 - year - old black man developed fever, chills, fatigue, night sweats, tender lymphadenopathy, and a Entitygeneralized, pruritic, macular eruption 3 weeks after starting Entityminocycline therapy for acne.
1.0000 Adverse-Effect A 22 - year - old black man developed fever, Entitychills , fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Entityminocycline therapy for acne.
1.0000 Adverse-Effect A 22 - year - old black man developed fever, chills, Entityfatigue , night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Entityminocycline therapy for acne.
0.9999 Adverse-Effect A 22 - year - old black man developed Entityfever , chills, fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Entityminocycline therapy for acne.
0.9999 Adverse-Effect A 22 - year - old black man developed fever, chills, fatigue, Entitynight sweats , tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Entityminocycline therapy for acne.
0.9999 Adverse-Effect A 22 - year - old black man developed fever, chills, fatigue, night sweats, Entitytender lymphadenopathy , and a generalized, pruritic, macular eruption 3 weeks after starting Entityminocycline therapy for acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of chronic, nonproductive Entitycough secondary to the angiotensin - converting enzyme ( ACE ) inhibitor Entityquinapril , with complete resolution after switching to another ACE inhibitor, fosinopril.
0.9995 Adverse-Effect OBJECTIVE : To report a case of chronic, nonproductive Entitycough secondary to the angiotensin - converting enzyme ( ACE ) inhibitor quinapril, with complete resolution after switching to another ACE inhibitor, Entityfosinopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have described three patients with hepatitis C for whom IFN - alpha and Entityribavirin were prescribed and who developed two successive phases of silent Entitythyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.9998 Adverse-Effect We have described three patients with hepatitis C for whom IFN - alpha and Entityribavirin were prescribed and who developed two successive phases of silent thyroiditis followed by Entityhyperthryroidism relapse due to Graves'disease.
0.9995 Adverse-Effect We have described three patients with hepatitis C for whom EntityIFN - alpha and ribavirin were prescribed and who developed two successive phases of silent Entitythyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.9984 Adverse-Effect We have described three patients with hepatitis C for whom EntityIFN - alpha and ribavirin were prescribed and who developed two successive phases of silent thyroiditis followed by Entityhyperthryroidism relapse due to Graves'disease.
1.0000 Adverse-Effect We have described three patients with hepatitis C for whom IFN - alpha and Entityribavirin were prescribed and who developed two successive phases of Entitysilent thyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.9997 Adverse-Effect We have described three patients with hepatitis C for whom EntityIFN - alpha and ribavirin were prescribed and who developed two successive phases of Entitysilent thyroiditis followed by hyperthryroidism relapse due to Graves'disease.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In patients with swallowing dysfunction and pneumonia, a history of Entitymineral oil use should be obtained and a diagnosis of EntityELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.9999 Adverse-Effect In patients with swallowing dysfunction and Entitypneumonia , a history of Entitymineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.9997 Adverse-Effect In patients with swallowing dysfunction and pneumonia, a history of mineral oil use should be obtained and a diagnosis of EntityELP should be considered in the differential diagnoses if Entitymineral oil use has occurred.
0.9990 Adverse-Effect In patients with Entityswallowing dysfunction and pneumonia, a history of Entitymineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.9933 Adverse-Effect In patients with Entityswallowing dysfunction and pneumonia, a history of mineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if Entitymineral oil use has occurred.
0.9933 Adverse-Effect In patients with swallowing dysfunction and Entitypneumonia , a history of mineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if Entitymineral oil use has occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Life - threatening Entityadrenal suppression , requiring hydrocortisone supplementation and intensive therapy, was observed and successfully treated in a newborn, whose mother had received high - dose Entitymethylprednisolone in late pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe the temporal association of the abnormal liver enzymes in this patient, in the absence of other offending agents, argues strongly in favor of Entity6 - TG as a cause of Entityliver enzyme abnormalities .
1.0000 Adverse-Effect We believe the temporal association of the Entityabnormal liver enzymes in this patient, in the absence of other offending agents, argues strongly in favor of Entity6 - TG as a cause of liver enzyme abnormalities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with imminent gangrene of the extremities caused by Entityergot - induced Entityarteriospasm underwent mechanical dilatation of the arteries when conventional measures such as anticoagulation, vasodilation, and sympathetic blockade produced no improvement.
1.0000 Adverse-Effect Two patients with imminent Entitygangrene of the extremities caused by Entityergot - induced arteriospasm underwent mechanical dilatation of the arteries when conventional measures such as anticoagulation, vasodilation, and sympathetic blockade produced no improvement.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients receiving Entityamifostine who develop only Entityfever should be evaluated for an adverse drug reaction, as well as for sepsis and fevers of neutropenia, and it may be necessary to discontinue the drug.
1.0000 Adverse-Effect Patients receiving Entityamifostine who develop only fever should be evaluated for an adverse drug reaction, as well as for Entitysepsis and fevers of neutropenia, and it may be necessary to discontinue the drug.
0.9999 Adverse-Effect Patients receiving Entityamifostine who develop only fever should be evaluated for an adverse drug reaction, as well as for sepsis and Entityfevers of neutropenia , and it may be necessary to discontinue the drug.
Score Relation Text (Head - Tail)
0.9937 Adverse-Effect Retrospectively, Entitybucillamine was believed to be the cause of the Entitygiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9636 Adverse-Effect Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to EntityD - penicillamine , which was the subject of an abundance of reports of Entitymammary hyperplasia .
0.9969 Adverse-Effect Retrospectively, bucillamine was believed to be the cause of the Entitygiant hypertrophy because of its structural similarity Entityto D - penicillamine , which was the subject of an abundance of reports of mammary hyperplasia.
0.9888 Adverse-Effect Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of Entitymammary Entitymammary hyperplasia .
0.9859 Adverse-Effect Retrospectively, Entitybucillamine was believed to be the cause of the Entitygiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9857 Adverse-Effect Retrospectively, Entitybucillamine was believed to be the cause of the Entitygiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9856 Adverse-Effect Retrospectively, Entitybucillamine was believed to be the cause of the Entitygiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9855 Adverse-Effect Retrospectively, Entitybucillamine was believed to be the cause of the Entitygiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9852 Adverse-Effect Retrospectively, Entitybucillamine was believed to be the cause of the Entitygiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.8666 Adverse-Effect Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity Entityto D - penicillamine , which was the subject of an abundance of reports of Entitymammary hyperplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both patients were then treated with a carboplatin alternative to Entitycisplatin in the following courses, which resulted in neither a relapse of the Entitycolitis nor a recurrence of the malignancies up to this time.
0.9999 Adverse-Effect Both patients were then treated with a carboplatin alternative to Entitycisplatin in the following courses, which resulted in neither a relapse of the colitis nor a recurrence of the Entitymalignancies up to this time.
0.9999 Adverse-Effect Both patients were then treated with a Entitycarboplatin alternative to cisplatin in the following courses, which resulted in neither a relapse of the Entitycolitis nor a recurrence of the malignancies up to this time.
0.9996 Adverse-Effect Both patients were then treated with a Entitycarboplatin alternative to cisplatin in the following courses, which resulted in neither a relapse of the colitis nor a recurrence of the Entitymalignancies up to this time.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE / OBJECTIVES : To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase ( DPD ) deficiency, which predisposes patients with cancer to potentially Entitylethal adverse reactions following Entity5 - fluorouracil ( 5 - FU ) - based chemotherapy.
0.9999 Adverse-Effect PURPOSE / OBJECTIVES : To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase ( DPD ) deficiency, which predisposes patients with cancer to potentially Entitylethal adverse reactions following 5 - fluorouracil ( Entity5 - FU ) - based chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The aim of this report is to describe the clinical and electroencephalographic findings seen in an elderly woman without previous history of seizures who developed a Entitynonconvulsive generalized status epilepticus following acute withdrawal of Entitylorazepam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 71 - year - old man with paroxysmal atrial fibrillation who had a previous anterior myocardial infarction exhibited Entitygranulocytopenia 8 days following the administration of oral sustained - release Entityprocainamide ( 750 mg / day ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a continuous ambulatory peritoneal dialysis ( CAPD ) patient that developed Entityvancomycin - induced Entityagranulocytosis during treatment for methicillin - resistant Staphylococcus aureus ( MRSA ) - associated external cuff infection and pneumonia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Entityisradipine has been associated with Entityhepatocellular injury , there are no reports of fulminant liver failure with this agent, and our patient had been treated for > 2 years without signs of toxicity.
0.9998 Adverse-Effect Although Entityisradipine has been associated with hepatocellular injury, there are no reports of Entityfulminant liver failure with this agent, and our patient had been treated for > 2 years without signs of toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with CREST syndrome ( calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia ) who paradoxically experienced Entityworsening of Raynaud's phenomenon when using Entityyohimbine for ED.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A patient is described with the characteristic features of Entityphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, Entitytibial and facial oedema , pinhead - sized facial pustules and abnormal liver function tests.
0.9999 Adverse-Effect A patient is described with the characteristic features of Entityphenytoin hypersensitivity syndrome ( PHS ) including fever, Entityerythroderma , tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
0.9999 Adverse-Effect A patient is described with the characteristic features of Entityphenytoin hypersensitivity syndrome ( PHS ) including Entityfever , erythroderma, tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
0.9998 Adverse-Effect A patient is described with the characteristic features of Entityphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, Entitypinhead - sized facial pustules and abnormal liver function tests.
0.9998 Adverse-Effect A patient is described with the characteristic features of Entityphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, pinhead - sized facial pustules and Entityabnormal liver function tests .
Adverse-Effect A patient is described with the characteristic features of Entityphenytoin Entityphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although transient increases in ectopy after Entitybretylium therapy have been described, presumably due to catecholamine release, the occurrence of life - threatening Entityventricular arrhythmia leading to cardiac arrest has not previously been emphasized.
0.9998 Adverse-Effect Although transient increases in ectopy after Entitybretylium therapy have been described, presumably due to catecholamine release, the occurrence of life - threatening ventricular arrhythmia leading to Entitycardiac arrest has not previously been emphasized.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Entitypancytopenia in a 23 - year - old man with Crohn's disease who was treated with Entity5 - aminosalicylic acid ( Pentasa ; Nisshin, Tokyo, Japan ) 3. 0 g / day.
0.9999 Adverse-Effect We report a case of Entitypancytopenia in a 23 - year - old man with Crohn's disease who was treated with 5 - aminosalicylic acid ( EntityPentasa ; Nisshin, Tokyo, Japan ) 3. 0 g / day.
0.9998 Adverse-Effect We report a case of Entitypancytopenia in a 23 - year - old man with Crohn's disease who was treated with 5 - aminosalicylic acid ( Pentasa ; EntityNisshin , Tokyo, Japan ) 3. 0 g / day.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect EntityExtrapyramidal side effects induced by some selective serotonin reuptake inhibitors ( SSRIs ), i. e. Entityfluoxetine and sertraline, have been previously reported in patients with depression and obsessive - compulsive disorder ( OCD ).
0.9997 Adverse-Effect EntityExtrapyramidal side effects induced by some selective serotonin reuptake inhibitors ( SSRIs ), i. e. fluoxetine and Entitysertraline , have been previously reported in patients with depression and obsessive - compulsive disorder ( OCD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because Entityetoposide - induced Entitypulmonary toxicity is an uncommon but serious adverse event, clinicians must be vigilant about the possibility of it, so that the optimal treatment can start as soon as possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five cases ( four from the literature and one new case ) are presented in which patients unsuspected of having vitamin B12 deficiency developed Entitysubacute combined degeneration of the spinal cord following Entitynitrous oxide anesthesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of a man treated with an EGFR - inhibitor ( Entityerlotinib ) for a cell lung cancer who developed Entityskin manifestations localized in an uncommon area and with an atypical evolution.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Physicians should be cognizant of this potential complication in patients receiving Entitythalidomide or thalidomide - like drugs who present with Entityfever and pulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9994 Adverse-Effect Physicians should be cognizant of this potential complication in patients receiving Entitythalidomide or thalidomide - like drugs who present with fever and Entitypulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9999 Adverse-Effect Physicians should be cognizant of this potential complication in patients receiving thalidomide or Entitythalidomide - like drugs who present with Entityfever and pulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9998 Adverse-Effect Physicians should be cognizant of this potential complication in patients receiving thalidomide or Entitythalidomide - like drugs who present with fever and Entitypulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect This article describes two cases of aplastic anemia, at least one of which was almost certainly induced by the use of methazolamide, and one case of Entityagranulocytosis related to the use of Entitymethazolamide .
0.5641 Adverse-Effect This article describes two cases of Entityaplastic anemia , at least one of which was almost certainly induced by the use of Entitymethazolamide , and one case of agranulocytosis related to the use of methazolamide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Entitylacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., Entitydizziness , ataxia, diplopia, and somnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Entitylacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, ataxia, Entitydiplopia , and somnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Entitylacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, Entityataxia , diplopia, and somnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Entitylacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, ataxia, diplopia, and Entitysomnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Entitylacosamide doses up to 600 mg / day include Entitynonspecific central nervous system effects ( e. g., dizziness, ataxia, diplopia, and somnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Entitylacosamide doses up to 600 mg / day include nonspecific Entitycentral nervous system effects ( e. g., dizziness, ataxia, diplopia, and somnolence ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this healthy population, the relative risk of developing Entityendometrial carcinoma in the Entitytamoxifen arm was 2. 54, although when stratified by age, in women over 50, the risk grew to 4. 01.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : We queried 35 rheumatologists at the Robert Breck Brigham Arthritis Center to determine if Entityweight loss had occurred as an adverse event in patients treated with Entityleflunomide between November 1998 and January 2000.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible lethal renal failure with Entityanuria , the day after 5 g / m2 bolus Entityifosfamide .
0.9999 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an Entityirreversible lethal renal failure with anuria, the day after 5 g / m2 bolus Entityifosfamide .
1.0000 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with Entitycisplatin , developed an Entityirreversible lethal renal failure with anuria, the day after 5 g / m2 bolus ifosfamide.
0.9998 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible Entitylethal renal failure with anuria, the day after 5 g / m2 bolus Entityifosfamide .
0.9998 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with Entitycisplatin , developed an irreversible Entitylethal renal failure with anuria, the day after 5 g / m2 bolus ifosfamide.
0.9997 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with Entitycisplatin , developed an irreversible lethal renal failure with Entityanuria , the day after 5 g / m2 bolus ifosfamide.
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect Until additional data are available, if intravenous acyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of Entitylithium Entitylithium toxicity and measuring serum lithium levels every second or third day.
0.9946 Adverse-Effect Until additional data are available, if intravenous Entityacyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of Entitylithium toxicity and measuring serum lithium levels every second or third day.
0.9990 Adverse-Effect Until additional data are available, if intravenous acyclovir is administered concurrently with Entitylithium , we recommend closely monitoring patients for signs of Entitylithium toxicity and measuring serum lithium levels every second or third day.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although they had complex medical problems, the high serum concentrations of ampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the Entityseizures were related to the Entityampicillin therapy.
0.9993 Adverse-Effect Although they had complex medical problems, the high serum concentrations of Entityampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the Entityseizures were related to the ampicillin therapy.
0.9999 Adverse-Effect Although they had complex medical problems, the high serum concentrations of Entityampicillin at the time of Entityseizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the ampicillin therapy.
0.9995 Adverse-Effect Although they had complex medical problems, the high serum concentrations of ampicillin at the time of Entityseizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the Entityampicillin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of an elderly woman with a pre - existing history of ischaemic heart disease, who was treated with Entityvenlafaxine , and developed Entityacute myocardial ischaemia within the first week of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with recurrent, increasingly severe episodes of PPE, ultimately complicated by a severe Entitybullous eruption , following successive cycles of high - dose Entitycytarabine for the treatment of acute lymphoblastic leukaemia.
0.9999 Adverse-Effect We report a patient with recurrent, increasingly severe episodes of EntityPPE , ultimately complicated by a severe bullous eruption, following successive cycles of high - dose Entitycytarabine for the treatment of acute lymphoblastic leukaemia.
1.0000 Adverse-Effect We report a patient with recurrent, increasingly severe episodes of PPE, ultimately complicated by a Entitysevere bullous eruption , following successive cycles of high - dose Entitycytarabine for the treatment of acute lymphoblastic leukaemia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The evidence of high plasmatic levels of CBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of EntityCBZ could have represented the precipitating of the episode of Entityacute pancreatitis .
0.9983 Adverse-Effect The evidence of high plasmatic levels of EntityCBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of CBZ could have represented the precipitating of the episode of Entityacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Assessment of cortisol response was by Entityinsulin - induced Entityhypoglycaemia in three cases, by short tetracosactrin test in two, and by low - dose tetracosactrin and 24 - hour urinary cortisol / creatinine ratio in one.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityanaphylactoid reaction due solely to the use of EntityGelofusine in a patient with non - haemorrhagic hypovolaemia is presented, with a discussion on the management and the use of allergy identification jewellery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : While Entitythrombosis has been reported with EntityGnRH - a therapy in men with prostate cancer, its association with treatment in this benign case may have been a consequence of the massive tumor size.
0.9998 Adverse-Effect CONCLUSION : While thrombosis has been reported with EntityGnRH - a therapy in men with prostate cancer, its association with treatment in this benign case may have been a consequence of the Entitymassive tumor size .
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect Idiosyncratic factors involving vasopressin receptor affinity and distribution, Entityvasopressin - associated Entityvasodilation in some vascular beds, and the effect of vasopressin on the renin - angiotensin system may further contribute to impaired tissue perfusion.
0.9842 Adverse-Effect Idiosyncratic factors involving vasopressin receptor affinity and distribution, vasopressin - associated vasodilation in some vascular beds, and the effect of Entityvasopressin on the renin - angiotensin system may further contribute to Entityimpaired tissue perfusion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 35 - year - old woman presented with neurotoxicity correlated to an i. v. regimen of Entity5 - fluorouracil as episodes of Entityacute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum.
0.9998 Adverse-Effect A 35 - year - old woman presented with Entityneurotoxicity correlated to an i. v. regimen of Entity5 - fluorouracil as episodes of acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nine eyes from 6 patients, 74 years to 90 years of age, referred by ophthalmologists for repair of Entitycicatricial entropion after at least 2 years of twice - a - day application of Entitydipivefrin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMethotrexate - associated Entitynephropathy is a rare complication in pediatric oncology, and a review of the literature suggests that exposure to nephrotoxic agents may be a significant but perhaps underrecognized risk factor for its development.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this paper, we report a case of Entitysevere hypercalcemia of immobilization in a 40 - year - old hemodialyzed woman treated by Entitycinacalcet HCl for a severe HPTH - II ( PTH > 1, 000 pg / mL ).
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although combinations of belladonna, ergotamine, and Entityphenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with Entityanticonvulsant hypersensitivity syndrome .
0.9996 Adverse-Effect Although combinations of Entitybelladonna , ergotamine, and phenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with Entityanticonvulsant hypersensitivity syndrome .
0.9996 Adverse-Effect Although combinations of belladonna, Entityergotamine , and phenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with Entityanticonvulsant hypersensitivity syndrome .
1.0000 Adverse-Effect Although combinations of belladonna, ergotamine, and Entityphenobarbital have been used for medical treatment of Entitymenopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
0.9999 Adverse-Effect Although combinations of belladonna, Entityergotamine , and phenobarbital have been used for medical treatment of Entitymenopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
0.9999 Adverse-Effect Although combinations of Entitybelladonna , ergotamine, and phenobarbital have been used for medical treatment of Entitymenopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect OBJECTIVE : To report the occurrence of acute cytolytic hepatitis in a patient exposed to pulse itraconazole therapy for 24 weeks and provide a concise review of the literature on cases of Entityitraconazole - induced Entityhepatitis .
0.9846 Adverse-Effect OBJECTIVE : To report the occurrence of Entityacute cytolytic hepatitis in a patient exposed to pulse Entityitraconazole therapy for 24 weeks and provide a concise review of the literature on cases of itraconazole - induced hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect INTRODUCTION : In resource limited settings patients on antiretroviral treatment who develop Entitystavudine induced Entityhyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Although Entitymirtazapine offers clinicians a combination of strong efficacy and good safety, we suggest bearing EntitySS in mind when prescribing this drug, especially in frail, elderly patients with underlying chronic conditions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first reported case, in an adult, of Entitycholestyramine induced Entityhyperchloremic metabolic acidosis is a 70 year old female with a two year history of primary biliary cirrhosis confirmed by histologic and immunologic criteria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have successfully overcome Entitysevere neutropenia in an RA patient treated with Entitygold salts, using granulocyte colony - stimulating factor ( G - CSF ), reducing the duration of neutropenia and risk of infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with docetaxel and Entitygemcitabine producing Entitysevere respiratory insufficiency , and simulating a progression of the tumor.
1.0000 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with EntityBOOP after chemotherapy with Entitydocetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.
0.9999 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with EntityBOOP after chemotherapy with docetaxel and Entitygemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.
0.9999 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with Entitydocetaxel and gemcitabine producing Entitysevere respiratory insufficiency , and simulating a progression of the tumor.
0.9999 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with docetaxel and Entitygemcitabine producing severe respiratory insufficiency, and simulating a Entityprogression of the tumor .
0.9997 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with Entitydocetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a Entityprogression of the tumor .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report details a case of Entitybilateral avascular necrosis of the femoral heads in a patient receiving'standard'doses of Entitydexamethasone as part of the antiemetic regimen used in cisplatin - based combination chemotherapy.
0.9989 Adverse-Effect This report details a case of Entitybilateral avascular necrosis of the femoral heads in a patient receiving'standard'doses of dexamethasone as part of the antiemetic regimen used in Entitycisplatin - based combination chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the present paper the authors describe 2 female patients who developed Entityincontinence secondary to the selective serotonin reuptake inhibitors Entityparoxetine and sertraline, as well as a third who developed this side effect on venlafaxine.
0.9999 Adverse-Effect In the present paper the authors describe 2 female patients who developed Entityincontinence secondary to the selective serotonin reuptake inhibitors paroxetine and Entitysertraline , as well as a third who developed this side effect on venlafaxine.
0.9967 Adverse-Effect In the present paper the authors describe 2 female patients who developed Entityincontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on Entityvenlafaxine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Exacerbation of Entity5 - FU Entitydermatologic toxicities in patients with preexisting conditions suggests the importance of aggressive ocular prophylaxis, using frequent ocular lubrication and topical steroid preparations with concurrent medical management of pre - existing dermatologic conditions.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect In this report, two newborns with congenital heart anomalies demonstrated the Entityharlequin color change , one whose skin findings showed a course related to the dose of systemic Entityprostaglandin E1 , suggesting a possible association.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect One explanation for the noted Entityincrease in the theophylline level Entitytheophylline level is that metabolism occurs mainly by cytochrome P450 ( CYP 1A2 ), an enzyme that is known to be inhibited with high concentrations of zafirlukast.
0.9995 Adverse-Effect One explanation for the noted Entityincrease in the theophylline level is that metabolism occurs mainly by cytochrome P450 ( CYP 1A2 ), an enzyme that is known to be inhibited with high concentrations of Entityzafirlukast .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with EntityIFN - associated Entityretinopathy who had developed macular edema and reduced visual acuity during the clinical course of IFN therapy were observed.
0.9999 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with IFN - associated retinopathy who had developed macular edema and Entityreduced visual acuity during the clinical course of EntityIFN therapy were observed.
0.9985 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with IFN - associated retinopathy who had developed Entitymacular edema and reduced visual acuity during the clinical course of EntityIFN therapy were observed.
0.9980 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with EntityIFN - associated retinopathy who had developed Entitymacular edema and reduced visual acuity during the clinical course of IFN therapy were observed.
0.9974 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with EntityIFN - associated retinopathy who had developed macular edema and Entityreduced visual acuity during the clinical course of IFN therapy were observed.
0.9937 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with IFN - associated Entityretinopathy who had developed macular edema and reduced visual acuity during the clinical course of EntityIFN therapy were observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entitysideroblastic anemia is presented in a patient with a left ventricular assist device drive - line infection who was receiving Entitylinezolid , an antibiotic used for serious infections with gram - positive organisms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of rhinitis, conjunctivitis and Entityperspiration immediately after the administration of salmon Entitycalcitonin with nasal spray or intramuscular administration ( Calsynar ).
1.0000 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of rhinitis, conjunctivitis and Entityperspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( EntityCalsynar ).
1.0000 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of rhinitis, Entityconjunctivitis and perspiration immediately after the administration of salmon Entitycalcitonin with nasal spray or intramuscular administration ( Calsynar ).
0.9999 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of Entityrhinitis , conjunctivitis and perspiration immediately after the administration of salmon Entitycalcitonin with nasal spray or intramuscular administration ( Calsynar ).
0.9999 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of Entityrhinitis , conjunctivitis and perspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( EntityCalsynar ).
0.9999 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of rhinitis, Entityconjunctivitis and perspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( EntityCalsynar ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Entitylevodopa levels demonstrated Entitymarked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with painful dysesthesia.
1.0000 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Entitylevodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with Entitypainful dysesthesia .
1.0000 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Entitylevodopa levels demonstrated marked motor hyperactivity during augmentation, with Entityanarchic discharges of motor unit potentials , tonic grouped discharges and flexor spasms, associated with painful dysesthesia.
0.9999 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Entitylevodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, Entitytonic grouped discharges and flexor spasms, associated with painful dysesthesia.
0.9999 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Entitylevodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and Entityflexor spasms , associated with painful dysesthesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Currently the use of Entityzidovudine is one of the few specific measures available, and as a potentially Entityteratogenic and fetotoxic agent, any decision for its use requires evaluation of the potential for fetal damage.
0.9999 Adverse-Effect Currently the use of Entityzidovudine is one of the few specific measures available, and as a potentially teratogenic and fetotoxic agent, any decision for its use requires evaluation of the potential for Entityfetal damage .
0.9999 Adverse-Effect Currently the use of Entityzidovudine is one of the few specific measures available, and as a potentially teratogenic and Entityfetotoxic agent, any decision for its use requires evaluation of the potential for fetal damage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient is presented with typical hyperthyroidism, who developed a severe proximal muscle weakness and a Entityraised creatine phosphokinase after treatment for hyperthyroidism with Entitypropylthiouracil ( 100 mg orally, three times a day ).
1.0000 Adverse-Effect A patient is presented with typical hyperthyroidism, who developed a Entitysevere proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with Entitypropylthiouracil ( 100 mg orally, three times a day ).
0.9999 Adverse-Effect A patient is presented with typical Entityhyperthyroidism , who developed a severe proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with Entitypropylthiouracil ( 100 mg orally, three times a day ).
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect After a six - week course of low - dose Entitycyclosporine A , she developed a severe but reversible Entityloss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.
0.9997 Adverse-Effect After a six - week course of low - dose Entitycyclosporine A , she developed a severe but reversible loss of glomerular filtration rate and Entityeffective renal plasma flow despite of low cyclosporine A plasma levels.
0.9998 Adverse-Effect After a six - week course of low - dose Entitycyclosporine A , she developed a severe but Entityreversible loss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that the previous classification of Entitynitrofurantoin induced Entitylung injury into " acute " and " chronic " injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.
Adverse-Effect We suggest that the previous classification of Entitynitrofurantoin Entitynitrofurantoin induced lung injury into " acute " and " chronic " injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the clinical course of a woman with cryptococcal meningitis and no previous cardiac disease who developed a Entityfatal cardiac arrhythmia after an acute overdose of Entityamphotericin B and to review its toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The following is a case report analysis intended to draw attention to the need for better care coordination by describing the observed relationship of Entityolanzapine to metabolic changes manifested as Entityuncontrolled diabetes mellitus and weight gain.
0.9998 Adverse-Effect The following is a case report analysis intended to draw attention to the need for better care coordination by describing the observed relationship of Entityolanzapine to metabolic changes manifested as uncontrolled diabetes mellitus and Entityweight gain .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We consider asterixis to be an easily overlooked sign of Entityneurotoxicity , which may occur even at low or moderate dosage levels, if certain drugs as Entitylithium or clozapine are used in combination with CBZ.
0.9999 Adverse-Effect We consider asterixis to be an easily overlooked sign of Entityneurotoxicity , which may occur even at low or moderate dosage levels, if certain drugs as lithium or Entityclozapine are used in combination with CBZ.
0.9999 Adverse-Effect We consider asterixis to be an easily overlooked sign of Entityneurotoxicity , which may occur even at low or moderate dosage levels, if certain drugs as lithium or clozapine are used in combination with EntityCBZ .
0.9998 Adverse-Effect We consider Entityasterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as Entitylithium or clozapine are used in combination with CBZ.
0.9995 Adverse-Effect We consider Entityasterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as lithium or Entityclozapine are used in combination with CBZ.
0.9995 Adverse-Effect We consider Entityasterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as lithium or clozapine are used in combination with EntityCBZ .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was hypothesized that valproic acid may interfere with glucuronidation of Entitylamotrigine , leading to Entityincreased serum lamotrigine levels , or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite.
0.9995 Adverse-Effect It was hypothesized that Entityvalproic acid may interfere with glucuronidation of lamotrigine, leading to Entityincreased serum lamotrigine levels , or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite.
0.9995 Adverse-Effect It was hypothesized that valproic acid may interfere with glucuronidation of Entitylamotrigine , leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in Entityaccumulation of a toxic intermediate metabolite .
0.9990 Adverse-Effect It was hypothesized that Entityvalproic acid may interfere with glucuronidation of lamotrigine, leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in Entityaccumulation of a toxic intermediate metabolite .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A retrospective report of the first case of Entitygemcitabine - related EntityHUS , in a patient with metastatic pancreatic adenocarcinoma, treated with a variety of standard therapies in addition to rituximab is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of EntityHUS in an advanced ovarian cancer patient treated with Entitycarboplatin and gemcitabine, and described its favorable outcome after chemotherapy interruption and supportive care with a 1 year follow - up.
1.0000 Adverse-Effect We present a case of EntityHUS in an advanced ovarian cancer patient treated with carboplatin and Entitygemcitabine , and described its favorable outcome after chemotherapy interruption and supportive care with a 1 year follow - up.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with transitional cell carcinoma of the renal pelvis who developed respiratory dysfunction and an Entityabnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with Entitypiritrexim , a methotrexate analog.
0.9999 Adverse-Effect We describe a patient with transitional cell carcinoma of the renal pelvis who developed Entityrespiratory dysfunction and an abnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with Entitypiritrexim , a methotrexate analog.
0.9999 Adverse-Effect We describe a patient with transitional cell carcinoma of the renal pelvis who developed respiratory dysfunction and an Entityabnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with piritrexim, a Entitymethotrexate analog.
0.9998 Adverse-Effect We describe a patient with transitional cell carcinoma of the renal pelvis who developed Entityrespiratory dysfunction and an abnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with piritrexim, a Entitymethotrexate analog.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The Entitypiloerection observed after the replacement of Entityfluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran.
0.9978 Adverse-Effect CONCLUSIONS : The Entitypiloerection observed after the replacement of fluvoxamine with Entitymilnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran.
0.9850 Adverse-Effect CONCLUSIONS : The Entitypiloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous Entitynorepinephrine induced by milnacipran.
0.9799 Adverse-Effect CONCLUSIONS : The Entitypiloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by Entitymilnacipran .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In summary, we report herein the first case of EntitySIADH believed to be an adverse effect of Entitymizoribin , which may therefore needed to be added to the list of drugs which can induce SIADH.
1.0000 Adverse-Effect In summary, we report herein the first case of SIADH believed to be an adverse effect of Entitymizoribin , which may therefore needed to be added to the list of drugs which can induce EntitySIADH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During the first days of Entityarsenic trioxide treatment a rapid Entitydecrease in the D - dimers was seen ( normal values reached until day 7 ), together with a slight decrease in peripheral blood leukocytes.
0.9994 Adverse-Effect During the first days of Entityarsenic trioxide treatment a rapid decrease in the D - dimers was seen ( normal values reached until day 7 ), together with a Entityslight decrease in peripheral blood leukocytes .
0.9993 Adverse-Effect During the first days of Entityarsenic trioxide treatment a rapid decrease in the D - dimers was seen ( normal values reached until day 7 ), together with a slight Entitydecrease in peripheral blood leukocytes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, although Entitygarenoxacin reportedly causes fewer adverse reactions for Entitycardiac rhythms than third - generation quinolone antibiotics, one must be cautious of the interference of other drugs during hypokalemia in order to prevent TdP.
0.9993 Adverse-Effect Therefore, although Entitygarenoxacin reportedly causes fewer adverse reactions for cardiac rhythms than third - generation quinolone antibiotics, one must be cautious of the interference of other drugs during Entityhypokalemia in order to prevent TdP.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of seizures and Entitytransient blindness at different times after i. v. pulse Entitymethylprednisolone ( IVPMP ) treatment.
1.0000 Adverse-Effect Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of Entityseizures and transient blindness at different times after i. v. pulse Entitymethylprednisolone ( IVPMP ) treatment.
1.0000 Adverse-Effect Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of seizures and Entitytransient blindness at different times after i. v. pulse methylprednisolone ( EntityIVPMP ) treatment.
0.9999 Adverse-Effect Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of Entityseizures and transient blindness at different times after i. v. pulse methylprednisolone ( EntityIVPMP ) treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Entitydapsone Entityhypersensitivity syndrome , consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of fever, headache, nausea, Entityvomiting , lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of fever, headache, Entitynausea , vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of fever, Entityheadache , nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, Entityhepatitis , hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, Entityhemolysis , leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, Entityleukopenia , and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of Entityfever , headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, Entitylymphadenopathy , hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9998 Adverse-Effect A Entitydapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and Entitymononucleosis , has been described in patients treated with the drug for leprosy.
Score Relation Text (Head - Tail)
0.9992 Adverse-Effect Cardiac glycosides are thought to prevent Entitydoxorubicin Entitycardiomyopathy by competitively inhibiting doxorubicin at its receptor sites, but ouabain has a much shorter half life than doxorubicin and its metabolites and so is less effective than digoxin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard Entityinsulin desensitization, could control Entityallergic symptoms in a patient allergic to both NPH and regular insulin.
0.9988 Adverse-Effect OBJECTIVE : The purpose of this study was to determine whether desensitization to EntityNPH insulin , as well as standard insulin desensitization, could control Entityallergic symptoms in a patient allergic to both NPH and regular insulin.
1.0000 Adverse-Effect OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard insulin desensitization, could control Entityallergic symptoms in a patient allergic to both EntityNPH and regular insulin.
0.9998 Adverse-Effect OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard insulin desensitization, could control Entityallergic symptoms in a patient allergic to both NPH and regular Entityinsulin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ RD ], limb dyskinesia, and Entityorofacial dyskinesia ) following abrupt withdrawal of Entityrisperidone therapy.
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ EntityRD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of Entityrisperidone therapy.
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ RD ], Entitylimb dyskinesia , and orofacial dyskinesia ) following abrupt withdrawal of Entityrisperidone therapy.
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including Entityrespiratory dyskinesia [ RD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of Entityrisperidone therapy.
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed EntityTD at multiple sites, ( including respiratory dyskinesia [ RD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of Entityrisperidone therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We conjectured that the side effects of Entityinsulin , such as Entityanti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.
0.9993 Adverse-Effect We conjectured that the side effects of Entityinsulin , such as anti - natriuresis and Entityincreased vascular permeability , might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.
0.9992 Adverse-Effect We conjectured that the side effects of Entityinsulin , such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, Entityhyperinsulinaemia and hypoalbuminaemia.
0.9990 Adverse-Effect We conjectured that the side effects of Entityinsulin , such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and Entityhypoalbuminaemia .
0.9975 Adverse-Effect We conjectured that the side effects of Entityinsulin , such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies Entityinsulin insensitivity , hyperinsulinaemia and hypoalbuminaemia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We present two cases in which both patients suffered with EntityCLS , which we believe was caused following administration of Entitygranulocyte colony - stimulating factor , to our knowledge not described in the intensive care patient previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Entity5 - FU - induced Entityneurologic symptoms such as encephalopathy and coma.
0.9998 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Entity5 - FU - induced neurologic symptoms such as Entityencephalopathy and coma.
0.9998 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Entity5 - FU - induced neurologic symptoms such as encephalopathy and Entitycoma .
0.9996 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute Entity5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced Entityneurologic symptoms such as encephalopathy and coma.
0.9995 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute Entity5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as encephalopathy and Entitycoma .
0.9994 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute Entity5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as Entityencephalopathy and coma.
Adverse-Effect The principle treatment for DPD - deficient patients with Entitysevere acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Entity5 - FU - induced neurologic symptoms such as encephalopathy and coma.
Adverse-Effect The principle treatment for DPD - deficient patients with Entitysevere acute 5 - FU reactions Entity5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as encephalopathy and coma.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A case report is presented concerning the administration of ketanserin in the treatment of pulmonary vasoconstriction and Entityright ventricular failure following the infusion of Entityprotamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.9987 Adverse-Effect A case report is presented concerning the administration of ketanserin in the treatment of Entitypulmonary vasoconstriction and right ventricular failure following the infusion of Entityprotamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.9997 Adverse-Effect A case report is presented concerning the administration of Entityketanserin in the treatment of Entitypulmonary vasoconstriction and right ventricular failure following the infusion of protamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.9974 Adverse-Effect A case report is presented concerning the administration of Entityketanserin in the treatment of pulmonary vasoconstriction and Entityright ventricular failure following the infusion of protamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This patient developed sequential symptoms including alternative hemiparesis, dysarthria and Entityaltered consciousness 5 days after the second course of EntityHD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9999 Adverse-Effect This patient developed sequential symptoms including alternative hemiparesis, Entitydysarthria and altered consciousness 5 days after the second course of EntityHD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9998 Adverse-Effect This patient developed sequential symptoms including alternative Entityhemiparesis , dysarthria and altered consciousness 5 days after the second course of EntityHD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9994 Adverse-Effect This patient developed sequential symptoms including alternative hemiparesis, dysarthria and Entityaltered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with Entityleucovorin rescue.
0.9989 Adverse-Effect This patient developed sequential symptoms including alternative hemiparesis, Entitydysarthria and altered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with Entityleucovorin rescue.
0.9983 Adverse-Effect This patient developed sequential symptoms including alternative Entityhemiparesis , dysarthria and altered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with Entityleucovorin rescue.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFK506 , which began to be administered 12 days earlier, rose to a level of 44 ng / mL ( normal range, 10 - 20 ng / mL ) 1 day before Entityneurologic abnormalities began.
Score Relation Text (Head - Tail)
0.6453 Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : Entityindinavir ( renal colic and Entityfever ), nelfinavir ( cutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and Entityefavirenz ( nausea and Entitytemporary memory loss ).
Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and Entityefavirenz ( Entitynausea and temporary memory loss ).
Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : Entityindinavir ( Entityrenal colic and fever ), nelfinavir ( cutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), Entitynelfinavir ( Entitycutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A 74 - year - old man received oral administration of Entitypilsicainide , a pure sodium channel blocker with slow recovery kinetics, to convert paroxysmal atrial fibrillation to sinus rhythm and developed Entityloss of consciousness two days later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on the Naranjo algorithm, the adverse reaction observed was probably related to the hydroxyurea treatment ( score = 6 ) ; however, the Entityhydroxyurea chemotherapy could not be discontinued because of the Entitymyeloproliferative disorder .
0.9983 Adverse-Effect Based on the Naranjo algorithm, the adverse reaction observed was probably related to the Entityhydroxyurea treatment ( score = 6 ) ; however, the hydroxyurea chemotherapy could not be discontinued because of the Entitymyeloproliferative disorder .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityMinor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving Entityouabain , and none of the 16 who were receiving digoxin.
0.9998 Adverse-Effect EntityMinor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving ouabain, and none of the 16 who were receiving Entitydigoxin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Phenytoin was discontinued after admission ; however, Entityphenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which Entityswelling of the face and legs and pruritus developed.
0.9998 Adverse-Effect Phenytoin was discontinued after admission ; however, Entityphenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which swelling of the face and legs and Entitypruritus developed.
0.9994 Adverse-Effect EntityPhenytoin was discontinued after admission ; however, phenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which Entityswelling of the face and legs and pruritus developed.
0.9992 Adverse-Effect EntityPhenytoin was discontinued after admission ; however, phenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which swelling of the face and legs and Entitypruritus developed.
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect It is concluded that ' Entitycerebral atrophy ' on CT scans may represent an accumulative effect of EntityACTH and that ACTH should be given with the utmost discretion, and in as low a dose as possible.
0.9266 Adverse-Effect It is concluded that ' Entitycerebral atrophy ' on CT scans may represent an accumulative effect of ACTH and that EntityACTH should be given with the utmost discretion, and in as low a dose as possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of advanced ovarian carcinoma who developed difficulty walking because of marked pain in the lower extremities and Entityloss of proprioception 25 days after treatment with weekly Entitytaxol ( 80 mg / m ( 2 ) x3 ).
1.0000 Adverse-Effect We describe a case of advanced ovarian carcinoma who developed difficulty walking because of Entitymarked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly Entitytaxol ( 80 mg / m ( 2 ) x3 ).
0.9999 Adverse-Effect We describe a case of advanced ovarian carcinoma who developed Entitydifficulty walking because of marked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly Entitytaxol ( 80 mg / m ( 2 ) x3 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a 26 - year - old female with diffuse large B - cell lymphoma who died of Entitysevere pulmonary fibrosis 81 days after the administration of high - dose EntityBCNU ( 600 mg / m2 ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Symptoms and signs of Entityaugmentation were related to low plasma Entitylevodopa levels, abating 75 minutes after oral levodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma levodopa concentration.
0.9985 Adverse-Effect Symptoms and signs of Entityaugmentation were related to low plasma levodopa levels, abating 75 minutes after oral Entitylevodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma levodopa concentration.
0.9977 Adverse-Effect Symptoms and signs of Entityaugmentation were related to low plasma levodopa levels, abating 75 minutes after oral levodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma Entitylevodopa concentration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : Double - blind, placebo - controlled titrated oral challenges with pancreatic enzymes resulted in definite Entityvomiting within 1 to 1. 5 hours after challenges with EntityViokase and Pancrease MT 16, but not with placebo.
0.9999 Adverse-Effect METHODS : Double - blind, placebo - controlled titrated oral challenges with pancreatic enzymes resulted in definite Entityvomiting within 1 to 1. 5 hours after challenges with Viokase and EntityPancrease MT 16 , but not with placebo.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After ruling out a hydrotelluric source of fluorine, the patient's Entityfluorosis was linked to chronic use of Entityniflumic acid , following the publication in 1978 of the 2 previously reported cases affected by this drug.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect PURPOSE : To investigate the concentration - side effect relationship in a patient with severe Entityacyclovir - induced Entityneurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir.
0.9967 Adverse-Effect PURPOSE : To investigate the concentration - side effect relationship in a patient with severe acyclovir - induced neurotoxicity and to summarize the information available in the literature about Entitycentral nervous system side effects due to Entityacyclovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 5 - year - old boy with CF who had a stricture of the hepatic flexure region with associated narrowing due to Entitysubmucosal fibrosis of the transverse colon , secondary to Entityhigh - lipase pancreatin therapy.
0.9996 Adverse-Effect We report a 5 - year - old boy with CF who had a stricture Entityof the hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Entityhigh - lipase pancreatin therapy.
0.9996 Adverse-Effect We report a 5 - year - old boy with CF who had a stricture of Entitythe hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Entityhigh - lipase pancreatin therapy.
0.9995 Adverse-Effect We report a 5 - year - old boy with CF who had a stricture of the Entityhepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Entityhigh - lipase pancreatin therapy.
Adverse-Effect We report a 5 - year - old boy with CF who had a Entitystricture of the hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Entityhigh - lipase pancreatin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The presented patient was treated with 200 mg EntityTCA and developed EntityCushing's syndrome 6 weeks later ( cortisol and ACTH concentrations were below limits of detection, TCA concentrations were > 3 micrograms / l ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Such a rapid and relentless progression of Entitymethyldopa - induced Entityliver injury is undoubtedly rare, but it may be prevented by careful supervision of patients who exhibit liver function abnormalities early in the course of therapy.
0.9986 Adverse-Effect Such a rapid and relentless progression of Entitymethyldopa - induced liver injury is undoubtedly rare, but it may be prevented by careful supervision of patients who exhibit Entityliver function abnormalities early in the course of therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report an HIV - infected woman who developed mild leukopenia as the first sign of a Entitynevirapine - related adverse event, which was followed by Entityskin and hepatic toxicity associated with a more severe leukopenia.
0.9996 Adverse-Effect We report an HIV - infected woman who developed mild Entityleukopenia as the first sign of a Entitynevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.
0.9994 Adverse-Effect We report an HIV - infected woman who developed mild leukopenia as the first sign of a Entitynevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe Entityleukopenia .
0.9997 Adverse-Effect We report an HIV - infected woman who developed Entitymild leukopenia as the first sign of a Entitynevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect An 11 - year - old boy who was treated with a relatively high dose of methotrimeprazine meleate ( EntityLevemepromazine ) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from Entityrespiratory distress syndrome .
0.9996 Adverse-Effect An 11 - year - old boy who was treated with a relatively high dose of Entitymethotrimeprazine meleate ( Levemepromazine ) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from Entityrespiratory distress syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The day after clozapine was stopped, while he was still receiving Entityclomipramine 150 mg / d, he began Entitybehaving oddly , started sweating profusely, shivering, and became tremulous, agitated, and confused.
0.9999 Adverse-Effect The day after Entityclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began Entitybehaving oddly , started sweating profusely, shivering, and became tremulous, agitated, and confused.
0.9999 Adverse-Effect The day after clozapine was stopped, while he was still receiving Entityclomipramine 150 mg / d, he began behaving oddly, started Entitysweating profusely , shivering, and became tremulous, agitated, and confused.
0.9999 Adverse-Effect The day after clozapine was stopped, while he was still receiving Entityclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, Entityshivering , and became tremulous, agitated, and confused.
0.9999 Adverse-Effect The day after clozapine was stopped, while he was still receiving Entityclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became Entitytremulous , agitated, and confused.
0.9999 Adverse-Effect The day after clozapine was stopped, while he was still receiving Entityclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, Entityagitated , and confused.
0.9998 Adverse-Effect The day after clozapine was stopped, while he was still receiving Entityclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and Entityconfused .
0.9998 Adverse-Effect The day after Entityclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, Entityshivering , and became tremulous, agitated, and confused.
0.9998 Adverse-Effect The day after Entityclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started Entitysweating profusely , shivering, and became tremulous, agitated, and confused.
0.9998 Adverse-Effect The day after Entityclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became Entitytremulous , agitated, and confused.
0.9997 Adverse-Effect The day after Entityclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, Entityagitated , and confused.
0.9997 Adverse-Effect The day after Entityclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and Entityconfused .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect PATIENTS : Two patients, ages 40 and 51 years, undergoing treatment with Entityinterferon alfa for malignant neoplasms experienced Entitysudden bilateral, sequential visual loss with disc - related field defects and segmental optic disc edema.
0.9996 Adverse-Effect PATIENTS : Two patients, ages 40 and 51 years, undergoing treatment with Entityinterferon alfa for malignant neoplasms experienced sudden bilateral, Entitysequential visual loss with disc - related field defects and segmental optic disc edema.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the case of a patient who had undergone cholecystectomy previously, but in whom Entitymorphine given in the Emergency Department precipitated Entitypain consistent with biliary colic ; the pain resolved promptly after administration of naloxone.
0.9999 Adverse-Effect We present the case of a patient who had undergone cholecystectomy previously, but in whom Entitymorphine given in the Emergency Department precipitated pain consistent with Entitybiliary colic ; the pain resolved promptly after administration of naloxone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 74 - year - old man with rheumatoid arthritis ( RA ) who developed syndrome of inappropriate secretion of antidiuretic hormone ( EntitySIADH ) 1. 5 months after commencement of Entitymizoribin prescription when his arthritis was improved.
0.9999 Adverse-Effect We describe a 74 - year - old man with rheumatoid arthritis ( RA ) who developed Entitysyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) 1. 5 months after commencement of Entitymizoribin prescription when his arthritis was improved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapamycin / Entitysirolimus - induced Entitypneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.
0.9996 Adverse-Effect EntityRapamycin / sirolimus - induced Entitypneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.
0.9193 Adverse-Effect Rapamycin / Entitysirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a Entitypulmonary infiltrate that reversed after ceasing SR therapy.
0.9026 Adverse-Effect EntityRapamycin / sirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a Entitypulmonary infiltrate that reversed after ceasing SR therapy.
Adverse-Effect Rapamycin / sirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a Entitypulmonary infiltrate that reversed after ceasing EntitySR therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed Entitysymptomatic cardiomyopathy only 4 months into treatment with a combination of Entitydaunomycin and all - trans retinoic acid ( ATRA ).
0.9999 Adverse-Effect We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed Entitysymptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all - trans retinoic acid ( EntityATRA ).
0.9996 Adverse-Effect We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed Entitysymptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and Entityall - trans retinoic acid ( ATRA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which EntityL - dopa Entityshortened the manic - depressive cycle length when administered in a double - blind trial.
0.9999 Adverse-Effect The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which EntityL - dopa Entitydopa shortened the manic - depressive cycle length when administered in a double - blind trial.
0.9997 Adverse-Effect The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which EntityL - dopa Entity- dopa shortened the manic - depressive cycle length when administered in a double - blind trial.
0.9994 Adverse-Effect The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which EntityL - dopa EntityL - dopa shortened the manic - depressive cycle length when administered in a double - blind trial.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Purple glove syndrome, named for its distinctive purple discoloration and Entityswelling of the hands in the distribution of a glove, is an uncommon complication of intravenous Entityphenytoin administration through small dorsal veins of the hands.
0.9999 Adverse-Effect EntityPurple glove syndrome , named for its distinctive purple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous Entityphenytoin administration through small dorsal veins of the hands.
0.9999 Adverse-Effect Purple glove syndrome, named for its distinctive Entitypurple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous Entityphenytoin administration through small dorsal veins of the hands.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, we present a case of Entityhypoglycaemic coma associated with EntitySP , an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases.
0.9992 Adverse-Effect In this report, we present a case of Entityhypoglycaemic coma associated with SP, an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of EntitySP increases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of intravenous Entitynitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an Entityincrease in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance.
1.0000 Adverse-Effect Administration of intravenous Entitynitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a Entitydecrease in blood flow that is best explained by an increase in pulmonary vascular resistance.
1.0000 Adverse-Effect Administration of intravenous Entitynitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an Entityincrease in pulmonary vascular resistance .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was postulated that the Entityallergic reaction was most likely caused by Entitycapecitabine or the intermediate metabolites based on the immediate reappearance of symptoms from the rechallenge, pharmacokinetic data, and well - tolerance of fluorouracil.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Prolonged responses were achieved with low doses of EntityHU ( 3 - 10 mg / kg / day ) and higher doses were associated with mild reversible hematologic or Entityhepatic toxicity and no further increases in Hb.
Adverse-Effect Prolonged responses were achieved with low doses of EntityHU ( 3 - 10 mg / kg / day ) and higher doses were associated with Entitymild reversible hematologic or hepatic toxicity and no further increases in Hb.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect This Entitypanic anxiety was not relieved by taking etizolam and flunitrazepam again, but subsided rapidly by the re - administration of Entitymianserin 30 mg / day, and because of that the depressive symptom also disappeared.
1.0000 Adverse-Effect This Entitypanic anxiety was not relieved by taking Entityetizolam and flunitrazepam again, but subsided rapidly by the re - administration of mianserin 30 mg / day, and because of that the depressive symptom also disappeared.
0.9998 Adverse-Effect This Entitypanic anxiety was not relieved by taking etizolam and Entityflunitrazepam again, but subsided rapidly by the re - administration of mianserin 30 mg / day, and because of that the depressive symptom also disappeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although visual hallucinations have not been reported as an adverse effect of this agent, we describe three patients who experienced complex visual hallucinations and Entityaltered mental status after Entityzonisamide treatment was begun or its dosage increased.
0.9998 Adverse-Effect Although visual hallucinations have not been reported as an adverse effect of this agent, we describe three patients who experienced complex Entityvisual hallucinations and altered mental status after Entityzonisamide treatment was begun or its dosage increased.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A child in whom a Entityphenobarbital Entityhypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
1.0000 Adverse-Effect A child in whom a Entityphenobarbital hypersensitivity drug reaction developed which consisted of Entityfever , a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Entityphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, Entityalopecia , icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Entityphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, Entitymyositis , and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Entityphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, Entityicterus , protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Entityphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and Entitynephritis , is described.
0.9999 Adverse-Effect A child in whom a Entityphenobarbital hypersensitivity drug reaction developed which consisted of fever, Entitya pruritic desquamating erythrodermic rash , alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Entityphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, Entityprotein - losing enteropathy , myositis, and nephritis, is described.
1.0000 Adverse-Effect A child in whom a Entityphenobarbital Entityhypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
1.0000 Adverse-Effect A child in whom a Entityphenobarbital Entityhypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Entityphenobarbital hypersensitivity drug reaction developed which consisted of fever, a Entitypruritic desquamating erythrodermic rash , alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed 5 reactions in 3 patients that appear to be related to a high dose - infusion time ratio, indicating that dose and rate of infusion may be important factors in precipitating Entityanaphylactoid reactions with Entitycisplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The present observation suggests, that a batch of different testing doses, including lower testing doses may help to differentiate between an allergic type of contact dermatitis and an Entityirritant type of reaction after treatment with Entitycalcipotriol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : Rhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure Several drugs have been associated with Entityrhabdomyolysis , including Entitylovastatin , a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
0.9998 Adverse-Effect DISCUSSION : EntityRhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure Several drugs have been associated with rhabdomyolysis, including Entitylovastatin , a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
0.9995 Adverse-Effect DISCUSSION : Rhabdomyolysis is a clinical syndrome resulting from the Entitydestruction of skeletal muscle that may progress to renal failure Several drugs have been associated with rhabdomyolysis, including Entitylovastatin , a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect After initiation of topical vitamin D3 ointment ( 20 micro g / g of Entitytacalcitol ) 10 g / day for the skin lesions, both the Entityserum level of calcium and urinary excretion of calcium increased gradually.
0.9964 Adverse-Effect After initiation of topical Entityvitamin D3 ointment ( 20 micro g / g of tacalcitol ) 10 g / day for the skin lesions, both the Entityserum level of calcium and urinary excretion of calcium increased gradually.
Adverse-Effect After initiation of topical Entityvitamin D3 ointment ( 20 micro g / g of tacalcitol ) 10 g / day for the skin lesions, both the Entityserum level of calcium and urinary excretion of calcium increased gradually.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The use of methotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which EntityMTX appeared to potentiate opportunistic infections and Entityaccelerate HIV disease .
0.9998 Adverse-Effect The use of Entitymethotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and Entityaccelerate HIV disease .
0.9998 Adverse-Effect The use of methotrexate ( EntityMTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and Entityaccelerate HIV disease .
1.0000 Adverse-Effect The use of methotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which EntityMTX appeared to Entitypotentiate opportunistic infections and accelerate HIV disease.
0.9998 Adverse-Effect The use of Entitymethotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to Entitypotentiate opportunistic infections and accelerate HIV disease.
0.9998 Adverse-Effect The use of methotrexate ( EntityMTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to Entitypotentiate opportunistic infections and accelerate HIV disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe Entitytoxic symptoms of Entitycarbamazepine , such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
1.0000 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and Entityataxia , which resolved within 5 days after Entityclarithromycin discontinuation.
1.0000 Adverse-Effect During Entityclarithromycin coadministration, four out of the seven patients developed moderate - to - severe Entitytoxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9999 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, Entitydizziness , and ataxia, which resolved within 5 days after Entityclarithromycin discontinuation.
0.9999 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as Entitydrowsiness , dizziness, and ataxia, which resolved within 5 days after Entityclarithromycin discontinuation.
0.9997 Adverse-Effect During Entityclarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as Entitydrowsiness , dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9997 Adverse-Effect During Entityclarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, Entitydizziness , and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9997 Adverse-Effect During Entityclarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and Entityataxia , which resolved within 5 days after clarithromycin discontinuation.
0.9997 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of Entitycarbamazepine , such as Entitydrowsiness , dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9996 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of Entitycarbamazepine , such as drowsiness, Entitydizziness , and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9996 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe Entitytoxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after Entityclarithromycin discontinuation.
0.9996 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of Entitycarbamazepine , such as drowsiness, dizziness, and Entityataxia , which resolved within 5 days after clarithromycin discontinuation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : We report the case of a 31 - year - old patient hospitalized due to behavioral alterations and treated with oral Entityzuclopenthixol , an antipsychotic from the thioxanthene family, who developed an acute, Entitypainful erection .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DIAGNOSIS : Severe Entitytemozolomide - induced Entityimmunosuppression , exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9999 Adverse-Effect DIAGNOSIS : Severe Entitytemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and Entitycutaneous Kaposi's sarcoma .
0.9999 Adverse-Effect DIAGNOSIS : Severe Entitytemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic Entityinfections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9998 Adverse-Effect DIAGNOSIS : Severe Entitytemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, Entitybrain abscess with Listeria monocytogenes , and cutaneous Kaposi's sarcoma.
0.9997 Adverse-Effect DIAGNOSIS : Severe Entitytemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound EntityT - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9999 Adverse-Effect DIAGNOSIS : Severe Entitytemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and Entitysimultaneous opportunistic infections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9999 Adverse-Effect DIAGNOSIS : Severe Entitytemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous Entityopportunistic infections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9998 Adverse-Effect DIAGNOSIS : Severe Entitytemozolomide - induced immunosuppression, Entityexacerbated by corticosteroids , with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Many clinicians appear to be concerned about the potential Entityhepatotoxicity of the opiate antagonist Entitynaltrexone ( NTX ) and this may be one reason why it is not used more widely in treating both heroin and alcohol abusers.
1.0000 Adverse-Effect Many clinicians appear to be concerned about the potential Entityhepatotoxicity of the opiate antagonist naltrexone ( EntityNTX ) and this may be one reason why it is not used more widely in treating both heroin and alcohol abusers.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our review of 194 RA patients and 38 PsA patients receiving MTX has identified four RA patients and one PsA patient with EntityMTX - induced Entitypneumonitis , giving a prevalence of 2. 1 % and 0. 03 %, respectively.
0.9759 Adverse-Effect Our review of 194 RA patients and 38 PsA patients receiving EntityMTX has identified four RA patients and one PsA patient with MTX - induced Entitypneumonitis , giving a prevalence of 2. 1 % and 0. 03 %, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 7 - year - old boy developed a Entitysevere unilateral grand mal seizure at the age of 5 years ( Entityphenobarbitone therapy ) ; 1. 5 years later valproate ( 2 - propylpentanoic acid, VPA ) was added to the therapy.
0.9999 Adverse-Effect A 7 - year - old boy developed a Entitysevere unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later Entityvalproate ( 2 - propylpentanoic acid, VPA ) was added to the therapy.
0.9998 Adverse-Effect A 7 - year - old boy developed a Entitysevere unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later valproate ( 2 - propylpentanoic acid, EntityVPA ) was added to the therapy.
0.9997 Adverse-Effect A 7 - year - old boy developed a Entitysevere unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later valproate ( Entity2 - propylpentanoic acid , VPA ) was added to the therapy.
Score Relation Text (Head - Tail)
0.9989 Adverse-Effect The authors suggest that fluoxetine - induced akathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of Entityfluoxetine - induced Entityakathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
0.9982 Adverse-Effect The authors suggest that Entityfluoxetine - induced Entityakathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of fluoxetine - induced akathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Given that discontinuation of nitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of Entitytoxic liver damage caused by Entitynitrofurantoin .
0.9778 Adverse-Effect Given that discontinuation of nitrofurantoin and introduction of Entitymethylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of Entitytoxic liver damage caused by nitrofurantoin.
0.9524 Adverse-Effect Given that discontinuation of Entitynitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of Entitytoxic liver damage caused by nitrofurantoin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report we present four patients treated with a combination of different psychotropic drugs, in whom Entityasterixis was triggered either by adding Entitycarbamazepine ( CBZ ) to a treatment regimen, or by increasing its dosage.
1.0000 Adverse-Effect In this report we present four patients treated with a combination of different psychotropic drugs, in whom Entityasterixis was triggered either by adding carbamazepine ( EntityCBZ ) to a treatment regimen, or by increasing its dosage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Approximately 15 min after the first administration of nebulised Entitymorphine the patient became markedly Entitybradypneic ( respiratory rate : 4 - 5 bpm ), hypotensive ( BP 70 / 40 mmHg ), and responded only partially to command.
0.9999 Adverse-Effect Approximately 15 min after the first administration of nebulised Entitymorphine the patient became markedly bradypneic ( respiratory rate : 4 - 5 bpm ), Entityhypotensive ( BP 70 / 40 mmHg ), and responded only partially to command.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Replicate brain magnetic resonance imaging examinations after six weeks and 11 months of Entitypenicillamine therapy documented the development of new Entitybrain lesions during this period, while liver biopsy specimen data disclosed that excellent hepatic decoppering had occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case emphasizes the importance of the evaluation of Entitylithium - associated Entitypolyuria with a direct measurement of plasma vasopressin, interpreted with simultaneous plasma and urine osmolality to secure the correct diagnosis and ensure appropriate therapeutic management.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 50 - year - old male patient with a 15 - year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of Entitycyclosporin A induced a Entitygeneralised pustular exacerbation and a aggravation of the joint condition.
0.9996 Adverse-Effect We report a 50 - year - old male patient with a 15 - year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of Entitycyclosporin A induced a generalised pustular exacerbation and a Entityaggravation of the joint condition .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An objective causality assessment indicated a probable relationship between Entityclotting abnormality and Entitywarfarin administration, although the degree of elevation of the INR was unusual in the light of the daily warfarin dose and duration of its exposure.
0.9401 Adverse-Effect An objective causality assessment indicated a probable relationship between Entityclotting abnormality and warfarin administration, although the degree of elevation of the INR was unusual in the light of the daily Entitywarfarin dose and duration of its exposure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Even though only a few cases of this adverse event have been reported in the literature, severe Entitydocetaxel - induced Entitypulmonary toxicity needs to be considered in the differential diagnosis when such patients present with respiratory symptoms.
0.9994 Adverse-Effect Even though only a few cases of this adverse event have been reported in the literature, severe Entitydocetaxel - induced pulmonary toxicity needs to be considered in the differential diagnosis when such patients present with Entityrespiratory symptoms .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A 68 - year - old man developed intense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to Entitybimatoprost 9 months after cataract surgery in an eye at low - risk for this Entitycystoid macular edema .
1.0000 Adverse-Effect METHODS : A 68 - year - old man developed intense conjunctival hyperemia and Entitycystoid macula edema after switching from Entitylatanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9999 Adverse-Effect METHODS : A 68 - year - old man developed Entityintense conjunctival hyperemia and cystoid macula edema after switching from Entitylatanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9999 Adverse-Effect METHODS : A 68 - year - old man developed intense conjunctival hyperemia and cystoid macula edema after switching from Entitylatanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this Entitycystoid macular edema .
0.9999 Adverse-Effect METHODS : A 68 - year - old man developed intense conjunctival hyperemia and Entitycystoid macula edema after switching from latanoprost to Entitybimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9997 Adverse-Effect METHODS : A 68 - year - old man developed Entityintense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to Entitybimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : A woman of 80 years, on long - term Entitywarfarin therapy presented with an Entityacute dissecting thoracic aortic aneurysm ; on investigation the only precipitating factor found was an international normalised ratio of 4. 8.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 57 - year - old man with acral erythrocyanosis progressing to acute digital ischemia and Entitygangrene that developed after combined chemotherapy ( Entitybleomycin and methotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
1.0000 Adverse-Effect We describe a 57 - year - old man with acral erythrocyanosis progressing to acute digital ischemia and Entitygangrene that developed after combined chemotherapy ( bleomycin and Entitymethotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
1.0000 Adverse-Effect We describe a 57 - year - old man with acral erythrocyanosis progressing to Entityacute digital ischemia and gangrene that developed after combined chemotherapy ( Entitybleomycin and methotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
0.9999 Adverse-Effect We describe a 57 - year - old man with acral erythrocyanosis progressing to Entityacute digital ischemia and gangrene that developed after combined chemotherapy ( bleomycin and Entitymethotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient required nursing home placement and a feeding gastrostomy as a result of the Entityworsening parkinsonism during Entityrisperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine.
0.9993 Adverse-Effect One patient required nursing home placement and a Entityfeeding gastrostomy as a result of the worsening parkinsonism during Entityrisperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine.
0.9990 Adverse-Effect One patient required nursing home placement and a feeding gastrostomy as a result of the Entityworsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from Entityrisperidone to clozapine.
0.9961 Adverse-Effect One patient required nursing home placement and a Entityfeeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from Entityrisperidone to clozapine.
0.9990 Adverse-Effect One patient required nursing home placement and a feeding gastrostomy as a result of the Entityworsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to Entityclozapine .
0.9962 Adverse-Effect One patient required nursing home placement and a Entityfeeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to Entityclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, azotemia, and Entityhyperkalemia shortly after completing a course of intravenous Entityimmunoglobulin ( IVIG ).
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, azotemia, and Entityhyperkalemia shortly after completing a course of intravenous immunoglobulin ( EntityIVIG ).
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, Entityazotemia , and hyperkalemia shortly after completing a course of intravenous Entityimmunoglobulin ( IVIG ).
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, Entityshortness of breath , azotemia, and hyperkalemia shortly after completing a course of intravenous Entityimmunoglobulin ( IVIG ).
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with Entitynausea , shortness of breath, azotemia, and hyperkalemia shortly after completing a course of intravenous Entityimmunoglobulin ( IVIG ).
0.9999 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, Entityazotemia , and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( EntityIVIG ).
0.9999 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, Entityshortness of breath , azotemia, and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( EntityIVIG ).
0.9999 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with Entitynausea , shortness of breath, azotemia, and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( EntityIVIG ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After therapy for diabetic coma with insulin ( containing the preservative Entitycresol ) and electrolyte solutions was started, the patient complained of Entityincreasing myalgia , developed a high fever and respiratory and metabolic acidosis and lost consciousness.
0.9999 Adverse-Effect After therapy for diabetic coma with insulin ( containing the preservative Entitycresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a Entityhigh fever and respiratory and metabolic acidosis and lost consciousness.
0.9999 Adverse-Effect After therapy for diabetic coma with insulin ( containing the preservative Entitycresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and Entityrespiratory and metabolic acidosis and lost consciousness.
0.9999 Adverse-Effect After therapy for diabetic coma with Entityinsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of Entityincreasing myalgia , developed a high fever and respiratory and metabolic acidosis and lost consciousness.
0.9999 Adverse-Effect After therapy for diabetic coma with insulin ( containing the preservative Entitycresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and respiratory and metabolic acidosis and Entitylost consciousness .
0.9998 Adverse-Effect After therapy for diabetic coma with Entityinsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and Entityrespiratory and metabolic acidosis and lost consciousness.
0.9998 Adverse-Effect After therapy for diabetic coma with Entityinsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a Entityhigh fever and respiratory and metabolic acidosis and lost consciousness.
0.9998 Adverse-Effect After therapy for diabetic coma with Entityinsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and respiratory and metabolic acidosis and Entitylost consciousness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A study of in vitro reactivity to L - T4, as assessed by peripheral blood lymphocyte transformation, was carried out in a patient with Hashimoto's disease who developed Entityleukopenia during treatment with EntityL - T4 .
0.9992 Adverse-Effect A study of in vitro reactivity to EntityL - T4 , as assessed by peripheral blood lymphocyte transformation, was carried out in a patient with Hashimoto's disease who developed Entityleukopenia during treatment with L - T4.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical course suggests that Entitycaffeine , which is present in oolong tea, was mainly responsible for the Entityrhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.9999 Adverse-Effect The clinical course suggests that Entitycaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the Entitydelirium , although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.9997 Adverse-Effect The clinical course suggests that Entitycaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause Entityrhabdomyolysis on rare occasions.
0.9995 Adverse-Effect The clinical course suggests that Entitycaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe Entityhyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.9997 Adverse-Effect The clinical course suggests that Entitycaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although Entitysevere hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and Entityataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Entitypentobarbital and pyrilamine maleate.
0.9999 Adverse-Effect A toxic encephalopathy characterized by Entitydepressed level of consciousness , marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Entitypentobarbital and pyrilamine maleate.
0.9999 Adverse-Effect A Entitytoxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Entitypentobarbital and pyrilamine maleate.
0.9999 Adverse-Effect A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and Entityataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Entitypyrilamine maleate .
0.9999 Adverse-Effect A toxic encephalopathy characterized by depressed level of consciousness, Entitymarked irritability , and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Entitypentobarbital and pyrilamine maleate.
0.9994 Adverse-Effect A Entitytoxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Entitypyrilamine maleate .
0.9994 Adverse-Effect A toxic encephalopathy characterized by Entitydepressed level of consciousness , marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Entitypyrilamine maleate .
0.9993 Adverse-Effect A toxic encephalopathy characterized by depressed level of consciousness, Entitymarked irritability , and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Entitypyrilamine maleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Careful follow - up of so - called " self - limited " Entityinsulin Entityedema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
0.9995 Adverse-Effect Careful follow - up of so - called " self - limited " Entityinsulin Entityinsulin edema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
0.4880 Adverse-Effect Careful follow - up of so - called " self - limited " Entityinsulin edema Entityedema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Entitymeningitis after using Entitytrimethoprim / sulfamethoxazole ( TMP / SMX ).
1.0000 Adverse-Effect We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Entitymeningitis after using trimethoprim / Entitysulfamethoxazole ( TMP / SMX ).
1.0000 Adverse-Effect We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Entitymeningitis after using trimethoprim / sulfamethoxazole ( TMP / EntitySMX ).
1.0000 Adverse-Effect We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Entitymeningitis after using trimethoprim / sulfamethoxazole ( EntityTMP / SMX ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report ( to our knowledge, for the first time in a child ) the emergence of Entitypsychosis in a 12 - year old white girl with an increased Entityefavirenz concentration and heterozygous gene polymorphism of the CYP2B6 - G516 T.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of a human immunodeficiency virus type 1 ( HIV - 1 ) - infected individual receiving combination antiretroviral therapy, which included ritonavir, who developed EntityCushing syndrome with profound complications after epidural Entitytriamcinolone injections.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Entityethambutol a nine - year - old boy developed Entitypolyarthritis , rash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
1.0000 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Entityethambutol a nine - year - old boy developed polyarthritis, Entityrash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
1.0000 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Entityethambutol a nine - year - old boy developed polyarthritis, rash and Entityhepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9999 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Entityethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with Entityanti - native DNA antibodies and positive antinuclear factor.
1.0000 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Entityrifampicin and ethambutol a nine - year - old boy developed Entitypolyarthritis , rash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9999 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Entityethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with anti - native DNA antibodies and Entitypositive antinuclear factor .
0.9999 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Entityrifampicin and ethambutol a nine - year - old boy developed polyarthritis, Entityrash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9999 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Entityrifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and Entityhepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9998 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Entityrifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with Entityanti - native DNA antibodies and positive antinuclear factor.
0.9998 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Entityrifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with anti - native DNA antibodies and Entitypositive antinuclear factor .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 43 - year - old woman who developed sore throat, swelling of the lips and oral cavity and Entitydysphagia , 2 weeks after the use of Entitybudesonide spray ( Budefat ) for treatment of bronchial asthma.
1.0000 Adverse-Effect We report a 43 - year - old woman who developed sore throat, swelling of the lips and oral cavity and Entitydysphagia , 2 weeks after the use of budesonide spray ( EntityBudefat ) for treatment of bronchial asthma.
1.0000 Adverse-Effect We report a 43 - year - old woman who developed Entitysore throat , swelling of the lips and oral cavity and dysphagia, 2 weeks after the use of Entitybudesonide spray ( Budefat ) for treatment of bronchial asthma.
1.0000 Adverse-Effect We report a 43 - year - old woman who developed sore throat, Entityswelling of the lips and oral cavity and dysphagia, 2 weeks after the use of Entitybudesonide spray ( Budefat ) for treatment of bronchial asthma.
0.9999 Adverse-Effect We report a 43 - year - old woman who developed Entitysore throat , swelling of the lips and oral cavity and dysphagia, 2 weeks after the use of budesonide spray ( EntityBudefat ) for treatment of bronchial asthma.
0.9998 Adverse-Effect We report a 43 - year - old woman who developed sore throat, Entityswelling of the lips and oral cavity and dysphagia, 2 weeks after the use of budesonide spray ( EntityBudefat ) for treatment of bronchial asthma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, in the mid - to - late 1980s, a series of letters to the editor and case reports announced an association between Entitytamoxifen therapy in women with breast cancer and the development of Entityendometrial carcinoma .
Score Relation Text (Head - Tail)
0.9967 Adverse-Effect We report a cae of Entityparanoid psychosis following use of a decongestant containing EntityPPA and summarize the case report literature of psychiatric adverse effects to PPA in which doses were known and stated to be within recommended guidelines.
0.4335 Adverse-Effect We report a cae of Entityparanoid psychosis following use of a decongestant containing PPA and summarize the case report literature of psychiatric adverse effects to EntityPPA in which doses were known and stated to be within recommended guidelines.
Adverse-Effect We report a cae of paranoid psychosis following use of a decongestant containing PPA and summarize the case report literature of Entitypsychiatric adverse effects to EntityPPA in which doses were known and stated to be within recommended guidelines.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To our knowledge, this is the first published case report of an adolescent girl with a mitochondrial disorder and depression who displayed both new - onset psychotic and Entityincreased mood symptoms during treatment with Entityrisperidone .
1.0000 Adverse-Effect OBJECTIVE : To our knowledge, this is the first published case report of an adolescent girl with a mitochondrial disorder and depression who displayed both new - onset Entitypsychotic and increased mood symptoms during treatment with Entityrisperidone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ten days after Entityitraconazole was started, he developed Entityparalytic ileus , neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
1.0000 Adverse-Effect Ten days after Entityitraconazole was started, he developed paralytic ileus, Entityneurogenic bladder , mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
1.0000 Adverse-Effect Ten days after Entityitraconazole was started, he developed paralytic ileus, neurogenic bladder, Entitymild left ptosis , and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
1.0000 Adverse-Effect Ten days after Entityitraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and Entityabsence of deep reflexes , with severe paralysis of the lower extremities and mild weakness of the upper extremities.
1.0000 Adverse-Effect Ten days after Entityitraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and Entitymild weakness of the upper extremities .
1.0000 Adverse-Effect Ten days after Entityitraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with Entitysevere paralysis of the lower extremities and mild weakness of the upper extremities.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Administration of intrathecal EntityAra - C in the same dose over longer intervals within 3 - 5 days between consecutive doses resulted in mild, transient neurological symptoms ( Entityparesthesias ) in only one of 30 patients so treated.
1.0000 Adverse-Effect Administration of intrathecal EntityAra - C in the same dose over longer intervals within 3 - 5 days between consecutive doses resulted in Entitymild, transient neurological symptoms ( paresthesias ) in only one of 30 patients so treated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving pegylated interferon alpha - 2a and Entityribavirin for 6 months, developed Entityprogressive malaise and anemia 6 months after the end of treatment.
0.9999 Adverse-Effect PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving pegylated interferon alpha - 2a and Entityribavirin for 6 months, developed progressive malaise and Entityanemia 6 months after the end of treatment.
0.9992 Adverse-Effect PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving Entitypegylated interferon alpha - 2a and ribavirin for 6 months, developed progressive malaise and Entityanemia 6 months after the end of treatment.
0.9992 Adverse-Effect PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving Entitypegylated interferon alpha - 2a and ribavirin for 6 months, developed Entityprogressive malaise and anemia 6 months after the end of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 46 - year - old African - American man experienced recurrent Entitygrand mal seizures during intravenous infusion of Entityamphotericin B , then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
1.0000 Adverse-Effect CASE SUMMARY : A 46 - year - old African - American man experienced Entityrecurrent grand mal seizures during intravenous infusion of Entityamphotericin B , then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
0.9836 Adverse-Effect CASE SUMMARY : A 46 - year - old African - American man experienced recurrent grand mal seizures during intravenous infusion of Entityamphotericin B , then Entitypetit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset short - of - breath, hemoptysis, and Entitysevere weakness , about 2 weeks after the administration of Entityleflunomide .
1.0000 Adverse-Effect We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset short - of - breath, Entityhemoptysis , and severe weakness, about 2 weeks after the administration of Entityleflunomide .
1.0000 Adverse-Effect We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset Entityshort - of - breath , hemoptysis, and severe weakness, about 2 weeks after the administration of Entityleflunomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week sulphasalazine syndrome ", a rare, but often fatal, Entityimmunoallergic reaction to Entitysulphasalazine .
0.9999 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week sulphasalazine syndrome ", a rare, but often Entityfatal , immunoallergic reaction to Entitysulphasalazine .
0.9972 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Entitysulphasalazine Entitysulphasalazine syndrome ", a rare, but often fatal, immunoallergic reaction to sulphasalazine.
0.9959 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Entitysulphasalazine syndrome ", a rare, but often Entityfatal , immunoallergic reaction to sulphasalazine.
0.9917 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Entitysulphasalazine syndrome ", a rare, but often fatal, Entityimmunoallergic reaction to sulphasalazine.
0.9910 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Entitysulphasalazine syndrome ", a rare, but often fatal, immunoallergic reaction to Entitysulphasalazine .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect After several unrevealing medical work - ups, he was found to have a Entityhigh blood lead level Entitylead level ( 122 microg / dL ) ; he has a history of scraping and sanding lead paint without adequate protective measures.
0.9950 Adverse-Effect After several unrevealing medical work - ups, he was found to have a Entityhigh blood lead level ( 122 microg / dL ) ; he has a history of scraping and sanding Entitylead paint without adequate protective measures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : The authors described a case of EntityHashimoto's disease during Entityinterferon - alpha ( IFN - alpha ) treatment for chronic viral C hepatitis in a patient with the specific genetic susceptibility associated with the thyroid disease.
0.9997 Adverse-Effect OBJECTIVES : The authors described a case of EntityHashimoto's disease during interferon - alpha ( EntityIFN - alpha ) treatment for chronic viral C hepatitis in a patient with the specific genetic susceptibility associated with the thyroid disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A high dose of Entitycotrimoxazole induced Entityhyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9999 Adverse-Effect A high dose of Entitycotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; Entityone patient became unconscious .
0.9999 Adverse-Effect A high dose of Entitycotrimoxazole induced hyperkalaemia with the Entityelevation of serum creatinine and blood urea , and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9999 Adverse-Effect A high dose of Entitycotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and Entityincreased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9999 Adverse-Effect A high dose of Entitycotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one Entitypatient became unconscious .
0.9999 Adverse-Effect A high dose of Entitycotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient Entitybecame unconscious .
0.9999 Adverse-Effect A high dose of Entitycotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became Entityunconscious .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on 7 patients ( 2 women, 5 men ) with chronic renal failure, who developed under a high dosage of the new diuretic Entitymuzolimine ( range 240 to 1440 mg per day ) Entityfatal neuromyeloencephalopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of fulminant adult respiratory distress syndrome ( EntityARDS ) associated with Entitypegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9998 Adverse-Effect We report the first case of fulminant Entityadult respiratory distress syndrome ( ARDS ) associated with Entitypegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9997 Adverse-Effect We report the first case of fulminant adult respiratory distress syndrome ( EntityARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and Entityribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9995 Adverse-Effect We report the first case of fulminant Entityadult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and Entityribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9995 Adverse-Effect We report the first case of fulminant adult respiratory distress syndrome ( EntityARDS ) associated with pegylated interferon alpha - 2a ( EntitypegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9990 Adverse-Effect We report the first case of fulminant Entityadult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( EntitypegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9998 Adverse-Effect We report the first case of Entityfulminant adult respiratory distress syndrome ( ARDS ) associated with Entitypegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9996 Adverse-Effect We report the first case of Entityfulminant adult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and Entityribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9992 Adverse-Effect We report the first case of Entityfulminant adult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( EntitypegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction ( IIR ), complicated 1 day later by Entitysevere swelling of the forearm and hand ipsilateral to the site of Entityinfliximab infusion.
0.9997 Adverse-Effect Here we describe a patient with Crohn's disease who developed a severe Entityinfliximab infusion reaction ( EntityIIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
0.9995 Adverse-Effect Here we describe a patient with Crohn's disease who developed a severe Entityinfliximab infusion reaction ( IIR ), complicated 1 day later by Entitysevere swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
0.9995 Adverse-Effect Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction ( EntityIIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of Entityinfliximab infusion.
Adverse-Effect Here we describe a patient with Crohn's disease who developed a Entitysevere infliximab infusion reaction Entityinfliximab infusion reaction ( IIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
Adverse-Effect Here we describe a patient with Crohn's disease who developed a Entitysevere infliximab infusion reaction ( IIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of Entityinfliximab infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, there remain questions concerning whether these drugs, especially methimazole ( EntityMMI ), may be associated with Entityaplasia cutis congenita ( ACC ) and how best to avoid impairment of fetal thyroid function during their use.
1.0000 Adverse-Effect However, there remain questions concerning whether these drugs, especially Entitymethimazole ( MMI ), may be associated with Entityaplasia cutis congenita ( ACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9999 Adverse-Effect However, there remain questions concerning whether these drugs, especially Entitymethimazole ( MMI ), may be associated with aplasia cutis congenita ( EntityACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9999 Adverse-Effect However, there remain questions concerning whether these drugs, especially methimazole ( EntityMMI ), may be associated with aplasia cutis congenita ( EntityACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9997 Adverse-Effect However, there remain questions concerning whether these drugs, especially Entitymethimazole ( MMI ), may be associated with aplasia cutis congenita ( ACC ) and how best to avoid Entityimpairment of fetal thyroid function during their use.
0.9996 Adverse-Effect However, there remain questions concerning whether these drugs, especially methimazole ( EntityMMI ), may be associated with aplasia cutis congenita ( ACC ) and how best to avoid Entityimpairment of fetal thyroid function during their use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 2, a 29 - year - old woman, developed bilateral optic neuritis combined with numbness of the lower extremities as well as Entitybowel and bladder dysfunction after a 22 - month use of Entityrecombinant interferon alpha - 2b for chronic myelogenous leukemia.
0.9998 Adverse-Effect Case 2, a 29 - year - old woman, developed bilateral optic neuritis combined with Entitynumbness of the lower extremities as well as bowel and bladder dysfunction after a 22 - month use of Entityrecombinant interferon alpha - 2b for chronic myelogenous leukemia.
0.9997 Adverse-Effect Case 2, a 29 - year - old woman, developed Entitybilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction after a 22 - month use of Entityrecombinant interferon alpha - 2b for chronic myelogenous leukemia.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect We report a case of a patient with mild chronic renal insufficiency who had been taking simvastatin for over a year and developed Entityacute weakness within 3 weeks after the start of treatment with Entitycolchicine for acute gouty bursitis.
0.9783 Adverse-Effect We report a case of a patient with mild chronic renal insufficiency who had been taking Entitysimvastatin for over a year and developed Entityacute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.
Adverse-Effect We report a case of a patient with Entitymild chronic renal insufficiency who had been taking Entitysimvastatin for over a year and developed acute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Entityepoprostenol , presented with Entityrapidly progressive erythema , scaling, nausea and vomiting, and fever.
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Entityepoprostenol , presented with rapidly progressive erythema, Entityscaling , nausea and vomiting, and fever.
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Entityepoprostenol , presented with rapidly progressive erythema, scaling, Entitynausea and vomiting, and fever.
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Entityepoprostenol , presented with rapidly progressive erythema, scaling, nausea and Entityvomiting , and fever.
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Entityepoprostenol , presented with rapidly progressive erythema, scaling, nausea and vomiting, and Entityfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : This case report showed that the clinical appearance of EntityHashimoto's disease after EntityIFN - alpha therapy for chronic C hepatitis in our patient was associated with a specific genetic predisposition ( DR5 ) for this pathology.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a patient with rheumatoid arthritis treated with low - dose Entitymethotrexate ( 15 mg / week ) who developed Entityinfection with both M. tuberculosis and M. chelonae after the revision of a prosthetic hip.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case histories are presented of two patients who developed lung disease associated with the use of Entitynitrofurantoin with histological features of Entitybronchiolitis obliterans organising pneumonia ( BOOP ), a rare but recognised form of drug induced injury.
1.0000 Adverse-Effect The case histories are presented of two patients who developed Entitylung disease associated with the use of Entitynitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia ( BOOP ), a rare but recognised form of drug induced injury.
1.0000 Adverse-Effect The case histories are presented of two patients who developed lung disease associated with the use of Entitynitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia ( EntityBOOP ), a rare but recognised form of drug induced injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A selective association between Entityfluoxetine and extensive, prominent Entityeye movements in nonrapid eye movement ( NREM ) sleep was detected, utilizing Fisher's exact one - tailed statistic ( p less than 0. 00001 for each comparison ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our findings suggest that Entityhyperkalemia can develop with the use of low - dose Entityheparin , within seven days of initiating heparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.
0.9998 Adverse-Effect Our findings suggest that Entityhyperkalemia can develop with the use of low - dose heparin, within seven days of initiating Entityheparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, weakness of the lower limbs, and Entityinflammatory reaction around dying cysticerci ) induced by Entitypraziquantel therapy, an event not described previously.
1.0000 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by Entitymyositis ( fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Entitypraziquantel therapy, an event not described previously.
1.0000 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, Entityweakness of the lower limbs , and inflammatory reaction around dying cysticerci ) induced by Entitypraziquantel therapy, an event not described previously.
0.9999 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by myositis ( Entityfever , diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Entitypraziquantel therapy, an event not described previously.
0.9999 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, Entitydiffuse myalgia , weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Entitypraziquantel therapy, an event not described previously.
0.9999 Adverse-Effect We describe a case of Entitydisseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Entitypraziquantel therapy, an event not described previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed Entityattacks of asthma when Entitycaptopril was added to the nadolol and dyazide treatment for his high blood pressure.
0.9997 Adverse-Effect A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed Entityattacks of asthma when captopril was added to the Entitynadolol and dyazide treatment for his high blood pressure.
0.9996 Adverse-Effect A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed Entityattacks of asthma when captopril was added to the nadolol and Entitydyazide treatment for his high blood pressure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of EntityMTX treatment a Entityprogressive visual loss and loss of consciousness which worsened during subsequent Ara - C treatment and led to death within 3 weeks.
0.9999 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and Entityloss of consciousness which worsened during subsequent EntityAra - C treatment and led to death within 3 weeks.
0.9999 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent EntityAra - C treatment and led to Entitydeath within 3 weeks.
0.9997 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a Entityprogressive visual loss and loss of consciousness which worsened during subsequent EntityAra - C treatment and led to death within 3 weeks.
0.9995 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of EntityMTX treatment a progressive visual loss and Entityloss of consciousness which worsened during subsequent Ara - C treatment and led to death within 3 weeks.
0.9990 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of EntityMTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent Ara - C treatment and led to Entitydeath within 3 weeks.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 32 - year - old man with a family history of type 2 diabetes mellitus presented with circulatory collapse and Entitydeep coma after 9 days of treatment with Entityperospirone hydrochloride , a recently developed atypical antipsychotic agent available only in Japan.
0.9999 Adverse-Effect A 32 - year - old man with a family history of type 2 diabetes mellitus presented with Entitycirculatory collapse and deep coma after 9 days of treatment with Entityperospirone hydrochloride , a recently developed atypical antipsychotic agent available only in Japan.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A woman with a 20 - year history of acral pustular psoriasis of Hallopeau and recurrent pustular lesions of the forearms and lower legs, developed a EntityB - cell lymphoma of the lip following 4 1 / 2 years of treatment with Entityrazoxane .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityFatal lung fibrosis caused by Entitypaclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.
0.9995 Adverse-Effect EntityFatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of Entitypaclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.
0.9995 Adverse-Effect EntityFatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of paclitaxel and Entitycarboplatin as combination chemotherapy for advanced ovarian cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since Entityimiquimod induces Entitylarge amounts of type I interferon production from TLR7 - expressing plasmacytoid dendritic cell precursors ( PDCs ), the natural interferon - producing cells of the peripheral blood, we asked whether PDCs are present in psoriatic skin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect As this relapse coincided with development of a strong delayed - type Entityhypersensitivity response to Entitytuberculin and improved after treatment with the anti - inflammatory agent oxpentifylline, it was probably caused by restoration of pathogen - specific cellular immunity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In view of our experience in the present case, it should be stressed that close monitoring of coagulation capacity is necessary in critically ill patients in order to avoid Entityfatal haemorrhage after initiating Entitywarfarin therapy regardless of the dosage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On day 4, following 3 doses of Entitydalteparin , the patient developed Entityacute respiratory distress attributable to a massive right hemothorax confirmed by computed tomography pulmonary angiography ( CTPA ) and intercostal drainage of 1500 mL of frank blood.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an 82 - year - old man who developed ventricular tachycardia and Torsades de Pointes ( EntityTdP ) after oral administration of Entitygarenoxacin , a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
1.0000 Adverse-Effect We report an 82 - year - old man who developed ventricular tachycardia and EntityTorsades de Pointes ( TdP ) after oral administration of Entitygarenoxacin , a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
0.9999 Adverse-Effect We report an 82 - year - old man who developed Entityventricular tachycardia and Torsades de Pointes ( TdP ) after oral administration of Entitygarenoxacin , a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After the dose of Entitymethylprednisolone was reduced from 40 mg to 20 mg i. v. q6h and shifted to other anti - asthma treatment by procaterol metered dose inhaler via spacer, the Entitypsychotic reaction disappeared a few hours later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cases are important in documenting that drug - induced dystonias do occur in patients with dementia, that Entityrisperidone appears to have contributed to Entitydystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.
0.9965 Adverse-Effect The cases are important in documenting that drug - induced Entitydystonias do occur in patients with dementia, that Entityrisperidone appears to have contributed to dystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He was started on oral Entitylansoprazole 60 mg twice daily and, on hospital day 2, his Entityplatelet count decreased to 102 x 10 ( 3 ) / mm ( 3 ) ; on hospital day 3, the platelet count was 36 x 10 ( 3 ) / mm ( 3 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we present the case of a woman who received high doses of Entitymethylprednisolone ( 1 g iv daily ) for active Graves'ophthalmopathy, and developed Entitysevere hypertension followed by myocardial infarction on the fifth day of treatment.
0.9999 Adverse-Effect Here we present the case of a woman who received high doses of Entitymethylprednisolone ( 1 g iv daily ) for active Graves'ophthalmopathy, and developed severe hypertension followed by Entitymyocardial infarction on the fifth day of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on three cases wherein treatment of Entitydexmedetomidine - induced Entitybradycardia with i. v. glycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.
0.9997 Adverse-Effect We report on three cases wherein treatment of dexmedetomidine - induced bradycardia with i. v. Entityglycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an Entityexaggerated increase of arterial blood pressure .
0.9837 Adverse-Effect We report on three cases wherein treatment of Entitydexmedetomidine - induced bradycardia with i. v. glycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an Entityexaggerated increase of arterial blood pressure .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect While the introduction of carmustine wafers ( EntityGliadel wafers ) into the tumor resection cavity has been shown to be a beneficial therapy for malignant glioma, it is recognized that clinically significant Entitycerebral edema is a potential adverse effect.
0.9996 Adverse-Effect While the introduction of Entitycarmustine wafers ( Gliadel wafers ) into the tumor resection cavity has been shown to be a beneficial therapy for malignant glioma, it is recognized that clinically significant Entitycerebral edema is a potential adverse effect.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CASE REPORT : We present a case of a 28 - yr - old male who developed a severe case of Entitynephrotic syndrome while being treated for relapsing / remitting Multiple Sclerosis ( RRMS ) with weekly injections of Entityinterferon beta 1a .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of ST elevation in right precordial leads compatible with Entitytype 1 Brugada syndrome following administration of Entitypropafenone in a patient with Wolff - Parkinson - White syndrome who was receiving lithium at concentrations within therapeutic levels.
0.9996 Adverse-Effect We report a case of EntityST elevation in right precordial leads compatible with type 1 Brugada syndrome following administration of Entitypropafenone in a patient with Wolff - Parkinson - White syndrome who was receiving lithium at concentrations within therapeutic levels.
0.9979 Adverse-Effect We report a case of ST elevation in right precordial leads compatible with Entitytype 1 Brugada syndrome following administration of propafenone in a patient with Wolff - Parkinson - White syndrome who was receiving Entitylithium at concentrations within therapeutic levels.
0.9973 Adverse-Effect We report a case of EntityST elevation in right precordial leads compatible with type 1 Brugada syndrome following administration of propafenone in a patient with Wolff - Parkinson - White syndrome who was receiving Entitylithium at concentrations within therapeutic levels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of acute pancreatitis ( EntityAP ) occurring in a patient under treatment with Entitycarbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
1.0000 Adverse-Effect The authors report a case of Entityacute pancreatitis ( AP ) occurring in a patient under treatment with Entitycarbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
1.0000 Adverse-Effect The authors report a case of acute pancreatitis ( EntityAP ) occurring in a patient under treatment with carbamazepine ( EntityCBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
0.9999 Adverse-Effect The authors report a case of Entityacute pancreatitis ( AP ) occurring in a patient under treatment with carbamazepine ( EntityCBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
Adverse-Effect The authors report a case of acute Entitypancreatitis ( AP ) occurring in a patient under treatment with Entitycarbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
Adverse-Effect The authors report a case of acute Entitypancreatitis ( AP ) occurring in a patient under treatment with carbamazepine ( EntityCBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course : 3 of these patients Entitydied of PCP occurring during the first month of treatment with Entityprednisone .
1.0000 Adverse-Effect These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course : 3 of these patients died of EntityPCP occurring during the first month of treatment with Entityprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A small initial dose of prazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and Entitysevere drop in blood pressure after the administration of the first dose of Entityprazosin .
0.9998 Adverse-Effect A small initial dose of Entityprazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and Entitysevere drop in blood pressure after the administration of the first dose of prazosin.
1.0000 Adverse-Effect A small initial dose of prazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and severe Entitydrop in blood pressure after the administration of the first dose of Entityprazosin .
0.9997 Adverse-Effect A small initial dose of Entityprazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and severe Entitydrop in blood pressure after the administration of the first dose of prazosin.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In a postural challenge test after administration of Entityisosorbide dinitrate ( 5 mg ), Entityblood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by syncope with a sudden decrease in pulse rate from 85 to 60 beats / min.
0.9997 Adverse-Effect In a postural challenge test after administration of Entityisosorbide dinitrate ( 5 mg ), blood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by Entitysyncope with a sudden decrease in pulse rate from 85 to 60 beats / min.
0.9996 Adverse-Effect In a postural challenge test after administration of Entityisosorbide dinitrate ( 5 mg ), blood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by syncope with a Entitysudden decrease in pulse rate from 85 to 60 beats / min.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of Entitydiarrhea and Entityclindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
1.0000 Adverse-Effect CONCLUSIONS : This report indicates Entityclindamycin phosphate vaginal cream as the most probable cause of EntityCDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9999 Adverse-Effect CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and Entityclindamycin administration, lack of concomitant medications, and documentation of EntityC. difficile toxin .
0.9998 Adverse-Effect CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of EntityCDIC due to the temporal relationship between the occurrence of diarrhea and Entityclindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9997 Adverse-Effect CONCLUSIONS : This report indicates Entityclindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of Entitydiarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9990 Adverse-Effect CONCLUSIONS : This report indicates Entityclindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of EntityC. difficile toxin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : EntityAmphotericin B deoxycholate has been reported to produce significant Entitycardiac toxicity , with ventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
0.9997 Adverse-Effect DISCUSSION : EntityAmphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with ventricular arrhythmias and Entitybradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
0.9997 Adverse-Effect DISCUSSION : EntityAmphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with Entityventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report suggests that Entityanemia can occur due to EntityMMF , in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and prednisone is used.
0.9996 Adverse-Effect This report suggests that Entityanemia can occur due to MMF, in particular when it is given with Entityprednisone , a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and prednisone is used.
0.9994 Adverse-Effect This report suggests that Entityanemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, Entitycyclosporine and prednisone is used.
0.9992 Adverse-Effect This report suggests that Entityanemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of EntityMMF , cyclosporine and prednisone is used.
0.9992 Adverse-Effect This report suggests that Entityanemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and Entityprednisone is used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, myalgia, and Entityleg weakness , shortly after starting treatment with Entitycolchicine .
1.0000 Adverse-Effect A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, Entitymyalgia , and leg weakness, shortly after starting treatment with Entitycolchicine .
1.0000 Adverse-Effect A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of Entityfatigue , myalgia, and leg weakness, shortly after starting treatment with Entitycolchicine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, hearing impairment in the left ear ( with progression to the right ear ), and Entityvertigo developed after 3 years of therapy with EntityPTU .
1.0000 Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, Entitytinnitus , hearing impairment in the left ear ( with progression to the right ear ), and vertigo developed after 3 years of therapy with EntityPTU .
1.0000 Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, hearing impairment in the left ear ( with Entityprogression to the right ear ), and vertigo developed after 3 years of therapy with EntityPTU .
0.9999 Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, Entityhearing impairment in the left ear ( with progression to the right ear ), and vertigo developed after 3 years of therapy with EntityPTU .
Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, Entityhearing impairment in the left ear ( with progression to the right ear ) , and vertigo developed after 3 years of therapy with EntityPTU .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case is remarkable since 1 ) ECM developed after subcutaneous and not after intramuscular injection, 2 ) the injection was given by the patient himself, and 3 ) Entityglatiramer acetate can induce Entityskin necrosis as a side effect.
0.9986 Adverse-Effect This case is remarkable since 1 ) EntityECM developed after subcutaneous and not after intramuscular injection, 2 ) the injection was given by the patient himself, and 3 ) Entityglatiramer acetate can induce skin necrosis as a side effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Subsequent in vivo / vitro studies clearly demonstrated that the Entityneurological effects were due to a synergistic action of Entitydesferrioxamine and prochlorperazine, probably resulting in exceptional fluxes of intra / extra cellular iron / copper disturbing noradrenergic and serotonergic systems.
0.9999 Adverse-Effect Subsequent in vivo / vitro studies clearly demonstrated that the Entityneurological effects were due to a synergistic action of desferrioxamine and Entityprochlorperazine , probably resulting in exceptional fluxes of intra / extra cellular iron / copper disturbing noradrenergic and serotonergic systems.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom Entityinfliximab therapy was associated with Entityperipheral neuropathy due to necrotizing vasculitis in one patient and to progression of preexisting mononeuritis multiplex in the other.
0.9999 Adverse-Effect We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom Entityinfliximab therapy was associated with peripheral neuropathy due to Entitynecrotizing vasculitis in one patient and to progression of preexisting mononeuritis multiplex in the other.
0.9999 Adverse-Effect We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom Entityinfliximab therapy was associated with peripheral neuropathy due to necrotizing vasculitis in one patient and to Entityprogression of preexisting mononeuritis multiplex in the other.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityMI related to the use of activated and non - activated EntityPCCs predominantly affects young patients who often have no preceding history of, or risk factors for, MI and tends to be associated with large cumulative doses of concentrate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a 56 - year - old female who exhibited drug refractory paroxysmal atrial fibrillation, in which marked prolongation of the QT interval and EntityT wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral Entitypirmenol therapy.
1.0000 Adverse-Effect We report on a 56 - year - old female who exhibited drug refractory paroxysmal atrial fibrillation, in which marked Entityprolongation of the QT interval and T wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral Entitypirmenol therapy.
0.9999 Adverse-Effect We report on a 56 - year - old female who exhibited Entitydrug refractory paroxysmal atrial fibrillation , in which marked prolongation of the QT interval and T wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral Entitypirmenol therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case of Entitylinezolid - associated Entityacute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9997 Adverse-Effect This case of linezolid - associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( EntityDRESS ) syndrome in a patient treated with Entitylinezolid raises concerns about the presumed renal safety of this drug.
0.9989 Adverse-Effect This case of linezolid - associated acute interstitial nephritis within the context of a Entitydrug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with Entitylinezolid raises concerns about the presumed renal safety of this drug.
0.9988 Adverse-Effect This case of Entitylinezolid - associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( EntityDRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9988 Adverse-Effect This case of Entitylinezolid - associated acute interstitial nephritis within the context of a Entitydrug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9954 Adverse-Effect This case of linezolid - associated Entityacute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with Entitylinezolid raises concerns about the presumed renal safety of this drug.
Score Relation Text (Head - Tail)
0.9983 Adverse-Effect INTRODUCTION : Although Entitygefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of Entityinterstitial lung disease ( ILD ), few case reports on erlotinib - induced ILD have been issued.
0.9949 Adverse-Effect INTRODUCTION : Although Entitygefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( EntityILD ), few case reports on erlotinib - induced ILD have been issued.
0.9931 Adverse-Effect INTRODUCTION : Although gefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( ILD ), few case reports on Entityerlotinib - induced EntityILD have been issued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A 44 - year - old man taking naproxen for chronic low back pain and a 20 - year - old woman on Entityoxaprozin for rheumatoid arthritis presented with Entitytense bullae and cutaneous fragility on the face and the back of the hands.
0.9999 Adverse-Effect RESULTS : A 44 - year - old man taking naproxen for chronic low back pain and a 20 - year - old woman on Entityoxaprozin for rheumatoid arthritis presented with tense bullae and Entitycutaneous fragility on the face and the back of the hands.
0.9994 Adverse-Effect RESULTS : A 44 - year - old man taking Entitynaproxen for chronic low back pain and a 20 - year - old woman on oxaprozin for rheumatoid arthritis presented with Entitytense bullae and cutaneous fragility on the face and the back of the hands.
0.9991 Adverse-Effect RESULTS : A 44 - year - old man taking Entitynaproxen for chronic low back pain and a 20 - year - old woman on oxaprozin for rheumatoid arthritis presented with tense bullae and Entitycutaneous fragility on the face and the back of the hands.
Score Relation Text (Head - Tail)
0.9979 Adverse-Effect The patient's previous rash and the temporal relation of this event and the ingestion of phenolphthalein, as well as the similarity of this case to other reports, point to Entityphenolphthalein as the cause of EntityTEN in this patient.
0.9892 Adverse-Effect The patient's previous Entityrash and the temporal relation of this event and the ingestion of Entityphenolphthalein , as well as the similarity of this case to other reports, point to phenolphthalein as the cause of TEN in this patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case history confirms that Entitygold treatment, even in the same patient, can give rise to a wide range of Entityskin disturbances , which in many cases do not break out until long after the drug has been withdrawn.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient receiving Entityvancomycin for a serious staphylococcal infection had a Entitylupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
1.0000 Adverse-Effect A patient receiving Entityvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a Entitymalar rash , pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
1.0000 Adverse-Effect A patient receiving Entityvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and Entityerythema of the cartilage of both ears , and tender erythematous and hemorrhagic lesions of the finger tips.
0.9999 Adverse-Effect A patient receiving Entityvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and Entityhemorrhagic lesions of the finger tips .
0.9999 Adverse-Effect A patient receiving Entityvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, Entitypain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
0.9999 Adverse-Effect A patient receiving Entityvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and Entitytender erythematous and hemorrhagic lesions of the finger tips.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Because the combination of Entitybleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Kaposi's sarcoma, clinicians should be aware of the risk of provoking acral necrosis in patients who develop EntityRaynaud's phenomenon under chemotherapy.
0.9997 Adverse-Effect Because the combination of Entitybleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Kaposi's sarcoma, clinicians should be aware of the risk of provoking Entityacral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.
0.9999 Adverse-Effect Because the combination of Entitybleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related EntityKaposi's sarcoma , clinicians should be aware of the risk of provoking acral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.
Score Relation Text (Head - Tail)
Adverse-Effect Methotrexate ( MTX ) is a commonly used second line agent for RA, and there have been several recent reports of EntityEpstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in EntityMTX - treated RA patients.
Adverse-Effect Methotrexate ( EntityMTX ) is a commonly used second line agent for RA, and there have been several recent reports of EntityEpstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in MTX - treated RA patients.
Adverse-Effect EntityMethotrexate ( MTX ) is a commonly used second line agent for RA, and there have been several recent reports of EntityEpstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in MTX - treated RA patients.
Score Relation Text (Head - Tail)
0.9977 Adverse-Effect We present a case of acute Entityepinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed Entitysevere allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.9871 Adverse-Effect We present a case of acute epinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed Entitysevere allergic reaction to intravenous immunoglobulin, and was subsequently given Entityepinephrine by mistake intravenously rather than subcutaneously.
0.9862 Adverse-Effect We present a case of acute Entityepinephrine toxicity resulting in Entityacute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.9974 Adverse-Effect We present a case of acute Entityepinephrine Entityepinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.7901 Adverse-Effect We present a case of acute epinephrine toxicity resulting in Entityacute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given Entityepinephrine by mistake intravenously rather than subcutaneously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a myeloma patient who developed Entitysevere paralytic ileus during Entitybortezomib therapy, which presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation, suggesting a direct causal relationship.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Entityamiodarone - induced Entitydestructive thyroiditis , as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
0.9985 Adverse-Effect These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Entityamiodarone - induced destructive thyroiditis, as reported in patients with Entitydestructive thyroiditis , such as subacute and silent thyroiditis.
0.9972 Adverse-Effect These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Entityamiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent Entitythyroiditis .
0.9981 Adverse-Effect These in vitro findings and clinical course suggest that EntityTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced Entitydestructive thyroiditis , as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
0.9976 Adverse-Effect These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Entityamiodarone - induced destructive thyroiditis, as reported in patients with destructive Entitythyroiditis , such as subacute and silent thyroiditis.
0.9940 Adverse-Effect These in vitro findings and clinical course suggest that EntityTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with Entitydestructive thyroiditis , such as subacute and silent thyroiditis.
0.9902 Adverse-Effect These in vitro findings and clinical course suggest that EntityTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with destructive Entitythyroiditis , such as subacute and silent thyroiditis.
0.9900 Adverse-Effect These in vitro findings and clinical course suggest that EntityTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent Entitythyroiditis .
Adverse-Effect These in vitro findings and clinical course suggest that EntityTRAb / TBII without thyroid - stimulating activity may develop in patients with Entityamiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Entity5 - ASA ), his skin eruptions were resolved, however, he developed Entityweakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9998 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Entity5 - ASA ), his skin eruptions were resolved, however, he developed weakness and Entityatrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9995 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Entity5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive Entityworsening of the dysesthesia in his legs and gait disturbance.
0.9995 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Entity5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and Entitygait disturbance .
0.9995 Adverse-Effect When SASP was changed to Entity5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed Entityweakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9994 Adverse-Effect When SASP was changed to Entity5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and Entityatrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9987 Adverse-Effect When SASP was changed to Entity5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive Entityworsening of the dysesthesia in his legs and gait disturbance.
0.9987 Adverse-Effect When SASP was changed to Entity5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and Entitygait disturbance .
0.9999 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Entity5 - ASA ), his Entityskin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9995 Adverse-Effect When EntitySASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed Entityweakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9994 Adverse-Effect When EntitySASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his Entityskin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9994 Adverse-Effect When EntitySASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and Entityatrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9993 Adverse-Effect When SASP was changed to Entity5 - aminosalicylic acid ( 5 - ASA ), his Entityskin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9987 Adverse-Effect When EntitySASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive Entityworsening of the dysesthesia in his legs and gait disturbance.
0.9987 Adverse-Effect When EntitySASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and Entitygait disturbance .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : Soon after initiation of Entityamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of Entityvisual " shining , " glare, color vision anomalies, and gradually decreased vision.
0.9998 Adverse-Effect CASE REPORT : Soon after initiation of Entityamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " Entityglare , color vision anomalies, and gradually decreased vision.
0.9997 Adverse-Effect CASE REPORT : Soon after initiation of Entityamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " glare, Entitycolor vision anomalies , and gradually decreased vision.
0.9996 Adverse-Effect CASE REPORT : Soon after initiation of Entityamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " glare, color vision anomalies, and gradually Entitydecreased vision .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mechanism of the Entitydecrease in plasma potassium induced by Entityphosphate treatment was investigated in a 24 - year - old hypertensive patient with hypophosphatemic osteomalacia, who was the youngest of four patients, belonging to a 23 number kindred of five generations.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 16 - year - old white male with acute biphenotypic leukemia developed evidence of the Entityeosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing Entitytryptophan , which were given during his initial induction chemotherapy and also after autologous marrow transplantation.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Subsequently, he developed Entityhyperglycemia ( fasting blood glucose 138 mg / dL ) that resolved when Entityolanzapine was stopped and recurred ( fasting blood glucose 150 mg / dL ) after 2 days of rechallenge with olanzapine 2. 5 mg twice daily.
0.9994 Adverse-Effect Subsequently, he developed Entityhyperglycemia ( fasting blood glucose 138 mg / dL ) that resolved when olanzapine was stopped and recurred ( fasting blood glucose 150 mg / dL ) after 2 days of rechallenge with Entityolanzapine 2. 5 mg twice daily.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The potential development of SJS / EntityTEN , a severe life - threatening illness, emphasizes the need for judicious use of EntityTMP - Sx and close monitoring and follow - up for patients who were given TMP - Sx for SSTIs.
0.9999 Adverse-Effect The potential development of EntitySJS / TEN, a severe life - threatening illness, emphasizes the need for judicious use of EntityTMP - Sx and close monitoring and follow - up for patients who were given TMP - Sx for SSTIs.
0.9997 Adverse-Effect The potential development of SJS / EntityTEN , a severe life - threatening illness, emphasizes the need for judicious use of TMP - Sx and close monitoring and follow - up for patients who were given EntityTMP - Sx for SSTIs.
0.9996 Adverse-Effect The potential development of EntitySJS / TEN, a severe life - threatening illness, emphasizes the need for judicious use of TMP - Sx and close monitoring and follow - up for patients who were given EntityTMP - Sx for SSTIs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with type 2 diabetes mellitus who, while treated with the antitumor necrosis factor - alpha blocking agent Entityetanercept for severe plaque psoriasis, experienced Entitypersistent hypoglycemia requiring the lowering and eventual elimination of his previous insulin regimen.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Case 1, a 62 - year - old woman, developed bilateral optic neuritis with decreased sensation of vibration and Entityincreased deep tendon reflex in the lower extremities after a seven - month use of Entityrecombinant interferon alpha - 2a for chronic active hepatitis C.
0.9998 Adverse-Effect Case 1, a 62 - year - old woman, developed Entitybilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven - month use of Entityrecombinant interferon alpha - 2a for chronic active hepatitis C.
0.9997 Adverse-Effect Case 1, a 62 - year - old woman, developed bilateral optic neuritis with Entitydecreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven - month use of Entityrecombinant interferon alpha - 2a for chronic active hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In all cases, drugs in addition to quetiapine were detected, but in cases # 1 and # 2, the cause of Entitydeath was considered to be a Entityquetiapine overdose and the other drugs were not considered to be contributory.
0.9997 Adverse-Effect In all cases, drugs in addition to Entityquetiapine were detected, but in cases # 1 and # 2, the cause of Entitydeath was considered to be a quetiapine overdose and the other drugs were not considered to be contributory.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Of particular interest in this patient is the Entityfluctuation of the QT interval at a stable dose of Entitymethadone , suggesting that a single normal electrocardiogram ( ECG ) does not guarantee that the patient is not at risk of ventricular arrhythmias.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityEthambutol is frequently used in the treatment of tuberculosis, and, although Entityoptic neuropathies have been reported with the use of ethambutol, this adverse side effect has been considered to be rare and generally reversible with discontinuation of the medication.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The authors suggest that in the absence of any proven benefit of itraconazole prophylaxis, and given the interaction of this drug with Entityvincristine leading to severe and even potentially Entityfatal toxicities , the combination use of these drugs should be avoided.
0.9996 Adverse-Effect The authors suggest that in the absence of any proven benefit of Entityitraconazole prophylaxis, and given the interaction of this drug with vincristine leading to severe and even potentially Entityfatal toxicities , the combination use of these drugs should be avoided.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Two 65 - year - old white men with coronary heart disease, given Entityniacin therapy for dyslipidemia for 5 months, developed Entityintense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment.
0.9998 Adverse-Effect Two 65 - year - old white men with coronary heart disease, given niacin therapy for dyslipidemia for 5 months, developed Entityintense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of Entityniacin treatment.
0.9997 Adverse-Effect Two 65 - year - old white men with coronary heart disease, given niacin therapy for dyslipidemia for 5 months, developed intense Entitydental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of Entityniacin treatment.
0.9995 Adverse-Effect Two 65 - year - old white men with coronary heart disease, given Entityniacin therapy for dyslipidemia for 5 months, developed intense Entitydental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related Entityhemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of Entitycisplatin , bleomycin, and methotrexate.
1.0000 Adverse-Effect A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related Entityhemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, Entitybleomycin , and methotrexate.
0.9999 Adverse-Effect A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related Entityhemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Entityskeletal fluorosis induced by prolonged treatment with Entityniflumic acid , a fast - acting non - steroid antiinflammatory agent, is reported in a 35 - year - old woman suffering from rheumatoid arthritis and treated, in addition, with corticosteroids.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : growth deficiency, Entitydevelopmental delay , craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
1.0000 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, Entitycraniosynostosis , blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
1.0000 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, Entityflat nasal bridge , abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
1.0000 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, Entityblepharophimosis , flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
0.9999 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including Entityhypoplastic thumbs and oligodactyly.
0.9999 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and Entitydistal limb defects including hypoplastic thumbs and oligodactyly.
0.9999 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and Entityoligodactyly .
1.0000 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : Entitygrowth deficiency , developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
1.0000 Adverse-Effect The reported cases of in utero exposure to Entitycyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, Entityabnormal ears , and distal limb defects including hypoplastic thumbs and oligodactyly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Seven of the eight cases of Entityacute leukemia occurred in a series of 553 patients treated with EntityTreosulfan for ovarian cancer in the period from 1970 to 1977 and followed closely for a total of 1159 patient - years up to February 1978.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, while cases of loop diuretic - induced Entitypancreatitis , including Entityfurosemide , have been published, the allergic manifestations with both sulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
1.0000 Adverse-Effect In addition, while cases of loop diuretic - induced pancreatitis, including furosemide, have been published, the Entityallergic manifestations with both Entitysulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
0.9958 Adverse-Effect In addition, while cases of loop diuretic - induced pancreatitis, including Entityfurosemide , have been published, the Entityallergic manifestations with both sulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
0.9643 Adverse-Effect In addition, while cases of loop diuretic - induced Entitypancreatitis , including furosemide, have been published, the allergic manifestations with both Entitysulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cause of these previously unreported side effects of Entityniacin therapy is uncertain but may be related to Entityprostaglandin - mediated vasodilatation , hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of pain to the teeth.
1.0000 Adverse-Effect The cause of these previously unreported side effects of Entityniacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of Entitypain to the teeth .
0.9999 Adverse-Effect The cause of these previously unreported side effects of Entityniacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, Entityhyperalgesia of sensory nerve receptors , and potentiation of inflammation in the gingiva with referral of pain to the teeth.
0.9999 Adverse-Effect The cause of these previously unreported side effects of Entityniacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, hyperalgesia of sensory nerve receptors, and Entitypotentiation of inflammation in the gingiva with referral of pain to the teeth.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To document a case of serotonin syndrome ( EntitySS ) associated with Entitymirtazapine monotherapy, review the previously reported cases of SS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
1.0000 Adverse-Effect OBJECTIVE : To document a case of Entityserotonin syndrome ( SS ) associated with Entitymirtazapine monotherapy, review the previously reported cases of SS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
0.9981 Adverse-Effect OBJECTIVE : To document a case of serotonin syndrome ( SS ) associated with Entitymirtazapine monotherapy, review the previously reported cases of EntitySS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A variety of Entitymovement disorders are known to occur in association with Entitycarbamazepine ( CBZ ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
1.0000 Adverse-Effect A variety of movement disorders are known to occur in association with carbamazepine ( EntityCBZ ) therapy in adults and children, but development of Entitytics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
0.9999 Adverse-Effect A variety of movement disorders are known to occur in association with Entitycarbamazepine ( CBZ ) therapy in adults and children, but development of Entitytics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
0.9999 Adverse-Effect A variety of Entitymovement disorders are known to occur in association with carbamazepine ( EntityCBZ ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although the two local anesthetics usually do not cause methemoglobinemia, we suspect that the displacement of Entitylidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of Entitymethemoglobinemia .
0.9986 Adverse-Effect Although the two local anesthetics usually do not cause Entitymethemoglobinemia , we suspect that the displacement of Entitylidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of methemoglobinemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Entitypancytopenia 48 months postchemotherapy with Entityetoposide , prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Entitypancytopenia 48 months postchemotherapy with etoposide, Entityprednisone , vincristine, cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Entitypancytopenia 48 months postchemotherapy with etoposide, prednisone, Entityvincristine , cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Entitypancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, Entitycyclophosphamide , doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Entitypancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, Entitydoxorubicin , and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Entitypancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and Entityrituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.9990 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Entitypancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab ( EntityR - EPOCH ) for diffuse large B - cell lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report five cases of carboplatin ( CBDCA ) Entityhypersensitivity after weekly low - dose Entitypaclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
1.0000 Adverse-Effect We report five cases of carboplatin ( EntityCBDCA ) Entityhypersensitivity after weekly low - dose paclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
0.9984 Adverse-Effect We report five cases of Entitycarboplatin ( CBDCA ) Entityhypersensitivity after weekly low - dose paclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, we recently saw two patients with renal tuberculosis treated with Entityethambutol in whom Entityvisual loss from toxic optic neuropathies was severe and irreversible despite careful ophthalmological monitoring and prompt discontinuation of the agent at the first sign of impaired visual function.
0.9999 Adverse-Effect However, we recently saw two patients with renal tuberculosis treated with Entityethambutol in whom visual loss from Entitytoxic optic neuropathies was severe and irreversible despite careful ophthalmological monitoring and prompt discontinuation of the agent at the first sign of impaired visual function.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The aim of this paper is to report the case of Entityrosaceiform eruption induced by Entityerlotinib in an 81 - year - old - man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Recently, her serum Entitytheophylline Entitytheophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9996 Adverse-Effect Recently, her serum Entitytheophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Entityzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9987 Adverse-Effect Recently, her serum Entitytheophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( EntityAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum Entitytheophylline Entitylevels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum Entitytheophylline levels Entityhad increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum theophylline Entitylevels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Entityzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum theophylline levels Entityhad increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Entityzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum theophylline levels had Entityincreased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Entityzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9999 Adverse-Effect Recently, her serum Entitytheophylline levels had Entityincreased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9999 Adverse-Effect Recently, her serum theophylline Entitylevels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( EntityAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9999 Adverse-Effect Recently, her serum theophylline levels Entityhad increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( EntityAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9999 Adverse-Effect Recently, her serum theophylline levels had Entityincreased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( EntityAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The current report describes a man who was prescribed Entityzonisamide for epilepsy and subsequently developed widespread Entityskin rash , acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Entityzonisamide for epilepsy and subsequently developed widespread skin rash, Entityacute kidney injury , high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Entityzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, Entityhigh - grade fever , eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Entityzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, Entityeosinophilia , liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Entityzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, Entitylymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Entityzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, Entityliver dysfunction , lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.9999 Adverse-Effect The current report describes a man who was prescribed Entityzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 Entityimmunoglobulin G titer .
Adverse-Effect The current report describes a man who was prescribed Entityzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and Entityan increase in antihuman herpesvirus - 6 immunoglobulin G titer .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityOxcarbazepine - associated Entityangioedema manifested by swelling of the face, eyes, lips, or tongue or difficulty swallowing or breathing ( or both ) is a rare but potentially life - threatening reaction for which early recognition and management are vital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We describe here a case of a 60 year old female that experienced a relapse of Entitysymptomatic hyperlactatemia after being switched from Entitystavudine to zidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.
0.9999 Adverse-Effect CASE REPORT : We describe here a case of a 60 year old female that experienced a relapse of Entitysymptomatic hyperlactatemia after being switched from stavudine to Entityzidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect CONCLUSIONS : SD - OCT and AO detected abnormalities that correlate topographically with visual field loss from Entityhydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or Entityobjective visual field loss .
0.9992 Adverse-Effect CONCLUSIONS : SD - OCT and AO detected abnormalities that correlate topographically with Entityvisual field loss from Entityhydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.
0.9987 Adverse-Effect CONCLUSIONS : SD - OCT and AO detected Entityabnormalities that correlate topographically with visual field loss from Entityhydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed severe skin rash and Entitybone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 Entitymethotrexate ( MTX ).
1.0000 Adverse-Effect A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed Entitysevere skin rash and bone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 Entitymethotrexate ( MTX ).
1.0000 Adverse-Effect A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed severe skin rash and Entitybone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 methotrexate ( EntityMTX ).
0.9999 Adverse-Effect A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed Entitysevere skin rash and bone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 methotrexate ( EntityMTX ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical course suggested that recombinant alpha - 2b peginterferon plus Entityribavirin provoked Entitytype 1 diabetes mellitus , therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
0.9997 Adverse-Effect The clinical course suggested that Entityrecombinant alpha - 2b peginterferon plus ribavirin provoked Entitytype 1 diabetes mellitus , therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
0.9997 Adverse-Effect The clinical course suggested that recombinant Entityalpha - 2b peginterferon plus ribavirin provoked Entitytype 1 diabetes mellitus , therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An episode of Entityleukoencephalopathy is reported in a 13 - year - old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4 - hour infusion of 500 mg / m2 Entitymethotrexate and 12 mg intrathecal methotrexate.
0.9999 Adverse-Effect An episode of Entityleukoencephalopathy is reported in a 13 - year - old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4 - hour infusion of 500 mg / m2 methotrexate and 12 mg intrathecal Entitymethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, one patient who developed Entitygangrene after Entitybleomycin and vincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9999 Adverse-Effect In this report, one patient who developed Entitygangrene after bleomycin and Entityvincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9999 Adverse-Effect In this report, one patient who developed Entitygangrene after bleomycin and vincristine / Entityvinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9997 Adverse-Effect In this report, one patient who developed gangrene after bleomycin and vincristine / Entityvinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of Entitysevere Raynaud's phenomenon related to the same regimen are presented.
0.9994 Adverse-Effect In this report, one patient who developed gangrene after bleomycin and Entityvincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of Entitysevere Raynaud's phenomenon related to the same regimen are presented.
0.9993 Adverse-Effect In this report, one patient who developed gangrene after Entitybleomycin and vincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of Entitysevere Raynaud's phenomenon related to the same regimen are presented.
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had gained weight and developed Entityamenorrhea while being treated with Entityvalproate lost weight and resumed menstruating after the change in medication.
0.9909 Adverse-Effect The Entitypolycystic changes disappeared from the ovaries in 2 of the women after Entityvalproate therapy was discontinued, and the 2 women who had gained weight and developed amenorrhea while being treated with valproate lost weight and resumed menstruating after the change in medication.
Adverse-Effect The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had Entitygained weight and developed amenorrhea while being treated with Entityvalproate lost weight and resumed menstruating after the change in medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Entityrisperidone had an initial good response to the medication followed by development of Entityintolerable affect , including feelings of agitation and depression and periods of crying and insomnia.
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Entityrisperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and Entityinsomnia .
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Entityrisperidone had an initial good response to the medication followed by development of intolerable affect, including Entityfeelings of agitation and depression and periods of crying and insomnia.
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Entityrisperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and Entitydepression and periods of crying and insomnia.
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Entityrisperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and Entityperiods of crying and insomnia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of drug - induced EntityKaposi's sarcoma ( KS ) on the sole of the right foot in a 71 - year - old man, treated for 6 months with corticosteroid therapy ( Entityprednisolone 25 mg / day ) for pericardial effusion.
1.0000 Adverse-Effect We report a case of drug - induced Kaposi's sarcoma ( EntityKS ) on the sole of the right foot in a 71 - year - old man, treated for 6 months with corticosteroid therapy ( Entityprednisolone 25 mg / day ) for pericardial effusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and Entityazathioprine , developed Entitythrombosis of the central retinal vein 5 years following the transplantation.
0.9999 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, Entityprednisone and azathioprine, developed Entitythrombosis of the central retinal vein 5 years following the transplantation.
0.9999 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of Entitycyclosporin , prednisone and azathioprine, developed Entitythrombosis of the central retinal vein 5 years following the transplantation.
1.0000 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and Entityazathioprine , developed Entitythrombosis of the central retinal vein 5 years following the transplantation.
0.9999 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, Entityprednisone and azathioprine, developed Entitythrombosis of the central retinal vein 5 years following the transplantation.
0.9999 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of Entitycyclosporin , prednisone and azathioprine, developed Entitythrombosis of the central retinal vein 5 years following the transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Entitycyclosporine A Entitynephrotoxicity .
0.9997 Adverse-Effect Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the Entityincrease in proteinuria , we suggest that in this case the tubules and / or interstitium are the main targets for Entitycyclosporine A nephrotoxicity.
0.9986 Adverse-Effect Based upon the observed Entityfall of the filtration fraction , the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Entitycyclosporine A nephrotoxicity.
0.9795 Adverse-Effect Based upon the observed fall of the filtration fraction, the Entityrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Entitycyclosporine A nephrotoxicity.
1.0000 Adverse-Effect Based upon the observed fall of the filtration fraction, the Entityrise in the relative clearance of Entity99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
1.0000 Adverse-Effect Based upon the observed fall of the filtration fraction, the Entityrise in the relative clearance of Entity99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.9988 Adverse-Effect Based upon the observed fall of the filtration fraction, the Entityrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Entitycyclosporine A nephrotoxicity.
0.9988 Adverse-Effect Based upon the observed fall of the filtration fraction, the Entityrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Entitycyclosporine A nephrotoxicity.
0.9983 Adverse-Effect Based upon the observed Entityfall of the filtration fraction , the rise in the relative clearance of Entity99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.9975 Adverse-Effect Based upon the observed fall of the filtration fraction, the Entityrise in the relative clearance of 99Tc - dimercaptosuccinic acid Entity99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.9952 Adverse-Effect Based upon the observed fall of the filtration fraction, the rise in the relative clearance of Entity99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A Entitynephrotoxicity .
0.9820 Adverse-Effect Based upon the observed fall of the filtration fraction, the rise in the relative clearance of Entity99Tc - dimercaptosuccinic acid and the Entityincrease in proteinuria , we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Although there is one case report of Entitycholesterol crystal embolization following Entityt - PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.9999 Adverse-Effect Although there is one case report of cholesterol crystal embolization following t - PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of Entityatheroembolic acute renal failure following Entityt - PA therapy.
0.9878 Adverse-Effect Although there is one case report of cholesterol crystal embolization following Entityt - PA therapy with only Entityextrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.9964 Adverse-Effect Although there is one case report of Entitycholesterol crystal embolization following t Entity- PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.9882 Adverse-Effect Although there is one case report of cholesterol crystal embolization following t Entity- PA therapy with only Entityextrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Rebound Entityhyperglycemia was observed with both intermediate ( Entityneutral protamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
0.9998 Adverse-Effect Rebound Entityhyperglycemia was observed with both intermediate ( neutral Entityprotamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
0.9997 Adverse-Effect Rebound Entityhyperglycemia was observed with both intermediate ( neutral protamine hagedorn ) and long - acting ( Entityprotamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Adverse-Effect EntityRebound hyperglycemia was observed with both intermediate ( neutral Entityprotamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Adverse-Effect EntityRebound hyperglycemia was observed with both intermediate ( neutral protamine hagedorn ) and long - acting ( Entityprotamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Entitystatus migrainosus after the introduction of Entityoxcarbazepine ( OXC ), as part of a switch off from carbamazepine ( CBZ ).
1.0000 Adverse-Effect The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Entitystatus migrainosus after the introduction of oxcarbazepine ( EntityOXC ), as part of a switch off from carbamazepine ( CBZ ).
0.9999 Adverse-Effect The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Entitystatus migrainosus after the introduction of oxcarbazepine ( OXC ), as part of a switch off from carbamazepine ( EntityCBZ ).
0.9999 Adverse-Effect The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Entitystatus migrainosus after the introduction of oxcarbazepine ( OXC ), as part of a switch off from Entitycarbamazepine ( CBZ ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the risk of severe AIHA in CLL patients with a history of AIHA or Entitypositivation of the DAT during previous Entityfludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9999 Adverse-Effect Physicians should be aware of the risk of severe AIHA in CLL patients with a history of EntityAIHA or positivation of the DAT during previous Entityfludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9999 Adverse-Effect Physicians should be aware of the risk of severe EntityAIHA in CLL patients with a history of AIHA or positivation of the DAT during previous Entityfludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9997 Adverse-Effect Physicians should be aware of the risk of severe AIHA in CLL patients with a history of AIHA or Entitypositivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during Entityfludarabine treatment.
0.9996 Adverse-Effect Physicians should be aware of the risk of severe AIHA in CLL patients with a history of EntityAIHA or positivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during Entityfludarabine treatment.
0.9996 Adverse-Effect Physicians should be aware of the risk of severe EntityAIHA in CLL patients with a history of AIHA or positivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during Entityfludarabine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / EntityTEN ) secondary to Entitytrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9997 Adverse-Effect We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( EntitySJS / TEN ) secondary to Entitytrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9997 Adverse-Effect We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / EntityTEN ) secondary to trimethoprim - sulfamethoxazole ( EntityTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9996 Adverse-Effect We report a case of EntityStevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / TEN ) secondary to Entitytrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9996 Adverse-Effect We report a case of Stevens - Johnson syndrome / Entitytoxic epidermal necrolysis ( SJS / TEN ) secondary to Entitytrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9991 Adverse-Effect We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( EntitySJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( EntityTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9989 Adverse-Effect We report a case of EntityStevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( EntityTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9986 Adverse-Effect We report a case of Stevens - Johnson syndrome / Entitytoxic epidermal necrolysis ( SJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( EntityTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Sustained - release Entityverapamil is thought to be the cause of the Entityasthma attack in this patient because she was not taking any other preparations ; the symptoms started with the administration of sustained - release verapamil and were relieved after its discontinuation.
0.9999 Adverse-Effect CONCLUSIONS : Sustained - release verapamil is thought to be the cause of the Entityasthma attack in this patient because she was not taking any other preparations ; the symptoms started with the administration of sustained - release Entityverapamil and were relieved after its discontinuation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Further studies are necessary to evaluate whether the study of HLA antigens may be a very useful tool to detect the patients with a predisposition to develop autoimmune thyroiditis, in order to make a early diagnosis of Entitythyroid disorders during the EntityIFN - alpha treatment.
0.9980 Adverse-Effect Further studies are necessary to evaluate whether the study of HLA antigens may be a very useful tool to detect the patients with a predisposition to develop Entityautoimmune thyroiditis , in order to make a early diagnosis of thyroid disorders during the EntityIFN - alpha treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed postprandial hyperglycemia and Entityglycosuria during a period of topical administration of a corticosteroid cream, Entityhalcinonide cream 0. 1 %, under occlusion.
1.0000 Adverse-Effect A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed Entitypostprandial hyperglycemia and glycosuria during a period of topical administration of a corticosteroid cream, Entityhalcinonide cream 0. 1 %, under occlusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and Entitypositive anti - nuclear antibody ( ANA ) two weeks after administration of Entitycarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, Entityleukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Entitycarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, Entityrash , fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Entitycarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, Entityfever , leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Entitycarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, Entityrash , fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( EntityCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, Entityleukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( EntityCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, Entityrash , fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; EntityTegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed Entitysystemic lupus erythematosus ( SLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Entitycarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, Entityleukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; EntityTegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and Entitypositive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( EntityCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and Entitypositive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; EntityTegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, Entityfever , leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( EntityCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, Entityfever , leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; EntityTegretol ) used against benign Rolandic epilepsy.
0.9998 Adverse-Effect A 14 - year - old female developed Entitysystemic lupus erythematosus ( SLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( EntityCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9998 Adverse-Effect A 14 - year - old female developed Entitysystemic lupus erythematosus ( SLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; EntityTegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( EntityANA ) two weeks after administration of Entitycarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( EntityANA ) two weeks after administration of carbamazepine ( EntityCBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( EntityANA ) two weeks after administration of carbamazepine ( CBZ ; EntityTegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( EntitySLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Entitycarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9998 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( EntitySLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( EntityCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9998 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( EntitySLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; EntityTegretol ) used against benign Rolandic epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since the Entitythrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of Entityciprofloxacin and tazobactam / piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
0.9998 Adverse-Effect Since the Entitythrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and tazobactam / Entitypiperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
0.9998 Adverse-Effect Since the Entitythrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and Entitytazobactam / piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our findings suggest that significant Entityprogression of marrow reticulin fibrosis during Entityimatinib therapy can be an indicator for a return or progression of CML and, in some patients with CML, imatinib may promote cytogenetic clonal evolution, resulting in a poor response to treatment.
0.4811 Adverse-Effect Our findings suggest that significant Entityprogression of marrow reticulin fibrosis during imatinib therapy can be an indicator for a return or progression of CML and, in some patients with CML, Entityimatinib may promote cytogenetic clonal evolution, resulting in a poor response to treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ciprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of Entityciprofloxacin - induced Entityhemorrhagic vasculitis , it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.9991 Adverse-Effect Ciprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of Entityciprofloxacin - induced hemorrhagic vasculitis, it might be interpreted as Entityprogression of infection , instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.9805 Adverse-Effect EntityCiprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of ciprofloxacin - induced Entityhemorrhagic vasculitis , it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.9709 Adverse-Effect EntityCiprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of ciprofloxacin - induced hemorrhagic vasculitis, it might be interpreted as Entityprogression of infection , instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Entitymoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Entityheadache , dizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Entitymoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Entitydizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Entitymoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Entityinsomnia .
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( Entitylevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Entityheadache , dizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Entitygatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Entityheadache , dizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Entitytrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Entityheadache , dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, Entitysparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Entityheadache , dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( Entitylevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Entityinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Entitytrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Entityinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Entitygatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Entityinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( Entitylevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Entitydizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Entitytrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Entitydizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Entitygatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Entitydizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Entitygrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Entityheadache , dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, Entitysparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Entityinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, Entitysparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Entitydizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Entitygrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Entityinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Entitygrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Entitydizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Entitymoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Entitycentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( Entitylevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Entitycentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Entitygatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Entitycentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Entitytrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Entitycentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9998 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, Entitysparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Entitycentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9998 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Entitygrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Entitycentral nervous system - related adverse effects , including headache, dizziness and insomnia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected Entityinsulin could explain the Entitydedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
1.0000 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the Entityreversion that was induced by the local injection of Entitydexamethasone .
0.9999 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected Entityinsulin could explain the Entitydedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
0.9999 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the Entitydedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of Entitydexamethasone .
0.9998 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the Entitydedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of Entitydexamethasone .
0.9990 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected Entityinsulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the Entityreversion that was induced by the local injection of dexamethasone.
Adverse-Effect CONCLUSIONS : In our reported case, a local Entityhyperproduction of TNF - alpha from macrophages that was induced by the injected Entityinsulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Factors that suggested an association between the Entitysevere angioedematous reaction and EntityBP topical application include the strong reaction to BP in the patch - test, the temporal relationship, the complete resolution of symptoms after the drug was withdrawn and the absence of other identified explanations.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect To develop information on the relative rarity or frequency of Entityneurologic worsening with the initiation of Entitypenicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with penicillamine.
0.9872 Adverse-Effect To develop information on the Entityrelative rarity or frequency of neurologic worsening with the initiation of Entitypenicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with penicillamine.
Adverse-Effect To develop information on the relative rarity or frequency of neurologic worsening with the initiation of penicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with Entityneurologic disease and having been treated with Entitypenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The risk of developing EntitysAML is estimated to be between 1 % and 5 %, 2 - 20 years after exposure to Entityetoposide but may also be related to cumulative drug doses, treatment schedules, host factors and co - administration of other antineoplastic agents.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The presence of a lymphocyte alveolitis with a predominance of CD4 + T cells in 3 RA patients and CD8 + T cells with a concomitant increase in neutrophils in another case suggests that immunologically mediated reactions may be one damage mechanism in EntityMTX - induced Entitypneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityRenal failure appeared 8 to 17 days after beginning Entitygentamicin therapy and was characterized by creatinine clearances 4 to 10 ml / min, urine to plasma creatinine ratios less than 20, urinary sodium concentrations 16 to 60 mEq / liter, proteinuria, and cylindruria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of Entityheadaches , dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, Entitydifficulty with speech , weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, Entityweakness , and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, Entitydizziness , difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of Entityheadaches , dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9998 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a Entitymaculopapular rash was noted.
0.9997 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, Entitydifficulty with speech , weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, Entityweakness , and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, Entitydizziness , difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9995 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9995 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a Entitymaculopapular rash was noted.
0.9985 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs , where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs , where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9995 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9995 Adverse-Effect He had been taking trimethoprim - Entitysulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9986 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9985 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9985 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9985 Adverse-Effect He had been taking Entitytrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Entityitching on the trunk of his body and legs, where a maculopapular rash was noted.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A clinically atypical, neuropathologically verified case of EntityCreutzfeldt - Jakob disease is described in a 32 - year - old New Zealand woman with idiopathic hypopituitarism who had been treated in late adolescence ( 1970 to 1973 ) with Entityhuman growth hormone processed from pooled cadaveric pituitary glands.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a series of 104 cases of intentional or inadvertent use of Entityzidovudine at differing gestations in pregnancy, there were eight spontaneous Entityfirst trimester abortions , eight therapeutic terminations, and eight cases of fetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
0.9999 Adverse-Effect In a series of 104 cases of intentional or inadvertent use of Entityzidovudine at differing gestations in pregnancy, there were eight spontaneous first trimester abortions, eight therapeutic terminations, and eight cases of Entityfetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
1.0000 Adverse-Effect In a series of 104 cases of intentional or inadvertent use of Entityzidovudine at differing gestations in pregnancy, there were eight Entityspontaneous first trimester abortions , eight therapeutic terminations, and eight cases of fetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
Score Relation Text (Head - Tail)
0.9975 Adverse-Effect This is the first reported case of EntityBOOP associated with single - agent Entityrituximab , and along with two other patients we describe, as well as two prior reports of BOOP in NHL patients receiving rituximab - based combinations, strengthens the possibility of a causal relationship.
0.9940 Adverse-Effect This is the first reported case of BOOP associated with single - agent rituximab, and along with two other patients we describe, as well as two prior reports of EntityBOOP in NHL patients receiving Entityrituximab - based combinations, strengthens the possibility of a causal relationship.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient completed a 10 - month follow - up, maintaining a complete resolution of the treated skin lesions ; however, the development of a Entitypainful hand ulcer , possibly associated with the Entityhydroxyurea , and new skin cancers were observed at the last follow - up visit.
0.9987 Adverse-Effect The patient completed a 10 - month follow - up, maintaining a complete resolution of the treated skin lesions ; however, the development of a painful hand ulcer, possibly associated with the Entityhydroxyurea , and new Entityskin cancers were observed at the last follow - up visit.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case is presented of a 72 - year - old man with hormone - refractory prostate cancer and weekly administration of 30 mg / m2 Entitydocetaxel who developed Entitysubacute interstitial pneumonitis - related pulmonary fibrosis after seven doses and died despite mechanical ventilation and high - dose corticosteroid treatment.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Therefore, it is reasonable to conclude that : 1 ) 2 - CdA can induce durable complete remission in MCD patients but unfortunately it can not cure the disease ; 2 ) the possibility that Entity2 - CdA may accelerate the Entitytransformation of MCD to NHL can not be ruled out.
0.9745 Adverse-Effect Therefore, it is reasonable to conclude that : 1 ) Entity2 - CdA can induce durable complete remission in MCD patients but unfortunately it can not cure the disease ; 2 ) the possibility that 2 - CdA may accelerate the Entitytransformation of MCD to NHL can not be ruled out.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and pustules on his face and trunk, malaise, and Entityfever up to 39 degrees C one day after the administration of Entitysalazosulfapyridine .
1.0000 Adverse-Effect A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and pustules on his face and trunk, Entitymalaise , and fever up to 39 degrees C one day after the administration of Entitysalazosulfapyridine .
0.9999 Adverse-Effect A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and Entitypustules on his face and trunk, malaise, and fever up to 39 degrees C one day after the administration of Entitysalazosulfapyridine .
0.9999 Adverse-Effect A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with Entitydiffuse erythema and pustules on his face and trunk, malaise, and fever up to 39 degrees C one day after the administration of Entitysalazosulfapyridine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case report of a patient with alveolar hydatid disease, whose treatment with Entitymebendazole was brief due to side effects of Entityalopecia and granulocytopenia ; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.
1.0000 Adverse-Effect We present a case report of a patient with alveolar hydatid disease, whose treatment with Entitymebendazole was brief due to side effects of alopecia and Entitygranulocytopenia ; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 male patients, a 49 - year - old with psoriatic arthritis and impaired renal function and a 43 - year - old renal transplant recipient, who both sustained a marked Entitydecline in glomerular filtration rate in conjunction with a selective inhibitor of cyclooxygenase - 2 ( COX - 2 ), Entityrofecoxib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and Entitybile stasis , demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Entitymethimazole daily.
1.0000 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with Entitygranulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Entitymethimazole daily.
1.0000 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of Entityfatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Entitymethimazole daily.
0.9998 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and Entitycholestasis , and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Entitymethimazole daily.
0.9998 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of Entityleucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Entitymethimazole daily.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect On the fifth day after administration of a high dose of EntityARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, Entitysepsis , and death on the 22nd day.
0.9996 Adverse-Effect On the fifth day after administration of a high dose of EntityARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and Entitydeath on the 22nd day.
0.9999 Adverse-Effect On the fifth day after administration of a high dose of EntityARA - C ( 2 g / m2 intravenously every 12 hours ), she developed Entitybullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death on the 22nd day.
0.9995 Adverse-Effect On the fifth day after administration of a high dose of EntityARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to Entitynecrosis , sepsis, and death on the 22nd day.
Adverse-Effect On the fifth day after administration of a high dose of EntityARA - C ( 2 g / m2 intravenously every 12 hours ), she developed Entitybullous lesions on the hands and soles that disseminated, evolving to necrosis , sepsis, and death on the 22nd day.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is presumed that her Entityhyperchloremic metabolic acidosis was secondary to Entitycholestyramine because of the similarity to pediatric reports ; the rapid and lasting response to intravenous sodium bicarbonate ; the absence of another etiology ; normal serum potassium, chloride and bicarbonate despite continued spironolactone therapy after recovery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of EntityMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including Entityacute renal failure , pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of EntityMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, Entitypancytopenia , vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of EntityMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, Entitydiarrhea , elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of EntityMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, Entityjaundice , mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of EntityMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, Entityvomiting , diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of EntityMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and Entitypyrexia .
0.9999 Adverse-Effect Previous studies have demonstrated the interaction of EntityMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, Entitymucosal ulcerations , and pyrexia.
0.9999 Adverse-Effect Previous studies have demonstrated the interaction of EntityMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, Entityelevated liver transaminases , jaundice, mucosal ulcerations, and pyrexia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, risperidone, and Entitycarbamazepine ) presenting with mixed EntitySS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
1.0000 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, risperidone, and Entitycarbamazepine ) presenting with mixed SS / EntityNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9999 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( Entityvenlafaxine , topiramate, divalproex sodium, risperidone, and carbamazepine ) presenting with mixed SS / EntityNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9999 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, Entityrisperidone , and carbamazepine ) presenting with mixed SS / EntityNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9998 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, Entitytopiramate , divalproex sodium, risperidone, and carbamazepine ) presenting with mixed SS / EntityNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9998 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( Entityvenlafaxine , topiramate, divalproex sodium, risperidone, and carbamazepine ) presenting with mixed EntitySS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9998 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, Entityrisperidone , and carbamazepine ) presenting with mixed EntitySS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9998 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, Entitytopiramate , divalproex sodium, risperidone, and carbamazepine ) presenting with mixed EntitySS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9997 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, Entitydivalproex sodium , risperidone, and carbamazepine ) presenting with mixed SS / EntityNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9997 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, Entitydivalproex sodium , risperidone, and carbamazepine ) presenting with mixed EntitySS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
Score Relation Text (Head - Tail)
0.9989 Adverse-Effect After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely Entitypegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced Entityhepatitis .
0.9956 Adverse-Effect After rechallenge with monotherapy pegvisomant, however, the Entityhepatic enzyme disturbances reappeared within a few weeks, indicating that most likely Entitypegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
0.9999 Adverse-Effect After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting Entitysomatostatin analog or the combination of these two drugs was responsible for this case of drug - induced Entityhepatitis .
0.9902 Adverse-Effect After rechallenge with monotherapy pegvisomant, however, the Entityhepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting Entitysomatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
Adverse-Effect After rechallenge with monotherapy Entitypegvisomant , however, the Entityhepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible pathophysiological mechanisms which may have been operative in this case include : a direct central nervous system ( CNS ) toxic effect of valproic acid ; a paradoxical epileptogenic effect secondary to the drug ; and an indirect CNS toxic effect mediated through Entityvalproic acid - induced Entityhyperammonemia .
0.8683 Adverse-Effect Possible pathophysiological mechanisms which may have been operative in this case include : a direct central nervous system ( CNS ) toxic effect of Entityvalproic acid ; a paradoxical epileptogenic effect secondary to the drug ; and an indirect CNS toxic effect mediated through valproic acid - induced Entityhyperammonemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors also determined that their case of myositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of radiation recall, thereby bringing the number of patients who developed Entityradiation recall to Entitygemcitabine and were discussed in the current study to 13.
0.9999 Adverse-Effect The authors also determined that their case of Entitymyositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of radiation recall, thereby bringing the number of patients who developed radiation recall to Entitygemcitabine and were discussed in the current study to 13.
0.9998 Adverse-Effect The authors also determined that their case of myositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of Entityradiation recall , thereby bringing the number of patients who developed radiation recall to Entitygemcitabine and were discussed in the current study to 13.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings suggest that Entityclozapine - induced Entityseizures can be successfully treated, that gradual dose titration can reduce the likelihood of further episodes of seizures and that concomitant use of a suitable mood stabilizer / anti - epileptic medication can improve the outcome of treatment - resistant schizophrenia.
0.9964 Adverse-Effect These findings suggest that Entityclozapine - induced seizures can be successfully treated, that gradual dose titration can reduce the likelihood of further episodes of Entityseizures and that concomitant use of a suitable mood stabilizer / anti - epileptic medication can improve the outcome of treatment - resistant schizophrenia.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We report the case histories of two patients with histologically confirmed adenocarcinoma of the prostate, both of whom had been treated with steroidal anti - androgen therapy in the form of Entitycyproterone acetate prior to radical or palliative pelvic irradiation, and who subsequently developed Entityfemoral head avascular necrosis .
0.9993 Adverse-Effect We report the case histories of two patients with histologically confirmed Entityadenocarcinoma of the prostate , both of whom had been treated with steroidal anti - androgen therapy in the form of Entitycyproterone acetate prior to radical or palliative pelvic irradiation, and who subsequently developed femoral head avascular necrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Entitythrombin were Entityslow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.9999 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Entitythrombin were slow to awaken ; one had evidence of Entityvasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.9998 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Entitythrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and Entitymultiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.9996 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Entitythrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with Entityintracranial hypertension .
0.9994 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Entitythrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized Entityfrontal hematoma with intracranial hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : The estimated number of EntityAccutane prescriptions for reproductive - aged women has more than doubled in the past 10 years ; it is the most widely used Entityteratogenic drug in the United States, with approximately 2. 5 per 1, 000 reproductive - aged women exposed to Accutane in 1999.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Entityeosinophilia two weeks after receiving Entitytrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
1.0000 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Entityeosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( EntitySMX ) treatment.
0.9999 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Entityeosinophilia two weeks after receiving trimethoprim ( TMP ) - Entitysulfamethoxazole ( SMX ) treatment.
0.9999 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Entityeosinophilia two weeks after receiving trimethoprim ( EntityTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9999 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Entityatypical lymphocytosis , and eosinophilia two weeks after receiving Entitytrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9999 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Entitycervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving Entitytrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9998 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Entityfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving Entitytrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9998 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Entityhepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving Entitytrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9998 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Entityskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving Entitytrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9997 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Entityatypical lymphocytosis , and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( EntitySMX ) treatment.
0.9997 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Entitycervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( EntitySMX ) treatment.
0.9997 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Entityfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( EntitySMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Entityhepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( EntitySMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Entitycervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Entitysulfamethoxazole ( SMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Entityfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Entitysulfamethoxazole ( SMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Entityskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( EntitySMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Entityatypical lymphocytosis , and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Entitysulfamethoxazole ( SMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Entityhepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Entitysulfamethoxazole ( SMX ) treatment.
0.9995 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Entityskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Entitysulfamethoxazole ( SMX ) treatment.
0.9995 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Entitycervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( EntityTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9995 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Entityfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( EntityTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9995 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Entityatypical lymphocytosis , and eosinophilia two weeks after receiving trimethoprim ( EntityTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9994 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Entityhepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( EntityTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9994 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Entityskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( EntityTMP ) - sulfamethoxazole ( SMX ) treatment.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although it is difficult to be certain of the direct link of amiodarone on the basis of a single case, it is reasonable to presume that this histopathology is associated with Entityamiodarone - induced Entityhypothyroidism and that involution changes represent the hypofunctional status of this drug - induced disorder.
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect It also highlights a current major etiologic question, that is, whether and to what degree Entitylead exposure contributes to the development of Entityhypertension , and raises the issue of whether lead - induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
0.9993 Adverse-Effect It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether Entitylead - induced Entityhypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
0.9481 Adverse-Effect It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether Entitylead - induced hypertension constitutes a subset of Entityhypertension that is especially amenable to therapy with dietary calcium.
Adverse-Effect It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether Entitylead Entitylead - induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect EntityRisperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of extrapyramidal side effects including tardive dyskinesia ( EntityTD ).
0.9999 Adverse-Effect EntityRisperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of extrapyramidal side effects including Entitytardive dyskinesia ( TD ).
0.9999 Adverse-Effect EntityRisperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of Entityextrapyramidal side effects including tardive dyskinesia ( TD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as Entitynephrotoxicity , ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
1.0000 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, Entitygastrointestinal disturbances , blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
1.0000 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, Entityototoxicity , gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
1.0000 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " Entityred man syndrome " and anaphylaxis.
1.0000 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, Entityblood disorders , and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9999 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and Entityanaphylaxis .
0.9999 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of Entityhypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9998 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an Entityanaphylactoid reaction known as " red man syndrome " and anaphylaxis.
1.0000 Adverse-Effect EntityVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an Entityanaphylactoid reaction known as " red man syndrome " and anaphylaxis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Entityamiodarone for 4 years, developed Entitythyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9999 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Entityamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by Entitytransiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9995 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Entityamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Entitythyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9999 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Entityamiodarone for 4 years, developed thyrotoxicosis with Entitysubacute onset , accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9997 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Entityamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Entitythyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9995 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Entityamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Entitythyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9994 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Entityamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Entitythyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9991 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Entityamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( EntityTRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
Score Relation Text (Head - Tail)
0.9414 Adverse-Effect EntityThrombocytopenia with or without microangiopathy following Entityquinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.6825 Adverse-Effect Thrombocytopenia with or without microangiopathy following quinine is often referred to as Entityquinine " Entityhypersensitivity . " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.6060 Adverse-Effect Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " Entityquinine - associated TTP / EntityHUS . " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
Adverse-Effect Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " Entityquinine - associated EntityTTP / HUS . " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Intravenous Entityverapamil therapy in babies may cause Entityapnea , hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9924 Adverse-Effect Intravenous Entityverapamil therapy in babies may cause apnea, Entityhypotension , and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9874 Adverse-Effect Intravenous Entityverapamil therapy in babies may cause apnea, hypotension, and Entitybradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9707 Adverse-Effect Intravenous Entityverapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause Entitysudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9533 Adverse-Effect Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; Entityquinidine may be related to the death ; children with " familial seizure disorders " may in fact have the Entitylong QT interval syndrome .
0.8352 Adverse-Effect Intravenous Entityverapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of Entityatrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.5138 Adverse-Effect Intravenous verapamil therapy in babies may cause Entityapnea , hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; Entityquinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.7548 Adverse-Effect Intravenous Entityverapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the Entitylong QT interval syndrome .
0.6422 Adverse-Effect Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause Entitysudden death ; Entityquinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
Adverse-Effect Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; Entityquinidine may be related to the Entitydeath ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The pharmaceutical company producing EntityHalfan has reported 8 Entitycardiac arrests , leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9999 Adverse-Effect The pharmaceutical company producing Halfan has reported 8 cardiac arrests, leading to 6 Entitydeaths , when a higher dose than recommended was used, there was recent or concomitant treatment with Entitymefloquine , there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9997 Adverse-Effect The pharmaceutical company producing EntityHalfan has reported 8 cardiac arrests, leading to 6 Entitydeaths , when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9997 Adverse-Effect The pharmaceutical company producing Halfan has reported 8 Entitycardiac arrests , leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with Entitymefloquine , there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9998 Adverse-Effect The pharmaceutical company producing Halfan has reported 8 cardiac arrests, leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with Entitymefloquine , there was pre - existing Entityprolongation of the QT interval or the patient had a thiamine deficiency.
0.9983 Adverse-Effect The pharmaceutical company producing EntityHalfan has reported 8 cardiac arrests, leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing Entityprolongation of the QT interval or the patient had a thiamine deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The administration of " sweet spirits of nitre " ( Entity4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by Entityacute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9997 Adverse-Effect The administration of " sweet spirits of nitre " ( Entity4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and Entitysevere anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9995 Adverse-Effect The administration of " Entitysweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by Entityacute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9987 Adverse-Effect The administration of " Entitysweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and Entitysevere anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9980 Adverse-Effect The administration of " sweet spirits of nitre " ( Entity4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin Entitydied from the consequences of hypoxemia.
0.9980 Adverse-Effect The administration of " Entitysweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin Entitydied from the consequences of hypoxemia.
0.9946 Adverse-Effect The administration of " sweet spirits of nitre " ( Entity4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of Entityhypoxemia .
0.9944 Adverse-Effect The administration of " Entitysweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of Entityhypoxemia .
0.9996 Adverse-Effect The administration of " sweet Entityspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by Entityacute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9988 Adverse-Effect The administration of " sweet Entityspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and Entitysevere anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9982 Adverse-Effect The administration of " sweet Entityspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin Entitydied from the consequences of hypoxemia.
0.9949 Adverse-Effect The administration of " sweet Entityspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of Entityhypoxemia .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Although the literature on the use of Entityrisperidone in elderly patients with dementia consists largely of uncontrolled trials, case reports, and chart reviews, it appears that this agent is effective for managing agitation in this population and does so with a low frequency of Entityextrapyramidal symptoms ( EPS ).
0.9995 Adverse-Effect Although the literature on the use of Entityrisperidone in elderly patients with dementia consists largely of uncontrolled trials, case reports, and chart reviews, it appears that this agent is effective for managing agitation in this population and does so with a low frequency of extrapyramidal symptoms ( EntityEPS ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Entitycisplatin without complications experienced Entityhypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9998 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced Entityhypersensitivity reactions to Entitycisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9984 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Entitycisplatin : one, involving intrahepatic artery infusion, manifested Entitygeneral erythema , dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9964 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Entitycisplatin : one, involving intrahepatic artery infusion, manifested general erythema, Entitydyspnea , and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9951 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Entitycisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and Entityhypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9916 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Entitycisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, Entitydyspnea , and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9916 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Entitycisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested Entityabdominal pain , general erythema, and fever.
0.9907 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Entitycisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and Entityfever .
0.9894 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Entitycisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and Entityhypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9857 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Entitycisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested Entitygeneral erythema , dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9852 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Entitycisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, Entitygeneral erythema , and fever.
0.9839 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Entitycisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested Entityabdominal pain , general erythema, and fever.
0.9835 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Entitycisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and Entityfever .
0.9733 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Entitycisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, Entitygeneral erythema , and fever.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report 5 patients ( 3 patients with chronic hepatitis C treated with pegylated interferon alfa - 2b in association with oral ribavirin and two patients with chronic myelocytic leukemia ) who developed Entitylocal cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of Entitypegylated interferon alfa - 2b at different doses.
0.9990 Adverse-Effect We report 5 patients ( 3 patients with chronic hepatitis C treated with pegylated interferon alfa - 2b in association with oral Entityribavirin and two patients with chronic myelocytic leukemia ) who developed Entitylocal cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of pegylated interferon alfa - 2b at different doses.
0.9968 Adverse-Effect We report 5 patients ( 3 patients with chronic hepatitis C treated with Entitypegylated interferon alfa - 2b in association with oral ribavirin and two patients with chronic myelocytic leukemia ) who developed Entitylocal cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of pegylated interferon alfa - 2b at different doses.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of Entitybleomycin - induced Entityhyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
0.9953 Adverse-Effect Although this type of Entityhyperpigmentation has been previously seen in patients with cancer who are receiving Entitybleomycin , this is, to our knowledge, the first reported case of bleomycin - induced hyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
0.8172 Adverse-Effect Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of Entitybleomycin - induced hyperpigmentation in an AIDS patient and should be added to the growing list of Entitycutaneous eruptions seen in these patients.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Our report suggested that EntityCBDCA Entityhypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA hypersensitivity can occur even with low - dose CBDCA administration.
0.9996 Adverse-Effect Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because EntityCBDCA Entityhypersensitivity can occur even with low - dose CBDCA administration.
0.9995 Adverse-Effect Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA Entityhypersensitivity can occur even with low - dose EntityCBDCA administration.
0.5250 Adverse-Effect Our report suggested that CBDCA Entityhypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because EntityCBDCA hypersensitivity can occur even with low - dose CBDCA administration.
0.8084 Adverse-Effect Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that EntityCBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA Entityhypersensitivity can occur even with low - dose CBDCA administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of Entityacute dystonic reactions associated with Entitypimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following pimozide withdrawal, as well as during subsequent thioridazine administration.
0.9994 Adverse-Effect This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of Entityacute dystonic reactions associated with pimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following pimozide withdrawal, as well as during subsequent Entitythioridazine administration.
0.9992 Adverse-Effect This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of Entityacute dystonic reactions associated with pimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following Entitypimozide withdrawal, as well as during subsequent thioridazine administration.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We have seen a case of terminal malignant melanoma in which clinical manifestations, indicative of Entityanterior spinal artery syndrome , developed following the injection of 0. 3 ml of 10 % Entityphenol - glycerine into the cervical subarachnoid space at the C4 - - C5 level for the control of severe right arm pain.
0.9994 Adverse-Effect We have seen a case of Entityterminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome, developed following the injection of 0. 3 ml of 10 % Entityphenol - glycerine into the cervical subarachnoid space at the C4 - - C5 level for the control of severe right arm pain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Contrary to previous recommendations, our experience cautions against the further use of high - dose Entitycytarabine in patients who develop EntityPPE , and is a timely reminder of the potential toxicity of this agent, which is now increasingly being used as first - line treatment in the management of haematologic malignancies.
Score Relation Text (Head - Tail)
Adverse-Effect Attempts were made to stop and then restart the Entitytheophylline therapy at progressively lower doses ; however, with each attempt, the patient's Entityreaction to the drug became more toxic , with serum theophylline levels ranging between 99. 9 and 149. 9 micromol / L ( 18 and 27 microg / mL ).
Adverse-Effect Attempts were made to stop and then restart the theophylline therapy at progressively lower doses ; however, with each attempt, the patient's Entityreaction to the drug became more toxic , with serum Entitytheophylline levels ranging between 99. 9 and 149. 9 micromol / L ( 18 and 27 microg / mL ).
Score Relation Text (Head - Tail)
0.9991 Adverse-Effect Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a prolonged seizure, a serotonin syndrome and a Entityfocal seizure ) of severe Entitylithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
0.9990 Adverse-Effect Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a Entityprolonged seizure , a serotonin syndrome and a focal seizure ) of severe Entitylithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
0.9990 Adverse-Effect Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a prolonged seizure, a Entityserotonin syndrome and a focal seizure ) of severe Entitylithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Eleven patients developed Entityinfection requiring hospitalization while taking Entityleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
1.0000 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Entityleflunomide including : Entitylower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9999 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Entityleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), Entitydisseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9999 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Entityleflunomide including : lower respiratory tract infections ( 3 ), Entitycellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9999 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Entityleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), Entityabdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9998 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Entityleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), Entitymycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9998 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Entityleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable EntityTB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9998 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Entityleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and Entitygastroenteritis ( 1 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During dose - finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving Entitypantoprazole developed Entityperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9981 Adverse-Effect During dose - finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving Entityomeprazole and two young female volunteers receiving pantoprazole developed Entityperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9971 Adverse-Effect During dose - finding studies for intravenous proton pump inhibitors omeprazole and Entitypantoprazole , three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed Entityperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9967 Adverse-Effect During dose - finding studies for intravenous proton pump inhibitors Entityomeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed Entityperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only two case reports of adults with allergic contact dermatitis to this chemical exist in the literature, and we describe three more cases of children with recalcitrant atopic dermatitis found to have potential Entityallergic contact dermatitis to Entitybisabolol - a component of the Aquaphor emollient they were using to treat their atopic dermatitis.
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect We describe the infectious toxicities experienced by the first two patients in our institution treated with dexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of Entityinfectious complications with Entitydexamethasone .
0.9954 Adverse-Effect We describe the Entityinfectious toxicities experienced by the first two patients in our institution treated with Entitydexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.
0.7104 Adverse-Effect We describe the Entityinfectious toxicities experienced by the first two patients in our institution treated with dexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the Entitydexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and Entityhydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered Entitymethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9999 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed Entityleukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered Entitymethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9998 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and Entityhydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Entitymethotrexate and cranial irradiation.
0.9997 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed Entityleukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Entitymethotrexate and cranial irradiation.
1.0000 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to Entitycentral nervous system prophylaxis by, in the first case intrathecally administered Entitymethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9999 Adverse-Effect We report the case histories of identical twin brothers who developed Entityconcordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered Entitymethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9998 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to Entitycentral nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Entitymethotrexate and cranial irradiation.
0.9996 Adverse-Effect We report the case histories of identical twin brothers who developed Entityconcordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Entitymethotrexate and cranial irradiation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Entitycitalopram developed Entityconfusion , agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
1.0000 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with Entityserotonin syndrome , following initiation of Entityfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9999 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Entitycitalopram developed confusion, Entityagitation , tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9999 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Entitycitalopram developed confusion, agitation, Entitytachycardia , tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9998 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Entitycitalopram developed confusion, agitation, tachycardia, tremors, Entitymyoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9998 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Entitycitalopram developed confusion, agitation, tachycardia, Entitytremors , myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9998 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and Entityunsteady gait , consistent with serotonin syndrome, following initiation of Entityfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9998 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Entitycitalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and Entityunsteady gait , consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, Entitymyoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Entityfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with Entityserotonin syndrome , following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Entityfentanyl .
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Entitycitalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with Entityserotonin syndrome , following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, Entitytremors , myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Entityfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, Entityagitation , tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Entityfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, Entitytachycardia , tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Entityfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9995 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed Entityconfusion , agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Entityfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9993 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, Entitymyoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Entityfentanyl .
0.9992 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and Entityunsteady gait , consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Entityfentanyl .
0.9991 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, Entityagitation , tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Entityfentanyl .
0.9991 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, Entitytremors , myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Entityfentanyl .
0.9991 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, Entitytachycardia , tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Entityfentanyl .
0.9987 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed Entityconfusion , agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Entityfentanyl .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe longitudinal diffusion - weighted MRI findings of Entitysub - acute leukoencephalopathy following Entitymethotrexate therapy in a 24 - year - old man diagnosed with pre - B - cell acute lymphoblastic leukemia ( ALL ), presenting with right - sided paralysis and aphasia after second consolidation with intrathecal triple - drug therapy given intrathecally.
0.9998 Adverse-Effect We describe longitudinal diffusion - weighted MRI findings of sub - acute leukoencephalopathy following Entitymethotrexate therapy in a 24 - year - old man diagnosed with pre - B - cell acute lymphoblastic leukemia ( ALL ), presenting with right - sided paralysis and Entityaphasia after second consolidation with intrathecal triple - drug therapy given intrathecally.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes an individual with mental retardation who experienced Entitybehavioral exacerbation associated with Entityclonazepam prescribed at 2 mg / day ( 0. 02 mg / kg / day ) to treat aggression, self - injurious behavior, property destruction, and screaming, which was measured with a 15 - minute partial interval recording measurement method.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about Entitylithium ' s potential Entityteratogenicity , and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9994 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about Entitylithium ' s potential teratogenicity, and it has been implicated in EntityEpstein's anomaly , a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9992 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in EntityEpstein's anomaly , a congenital heart defect among infants born to women taking Entitylithium ; as with other medications, however, the data have specific limitations.
0.9985 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about lithium's potential Entityteratogenicity , and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking Entitylithium ; as with other medications, however, the data have specific limitations.
1.0000 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Epstein's anomaly, a Entitycongenital heart defect among infants born to women taking Entitylithium ; as with other medications, however, the data have specific limitations.
0.9992 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about Entitylithium ' s potential teratogenicity, and it has been implicated in Epstein's anomaly, a Entitycongenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9990 Adverse-Effect In this article Entitylithium is not discussed, although there are a number of concerns about lithium's potential Entityteratogenicity , and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9975 Adverse-Effect In this article Entitylithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in EntityEpstein's anomaly , a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9971 Adverse-Effect In this article Entitylithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Epstein's anomaly, a Entitycongenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 61 - year - old woman with no apparent risk factors for liver injury developed Entityacute hepatitis one week after the final dose of a long - term course of pulse Entityitraconazole therapy ( 200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk ) for onychomycosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( EntityARA - C ) ; among them, along with myelosuppression, five experienced Entityfever , infectious complications, gastrointestinal tract symptoms and severe myalgias.
0.9999 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( EntityARA - C ) ; among them, along with myelosuppression, five experienced fever, Entityinfectious complications , gastrointestinal tract symptoms and severe myalgias.
0.9998 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Entitycytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced Entityfever , infectious complications, gastrointestinal tract symptoms and severe myalgias.
0.9998 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( EntityARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, Entitygastrointestinal tract symptoms and severe myalgias.
0.9997 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( EntityARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and Entitysevere myalgias .
0.9995 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Entitycytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, Entityinfectious complications , gastrointestinal tract symptoms and severe myalgias.
0.9991 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Entitycytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, Entitygastrointestinal tract symptoms and severe myalgias.
0.9991 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Entitycytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and Entitysevere myalgias .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect 1. EntityChanges in the plasma cortisol level were reported in a male patient with panic disorder during the period of low - dose Entityalprazolam treatment ( mean 0. 62 + / - 0. 15 mg / day ) compared with during the period of high - dose period ( mean 1. 08 + / - 0. 28 mg / day ).
Score Relation Text (Head - Tail)
0.9979 Adverse-Effect DISCUSSION : After exclusion of other causes, the onset of Entitythrombocytopenia after administration of Entitylansoprazole , the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an idiosyncratic thrombocytopenic response to lansoprazole.
0.9996 Adverse-Effect DISCUSSION : After exclusion of other causes, the onset of thrombocytopenia after administration of lansoprazole, the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an Entityidiosyncratic thrombocytopenic response to Entitylansoprazole .
Adverse-Effect DISCUSSION : After exclusion of other causes, the onset of thrombocytopenia after administration of lansoprazole, the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an idiosyncratic Entitythrombocytopenic response to Entitylansoprazole .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In a single practice during the 21 years 1971 - 1991, the incidence of Entitygestational diabetes in pregnancies in which Entitynorethisterone was prescribed was 32. 4 % ( 22 of 69 ) in comparison with 7. 1 % in pregnancies in which the women did not take norethisterone ( 137 of 1, 684 ) ( p < 0. 001 ).
0.9987 Adverse-Effect In a single practice during the 21 years 1971 - 1991, the incidence of Entitygestational diabetes in pregnancies in which norethisterone was prescribed was 32. 4 % ( 22 of 69 ) in comparison with 7. 1 % in pregnancies in which the women did not take Entitynorethisterone ( 137 of 1, 684 ) ( p < 0. 001 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings are consistent with an immune - complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the Entityrenal disease associated with Entitygold therapy in rheumatoid arthritis.
0.9999 Adverse-Effect These findings are consistent with an immune - complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by Entitygold therapy may be a causative factor in the Entityrenal disease associated with gold therapy in rheumatoid arthritis.
0.8323 Adverse-Effect These findings are consistent with an immune - complex form of glomerulopathy in which Entitygold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the Entityrenal disease associated with gold therapy in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The latter form ( EntityMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, Entityacute and chronic pulmonary reactions , peripheral neuropathy, blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
1.0000 Adverse-Effect The latter form ( EntityMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and Entityallergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
1.0000 Adverse-Effect The latter form ( EntityMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, Entityperipheral neuropathy , blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9999 Adverse-Effect The latter form ( EntityMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - Entityliver damage , acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9999 Adverse-Effect The latter form ( EntityMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, Entityblood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect RESULTS : After 4 - to 14 - month period of therapy with the combination of indapamide ( 2. 5 mg / day ) and fosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with Entityindapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of Entitydiabetes diagnoses.
0.9997 Adverse-Effect RESULTS : After 4 - to 14 - month period of therapy with the combination of indapamide ( 2. 5 mg / day ) and Entityfosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with indapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of Entitydiabetes diagnoses.
0.9997 Adverse-Effect RESULTS : After 4 - to 14 - month period of therapy with the combination of Entityindapamide ( 2. 5 mg / day ) and fosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with indapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of Entitydiabetes diagnoses.
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect This case demonstrates an occupational activity ( construction ) that has now become the dominant source of lead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic Entitylead Entitylead toxicity , and the importance of preventing further exposure and using proper methods to treat acute toxicity.
0.9942 Adverse-Effect This case demonstrates an occupational activity ( construction ) that has now become the dominant source of lead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic Entitylead toxicity, and the importance of preventing further exposure and using proper methods to treat Entityacute toxicity .
0.9823 Adverse-Effect This case demonstrates an occupational activity ( construction ) that has now become the dominant source of Entitylead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic Entitylead toxicity , and the importance of preventing further exposure and using proper methods to treat acute toxicity.
0.9681 Adverse-Effect This case demonstrates an occupational activity ( construction ) that has now become the dominant source of Entitylead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic lead toxicity, and the importance of preventing further exposure and using proper methods to treat Entityacute toxicity .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and EntityFraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Entityplatelet activation with the patient's serum.
0.9997 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins EntityFragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Entityplatelet activation with the patient's serum.
0.9992 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard Entityheparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Entityplatelet activation with the patient's serum.
1.0000 Adverse-Effect By means of the in vitro Entityheparin - induced Entityplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9997 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the Entityenoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Entityplatelet activation with the patient's serum.
0.9993 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( EntitySanofi Labaz , Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Entityplatelet activation with the patient's serum.
0.9863 Adverse-Effect By means of the in vitro heparin - induced Entityplatelet activation ( HIPA ) assay it was shown that standard Entityheparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9862 Adverse-Effect By means of the in vitro Entityheparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Entityplatelet activation with the patient's serum.
0.9856 Adverse-Effect By means of the in vitro heparin - induced Entityplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and EntityFraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9828 Adverse-Effect By means of the in vitro heparin - induced Entityplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins EntityFragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9641 Adverse-Effect By means of the in vitro heparin - induced Entityplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the Entityenoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9625 Adverse-Effect By means of the in vitro heparin - induced Entityplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( EntitySanofi Labaz , Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine EntityClexane ( Nattermann, Cologne, FRG ), all induced Entityplatelet activation with the patient's serum.
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral Entityleishmaniasis associated with Entitycutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9858 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( EntityCS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Entitycutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9784 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with EntityCS for asthma, a severe visceral leishmaniasis associated with Entitycutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9762 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Entityvisceral involvement after cutaneous leishmaniasis in a man receiving EntityCS .
0.9724 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in Entitycorticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Entitycutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9530 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Entityvisceral involvement after cutaneous Entityleishmaniasis in a man receiving CS.
0.9413 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual Entityleishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Entitycutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9276 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( EntityCS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Entityvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8765 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in Entitycorticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Entityvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8750 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with EntityCS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Entityvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8479 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Entitycutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving EntityCS .
0.7184 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual Entityleishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Entityvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.7129 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral Entityleishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Entityvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.6962 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Entitycutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous Entityleishmaniasis in a man receiving CS.
Adverse-Effect CASE PRESENTATION : Three cases of EntityLeishmania infantum leishmaniasis in Entitycorticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in Entitycorticosteroid ( CS ) - treated patients are reported : an isolated Entitylingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after Entitycutaneous leishmaniasis in a man receiving EntityCS .
Adverse-Effect CASE PRESENTATION : Three cases of EntityLeishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with EntityCS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated Entitylingual leishmaniasis in a farmer treated with EntityCS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an acute ischemic event, possibly related to a Entitytransient coronary vasoconstriction induced by the Entitydopamine infusion.
0.9998 Adverse-Effect Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an Entityacute ischemic event , possibly related to a transient coronary vasoconstriction induced by the Entitydopamine infusion.
Adverse-Effect Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an acute ischemic event, possibly related to a transient Entitycoronary vasoconstriction induced by the Entitydopamine infusion.
Score Relation Text (Head - Tail)
0.9861 Adverse-Effect Its overall Entitytoxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially fatal symptom complex referred to as " Entityretinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.9840 Adverse-Effect Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially fatal symptom complex referred to as " Entityretinoic acid Entityretinoic acid syndrome . " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.9809 Adverse-Effect Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a Entitypotentially fatal symptom complex referred to as " Entityretinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.9776 Adverse-Effect Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially Entityfatal symptom complex referred to as " Entityretinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We further used immunohistochemistry ( IHC ) to examine the relative role of platelet - derived growth factor - B ( PDGF - B ), insulin - like growth factor I ( IGF - I ), transforming growth factor - beta1 ( TGF - beta1 ) and cyclooxygenase - 2 ( COX - 2 ) in the pathogenesis of EntityBCNU - related Entitypulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The present findings suggest that : ( i ) amantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in EntityL - dopa induced Entitydyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.9310 Adverse-Effect CONCLUSION : The present findings suggest that : ( i ) amantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced Entitydyskinesias may differ from those involved in EntityL - dopa induced dyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.6383 Adverse-Effect CONCLUSION : The present findings suggest that : ( i ) Entityamantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced Entitydyskinesias may differ from those involved in L - dopa induced dyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.6129 Adverse-Effect CONCLUSION : The present findings suggest that : ( i ) Entityamantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in L - dopa induced Entitydyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( EntityMTX ) ( 12 g / m2 ), and went on to develop Entityacute renal failure with life - threatening hyperkalemia 29 hours later.
0.9999 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme Entityelevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Entitymethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9998 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending Entityrenal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Entitymethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9998 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Entitymethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop Entityacute renal failure with life - threatening hyperkalemia 29 hours later.
0.9997 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme Entityelevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( EntityMTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9995 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending Entityrenal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( EntityMTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9999 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of Entityimpending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Entitymethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9998 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of Entityimpending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( EntityMTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although risk factors for EntityMTX - induced Entitypulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.7323 Adverse-Effect Although risk factors for EntityMTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and Entitymild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.5160 Adverse-Effect Although risk factors for EntityMTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by Entitypulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.4001 Adverse-Effect Although risk factors for EntityMTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX Entitypneumonitis .
Adverse-Effect Although risk factors for MTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of EntityMTX Entitypneumonitis .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A retrospective epidemiological study of deaths from Entityhepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( Entityvinyl chloride ,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9998 Adverse-Effect A retrospective epidemiological study of deaths from Entityhepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride, ' EntityThorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9997 Adverse-Effect A retrospective epidemiological study of deaths from Entityhepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and Entityinorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9999 Adverse-Effect A retrospective epidemiological study of Entitydeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( Entityvinyl chloride ,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9999 Adverse-Effect A retrospective epidemiological study of Entitydeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride, ' EntityThorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9998 Adverse-Effect A retrospective epidemiological study of Entitydeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and Entityinorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9993 Adverse-Effect A retrospective epidemiological study of Entitydeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of Entityandrogenic - anabolic steroids .
0.9988 Adverse-Effect A retrospective epidemiological study of deaths from Entityhepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of Entityandrogenic - anabolic steroids .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of Entityrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour EntityMTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
0.9954 Adverse-Effect Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of Entityrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for EntityMTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
0.9935 Adverse-Effect Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of Entityrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour EntityMTX infusion.
0.9376 Adverse-Effect Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and Entitycarboxypeptidase G2 , we present this case to emphasize that signs of Entityrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We suggest that Entitynicotinic acid was the cause of his Entityliver disease , that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9946 Adverse-Effect We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of Entitynicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of Entityhepatotoxicity .
0.9397 Adverse-Effect We suggest that nicotinic acid was the cause of his Entityliver disease , that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of Entitynicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9879 Adverse-Effect We suggest that Entitynicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of Entityliver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9872 Adverse-Effect We suggest that Entitynicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the Entityhepatic failure , and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9720 Adverse-Effect We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the Entityhepatic failure , and that the probable increased use of Entitynicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.8768 Adverse-Effect We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of Entityliver injury and the severity of the hepatic failure, and that the probable increased use of Entitynicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.4252 Adverse-Effect We suggest that Entitynicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of Entityhepatotoxicity .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and Entitypersistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Entitymequitazine .
0.9994 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Entitymequitazine for 6 months, and there were strong positive photopatch test results with immediate Entityerythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9989 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Entityerythema reaction, cross - reaction to Entitypromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9985 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Entitydecreased MED to both UVA and UVB , and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Entitymequitazine .
0.9985 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Entitypromethazine , decreased MED to both UVA and UVB, and Entitypersistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9972 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Entitymequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and Entitypersistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9970 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Entitymequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Entitydecreased MED to both UVA and UVB , and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9969 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Entityerythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Entitymequitazine .
0.9962 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Entitypromethazine , Entitydecreased MED to both UVA and UVB , and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9998 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Entitycross - reaction to Entitypromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9997 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Entitymequitazine for 6 months, and there were strong positive photopatch test results with immediate Entityerythema reaction , cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9995 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Entityerythema reaction , cross - reaction to Entitypromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9986 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Entitymequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Entitycross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9986 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Entityerythema reaction , cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Entitymequitazine .
0.9965 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Entitycross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Entitymequitazine .
0.9963 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Entitydecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Entitymequitazine .
0.9957 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Entitydecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Entitymequitazine .
0.9930 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Entitymequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Entitydecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9923 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Entitymequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Entitydecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9911 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Entitypromethazine , Entitydecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9902 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Entitypromethazine , Entitydecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Entitycross - reaction to promethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Entitymequitazine .
Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Entitycross - reaction to promethazine Entitypromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Entitymequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Entitycross - reaction to promethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Major points illustrated are, ( 1 ) occurrence of EntityHIT with any dose or form of Entityheparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and warfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to heparin and disappearance of HIT antibodies over time.
0.9655 Adverse-Effect Major points illustrated are, ( 1 ) occurrence of EntityHIT with any dose or form of heparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and warfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to Entityheparin and disappearance of HIT antibodies over time.
0.9587 Adverse-Effect Major points illustrated are, ( 1 ) occurrence of EntityHIT with any dose or form of heparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and Entitywarfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to heparin and disappearance of HIT antibodies over time.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the EntityMP - induced Entitytransient renal failure .
0.9934 Adverse-Effect These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an EntityMP therapy and the associated Entityrenal interstitial edema , proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced transient renal failure.
0.9868 Adverse-Effect These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated Entityrenal interstitial edema , proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the EntityMP - induced transient renal failure.
0.9720 Adverse-Effect These findings mean that the effect of the EntityMP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced Entitytransient renal failure .
0.9662 Adverse-Effect These findings mean that the effect of the EntityMP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated Entityrenal interstitial edema , proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced transient renal failure.
0.9527 Adverse-Effect These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an EntityMP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced Entitytransient renal failure .